PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lallement, R; Quemerais, E; Bertaux, JL; Sandel, BR; Izmodenov, V				Lallement, Rosine; Quemerais, Eric; Bertaux, Jean-Loup; Sandel, Bill R.; Izmodenov, Vlad			Voyager Measurements of Hydrogen Lyman-alpha Diffuse Emission from the Milky Way	SCIENCE			English	Article							OUTER HELIOSPHERE; INTERSTELLAR HYDROGEN; LINE-PROFILE; GALAXIES; RADIATION; MODEL; WIND; GLOW; TEMPERATURE; POPULATIONS	Doppler-shifted hydrogen Lyman-alpha (Ly alpha) emission from galaxies is currently measured and used in cosmology as an indicator of star formation. Until now, the Milky Way emission has not been detected, owing to far brighter local sources, including the H (hydrogen) glow, i.e., solar Ly alpha radiation backscattered by interstellar atoms that flow within the solar system. Because observations from the Voyager spacecraft, now leaving the heliosphere, are decreasingly affected by the H glow, the ultraviolet spectrographs are detecting Ly alpha diffuse emission from our Galaxy. The surface brightness toward nearby star-forming regions is about 3 to 4 rayleighs. The escape fraction of the radiation from the brightest H II regions is on the order of 3% and is highly spatially variable. These results will help in constraining models of Ly alpha radiation transfer in distant galaxies.	[Lallement, Rosine] Univ Paris Diderot, CNRS, Observ Paris, F-92190 Meudon, France; [Lallement, Rosine; Quemerais, Eric; Bertaux, Jean-Loup] Univ Versailles St Quentin, Inst Pierre Simon Laplace LATMOS IPSL, Guyancourt, France; [Sandel, Bill R.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85719 USA; [Izmodenov, Vlad] Moscow MV Lomonosov State Univ, Moscow, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; Lomonosov Moscow State University	Lallement, R (corresponding author), Univ Paris Diderot, CNRS, Observ Paris, Pl Jules Janssen, F-92190 Meudon, France.	rosine.lallement@obspm.fr	Izmodenov, Vladislav V/K-6073-2012	Izmodenov, Vladislav V/0000-0002-1748-0982				Baek S, 2009, ASTRON ASTROPHYS, V495, P389, DOI 10.1051/0004-6361:200810757; BARANOV VB, 1993, J GEOPHYS RES-SPACE, V98, P15157, DOI 10.1029/93JA01171; BERTAUX JL, 1971, ASTRON ASTROPHYS, V11, P200; BERTAUX JL, 1976, ASTRON ASTROPHYS, V46, P19; BROADFOOT AL, 1977, SPACE SCI REV, V21, P183, DOI 10.1007/BF00200850; BROCKLEHURST M, 1971, MON NOT R ASTRON SOC, V153, P471, DOI 10.1093/mnras/153.4.471; BUSS RH, 1995, ASTROPHYS J, V454, pL55, DOI 10.1086/187743; CHARLOT S, 1993, ASTROPHYS J, V415, P580, DOI 10.1086/173187; Clarke JT, 1998, ASTROPHYS J, V499, P482, DOI 10.1086/305628; Deharveng JM, 2008, ASTROPHYS J, V680, P1072, DOI 10.1086/587953; DRAINE BT, 1978, NATURE, V271, P730, DOI 10.1038/271730a0; FIELD GB, 1959, ASTROPHYS J, V129, P551, DOI 10.1086/146654; Finkbeiner DP, 2003, ASTROPHYS J SUPPL S, V146, P407, DOI 10.1086/374411; Gronwall C, 2007, ASTROPHYS J, V667, P79, DOI 10.1086/520324; Hansen M, 2006, MON NOT R ASTRON SOC, V367, P979, DOI 10.1111/j.1365-2966.2005.09870.x; Hayes M, 2010, NATURE, V464, P562, DOI 10.1038/nature08881; Izmodenov VV, 1999, J GEOPHYS RES-SPACE, V104, P4731, DOI 10.1029/1998JA900122; Kornei KA, 2010, ASTROPHYS J, V711, P693, DOI 10.1088/0004-637X/711/2/693; LALLEMENT R, 1984, ASTRON ASTROPHYS, V140, P243; LEQUEUX J, 1995, ASTRON ASTROPHYS, V301, P18; Linsky JL, 1996, ASTROPHYS J, V463, P254, DOI 10.1086/177238; Liszt H, 2001, ASTRON ASTROPHYS, V371, P698, DOI 10.1051/0004-6361:20010395; NEUFELD DA, 1990, ASTROPHYS J, V350, P216, DOI 10.1086/168375; Ostlin G, 2009, ASTRON J, V138, P923, DOI 10.1088/0004-6256/138/3/923; Pogorelov NV, 2009, ASTROPHYS J, V696, P1478, DOI 10.1088/0004-637X/696/2/1478; Quemerais E, 2008, ASTRON ASTROPHYS, V488, P351, DOI 10.1051/0004-6361:20078204; Quemerais E, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009871; Quemerais E, 1996, ASTRON ASTROPHYS, V308, P279; Quemerais E, 2010, ASTROPHYS J, V711, P1257, DOI 10.1088/0004-637X/711/2/1257; QUEMERAIS E, 1995, ASTRON ASTROPHYS, V299, P249; Richling S, 2003, ASTROPHYS SPACE SCI, V284, P361, DOI 10.1023/A:1024090313388; SAVAGE BD, 1974, ASTROPHYS J, V191, P659, DOI 10.1086/153007; Steidel C. C., 2011, ARXIV11012204; THOMAS GE, 1971, ASTRON ASTROPHYS, V11, P218; THOMAS GE, 1976, ASTRON ASTROPHYS, V51, P283; Vacca WD, 1996, ASTROPHYS J, V460, P914, DOI 10.1086/177020; Verhamme A, 2006, ASTRON ASTROPHYS, V460, P397, DOI 10.1051/0004-6361:20065554; WOUTHUYSEN SA, 1952, ASTRON J, V57, P31, DOI 10.1086/106661	38	21	21	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1665	1669		10.1126/science.1197340	http://dx.doi.org/10.1126/science.1197340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144462				2022-12-28	WOS:000298344000057
J	Fong, TC; Hoffmann, B				Fong, Tiffany C.; Hoffmann, Beatrice			Disappearance of a Breast Prosthesis during Pilates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fong, Tiffany C.; Hoffmann, Beatrice] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Fong, TC (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.		Fong, Tiffany/AFP-3869-2022	Hoffmann, Beatrice/0000-0002-1820-9430					0	9	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2305	2305		10.1056/NEJMicm1102594	http://dx.doi.org/10.1056/NEJMicm1102594			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168645				2022-12-28	WOS:000298031800011
J	Hughes, V				Hughes, Virginia			MICROENVIRONMENT Neighbourhood watch	NATURE			English	Editorial Material							CELL-LINES; MYELOMA; ADHESION											Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; UCHIYAMA H, 1993, BLOOD, V82, P3712; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	3	12	12	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S48	S49		10.1038/480S48a	http://dx.doi.org/10.1038/480S48a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169803				2022-12-28	WOS:000298033000008
J	Hawkes, N				Hawkes, Nigel			HEALTHCARE REGULATION The Care Quality Commission: unfit for purpose?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d8034	10.1136/bmj.d8034	http://dx.doi.org/10.1136/bmj.d8034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171349				2022-12-28	WOS:000298317800001
J	Kumar, S; Duester, G				Kumar, Sandeep; Duester, Gregg			SnapShot: Retinoic Acid Signaling	CELL			English	Editorial Material									[Kumar, Sandeep; Duester, Gregg] Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Kumar, S (corresponding author), Sanford Burnham Med Res Inst, Dev & Aging Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Duester, Gregg/0000-0003-4335-3650	NCRR NIH HHS [R21 RR032045-01, R21 RR032045] Funding Source: Medline; NIGMS NIH HHS [R01 GM062848-08, R01 GM062848] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR032045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Diez del Corral R, 2003, NEURON, V40, P65; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	12	26	28	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1422	U233		10.1016/j.cell.2011.11.034	http://dx.doi.org/10.1016/j.cell.2011.11.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153083	Green Accepted, Bronze			2022-12-28	WOS:000298148100029
J	Parak, WJ				Parak, Wolfgang J.			Complex Colloidal Assembly	SCIENCE			English	Editorial Material							SUPERLATTICES; NANOPARTICLES; NANOCRYSTALS; CLUSTERS; SHAPE		[Parak, Wolfgang J.] Univ Marburg, Fachbereich Phys, D-35037 Marburg, Germany; [Parak, Wolfgang J.] Univ Marburg, Wissensch Zentrum Mat Wissensch, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Parak, WJ (corresponding author), Univ Marburg, Fachbereich Phys, Renthof 7, D-35037 Marburg, Germany.	wolfgang.parak@physik.uni-marburg.de	Parak, Wolfgang/M-3998-2014	Parak, Wolfgang/0000-0003-1672-6650				EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Smalley RE, 2001, SCI AM, V285, P76, DOI 10.1038/scientificamerican0901-76; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; VOSSMEYER T, 1995, SCIENCE, V267, P1476, DOI 10.1126/science.267.5203.1476; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	14	53	54	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1359	1360		10.1126/science.1215080	http://dx.doi.org/10.1126/science.1215080			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158812				2022-12-28	WOS:000297787700040
J	Rechavi, O; Minevich, G; Hobert, O				Rechavi, Oded; Minevich, Gregory; Hobert, Oliver			Transgenerational Inheritance of an Acquired Small RNA-Based Antiviral Response in C. elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; ANIMAL VIRUS; INTERFERENCE; REQUIREMENTS; REPLICATION; MECHANISM; CLEAVAGE; PATHWAY; RDE-1	Induced expression of the Flock House virus in the soma of C. elegans results in the RNAi-dependent production of virus-derived, small-interfering RNAs (viRNAs), which in turn silence the viral genome. We show here that the viRNA-mediated viral silencing effect is transmitted in a non-Mendelian manner to many ensuing generations. We show that the viral silencing agents, viRNAs, are transgenerationally transmitted in a template-independent manner and work in trans to silence viral genomes present in animals that are deficient in producing their own viRNAs. These results provide evidence for the transgenerational inheritance of an acquired trait, induced by the exposure of animals to a specific, biologically relevant physiological challenge. The ability to inherit such extragenic information may provide adaptive benefits to an animal.	[Rechavi, Oded; Minevich, Gregory; Hobert, Oliver] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Rechavi, O (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.	odedrechavi@gmail.com; or38@columbia.edu		Minevich, Gregory/0000-0002-7115-4416; Hobert, Oliver/0000-0002-7634-2854	Bikura postdoc fellowship; Gruss Lipper postdoc fellowship; T32 predoctoral training grant [T32HD055165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER	Bikura postdoc fellowship; Gruss Lipper postdoc fellowship; T32 predoctoral training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Boyanov for small RNA preparation and deep sequencing; C. Mello for providing unc-linked rde strains; S.W. Ding for the FR1gfp transgene; Richard Friedman for advice on statistical methods; and Piali Sengupta, Sarah Hall, Iva Greenwald, and members of the Hobert lab for comments on the manuscript. O.R. is funded by a Bikura postdoc fellowship and a Gruss Lipper postdoc fellowship, and G.M. by a T32 predoctoral training grant (T32HD055165). O.H. is an investigator of the HHMI.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BALL LA, 1994, ARCH VIROL, P407; Blanchard D, 2011, RNA BIOL, V8, P458, DOI 10.4161/rna.8.3.14657; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Drummond AJ, 2011, GENEIOUS V5 5; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Groenenboom MAC, 2005, PLOS COMPUT BIOL, V1, P155, DOI 10.1371/journal.pcbi.0010021; Johnson KL, 1997, J VIROL, V71, P3323, DOI 10.1128/JVI.71.4.3323-3327.1997; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Parrish S, 2001, RNA, V7, P1397; Poole RJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002109; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Weismann A., 1889, ESSAYS HEREDITY; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	39	228	230	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1248	1256		10.1016/j.cell.2011.10.042	http://dx.doi.org/10.1016/j.cell.2011.10.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22119442	Bronze, Green Accepted			2022-12-28	WOS:000298148100015
J	Binns, WR				Binns, W. Robert			Cosmic-Ray Origins	SCIENCE			English	Editorial Material							SUPERBUBBLE ORIGIN; STARS; REGION		[Binns, W. Robert] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Binns, W. Robert] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Binns, WR (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	wrb@wustl.edu						Ackermann M, 2011, SCIENCE, V334, P1103, DOI 10.1126/science.1210311; Aharonian F, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/9/096901; ALIU E, 2011, 32 INT COSM RAY C BE; Binns WR, 2005, ASTROPHYS J, V634, P351, DOI 10.1086/496959; Compton AH, 1933, PHYS REV, V43, P387, DOI 10.1103/PhysRev.43.387; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Hess VF, 1912, PHYS Z, V13, P1084; Higdon JC, 2003, ASTROPHYS J, V590, P822, DOI 10.1086/375192; Kolaczkowski Z, 2004, ACTA ASTRONOM, V54, P33; Meynet G, 2003, ASTRON ASTROPHYS, V404, P975, DOI 10.1051/0004-6361:20030512; Rauch BF, 2009, ASTROPHYS J, V697, P2083, DOI 10.1088/0004-637X/697/2/2083; Uchiyama Y, 2002, ASTROPHYS J, V571, P866, DOI 10.1086/340121; Wright NJ, 2010, ASTROPHYS J, V713, P871, DOI 10.1088/0004-637X/713/2/871	14	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1071	1072		10.1126/science.1213490	http://dx.doi.org/10.1126/science.1213490			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116872				2022-12-28	WOS:000297313900033
J	Erwin, DH; Laflamme, M; Tweedt, SM; Sperling, EA; Pisani, D; Peterson, KJ				Erwin, Douglas H.; Laflamme, Marc; Tweedt, Sarah M.; Sperling, Erik A.; Pisani, Davide; Peterson, Kevin J.			The Cambrian Conundrum: Early Divergence and Later Ecological Success in the Early History of Animals	SCIENCE			English	Article							EVOLUTION; ORIGIN; CONSTRUCTION; MICRORNAS; RADIATION; FOSSILS; RECORD; MACROEVOLUTION; PHYLOGENOMICS; PRESERVATION	Diverse bilaterian clades emerged apparently within a few million years during the early Cambrian, and various environmental, developmental, and ecological causes have been proposed to explain this abrupt appearance. A compilation of the patterns of fossil and molecular diversification, comparative developmental data, and information on ecological feeding strategies indicate that the major animal clades diverged many tens of millions of years before their first appearance in the fossil record, demonstrating a macroevolutionary lag between the establishment of their developmental toolkits during the Cryogenian [(850 to 635 million years ago Ma)] and the later ecological success of metazoans during the Ediacaran (635 to 541 Ma) and Cambrian (541 to 488 Ma) periods. We argue that this diversification involved new forms of developmental regulation, as well as innovations in networks of ecological interaction within the context of permissive environmental circumstances.	[Erwin, Douglas H.; Laflamme, Marc; Tweedt, Sarah M.] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Tweedt, Sarah M.] Univ Maryland, College Pk, MD 20742 USA; [Sperling, Erik A.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Pisani, Davide] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute; University System of Maryland; University of Maryland College Park; Harvard University; Maynooth University; Dartmouth College	Erwin, DH (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, MRC-121,POB 37012, Washington, DC 20013 USA.	erwind@si.edu; kevin.j.peterson@dartmouth.edu	Peterson, Kevin J/A-2188-2009; Pisani, Davide/ABD-5225-2021	Pisani, Davide/0000-0003-0949-6682; Erwin, Douglas/0000-0003-2518-5614	NASA National Astrobiology Institute; Smithsonian Institution Fellowship; Agouron Geobiology Fellowship; NSF; Science Foundation Ireland [08/RFP/EOB1595]	NASA National Astrobiology Institute; Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History); Agouron Geobiology Fellowship; NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a NASA National Astrobiology Institute grant (D. H. E and K.J.P) supporting M. L., S. M. T., and E. A. S., and a Smithsonian Institution Fellowship (M. L). E. A. S is also supported by an Agouron Geobiology Fellowship. K.J.P. is also supported by the NSF. D. P. is supported by a Science Foundation Ireland Research Frontier Programme grant (08/RFP/EOB1595). All molecular analyses were performed with the computing infrastructures provided by the Irish Center for High End Computing and the National University of Ireland Maynooth High Performance Computing facility. All data used in the paper are included as files in the SOM. We appreciate technical assistance from L. Campbell and comments from P. Donoghue, G. Edgecombe, G. Narbonne, B. Runnegar, two anonymous reviewers, and the Bio 28 Class of Dartmouth College (2011).	Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bowring SA, 2007, AM J SCI, V307, P1097, DOI 10.2475/10.2007.01; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Bush AM, 2011, TOP GEOBIOL, V36, P111, DOI 10.1007/978-94-007-0680-4_5; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Darwin, 1859, ORIGINS SPECIES MEAN; Davidson EH, 2009, COLD SH Q B, V74, P65, DOI 10.1101/sqb.2009.74.042; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2010, J EXP ZOOL PART B, V314B, P182, DOI 10.1002/jez.b.21329; ERWIN DH, 1987, EVOLUTION, V41, P1177, DOI 10.1111/j.1558-5646.1987.tb02459.x; Erwin DH, 2012, CAMBRIAN EXPLOSION C; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Erwin DH, 2009, PHILOS T R SOC B, V364, P2253, DOI 10.1098/rstb.2009.0038; Fedonkin MA, 2007, GEOL SOC SPEC PUBL, V286, P157, DOI 10.1144/SP286.12; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Ivantsov AY, 2009, PALEONTOL J+, V43, P601, DOI 10.1134/S003103010906001X; Jensen S, 2005, PALAEOGEOGR PALAEOCL, V220, P19, DOI 10.1016/j.palaeo.2003.09.035; Jensen Soren, 2006, V27, P115; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kouchinsky A., 2011, GEOL MAG, P1; LANDING E, 1994, GEOLOGY, V22, P179, DOI 10.1130/0091-7613(1994)022<0179:PCBGSR>2.3.CO;2; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Marshall CR, 2010, EVOLUTION, V64, P1189, DOI 10.1111/j.1558-5646.2009.00908.x; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2004, SCIENCE, V305, P1141, DOI 10.1126/science.1099727; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Porter SM, 2004, PALAIOS, V19, P178, DOI 10.1669/0883-1351(2004)019<0178:CTPWTF>2.0.CO;2; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; RUNNEGAR B, 1982, LETHAIA, V15, P199, DOI 10.1111/j.1502-3931.1982.tb00645.x; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; SEILACHER A, 1989, LETHAIA, V22, P229, DOI 10.1111/j.1502-3931.1989.tb01332.x; Shields-Zhou G., 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/GSATG102A.1; Sperling EA, 2011, GEOBIOLOGY, V9, P24, DOI 10.1111/j.1472-4669.2010.00259.x; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Szaniawski H, 2002, ACTA PALAEONTOL POL, V47, P405; Valentine J. W., 1987, DEV EVOLUTIONARY PRO; Valentine JW, 1999, DEVELOPMENT, V126, P851; Waggoner B, 2003, INTEGR COMP BIOL, V43, P104, DOI 10.1093/icb/43.1.104; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2009, TRENDS ECOL EVOL, V24, P31, DOI 10.1016/j.tree.2008.07.015	73	826	867	9	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1091	1097		10.1126/science.1206375	http://dx.doi.org/10.1126/science.1206375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116879				2022-12-28	WOS:000297313900040
J	Ferreira, IRD; Magalhaes, SP				da Silva Ferreira, Ivo Ricardo; Magalhaes, Sara Pinto			Cysticercosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[da Silva Ferreira, Ivo Ricardo; Magalhaes, Sara Pinto] Ctr Hosp Porto, Oporto, Portugal		Ferreira, IRD (corresponding author), Ctr Hosp Porto, Oporto, Portugal.	ivoferreira@ecsaude.uminho.pt							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					E41	E41						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851PF	22111738				2022-12-28	WOS:000297282600001
J	Gardner, MK; Zanic, M; Gell, C; Bormuth, V; Howard, J				Gardner, Melissa K.; Zanic, Marija; Gell, Christopher; Bormuth, Volker; Howard, Jonathon			Depolymerizing Kinesins Kip3 and MCAK Shape Cellular Microtubule Architecture by Differential Control of Catastrophe	CELL			English	Article							DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; MITOTIC-SPINDLE; IN-VITRO; GTP CAP; CHROMOSOME CONGRESSION; STABILIZE MICROTUBULES; DEPENDENT MANNER; YEAST KINESIN-8; FISSION YEAST	Microtubules are dynamic filaments whose ends alternate between periods of slow growth and rapid shortening as they explore intracellular space and move organelles. A key question is how regulatory proteins modulate catastrophe, the conversion from growth to shortening. To study this process, we reconstituted microtubule dynamics in the absence and presence of the kinesin-8 Kip3 and the kinesin-13 MCAK. Surprisingly, we found that, even in the absence of the kinesins, the microtubule catastrophe frequency depends on the age of the microtubule, indicating that catastrophe is a multi-step process. Kip3 slowed microtubule growth in a length-dependent manner and increased the rate of aging. In contrast, MCAK eliminated the aging process. Thus, both kinesins are catastrophe factors; Kip3 mediates fine control of microtubule length by narrowing the distribution of maximum lengths prior to catastrophe, whereas MCAK promotes rapid restructuring of the microtubule cytoskeleton by making catastrophe a first-order random process.	[Gardner, Melissa K.; Zanic, Marija; Gell, Christopher; Bormuth, Volker; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Gardner, Melissa K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Zanic, Marija/0000-0002-5127-5819; Gell, Christopher/0000-0002-6628-8292	Whitaker International Scholar Fellowship; International Human Frontier Science Program Organization; Boehringer Ingelheim Fonds	Whitaker International Scholar Fellowship; International Human Frontier Science Program Organization(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	The authors thank members of the Howard Laboratory, in particular the Muffins Group, for advice and assistance. We thank Dr. V. Varga and Dr. C. Friel for protein and advice. M. K. G. was supported by a Whitaker International Scholar Fellowship, M. Z. by a Cross-Disciplinary Fellowship from the International Human Frontier Science Program Organization, and V. B. by a fellowship from the Boehringer Ingelheim Fonds.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CASSIMERIS LU, 1986, J CELL BIOL, V102, P2023, DOI 10.1083/jcb.102.6.2023; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Newton CN, 2004, FEBS LETT, V572, P80, DOI 10.1016/j.febslet.2004.06.093; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Odde DJ, 1996, AICHE J, V42, P1434, DOI 10.1002/aic.690420524; ODDE DJ, 1995, BIOPHYS J, V69, P796, DOI 10.1016/S0006-3495(95)79953-2; Phillips R., 2008, PHYS BIOL CELL; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Rice J., 1995, MATH STAT DATA ANAL; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Stepanova T, 2010, CURR BIOL, V20, P1023, DOI 10.1016/j.cub.2010.04.024; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VOTER WA, 1991, CELL MOTIL CYTOSKEL, V18, P55, DOI 10.1002/cm.970180106; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; Wargacki MM, 2010, CELL CYCLE, V9, P2581, DOI 10.4161/cc.9.13.12076; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585	59	148	150	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1092	1103		10.1016/j.cell.2011.10.037	http://dx.doi.org/10.1016/j.cell.2011.10.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118464	Bronze			2022-12-28	WOS:000297376600020
J	Kasper, R; Huang, B				Kasper, Robert; Huang, Bo			SnapShot: Light Microscopy	CELL			English	Editorial Material							FLUORESCENCE MICROSCOPY		[Kasper, Robert; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kasper, R (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.				OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008479] Funding Source: NIH RePORTER; NIH HHS [DP2 OD008479, 1DP2OD008479-01] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Wang LV, 2009, OPT SCI ENG-CRC, V144, P1, DOI 10.1201/9781420059922; Zysk AM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793736	10	3	3	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1198	U266		10.1016/j.cell.2011.11.015	http://dx.doi.org/10.1016/j.cell.2011.11.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118471	Bronze			2022-12-28	WOS:000297376600031
J	Katan, AJ; Dekker, C				Katan, Allard J.; Dekker, Cees			High-Speed AFM Reveals the Dynamics of Single Biomolecules at the Nanometer Scale	CELL			English	Review							ATOMIC-FORCE MICROSCOPY; CANTILEVERS; MEMBRANE	Atomic force microscopy allows visualization of biomolecules with nanometer resolution under physiological conditions. Recent advances have improved the time resolution of the technique from minutes to tens of milliseconds, meaning that it is now possible to watch single biomolecules in action in real time. Here, we review this development.	[Katan, Allard J.; Dekker, Cees] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.dekker@tudelft.nl	Katan, Allard J/B-9670-2008	Katan, Allard J/0000-0002-7185-6274; Dekker, Cees/0000-0001-6273-071X				Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Casuso I, 2010, BIOPHYS J, V99, pL47, DOI 10.1016/j.bpj.2010.07.028; Disseldorp ECM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3361215; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Fukuma T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2405361; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Miyagi A, 2011, BIOCHEMISTRY-US, V50, P7901, DOI 10.1021/bi200946z; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030; Sanchez H, 2011, INTEGR BIOL-UK, V3, P1127, DOI 10.1039/c1ib00039j; Schitter G, 2007, IEEE T CONTR SYST T, V15, P906, DOI 10.1109/TCST.2007.902953; Shibata M, 2011, ANGEW CHEM INT EDIT, V50, P4410, DOI 10.1002/anie.201007544; Stroh CM, 2004, BIOPHYS J, V87, P1981, DOI 10.1529/biophysj.104.043331; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177	20	63	66	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					979	982		10.1016/j.cell.2011.11.017	http://dx.doi.org/10.1016/j.cell.2011.11.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118456	Bronze			2022-12-28	WOS:000297376600011
J	Tyrer, P				Tyrer, Peter			Has the closure of psychiatric beds gone too far? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CASE-MANAGEMENT; COMMUNITY; SERVICE; ENGLAND; CARE		Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W8 8RP, England	Imperial College London	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W8 8RP, England.	p.tyrer@imperial.ac.uk						[Anonymous], 2011, LANCET, V378, P1, DOI 10.1016/S0140-6736(11)60999-9; Appleby L, 2011, NATL CONFIDENTIAL IN; Burns T, 1999, LANCET, V353, P2185, DOI 10.1016/S0140-6736(98)12191-8; Fazel S, 2009, BRIT J PSYCHIAT, V194, P183, DOI 10.1192/bjp.bp.107.046490; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; Jacobs R, 2011, BRIT J PSYCHIAT, V199, P71, DOI 10.1192/bjp.bp.110.079830; Niehaus DJH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-44; Osborn DPJ, 2010, BRIT J PSYCHIAT, V197, pS41, DOI 10.1192/bjp.bp.110.081109; Rosen A, 2001, AUST NZ J PSYCHIAT, V35, P731, DOI 10.1046/j.1440-1614.2001.00956.x; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Thornicroft G, 2004, BRIT J PSYCHIAT, V185, P283, DOI 10.1192/bjp.185.4.283; TYRER P, 1989, BRIT MED J, V299, P298, DOI 10.1136/bmj.299.6694.298	12	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2011	343								d7457	10.1136/bmj.d7457	http://dx.doi.org/10.1136/bmj.d7457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857ND	22110255				2022-12-28	WOS:000297724300005
J	Fletcher, J; Wilcken, B				Fletcher, Janice; Wilcken, Bridget			Neonatal screening for lysosomal storage disorders	LANCET			English	Editorial Material							NEWBORN; DISEASE		[Fletcher, Janice] Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia; [Fletcher, Janice] Univ Adelaide, Adelaide, SA, Australia; [Wilcken, Bridget] Sydney Childrens Hosp Network, Sydney, NSW, Australia; [Wilcken, Bridget] Univ Sydney, Sydney, NSW 2006, Australia	SA Pathology; Womens & Childrens Hospital Australia; University of Adelaide; University of Sydney	Fletcher, J (corresponding author), Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia.	janice.fletcher@adelaide.edu.au						Calonge N, 2010, GENET MED, V12, P153, DOI 10.1097/GIM.0b013e3181d2af04; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; Connock M, 2006, HEALTH TECHNOL ASSES, V10, P1; Farrell PM, 2005, J PEDIATR-US, V147, pS30, DOI 10.1016/j.jpeds.2005.08.012; Hayes IM, 2007, CLIN GENET, V71, P446, DOI 10.1111/j.1399-0004.2007.00783.x; Hwu WL, 2009, HUM MUTAT, V30, P1397, DOI 10.1002/humu.21074; Mechtler TP, 2012, LANCET, V379, P335, DOI 10.1016/S0140-6736(11)61266-X; Nakamura K, 2011, AM J MED GENET C, V157C, P63, DOI 10.1002/ajmg.c.30291; Pollitt RJ, 2007, J INHERIT METAB DIS, V30, P423, DOI 10.1007/s10545-007-0647-2; Prosser LA, 2008, ARCH PEDIAT ADOL MED, V162, P870, DOI 10.1001/archpediatrics.2008.1; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; UK National Screening Committee, PROGR APPR CRIT; Wilcken B, 2009, PEDIATRICS, V124, pE241, DOI 10.1542/peds.2008-0586	13	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					294	295		10.1016/S0140-6736(11)61744-3	http://dx.doi.org/10.1016/S0140-6736(11)61744-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	889BA	22133538				2022-12-28	WOS:000300047300013
J	Sanjeevi, CB				Sanjeevi, Carani B.			Autoimmune diseases and risk of pulmonary embolism	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM		[Sanjeevi, Carani B.] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Sanjeevi, Carani B.] Karolinska Univ Hosp Solna, Ctr Mol Med, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sanjeevi, CB (corresponding author), Karolinska Inst, Dept Med Solna, Stockholm, Sweden.	sanjeevi.carani@ki.se						Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Lin HC, 2010, J THROMB HAEMOST, V8, P2176, DOI 10.1111/j.1538-7836.2010.03993.x; Ludvigsson JF, 2007, BRIT J HAEMATOL, V139, P121, DOI 10.1111/j.1365-2141.2007.06766.x; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; Merkel PA, 2005, ANN INTERN MED, V142, P620, DOI 10.7326/0003-4819-142-8-200505030-00011; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Stein PD, 2009, AM J MED SCI, V337, P259, DOI 10.1097/MAJ.0b013e31818bbb8b; Wang JY, 2009, WORLD J GASTROENTERO, V15, P927, DOI 10.3748/wjg.15.927; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	10	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					200	201		10.1016/S0140-6736(11)61510-9	http://dx.doi.org/10.1016/S0140-6736(11)61510-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22119578				2022-12-28	WOS:000299316100014
J	Weiss, RB; Atkins, JF				Weiss, Robert B.; Atkins, John F.			Translation Goes Global	SCIENCE			English	Editorial Material							MESSENGER-RNA; IDENTIFICATION; ACT		[Weiss, Robert B.; Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, John F.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork, Ireland	Utah System of Higher Education; University of Utah; University College Cork	Weiss, RB (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	bob.weiss@genetics.utah.edu; j.atkins@ucc.ie		Atkins, John/0000-0001-7933-0165				CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	14	13	15	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1509	1510		10.1126/science.1216974	http://dx.doi.org/10.1126/science.1216974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174241				2022-12-28	WOS:000298091400040
J	Delude, C				Delude, Cathryn			TUMORIGENESIS Testing ground for cancer stem cells	NATURE			English	Editorial Material																		Brennan SK, 2009, J MOL MED, V87, P1079, DOI 10.1007/s00109-009-0531-7; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430	3	31	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S43	S45		10.1038/480S43a	http://dx.doi.org/10.1038/480S43a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169801	Bronze			2022-12-28	WOS:000298033000006
J	Epstein, AM; Jha, AK; Orav, EJ				Epstein, Arnold M.; Jha, Ashish K.; Orav, E. John			The Relationship between Hospital Admission Rates and Rehospitalizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; DISEASE MANAGEMENT PROGRAMS; MEDICARE BENEFICIARIES; READMISSION RATES; SOCIOECONOMIC-STATUS; ADMINISTRATIVE DATA; 30-DAY READMISSION; RANDOMIZED-TRIALS; TRANSITIONAL CARE; CLINICAL-OUTCOMES	BACKGROUND Efforts to reduce hospital readmissions have focused primarily on improving transitional care. Yet variation in readmission rates may more closely reflect variation in the underlying hospitalization rates than differences in the quality of care during and after discharge. METHODS We used national Medicare data to calculate, for each local hospital referral region (HRR), the 30-day, 60-day, and 90-day readmission rates among patients discharged with congestive heart failure or pneumonia. We also calculated population-based all-cause admission rates among Medicare enrollees in each HRR. We examined the variation in HRR readmission rates that was explained by overall hospitalization rates versus differences in patients' coexisting conditions, quality of discharge planning, physician supply, and bed supply. RESULTS HRR readmission rates ranged from 11 to 32% for congestive heart failure and from 8 to 27% for pneumonia. In univariate analyses, all-cause admission rates accounted for the highest proportion of regional variation in readmission rates for congestive heart failure (28%, 34%, and 37% at 30, 60, and 90 days, respectively); the next highest proportions were explained by case mix (11%, 15%, and 18%) and the number of cardiologists per capita (12%, 14%, and 15%). Results for pneumonia were similar, except that the number of pulmonologists per capita accounted for a lower proportion of the variation (6%, 8%, and 7%, respectively). In multivariate analyses, admission rates accounted for 16 to 24% of the variation for congestive heart failure and 11 to 20% for pneumonia; no other factor accounted for more than 6%. CONCLUSIONS We found a substantial association between regional rates of rehospitalization and overall admission rates. Programs directed at shared savings from lower utilization of hospital services might be more successful in reducing readmissions than programs initiated to date. (Funded by the Commonwealth Fund.)	[Epstein, Arnold M.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Epstein, Arnold M.; Jha, Ashish K.; Orav, E. John] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Epstein, AM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	aepstein@hsph.harvard.edu	Hug, Balthasar L./G-1568-2010		Commonwealth Fund	Commonwealth Fund	Supported by the Commonwealth Fund.	[Anonymous], 2011, SUPPL SENS CAR; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Auerbach AD, 2010, J AM COLL SURGEONS, V211, P601, DOI 10.1016/j.jamcollsurg.2010.07.006; Auerbach AD, 2009, ANN INTERN MED, V150, P696, DOI 10.7326/0003-4819-150-10-200905190-00007; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Dartmouth Medical School Center for the Evaluative Clinical Sciences, 1998, DARTM ATL HLTH CAR; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elliott MN, 2005, HEALTH SERV RES, V40, P2096, DOI 10.1111/j.1475-6773.2005.00476.x; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; HoltzEakin D, 2004, COMMUNICATION   1013; Hummel SL, 2010, CIRC-HEART FAIL, V3, P244, DOI 10.1161/CIRCHEARTFAILURE.109.884098; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2162, DOI 10.1111/j.1475-6773.2005.00470.x; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2078, DOI 10.1111/j.1475-6773.2005.00471.x; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; PHILLIPS CO, 2004, JAMA-J AM MED ASSOC, V292, P1022; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schneider J K, 1993, Clin Nurs Res, V2, P41, DOI 10.1177/105477389300200105; Smith DM, 2000, J CLIN EPIDEMIOL, V53, P1113, DOI 10.1016/S0895-4356(00)00236-5; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Yamokoski LM, 2007, J CARD FAIL, V13, P8, DOI 10.1016/j.cardfail.2006.10.002; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	53	199	203	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2287	2295		10.1056/NEJMsa1101942	http://dx.doi.org/10.1056/NEJMsa1101942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861PN	22168643				2022-12-28	WOS:000298031800009
J	McLellan, JS; Pancera, M; Carrico, C; Gorman, J; Julien, JP; Khayat, R; Louder, R; Pejchal, R; Sastry, M; Dai, KF; O'Dell, S; Patel, N; Shahzad-ul-Hussan, S; Yang, YP; Zhang, BS; Zhou, TQ; Zhu, J; Boyington, JC; Chuang, GY; Diwanji, D; Georgiev, I; Do Kwon, Y; Lee, D; Louder, MK; Moquin, S; Schmidt, SD; Yang, ZY; Bonsignori, M; Crump, JA; Kapiga, SH; Sam, NE; Haynes, BF; Burton, DR; Koff, WC; Walker, LM; Phogat, S; Wyatt, R; Orwenyo, J; Wang, LX; Arthos, J; Bewley, CA; Mascola, JR; Nabel, GJ; Schief, WR; Ward, AB; Wilson, IA; Kwong, PD				McLellan, Jason S.; Pancera, Marie; Carrico, Chris; Gorman, Jason; Julien, Jean-Philippe; Khayat, Reza; Louder, Robert; Pejchal, Robert; Sastry, Mallika; Dai, Kaifan; O'Dell, Sijy; Patel, Nikita; Shahzad-ul-Hussan, Syed; Yang, Yongping; Zhang, Baoshan; Zhou, Tongqing; Zhu, Jiang; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Diwanji, Devan; Georgiev, Ivelin; Do Kwon, Young; Lee, Doyung; Louder, Mark K.; Moquin, Stephanie; Schmidt, Stephen D.; Yang, Zhi-Yong; Bonsignori, Mattia; Crump, John A.; Kapiga, Saidi H.; Sam, Noel E.; Haynes, Barton F.; Burton, Dennis R.; Koff, Wayne C.; Walker, Laura M.; Phogat, Sanjay; Wyatt, Richard; Orwenyo, Jared; Wang, Lai-Xi; Arthos, James; Bewley, Carole A.; Mascola, John R.; Nabel, Gary J.; Schief, William R.; Ward, Andrew B.; Wilson, Ian A.; Kwong, Peter D.			Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9	NATURE			English	Article							ENVELOPE GLYCOPROTEINS; POTENT NEUTRALIZATION; DEXTRAN SULFATE; IMMUNODEFICIENCY; EPITOPE; SOFTWARE; BINDING; REGION; CRYSTALLIZATION; ARCHITECTURE	Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded beta-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.	[McLellan, Jason S.; Pancera, Marie; Gorman, Jason; Louder, Robert; Sastry, Mallika; Dai, Kaifan; O'Dell, Sijy; Shahzad-ul-Hussan, Syed; Yang, Yongping; Zhang, Baoshan; Zhou, Tongqing; Zhu, Jiang; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Georgiev, Ivelin; Do Kwon, Young; Lee, Doyung; Louder, Mark K.; Moquin, Stephanie; Schmidt, Stephen D.; Yang, Zhi-Yong; Mascola, John R.; Nabel, Gary J.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Carrico, Chris; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Julien, Jean-Philippe; Khayat, Reza; Pejchal, Robert; Diwanji, Devan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Khayat, Reza; Pejchal, Robert; Diwanji, Devan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Patel, Nikita; Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDKD, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kapiga, Saidi H.; Sam, Noel E.] Kilimanjaro Reprod Hlth Programme, Moshi, Tanzania; [Wyatt, Richard] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, TSRI, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Koff, Wayne C.; Phogat, Sanjay] IAVI, New York, NY 10004 USA; [Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Orwenyo, Jared; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Wang, Xin/AAN-8435-2021; Wang, Lai-Xi/E-8755-2019; Crump, John A./AAZ-6412-2020; Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Crump, John A./AAZ-6289-2020; Schmidt, Stephen/AAC-6967-2019; Wang, Lai-Xi/E-8790-2019; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Louder, Robert/F-4713-2014; Bonsignori, Mattia/AAE-7678-2019; wang, xl/Y-8251-2019; Gorman, Jason/AGG-9417-2022; Do Kwon, Young/A-6957-2010; Schief, William/ABF-3645-2020; Zhou, Tongqing/A-6880-2010	Wang, Xin/0000-0002-4457-7376; Crump, John A./0000-0002-4529-102X; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Crump, John A./0000-0002-4529-102X; Wang, Lai-Xi/0000-0003-4293-5819; Louder, Robert/0000-0002-6944-9346; Bonsignori, Mattia/0000-0003-2973-2101; Do Kwon, Young/0000-0002-1188-7458; Schief, William/0000-0002-1120-0150; Zhou, Tongqing/0000-0002-3935-4637; Bewley, Carole/0000-0003-2203-0852; Moquin, Stephanie/0000-0002-8696-4315; Kapiga, Saidi/0000-0003-1753-4060; Gorman, Jason/0000-0002-3775-6560; Carrico, Chris/0000-0003-0939-9006; Julien, Jean-Philippe/0000-0001-7602-3995; McLellan, Jason/0000-0003-3991-542X	National Institutes of Health (NIH); International AIDS Vaccine Initiative; Ragon Institute; Canadian Institute of Health Research; NIH through the National Center for Research Resources [RR017573]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, ZIAAI000883, ZIAAI005022, R01AI084817, ZIAAI005095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Ragon Institute; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NIH through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Changela and X. Wu for assistance with mapping the PG16 paratope, J. Sodroski for discussions, J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. Support for this work was provided by the Intramural Research Program of the National Institutes of Health (NIH), by the International AIDS Vaccine Initiative, by the Ragon Institute, by the Canadian Institute of Health Research and by grants from the NIH. The three-dimensional reconstructions were conducted at the National Resource for Automated Molecular Microscopy (NRAMM), which is supported by the NIH through the National Center for Research Resources' P41 program(RR017573). Use of sector 22 (Southeast Regional Collaborative Access Team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 2011, PYMOL MOL GRAPH SYST; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Cauerhff A, 2000, J IMMUNOL, V165, P6422, DOI 10.4049/jimmunol.165.11.6422; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; HE XM, 1992, P NATL ACAD SCI USA, V89, P7154, DOI 10.1073/pnas.89.15.7154; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kabat EA, 1991, SEQUENCES PROTEINS I; Karasavvas N, 2011, AIDS RES HUM RETROV, V27, pA29; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore PL, 2011, AIDS RES HUM RETROV, V27, pA29; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Ross SA, 2001, PROTEIN SCI, V10, P450, DOI 10.1110/ps.32501; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; SCHOLS D, 1990, VIROLOGY, V175, P556, DOI 10.1016/0042-6822(90)90440-3; Sloan DJ, 1999, PROTEIN SCI, V8, P1643, DOI 10.1110/ps.8.8.1643; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2011, AIDS RES HUM RETROV, V27, pA21	69	648	711	0	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					336	U86		10.1038/nature10696	http://dx.doi.org/10.1038/nature10696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22113616	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000298033000044
J	Feinmann, J				Feinmann, Jane			BMJ CHRISTMAS APPEAL Pulse oximeters for all	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d8085	10.1136/bmj.d8085	http://dx.doi.org/10.1136/bmj.d8085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171350				2022-12-28	WOS:000298317800002
J	Zhu, PJ; Huang, W; Kalikulov, D; Yoo, JW; Placzek, AN; Stoica, L; Zhou, HY; Bell, JC; Friedlander, MJ; Krnjevic, K; Noebels, JL; Costa-Mattioli, M				Zhu, Ping Jun; Huang, Wei; Kalikulov, Djanenkhodja; Yoo, Jong W.; Placzek, Andon N.; Stoica, Loredana; Zhou, Hongyi; Bell, John C.; Friedlander, Michael J.; Krnjevic, Kresimir; Noebels, Jeffrey L.; Costa-Mattioli, Mauro			Suppression of PKR Promotes Network Excitability and Enhanced Cognition by Interferon-gamma-Mediated Disinhibition	CELL			English	Article							DEPENDENT PROTEIN-KINASE; TERM SYNAPTIC PLASTICITY; RAT HIPPOCAMPAL SLICE; CA1 PYRAMIDAL CELLS; IFN-GAMMA; MEMORY CONSOLIDATION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; GABAERGIC NEURONS; TRANSGENIC MICE	The double-stranded RNA-activated protein kinase (PKR) was originally identified as a sensor of virus infection, but its function in the brain remains unknown. Here, we report that the lack of PKR enhances learning and memory in several behavioral tasks while increasing network excitability. In addition, loss of PKR increases the late phase of long-lasting synaptic potentiation (L-LTP) in hippocampal slices. These effects are caused by an interferon-gamma (IFN-gamma)-mediated selective reduction in GABAergic synaptic action. Together, our results reveal that PKR finely tunes the network activity that must be maintained while storing a given episode during learning. Because PKR activity is altered in several neurological disorders, this kinase presents a promising new target for the treatment of cognitive dysfunction. As a first step in this direction, we show that a selective PKR inhibitor replicates the Pkr(-/-) phenotype in WT mice, enhancing long-term memory storage and L-LTP.	[Zhu, Ping Jun; Huang, Wei; Kalikulov, Djanenkhodja; Placzek, Andon N.; Stoica, Loredana; Zhou, Hongyi; Friedlander, Michael J.; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zhu, Ping Jun; Huang, Wei; Stoica, Loredana; Zhou, Hongyi; Costa-Mattioli, Mauro] Baylor Coll Med, Ctr Addict Learning & Memory, Houston, TX 77030 USA; [Yoo, Jong W.; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Ottawa; Ottawa Hospital Research Institute; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu		Noebels, Jeffrey/0000-0002-2887-0839	Searle award [09-SSP-211]; George and Cynthia Mitchell Foundation; Baylor IDDRC; NINDS [NS 29709]; NICHD [HD24064]; NEI [EY12782]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708, R01NS029709] Funding Source: NIH RePORTER	Searle award; George and Cynthia Mitchell Foundation; Baylor IDDRC; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Buzsaki, H. Zoghbi, and M. Rasband for comments on an early version of the manuscript. This work was supported by funds to M.C.-M. (Searle award 09-SSP-211; George and Cynthia Mitchell Foundation, Baylor IDDRC), J.L.N. (NINDS NS 29709, NICHD HD24064, Baylor IDDRC), and M.J.F. (NEI EY12782). The authors declare no competing financial interests.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; ABRAHAM WC, 1986, NEUROSCI LETT, V70, P217, DOI 10.1016/0304-3940(86)90466-0; Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Buzsaki G, 2006, RYTHMS BRAIN; Carnevalli LS, 2006, BIOCHEM J, V397, P187, DOI 10.1042/BJ20051643; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Couturier J, 2010, J BIOL CHEM, V285, P1272, DOI 10.1074/jbc.M109.041954; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gusev PA, 2001, J NEUROPHYSIOL, V86, P881, DOI 10.1152/jn.2001.86.2.881; HAEFELY W, 1990, NEUROCHEM RES, V15, P169, DOI 10.1007/BF00972207; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Heaton P, 2004, J CHILD PSYCHOL PSYC, V45, P899, DOI 10.1111/j.1469-7610.2004.t01-1-00284.x; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; Hughes JR, 2010, EPILEPSY BEHAV, V17, P147, DOI 10.1016/j.yebeh.2009.12.014; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ingrand S, 2007, FEBS LETT, V581, P4473, DOI 10.1016/j.febslet.2007.08.022; IZQUIERDO I, 1991, TRENDS PHARMACOL SCI, V12, P260, DOI 10.1016/0165-6147(91)90567-C; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER M, 1993, BRAIN RES, V619, P157, DOI 10.1016/0006-8993(93)91607-T; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Paquet C, 2009, J NEUROPATH EXP NEUR, V68, P190, DOI 10.1097/NEN.0b013e318196cd7c; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2005, ELECTROENCEPHALOGRAP, P505; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0	60	138	151	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1384	1396		10.1016/j.cell.2011.11.029	http://dx.doi.org/10.1016/j.cell.2011.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153080	Green Accepted, Bronze			2022-12-28	WOS:000298148100025
J	Ryan, MJ				Ryan, Michael J.			Replication in Field Biology: The Case of the Frog-Eating Bat	SCIENCE			English	Editorial Material							NEOTROPICAL FROG; PREDATION; EVOLUTION; BEHAVIOR	Studies conducted in the field offer unique opportunities to observe nature, but achieving true replication under natural conditions is challenging. As demonstrated by the discovery of frog eating by a charismatic bat, biology conducted in the field generally follows an interesting progression that includes discovery, demonstration, experimentation, and verification.	[Ryan, Michael J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Ryan, Michael J.] STRI, Balboa, Panama	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute	Ryan, MJ (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	mryan@mail.utexas.edu						Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; BRUNS V, 1989, J MORPHOL, V199, P103, DOI 10.1002/jmor.1051990109; Darwin C., 1871, P475; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; GOODALL J, 1964, NATURE, V201, P124; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Palmer AR, 2000, ANNU REV ECOL SYST, V31, P441, DOI 10.1146/annurev.ecolsys.31.1.441; RAND AS, 1981, Z TIERPSYCHOL, V57, P209; Ryan M. J., 1985, TUNGARA FROG STUDY S; RYAN MJ, 1981, BEHAV ECOL SOCIOBIOL, V8, P273, DOI 10.1007/BF00299526; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677	15	29	31	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1229	1230		10.1126/science.1214532	http://dx.doi.org/10.1126/science.1214532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144615				2022-12-28	WOS:000297553600036
J	Auerbach, BD; Osterweil, EK; Bear, MF				Auerbach, Benjamin D.; Osterweil, Emily K.; Bear, Mark F.			Mutations causing syndromic autism define an axis of synaptic pathophysiology	NATURE			English	Article							LONG-TERM DEPRESSION; FRAGILE-X-SYNDROME; HIPPOCAMPAL AREA CA1; TUBEROUS-SCLEROSIS; PROTEIN-SYNTHESIS; MENTAL-RETARDATION; MOUSE MODEL; MAMMALIAN TARGET; RAT HIPPOCAMPUS; MTOR	Tuberous sclerosis complex and fragile X syndrome are genetic diseases characterized by intellectual disability and autism. Because both syndromes are caused by mutations in genes that regulate protein synthesis in neurons, it has been hypothesized that excessive protein synthesis is one core pathophysiological mechanism of intellectual disability and autism. Using electrophysiological and biochemical assays of neuronal protein synthesis in the hippocampus of Tsc2(+/-) and Fmr1(-/y) mice, here we show that synaptic dysfunction caused by these mutations actually falls at opposite ends of a physiological spectrum. Synaptic, biochemical and cognitive defects in these mutants are corrected by treatments that modulate metabotropic glutamate receptor 5 in opposite directions, and deficits in the mutants disappear when the mice are bred to carry both mutations. Thus, normal synaptic plasticity and cognition occur within an optimal range of metabotropic glutamate-receptor-mediated protein synthesis, and deviations in either direction can lead to shared behavioural impairments.	[Auerbach, Benjamin D.; Osterweil, Emily K.; Bear, Mark F.] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu		Osterweil, Emily/0000-0003-0582-2284; Bear, Mark/0000-0002-9903-2541	National Institute of Mental Health [T32 MH-082718, T32-MH-074249]; National Institute of Child Health and Human Development [2R01HD046943]; Department of Defense [W81XWH-11-1-0252]; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH074249, T32MH082718] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partly supported by grants from the National Institute of Mental Health (T32 MH-082718 and T32-MH-074249), the National Institute of Child Health and Human Development (2R01HD046943), the Department of Defense (W81XWH-11-1-0252) and The Simons Foundation. We acknowledge A. Heynen for advice and comments, as well as K. Oram, E. Sklar and S. Meagher for technical and administrative assistance. Monoclonal Arc antibody was a gift from P. Worley.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Krueger DD, 2010, J MOL NEUROSCI, V42, P1, DOI 10.1007/s12031-010-9338-9; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stiedl O, 1999, BEHAV NEUROSCI, V113, P496, DOI 10.1037/0735-7044.113.3.496; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107	43	444	474	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					63	U222		10.1038/nature10658	http://dx.doi.org/10.1038/nature10658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22113615	Green Accepted, Green Submitted			2022-12-28	WOS:000298031900033
J	Williams, K; Woolf, R; Morrison, D				Williams, Katie; Woolf, Richard; Morrison, Danny			PICTURE QUIZ Periocular lesion in an infant	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS HEMANGIOMAS; PROPRANOLOL; RISK		[Williams, Katie; Morrison, Danny] Guys & St Thomas NHS Fdn Trust, Childrens Eye Dept, London SE1 7EH, England; [Woolf, Richard] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Williams, K (corresponding author), Guys & St Thomas NHS Fdn Trust, Childrens Eye Dept, London SE1 7EH, England.	kmw.email@gmail.com		Williams, Katie M/0000-0003-4596-3938; Woolf, Richard/0000-0003-3200-0075				Bauland CG, 2006, PLAST RECONSTR SURG, V117, p29E, DOI 10.1097/01.prs.0000197134.72984.cb; Bennett ML, 2001, ARCH DERMATOL, V137, P1208; Bruckner AL, 2003, J AM ACAD DERMATOL, V48, P477, DOI 10.1067/mjd.2003.200; Claerhout I, 2011, BRIT J OPHTHALMOL, V95, P1199, DOI 10.1136/bjo.2010.192245; David LR, 2003, BRIT J PLAST SURG, V56, P317, DOI 10.1016/S0007-1226(03)00152-8; Frieden Ilona J, 2005, Pediatr Dermatol, V22, P383, DOI 10.1111/j.1525-1470.2005.00102.x; Golitz L E, 1986, Pediatr Dermatol, V3, P145, DOI 10.1111/j.1525-1470.1986.tb00506.x; Haider KM, 2010, J AAPOS, V14, P251, DOI 10.1016/j.jaapos.2010.05.002; Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819; Manunza F, 2010, BRIT J DERMATOL, V162, P466, DOI 10.1111/j.1365-2133.2009.09597.x; Metry DW, 2006, AM J MED GENET A, V140A, P975, DOI 10.1002/ajmg.a.31189; Orlow SJ, 1997, J PEDIATR-US, V131, P643, DOI 10.1016/S0022-3476(97)70079-9; Roberts N, 2009, CLIN MED, V9, P385, DOI 10.7861/clinmedicine.9-4-385; Schwartz SR, 2006, J AAPOS, V10, P262, DOI 10.1016/j.jaapos.2006.01.210; Storch CH, 2010, BRIT J DERMATOL, V163, P269, DOI 10.1111/j.1365-2133.2010.09848.x; Wolff K, 2009, FITZPATRICKS COLOR A, P192	16	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 28	2011	343								d7461	10.1136/bmj.d7461	http://dx.doi.org/10.1136/bmj.d7461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EJ	22123913				2022-12-28	WOS:000298937900006
J	Li, W; Pohl, T; Rost, JM; Rittenhouse, ST; Sadeghpour, HR; Nipper, J; Butscher, B; Balewski, JB; Bendkowsky, V; Low, R; Pfau, T				Li, W.; Pohl, T.; Rost, J. M.; Rittenhouse, Seth T.; Sadeghpour, H. R.; Nipper, J.; Butscher, B.; Balewski, J. B.; Bendkowsky, V.; Loew, R.; Pfau, T.			A Homonuclear Molecule with a Permanent Electric Dipole Moment	SCIENCE			English	Article							PENDULAR STATES; RYDBERG; POLAR; ATOM	Permanent electric dipole moments in molecules require a breaking of parity symmetry. Conventionally, this symmetry breaking relies on the presence of heteronuclear constituents. We report the observation of a permanent electric dipole moment in a homonuclear molecule in which the binding is based on asymmetric electronic excitation between the atoms. These exotic molecules consist of a ground-state rubidium (Rb) atom bound inside a second Rb atom electronically excited to a high-lying Rydberg state. Detailed calculations predict appreciable dipole moments on the order of 1 Debye, in excellent agreement with the observations.	[Rittenhouse, Seth T.; Sadeghpour, H. R.] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys ITAMP, Cambridge, MA 02138 USA; [Li, W.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Li, W.; Pohl, T.; Rost, J. M.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Nipper, J.; Butscher, B.; Balewski, J. B.; Bendkowsky, V.; Loew, R.; Pfau, T.] Univ Stuttgart, Inst Phys, D-70569 Stuttgart, Germany	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Nottingham; Max Planck Society; University of Stuttgart	Sadeghpour, HR (corresponding author), Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys ITAMP, 60 Garden St, Cambridge, MA 02138 USA.	hrs@cfa.harvard.edu	Pohl, Thomas/B-5133-2013; Li, Weibin/E-6807-2011; Loew, Robert/I-8206-2014; Pfau, Tilman/G-1774-2011	Li, Weibin/0000-0001-6731-1311; Pfau, Tilman/0000-0003-3272-3468; Pohl, Thomas/0000-0002-4093-3644; Rost, Jan M./0000-0002-8306-1743	NSF through ITAMP [0653021]; Harvard Department of Physics; Smithsonian Astrophysical Observatory; European Union; Deutsche Forschungsgemeinschaft [SFB/TRR21, PF 381/4-2]	NSF through ITAMP(National Science Foundation (NSF)); Harvard Department of Physics; Smithsonian Astrophysical Observatory; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Feist and P. Julienne for useful discussions in the preparation of this work and L. Kukota for her assistance. Supported by NSF grant 0653021 through ITAMP, the Harvard Department of Physics, and the Smithsonian Astrophysical Observatory (S. T. R. and H. R. S.), a European Union Marie Curie Fellowship (W. L.), and the Deutsche Forschungsgemeinschaft within SFB/TRR21 and the project PF 381/4-2.	Bahrim C, 2001, J PHYS B-AT MOL OPT, V34, pL195, DOI 10.1088/0953-4075/34/6/107; Bendkowsky V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.163201; Bendkowsky V, 2009, NATURE, V458, P1005, DOI 10.1038/nature07945; BERNREUTHER W, 1991, REV MOD PHYS, V63, P313, DOI 10.1103/RevModPhys.63.313; BLOCK PA, 1992, PHYS REV LETT, V68, P1303, DOI 10.1103/PhysRevLett.68.1303; Butscher B, 2010, NAT PHYS, V6, P970, DOI [10.1038/nphys1828, 10.1038/NPHYS1828]; Butscher B, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184004; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Deiglmayr J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.133004; Fermi E., 1934, NUOVO CIMENTO, V11, P157, DOI DOI 10.1007/BF02959829; FRIEDRICH B, 1991, NATURE, V353, P412, DOI 10.1038/353412a0; Gallagher T. F., 1994, RYDBERG ATOMS; Gonzalez-Ferez R, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/43001; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Hamilton EL, 2002, J PHYS B-AT MOL OPT, V35, pL199, DOI 10.1088/0953-4075/35/10/102; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Liu ICH, 2006, EUR PHYS J D, V40, P65, DOI 10.1140/epjd/e2006-00098-x; Liu ICH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.173001; LORENZEN CJ, 1984, Z PHYS A-HADRON NUCL, V315, P127, DOI 10.1007/BF01419370; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; OMONT A, 1977, J PHYS-PARIS, V38, P1343, DOI 10.1051/jphys:0197700380110134300; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Rittenhouse ST, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184005; Rittenhouse ST, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.243002; ROST JM, 1992, PHYS REV LETT, V68, P1299, DOI 10.1103/PhysRevLett.68.1299; Schoffler MS, 2008, SCIENCE, V320, P920, DOI 10.1126/science.1154989; Seideman T, 2005, ADV ATOM MOL OPT PHY, V52, P289, DOI 10.1016/S1049-250X(05)52006-8; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543	30	115	115	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1110	1114		10.1126/science.1211255	http://dx.doi.org/10.1126/science.1211255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116881				2022-12-28	WOS:000297313900044
J	Fischer, ES; Scrima, A; Bohm, K; Matsumoto, S; Lingaraju, GM; Faty, M; Yasuda, T; Cavadini, S; Wakasugi, M; Hanaoka, F; Iwai, S; Gut, H; Sugasawa, K; Thoma, NH				Fischer, Eric S.; Scrima, Andrea; Boehm, Kerstin; Matsumoto, Syota; Lingaraju, Gondichatnahalli M.; Faty, Mahamadou; Yasuda, Takeshi; Cavadini, Simone; Wakasugi, Mitsuo; Hanaoka, Fumio; Iwai, Shigenori; Gut, Heinz; Sugasawa, Kaoru; Thomae, Nicolas H.			The Molecular Basis of CRL4(DDB2/CSA) Ubiquitin Ligase Architecture, Targeting, and Activation	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; UV-DAMAGED-DNA; PIGMENTOSUM GROUP-E; COP9 SIGNALOSOME; BINDING PROTEIN; IN-VIVO; STRUCTURAL INSIGHTS; COCKAYNE-SYNDROME; XPC COMPLEX; HISTONE H2A	The DDB1-CUL4-RBX1 (CRL4) ubiquitin ligase family regulates a diverse set of cellular pathways through dedicated substrate receptors (DCAFs). The DCAF DDB2 detects UV-induced pyrimidine dimers in the genome and facilitates nucleotide excision repair. We provide the molecular basis for DDB2 receptor-mediated cyclobutane pyrimidine dimer recognition in chromatin. The structures of the fully assembled DDB1-DDB2-CUL4A/B-RBX1 (CRL4 DDB2) ligases reveal that the mobility of the ligase arm creates a defined ubiquitination zone around the damage, which precludes direct ligase activation by DNA lesions. Instead, the COP9 signalosome (CSN) mediates the CRL4 DDB2 inhibition in a CSN5 independent, nonenzymatic, fashion. In turn, CSN inhibition is relieved upon DNA damage binding to the DDB2 module within CSN-CRL4 DDB2. The Cockayne syndrome A DCAF complex crystal structure shows that CRL4 DCAF(WD40) ligases share common architectural features. Our data support a general mechanism of ligase activation, which is induced by CSN displacement from CRL4 DCAF on substrate binding to the DCAF.	[Fischer, Eric S.; Scrima, Andrea; Boehm, Kerstin; Lingaraju, Gondichatnahalli M.; Faty, Mahamadou; Cavadini, Simone; Gut, Heinz; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Grad Sch Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Yasuda, Takeshi] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; [Wakasugi, Mitsuo] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kanazawa, Ishikawa 9201192, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan; [Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Fischer, Eric S.] Univ Basel, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Kobe University; Kobe University; National Institutes for Quantum Science & Technology; Kanazawa University; Gakushuin University; Osaka University; University of Basel	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	Yasuda, Takeshi/AAJ-4044-2021; Wakasugi, Mitsuo/D-8417-2015; Matsumoto, Syota/GOE-6847-2022; Fischer, Eric/B-3924-2013	Wakasugi, Mitsuo/0000-0001-9593-0566; Fischer, Eric/0000-0001-7337-6306; Thoma, Nicolas/0000-0003-2685-906X; Matsumoto, Syota/0000-0002-8776-2096	Novartis Research Foundation; European Research Council [RC-2010-StG 260481-MoBa-CS]; OncoSuisse [OCS-02365-02-2009]; Swiss National Science Foundation [31003A_120205]; SNF Ambizione; EMBO STF; Novartis; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21510055, 22131008, 20241013] Funding Source: KAKEN	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); OncoSuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF Ambizione; EMBO STF; Novartis(Novartis); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2010-StG 260481-MoBa-CS), OncoSuisse (OCS-02365-02-2009), and the Swiss National Science Foundation (31003A_120205); an SNF Ambizione Grant (A. S.), an EMBO STF (E. S. F.), and Novartis Presidential Fellowship (G. M. L.). K. S. was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Takeda Science Foundation. We thank Susan Gasser, Dirk Schubeler, Lukas Leder, Martin Renatus, and Philip Jeffrey for help and discussion. We are grateful to Daniel Hess and Dominique Klein (FMI protein analysis facility) for carrying out the mass-spectrometric analysis. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Creighton T.E., 1992, PROTEINS STRUCTURES; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; GALE JM, 1988, J MOL BIOL, V204, P949, DOI 10.1016/0022-2836(88)90054-X; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hannss R, 2011, FEBS LETT, V585, P2845, DOI 10.1016/j.febslet.2011.04.027; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P639, DOI 10.1111/j.1751-1097.1989.tb04320.x; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2010, MUTAT RES-FUND MOL M, V685, P29, DOI 10.1016/j.mrfmmm.2009.08.004; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	54	297	320	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1024	1039		10.1016/j.cell.2011.10.035	http://dx.doi.org/10.1016/j.cell.2011.10.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118460	Bronze			2022-12-28	WOS:000297376600015
J	Piskounova, E; Polytarchou, C; Thornton, JE; LaPierre, RJ; Pothoulakis, C; Hagan, JP; Iliopoulos, D; Gregory, RI				Piskounova, Elena; Polytarchou, Christos; Thornton, James E.; LaPierre, Robert J.; Pothoulakis, Charalabos; Hagan, John P.; Iliopoulos, Dimitrios; Gregory, Richard I.			Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms	CELL			English	Article							PROMOTES TRANSFORMATION; FEEDBACK LOOP; SELF-RENEWAL; LIN-28; MATURATION; EXPRESSION; CELLS; DIFFERENTIATION; METASTASIS; SUPPRESSES	Lin28A and Lin28B selectively block the expression of let-7 microRNAs and function as oncogenes in a variety of human cancers. Lin28A recruits a TUTase (Zcchc11/TUT4) to let-7 precursors to block processing by Dicer in the cell cytoplasm. Here we find that unlike Lin28A, Lin28B represses let-7 processing through a Zcchc11-independent mechanism. Lin28B functions in the nucleus by sequestering primary let-7 transcripts and inhibiting their processing by the Microprocessor. The inhibitory effects of Zcchc11 depletion on the tumorigenic capacity and metastatic potential of human cancer cells and xenografts are restricted to Lin28A-expressing tumors. Furthermore, the majority of human colon and breast tumors analyzed exclusively express either Lin28A or Lin28B. Lin28A is expressed in HER2-overexpressing breast tumors, whereas Lin28B expression characterizes triple-negative breast tumors. Overall our results illuminate the distinct mechanisms by which Lin28A and Lin28B function and have implications for the development of new strategies for cancer therapy.	[Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Piskounova, Elena; Thornton, James E.; LaPierre, Robert J.; Hagan, John P.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Polytarchou, Christos; Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Hagan, John P.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Ohio State University	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	dimitrios_iliopoulos@dfci.harvard.edu; rgregory@enders.tch.harvard.edu	Iliopoulos, Dimitrios/AAE-9106-2019	Hagan, John/0000-0003-0295-4898; Piskounova, Elena/0000-0002-8554-8475	US National Institute of General Medical Sciences (NIGMS) [1R01GM086386-01A1]; Harvard Stem Cell Institute; American Cancer Society [121635-RSG-11-175-01-RMC]; Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard Stem Cell Institute; American Cancer Society(American Cancer Society); Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Akihiko Yoshimura, Keio University, Japan, for the human Flag-Zcchc11 plasmid; Dr. Na Liu, Memorial Sloan Kettering Cancer Center, for the Myc-Ago2 plasmid; Dr. Bharat Ramratnam, Brown University, for the GFP-Drosha plasmid; and Dr. Ramin Shiekhattar, Wistar Institute, for the FlagEif6 expression plasmid. We thank Chiara Giacomelli, Dr. Saurabh Patel, and Dr. Maria Hatziapostolou for technical assistance. R. I. G. was supported by grants from the US National Institute of General Medical Sciences (NIGMS) (1R01GM086386-01A1), The Harvard Stem Cell Institute, and The American Cancer Society (121635-RSG-11-175-01-RMC). R. I. G. is a Pew Research Scholar. D. I. was supported by start-up funds from the Department of Cancer Immunology & AIDS at Dana-Farber Cancer Institute.	Barh D, 2010, CURR ONCOL, V17, P70; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Slack F, 2009, CELL CYCLE, V8, P1823, DOI 10.4161/cc.8.12.8639; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	50	447	471	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1066	1079		10.1016/j.cell.2011.10.039	http://dx.doi.org/10.1016/j.cell.2011.10.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118463	Green Accepted, Bronze			2022-12-28	WOS:000297376600018
J	Shackelton, JB; English, JC				Shackelton, Jeffery B.; English, Joseph C., III			Acute-Onset Reticulated White Lip	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LICHEN-PLANUS		[Shackelton, Jeffery B.; English, Joseph C., III] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	English, JC (corresponding author), Univ Pittsburgh, Dept Dermatol, 200 Lothrop St,Ste 3880,Presby S Tower, Pittsburgh, PA 15213 USA.	englishjc@upmc.edu						Ellgehausen P, 1998, CLIN DERMATOL, V16, P325, DOI 10.1016/S0738-081X(98)00004-2; HALEVY S, 1993, J AM ACAD DERMATOL, V29, P249, DOI 10.1016/0190-9622(93)70176-T; LAURBERG G, 1991, J AM ACAD DERMATOL, V24, P434, DOI 10.1016/0190-9622(91)70067-C; VANDENHAUTE V, 1989, DERMATOLOGICA, V179, P10, DOI 10.1159/000248091; Zakrzewska JM, 2005, BRIT J DERMATOL, V153, P336, DOI 10.1111/j.1365-2133.2005.06493.x	5	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2267	2268		10.1001/jama.2011.1728	http://dx.doi.org/10.1001/jama.2011.1728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22110110				2022-12-28	WOS:000297255500030
J	Zhou, CK; Slaughter, BD; Unruh, JR; Eldakak, A; Rubinstein, B; Li, R				Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Eldakak, Amr; Rubinstein, Boris; Li, Rong			Motility and Segregation of Hsp104-Associated Protein Aggregates in Budding Yeast	CELL			English	Article							IMAGE CORRELATION SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; DAMAGED PROTEINS; ACTIN CYTOSKELETON; CHAPERONE HSP104; CELL-GROWTH; LIFE-SPAN; DISAGGREGATION; INHERITANCE; MECHANISM	During yeast cell division, aggregates of damaged proteins are segregated asymmetrically between the bud and the mother. It is thought that protein aggregates are cleared from the bud via actin cable-based retrograde transport toward the mother and that Bni1p formin regulates this transport. Here, we examined the dynamics of Hsp104-associated protein aggregates by video microscopy, particle tracking, and image correlation analysis. We show that protein aggregates undergo random walk without directional bias. Clearance of heat-induced aggregates from the bud does not depend on formin proteins but occurs mostly through dissolution via Hsp104p chaperon. Aggregates formed naturally in aged cells also exhibit random walk but do not dissolve during observation. Although our data do not disagree with a role for actin or cell polarity in aggregate segregation, modeling suggests that their asymmetric inheritance can be a predictable outcome of aggregates' slow diffusion and the geometry of yeast cells.	[Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Eldakak, Amr; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zhou, Chuankai; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Unruh, Jay/0000-0003-3077-4990	NIH [RO1-GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank I. Pinto for assistance with yeast strain construction, J. Zhu and A. Box for help with aged cell sorting, A. Das for assistance in microscopy, and B. Liu and T. Nystrom for kindly providing their Hsp104-GFP strain. This work was supported by NIH grant RO1-GM057063 to R. L.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Chen CY, 2003, EXP GERONTOL, V38, P1051, DOI 10.1016/S0531-5565(03)00186-4; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Knorre DA, 2010, CELL CYCLE, V9, P4501, DOI 10.4161/cc.9.22.13683; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	30	97	98	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1186	1196		10.1016/j.cell.2011.11.002	http://dx.doi.org/10.1016/j.cell.2011.11.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118470	Green Accepted, Bronze			2022-12-28	WOS:000297376600027
J	Lip, GYH; Tse, HF; Lane, DA				Lip, Gregory Y. H.; Tse, Hung Fat; Lane, Deirdre A.			Atrial fibrillation	LANCET			English	Article							STROKE RISK STRATIFICATION; CARDIAC RESYNCHRONIZATION THERAPY; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; HEART RHYTHM ASSOCIATION; CARDIOLOGY WORKING GROUP; LONG-TERM SURVIVAL; PREDICTING STROKE; EUROPEAN-SOCIETY; SINUS RHYTHM	The management of atrial fibrillation has evolved greatly in the past few years, and many areas have had substantial advances or developments. Recognition of the limitations of aspirin and the availability of new oral anticoagulant drugs that overcome the inherent drawbacks associated with warfarin will enable widespread application of effective thromboprophylaxis with oral anticoagulants. The emphasis on stroke risk stratification has shifted towards identification of so-called truly low-risk patients with atrial fibrillation who do not need antithrombotic therapy, whereas oral anticoagulation therapy should be considered in patients with one or more risk factors for stroke. New antiarrhythmic drugs, such as dronedarone and vernakalant, have provided some additional opportunities for rhythm control in atrial fibrillation. However, the management of the disorder is increasingly driven by symptoms. The availability of non-pharmacological approaches, such as ablation, has allowed additional options for the management of atrial fibrillation in patients who are unsuitable for or intolerant of drug approaches.	[Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England; [Tse, Hung Fat] Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Birmingham; University of Hong Kong	Lip, GYH (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk	Tse, Hung-Fat/C-4426-2009; Lane, Deirdre/AAX-1866-2020	Tse, Hung-Fat/0000-0002-9578-7808; Lane, Deirdre/0000-0002-5604-9378	Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Bayer	Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Bayer(Bayer AG)	GYHL has received funding for research, educational symposia, consultancy, and lecturing from different manufacturers of drugs used for the treatment of atrial fibrillation and thrombosis. He was Clinical Adviser for the UK National Institute for Health and Clinical Excellence (NICE) guidelines on atrial fibrillation management. He was on the writing committee of the 2010 ESC guidelines on atrial fibrillation, and is Deputy Editor (content expert) for the 9th American College Chest Physicians guidelines on antithrombotic therapy for atrial fibrillation. HFT has received funding for research, educational symposia, consultancy, or lecturing from different manufacturers of devices (Cordis Webster, St Jude Medical, and Medtronic) and drugs (Bayers, Boehringer Ingelheim, Sanofi-Aventis, Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo Sankyo) used for the treatment of atrial fibrillation. DAL has received funding for research, educational symposia, consultancy, and lecturing from different manufacturers of drugs used for the treatment of atrial fibrillation and thrombosis (Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, and Bayer), and is a panellist on the American College Chest Physicians guidelines for the antithrombotic management of atrial fibrillation.	Ahrens I, 2010, THROMB HAEMOSTASIS, V104, P49, DOI 10.1160/TH09-05-0327; Aliot E, 2010, EUROPACE, V12, P626, DOI 10.1093/europace/euq109; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Baruch L, 2007, STROKE, V38, P2459, DOI 10.1161/STROKEAHA.106.477133; Block PC, 2009, JACC-CARDIOVASC INTE, V2, P594, DOI 10.1016/j.jcin.2009.05.005; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Boriani G, 2011, STROKE, V42, P1768, DOI 10.1161/STROKEAHA.110.609297; Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; Brignole M, 2005, EUR HEART J, V26, P712, DOI 10.1093/eurheartj/ehi069; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2011, J AM COLL CARDIOL, V57, P313, DOI 10.1016/j.jacc.2010.07.046; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cappato R, 2009, J AM COLL CARDIOL, V53, P1798, DOI 10.1016/j.jacc.2009.02.022; Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Connolly SJ, 2009, CIRCULATION, V120, P1174, DOI 10.1161/CIRCULATIONAHA.109.875252; Davy JM, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.06.010; DEVEREAUX PJ, 2001, BRIT MED J, V323, P1; Dewire J, 2010, NAT REV CARDIOL, V7, P129, DOI 10.1038/nrcardio.2009.232; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Food and Drug Administration, 2011, FDA DRUG SAF COMM SE; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Fuller R, 2004, AGE AGEING, V33, P608, DOI 10.1093/ageing/afh202; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia DA, 2010, THROMB HAEMOSTASIS, V104, P1099, DOI 10.1160/TH10-07-0491; Gasparini M, 2008, EUR HEART J, V29, P1644, DOI 10.1093/eurheartj/ehn133; Gasparini M, 2010, EUR HEART J, V31, P976, DOI 10.1093/eurheartj/ehp572; Gillis AM, 2011, CAN J CARDIOL, V27, P47, DOI 10.1016/j.cjca.2010.11.001; Glatter KA, 2001, CIRCULATION, V104, P1933, DOI 10.1161/hc4101.097538; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hindricks G, 2005, CIRCULATION, V112, P307, DOI 10.1161/CIRCULATIONAHA.104.518837; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Hohnloser SH, 2010, EUR HEART J, V31, P1717, DOI 10.1093/eurheartj/ehq113; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Holbrook A, 2007, CAN MED ASSOC J, V176, P1583, DOI 10.1503/cmaj.060837; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Howitt A, 1999, BMJ-BRIT MED J, V318, P1324, DOI 10.1136/bmj.318.7194.1324; Hughes M, 2007, QJM-INT J MED, V100, P599, DOI 10.1093/qjmed/hcm076; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Johnson WD, 2000, EUR J CARDIO-THORAC, V17, P718, DOI 10.1016/S1010-7940(00)00419-X; Kaireviciute D, 2009, EUR HEART J, V30, P410, DOI 10.1093/eurheartj/ehn609; Kanderian AS, 2008, J AM COLL CARDIOL, V52, P924, DOI 10.1016/j.jacc.2008.03.067; Karthikeyan G, 2010, THROMB HAEMOSTASIS, V104, P45, DOI 10.1160/TH09-11-0757; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Lakshminarayan K, 2006, STROKE, V37, P1969, DOI 10.1161/01.STR.0000230607.07928.17; Le Heuzey JY, 2010, J CARDIOVASC ELECTR, V21, P597, DOI 10.1111/j.1540-8167.2010.01764.x; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Lip GYH, 2007, EUR J INTERN MED, V18, P202, DOI 10.1016/j.ejim.2006.11.005; Lip GYH, 2007, LANCET NEUROL, V6, P981, DOI 10.1016/S1474-4422(07)70264-8; Lip GYH, 2007, LANCET, V370, P604, DOI 10.1016/S0140-6736(07)61300-2; Lip GYH, 2011, EUROPACE, V13, P723, DOI 10.1093/europace/eur126; Lip GYH, 2011, AM J MED, V124, P111, DOI 10.1016/j.amjmed.2010.05.007; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GYH, 2010, THROMB HAEMOSTASIS, V103, P13, DOI 10.1160/TH09-08-0580; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Lubitz SA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P291, DOI 10.1161/CIRCEP.110.942441; ManSonHing M, 1996, ARCH INTERN MED, V156, P1841, DOI 10.1001/archinte.156.16.1841; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nair GM, 2009, J CARDIOVASC ELECTR, V20, P138, DOI 10.1111/j.1540-8167.2008.01285.x; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR NAT CLIN GU; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Noheria A, 2008, ARCH INTERN MED, V168, P581, DOI 10.1001/archinte.168.6.581; Ogawa S, 2009, CIRC J, V73, P242, DOI 10.1253/circj.CJ-08-0608; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Ozcan C, 2001, NEW ENGL J MED, V344, P1043, DOI 10.1056/NEJM200104053441403; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1089, DOI 10.1016/j.jacc.2009.04.085; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2011, J CARDIOVASC ELECTR, V22, P25, DOI 10.1111/j.1540-8167.2010.01858.x; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Rash A, 2007, AGE AGEING, V36, P151, DOI 10.1093/ageing/afl129; Rasmussen LH, 2011, J THROMB HAEMOST, V9, P1301, DOI 10.1111/j.1538-7836.2011.04308.x; Reynolds MR, 2010, CIRC-CARDIOVASC QUAL, V3, P615, DOI 10.1161/CIRCOUTCOMES.110.957563; Roberts JD, 2010, J AM COLL CARDIOL, V55, P705, DOI 10.1016/j.jacc.2009.12.005; Roskell NS, 2010, THROMB HAEMOSTASIS, V104, P1106, DOI 10.1160/TH10-10-0642; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shen AYJ, 2010, J NATL MED ASSOC, V102, P906; Simonian SM, 2010, INTERN EMERG MED, V5, P421, DOI 10.1007/s11739-010-0385-6; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880; The-Stroke-Prevention-in-Atrial-Fibrillation-Investigators, 1993, J STROKE CEREBROVASC, V3, P181; Thomson RG, 2007, QUAL SAF HEALTH CARE, V16, P216, DOI 10.1136/qshc.2006.018481; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; van Walraven C, 2009, STROKE, V40, P1410, DOI 10.1161/STROKEAHA.108.526988; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wann LS, 2011, CIRCULATION, V123, P104, DOI 10.1161/CIR.0b013e3181fa3cf4; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yannopoulos D, 2007, J AM COLL CARDIOL, V50, P1246, DOI 10.1016/j.jacc.2007.04.096	134	298	311	3	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					648	661		10.1016/S0140-6736(11)61514-6	http://dx.doi.org/10.1016/S0140-6736(11)61514-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897ES	22166900				2022-12-28	WOS:000300629000036
J	Underwood, J				Underwood, James			Post-mortem imaging and autopsy: rivals or allies?	LANCET			English	Editorial Material							DIAGNOSIS		Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Underwood, J (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	jceu@shef.ac.uk						Biggs MJP, 2009, J CLIN PATHOL, V62, P525, DOI 10.1136/jcp.2008.062117; Britton P, 2008, BODY SCANS INSTEAD P; Burton JL, 2003, J CLIN PATHOL, V56, P537, DOI 10.1136/jcp.56.7.537; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Department of Health Department for Education and Employment Home Office, 2001, REM RET US HUM ORG T; National Confidential Enquiry into Patient Outcome and Death, 2006, COR AUT DO WE DES BE; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Pounder D, 2011, J ROY SOC MED, V104, P19, DOI 10.1258/jrsm.2010.100207; Roberts ISD, 2011, CLIN RADIOL, V66, P645, DOI 10.1016/j.crad.2011.01.007; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Saunders SL, 2011, INT J LEGAL MED, V125, P609, DOI 10.1007/s00414-011-0559-4	12	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					100	102		10.1016/S0140-6736(11)61584-5	http://dx.doi.org/10.1016/S0140-6736(11)61584-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22112685				2022-12-28	WOS:000299317700013
J	Rosenblum, MD; Gratz, IK; Paw, JS; Lee, K; Marshak-Rothstein, A; Abbas, AK				Rosenblum, Michael D.; Gratz, Iris K.; Paw, Jonathan S.; Lee, Karen; Marshak-Rothstein, Ann; Abbas, Abul K.			Response to self antigen imprints regulatory memory in tissues	NATURE			English	Article							T-CELLS; IN-VIVO; EXPRESSION; AUTOANTIGEN; HOMEOSTASIS; AUTOIMMUNE; DEPLETION; DISEASES; MICE	Immune homeostasis in tissues is achieved through a delicate balance between pathogenic T-cell responses directed at tissue-specific antigens and the ability of the tissue to inhibit these responses. The mechanisms by which tissues and the immune system communicate to establish and maintain immune homeostasis are currently unknown. Clinical evidence suggests that chronic or repeated exposure to self antigen within tissues leads to an attenuation of pathological autoimmune responses, possibly as a means to mitigate inflammatory damage and preserve function. Many human organ-specific autoimmune diseases are characterized by the initial presentation of the disease being the most severe, with subsequent flares being of lesser severity and duration(1). In fact, these diseases often spontaneously resolve, despite persistent tissue autoantigen expression(2). In the practice of antigen-specific immunotherapy, allergens or self antigens are repeatedly injected in the skin, with a diminution of the inflammatory response occurring after each successive exposure(3). Although these findings indicate that tissues acquire the ability to attenuate autoimmune reactions upon repeated responses to antigens, the mechanism by which this occurs is unknown. Here we show that upon expression of self antigen in a peripheral tissue, thymus-derived regulatory T cells (T-reg cells) become activated, proliferate and differentiate into more potent suppressors, which mediate resolution of organ-specific autoimmunity in mice. After resolution of the inflammatory response, activated T-reg cells are maintained in the target tissue and are primed to attenuate subsequent autoimmune reactions when antigen is re-expressed. Thus, T-reg cells function to confer 'regulatory memory' to the target tissue. These findings provide a framework for understanding how T-reg cells respond when exposed to self antigen in peripheral tissues and offer mechanistic insight into how tissues regulate autoimmunity.	[Gratz, Iris K.; Paw, Jonathan S.; Abbas, Abul K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Rosenblum, Michael D.; Paw, Jonathan S.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Lee, Karen] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Marshak-Rothstein, Ann] Univ Massachusetts, Div Rheumatol, Dept Med, Worcester, MA 01655 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; University of Massachusetts System; University of Massachusetts Worcester	Abbas, AK (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	Abul.Abbas@ucsf.edu	Gratz, Iris K/L-6267-2015	Gratz, Iris K/0000-0001-7470-7277	Dermatology Foundation; UCSF Department of Dermatology; NIH [P01 AI35297, R01 AI73656, U19 AI56388, AR055634]; Scleroderma Research Foundation; Austrian Science Fund (FWF) [J2997-B13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073656, U19AI056388, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055634, K08AR062064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM058724] Funding Source: NIH RePORTER	Dermatology Foundation; UCSF Department of Dermatology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Benetiz for assistance with animal husbandry, S. Isakson for genotyping, S.-w. Jiang and M. Lee for cell sorting, and K. Ravid and G. Martin for derivation of TRE-TGO transgenic mice. We thank S. Ziegler, Benaroya Research Institute, for transgenic mice. M. D. R. is supported by a Dermatology Foundation Career Development Award and the UCSF Department of Dermatology. This work was partially funded through NIH grants P01 AI35297, R01 AI73656 and U19 AI56388 (to A. K. A.); NIH grant AR055634 to (A.M.-R.); and the Scleroderma Research Foundation (A.M.-R.). I. K. G. is supported by an Erwin Schroedinger Fellowship from the Austrian Science Fund (FWF), J2997-B13.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; James WD, 2006, ANDREWS DIS SKIN CLI, V10th, P308; Kurtulus S, 2010, IMMUNOL REV, V236, P54, DOI 10.1111/j.1600-065X.2010.00920.x; Lara-Corrales I, 2010, SEMIN CUTAN MED SURG, V29, P85, DOI 10.1016/j.sder.2010.03.005; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mouquet H, 2008, TISSUE ANTIGENS, V71, P464, DOI 10.1111/j.1399-0039.2008.01020.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Tenorio EP, 2011, FEMS IMMUNOL MED MIC, V62, P362, DOI 10.1111/j.1574-695X.2011.00805.x; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Saff RR, 2004, J IMMUNOL, V172, P6598, DOI 10.4049/jimmunol.172.11.6598; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Wada N, 2011, J INVEST DERMATOL, V131, P410, DOI 10.1038/jid.2010.330; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	17	205	213	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					538	U164		10.1038/nature10664	http://dx.doi.org/10.1038/nature10664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121024	Green Accepted			2022-12-28	WOS:000298318000064
J	Aiken, AM; Mturi, N; Njuguna, P; Mohammed, S; Berkley, JA; Mwangi, I; Mwarumba, S; Kitsao, BS; Lowe, BS; Morpeth, SC; Hall, AJ; Khandawalla, I; Scott, JAG				Aiken, Alexander M.; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Hall, Andrew J.; Khandawalla, Iqbal; Scott, J. Anthony G.		Kilifi Bacteraemia Surveillance	Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study	LANCET			English	Article							CARE-ASSOCIATED INFECTION; DEVELOPING-COUNTRIES; MALAWIAN CHILDREN; BLOOD-TRANSFUSION; SALMONELLA; SEPTICEMIA; MORTALITY; OUTBREAK; TANZANIA; FEATURES	Background In sub-Saharan Africa, community-acquired bacteraemia is an important cause of illness and death in children. Our aim was to establish the magnitude and causes of hospital-acquired (nosocomial) bacteraemia in African children. Methods We reviewed prospectively collected surveillance data of 33 188 admissions to Kilifi District Hospital, Kenya, between April 16, 2002, and Sept 30, 2009. We defined bacteraemia as nosocomial if it occurred 48 h or more after admission. We estimated the per-admission risk, daily rate, effect on mortality, and microbial cause of nosocomial bacteraemia and analysed risk factors by multivariable Cox regression. The effect on morbidity was measured as the increase in hospital stay by comparison with time-matched patients without bacteraemia. Findings The overall risk of nosocomial bacteraemia during this period was 5.9/1000 admissions (95% CI 5.2-6.9) but we recorded an underlying rise in risk of 27% per year. The incidence was 1.0/1000 days in hospital (0.87-1.14), which is about 40 times higher than that of community-acquired bacteraemia in the same region. Mortality in patients with nosocomial bacteraemia was 53%, compared with 24% in community-acquired bacteraemia and 6% in patients without bacteraemia. In survivors, nosocomial bacteraemia lengthened hospital stay by 10.1 days (3.0-17.2). Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Acinetobacter spp, group D streptococci, and Pseudomonas aeruginosa accounted for three-quarters of nosocomial infections. Nosocomial bacteraemia was significantly associated with severe mal nutrition (hazard ratio 2.52, 95% CI 1.79-3.57) and blood transfusion in children without severe anaemia (4.99; 3.39-7.37). Interpretation Our findings show that although nosocomial bacteraemia is rare, it has serious effects on morbidity and mortality, and the microbiological causes are distinct from those of community-acquired bacteraemia. Nosocomial infections are largely unrecognised or undocumented as a health risk in low-income countries, but they are likely to become public health priorities as awareness of their occurrence increases and as other prominent childhood diseases are progressively controlled.	[Aiken, Alexander M.; Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Berkley, James A.; Mwangi, Isaiah; Mwarumba, Salim; Kitsao, Barnes S.; Lowe, Brett S.; Morpeth, Susan C.; Scott, J. Anthony G.] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya; [Aiken, Alexander M.; Hall, Andrew J.] London Sch Hyg & Trop Med, London WC1, England; [Mturi, Neema; Njuguna, Patricia; Mohammed, Shebe; Khandawalla, Iqbal] Kilifi Dist Hosp, Minist Med Serv, Kilifi, Kenya; [Berkley, James A.; Lowe, Brett S.; Morpeth, Susan C.; Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Aiken, AM (corresponding author), POB 43640, Nairobi 00100, Kenya.	aaiken@nairobi.kemri-wellcome.org	Aiken, Alexander/AAP-7661-2021	Aiken, Alexander/0000-0003-3372-9036; Berkley, James/0000-0002-1236-849X	Wellcome Trust; Kenya Medical Research Institute-Wellcome Trust; Wellcome Trust of Great Britain [085042, 081835]	Wellcome Trust(Wellcome TrustEuropean Commission); Kenya Medical Research Institute-Wellcome Trust; Wellcome Trust of Great Britain(Wellcome Trust)	Wellcome Trust.; Surveillance at Kilifi District Hospital is funded by the Kenya Medical Research Institute-Wellcome Trust Research Programme. AA and JAGS are supported by research fellowships from the Wellcome Trust of Great Britain (grant numbers 085042 and 081835, respectively). We thank Kilifi District Hospital clinical team and laboratory staff for their involvement in data collection and the ICT staff of the Kenya Medical Research Institute-Wellcome Trust Research Programme for their diligent work on data entry and data management. This study is published with the permission of the Director of Kenya Medical Research Institute.	AIKEN CGA, 1992, ARCH DIS CHILD, V67, P595, DOI 10.1136/adc.67.5.595; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Callas PW, 1998, AM J IND MED, V33, P33; COTTON MF, 1992, S AFR MED J, V81, P87; de Irala-Estevez J, 2001, INTENS CARE MED, V27, P1254, DOI 10.1007/s001340101007; Hassall O, 2009, TRANSFUSION, V49, P2594, DOI 10.1111/j.1537-2995.2009.02344.x; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Iregbu K C, 2007, Afr J Med Med Sci, V36, P225; *MIN MED SERV KEN, 2010, NAT INF PREV CONTR G; MURPHY SA, 1994, E AFR MED J, V71, P271; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Pedro R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-307; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Rosenthal VD, 2011, LANCET, V377, P186, DOI 10.1016/S0140-6736(10)62005-3; Schulgen G, 2000, J CLIN EPIDEMIOL, V53, P409, DOI 10.1016/S0895-4356(99)00182-1; Tagny CT, 2008, TRANSFUSION, V48, P1256, DOI 10.1111/j.1537-2995.2008.01697.x; Vaagland H, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-35; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Walsh AL, 2002, T ROY SOC TROP MED H, V96, P276, DOI 10.1016/S0035-9203(02)90098-2; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	30	86	87	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					2021	2027		10.1016/S0140-6736(11)61622-X	http://dx.doi.org/10.1016/S0140-6736(11)61622-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22133536	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000298144200026
J	Slattery, M; Riley, T; Liu, P; Abe, N; Gomez-Alcala, P; Dror, I; Zhou, TY; Rohs, R; Honig, B; Bussemaker, HJ; Mann, RS				Slattery, Matthew; Riley, Todd; Liu, Peng; Abe, Namiko; Gomez-Alcala, Pilar; Dror, Iris; Zhou, Tianyin; Rohs, Remo; Honig, Barry; Bussemaker, Harmen J.; Mann, Richard S.			Cofactor Binding Evokes Latent Differences in DNA Binding Specificity between Hox Proteins	CELL			English	Article							TRANSCRIPTION FACTOR; FUNCTIONAL SPECIFICITY; HOMEODOMAIN PROTEINS; RUNT DOMAIN; RECOGNITION; EXTRADENTICLE; DROSOPHILA; GENES; COMPLEX; SEGMENTATION	Members of transcription factor families typically have similar DNA binding specificities yet execute unique functions in vivo. Transcription factors often bind DNA as multiprotein complexes, raising the possibility that complex formation might modify their DNA binding specificities. To test this hypothesis, we developed an experimental and computational platform, SELEX-seq, that can be used to determine the relative affinities to any DNA sequence for any transcription factor complex. Applying this method to all eight Drosophila Hox proteins, we show that they obtain novel recognition properties when they bind DNA with the dimeric cofactor Extradenticle-Homothorax (Exd). Exd-Hox specificities group into three main classes that obey Hox gene collinearity rules and DNA structure predictions suggest that anterior and posterior Hox proteins prefer DNA sequences with distinct minor groove topographies. Together, these data suggest that emergent DNA recognition properties revealed by interactions with cofactors contribute to transcription factor specificities in vivo.	[Dror, Iris; Zhou, Tianyin; Rohs, Remo] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Slattery, Matthew; Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Riley, Todd; Gomez-Alcala, Pilar; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Riley, Todd; Liu, Peng; Honig, Barry; Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Liu, Peng; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gomez-Alcala, Pilar] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	University of Southern California; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Rohs, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, 1050 Childs Way, Los Angeles, CA 90089 USA.	rohs@usc.edu; bh6@columbia.edu; hjb2004@columbia.edu; rsm10@columbia.edu	Zhou, Tianyin/E-3830-2015; Dror, Iris/K-2042-2012		NIH [U54CA121852, R01GM054510, R01HG003008, R01GM030518, P50GM071508]; John Simon Guggenheim Foundation; Columbia University; USC; Andrew Viterbi Fellowship; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518, P50GM071508, R01GM054510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Simon Guggenheim Foundation; Columbia University; USC; Andrew Viterbi Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Bussemaker, Honig, Mann, and Rohs labs for comments and feedback during the course of these studies; B. Snyder for programming support; W. Shin and C. Hawkins for early contributions to the analysis of SELEX-seq data; A. Boyanov for sequencing support; and K. Lelli for constructs. This work was supported by NIH grants U54CA121852, R01GM054510, R01HG003008, R01GM030518, and P50GM071508, a John Simon Guggenheim Foundation Fellowship, Columbia University's RISE program, USC start-up funds, the USC-Technion Visiting Fellows Program, and an Andrew Viterbi Fellowship. Author contributions: M.S. designed and executed the SELEX experiments and contributed to the analysis of the SELEX data. T.R. designed and executed the analysis of the SELEX-seq data. P.L. carried out and analyzed Monte Carlo simulations. N.A. carried out later rounds of SELEX and EMSA-based validation experiments. P.G.-A. analyzed Ubx ChIP data. I. D. executed high-throughput DNA shape analysis. T.Z. developed high-throughput DNA shape prediction method. R.R. and B.H. supervised and designed DNA shape analyses. H.J.B. supervised and designed the analysis of the SELEX-seq data. R.S.M. supervised and designed SELEX experiments; contributed to the analysis of the SELEX data and shape analyses.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hueber SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010820; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Joshi R, 2010, GENE DEV, V24, P1533, DOI 10.1101/gad.1936910; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; Lu QA, 1997, ONCOGENE, V14, P75, DOI 10.1038/sj.onc.1200799; Lutz B, 1996, GENE DEV, V10, P176, DOI 10.1101/gad.10.2.176; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; TREISMAN J, 1989, CELL, V59, P553; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	54	330	333	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1270	1282		10.1016/j.cell.2011.10.053	http://dx.doi.org/10.1016/j.cell.2011.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153072	Bronze, Green Accepted			2022-12-28	WOS:000298148100017
J	McConnell, NJ; Ma, CP; Gebhardt, K; Wright, SA; Murphy, JD; Lauer, TR; Graham, JR; Richstone, DO				McConnell, Nicholas J.; Ma, Chung-Pei; Gebhardt, Karl; Wright, Shelley A.; Murphy, Jeremy D.; Lauer, Tod R.; Graham, James R.; Richstone, Douglas O.			Two ten-billion-solar-mass black holes at the centres of giant elliptical galaxies	NATURE			English	Article							SIGMA; MASS; EVOLUTION; QUASARS; MERGERS	Observational work conducted over the past few decades indicates that all massive galaxies have supermassive black holes at their centres. Although the luminosities and brightness fluctuations of quasars in the early Universe suggest that some were powered by black holes with masses greater than 10 billion solar masses(1,2), the remnants of these objects have not been found in the nearby Universe. The giant elliptical galaxy Messier 87 hosts the hitherto most massive known black hole, which has a mass of 6.3 billion solar masses(3,4). Here we report that NGC 3842, the brightest galaxy in a cluster at a distance from Earth of 98 megaparsecs, has a central black hole with a mass of 9.7 billion solar masses, and that a black hole of comparable or greater mass is present in NGC 4889, the brightest galaxy in the Coma cluster (at a distance of 103 megaparsecs). These two black holes are significantly more massive than predicted by linearly extrapolating the widely used correlations between black-hole mass and the stellar velocity dispersion or bulge luminosity of the host galaxy(5-9). Although these correlations remain useful for predicting black-hole masses in less massive elliptical galaxies, our measurements suggest that different evolutionary processes influence the growth of the largest galaxies and their black holes.	[McConnell, Nicholas J.; Ma, Chung-Pei; Wright, Shelley A.; Graham, James R.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Gebhardt, Karl; Murphy, Jeremy D.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Lauer, Tod R.] Natl Opt Astron Observ, Tucson, AZ 85726 USA; [Graham, James R.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Richstone, Douglas O.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; National Optical Astronomy Observatory; University of Toronto; University of Michigan System; University of Michigan	McConnell, NJ (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	nmcc@berkeley.edu; cpma@berkeley.edu		McConnell, Nicholas/0000-0001-5344-2062; Lauer, Tod/0000-0003-3234-7247; Gebhardt, Karl/0000-0002-8433-8185; Wright, Shelley/0000-0003-1034-8054	National Science Foundation; NASA; Miller Institute for Basic Research in Science, University of California, Berkeley; G. and C. Mitchell	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Miller Institute for Basic Research in Science, University of California, Berkeley(University of California System); G. and C. Mitchell	N.J.M., C.-P.M, K.G. and J.R.G. are supported by the National Science Foundation. C.-P. M. is supported by NASA and by the Miller Institute for Basic Research in Science, University of California, Berkeley. S. A. W. is supported by NASA through a Hubble Fellowship. Data presented here were obtained using the Gemini Observatory, the W. M. Keck Observatory and the McDonald Observatory. The Gemini Observatory is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the National Science Foundation on behalf of the Gemini partnership. The W. M. Keck Observatory is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The McDonald Observatory is operated by the University of Texas at Austin. The instrument VIRUS-P was funded by G. and C. Mitchell. Stellar orbit models were run using the facilities at the Texas Advanced Computing Center at The University of Texas at Austin.	Allington-Smith J, 2002, PUBL ASTRON SOC PAC, V114, P892, DOI 10.1086/341712; Boylan-Kolchin M, 2006, MON NOT R ASTRON SOC, V369, P1081, DOI 10.1111/j.1365-2966.2006.10379.x; Dalla Bonta E, 2009, ASTROPHYS J, V690, P537, DOI 10.1088/0004-637X/690/1/537; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; DRESSLER A, 1989, IAU S, V134, P217; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Hill GJ, 2008, PROC SPIE, V7014, DOI 10.1117/12.790235; Hopkins PF, 2007, ASTROPHYS J, V659, P976, DOI 10.1086/512091; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; Laine S, 2003, ASTRON J, V125, P478, DOI 10.1086/345823; Larkin J., 2006, P SOC PHOTOOPT INSTR, V6269; Lauer TR, 2007, ASTROPHYS J, V670, P249, DOI 10.1086/522083; Lauer TR, 2007, ASTROPHYS J, V662, P808, DOI 10.1086/518223; Loubser SI, 2008, MON NOT R ASTRON SOC, V391, P1009, DOI 10.1111/j.1365-2966.2008.13813.x; McConnell NJ, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/100; Netzer H, 2003, ASTROPHYS J, V583, pL5, DOI 10.1086/368012; Nowak N, 2008, MON NOT R ASTRON SOC, V391, P1629, DOI 10.1111/j.1365-2966.2008.13960.x; POSTMAN M, 1995, ASTROPHYS J, V440, P28, DOI 10.1086/175245; Robertson B, 2006, ASTROPHYS J, V641, P90, DOI 10.1086/500348; SARGENT WLW, 1978, ASTROPHYS J, V221, P731, DOI 10.1086/156077; SCHWARZSCHILD M, 1979, ASTROPHYS J, V232, P236, DOI 10.1086/157282; Vestergaard M, 2008, ASTROPHYS J LETT, V674, pL1, DOI 10.1086/528981	25	267	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					215	218		10.1038/nature10636	http://dx.doi.org/10.1038/nature10636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158244	Green Submitted			2022-12-28	WOS:000297744200045
J	Santer, BD; Wigley, TML; Taylor, KE				Santer, B. D.; Wigley, T. M. L.; Taylor, K. E.			The Reproducibility of Observational Estimates of Surface and Atmospheric Temperature Change	SCIENCE			English	Editorial Material							TRENDS	Although concerns have been expressed about the reliability of surface temperature data sets, findings of pronounced surface warming over the past 60 years have been independently reproduced by multiple groups. In contrast, an initial finding that the lower troposphere cooled since 1979 could not be reproduced. Attempts to confirm this apparent cooling trend led to the discovery of errors in the initial analyses of satellite-based tropospheric temperature measurements.	[Santer, B. D.; Taylor, K. E.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA; [Wigley, T. M. L.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Center Atmospheric Research (NCAR) - USA	Santer, BD (corresponding author), Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA.	santer1@llnl.gov	Santer, Benjamin D/F-9781-2011; Santer, Ben/ABA-1099-2021; Taylor, Karl E/F-7290-2011	Taylor, Karl E/0000-0002-6491-2135				Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Christy JR, 2003, J ATMOS OCEAN TECH, V20, P613, DOI 10.1175/1520-0426(2003)20<613:EEOVOM>2.0.CO;2; FOLLAND CK, 1984, NATURE, V310, P670, DOI 10.1038/310670a0; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; JONES PD, 1986, NATURE, V322, P430, DOI 10.1038/322430a0; JONES PD, 1982, MON WEATHER REV, V110, P59, DOI 10.1175/1520-0493(1982)110<0059:VISATP>2.0.CO;2; Jones PD, 2010, CLIMATIC CHANGE, V100, P59, DOI 10.1007/s10584-010-9836-3; Mears CA, 2005, SCIENCE, V309, P1548, DOI 10.1126/science.1114772; Santer BD, 2008, INT J CLIMATOL, V28, P1703, DOI 10.1002/joc.1756; Santer BD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016263; Santer BD, 2005, SCIENCE, V309, P1551, DOI 10.1126/science.1114867; Schlesinger J., 2004, LOS ANGELES TIM 0122; Sherwood SC, 2005, SCIENCE, V309, P1556, DOI 10.1126/science.1115640; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Thorne PW, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015487; Truzzi M, 1978, ZETETIC SCHOLAR, V1, P11; Wentz FJ, 1998, NATURE, V394, P661, DOI 10.1038/29267; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2	19	20	20	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1232	1233		10.1126/science.1216273	http://dx.doi.org/10.1126/science.1216273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144617				2022-12-28	WOS:000297553600038
J	Strid, J; Sobolev, O; Zafirova, B; Polic, B; Hayday, A				Strid, Jessica; Sobolev, Olga; Zafirova, Biljana; Polic, Bojan; Hayday, Adrian			The Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy	SCIENCE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; NKT CELLS; NKG2D; EXPRESSION; LIGANDS; ASTHMA; MICE	Epithelial cells respond to physicochemical damage with up-regulation of major histocompatibility complex-like ligands that can activate the cytolytic potential of neighboring intraepithelial T cells by binding the activating receptor, NKG2D. The systemic implications of this lymphoid stress-surveillance response, however, are unknown. We found that antigens encountered at the same time as cutaneous epithelial stress induced strong primary and secondary systemic, T helper 2 (T(H)2)-associated atopic responses in mice. These responses required NKG2D-dependent communication between dysregulated epithelial cells and tissue-associated lymphoid cells. These data are germane to uncertainty over the afferent induction of T(H)2 responses and provide a molecular framework for considering atopy as an important component of the response to tissue damage and carcinogenesis.	[Strid, Jessica; Sobolev, Olga; Hayday, Adrian] Canc Res UK, London Res Inst, London WC2A 3LY, England; [Strid, Jessica; Sobolev, Olga; Hayday, Adrian] Kings Coll London, Guys Hosp, Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Zafirova, Biljana; Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, HR-51000 Rijeka, Croatia	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Rijeka	Hayday, A (corresponding author), Canc Res UK, London Res Inst, London WC2A 3LY, England.	adrian.hayday@kcl.ac.uk	Polic, Bojan/B-8622-2014	Polic, Bojan/0000-0003-3930-9630; HAYDAY, ADRIAN/0000-0002-9495-5793; Strid, Jessica/0000-0003-3690-2201	Wellcome Trust; National Institute of Health Research cBRC; Croatian Ministry of Science, Education and Sports [062-0621261-1271]	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research cBRC; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	We thank M. Girardi, M. L. Michel, and M. Wencker for materials and advice; A. Yates for statistical assistance; P. Vantourout, G. Turchinovich, and R. Tigelaar for discussions; S. Diebold and C. Reis e Sousa for mice; and for funding, a Wellcome Trust Programme grant (A. H. and J.S.), a National Institute of Health Research cBRC grant (A. H. and O.S.), and Croatian Ministry of Science, Education and Sports grant 062-0621261-1271 (B.Z. and B. P.). The data reported in this paper are tabulated in the main paper and the supporting online material.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Herrick CA, 2003, J IMMUNOL, V170, P2488, DOI 10.4049/jimmunol.170.5.2488; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Nishijima T, 1997, J INVEST DERMATOL, V109, P175, DOI 10.1111/1523-1747.ep12319282; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Le TA, 2011, INT ARCH ALLERGY IMM, V155, P31, DOI 10.1159/000318679; Van Hemelrijck M, 2010, CANCER CAUSE CONTROL, V21, P1657, DOI 10.1007/s10552-010-9594-6; Vemijlen D., 2007, J IMMUNOL, V178, P4304; WEN L, 1994, NATURE, V369, P654, DOI 10.1038/369654a0; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024; Zhang TT, 2010, P NATL ACAD SCI USA, V107, P3040, DOI 10.1073/pnas.0915072107	25	108	111	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1293	1297		10.1126/science.1211250	http://dx.doi.org/10.1126/science.1211250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144628	Green Accepted			2022-12-28	WOS:000297553600055
J	Capitanio, FA; Faccenna, C; Zlotnik, S; Stegman, DR				Capitanio, F. A.; Faccenna, C.; Zlotnik, S.; Stegman, D. R.			Subduction dynamics and the origin of Andean orogeny and the Bolivian orocline	NATURE			English	Article							ALTIPLANO-PUNA; TECTONICS; PLATEAU; EVOLUTION; GEOMETRY; CLIMATE; UPLIFT; ZONES; RISE	The building of the Andes results from the subduction of the oceanic Nazca plate underneath the South American continent(1,2). However, how and why the Andes and their curvature, the Bolivian orocline, formed in the Cenozoic era (65.5 million years (Myr) ago to present), despite subduction continuing since the Mesozoic era(3) (251.0-65.5 Myr ago), is still unknown. Three-dimensional numerical subduction models demonstrate that variations in slab thickness, arising from the Nazca plate's age at the trench, produce a cordilleran morphology consistent with that observed(1,2). The age-dependent sinking of the slab in the mantle drives traction towards the trench at the base of the upper plate, causing it to thicken. Thus, subducting older Nazca plate below the Central Andes can explain the locally thickened crust and higher elevations. Here we demonstrate that resultant thickening of the South American plate modifies both shear force gradients and migration rates along the trench to produce a concave margin that matches the Bolivian orocline. Additionally, the varying forcing along the margin allows stress belts to form in the upper-plate interior, explaining the widening of the Central Andes and the different tectonic styles found on their margins, the Eastern and Western Cordilleras(2). The rise of the Central Andes and orocline formation are directly related to the local increase of Nazca plate age and an age distribution along the margin similar to that found today; the onset of these conditions only occurred in the Eocene epoch(4). This may explain the enigmatic delay of the Andean orogeny, that is, the formation of the modern Andes.	[Capitanio, F. A.; Zlotnik, S.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Faccenna, C.] Univ Roma Tre, Dipartimento Sci Geog, I-00146 Rome, Italy; [Zlotnik, S.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Zlotnik, S.] UPC Barcelona Tech, Dept Matemat Aplicada 3, Lab Calcul Numer, E-08034 Barcelona, Spain; [Stegman, D. R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Monash University; Roma Tre University; Monash University; Universitat Politecnica de Catalunya; University of California System; University of California San Diego; Scripps Institution of Oceanography	Capitanio, FA (corresponding author), Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia.	fabio.capitanio@monash.edu	Capitanio, Fabio/Q-8670-2019; Stegman, Dave/F-5794-2010; Zlotnik, Sergio/A-3462-2011; Capitanio, Fabio/E-8774-2010	Capitanio, Fabio/0000-0003-2131-8723; Stegman, Dave/0000-0001-8012-6145; Zlotnik, Sergio/0000-0001-9674-8950; Faccenna, Claudio/0000-0003-0765-4165	Australian Research Council [DP0987374]; G. Unger Vetlesen Foundation	Australian Research Council(Australian Research Council); G. Unger Vetlesen Foundation	We thank M. Faccenda, R. F. Weinberg and J. P. Brun for discussions. F. A. C. was supported by the Australian Research Council's Discovery Projects DP0987374. D. R. S. was supported in part by the G. Unger Vetlesen Foundation.	Allmendinger RW, 1996, TECTONOPHYSICS, V259, P1, DOI 10.1016/0040-1951(96)00024-8; Allmendinger RW, 2005, GEOLOGY, V33, P905, DOI 10.1130/G21779.1; Allmendinger RW, 1997, ANNU REV EARTH PL SC, V25, P139, DOI 10.1146/annurev.earth.25.1.139; Arriagada C, 2008, TECTONICS, V27, DOI 10.1029/2008TC002269; Beck SL, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000124; Capitanio FA, 2010, TECTONOPHYSICS, V483, P80, DOI 10.1016/j.tecto.2009.08.020; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Elger K, 2005, TECTONICS, V24, DOI 10.1029/2004TC001675; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; GEPHART JW, 1994, J GEOPHYS RES-SOL EA, V99, P12279, DOI 10.1029/94JB00129; Gerbault M, 2005, TECTONOPHYSICS, V399, P59, DOI 10.1016/j.tecto.2004.12.015; Gutscher MA, 2000, TECTONICS, V19, P814, DOI 10.1029/1999TC001152; Husson L, 2004, EARTH PLANET SC LETT, V222, P1037, DOI 10.1016/j.epsl.2004.03.041; Iaffaldano G, 2008, GEOLOGY, V36, P443, DOI 10.1130/G24489A.1; ISACKS BL, 1988, J GEOPHYS RES-SOLID, V93, P3211, DOI 10.1029/JB093iB04p03211; JORDAN TE, 1983, GEOL SOC AM BULL, V94, P341, DOI 10.1130/0016-7606(1983)94<341:ATRTGO>2.0.CO;2; Kley J, 1998, GEOLOGY, V26, P723, DOI 10.1130/0091-7613(1998)026<0723:TSACTI>2.3.CO;2; Lamb S, 2003, NATURE, V425, P792, DOI 10.1038/nature02049; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Morra G, 2006, GEOLOGY, V34, P877, DOI 10.1130/G22462.1; Mpodozis C., 1990, GEOLOGY ANDES ITS RE, V11, P59; PARDOCASAS F, 1987, TECTONICS, V6, P233, DOI 10.1029/TC006i003p00233; Russo RM, 1996, GEOLOGY, V24, P511, DOI 10.1130/0091-7613(1996)024<0511:CFMDAT>2.3.CO;2; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Sdrolias M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001090; Sobolev SV, 2005, GEOLOGY, V33, P617, DOI 10.1130/G21557.1; van Hunen J, 2002, TECTONOPHYSICS, V352, P317, DOI 10.1016/S0040-1951(02)00263-9; WDOWINSKI S, 1989, J GEOPHYS RES-SOLID, V94, P10331, DOI 10.1029/JB094iB08p10331; Yanez G, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002494	29	132	133	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					83	86		10.1038/nature10596	http://dx.doi.org/10.1038/nature10596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22113613				2022-12-28	WOS:000298031900038
J	Lollar, KW; Bien, AG				Lollar, Kevin W.; Bien, Alexander G.			Persistent Stapedial Artery Visualized through a Perforated Tympanic Membrane	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lollar, Kevin W.; Bien, Alexander G.] Univ Missouri, Sch Med, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Lollar, KW (corresponding author), Univ Missouri, Sch Med, Columbia, MO 65211 USA.	kevin.lollar@hrhonline.org							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					E42	E42		10.1056/NEJMicm1014000	http://dx.doi.org/10.1056/NEJMicm1014000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129269				2022-12-28	WOS:000297499000001
J	Schuur, EAG; Abbott, B				Schuur, Edward A. G.; Abbott, Benjamin		Permafrost Carbon Network	High risk of permafrost thaw	NATURE			English	Editorial Material							CARBON RELEASE		[Schuur, Edward A. G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Abbott, Benjamin] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks	Schuur, EAG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	tschuur@ufl.edu	Abbott, Benjamin W./G-1733-2017; Krinner, Gerhard/A-6450-2011; Hayes, Daniel/B-8968-2012; Riley, William J/D-3345-2015	Abbott, Benjamin W./0000-0001-5861-3481; Krinner, Gerhard/0000-0002-2959-5920; Riley, William J/0000-0002-4615-2304	Directorate For Geosciences [0856864] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Mack MC, 2011, NATURE, V475, P489, DOI 10.1038/nature10283; Schaefer K, 2011, TELLUS B, V63, P165, DOI 10.1111/j.1600-0889.2011.00527.x; Schneider von Deimling T, 2011, BIOGEOSCIENCES DISCU, V8, P4727; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040	10	186	195	14	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					32	33		10.1038/480032a	http://dx.doi.org/10.1038/480032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129707	Green Submitted, Bronze			2022-12-28	WOS:000298031900015
J	Trail, D; Watson, EB; Tailby, ND				Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.			The oxidation state of Hadean magmas and implications for early Earth's atmosphere	NATURE			English	Article							DETRITAL ZIRCONS; MELT INCLUSIONS; OXYGEN FUGACITY; TI; ELEMENTS; HISTORY; MANTLE; MA	Magmatic outgassing of volatiles from Earth's interior probably played a critical part in determining the composition of the earliest atmosphere, more than 4,000 million years (Myr) ago(1). Given an elemental inventory of hydrogen, carbon, nitrogen, oxygen and sulphur, the identity of molecular species in gaseous volcanic emanations depends critically on the pressure (fugacity) of oxygen. Reduced melts having oxygen fugacities close to that defined by the iron-wustite buffer would yield volatile species such as CH4, H-2, H2S, NH3 and CO, whereas melts close to the fayalite-magnetite-quartz buffer would be similar to present-day conditions and would be dominated by H2O, CO2, SO2 and N-2 (refs 1-4). Direct constraints on the oxidation state of terrestrial magmas before 3,850 Myr before present (that is, the Hadean eon) are tenuous because the rock record is sparse or absent. Samples from this earliest period of Earth's history are limited to igneous detrital zircons that pre-date the known rock record, with ages approaching similar to 4,400 Myr (refs 5-8). Here we report a redox-sensitive calibration to determine the oxidation state of Hadean magmatic melts that is based on the incorporation of cerium into zircon crystals. We find that the melts have average oxygen fugacities that are consistent with an oxidation state defined by the fayalite-magnetite-quartz buffer, similar to present-day conditions. Moreover, selected Hadean zircons (having chemical characteristics consistent with crystallization specifically from mantle-derived melts) suggest oxygen fugacities similar to those of Archaean and present-day mantle-derived lavas(2-4,9,10) as early as similar to 4,350 Myr before present. These results suggest that outgassing of Earth's interior later than similar to 200 Myr into the history of Solar System formation would not have resulted in a reducing atmosphere.	[Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12181 USA; [Trail, Dustin; Watson, E. Bruce; Tailby, Nicholas D.] Rensselaer Polytech Inst, New York Ctr Astrobiol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Trail, D (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12181 USA.	traild@rpi.edu		Trail, Dustin/0000-0003-3505-4351	NASA Astrobiology Institute [NNA09DA80A]	NASA Astrobiology Institute	This work was supported by the NASA Astrobiology Institute (grant no. NNA09DA80A to The New York Center for Astrobiology).	AYERS JC, 1992, AM MINERAL, V77, P1080; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Burgisser A, 2007, NATURE, V445, P194, DOI 10.1038/nature05509; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CARMICHAEL ISE, 1990, REV MINERAL, V24, P191; Cavosie A. J., 2006, GEOCHIM COSMOCHIM AC, V69, P637; Cavosie AJ, 2009, AM MINERAL, V94, P926, DOI 10.2138/am.2009.2982; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Cherniak DJ, 1997, CHEM GEOL, V134, P289, DOI 10.1016/S0009-2541(96)00098-8; Coogan LA, 2006, GEOLOGY, V34, P633, DOI 10.1130/G22737.1; Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Fu B, 2008, CONTRIB MINERAL PETR, V156, P197, DOI 10.1007/s00410-008-0281-5; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; HINTON RW, 1991, GEOCHIM COSMOCHIM AC, V55, P3287, DOI 10.1016/0016-7037(91)90489-R; Hopkins M, 2008, NATURE, V456, P493, DOI 10.1038/nature07465; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Mallmann G, 2009, J PETROL, V50, P1765, DOI 10.1093/petrology/egp053; McLane J. E, 1973, GEOCHIM COSM SUPPL, V1, P1061; Reid MR, 2011, CONTRIB MINERAL PETR, V161, P293, DOI 10.1007/s00410-010-0532-0; Rubatto D, 2007, CHEM GEOL, V241, P38, DOI 10.1016/j.chemgeo.2007.01.027; Sano Y, 2002, CHEM GEOL, V184, P217, DOI 10.1016/S0009-2541(01)00366-7; Schmitt AK, 2011, EARTH PLANET SC LETT, V302, P349, DOI 10.1016/j.epsl.2010.12.022; Taylor DJ, 2009, EARTH PLANET SC LETT, V279, P157, DOI 10.1016/j.epsl.2008.12.030; Thomas JB, 2002, GEOCHIM COSMOCHIM AC, V66, P2887, DOI 10.1016/S0016-7037(02)00881-5; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Trail D, 2011, AM MINERAL, V96, P60, DOI 10.2138/am.2011.3506; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; Watson EB, 2005, SCIENCE, V308, P841, DOI 10.1126/science.1110873; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5	33	384	417	11	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					79	U238		10.1038/nature10655	http://dx.doi.org/10.1038/nature10655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129728				2022-12-28	WOS:000298031900037
J	Das, P				Das, Pamela			Profile Tewodros Melesse: an architect of sexual and reproductive health	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 26	2011	378	9806					1841	1841		10.1016/S0140-6736(11)61800-X	http://dx.doi.org/10.1016/S0140-6736(11)61800-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	22118435				2022-12-28	WOS:000297695800018
J	Levine, B; Elazar, Z				Levine, Beth; Elazar, Zvulun			Inheriting Maternal mtDNA	SCIENCE			English	Editorial Material							MITOCHONDRIAL-DNA; AUTOPHAGY; UBIQUITIN		[Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Weizmann Institute of Science	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dept Internal Med, Ctr Autophagy Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu; zvulun.elazar@weizmann.ac.il			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA109618] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	14	15	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1069	1070		10.1126/science.1215480	http://dx.doi.org/10.1126/science.1215480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116870	Green Accepted			2022-12-28	WOS:000297313900031
J	Chen, LQ; Qu, XQ; Hou, BH; Sosso, D; Osorio, S; Fernie, AR; Frommer, WB				Chen, Li-Qing; Qu, Xiao-Qing; Hou, Bi-Huei; Sosso, Davide; Osorio, Sonia; Fernie, Alisdair R.; Frommer, Wolf B.			Sucrose Efflux Mediated by SWEET Proteins as a Key Step for Phloem Transport	SCIENCE			English	Article							DISEASE-SUSCEPTIBILITY GENE; BACTERIAL-BLIGHT; SUGAR-BEET; RICE; RESISTANCE; CARBON; XA13; MECHANISMS; EXPRESSION; SYSTEMS	Plants transport fixed carbon predominantly as sucrose, which is produced in mesophyll cells and imported into phloem cells for translocation throughout the plant. It is not known how sucrose migrates from sites of synthesis in the mesophyll to the phloem, or which cells mediate efflux into the apoplasm as a prerequisite for phloem loading by the SUT sucrose-H(+) (proton) cotransporters. Using optical sucrose sensors, we identified a subfamily of SWEET sucrose efflux transporters. AtSWEET11 and 12 localize to the plasma membrane of the phloem. Mutant plants carrying insertions in AtSWEET11 and 12 are defective in phloem loading, thus revealing a two-step mechanism of SWEET-mediated export from parenchyma cells feeding H(+)-coupled import into the sieve element-companion cell complex. We discuss how restriction of intercellular transport to the interface of adjacent phloem cells may be an effective mechanism to limit the availability of photosynthetic carbon in the leaf apoplasm in order to prevent pathogen infections.	[Chen, Li-Qing; Qu, Xiao-Qing; Hou, Bi-Huei; Sosso, Davide; Frommer, Wolf B.] Carnegie Inst Washington, Stanford, CA 94305 USA; [Qu, Xiao-Qing] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Beijing 100193, Peoples R China; [Osorio, Sonia; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	Carnegie Institution for Science; China Agricultural University; Max Planck Society	Frommer, WB (corresponding author), Carnegie Inst Washington, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Osorio, Sonia/M-2258-2014; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Osorio, Sonia/0000-0002-0159-6091; Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115	U.S. Department of Energy [DE-FG02-04ER15542]; National Institute of Diabetes and Digestive and Kidney Diseases [1RO1DK079109]; Chinese Scholarship Council [2009635108]; Max-Planck-Gesellschaft; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chinese Scholarship Council(China Scholarship Council); Max-Planck-Gesellschaft(Max Planck Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Grossmann and D. Ehrhardt for advice and help with confocal imaging; J. Bailey-Serres for help with the translatome analyses; K. Barton and T. Liu for plastic embedding and sectioning help and advice; and V. Lanquar and A. Jones for critical reading of the manuscript. Supported by U.S. Department of Energy grant DE-FG02-04ER15542 and National Institute of Diabetes and Digestive and Kidney Diseases grant 1RO1DK079109 (W. B. F.); the Carnegie Institution and the Scholarship Program of the Chinese Scholarship Council (grant 2009635108) (X.-Q. Q.); and the Max-Planck-Gesellschaft (S.O. and A. R. F.). Author contributions: W. B. F. and L.-Q. C. conceived and designed the experiments. L.-Q. C., X.-Q. Q., D. S., B.-H. H., and S. O. performed the experiments. W. B. F., L.-Q. C., X.-Q. Q., D. S., B.-H. H., S. O., and A. R. F. analyzed the data. L.-Q. C. and W. B. F. wrote the manuscript.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Fu QS, 2011, PLANT PHYSIOL, V157, P1518, DOI 10.1104/pp.111.184820; GEIGER DR, 1974, PLANT PHYSIOL, V54, P892, DOI 10.1104/pp.54.6.892; GIAQUINTA RT, 1983, ANNU REV PLANT PHYS, V34, P347, DOI 10.1146/annurev.pp.34.060183.002023; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Haritatos E, 2000, PLANTA, V211, P105, DOI 10.1007/s004250000268; Lager I, 2006, J BIOL CHEM, V281, P30875, DOI 10.1074/jbc.M605257200; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; LEMOINE R, 1989, FEBS LETT, V249, P129, DOI 10.1016/0014-5793(89)80030-4; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; MAYNARD JW, 1982, PLANT PHYSIOL, V70, P1436, DOI 10.1104/pp.70.5.1436; Okumoto S, 2008, NEW PHYTOL, V180, P271, DOI 10.1111/j.1469-8137.2008.02611.x; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Paterson AH, 2011, P NATL ACAD SCI USA, V108, P10931, DOI 10.1073/pnas.1107959108; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; RIESMEIER JW, 1994, EMBO J, V13, P1; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; Sutton PN, 2007, PHYSIOL PLANTARUM, V129, P787, DOI 10.1111/j.1399-3054.2007.00863.x; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046; Zhou YC, 2009, J EXP BOT, V60, P71, DOI 10.1093/jxb/ern254; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	33	734	804	56	549	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					207	211		10.1126/science.1213351	http://dx.doi.org/10.1126/science.1213351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22157085				2022-12-28	WOS:000299033100050
J	Balazs, AB; Chen, J; Hong, CM; Rao, DS; Yang, LL; Baltimore, D				Balazs, Alejandro B.; Chen, Joyce; Hong, Christin M.; Rao, Dinesh S.; Yang, Lili; Baltimore, David			Antibody-based protection against HIV infection by vectored immunoprophylaxis	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEDIATED GENE-TRANSFER; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; ADENOASSOCIATED VIRUS; THERAPEUTIC LEVELS; FACTOR-IX; BROAD; EXPRESSION; DESIGN	Despite tremendous efforts, development of an effective vaccine against human immunodeficiency virus (HIV) has proved an elusive goal. Recently, however, numerous antibodies have been identified that are capable of neutralizing most circulating HIV strains(1-5). These antibodies all exhibit an unusually high level of somatic mutation(6), presumably owing to extensive affinity maturation over the course of continuous exposure to an evolving antigen(7). Although substantial effort has focused on the design of immunogens capable of eliciting antibodies de novo that would target similar epitopes(8-10), it remains uncertain whether a conventional vaccine will be able to elicit analogues of the existing broadly neutralizing antibodies. As an alternative to immunization, vector-mediated gene transfer could be used to engineer secretion of the existing broadly neutralizing antibodies into the circulation. Here we describe a practical implementation of this approach, which we call vectored immunoprophylaxis (VIP), which in mice induces lifelong expression of these monoclonal antibodies at high concentrations from a single intramuscular injection. This is achieved using a specialized adeno-associated virus vector optimized for the production of full-length antibody from muscle tissue. We show that humanized mice receiving VIP appear to be fully protected from HIV infection, even when challenged intravenously with very high doses of replication-competent virus. Our results suggest that successful translation of this approach to humans may produce effective prophylaxis against HIV.	[Balazs, Alejandro B.; Chen, Joyce; Hong, Christin M.; Yang, Lili; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baltimore, D (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/ABG-1257-2021; Rao, Dinesh/AAE-9625-2019	Rao, Dinesh/0000-0002-0794-9337; Chen, Joyce/0000-0001-7851-8457; Balazs, Alejandro/0000-0002-1767-3944; Hong, Christin/0000-0003-1826-9246	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative [37866]; National Institutes of Health through the National Institute of Allergy and Infectious Disease (NIAID) [HHSN266200500035C]; Joint Center for Translational Medicine; amfAR [107756-47-RFVA]; National Institutes of Health [1K08CA133521]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K08AI050035] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; National Institutes of Health through the National Institute of Allergy and Infectious Disease (NIAID); Joint Center for Translational Medicine; amfAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Wilson for AAV8-related plasmids and assistance, D. Burton for b12 and 2G12 expression plasmids, G. Nabel for 4E10, 2F5 and VRC01 expression plasmids, and the Caltech Protein Expression Center for providing purified antibodies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: pNL4-3 from M. Martin, and TZM-bl cells from J. Kappes and X. Wu. We thank J. Bloom, D. Kotton, D. Majumdar, G. Mostoslavsky, R. O'Connell and A. Sigal for comments, and other members of the Baltimore laboratory for their assistance in performing this work. This project was supported by the Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative (awarded to D. B.) Grand Challenge grant 37866 and by the National Institutes of Health (HHSN266200500035C) through a contract from the National Institute of Allergy and Infectious Disease (NIAID) and by the Joint Center for Translational Medicine. A. B. B. is supported by amfAR postdoctoral research fellowship 107756-47-RFVA. D. S. R. is supported by career development award 1K08CA133521 from the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Breous E, 2010, MOL THER, V18, P766, DOI 10.1038/mt.2009.301; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Diskin R., 2011, SCIENCE         1027, DOI [10.1126/science.1213782, DOI 10.1126/SCIENCE.1213782]; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; KALUZA G, 1992, PATHOL RES PRACT, V188, P91, DOI 10.1016/S0344-0338(11)81162-3; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; West AP, 2012, J VIROL, V86, P195, DOI 10.1128/JVI.05848-11; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	408	450	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					81	U88		10.1038/nature10660	http://dx.doi.org/10.1038/nature10660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139420	Green Accepted, Green Submitted			2022-12-28	WOS:000298836900033
J	Garcia-Castellanos, D; Villasenor, A				Garcia-Castellanos, D.; Villasenor, A.			Messinian salinity crisis regulated by competing tectonics and erosion at the Gibraltar arc	NATURE			English	Article							SLAB DETACHMENT; RIVER INCISION; DESICCATION; CHRONOLOGY; EVOLUTION; DYNAMICS; MOROCCO; BEDROCK; EVENTS; UPLIFT	The Messinian salinity crisis(1,2) (5.96 to 5.33 million years ago) was caused by reduced water inflow from the Atlantic Ocean to the Mediterranean Sea resulting in widespread salt precipitation and a decrease in Mediterranean sea level of about 1.5 kilometres due to evaporation(3). The reduced connectivity between the Atlantic and the Mediterranean at the time of the salinity crisis is thought to have resulted from tectonic uplift of the Gibraltar arc seaway and global sea-level changes, both of which control the inflow of water required to compensate for the hydrological deficit of the Mediterranean(1,4). However, the different timescales on which tectonic uplift and changes in sea level occur are difficult to reconcile with the long duration of the shallow connection between the Mediterranean and the Atlantic(5) needed to explain the large amount of salt precipitated. Here we use numerical modelling to show that seaway erosion caused by the Atlantic inflow could sustain such a shallow connection between the Atlantic and the Mediterranean by counteracting tectonic uplift. The erosion and uplift rates required are consistent with previous mountain erosion studies, with the present altitude of marine sediments in the Gibraltar arc(6,7) and with geodynamic models suggesting a lithospheric slab tear underneath the region(8-10). The moderate Mediterranean sea-level drawdown during the early stages of the Messinian salinity crisis(3,5) can be explained by an uplift of a few millimetres per year counteracted by similar rates of erosion due to Atlantic inflow. Our findings suggest that the competition between uplift and erosion can result in harmonic coupling between erosion and the Mediterranean sea level, providing an alternative mechanism for the cyclicity observed in early salt precipitation deposits and calling into question previous ideas regarding the timing of the events that occurred during the Messinian salinity crisis(1).	[Garcia-Castellanos, D.; Villasenor, A.] CSIC, Inst Ciencias Tierra Jaume Almera, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN)	Garcia-Castellanos, D (corresponding author), CSIC, Inst Ciencias Tierra Jaume Almera, Sole & Sabaris S-N, E-08028 Barcelona, Spain.	danielgc@ictja.csic.es	Villasenor, Antonio/A-8037-2008; Garcia-Castellanos, Daniel/B-1203-2008	Villasenor, Antonio/0000-0001-8592-4832; Garcia-Castellanos, Daniel/0000-0001-8454-8572	Spanish government [CGL2009-09662, CGL2006-05493, CGL2008-03474-E/BTE, CSD2006-00041]	Spanish government(Spanish GovernmentEuropean Commission)	We thank P. Meijer, S. Giralt, L. Matenco and C. Ayora for comments and criticisms on earlier versions of the manuscript. This work was funded by the Spanish government through the projects ATIZA (CGL2009-09662), TopoAtlas (CGL2006-05493), TopoMed (CGL2008-03474-E/BTE) and TopoIberia (CSD2006-00041).	AHARON P, 1993, GEOLOGY, V21, P771, DOI 10.1130/0091-7613(1993)021<0771:SLEITS>2.3.CO;2; Andrews ER, 2009, TECTONOPHYSICS, V464, P60, DOI 10.1016/j.tecto.2007.09.004; Attal M, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001875; Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; Babault J, 2008, TERRA NOVA, V20, P102, DOI 10.1111/j.1365-3121.2008.00794.x; BARBER PM, 1981, MAR GEOL, V44, P253, DOI 10.1016/0025-3227(81)90053-0; Blanc PL, 2006, PALAEOGEOGR PALAEOCL, V238, P349, DOI 10.1016/j.palaeo.2006.03.033; Blanc PL, 2002, GEODIN ACTA, V15, P303, DOI 10.1016/S0985-3111(02)01095-1; Briand F., 2008, CIESM WORKSHOP MONOG, V30; BRYDEN HL, 1984, OCEANOL ACTA, V7, P289; Clauzon G, 1996, GEOLOGY, V24, P363, DOI 10.1130/0091-7613(1996)024<0363:AIOTMS>2.3.CO;2; CLAUZON G, 1978, MAR GEOL, V27, P231, DOI 10.1016/0025-3227(78)90033-6; COMAS M. C., 1999, P OCEAN DRILL PROGRA, V161, P555, DOI [DOI 10.2973/ODP.PROC.SR.161.262.1999, DOI 10.2973/ODP.PROC]; de Lange GJ, 2010, MAR GEOL, V275, P273, DOI 10.1016/j.margeo.2010.05.003; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Elliot W.J., 1989, 3 NSERL USDAARS PURD; Fauquette S, 2006, PALAEOGEOGR PALAEOCL, V238, P281, DOI 10.1016/j.palaeo.2006.03.029; Flecker R, 2006, SEDIMENT GEOL, V188, P189, DOI 10.1016/j.sedgeo.2006.03.005; Garces M, 1998, EARTH PLANET SC LETT, V163, P69, DOI 10.1016/S0012-821X(98)00176-9; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Gargani J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029885; Gerya TV, 2004, EARTH PLANET SC LETT, V226, P101, DOI 10.1016/j.epsl.2004.07.022; Gladstone R, 2007, PALAEOGEOGR PALAEOCL, V251, P254, DOI 10.1016/j.palaeo.2007.03.050; Govers R, 2009, GEOLOGY, V37, P167, DOI 10.1130/G25141A.1; Hilgen F, 2007, STRATIGRAPHY, V4, P231; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Iribarren L, 2009, TECTONOPHYSICS, V475, P68, DOI 10.1016/j.tecto.2008.11.029; Just J, 2011, GEO-MAR LETT, V31, P51, DOI 10.1007/s00367-010-0213-z; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Krijgsman W, 1999, MAR GEOL, V153, P147, DOI 10.1016/S0025-3227(98)00084-X; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; Meijer PT, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000956; Meijer PT, 2005, EARTH PLANET SC LETT, V240, P510, DOI 10.1016/j.epsl.2005.09.029; Rohling EJ, 2008, EARTH PLANET SC LETT, V275, P165, DOI 10.1016/j.epsl.2008.08.022; ROUCHY JM, 1992, GEOLOGY, V20, P629, DOI 10.1130/0091-7613(1992)020<0629:LMEITM>2.3.CO;2; Ryan WBF, 2009, SEDIMENTOLOGY, V56, P95, DOI 10.1111/j.1365-3091.2008.01031.x; Schneck R, 2010, PALAEOGEOGR PALAEOCL, V286, P149, DOI 10.1016/j.palaeo.2009.12.011; Spakman W., 2004, TRANSMED ATLAS MEDIT, P31, DOI DOI 10.1007/978-3-642-18919-7_2; Turowski JM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000697; Villasenor A., 2003, GEOPH RES ABSTR, V5; WEIJERMARS R, 1988, TECTONOPHYSICS, V148, P211, DOI 10.1016/0040-1951(88)90129-1; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Whipple KX, 2000, GEOL SOC AM BULL, V112, P490, DOI 10.1130/0016-7606(2000)112<0490:RIIBMA>2.3.CO;2; Wobus C, 2005, NATURE, V434, P1008, DOI 10.1038/nature03499	45	173	174	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					359	U108		10.1038/nature10651	http://dx.doi.org/10.1038/nature10651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170684				2022-12-28	WOS:000298033000049
J	Hu, JJ; Prinz, WA; Rapoport, TA				Hu, Junjie; Prinz, William A.; Rapoport, Tom A.			Weaving the Web of ER Tubules	CELL			English	Review							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL FUSION; MEMBRANE-PROTEINS; HOMOTYPIC FUSION; GOLGI-APPARATUS; ATLASTIN; MICROTUBULES; MECHANISMS; REVEALS		[Hu, Junjie] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Hu, Junjie] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Nankai University; Nankai University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hu, JJ (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China.	huj@nankai.edu.cn; tom_rapoport@hms.harvard.edu	Hu, Junjie/F-9713-2013		National Basic Research Program of China (973 Program) [2010CB833702]; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.H. is supported by the National Basic Research Program of China (973 Program, Grant 2010CB833702). W.A.P. is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. T.A.R. is a Howard Hughes Medical Institute Investigator.	Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Griffing LR, 2010, BIOCHEM SOC T, V38, P747, DOI 10.1042/BST0380747; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Lee M, 2009, DEV BIOL, V330, P250, DOI 10.1016/j.ydbio.2009.03.019; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	31	103	108	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1226	1231		10.1016/j.cell.2011.11.022	http://dx.doi.org/10.1016/j.cell.2011.11.022			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153070	Green Accepted, Bronze			2022-12-28	WOS:000298148100013
J	Levaot, N; Voytyuk, O; Dimitriou, I; Sircoulomb, F; Chandrakumar, A; Deckert, M; Krzyzanowski, PM; Scotter, A; Gu, SQ; Janmohamed, S; Cong, F; Simoncic, PD; Ueki, Y; La Rose, J; Rottapel, R				Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Deckert, Marcel; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Cong, Feng; Simoncic, Paul D.; Ueki, Yasuyoshi; La Rose, Jose; Rottapel, Robert			Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism	CELL			English	Article							ADAPTER PROTEIN 3BP2; TYROSINE KINASE; POLY(ADP-RIBOSE) POLYMERASE; TELOMERE LENGTH; IDENTIFICATION; SH3BP2; SRC; ACTIVATION; EXPRESSION; PP60C-SRC	Cherubism is an autosomal-dominant syndrome characterized by inflammatory destructive bony lesions resulting in symmetrical deformities of the facial bones. Cherubism is caused by mutations in Sh3bp2, the gene that encodes the adaptor protein 3BP2. Most identified mutations in 3BP2 lie within the peptide sequence RSPPDG. A mouse model of cherubism develops hyperactive bone-remodeling osteoclasts and systemic inflammation characterized by expansion of the myelomonocytic lineage. The mechanism by which cherubism mutations alter 3BP2 function has remained obscure. Here we show that Tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family, regulates 3BP2 stability through ADP-ribosylation and subsequent ubiquitylation by the E3-ubiquitin ligase RNF146 in osteoclasts. Cherubism mutations uncouple 3BP2 from Tankyrase-mediated protein destruction, which results in its stabilization and subsequent hyperactivation of the SRC, SYK, and VAV signaling pathways.	[Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Simoncic, Paul D.; La Rose, Jose; Rottapel, Robert] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Levaot, Noam; Voytyuk, Oleksandr; Dimitriou, Ioannis; Sircoulomb, Fabrice; Chandrakumar, Arun; Krzyzanowski, Paul M.; Scotter, Andrew; Gu, Shengqing; Janmohamed, Salima; Simoncic, Paul D.; La Rose, Jose; Rottapel, Robert] Univ Toronto, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Deckert, Marcel] Univ Nice, INSERM, UMR576, F-06202 Nice, France; [Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Ueki, Yasuyoshi] Univ Missouri, Sch Dent, Kansas City, MO 64108 USA; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Novartis; University of Missouri System; University of Missouri Kansas City; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rottapel, R (corresponding author), Univ Toronto, Ontario Canc Inst, 101 Coll St,Rm 8-703,Toronto Med Discovery Tower, Toronto, ON M5G 1L7, Canada.	rottapel@uhnres.utoronto.ca	Deckert, Marcel/T-3566-2019; Levaot, Noam/AAA-3052-2022; Deckert, Marcel/M-4998-2016	Deckert, Marcel/0000-0003-2094-559X; Levaot, Noam/0000-0001-7747-3883; Gu, Shengqing/0000-0002-4200-0864; Krzyzanowski, Paul/0000-0001-6430-5995; Rottapel, Robert/0000-0002-6024-5558	Terry Fox Research Institute [20003]; Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long Term Care; Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital; Arthritis Centre, University of Toronto; Charles H. Hood Foundation, Inc., Boston, MA; National Institutes of Health [R01DE020835]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020835] Funding Source: NIH RePORTER	Terry Fox Research Institute; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital; Arthritis Centre, University of Toronto; Charles H. Hood Foundation, Inc., Boston, MA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the Terry Fox Research Institute (TFPP Grant #20003), by the Canadian Cancer Society Research Institute, and by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. R.R. is supported by the Amgen Chair for Cancer Research from the PMHF at the Ontario Cancer Institute, Princess Margaret Hospital. N.L. was supported by the Arthritis Centre for Excellence Fellowship, University of Toronto. Y.U. was supported by the Charles H. Hood Foundation, Inc., Boston, MA and research grant R01DE020835 from the National Institutes of Health. We thank Gerald Gish for providing the peptides and Sebastian Geuttler for assistance with the fluorescence polarization experiments. We thank Ben Neel and Norman Iscove for discussion regarding the chimera experiments. We thank Mauricio Medrano for graphic design. We thank Frank Sicheri, Sebastian Geuttler, Ernst Reichenberger, Gregg Morin, Vuk Stambolic, and Ben Neel for critical reading of the manuscript.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 2006, M S-MED SCI, V22, P1081, DOI 10.1051/medsci/200622121081; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; JONES WA, 1950, J BONE JOINT SURG BR, V32, P334, DOI 10.1302/0301-620X.32B3.334; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	33	140	141	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1324	1339		10.1016/j.cell.2011.10.045	http://dx.doi.org/10.1016/j.cell.2011.10.045			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153076	Green Accepted, Bronze			2022-12-28	WOS:000298148100021
J	Delamothe, T				Delamothe, Tony			Reading the riot acts	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7935	10.1136/bmj.d7935	http://dx.doi.org/10.1136/bmj.d7935			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SP	22162384				2022-12-28	WOS:000298039800006
J	Olshansky, SJ				Olshansky, S. Jay			Aging of US Presidents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Illinois, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olshansky, SJ (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	sjayo@uic.edu						[Anonymous], WORKSH REP BIOM AG P; [Anonymous], CBS NEWS; Bell FC, LIFE TABLES US SOCIA; Freiman A, 2004, J CUTAN MED SURG, V8, P415, DOI 10.1007/s10227-005-0020-8; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435	6	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2328	2329		10.1001/jama.2011.1786	http://dx.doi.org/10.1001/jama.2011.1786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147378	Bronze			2022-12-28	WOS:000297680300017
J	Rosu, S; Libuda, DE; Villeneuve, AM				Rosu, Simona; Libuda, Diana E.; Villeneuve, Anne M.			Robust Crossover Assurance and Regulated Interhomolog Access Maintain Meiotic Crossover Number	SCIENCE			English	Article							DNA BREAK REPAIR; CROSSING-OVER; C-ELEGANS; MEIOSIS; RECOMBINATION; MECHANISM; INTERFERENCE; HOMEOSTASIS; SYNAPSIS	Most organisms rely on interhomolog crossovers (COs) to ensure proper meiotic chromosome segregation but make few COs per chromosome pair. By monitoring repair events at a defined double-strand break (DSB) site during Caenorhabditis elegans meiosis, we reveal mechanisms that ensure formation of the obligate CO while limiting CO number. We find that CO is the preferred DSB repair outcome in the absence of inhibitory effects of other (nascent) recombination events. Thus, a single DSB per chromosome pair is largely sufficient to ensure CO formation. Further, we show that access to the homolog as a repair template is regulated, shutting down simultaneously for both CO and noncrossover (NCO) pathways. We propose that regulation of interhomolog access limits CO number and contributes to CO interference.	[Rosu, Simona; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Libuda, Diana E.; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	annev@stanford.edu		Libuda, Diana/0000-0002-4944-1814	NIH [R01GM67268]; Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268, T32GM007790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge V. Robert, E. Jorgensen, and J.-L. Bessereau for sharing data and strains central to the Mos1 assay before publication and thank K. Zawadzki and S. Mlynarczyk-Evans for comments on the manuscript and M. Zetka, J. Culotti, A. Dernburg, and Caenorhabditis Genetics Center for reagents and strains. This work was supported by NIH grant R01GM67268 to A. M. V. and a Helen Hay Whitney Fellowship to D. E. L. Author contributions: Most experiments were conceived and data analyzed by S. R. and A. M. V. S. R. performed all experiments except for those in figs. S2D and S4, which were performed and analyzed by D.E.L.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hyppa RW, 2010, CELL, V142, P243, DOI 10.1016/j.cell.2010.05.041; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kelly KO, 2000, GENETICS, V156, P617; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robert VJ, 2008, GENETICS, V180, P673, DOI 10.1534/genetics.108.089698; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	17	87	88	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1286	1289		10.1126/science.1212424	http://dx.doi.org/10.1126/science.1212424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144627	Green Accepted			2022-12-28	WOS:000297553600053
J	Bohmer, RMJ				Bohmer, Richard M. J.			The Four Habits of High-Value Health Care Organizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPROVEMENT		Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Bohmer, RMJ (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Bohmer R. M., 2009, DESIGNING CARE; E Nelson, 2011, VALUE DESIGN DEV CLI; Horbar JD, 2003, PEDIATRICS, V111; James BC, 2011, HEALTH AFFAIR, V30, P1185, DOI 10.1377/hlthaff.2011.0358; Rathod RH, 2010, CONGENIT HEART DIS, V5, P343, DOI 10.1111/j.1747-0803.2010.00438.x	5	68	70	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2045	2047		10.1056/NEJMp1111087	http://dx.doi.org/10.1056/NEJMp1111087			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	854MO	22129249				2022-12-28	WOS:000297499000002
J	Wicherts, JM				Wicherts, Jelte M.			Psychology must learn a lesson from fraud case	NATURE			English	Editorial Material									Univ Amsterdam, Dept Psychol, NL-1018 XA Amsterdam, Netherlands	University of Amsterdam	Wicherts, JM (corresponding author), Univ Amsterdam, Dept Psychol, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	J.M.Wicherts@uva.nl	Wicherts, Jelte M./A-2664-2008	Wicherts, Jelte M./0000-0003-2415-2933				Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; 2011, NATURE, V479, P15; 2011, NATURE, V479, P151	3	39	40	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					7	7		10.1038/480007a	http://dx.doi.org/10.1038/480007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PO	22129686	Bronze			2022-12-28	WOS:000298031900006
J	Hammond, P				Hammond, Phil			SEXUAL HEALTH Warts and all at last: HPV vaccination	BRITISH MEDICAL JOURNAL			English	Editorial Material												hamm82@msn.com						[Anonymous], 2006, LANCET, V368, P1212; *BRIT ASS SEX HLTH, 2011, BASHH WELC HPV VACC, pD3482; FAIRLEY CK, 2010, 2010 AUSTR SEX HLTH, pD3482; *GLAXOSMITHKLINE, GLAXOSMITHKLINE STAT, pD3482; HAMMOND P, 2011, PRIVATE EYE, V1282, P12; Hammond P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2186; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Kmietowicz Z, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7694	8	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7779	10.1136/bmj.d7779	http://dx.doi.org/10.1136/bmj.d7779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131211				2022-12-28	WOS:000298037300005
J	Sedrakyan, A; Normand, SLT; Dabic, S; Jacobs, S; Graves, S; Marinac-Dabic, D				Sedrakyan, Art; Normand, Sharon-Lise T.; Dabic, Stefan; Jacobs, Samantha; Graves, Stephen; Marinac-Dabic, Danica			Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METAL-ON-METAL; FEMORAL HEADS; ARTHROPLASTY; REPLACEMENT; REVISION; THA; ARTICULATION; COBALT; JOINT; DISLOCATION	Objective To determine comparative safety and effectiveness of combinations of bearing surfaces of hip implants. Design Systematic review of clinical trials, observational studies, and registries. Data sources Medline, Embase, Cochrane Controlled Trials Register, reference lists of articles, annual reports of major registries, summaries of safety and effectiveness for pre-market application and mandated post-market studies at the United States Food and Drug Administration. Study selection Criteria for inclusion were comparative studies in adults reporting information for various combinations of bearings (such as metal on metal and ceramic on ceramic). Data search, abstraction, and analyses were independently performed and confirmed by at least two authors. Qualitative data syntheses were performed. Results There were 3139 patients and 3404 hips enrolled in 18 comparative studies and over 830 000 operations in national registries. The mean age range in the trials was 42-71, and 26-88% were women. Disease specific functional outcomes and general quality of life scores were no different or they favoured patients receiving metal on polyethylene rather than metal on metal in the trials. While one clinical study reported fewer dislocations associated with metal on metal implants, in the three largest national registries there was evidence of higher rates of implant revision associated with metal on metal implants compared with metal on polyethylene. One trial reported fewer revisions with ceramic on ceramic compared with metal on polyethylene implants, but data from national registries did not support this finding. Conclusions There is limited evidence regarding comparative effectiveness of various hip implant bearings. Results do not indicate any advantage for metal on metal or ceramic on ceramic implants compared with traditional metal on polyethylene or ceramic on polyethylene bearings.	[Sedrakyan, Art] Weill Cornell Med Coll, New York, NY 10065 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sedrakyan, Art; Dabic, Stefan; Jacobs, Samantha; Marinac-Dabic, Danica] US FDA, Off Surveillance & Biometr, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Graves, Stephen] Univ Melbourne, Melbourne, Vic 3010, Australia	Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Food & Drug Administration (FDA); University of Melbourne	Sedrakyan, A (corresponding author), Weill Cornell Med Coll, 402 E 67th St,Suite 223, New York, NY 10065 USA.	ars2013@med.cornell.edu	Graves, Stephen E/A-9463-2016	Graves, Stephen E/0000-0002-1629-319X; Normand, Sharon-Lise/0000-0001-7027-4769; Marinac-Dabic, Danica/0000-0002-1824-0104	US Food and Drug Administration Center for Devices and Radiological Health	US Food and Drug Administration Center for Devices and Radiological Health	The study is funded by the US Food and Drug Administration Center for Devices and Radiological Health. The authors accept full responsibility for the conduct of the study, had access to the data, and controlled the decision to publish. The opinions expressed in this article are those of the authors and not necessarily those of the Food and Drug Administration.	[Anonymous], MED DEVICE ALERT ALL; [Anonymous], J J UNIT RECALLS 930; Bascarevic Z, 2010, INT ORTHOP, V34, P1129, DOI 10.1007/s00264-009-0899-6; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; Capello WN, 2008, J ARTHROPLASTY, V23, P39, DOI 10.1016/j.arth.2008.06.003; Capello William N, 2005, Instr Course Lect, V54, P171; Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P650, DOI 10.1302/0301-620X.85B5.13993; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Cuckler JM, 2004, J ARTHROPLASTY, V19, P41, DOI 10.1016/j.arth.2004.09.006; D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39; D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P151, DOI 10.1097/01.blo.0000194084.67364.6c; Dahlstrand H, 2009, J ARTHROPLASTY, V24, P837, DOI 10.1016/j.arth.2008.07.019; Delaunay CP, 2008, CLIN ORTHOP RELAT R, V466, P340, DOI 10.1007/s11999-007-0045-y; Dorr LD, 2004, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000150343.66755.79; Engh CA, 2009, CLIN ORTHOP RELAT R, V467, P101, DOI 10.1007/s11999-008-0540-9; Godlee F., 2011, BMJ-BRIT MED J, V342, pd3123, DOI DOI 10.1136/BMJ.D3123; Grubl A, 2006, J BONE JOINT SURG BR, V88B, P1003, DOI 10.1302/0301-620X.88B8; Hamilton WG, 2010, CLIN ORTHOP RELAT R, V468, P358, DOI 10.1007/s11999-009-1091-4; Hooper GJ, 2009, J BONE JOINT SURG BR, V91B, P451, DOI 10.1302/0301-620X.91B4.21363; Jacobs M, 2004, J ARTHROPLASTY, V19, P48, DOI 10.1016/j.arth.2004.06.021; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P876, DOI 10.1302/0301-620X.93B7.26657; Kawate K, 2009, J ARTHROPLASTY, V24, P1221, DOI 10.1016/j.arth.2009.05.023; Kim YH, 2009, J ARTHROPLASTY, V24, P885, DOI 10.1016/j.arth.2008.05.009; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lewis PM, 2010, J ARTHROPLASTY, V25, P392, DOI 10.1016/j.arth.2009.01.013; Lombardi AV, 2010, CLIN ORTHOP RELAT R, V468, P367, DOI 10.1007/s11999-009-1143-9; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; Meier B, 2001, NY TIMES        0310; Mullins MM, 2007, J ARTHROPLASTY, V22, P833, DOI 10.1016/j.arth.2006.10.003; Ochs U, 2007, Z ORTHOP UNFALLCHIR, V145, pS20, DOI 10.1055/s-2007-965655; Paxton EW, 2010, J BONE JOINT SURG AM, V92A, P117, DOI 10.2106/JBJS.J.00807; Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908; Poggie RA, 2007, J BONE JOINT SURG AM, V89A, P367, DOI 10.2106/JBJS.F.00148; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Skinner J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3009; Soderman P, 2001, ACTA ORTHOP SCAND, V72, P113, DOI 10.1080/000164701317323345; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Schewelov T, 2005, J BONE JOINT SURG BR, V87B, P1631, DOI 10.1302/0301-620X.87B12.16873; Zijlstra WP, 2009, ORTHOPEDICS, V32, P479, DOI 10.3928/01477447-20090527-06	39	36	37	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2011	343								d7434	10.1136/bmj.d7434	http://dx.doi.org/10.1136/bmj.d7434			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EL	22127517	Green Published, hybrid			2022-12-28	WOS:000298938100007
J	Duffy, TS				Duffy, Thomas S.			EARTH SCIENCE Probing the core's light elements	NATURE			English	Editorial Material							IRON; CONSTRAINTS		Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Duffy, TS (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	duffy@princeton.edu	Duffy, Thomas S/C-9140-2017	Duffy, Thomas S/0000-0002-5357-1259				Alfe D, 2002, EARTH PLANET SC LETT, V195, P91, DOI 10.1016/S0012-821X(01)00568-4; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Buffett BA, 1996, J GEOPHYS RES-SOL EA, V101, P7989, DOI 10.1029/95JB03539; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; Huang HJ, 2011, NATURE, V479, P513, DOI 10.1038/nature10621; Huang HJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006514; JEPHCOAT A, 1987, NATURE, V325, P332, DOI 10.1038/325332a0; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; MCQUEEN RG, 1966, J GEOPHYS RES, V71, P1751, DOI 10.1029/JZ071i006p01751; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763	12	5	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					480	481		10.1038/479480a	http://dx.doi.org/10.1038/479480a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113686				2022-12-28	WOS:000297285600036
J	Grbic, M; Van Leeuwen, T; Clark, RM; Rombauts, S; Rouze, P; Grbic, V; Osborne, EJ; Dermauw, W; Phuong, CTN; Ortego, F; Hernandez-Crespo, P; Diaz, I; Martinez, M; Navajas, M; Sucena, E; Magalhaes, S; Nagy, L; Pace, RM; Djuranovic, S; Smagghe, G; Iga, M; Christiaens, O; Veenstra, JA; Ewer, J; Villalobos, RM; Hutter, JL; Hudson, SD; Velez, M; Yi, SV; Zeng, J; Pires-daSilva, A; Roch, F; Cazaux, M; Navarro, M; Zhurov, V; Acevedo, G; Bjelica, A; Fawcett, JA; Bonnet, E; Martens, C; Baele, G; Wissler, L; Sanchez-Rodriguez, A; Tirry, L; Blais, C; Demeestere, K; Henz, SR; Gregory, TR; Mathieu, J; Verdon, L; Farinelli, L; Schmutz, J; Lindquist, E; Feyereisen, R; Van de Peer, Y				Grbic, Miodrag; Van Leeuwen, Thomas; Clark, Richard M.; Rombauts, Stephane; Rouze, Pierre; Grbic, Vojislava; Osborne, Edward J.; Dermauw, Wannes; Phuong Cao Thi Ngoc; Ortego, Felix; Hernandez-Crespo, Pedro; Diaz, Isabel; Martinez, Manuel; Navajas, Maria; Sucena, Elio; Magalhaes, Sara; Nagy, Lisa; Pace, Ryan M.; Djuranovic, Sergej; Smagghe, Guy; Iga, Masatoshi; Christiaens, Olivier; Veenstra, Jan A.; Ewer, John; Mancilla Villalobos, Rodrigo; Hutter, Jeffrey L.; Hudson, Stephen D.; Velez, Marisela; Yi, Soojin V.; Zeng, Jia; Pires-daSilva, Andre; Roch, Fernando; Cazaux, Marc; Navarro, Marie; Zhurov, Vladimir; Acevedo, Gustavo; Bjelica, Anica; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Wissler, Lothar; Sanchez-Rodriguez, Aminael; Tirry, Luc; Blais, Catherine; Demeestere, Kristof; Henz, Stefan R.; Gregory, T. Ryan; Mathieu, Johannes; Verdon, Lou; Farinelli, Laurent; Schmutz, Jeremy; Lindquist, Erika; Feyereisen, Rene; Van de Peer, Yves			The genome of Tetranychus urticae reveals herbivorous pest adaptations	NATURE			English	Article							HOX GENES; SPIDER; MODEL; MITE	The spider mite Tetranychus urticae is a cosmopolitan agricultural pest with an extensive host plant range and an extreme record of pesticide resistance. Here we present the completely sequenced and annotated spider mite genome, representing the first complete chelicerate genome. At 90 megabases T. urticae has the smallest sequenced arthropod genome. Compared with other arthropods, the spider mite genome shows unique changes in the hormonal environment and organization of the Hox complex, and also reveals evolutionary innovation of silk production. We find strong signatures of polyphagy and detoxification in gene families associated with feeding on different hosts and in new gene families acquired by lateral gene transfer. Deep transcriptome analysis of mites feeding on different plants shows how this pest responds to a changing host environment. The T. urticae genome thus offers new insights into arthropod evolution and plant-herbivore interactions, and provides unique opportunities for developing novel plant protection strategies.	[Rombauts, Stephane; Rouze, Pierre; Phuong Cao Thi Ngoc; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Grbic, Miodrag; Grbic, Vojislava; Cazaux, Marc; Navarro, Marie; Zhurov, Vladimir; Acevedo, Gustavo; Bjelica, Anica] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Grbic, Miodrag; Grbic, Vojislava] UR, CSIC, Inst Ciencias Vid & Vino, Logrono 26006, Spain; [Van Leeuwen, Thomas; Dermauw, Wannes; Smagghe, Guy; Iga, Masatoshi; Christiaens, Olivier; Tirry, Luc] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Clark, Richard M.; Osborne, Edward J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rombauts, Stephane; Rouze, Pierre; Phuong Cao Thi Ngoc; Fawcett, Jeffrey A.; Bonnet, Eric; Martens, Cindy; Baele, Guy; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Ortego, Felix; Hernandez-Crespo, Pedro] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Diaz, Isabel; Martinez, Manuel] UPM INIA, Ctr Biotecnol & Genom Plantas, Madrid 28223, Spain; [Navajas, Maria] Montpellier SupAgro, Cirad, IRD, INRA,UMR CBGP, F-34988 Montferrier Sur Lez, France; [Sucena, Elio] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Sucena, Elio] Univ Lisbon, Fac Ciencias, Dept Biol Anim, P-1749016 Lisbon, Portugal; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal; [Nagy, Lisa; Pace, Ryan M.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Djuranovic, Sergej] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Veenstra, Jan A.] Univ Bordeaux 1, Inst Neurosci Cognit & Integrat Aquitaine, F-33405 Talence, France; [Ewer, John; Mancilla Villalobos, Rodrigo] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2360102, Chile; [Hutter, Jeffrey L.; Hudson, Stephen D.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 5B7, Canada; [Velez, Marisela] CSIC, Inst Catalisis & Petroleoquim, E-28040 Madrid, Spain; [Velez, Marisela] Univ Autonoma Madrid, Fac Ciencias, IMDEA Nanociencias, Madrid 28050, Spain; [Yi, Soojin V.; Zeng, Jia] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Pires-daSilva, Andre] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Roch, Fernando] Univ Toulouse 3, Univ Toulouse, UPS, Ctr Dev Biol, F-31062 Toulouse, France; [Roch, Fernando] CNRS, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France; [Wissler, Lothar] Univ Munster, Inst Evolut & Biodivers, Evolutionary Bioinformat Grp, D-48149 Munster, Germany; [Sanchez-Rodriguez, Aminael] Katholieke Univ Leuven, Dept Microbial & Mol Syst, CMPG, B-3001 Louvain, Belgium; [Blais, Catherine] Univ Paris 06, CNRS, UMR 7622, Equipe Biogenese Signaux Hormonaux, F-75005 Paris, France; [Demeestere, Kristof] Univ Ghent, Fac Biosci Engn, Dept Sustainable Organ Chem & Technol, Res Grp EnVOC, B-9000 Ghent, Belgium; [Henz, Stefan R.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Gregory, T. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Mathieu, Johannes] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Verdon, Lou] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada; [Farinelli, Laurent] Fasteris SA, CH-1228 Plan Les Ouates, Switzerland; [Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Schmutz, Jeremy; Lindquist, Erika] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Feyereisen, Rene] Univ Nice Sophia Antipolis, F-06903 Sophia Antipolis, France; [Feyereisen, Rene] CNRS, INRA, UMR 1301, F-06903 Sophia Antipolis, France	Flanders Institute for Biotechnology (VIB); Ghent University; Western University (University of Western Ontario); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Ghent University; Utah System of Higher Education; University of Utah; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad Politecnica de Madrid; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; University of Arizona; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universidad de Valparaiso; Western University (University of Western Ontario); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Autonomous University of Madrid; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Arlington; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Munster; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Max Planck Society; University of Guelph; Cornell University; Boyce Thompson Institute for Plant Research; Agriculture & Agri Food Canada; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); INRAE	Van de Peer, Y (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	mgrbic@uwo.ca; yves.vandepeer@psb.ugent.be	Acevedo-Hernandez, Gustavo J./D-5745-2011; Sucena, Élio/M-1753-2015; Grbic, Miodrag/AID-4825-2022; Pace, Ryan/AAY-7774-2020; NAVAJAS, Maria/AAM-2294-2020; Silva, André/HHN-2071-2022; Smagghe, Guy/AAE-8914-2019; Ortego, Félix/F-9402-2011; Velez, Marisela/F-2900-2013; Diaz, Isabel/I-8840-2014; Rombauts, Stephane/P-2420-2019; Van Leeuwen, Thomas/H-5036-2013; Pedro, Hernandez-Crespo/H-9937-2015; Christiaens, Olivier/AAB-3634-2019; Feyereisen, René/I-3140-2012; Sucena, Élio/ABF-6684-2020; da Silva, Andre Pires/B-1066-2008; Veenstra, Jan/B-4610-2008; Pace, Ryan/I-5272-2015; Martinez, Manuel/I-8743-2014; Van de Peer, Yves/AAE-7666-2019; Fawcett, Jeffrey/B-4145-2008; Dermauw, Wannes/H-1583-2015; Feyereisen, René/Y-7514-2019; Baele, Guy/R-8157-2017; S., Magalhaes/B-9673-2012; Van de Peer, Yves/D-4388-2009; Schmutz, Jeremy/N-3173-2013; Rombauts, Stephane M/D-7640-2014; mancilla, rodrigo/C-8380-2011	Acevedo-Hernandez, Gustavo J./0000-0002-3959-9220; Sucena, Élio/0000-0001-8810-870X; NAVAJAS, Maria/0000-0002-0702-4238; Smagghe, Guy/0000-0001-8334-3313; Ortego, Félix/0000-0002-7778-8508; Velez, Marisela/0000-0002-9424-510X; Diaz, Isabel/0000-0001-9865-902X; Rombauts, Stephane/0000-0002-3985-4981; Pedro, Hernandez-Crespo/0000-0001-9350-3640; Christiaens, Olivier/0000-0001-5850-340X; Feyereisen, René/0000-0002-9560-571X; Sucena, Élio/0000-0001-8810-870X; da Silva, Andre Pires/0000-0002-0741-7197; Pace, Ryan/0000-0002-8771-2603; Martinez, Manuel/0000-0002-7826-5872; Van de Peer, Yves/0000-0003-4327-3730; Dermauw, Wannes/0000-0003-4612-8969; Feyereisen, René/0000-0002-9560-571X; Baele, Guy/0000-0002-1915-7732; S., Magalhaes/0000-0002-8609-7768; Van de Peer, Yves/0000-0003-4327-3730; Schmutz, Jeremy/0000-0001-8062-9172; Rombauts, Stephane M/0000-0002-3985-4981; Mancilla, Rodrigo A/0000-0001-8112-2381; Bonnet, Eric/0000-0002-8468-2867; Fawcett, Jeffrey/0000-0003-3907-2135; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Veenstra, Jan Adrianus/0000-0002-2783-0018; Djuranovic, Sergej/0000-0002-9417-0822; Cao Thi Ngoc, Phuong/0000-0002-3059-9179; Ewer, John/0000-0002-6806-3628; Van Leeuwen, Thomas/0000-0003-4651-830X	NSERC [STPGP 322206-05]; Marie Curie Incoming International Fellowship; OECD [JA00053351]; Ontario Research Fund-Global Leadership in Genomics and Life Sciences [GL2-01-035]; Belgian Federal Science Policy Office IUAP [P6/25]; Fund for Scientific Research Flanders (FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Ghent University (MRP N2N); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Marie Curie Incoming International Fellowship(European Commission); OECD; Ontario Research Fund-Global Leadership in Genomics and Life Sciences; Belgian Federal Science Policy Office IUAP(Belgian Federal Science Policy Office); Fund for Scientific Research Flanders (FWO)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University (MRP N2N)(Ghent University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. G. and V. G. acknowledge support from NSERC Strategic Grant STPGP 322206-05, Marie Curie Incoming International Fellowship, OECD Co-operative Research Programme: Biological resource management for Sustainable Agricultural Systems JA00053351, and Ontario Research Fund-Global Leadership in Genomics and Life Sciences GL2-01-035. The genome and transcriptome sequencing projects were funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-046), JGI Community Sequencing Program grant 777506 to M. G., a University of Utah SEED grant ( to R. M. C.), and National Science Foundation (NSF) grant 0820985 ( to R. M. C., Principal Investigator L. Sieburth); work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract No. DE-AC02-05CH11231. Y.V.d. P. acknowledges support from the Belgian Federal Science Policy Office IUAP P6/25 (BioMaGNet), the Fund for Scientific Research Flanders (FWO), the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), and Ghent University (MRP N2N). T. V. L. is a post-doctoral fellow of the FWO. We acknowledge the work of J. Boore, T. Negrave, A. Migeon, P. Auger, L. Swevers and H. Van Langenhove. M. G. and V. G. thank D. Weigel, G. Schafer, M. Gerberding, R. Sommer, J. Felix and T. Nuernberger for discussions and support. The genome annotation of T. urticae is available at the VIB Department of Plant Systems Biology, Ghent University (http://bioinformatics.psb.ugent.be/webtools/bogas/).	Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Gerson U, 1985, SPIDER MITES THEIR A, P223; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Grbic M, 2007, BIOESSAYS, V29, P489, DOI 10.1002/bies.20564; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Keifer HH., 1975, MITES INJURIOUS EC P, P327; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; MOTHES U, 1981, CELL TISSUE RES, V221, P339, DOI 10.1007/BF00216738; OLIVER JH, 1977, ANNU REV ENTOMOL, V22, P407, DOI 10.1146/annurev.en.22.010177.002203; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; VectorBase, 2008, VECTORBASE IXODES SC; VEERMAN A, 1978, NATURE, V275, P234, DOI 10.1038/275234a0; Walter DE, 1999, MITES ECOLOGY EVOLUT	32	694	790	28	390	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					487	492		10.1038/nature10640	http://dx.doi.org/10.1038/nature10640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113690	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000297285600041
J	Turner, M				Turner, Michael			Should women be able to request a caesarean section? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL REQUEST; DELIVERY; RATES; RISK		UCD Ctr Human Reprod, Dublin, Ireland		Turner, M (corresponding author), UCD Ctr Human Reprod, Dublin, Ireland.	Michael.Turner@ucd.ie		Turner, Michael/0000-0003-0064-5098				Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Dahigren LS, 2009, J OBSTET GYNAECOL CA, V31, P808, DOI 10.1016/S1701-2163(16)34299-2; Kazandjian VA, 2007, J EVAL CLIN PRACT, V13, P16, DOI 10.1111/j.1365-2753.2006.00690.x; Larsson C, 2011, J OBSTET GYNAECOL CA, V33, P796, DOI 10.1016/S1701-2163(16)34982-9; Lavender T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004660.pub2; NICE, 2011, CLIN GUID CAES SECT; O'Dwyer V, 2011, INT J GYNEC IN PRESS; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Turner MJ, 2011, INT J GYNECOL OBSTET, V113, P175, DOI 10.1016/j.ijgo.2011.01.012; Wiklund I, 2007, ACTA OBSTET GYN SCAN, V86, P451, DOI 10.1080/00016340701217913; Zupancic JAF, 2008, CLIN PERINATOL, V35, P591, DOI 10.1016/j.clp.2008.07.001	11	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2011	343								d7570	10.1136/bmj.d7570	http://dx.doi.org/10.1136/bmj.d7570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875FH	22113838				2022-12-28	WOS:000299015300009
J	Arnold, D; Girling, A; Stevens, A; Lilford, R				Arnold, David; Girling, Alan; Stevens, Andrew; Lilford, Richard			Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TIME TRADE-OFF; VISUAL ANALOG SCALE; STANDARD GAMBLE; RATING-SCALE; EQ-5D; SF-6D; DIFFERENCE; VALIDITY; VALUES; STROKE	Background and objective Utilities ( values representing preferences) for healthcare priority setting are typically obtained indirectly by asking patients to fill in a quality of life questionnaire and then converting the results to a utility using population values. We compared such utilities with those obtained directly from patients or the public. Design Review of studies providing both a direct and indirect utility estimate. Selection criteria Papers reporting comparisons of utilities obtained directly (standard gamble or time trade off) or indirectly (European quality of life 5D [EQ-5D], short form 6D [SF-6D], or health utilities index [HUI]) from the same patient. Data sources PubMed and Tufts database of utilities. Statistical methods Sign test for paired comparisons between direct and indirect utilities; least squares regression to describe average relations between the different methods. Main outcome measures Mean utility scores (or median if means unavailable) for each method, and differences in mean (median) scores between direct and indirect methods. Results We found 32 studies yielding 83 instances where direct and indirect methods could be compared for health states experienced by adults. The direct methods used were standard gamble in 57 cases and time trade off in 60 ( 34 used both); the indirect methods were EQ-5D ( 67 cases), SF-6D ( 13), HUI-2 ( 5), and HUI-3 ( 37). Mean utility values were 0.81 (standard gamble) and 0.77 ( time trade off) for the direct methods; for the indirect methods: 0.59 (EQ-5D), 0.63 (SF-6D), 0.75 (HUI-2) and 0.68 (HUI- 3). Discussion Direct methods of estimating utilities tend to result in higher health ratings than the more widely used indirect methods, and the difference can be substantial. Use of indirect methods could have important implications for decisions about resource allocation: for example, non-lifesaving treatments are relatively more favoured in comparison with lifesaving interventions than when using direct methods.	[Stevens, Andrew; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Arnold, David] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales	University of Birmingham; Cardiff University	Lilford, R (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Girling, Alan J/A-7843-2012	Arnold, David/0000-0003-3158-7740	EPSRC [GR/S29874/01]; Medical Research Council [G0800808] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported through the MATCH programme (EPSRC Grant GR/S29874/01) although the views expressed are entirely the authors' own.	Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; Bleichrodt H, 2002, HEALTH ECON, V11, P447, DOI 10.1002/hec.688; Bleichrodt H, 1997, J HEALTH ECON, V16, P155, DOI 10.1016/S0167-6296(96)00509-7; Boonen A, 2007, ANN RHEUM DIS, V66, P771, DOI 10.1136/ard.2006.060384; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brazier J., 1999, HEALTH TECHNOL ASSES, V4, P174, DOI [10.1177/135581969900400310, DOI 10.1177/135581969900400310, DOI 10.3310/hta3090]; Bryan Stirling, 2005, Eur J Health Econ, V6, P253, DOI 10.1007/s10198-005-0299-9; Craig Benjamin M, 2009, Popul Health Metr, V7, P3, DOI 10.1186/1478-7954-7-3; Gold MR, 1996, COST EFFECTIVENESS H; Grutters JPC, 2007, QUAL LIFE RES, V16, P1439, DOI 10.1007/s11136-007-9237-x; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Lamers LM, 2006, MED DECIS MAKING, V26, P173, DOI 10.1177/0272989X06286480; Macran S, 2003, MED CARE, V41, P218; Martin AJ, 2000, INT J TECHNOL ASSESS, V16, P137, DOI 10.1017/S0266462300161124; Murphy R, 2001, J NEUROL NEUROSUR PS, V70, P679, DOI 10.1136/jnnp.70.5.679; *NIH CLINC EXC, 2008, NICE B PARL; Nord E., 1999, COST VALUE ANAL HLTH; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Puhan MA, 2007, J CLIN EPIDEMIOL, V60, P1029, DOI 10.1016/j.jclinepi.2007.03.001; Robinson A, 1997, SOC SCI MED, V45, P1289, DOI 10.1016/S0277-9536(97)00057-9; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; Stein K, 2005, APPL HEALTH ECON HEA, V4, P219, DOI 10.2165/00148365-200504040-00004; Stiggelbout AM, 1996, INT J TECHNOL ASSESS, V12, P291, DOI 10.1017/S0266462300009648; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Torrance GW, 2001, MED DECIS MAKING, V21, P329, DOI 10.1177/02729890122062622; *TUFTS MED CTR, 2008, CTR EV VAL RISK HLTH; van Stel HF, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-20; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	98	99	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2009	339								b2688	10.1136/bmj.b2688	http://dx.doi.org/10.1136/bmj.b2688			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	475IL	22128393	Green Published, hybrid			2022-12-28	WOS:000268351700007
J	Clay, R; CdeBaca, L; De Cock, KM; Goosby, E; Guttmacher, A; Jacobs, S; Pablos-Mendez, A; Polaski, S; Sheldon, G; Steinberg, D				Clay, Robert; CdeBaca, Luis; De Cock, Kevin M.; Goosby, Eric; Guttmacher, Alan; Jacobs, Susan; Pablos-Mendez, Ariel; Polaski, Sandra; Sheldon, George; Steinberg, Donald			A call for coordinated and evidence-based action to protect children outside of family care	LANCET			English	Editorial Material									[Clay, Robert; Pablos-Mendez, Ariel; Steinberg, Donald] US Agcy Int Dev, Washington, DC 20005 USA; [CdeBaca, Luis; Goosby, Eric; Jacobs, Susan; Sheldon, George] US Dept State, Washington, DC 20520 USA; [De Cock, Kevin M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Guttmacher, Alan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Polaski, Sandra] US Dept Labor, Washington, DC 20210 USA	United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Department of Labor	Clay, R (corresponding author), US Agcy Int Dev, Washington, DC 20005 USA.	rclay@usaid.gov						Centers for Disease Control and Prevention, VIOL CHILDR SURV VAC; Davis R., 2009, HUMAN CAPACITY CHILD; *INT LAB ORG, 2002, FUT CHILD LAB; International Labour Organization, STAT INF MON PROGR C; International Labour Organization, 2005, GLOB ALL CHILD LAB G; Namibian Ministry of Gender Equity and Child Welfare, 2007, HUM RES CAP GAP AN I; UNICEF, 2009, PROGR CHILDR REP CAR; UNICEF UNAIDS WHO UNFPA UNESCO, 2010, CHILDR AIDS 5 STOCKT; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; US Government, US GOV ASS HIGHL VUL; USAID, DEM HLTH SURV; USAID, 2009, JOB REM OV USAID CHI; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wulczyn F., 2010, ADAPTING SYSTEMS APP	14	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					E6	E8		10.1016/S0140-6736(11)61821-7	http://dx.doi.org/10.1016/S0140-6736(11)61821-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22166902				2022-12-28	WOS:000299317700002
J	Zhang, L; Ding, XJ; Cui, J; Xu, H; Chen, J; Gong, YN; Hu, LY; Zhou, Y; Ge, JN; Lu, QH; Liu, LP; Chen, S; Shao, F				Zhang, Li; Ding, Xiaojun; Cui, Jixin; Xu, Hao; Chen, Jing; Gong, Yi-Nan; Hu, Liyan; Zhou, Yan; Ge, Jianning; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng			Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappa B activation	NATURE			English	Article							ESCHERICHIA-COLI ADA; POLYUBIQUITIN CHAINS; EFFECTOR FAMILY; BINDING; PROTEIN; TAB3; PATHWAY; COMPLEX; DOMAIN; ZINC	NF-kappa B is crucial for innate immune defence against microbial infection(1,2). Inhibition of NF-kappa B signalling has been observed with various bacterial infections(3,4). The NF-kappa B pathway critically requires multiple ubiquitin-chain signals of different natures(5,6). The question of whether ubiquitin-chain signalling and its specificity in NF-kappa B activation are regulated during infection, and how this regulation takes place, has not been explored. Here we show that human TAB2 and TAB3, ubiquitin-chain sensory proteins involved in NF-kappa B signalling, are directly inactivated by enteropathogenic Escherichia coli NleE, a conserved bacterial type-III-secreted effector responsible for blocking host NF-kappa B signalling. NleE harboured an unprecedented S-adenosyl-L-methionine-dependent methyltransferase activity that specifically modified a zinc-coordinating cysteine in the Npl4 zinc finger ( NZF) domains in TAB2 and TAB3. Cysteine-methylated TAB2-NZF and TAB3-NZF ( truncated proteins only comprising the NZF domain) lost the zinc ion as well as the ubiquitin-chain binding activity. Ectopically expressed or type-III-secretion-system-delivered NleE methylated TAB2 and TAB3 in host cells and diminished their ubiquitin-chain binding activity. Replacement of the NZF domain of TAB3 with the NleE methylation-insensitive Npl4 NZF domain resulted in NleE-resistant NF-kappa B activation. Given the prevalence of zinc-finger motifs and activation of cysteine thiol by zinc binding, methylation of zinc-finger cysteine might regulate other eukaryotic pathways in addition to NF-kappa B signalling.	[Zhang, Li; Ding, Xiaojun; Cui, Jixin; Xu, Hao; Chen, Jing; Gong, Yi-Nan; Hu, Liyan; Zhou, Yan; Ge, Jianning; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Li] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Li] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	liu, li/HGC-0900-2022; Chen, Jing/AAM-1808-2020	Chen, Jing/0000-0002-9874-8150; Lu, Qiuhe/0000-0002-0202-7448	National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank I. Rosenshine for providing NleE deletion strains, K. Iwai for the HOIL-1L and HOIP expression plasmids, H. Sakurai for the phospho-TAK1 antibody, Z. Chen for TAB2/3 and Npl4-NZF chimera constructs, and S. Fukai for the NZF expression plasmid. We also thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by the National Basic Research Program of China (973 Programs, 2010CB835400 and 2012CB518700).	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Castro C, 2004, BIOCHEMISTRY-US, V43, P5341, DOI 10.1021/bi049821x; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Cui JX, 2011, TRENDS BIOCHEM SCI, V36, P532, DOI 10.1016/j.tibs.2011.07.003; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Koutmos M, 2008, P NATL ACAD SCI USA, V105, P3286, DOI 10.1073/pnas.0709960105; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Matthews RG, 1997, CURR OPIN CHEM BIOL, V1, P332, DOI 10.1016/S1367-5931(97)80070-1; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200	35	147	156	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					204	+		10.1038/nature10690	http://dx.doi.org/10.1038/nature10690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22158122				2022-12-28	WOS:000298981200040
J	Enden, T; Haig, Y; Klow, NE; Slagsvold, CE; Sandvik, L; Ghanima, W; Hafsahl, G; Holme, PA; Holmen, LO; Njaastad, AM; Sandbaek, G; Sandset, PM				Enden, Tone; Haig, Ylva; Klow, Nils-Einar; Slagsvold, Carl-Erik; Sandvik, Leiv; Ghanima, Waleed; Hafsahl, Geir; Holme, Pal Andre; Holmen, Lars Olaf; Njaastad, Anne Mette; Sandbaek, Gunnar; Sandset, Per Morten		CaVenT Study Grp	Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS; COMPRESSION STOCKINGS; THERAPY; MULTICENTER; UROKINASE	Background Conventional anticoagulant treatment for acute deep vein thrombosis (DVT) effectively prevents thrombus extension and recurrence, but does not dissolve the clot, and many patients develop post-thrombotic syndrome (PTS). We aimed to examine whether additional treatment with catheter-directed thrombolysis (CDT) using alteplase reduced development of PTS. Methods Participants in this open-label, randomised controlled trial were recruited from 20 hospitals in the Norwegian southeastern health region. Patients aged 18-75 years with a first-time iliofemoral DVT were included within 21 days from symptom onset. Patients were randomly assigned (1:1) by picking lowest number of sealed envelopes to conventional treatment alone or additional CDT. Randomisation was stratified for involvement of the pelvic veins with blocks of six. We assessed two co-primary outcomes: frequency of PTS as assessed by Villalta score at 24 months, and iliofemoral patency after 6 months. Analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00251771. Findings 209 patients were randomly assigned to treatment groups (108 control, 101 CDT). At completion of 24 months' follow-up, data for clinical status were available for 189 patients (90%; 99 control, 90 CDT). At 24 months, 37 (41.1%, 95% CI 31.5-51.4) patients allocated additional CDT presented with PTS compared with 55 (55.6%, 95% CI 45.7-65.0) in the control group (p=0.047). The difference in PTS corresponds to an absolute risk reduction of 14.4% (95% CI 0.2-27.9), and the number needed to treat was 7 (95% CI 4-502). Iliofemoral patency after 6 months was reported in 58 patients (65.9%, 95% CI 55.5-75.0) on CDT versus 45 (47.4%, 37.6-57.3) on control (p=0.012). 20 bleeding complications related to CDT included three major and five clinically relevant bleeds. Interpretation Additional CDT should be considered in patients with a high proximal DVT and low risk of bleeding.	[Enden, Tone; Holme, Pal Andre; Sandset, Per Morten] Oslo Univ Hosp, Dept Haematol, N-0424 Oslo, Norway; [Enden, Tone; Haig, Ylva; Klow, Nils-Einar; Hafsahl, Geir; Sandbaek, Gunnar] Oslo Univ Hosp, Dept Radiol & Nucl Med, N-0424 Oslo, Norway; [Slagsvold, Carl-Erik] Oslo Univ Hosp, Oslo Vasc Ctr, N-0424 Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Dept Clin Res, N-0424 Oslo, Norway; [Njaastad, Anne Mette] Oslo Univ Hosp, Dept Med, N-0424 Oslo, Norway; [Haig, Ylva; Klow, Nils-Einar; Sandvik, Leiv; Sandbaek, Gunnar; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ghanima, Waleed] Ostfold Hosp Trust Fredrikstad, Dept Med, Fredrikstad, Norway; [Holmen, Lars Olaf] Ostfold Hosp Trust Fredrikstad, Dept Radiol, Fredrikstad, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sandset, PM (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Box 4950, N-0424 Oslo, Norway.	p.m.sandset@medisin.uio.no	Sandset, Per Morten/J-8141-2019	Sandset, Per Morten/0000-0001-5556-8099	Oslo University Hospital; Research Council of Norway [175465/V50]; South-Eastern Norway Health Authority; University of Oslo; Oslo University Hospital Ulleval	Oslo University Hospital; Research Council of Norway(Research Council of Norway); South-Eastern Norway Health Authority; University of Oslo; Oslo University Hospital Ulleval	The sponsor of the trial was Oslo University Hospital. We thank all patients who participated in the trial and the many collaborators at the participating centres. The study was financially supported by grants from the Research Council of Norway (running costs, grant 175465/V50), the South-Eastern Norway Health Authority (fellowship to TE), the University of Oslo (fellowship to TE), and Oslo University Hospital Ulleval.	ARNESEN H, 1982, ACTA MED SCAND, V211, P65; Bergqvist D, 1997, ANN INTERN MED, V126, P454, DOI 10.7326/0003-4819-126-6-199703150-00006; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Broholm R, 2011, J VASC SURG, V54, p18S, DOI 10.1016/j.jvs.2011.06.021; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Chung JW, 2004, J VASC INTERV RADIOL, V15, P249, DOI 10.1097/01.RIV.0000109402.52762.8D; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; Enden T, 2009, J THROMB HAEMOST, V7, P1268, DOI 10.1111/j.1538-7836.2009.03464.x; Enden T, 2007, AM HEART J, V154, P808, DOI 10.1016/j.ahj.2007.07.010; Ghanima W, 2011, J THROMB HAEMOST, V9, P1261, DOI 10.1111/j.1538-7836.2011.04298.x; Grunwald MR, 2004, J VASC INTERV RADIOL, V15, P347, DOI 10.1097/01.RVI.0000121407.46920.15; Grunwald MR, 2004, CIRCULATION, V109, pE10, DOI 10.1161/01.CIR.0000111132.23469.70; Guanella R, 2011, J THROMB HAEMOST, V9, P2397, DOI 10.1111/j.1538-7836.2011.04516.x; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2002, ARCH INTERN MED, V162, P1144, DOI 10.1001/archinte.162.10.1144; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn SR, 2006, BRIT J HAEMATOL, V134, P357, DOI 10.1111/j.1365-2141.2006.06200.x; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kwak HS, 2005, J VASC INTERV RADIOL, V16, P815, DOI 10.1097/01.RVI.0000157690.91690.38; Ly Bernt, 2004, Tidsskr Nor Laegeforen, V124, P478; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Schweizer J, 1998, VASA-J VASCULAR DIS, V27, P167; Sharifi M, 2010, CATHETER CARDIO INTE, V76, P316, DOI 10.1002/ccd.22638; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Vedantham S, 2006, J VASC INTERV RADIOL, V17, P435, DOI 10.1097/01.RVI.0000197348.57762.15; Vedantham S, 2006, J VASC INTERV RADIOL, V17, P417, DOI 10.1097/01.RVI.0000197359.26571.C2; Villalta SBP, 1994, HAEMOSTASIS, V24, P157; Watson LI, 2004, COCHRANE DB SYST REV, V4; White RH, 2003, CIRCULATION, V107, P14, DOI [DOI 10.1161/01.C1R.0000078468.11849.66, 10.1161/01.CIR.0000078468.11849.66, DOI 10.1161/01.CIR.0000078468.11849.66, 10.1161/01.cir.0000078468.11849.66]	34	597	652	3	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					31	38		10.1016/S0140-6736(11)61753-4	http://dx.doi.org/10.1016/S0140-6736(11)61753-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	22172244				2022-12-28	WOS:000298913000035
J	Alvarez, JI; Dodelet-Devillers, A; Kebir, H; Ifergan, I; Fabre, PJ; Terouz, S; Sabbagh, M; Wosik, K; Bourbonniere, L; Bernard, M; van Horssen, J; de Vries, HE; Charron, F; Prat, A				Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J.; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonniere, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E.; Charron, Frederic; Prat, Alexandre			The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; ASTROCYTE-ENDOTHELIAL INTERACTIONS; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; SPECIFICATION; ANGIOGENESIS; INFLAMMATION; LYMPHOCYTES; DISRUPTION; EXPRESSION	The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. We showed that astrocytes secrete Sonic hedgehog and that BBB ECs express Hedgehog (Hh) receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrated a critical role of the Hh pathway in promoting the immune quiescence of BBB ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.	[Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonniere, Lyne; Bernard, Monique; Prat, Alexandre] Univ Montreal, Ctr Rech, Ctr Excellence Neur, Neuroimmunol Unit,Ctr Hosp Univ Montreal,Fac Med, Montreal, PQ H2L 4M1, Canada; [Fabre, Pierre J.; Charron, Frederic] Univ Montreal, Inst Rech Clin Montreal, Lab Mol Biol Neural Dev, Montreal, PQ H2W 1R7, Canada; [Fabre, Pierre J.; Charron, Frederic] Univ Montreal, Dept Med, Montreal, PQ H2W 1R7, Canada; [van Horssen, Jack; de Vries, Helga E.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Prat, A (corresponding author), Univ Montreal, Ctr Rech, Ctr Excellence Neur, Neuroimmunol Unit,Ctr Hosp Univ Montreal,Fac Med, Montreal, PQ H2L 4M1, Canada.	a.prat@umontreal.ca	Ifergan, Igal/AAI-9734-2020; Fabre, Pierre J/A-6800-2017; Fabre, Pierre/O-5763-2019; Ifergan, Igal/AAR-7849-2021; Charron, Frederic/O-8017-2019; Charron, Frederic/D-2140-2009	Fabre, Pierre J/0000-0002-5936-8120; Ifergan, Igal/0000-0003-2945-2580; Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Prat, Alexandre/0000-0001-6188-0580; Kebir, Hania/0000-0001-6174-8846; van Horssen, Jack/0000-0003-4078-7402; de Vries, Helga/0000-0001-7904-7124	Canadian Institutes of Health Research [MOP81880, MOP74700]; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada	This study was supported by grants from the Canadian Institutes of Health Research (MOP81880 to A. P. and MOP74700 to F. C.) and by the Multiple Sclerosis Society of Canada. We thank C. Podjaski and F. Berthelet for their technical help, J. P. Antel and M. Blain for providing primary cultures of human fetal astrocytes, and N. Arbour for providing critical feedback on experimental procedures.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Byrd N, 2004, TRENDS CARDIOVAS MED, V14, P308, DOI 10.1016/j.tcm.2004.09.003; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hashizume A, 2006, BIOCHEM BIOPH RES CO, V339, P996, DOI 10.1016/j.bbrc.2005.11.106; Hochman E, 2006, J BIOL CHEM, V281, P33860, DOI 10.1074/jbc.M605905200; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Prat A, 2002, ARCH NEUROL-CHICAGO, V59, P391, DOI 10.1001/archneur.59.3.391; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; RUBIN LL, 1991, ANN NY ACAD SCI, V633, P420; Saunders NR, 2008, TRENDS NEUROSCI, V31, P279, DOI 10.1016/j.tins.2008.03.003; Seifert T, 2005, J NEUROPATH EXP NEUR, V64, P404, DOI 10.1093/jnen/64.5.404; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Xu QG, 2008, NEUROSCIENCE, V152, P877, DOI 10.1016/j.neuroscience.2008.01.060	35	488	509	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1727	1731		10.1126/science.1206936	http://dx.doi.org/10.1126/science.1206936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144466				2022-12-28	WOS:000298344000074
J	Linsky, JL				Linsky, Jeffrey L.			Voyagers of Discovery	SCIENCE			English	Editorial Material							TERMINATION SHOCK		[Linsky, Jeffrey L.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Linsky, Jeffrey L.] NIST, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Linsky, JL (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	jlinsky@jilau1.colorado.edu						Hayes M, 2010, NATURE, V464, P562, DOI 10.1038/nature08881; Hester JJ, 1996, ASTRON J, V111, P2349, DOI 10.1086/117968; Lallement R, 2011, SCIENCE, V334, P1665, DOI 10.1126/science.1197340; Stern SA, 2008, SPACE SCI REV, V140, P155, DOI 10.1007/s11214-008-9407-3; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Stone EC, 2008, NATURE, V454, P71, DOI 10.1038/nature07022	6	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1647	1648		10.1126/science.1200166	http://dx.doi.org/10.1126/science.1200166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144467				2022-12-28	WOS:000298344000048
J	Appel, A				Appel, Adrianne			DRUGS More shots on target	NATURE			English	Editorial Material																			0	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S40	S42		10.1038/480S40a	http://dx.doi.org/10.1038/480S40a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169800	Bronze			2022-12-28	WOS:000298033000005
J	Graham-Rowe, D				Graham-Rowe, Duncan			OVERVIEW Multiple lines of attack	NATURE			English	Editorial Material																		Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837	1	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S34	S35		10.1038/480S34a	http://dx.doi.org/10.1038/480S34a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169797	Bronze			2022-12-28	WOS:000298033000002
J	Lucchinetti, CF; Popescu, BFG; Bunyan, RF; Moll, NM; Roemer, SF; Lassmann, H; Bruck, W; Parisi, JE; Scheithauer, BW; Giannini, C; Weigand, SD; Mandrekar, J; Ransohoff, RM				Lucchinetti, Claudia F.; Popescu, Bogdan F. G.; Bunyan, Reem F.; Moll, Natalia M.; Roemer, Shanu F.; Lassmann, Hans; Brueck, Wolfgang; Parisi, Joseph E.; Scheithauer, Bernd W.; Giannini, Caterina; Weigand, Stephen D.; Mandrekar, Jay; Ransohoff, Richard M.			Inflammatory Cortical Demyelination in Early Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL FOLLICLES; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CERVICAL LYMPH-NODES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; DENDRITIC CELLS; MATTER ATROPHY; CHOROID-PLEXUS; LESIONS; PATHOLOGY	BACKGROUND Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with long-standing, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)	[Lucchinetti, Claudia F.; Popescu, Bogdan F. G.; Bunyan, Reem F.; Roemer, Shanu F.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Parisi, Joseph E.; Scheithauer, Bernd W.; Giannini, Caterina] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Weigand, Stephen D.; Mandrekar, Jay] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Moll, Natalia M.; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Moll, Natalia M.; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Brueck, Wolfgang] Univ Gottingen, Univ Med Ctr, Gottingen, Germany; [Brueck, Wolfgang] Univ Gottingen, Dept Neuropathol, Univ Med Ctr, Gottingen, Germany; [Brueck, Wolfgang] Univ Gottingen, Inst Multiple Sclerosis Res, Hertie Fdn, Gottingen, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Medical University of Vienna; University of Gottingen; University of Gottingen; University of Gottingen	Lucchinetti, CF (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	lucchinetti.claudia@mayo.edu; ransohr@ccf.org	Giannini, Caterina/AAB-7551-2022; Lassmann, Hans/Z-2269-2019; Calabrese, Massimiliano/I-6195-2012	Lassmann, Hans/0000-0001-8617-5052; 	National Multiple Sclerosis Society (NMSS) [RG3185-B-3]; National Institutes of Health [1R01NS049577, P50NS38667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038667, R01NS049577] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Multiple Sclerosis Society (NMSS RG3185-B-3, to Dr. Lucchinetti) and the National Institutes of Health (1R01NS049577, to Dr. Lucchinetti, and P50NS38667, to Dr. Ransohoff).	Absinta M, 2011, NEUROLOGY, V76, P910, DOI 10.1212/WNL.0b013e31820f2e69; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Calabrese M, 2009, MULT SCLER J, V15, P933, DOI 10.1177/1352458509106510; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2009, MULT SCLER J, V15, P36, DOI 10.1177/1352458508096686; Calabrese M, 2008, J NEUROL, V255, P581, DOI 10.1007/s00415-008-0752-7; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2011, EXPERT REV NEUROTHER, V11, P425, DOI 10.1586/ERN.10.155; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; HART MN, 1975, J NEUROL NEUROSUR PS, V38, P585, DOI 10.1136/jnnp.38.6.585; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kutzelnigg A, 2006, J NEUROL SCI, V245, P123, DOI 10.1016/j.jns.2005.09.021; LASSMANN H, 1978, ACTA NEUROCHIR, V43, P35; LASSMANN H, 1981, J NEUROL SCI, V50, P109, DOI 10.1016/0022-510X(81)90046-0; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2008, BRAIN, V131, P1759, DOI 10.1093/brain/awn098; Lumsden CE, 1970, HDB CLINICAL NEUROLO, P217; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pittock SJ, 2005, J NEUROL NEUROSUR PS, V76, P1693, DOI 10.1136/jnnp.2004.060624; Popescu BFG, 2011, NEUROLOGY, V76, P1705, DOI 10.1212/WNL.0b013e31821a44f1; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rudick RA, 2009, J NEUROL SCI, V282, P106, DOI 10.1016/j.jns.2008.11.018; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Tallantyre EC, 2010, J MAGN RESON IMAGING, V32, P971, DOI 10.1002/jmri.22115; Tardif CL, 2010, LECT NOTES COMPUT SC, V6363, P181; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; VASS K, 1986, ACTA NEUROPATHOL, V70, P149, DOI 10.1007/BF00691433; Vercellino M, 2005, J NEUROPATH EXP NEUR, V64, P1101, DOI 10.1097/01.jnen.0000190067.20935.42; Vrenken H, 2008, J MAGN RESON IMAGING, V28, P1309, DOI 10.1002/jmri.21559; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74	50	716	739	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2188	2197		10.1056/NEJMoa1100648	http://dx.doi.org/10.1056/NEJMoa1100648			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150037	Green Published, Green Accepted			2022-12-28	WOS:000297731400004
J	Gartlehner, G; Hansen, RA; Morgan, LC; Thaler, K; Lux, L; Van Noord, M; Mager, U; Thieda, P; Gaynes, BN; Wilkins, T; Strobelberger, M; Lloyd, S; Reichenpfader, U; Lohr, KN				Gartlehner, Gerald; Hansen, Richard A.; Morgan, Laura C.; Thaler, Kylie; Lux, Linda; Van Noord, Megan; Mager, Ursula; Thieda, Patricia; Gaynes, Bradley N.; Wilkins, Tania; Strobelberger, Michaela; Lloyd, Stacey; Reichenpfader, Ursula; Lohr, Kathleen N.			Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							VENLAFAXINE EXTENDED-RELEASE; PLACEBO-CONTROLLED TRIAL; LONG-TERM TREATMENT; SEROTONIN REUPTAKE INHIBITORS; BUPROPION SUSTAINED-RELEASE; TREATMENT-RESISTANT DEPRESSION; RANDOMIZED CONTROLLED-TRIALS; PAROXETINE-CONTROLLED TRIAL; MIXED TREATMENT COMPARISONS; DOUBLE-BLIND	Background: Second-generation antidepressants dominate the management of major depressive disorder (MDD), but evidence on the comparative benefits and harms of these agents is contradictory. Purpose: To compare the benefits and harms of second-generation antidepressants for treating MDD in adults. Data Sources: English-language studies from PubMed, Embase, the Cochrane Library, PsycINFO, and International Pharmaceutical Abstracts from 1980 to August 2011 and reference lists of pertinent review articles and gray literature. Study Selection: 2 independent reviewers identified randomized trials of at least 6 weeks' duration to evaluate efficacy and observational studies with at least 1000 participants to assess harm. Data Extraction: Reviewers abstracted data about study design and conduct, participants, and interventions and outcomes and rated study quality. A senior reviewer checked and confirmed extracted data and quality ratings. Data Synthesis: Meta-analyses and mixed-treatment comparisons of response to treatment and weighted mean differences were conducted on specific scales to rate depression. On the basis of 234 studies, no clinically relevant differences in efficacy or effectiveness were detected for the treatment of acute, continuation, and maintenance phases of MDD. No differences in efficacy were seen in patients with accompanying symptoms or in subgroups based on age, sex, ethnicity, or comorbid conditions. Individual drugs differed in onset of action, adverse events, and some measures of health-related quality of life. Limitations: Most trials were conducted in highly selected populations. Publication bias might affect the estimates of some comparisons. Mixed-treatment comparisons cannot conclusively exclude differences in efficacy. Evidence within subgroups was limited. Conclusion: Current evidence does not warrant recommending a particular second-generation antidepressant on the basis of differences in efficacy. Differences in onset of action and adverse events may be considered when choosing a medication.	[Gartlehner, Gerald] Danube Univ, A-3500 Krems, Austria; Auburn Univ, Auburn, AL 36849 USA; RTI Int, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Ludwig Boltzmann Inst Hlth Promot Res, Vienna, Austria	Danube University Krems; Auburn University System; Auburn University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Ludwig Boltzmann Institute	Gartlehner, G (corresponding author), Danube Univ, Karl Dorrek Str 30, A-3500 Krems, Austria.	gerald.gartlehner@donau-uni.ac.at	Lux, Linda/GPX-3639-2022; Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Gaynes, Bradley/0000-0002-8283-5030; Hansen, Richard/0000-0002-4578-6698; Lohr, Kathleen/0000-0002-3825-0713; Griebler, Ursula/0000-0002-9958-3714; Van Noord, Megan G./0000-0002-4319-0946	Agency of Healthcare Research and Quality (AHRQ) [290200710056l 2]; North Carolina Department of Health and Human Services; Foundation for the National Institutes of Health; Danube University; National Institute of Mental Health	Agency of Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); North Carolina Department of Health and Human Services; Foundation for the National Institutes of Health; Danube University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This manuscript and the work it is derived from was commissioned by the Agency of Healthcare Research and Quality (AHRQ), through a contract to the xyz Evidence-based Practice Center (contract 290200710056l#2). While AHRQ has approved the assertion of copyright by the authors, as noted in the attached letter from the AHRQ Contracting Officer, the government retains rights to the use of the manuscript according to the contract and the Federal Acquisition Regulations (FAR). In order to facilitate and meet the need of public access to research works and findings funded by the government, AHRQ will publish the full report from which this manuscript is derived. The original report from which this manuscript was derived has undergone rigorous peer and public review through the Effective Health Care Program.; Dr. Gartlehner: Grant (money to institution): AHRQ. Dr. Hansen: Grant (money to institution): AHRQ; Consultancy: Novartis and Takeda Pharmaceutical Company; Grants/grants pending (money to institution): AHRQ, North Carolina Department of Health and Human Services, and the Foundation for the National Institutes of Health; Payment for development of educational presentations: WebMD. Ms. Morgan: Grant (money to institution): AHRQ. Dr. Thaler: Grant (money to institution): AHRQ. Ms. Lux: Grant (money to institution): AHRQ. Dr. Mager and Ms. Strobelberger: Grant (money to institution): Danube University. Ms. Thieda: Grant (money to institution): AHRQ. Dr. Gaynes: Grant (money to institution): AHRQ; Grants/grants pending (money to institution): National Institute of Mental Health. Ms. Lloyd: Grant (money to institution): AHRQ. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1590.	Aberg-Wistedt A, 2000, J CLIN PSYCHOPHARM, V20, P645, DOI 10.1097/00004714-200012000-00010; Allard P, 2004, INT J GERIATR PSYCH, V19, P1123, DOI 10.1002/gps.1190; ALVES C, 1999, PRIMARY CARE PSYCHIA, V5, P57; [Anonymous], 2004, REPORT CSM EXPERT WO; Aursnes I, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-14; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Baldomero EB, 2005, DEPRESS ANXIETY, V22, P68, DOI 10.1002/da.20080; Baldwin DS, 2006, INT CLIN PSYCHOPHARM, V21, P159, DOI 10.1097/01.yic.0000194377.88330.1d; Baldwin DS, 1996, J CLIN PSYCHIAT, V57, P46; Balk EM, 2005, J HEPATOL, V43, P729, DOI 10.1016/j.jhep.2005.07.005; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; BEASLEY CM, 1991, J CLIN PSYCHIAT, V52, P294; Behnke K, 2003, J CLIN PSYCHOPHARM, V23, P358, DOI 10.1097/01.jcp.0000085408.08426.05; Benkert O, 2000, J CLIN PSYCHIAT, V61, P656, DOI 10.4088/JCP.v61n0911; BENNIE EH, 1995, J CLIN PSYCHIAT, V56, P229; Berkrot B., 2010, US PRESCRIPTION DRUG; Bielski RJ, 2004, J CLIN PSYCHIAT, V65, P1190, DOI 10.4088/JCP.v65n0906; Birnbaum HG, 2009, PHARMACOECONOMICS, V27, P507, DOI 10.2165/00019053-200927060-00006; Boulenger JP, 2006, CURR MED RES OPIN, V22, P1331, DOI 10.1185/030079906X115513; Boyer P, 1998, PHARMACOECONOMICS, V13, P157, DOI 10.2165/00019053-199813010-00015; Burke WJ, 2002, J CLIN PSYCHIAT, V63, P331, DOI 10.4088/JCP.v63n0410; Cassano GB, 2002, J CLIN PSYCHIAT, V63, P396, DOI 10.4088/JCP.v63n0504; Chapman AL, 2010, HEALTH INFO LIBR J, V27, P22, DOI [10.1111/J.1471-1842.2009.00865.x, 10.1111/j.1471-1842.2009.00865.x]; Chouinard G, 1999, J AFFECT DISORDERS, V54, P39, DOI 10.1016/S0165-0327(98)00188-8; Cipriani A, 2008, J CLIN PSYCHIAT, V69, P1732, DOI 10.4088/JCP.v69n1108; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clayton AH, 2006, J CLIN PSYCHIAT, V67, P736, DOI 10.4088/JCP.v67n0507; Coleman C C, 1999, Ann Clin Psychiatry, V11, P205, DOI 10.3109/10401239909147072; Coleman CC, 2001, CLIN THER, V23, P1040, DOI 10.1016/S0149-2918(01)80090-4; Colonna L, 2005, CURR MED RES OPIN, V21, P1659, DOI 10.1185/030079905X65484; Corya SA, 2006, DEPRESS ANXIETY, V23, P364, DOI 10.1002/da.20130; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; CUNNINGHAM LA, 1994, J CLIN PSYCHOPHARM, V14, P99; De Nayer A, 2002, INT J NEUROPSYCHOPH, V5, P115, DOI 10.1017/S1461145702002857; Deeks J J, 2003, Health Technol Assess, V7, piii; Delgado PL, 2005, J CLIN PSYCHIAT, V66, P686, DOI 10.4088/JCP.v66n0603; Detke MJ, 2004, EUR NEUROPSYCHOPHARM, V14, P457, DOI 10.1016/j.euroneuro.2004.01.002; Devanand DP, 2005, AM J GERIAT PSYCHIAT, V13, P59, DOI 10.1176/appi.ajgp.13.1.59; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Dierick M, 1996, PROG NEURO-PSYCHOPH, V20, P57, DOI 10.1016/0278-5846(95)00292-8; Eckert L, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-30; Eckert L, 2006, CURR MED RES OPIN, V22, P2313, DOI 10.1185/030079906X148625; Ekselius L, 1997, INT CLIN PSYCHOPHARM, V12, P323, DOI 10.1097/00004850-199711000-00005; Fava M, 1998, Ann Clin Psychiatry, V10, P145; Fava M, 2002, J CLIN PSYCHOPHARM, V22, P137, DOI 10.1097/00004714-200204000-00006; Fava M, 2000, J AFFECT DISORDERS, V59, P119, DOI 10.1016/S0165-0327(99)00131-7; FEIGHNER JP, 1991, J CLIN PSYCHIAT, V52, P329; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Finkel SI, 1999, AM J GERIAT PSYCHIAT, V7, P221, DOI 10.1097/00019442-199908000-00006; Flament MF, 1999, INT CLIN PSYCHOPHARM, V14, P259; Franchini L, 2000, J AFFECT DISORDERS, V58, P233, DOI 10.1016/S0165-0327(99)00113-5; Franchini L, 1997, J CLIN PSYCHIAT, V58, P104, DOI 10.4088/JCP.v58n0303; Friedman RA, 2007, NEW ENGL J MED, V356, P2343, DOI 10.1056/NEJMp078015; GAGIANO CA, 1993, BR J CLIN RES, V4, P145; Gartlehner G, 2011, COMP EFFECTIVENESS 2; Gartlehner G., 2007, COMP EFFECTIVENESS 2, V7; Gartlehner G, 2006, J CLIN EPIDEMIOL, V59, P1040, DOI 10.1016/j.jclinepi.2006.01.011; Gartlehner G, 2009, LANCET, V373, P1761, DOI 10.1016/S0140-6736(09)60978-8; GERETSEGGER C, 1994, INT CLIN PSYCHOPHARM, V9, P25, DOI 10.1097/00004850-199400910-00004; Girardi P, 2009, HUM PSYCHOPHARM CLIN, V24, P177, DOI 10.1002/hup.1005; Goldstein DJ, 2004, J CLIN PSYCHOPHARM, V24, P389, DOI 10.1097/01.jcp.0000132448.65972.d9; Guelfi JD, 2001, J CLIN PSYCHOPHARM, V21, P425, DOI 10.1097/00004714-200108000-00010; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; HALIKAS JA, 1995, HUM PSYCHOPHARM CLIN, V10, pS125, DOI 10.1002/hup.470100807; Hansen RA, 2005, ANN INTERN MED, V143, P415, DOI 10.7326/0003-4819-143-6-200509200-00006; Hansen RA, 2009, MED DECIS MAKING, V29, P91, DOI 10.1177/0272989X08323298; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hicks JA, 2002, BRIT J PSYCHIAT, V180, P528, DOI 10.1192/bjp.180.6.528; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Ioannidis JPA, 2009, LANCET, V373, P1759, DOI 10.1016/S0140-6736(09)60974-0; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Keller MB, 2007, BIOL PSYCHIAT, V62, P1371, DOI 10.1016/j.biopsych.2007.04.040; Kennedy SH, 2006, CAN J PSYCHIAT, V51, P234, DOI 10.1177/070674370605100405; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Khazaie H, 2011, NEUROSCIENCES, V16, P42; Kiev A, 1997, J CLIN PSYCHIAT, V58, P146, DOI 10.4088/JCP.v58n0402; Krebs EE, 2008, PSYCHOSOMATICS, V49, P191, DOI 10.1176/appi.psy.49.3.191; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Leinonen E, 1999, INT CLIN PSYCHOPHARM, V14, P329, DOI 10.1097/00004850-199911000-00002; Lenox-Smith AJ, 2008, INT CLIN PSYCHOPHARM, V23, P113, DOI 10.1097/YIC.0b013e3282f424c2; Lepola UM, 2003, INT CLIN PSYCHOPHARM, V18, P211, DOI 10.1097/00004850-200307000-00003; Lilly Eli, 2004, DUL VERS PLAC PAR AC; Lin CH, 2008, J CLIN PSYCHIAT, V69, P54, DOI 10.4088/JCP.v69n0108; Lopez-Ibor J. J. Jr., 1993, European Psychiatry, V8, p17S; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mao PX, 2008, DEPRESS ANXIETY, V25, P46, DOI 10.1002/da.20222; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; MCPARTLIN GM, 1998, PRIMARY CARE PSYCHIA, V4, P127, DOI DOI 10.1016/J.BIOPSYCH.2007.04.040; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; Moore N, 2005, INT CLIN PSYCHOPHARM, V20, P131, DOI 10.1097/00004850-200505000-00002; National Health Service Centre for Reviews and Dissemination, 2001, 4 U YORK CTR REV DIS; Nemeroff CB, 2007, J PSYCHIATR RES, V41, P351, DOI 10.1016/j.jpsychires.2005.07.009; Newhouse Paul A., 2000, Journal of Clinical Psychiatry, V61, P559; Olfson M, 2008, J CLIN PSYCHIAT, V69, P425, DOI 10.4088/JCP.v69n0313; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Omori IM, 2009, J PSYCHOPHARMACOL, V23, P539, DOI 10.1177/0269881108089876; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Perahia DGS, 2006, EUR PSYCHIAT, V21, P367, DOI 10.1016/j.eurpsy.2006.03.004; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P12, DOI 10.1192/bjp.175.1.12; Ravindran AV, 2000, J CLIN PSYCHIAT, V61, P821, DOI 10.4088/JCP.v61n1103; Rocca P, 2005, J CLIN PSYCHIAT, V66, P360, DOI 10.4088/JCP.v66n0313; Rossini D, 2005, J CLIN PSYCHOPHARM, V25, P471, DOI 10.1097/01.jcp.0000177548.28961.e7; Rudolph RL, 1999, J AFFECT DISORDERS, V56, P171, DOI 10.1016/S0165-0327(99)00067-1; Rush AJ, 2001, NEUROPSYCHOPHARMACOL, V25, P131, DOI 10.1016/S0893-133X(00)00249-9; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Schatzberg A, 2006, AM J GERIAT PSYCHIAT, V14, P361, DOI 10.1097/01.JGP.0000194645.70869.3b; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; SCHONE W, 1993, J CLIN PSYCHOPHARM, V13, pS34; Schwan S, 2009, LANCET, V373, P1761, DOI 10.1016/S0140-6736(09)60977-6; Sechter D, 1999, EUR PSYCHIAT, V14, P41, DOI 10.1016/S0924-9338(99)80714-7; Segraves RT, 2000, J CLIN PSYCHOPHARM, V20, P122, DOI 10.1097/00004714-200004000-00002; Seyringer ME, 2009, LANCET, V373, P1760, DOI 10.1016/S0140-6736(09)60976-4; Silverstone PH, 1999, J CLIN PSYCHIAT, V60, P22, DOI 10.4088/JCP.v60n0105; Sir A, 2005, J CLIN PSYCHIAT, V66, P1312, DOI 10.4088/JCP.v66n1015; Soares CN, 2010, MENOPAUSE, V17, P700, DOI 10.1097/gme.0b013e3181d88962; Thase ME, 2011, J PSYCHIATR RES, V45, P412, DOI 10.1016/j.jpsychires.2010.07.009; Turner E, 2009, LANCET, V373, P1760, DOI 10.1016/S0140-6736(09)60975-2; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Tzanakaki M, 2000, INT CLIN PSYCHOPHARM, V15, P29, DOI 10.1097/00004850-200015010-00004; U.S. Food and Drug Administration, 2001, STAT REV NDA 21 323; U.S. Food and Drug Administration, 2010, GUID IND INV SAF REP; Vanelle JM, 1997, BRIT J PSYCHIAT, V170, P345, DOI 10.1192/bjp.170.4.345; VANMOFFAERT M, 1995, HUM PSYCHOPHARM CLIN, V10, P393, DOI 10.1002/hup.470100505; Versiani M, 2005, CNS DRUGS, V19, P137, DOI 10.2165/00023210-200519020-00004; Watanabe N, 2008, J CLIN PSYCHIAT, V69, P1404, DOI 10.4088/JCP.v69n0908; Weihs KL, 2000, J CLIN PSYCHIAT, V61, P196, DOI 10.4088/JCP.v61n0309; Weinmann S, 2008, PSYCHOPHARMACOLOGY, V196, P511, DOI 10.1007/s00213-007-0975-9; Wheatley DP, 1998, J CLIN PSYCHIAT, V59, P306, DOI 10.4088/JCP.v59n0606; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011; Wu E, 2008, CURR MED RES OPIN, V24, P2805, DOI 10.1185/03007990802336780 ; Yevtushenko VY, 2007, CLIN THER, V29, P2319, DOI 10.1016/j.clinthera.2007.11.014	136	225	231	0	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					772	U112		10.7326/0003-4819-155-11-201112060-00009	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00009			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147715				2022-12-28	WOS:000297988400006
J	Hamanaka, RB; Chandel, NS				Hamanaka, Robert B.; Chandel, Navdeep S.			Warburg Effect and Redox Balance	SCIENCE			English	Editorial Material							PYRUVATE-KINASE M2; CELLS; PKM2; METABOLISM		[Hamanaka, Robert B.; Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Hamanaka, RB (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA.	nav@northwestern.edu						Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bluemlein K, 2011, ONCOTARGET, V2, P393; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	15	88	91	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1219	1220		10.1126/science.1215637	http://dx.doi.org/10.1126/science.1215637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144609				2022-12-28	WOS:000297553600030
J	Carter, P				Carter, Philip			NHS REFORMS How attractive is the NHS to private providers?	BRITISH MEDICAL JOURNAL			English	Editorial Material												pc@pacarter.com						*OFF FAIR TRAD, 2011, PROGR RES EXPL ISS P, pD3482; Torjesen I, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7662; TRIGGLE N, 2011, BBC NEWS        0907, pD3482	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7682	10.1136/bmj.d7682	http://dx.doi.org/10.1136/bmj.d7682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131261				2022-12-28	WOS:000298037300002
J	O'Donnell, MJ; Yusuf, S; Mente, A; Gao, P; Mann, JF; Teo, K; McQueen, M; Sleight, P; Sharma, AM; Dans, A; Probstfield, J; Schmieder, RE				O'Donnell, Martin J.; Yusuf, Salim; Mente, Andrew; Gao, Peggy; Mann, Johannes F.; Teo, Koon; McQueen, Matthew; Sleight, Peter; Sharma, Arya M.; Dans, Antonio; Probstfield, Jeffrey; Schmieder, Roland E.			Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; DIETARY-SODIUM; SALT INTAKE; HYPERTENSION PREVENTION; MORTALITY; METAANALYSIS; DISEASE; REDUCTION; STROKE; HEALTH	Context The precise relationship between sodium and potassium intake and cardiovascular (CV) risk remains uncertain, especially in patients with CV disease. Objective To determine the association between estimated urinary sodium and potassium excretion (surrogates for intake) and CV events in patients with established CV disease or diabetes mellitus. Design, Setting, and Patients Observational analyses of 2 cohorts (N=28 880) included in the ONTARGET and TRANSCEND trials (November 2001-March 2008 from initial recruitment to final follow-up). We estimated 24-hour urinary sodium and potassium excretion from a morning fasting urine sample (Kawasaki formula). We used restricted cubic spline plots to describe the association between sodium and potassium excretion and CV events and mortality, and to identify reference categories for sodium and potassium excretion. We used Cox proportional hazards multivariable models to determine the association of urinary sodium and potassium with CV events and mortality. Main Outcome Measures CV death, myocardial infarction (MI), stroke, and hospitalization for congestive heart failure (CHF). Results At baseline, the mean (SD) estimated 24-hour excretion for sodium was 4.77 g (1.61); and for potassium was 2.19 g (0.57). After a median follow-up of 56 months, the composite outcome occurred in 4729 (16.4%) participants, including 2057 CV deaths, 1412 with MI, 1282 with stroke, and 1213 with hospitalization for CHF. Compared with the reference group with estimated baseline sodium excretion of 4 to 5.99 g per day (n=14 156; 6.3% participants with CV death, 4.6% with MI, 4.2% with stroke, and 3.8% admitted to hospital with CHF), higher baseline sodium excretion was associated with an increased risk of CV death (9.7% for 7-8 g/day; hazard ratio [HR], 1.53; 95% CI, 1.26-1.86; and 11.2% for >8 g/day; HR, 1.66; 95% CI, 1.31-2.10), MI (6.8%; HR, 1.48; 95% CI, 1.11-1.98 for >8 g/day), stroke (6.6%; HR, 1.48; 95% CI, 1.09-2.01 for >8 g/day), and hospitalization for CHF (6.5%; HR, 1.51; 1.12-2.05 for >8 g/day). Lower sodium excretion was associated with an increased risk of CV death (8.6%; HR, 1.19; 95% CI, 1.02-1.39 for 2-2.99 g/day; 10.6%; HR, 1.37; 95% CI, 1.09-1.73 for <2 g/day), and hospitalization for CHF (5.2%; HR, 1.23; 95% CI, 1.01-1.49 for 2-2.99 g/day) on multivariable analysis. Compared with an estimated potassium excretion of less than 1.5 g per day (n=2194; 6.2% with stroke), higher potassium excretion was associated with a reduced risk of stroke (4.7% [HR, 0.77; 95% CI, 0.63-0.94] for 1.5-1.99 g/day; 4.3% [HR, 0.73; 95% CI, 0.59-0.90] for 2-2.49 g/day; 3.9% [HR, 0.71; 95% CI, 0.56-0.91] for 2.5-3 g/day; and 3.5% [HR, 0.68; 95% CI, 0.49-0.92] for >3 g/day) on multivariable analysis. Conclusions The association between estimated sodium excretion and CV events was J-shaped. Compared with baseline sodium excretion of 4 to 5.99 g per day, sodium excretion of greater than 7 g per day was associated with an increased risk of all CV events, and a sodium excretion of less than 3 g per day was associated with increased risk of CV mortality and hospitalization for CHF. Higher estimated potassium excretion was associated with a reduced risk of stroke. JAMA. 2011;306(20):2229-2238	[O'Donnell, Martin J.; Yusuf, Salim; Mente, Andrew; Gao, Peggy; Teo, Koon; McQueen, Matthew] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [O'Donnell, Martin J.; Yusuf, Salim; Mente, Andrew; Gao, Peggy; Teo, Koon; McQueen, Matthew] Hamilton Hlth Sci, Hamilton, ON, Canada; [O'Donnell, Martin J.] NUI Galway, HRB Clin Res Facil, Galway, Ireland; [Mann, Johannes F.] Munich Gen Hosp, KfH Kidney Ctr, Erlangen, Germany; [Mann, Johannes F.] Univ Erlangen Nurnberg, Erlangen, Germany; [Sleight, Peter] John Radcliffe Hosp, Oxford OX3 9DU, England; [Sharma, Arya M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Dans, Antonio] Univ Philippines, Coll Med, Manila, Philippines; [Probstfield, Jeffrey] Univ Washington, Dept Med, Seattle, WA USA; [Schmieder, Roland E.] Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany	McMaster University; Population Health Research Institute; McMaster University; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; University of Erlangen Nuremberg; University of Oxford; University of Alberta; University of the Philippines System; University of the Philippines Manila; University of Washington; University of Washington Seattle; University of Erlangen Nuremberg	O'Donnell, MJ (corresponding author), McMaster Univ, Hamilton Gen Hosp, DBCVS Res Inst, Populat Hlth Res Inst, 237 Barton St E,3rd Floor, Hamilton, ON L8L 2X2, Canada.	odonnm@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020; Mann, Johannes/AAI-8803-2020	O'Donnell, Martin/0000-0002-7347-7761; Teo, Koon/0000-0002-3731-0956; Yusuf, Salim/0000-0003-4776-5601	Boehringer Ingelheim; Sanofi-aventis; Abbott Laboratories; Merck; Arena; Vivus; Novo-Nordisk; GlaxoSmithKline; NeuroSearch; Allergan; Eli Lilly; Genentech	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-aventis(Sanofi-Aventis); Abbott Laboratories(Abbott Laboratories); Merck(Merck & Company); Arena(Australian Renewable Energy Agency (ARENA)); Vivus; Novo-Nordisk(Novo Nordisk); GlaxoSmithKline(GlaxoSmithKline); NeuroSearch; Allergan(AbbVieAllergan); Eli Lilly(Eli Lilly); Genentech(Roche HoldingGenentech)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs O'Donnell, Yusuf, Teo, Sleight, Sharma, Dans, and Schmieder report receipt of consulting and lecture fees and research grants from Boehringer Ingelheim and from other companies manufacturing angiotensin II receptor blockers (pending completion) and receipt of support for travel to meetings for the study or other purposes from Boehringer Ingelheim. Dr Sleight reports receipt of fees for participation in review activites such as data monitoring boards, statistical analysis, and end point committees, and payment for service on the speakers bureau from Boehringer-Ingelheim. Dr McQueen reports pending grants from Sanofi-aventis. Dr Sharma reports receipt of consultancy fees from Abbott Laboratories, Merck, Arena, Vivus, Novo-Nordisk, Sanofi-aventis, GlaxoSmithKline, NeuroSearch, and Allergan; payment for expert testimony from GlaxoSmithKline; grants or pending grants from Abbott Laboratories; payment for service on speakers bureaus from Boehringer-Ingelheim, Abbott Labortories, Novo-Nordisk, Allerban, Johnson & Johnson, and Sanofi-aventis; and reimbursement for travel/accomodatons expenses from various companies. Dr Dans reports receipt of payment for service on the speakers bureau from Boehringer Ingelheim. Dr Probstfield reports receipt of consultancy fees from Eli Lilly, Sanofi-aventis, and Genentech; and grants or pending grants from Eli Lilly, Sanofi-aventis, and Abbott Laboratories. Dr Schmieder reports receipt of fees for participation in review activities such as data monitoring boards, statistical analysis, and end point committes from Boehringer Ingelheim. Drs Mente, Gao, and Mann report no disclosures.	Adachi T, 2001, CLIN EXP PHARMACOL P, V28, P877, DOI 10.1046/j.1440-1681.2001.03536.x; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Appel LJ, 2010, NEW ENGL J MED, V362, P650, DOI 10.1056/NEJMe0910352; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Campbell NRC, 2010, CAN J CARDIOL, V26, P236, DOI 10.1016/S0828-282X(10)70377-9; Cohen HW, 2007, CURR OPIN CARDIOL, V22, P306, DOI 10.1097/HCO.0b013e3281527901; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 1998, AM J EPIDEMIOL, V148, P431; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Dong J, 2010, CLIN J AM SOC NEPHRO, V5, P240, DOI 10.2215/CJN.05410709; DYER AR, 1994, AM J EPIDEMIOL, V139, P927, DOI 10.1093/oxfordjournals.aje.a117099; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Geleijnse JM, 2007, EUR J EPIDEMIOL, V22, P763, DOI 10.1007/s10654-007-9186-2; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hashimoto T, 2008, INTERNAL MED, V47, P399, DOI 10.2169/internalmedicine.47.0622; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Iseki K, 2002, HYPERTENS RES, V25, P731; KAGAN A, 1985, STROKE, V16, P390, DOI 10.1161/01.STR.16.3.390; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kumanyika SK, 2005, J HUM HYPERTENS, V19, P33, DOI 10.1038/sj.jhh.1001774; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; McCarron DA, 2009, CLIN J AM SOC NEPHRO, V4, P1878, DOI 10.2215/CJN.04660709; Mente A, 2009, J NUTR, V139, P743, DOI 10.3945/jn.108.098319; Morris RC, 2006, J AM COLL NUTR, V25, p262S, DOI 10.1080/07315724.2006.10719576; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organization, 2006, WHO FOR RED SALT INT; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	49	428	440	0	62	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2229	2238		10.1001/jama.2011.1729	http://dx.doi.org/10.1001/jama.2011.1729			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22110105	Green Published			2022-12-28	WOS:000297255500022
J	Jackevicius, CA; Chou, MM; Ross, JS; Shah, ND; Krumholz, HM				Jackevicius, Cynthia A.; Chou, Mindy M.; Ross, Joseph S.; Shah, Nilay D.; Krumholz, Harlan M.			Generic Atorvastatin and Health Care Costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jackevicius, Cynthia A.] Western Univ Hlth Sci, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Toronto, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Chou, Mindy M.] Indian Hlth Serv, San Fidel, NM USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, New Haven, CT USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Shah, Nilay D.] Mayo Clin, Rochester, MN USA	Western University of Health Sciences; University of Toronto; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Yale University; Yale University; Mayo Clinic	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.		, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL105270] Funding Source: Medline; NIA NIH HHS [K08 AG032886, K08 AG032886-04] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Food and Drug Administration, 2011, OR BOOK APPR DRUG PR; Kale MS, 2011, ARCH INTERN MED, V171, P1856, DOI 10.1001/archinternmed.2011.501; Peterson M., 2011, PFIZER MAY GET GENER; Stiles S., TIE ANNOUNCED SATURN; 2011, IMS HLTH        0407	5	52	54	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					201	204		10.1056/NEJMp1113112	http://dx.doi.org/10.1056/NEJMp1113112			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	877RZ	22149736	Green Accepted			2022-12-28	WOS:000299201400004
J	Kang, KJ; Panzano, VC; Chang, EC; Ni, LN; Dainis, AM; Jenkins, AM; Regna, K; Muskavitch, MAT; Garrity, PA				Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.; Garrity, Paul A.			Modulation of TRPA1 thermal sensitivity enables sensory discrimination in Drosophila	NATURE			English	Article							ION CHANNELS; HEAT ACTIVATION; TEMPERATURE; RECEPTOR; THERMODYNAMICS; CAPSAICIN; SENSATION; REVEALS; TRPV1B; TASTE	Discriminating among sensory stimuli is critical for animal survival. This discrimination is particularly essential when evaluating whether a stimulus is noxious or innocuous. From insects to humans, transient receptor potential (TRP) channels are key transducers of thermal, chemical and other sensory cues(1,2). Many TRPs are multimodal receptors that respond to diverse stimuli(1-3), but how animals distinguish sensory inputs activating the same TRP is largely unknown. Here we determine how stimuli activating Drosophila TRPA1 are discriminated. Although Drosophila TRPA1 responds to both noxious chemicals(4) and innocuous warming(5), we find that TRPA1-expressing chemosensory neurons respond to chemicals but not warmth, a specificity conferred by a chemosensory-specific TRPA1 isoform with reduced thermosensitivity compared to the previously described isoform. At the molecular level, this reduction results from a unique region that robustly reduces the channel's thermosensitivity. Cell-type segregation of TRPA1 activity is critical: when the thermosensory isoform is expressed in chemosensors, flies respond to innocuous warming with regurgitation, a nocifensive response. TRPA1 isoform diversity is conserved in malaria mosquitoes, indicating that similar mechanisms may allow discrimination of host-derived warmth-an attractant-from chemical repellents. These findings indicate that reducing thermosensitivity can be critical for TRP channel functional diversification, facilitating their use in contexts in which thermal sensitivity can be maladaptive.	[Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Kang, Kyeongjin; Panzano, Vincent C.; Chang, Elaine C.; Ni, Lina; Dainis, Alexandra M.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.] Boston Coll, Dept Biol, Newton, MA 02467 USA; [Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Muskavitch, Marc A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Brandeis University; Brandeis University; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health	Garrity, PA (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu		Garrity, Paul/0000-0002-8274-6564; Kang, KyeongJin/0000-0003-0446-469X	National Science Foundation [IOS-1025307]; National Institute of Mental Health [EUREKA R01 MH094721]; National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS044232, F31 NS071897-02]; Boston College; Division Of Integrative Organismal Systems [1025307] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, F31NS071897] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Boston College; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the P. A. G. laboratory, H. Garrity, L. Griffith, L. Huang, J. Rodriguez and M. Rosbash for helpful comments, and F. Marion-Poll and A. Dahanukar for guidance with tip-recording. This work was supported by grants from the National Science Foundation (IOS-1025307), National Institute of Mental Health (EUREKA R01 MH094721) and National Institute of Neurological Disorders and Stroke (NINDS) (PO1 NS044232) to P. A. G., a National Research Service Award from NINDS to V. C. P. (F31 NS071897-02) and the Boston College DeLuca Professorship to M.A.T.M.	Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; COHET Y, 1975, EXP GERONTOL, V10, P181, DOI 10.1016/0531-5565(75)90029-7; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Lu G, 2005, MOL PHARMACOL, V67, P1119, DOI 10.1124/mol.104.009852; Maekawa E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-10; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vos MH, 2006, J NEUROCHEM, V99, P1088, DOI 10.1111/j.1471-4159.2006.04145.x; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108	33	147	151	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					76	U82		10.1038/nature10715	http://dx.doi.org/10.1038/nature10715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139422	Green Accepted			2022-12-28	WOS:000298836900032
J	Hung, RJ; Pak, CW; Terman, JR				Hung, Ruei-Jiun; Pak, Chi W.; Terman, Jonathan R.			Direct Redox Regulation of F-Actin Assembly and Disassembly by Mical	SCIENCE			English	Article							METHIONINE OXIDATION; PROTEINS	Different types of cell behavior, including growth, motility, and navigation, require actin proteins to assemble into filaments. Here, we describe a biochemical process that was able to disassemble actin filaments and limit their reassembly. Actin was a specific substrate of the multidomain oxidation-reduction enzyme, Mical, a poorly understood actin disassembly factor that directly responds to Semaphorin/Plexin extracellular repulsive cues. Actin filament subunits were directly modified by Mical on their conserved pointed-end, which is critical for filament assembly. Mical posttranslationally oxidized the methionine 44 residue within the D-loop of actin, simultaneously severing filaments and decreasing polymerization. This mechanism underlying actin cytoskeletal collapse may have broad physiological and pathological ramifications.	[Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Grad Program Neurosci, Dallas, TX 75390 USA; [Pak, Chi W.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Terman, JR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	jonathan.terman@utsouthwestern.edu			Cancer Prevention Research Institute of Texas (CPRIT); NIH [DK091074, NS073968]; Welch Foundation [I-1749]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073968] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Brown, C. Cowan, H. Kramer, M. Rosen, and Terman lab members for assistance. Mass spectrometry was performed by Y. Li (University of Texas Southwestern Protein Chemistry Technology Center). We also thank Z. Chen, Y.-C. Kuo, K. Luby-Phelps, J. Merriam, H. Oda, V. Verkhusha, S. Weintraub, and Bloomington and Japanese Stock Centers. This work was supported by Cancer Prevention Research Institute of Texas (CPRIT) predoctoral (R.-J.H), NIH (DK091074) postdoctoral (C. W. P.), and NIH (NS073968) and Welch Foundation (I-1749) (J. R. T) grants. The data are presented in the figures and supporting online material.	BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Guan JQ, 2003, BIOCHEMISTRY-US, V42, P11992, DOI 10.1021/bi034914k; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Hung RJ, 2011, CYTOSKELETON, V68, P415, DOI 10.1002/cm.20527; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Sheterline P, 1998, ACTIN; Takamoto K, 2007, STRUCTURE, V15, P39, DOI 10.1016/j.str.2006.11.005; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; van Berkel WJH, 1999, METH MOL B, V131, P61	20	218	229	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1710	1713		10.1126/science.1211956	http://dx.doi.org/10.1126/science.1211956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22116028	Green Accepted			2022-12-28	WOS:000298344000069
J	Stadler, MB; Murr, R; Burger, L; Ivanek, R; Lienert, F; Scholer, A; Wirbelauer, C; Oakeley, EJ; Gaidatzis, D; Tiwari, VK; Schubeler, D				Stadler, Michael B.; Murr, Rabih; Burger, Lukas; Ivanek, Robert; Lienert, Florian; Schoeler, Anne; Wirbelauer, Christiane; Oakeley, Edward J.; Gaidatzis, Dimos; Tiwari, Vijay K.; Schuebeler, Dirk			DNA-binding factors shape the mouse methylome at distal regulatory regions	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; HYPERSENSITIVE SITES; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; METHYLATION CHANGES; GENE-REGULATION; IDENTIFICATION; ENHANCER; DEMETHYLATION	Methylation of cytosines is an essential epigenetic modification in mammalian genomes, yet the rules that govern methylation patterns remain largely elusive. To gain insights into this process, we generated base-pair-resolution mouse methylomes in stem cells and neuronal progenitors. Advanced quantitative analysis identified low-methylated regions (LMRs) with an average methylation of 30%. These represent CpG-poor distal regulatory regions as evidenced by location, DNase I hypersensitivity, presence of enhancer chromatin marks and enhancer activity in reporter assays. LMRs are occupied by DNA-binding factors and their binding is necessary and sufficient to create LMRs. A comparison of neuronal and stem-cell methylomes confirms this dependency, as cell-type-specific LMRs are occupied by cell-type-specific transcription factors. This study provides methylome references for the mouse and shows that DNA-binding factors locally influence DNA methylation, enabling the identification of active regulatory regions.	[Stadler, Michael B.; Murr, Rabih; Burger, Lukas; Ivanek, Robert; Lienert, Florian; Schoeler, Anne; Wirbelauer, Christiane; Gaidatzis, Dimos; Tiwari, Vijay K.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Stadler, Michael B.; Burger, Lukas; Schoeler, Anne; Gaidatzis, Dimos] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Lienert, Florian; Schoeler, Anne; Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Oakeley, Edward J.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of Basel; Novartis	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ivanek, Robert/A-8852-2008	Ivanek, Robert/0000-0002-8403-056X; Scholer, Anne/0000-0001-6354-1689; Murr, Rabih/0000-0002-3346-6590; Tiwari, Vijay/0000-0003-0292-6635; van Nimwegen, Erik/0000-0001-6338-1312	EMBO; Marie Curie International Incoming fellowship; Novartis Research Foundation; European Union (NoE) [FP7-HEALTH-2010-257082]; European Research Council (ERC EpiGePlas); SNF; Swiss initiative in Systems Biology	EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Incoming fellowship(European Commission); Novartis Research Foundation; European Union (NoE)(European Commission); European Research Council (ERC EpiGePlas)(European Research Council (ERC)); SNF; Swiss initiative in Systems Biology	The authors thank A. Fernandez, C. Kohler, V. Petitjean and F. Staedtler (Novartis) and I. Nissen and C. Beisel (ETH-BSSE) for performing next generation sequencing experiments. R. Lister and J. Ecker for technical advice on BisSeq library generation. D. Schmitz for the pcDNA6-IRES-Blasticidin vector. D. Anderson for the REST antibody. H. Jorgensen for REST cds. L. Hoerner for help in Sanger bisulphite sequencing. M. Lorincz, N. Thoma and members of the Schubeler laboratory for feedback on the manuscript. R. M. is supported by an EMBO long-term postdoctoral fellowship. V. K. T. is supported by a Marie Curie International Incoming fellowship and an EMBO long-term postdoctoral fellowship. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082), the European Research Council (ERC EpiGePlas), the SNF Sinergia program and the Swiss initiative in Systems Biology (Cell Plasticity).	Abbott A, 2011, NATURE, V477, P518, DOI 10.1038/477518a; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Boyle AP, 2009, EPIGENOMICS-UK, V1, P319, DOI 10.2217/epi.09.29; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen NM, 2009, GENOME RES, V19, P2193, DOI 10.1101/gr.096685.109; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROUDINE M, 1985, SCIENCE, V228, P1061, DOI 10.1126/science.2986289; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kinoshita K, 2007, BIOCHEM BIOPH RES CO, V353, P686, DOI 10.1016/j.bbrc.2006.12.071; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mares J, 2001, CANCER LETT, V166, P165, DOI 10.1016/S0304-3835(01)00402-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; SHARRARD RM, 1992, BRIT J CANCER, V65, P667, DOI 10.1038/bjc.1992.142; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tagoh H, 2004, BLOOD, V103, P2950, DOI 10.1182/blood-2003-09-3323; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934	50	920	950	6	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					490	495		10.1038/nature10716	http://dx.doi.org/10.1038/nature10716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22170606				2022-12-28	WOS:000298318000053
J	West, JD; Bergstrom, CT				West, Jevin D.; Bergstrom, Carl T.			Can Ignorance Promote Democracy?	SCIENCE			English	Editorial Material							COMPUTATION; CONSENSUS; EMERGENT		[West, Jevin D.; Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; The Santa Fe Institute	West, JD (corresponding author), Univ Washington, Dept Biol, Box 351800, Seattle, WA 98195 USA.	jevinw@u.washington.edu; cbergst@u.washington.edu	Bergstrom, Carl T./H-2299-2011	Bergstrom, Carl T./0000-0002-2070-385X				BENOR M, 1985, P 26 IEEE S FDN COMP, P408; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; Jefferson T., 1903, WRITINGS T JEFFERSON, V10, P4; Jefferson Thomas, 1903, WRITINGS T JEFFERSON, V13, P333; Kelso J., 1988, DYNAMIC PATTERNS COM, P293; Lachmann M, 2000, P ROY SOC B-BIOL SCI, V267, P1287, DOI 10.1098/rspb.2000.1140; LUO RC, 1989, IEEE T SYST MAN CYB, V19, P901, DOI 10.1109/21.44007; Peak D, 2004, P NATL ACAD SCI USA, V101, P918, DOI 10.1073/pnas.0307811100; Smith J M, 1998, MAJOR TRANSITIONS EV; Taylor AD, 2005, OUTLOOKS, P1, DOI 10.1017/CBO9780511614316; YOUNG HP, 1988, AM POLIT SCI REV, V82, P1231, DOI 10.2307/1961757	14	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1503	1504		10.1126/science.1216124	http://dx.doi.org/10.1126/science.1216124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174236				2022-12-28	WOS:000298091400035
J	Graber, C				Graber, Cynthia			AETIOLOGY The path to disease	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S54	S55		10.1038/480S54a	http://dx.doi.org/10.1038/480S54a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169806	Bronze			2022-12-28	WOS:000298033000012
J	Bukowski, R; Carpenter, M; Conway, D; Coustan, D; Dudley, DJ; Goldenberg, RL; Hogue, CJR; Koch, MA; Parker, CB; Pinar, H; Reddy, UM; Saade, GR; Silver, RM; Stoll, BJ; Varner, MW; Willinger, M				Bukowski, Radek; Carpenter, Marshall; Conway, Deborah; Coustan, Donald; Dudley, Donald J.; Goldenberg, Robert L.; Hogue, Carol J. Rowland; Koch, Matthew A.; Parker, Corette B.; Pinar, Halit; Reddy, Uma M.; Saade, George R.; Silver, Robert M.; Stoll, Barbara J.; Varner, Michael W.; Willinger, Marian		Stillbirth Collaborative Res Netwo	Causes of Death Among Stillbirths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL DISPARITY; PRENATAL-CARE; UNITED-STATES; RATES; RISK; CLASSIFICATION; MORTALITY; TRENDS; BIRTH	Context Stillbirth affects 1 in 160 pregnancies in the United States, equal to the number of infant deaths each year. Rates are higher than those of other developed countries and have stagnated over the past decade. There is significant racial disparity in the rate of stillbirth that is unexplained. Objective To ascertain the causes of stillbirth in a population that is diverse by race/ethnicity and geography. Design, Setting, and Participants A population-based study from March 2006 to September 2008 with surveillance for all stillbirths at 20 weeks or later in 59 tertiary care and community hospitals in 5 catchment areas defined by state and county boundaries to ensure access to at least 90% of all deliveries. Termination of a live fetus was excluded. Standardized evaluations were performed at delivery. Main Outcome Measures Medical history, fetal postmortem and placental pathology, karyotype, other laboratory tests, systematic assignment of causes of death. Results Of 663 women with stillbirth enrolled, 500 women consented to complete postmortem examinations of 512 neonates. A probable cause of death was found in 312 stillbirths (60.9%; 95% CI, 56.5%-65.2%) and possible or probable cause in 390 (76.2%; 95% CI, 72.2%-79.8%). The most common causes were obstetric conditions (150 [29.3%; 95% CI, 25.4%-33.5%]), placental abnormalities (121 [23.6%; 95% CI, 20.1%-27.6%]), fetal genetic/structural abnormalities (70 [13.7%; 95% CI, 10.9%-17.0%]), infection (66 [12.9%; 95% CI, 10.2%-16.2%]), umbilical cord abnormalities (53 [10.4%; 95% CI, 7.9%-13.4%]), hypertensive disorders (47 [9.2%; 95% CI, 6.9%-12.1%]), and other maternal medical conditions (40 [7.8%; 95% CI, 5.7%-10.6%]). A higher proportion of stillbirths in non-Hispanic black women compared with non-Hispanic white and Hispanic ones was associated with obstetric complications (43.5% [50] vs 23.7% [85]; difference, 19.8%; 95% CI, 9.7%-29.9%; P < .001) and infections (25.2% [29] vs 7.8% [28]; difference, 17.4%; 95% CI, 9.0%-25.8%; P < .001). Stillbirths occurring intrapartum and early in gestation were more common in non-Hispanic black women. Sources most likely to provide positive information regarding cause of death were placental histology (268 [52.3%; 95% CI, 47.9%-56.7%]), perinatal postmortem examination (161 [31.4%; 95% CI, 27.5%-35.7%]), and karyotype (32 of 357 with definitive results [9%; 95% CI, 6.3%-12.5%]). Conclusions A systematic evaluation led to a probable or possible cause in the majority of stillbirths. Obstetric conditions and placental abnormalities were the most common causes of stillbirth, although the distribution differed by race/ethnicity. JAMA. 2011;306(22):2459-2468	[Silver, Robert M.; Varner, Michael W.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA; [Silver, Robert M.; Varner, Michael W.] Intermt Healthcare, Maternal Fetal Med, Salt Lake City, UT USA; [Bukowski, Radek; Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX USA; [Carpenter, Marshall; Coustan, Donald] Brown Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Providence, RI 02912 USA; [Conway, Deborah; Dudley, Donald J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Antonio, TX 78229 USA; [Goldenberg, Robert L.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Hogue, Carol J. Rowland] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hogue, Carol J. Rowland] Emory Univ, Womens & Childrens Ctr, Atlanta, GA 30322 USA; [Koch, Matthew A.; Parker, Corette B.] RTI Int, Div Hlth Sci, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Pinar, Halit] Brown Univ, Sch Med, Dept Pathol & Lab Med, Div Perinatal & Pediat Pathol, Providence, RI 02912 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Texas System; University of Texas Health San Antonio; Drexel University; Emory University; Rollins School Public Health; Emory University; Research Triangle Institute; Brown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University; Children's Healthcare of Atlanta (CHOA)	Silver, RM (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, 30 N 1900 E,Room 2B200, Salt Lake City, UT 84132 USA.	bsilver@hsc.utah.edu	/AAO-2076-2020; Hogue, Carol J/H-5442-2012; Bukowski, Radek/B-6976-2013; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [U10-HD045953, U10-HD045925, U10-HD045952, U10-HDO45955, U10-HD045944, U01-HD045954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045954, U10HD045952, U10HD045925, U10HD045944, U10HD045953] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): U10-HD045953 Brown University; U10-HD045925 Emory University; U10-HD045952 University of Texas Medical Branch at Galveston; U10-HDO45955 University of Texas Health Sciences Center at San Antonio; U10-HD045944 University of Utah Health Sciences Center; and U01-HD045954 RTI International, RTP.	[Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2; Carey JC, 2000, INT J GYNECOL OBSTET, V69, P173, DOI 10.1016/S0020-7292(99)00219-2; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Fiscella K, 2004, MATERN CHILD HLTH J, V8, P45, DOI 10.1023/B:MACI.0000025726.53515.65; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2010, STILLBIRTH UNDERSTAN, P1; Graafmans WC, 2001, BRIT J OBSTET GYNAEC, V108, P1237, DOI 10.1111/j.1471-0528.2001.00291.x; Hankins G, 2002, SEMIN PERINATOL, V26, P1, DOI 10.1053/sper.2002.29840; Health Data OECD, 2008, HLTH DATA OECD 2008; Healthy People 2010, 2011, UND IMPR HLTH OBJ IM, VI; Healthy People 2010, 2011, UND IMPR HLTH OBJ IM; Healy AJ, 2006, OBSTET GYNECOL, V107, P625, DOI 10.1097/01.AOG.0000201978.83607.96; Heuser CC, 2010, OBSTET GYNECOL, V116, P1296, DOI 10.1097/AOG.0b013e3181fb8838; Hogue CJR, 2011, SEMIN PERINATOL, V35, P221, DOI 10.1053/j.semperi.2011.02.019; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe; Macdorman Marian F, 2008, NCHS Data Brief, P1; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Parast MM, 2008, HUM PATHOL, V39, P948, DOI 10.1016/j.humpath.2007.10.032; Parker CB, 2011, PAEDIATR PERINAT EP, V25, P425, DOI 10.1111/j.1365-3016.2011.01218.x; Pinar H, 2012, AM J PERINAT, V29, P187, DOI 10.1055/s-0031-1284228; Pinar H, 2011, AM J PERINAT, V28, P781, DOI 10.1055/s-0031-1281509; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Walsh CA, 2008, J MATERN-FETAL NEO M, V21, P493, DOI 10.1080/14767050802086669; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057	31	276	280	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2459	2468		10.1001/jama.2011.1823	http://dx.doi.org/10.1001/jama.2011.1823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166605	Green Accepted			2022-12-28	WOS:000297983300019
J	Bharti, N; Tatem, AJ; Ferrari, MJ; Grais, RF; Djibo, A; Grenfell, BT				Bharti, N.; Tatem, A. J.; Ferrari, M. J.; Grais, R. F.; Djibo, A.; Grenfell, B. T.			Explaining Seasonal Fluctuations of Measles in Niger Using Nighttime Lights Imagery	SCIENCE			English	Article							TRANSMISSION; DYNAMICS; EPIDEMIC	Measles epidemics in West Africa cause a significant proportion of vaccine-preventable childhood mortality. Epidemics are strongly seasonal, but the drivers of these fluctuations are poorly understood, which limits the predictability of outbreaks and the dynamic response to immunization. We show that measles seasonality can be explained by spatiotemporal changes in population density, which we measure by quantifying anthropogenic light from satellite imagery. We find that measles transmission and population density are highly correlated for three cities in Niger. With dynamic epidemic models, we demonstrate that measures of population density are essential for predicting epidemic progression at the city level and improving intervention strategies. In addition to epidemiological applications, the ability to measure fine-scale changes in population density has implications for public health, crisis management, and economic development.	[Bharti, N.; Grenfell, B. T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Bharti, N.; Grenfell, B. T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Ctr Hlth & Wellbeing, Princeton, NJ 08544 USA; [Tatem, A. J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA; [Tatem, A. J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Ferrari, M. J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ferrari, M. J.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Grais, R. F.] Epictr, F-75011 Paris, France; [Grais, R. F.] Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Djibo, A.] Minist Sante, DGSP, Niamey, Niger; [Tatem, A. J.; Grenfell, B. T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; Princeton University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Bharti, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nbharti@princeton.edu		Tatem, Andrew/0000-0002-7270-941X; Bharti, Nita/0000-0003-1940-7794; Freeman Grais, Rebecca/0000-0002-5037-8218	Bill and Melinda Gates Foundation [49446]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Bill and Melinda Gates Foundation. A.J.T. is supported by a grant from the Bill and Melinda Gates Foundation (49446). A.J.T., M.J.F., and B. T. G. are also supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, NIH. All DMSP OLS imagery is available from the Space Physics Interactive Data Resource (http://spidr.ngdc.noaa.gov/spidr/).	Agnew J, 2008, ENVIRON PLANN A, V40, P2285, DOI 10.1068/a41200; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Camargo M C, 2000, Rev Panam Salud Publica, V7, P359; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Ebener Steeve, 2005, Int J Health Geogr, V4, P5, DOI 10.1186/1476-072X-4-5; Elvidge CD, 1997, PHOTOGRAMM ENG REM S, V63, P727; Elvidge CD, 2009, COMPUT GEOSCI-UK, V35, P1652, DOI 10.1016/j.cageo.2009.01.009; FAULKINGHAM RH, 1975, POP STUD-J DEMOG, V29, P463, DOI [10.2307/2173939, 10.1080/00324728.1975.10412711]; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; HUTCHINS SS, 1990, AM J EPIDEMIOL, V132, P157, DOI 10.1093/oxfordjournals.aje.a115627; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Prothero RM, 2002, GLOBAL CHANGE HUMAN, V3, P20, DOI DOI 10.1023/A:1019636208598; Rain D., 2018, EATERS DRY SEASON CI, DOI 10.4324/9780429500886; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Word D. P., 2010, 20 EUR S COMP AID PR; Yameogo KR, 2005, INT J EPIDEMIOL, V34, P556, DOI 10.1093/ije/dyi001	27	147	151	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1424	1427		10.1126/science.1210554	http://dx.doi.org/10.1126/science.1210554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158822	Green Accepted			2022-12-28	WOS:000297787700059
J	Parada, LV				Vargas Parada, Laura			Life lessons	NATURE			English	Editorial Material							INFLUENZA; VACCINATE											Briand S, 2011, PUBLIC HEALTH, V125, P247, DOI 10.1016/j.puhe.2010.12.007; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Nabel GJ, 2011, NATURE, V471, P157, DOI 10.1038/471157a; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S11	S13		10.1038/480S11a	http://dx.doi.org/10.1038/480S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158294	Green Published			2022-12-28	WOS:000297744200008
J	Gaal, P; Szigeti, S; Panteli, D; Gaskins, M; van Ginneken, E				Gaal, Peter; Szigeti, Szabolcs; Panteli, Dimitra; Gaskins, Matthew; van Ginneken, Ewout			Major challenges ahead for Hungarian healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gaal, Peter] Semmelweis Univ, Hlth Serv Management Training Ctr, H-1085 Budapest, Hungary; [Szigeti, Szabolcs] WHO Country Off Hungary, Budapest, Hungary; [Panteli, Dimitra; Gaskins, Matthew; van Ginneken, Ewout] Berlin Univ Technol, Dept Hlth Care Management, Berlin, Germany; [van Ginneken, Ewout] European Observ Hlth Syst & Policies, Berlin, Germany	Semmelweis University; Technical University of Berlin; European Observatory on Health Systems & Policies	van Ginneken, E (corresponding author), Semmelweis Univ, Hlth Serv Management Training Ctr, H-1085 Budapest, Hungary.	ewout.vanginneken@tu-berlin.de	Gaal, Peter/A-7818-2008	Gaal, Peter/0000-0002-6815-9021; Gaskins, Matthew/0000-0001-6436-2703; Panteli, Dimitra/0000-0003-2110-3335				Adany R, 2008, NEPEGESZSEGUGY, V86, P5; Eke E, HLTH PROFES IN PRESS; European health for all databases (HFA-DB), EUR HLTH ALL DAT HFA; Eurostat, 2011, EU LAB FORC SURV; Gaal P, 2011, HLTH SYST TRANSIT, P1; Gaal P, 2004, THESIS LONDON SCH HY; Gaal P, WORLD SCI IN PRESS; Gaal P., 2010, IMPLEMENTING HLTH FI, P327; Gaal P, 2006, HEALTH POLICY, V77, P86, DOI 10.1016/j.healthpol.2005.07.024; Gaal Peter, 2004, HLTH CARE SYSTEMS TR; Government of the Hungarian Republic, 2010, NEMZ EG PROGR; Hungarian Central Statistical Office, 2011, STADAT TABL EMPL; Hungarian Central Statistical Office, 2011, HOUS STAT; Hungarian Central Statistical Office, 2009, YB HLTH STAT 2008; Kaman A, 2010, ASS LEAD HUNG DENT C; Ministry of Health, 2009, TAJ AZ EG DOLG LETSZ; Ministry of Health, 2008, TAJ AZ EG EVT NEP PR; National Institute for Strategic Health Research, 2011, OSSZEFOGLALO TAJEKOZ; Organisation for Economic Cooperation and Development, 2011, OECD HLTH DAT HLTH E; Wismar M, HLTH PROFESSIONAL MO	20	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2011	343								d7657	10.1136/bmj.d7657	http://dx.doi.org/10.1136/bmj.d7657			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874EV	22162289				2022-12-28	WOS:000298939100004
J	Weber, ME; Clark, PU; Ricken, W; Mitrovica, JX; Hostetler, SW; Kuhn, G				Weber, Michael E.; Clark, Peter U.; Ricken, Werner; Mitrovica, Jerry X.; Hostetler, Steven W.; Kuhn, Gerhard			Interhemispheric Ice-Sheet Synchronicity During the Last Glacial Maximum	SCIENCE			English	Article							SEA EMBAYMENT CONSTRAINTS; SOUTHEASTERN WEDDELL SEA; OCEAN CIRCULATION; DEGLACIAL HISTORY; RADIOCARBON CONSTRAINTS; CLIMATE VARIABILITY; RETREAT HISTORY; ROSS SEA; SEDIMENTATION; GREENLAND	The timing of the last maximum extent of the Antarctic ice sheets relative to those in the Northern Hemisphere remains poorly understood. We develop a chronology for the Weddell Sea sector of the East Antarctic Ice Sheet that, combined with ages from other Antarctic ice-sheet sectors, indicates that the advance to and retreat from their maximum extent was within dating uncertainties synchronous with most sectors of Northern Hemisphere ice sheets. Surface climate forcing of Antarctic mass balance would probably cause an opposite response, whereby a warming climate would increase accumulation but not surface melting. Our new data support teleconnections involving sea-level forcing from Northern Hemisphere ice sheets and changes in North Atlantic deep-water formation and attendant heat flux to Antarctic grounding lines to synchronize the hemispheric ice sheets.	[Weber, Michael E.; Ricken, Werner] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Hostetler, Steven W.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, US Geol Survey, Corvallis, OR 97331 USA; [Mitrovica, Jerry X.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Kuhn, Gerhard] Helmholtz Assoc, Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	University of Cologne; Oregon State University; United States Department of the Interior; United States Geological Survey; Harvard University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Weber, ME (corresponding author), Univ Cologne, Inst Geol & Mineral, Zuelpicher Str 49A, D-50674 Cologne, Germany.	michael.weber@uni-koeln.de	Weber, Michael/G-8707-2012	Kuhn, Gerhard/0000-0001-6069-7485; Weber, Michael E/0000-0003-2175-8980	Deutsche Forschungsgemeinschaft [WE2039/8-1, RI525/17-1, KU683/9-1, KU683/12-1]; U.S. NSF	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. NSF(National Science Foundation (NSF))	We thank the Deutsche Forschungsgemeinschaft (grants WE2039/8-1, RI525/17-1, KU683/9-1, and KU683/12-1) and the U.S. NSF Paleoclimate Program for financial support, the Alfred Wegener Institute for Polar and Marine Research for logistic support, J. Rethemeyer for conducting part of the AMS <SUP>14</SUP>C measurements, B. Weninger for discussing the <SUP>14</SUP>C data, D. Sprenk for assisting with the graphics, and A. Holzapfel for editorial work (all from Univ. of Cologne).	Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Anderson JB, 1999, GEOLOGY, V27, P179, DOI 10.1130/0091-7613(1999)027<0179:RCOISA>2.3.CO;2; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Bentley MJ, 1998, ANTARCT SCI, V10, P309, DOI 10.1017/S0954102098000388; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; Clark P. U., 2007, AM GEOPHYS UNION GEO, V315; Clark PU, 2011, GEOLOGY, V39, pE239, DOI 10.1130/G31533C.1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; De Deckker P, 2009, GLOBAL PLANET CHANGE, V66, P85, DOI 10.1016/j.gloplacha.2008.03.012; Denton GH, 2000, GEOGR ANN A, V82A, P167, DOI 10.1111/1468-0459.00121; DENTON GH, 1983, QUATERNARY RES, V20, P125, DOI 10.1016/0033-5894(83)90073-X; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Domack EW, 1999, QUATERNARY SCI REV, V18, P1445, DOI 10.1016/S0277-3791(99)00042-6; ELVERHOI A, 1981, NATURE, V293, P641, DOI 10.1038/293641a0; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; Evans J, 2005, QUATERNARY SCI REV, V24, P741, DOI 10.1016/j.quascirev.2004.10.007; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Griffiths SD, 2009, J CLIMATE, V22, P2905, DOI 10.1175/2008JCLI2540.1; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Heroy DC, 2007, QUATERNARY SCI REV, V26, P3286, DOI 10.1016/j.quascirev.2007.07.012; Hostetler S, 2006, QUATERNARY SCI REV, V25, P1168, DOI 10.1016/j.quascirev.2005.12.010; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; KUHN G, 1993, MAR GEOL, V113, P201, DOI 10.1016/0025-3227(93)90018-Q; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Licht KJ, 2004, SEDIMENT GEOL, V165, P343, DOI 10.1016/j.sedgeo.2003.11.020; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Mckay RM, 2008, PALAEOGEOGR PALAEOCL, V260, P245, DOI 10.1016/j.palaeo.2007.08.015; Murakami S, 2008, J CLIMATE, V21, P5008, DOI 10.1175/2008JCLI2104.1; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; PENCK A, 1928, SITZUNGSBER PREUS PM, V6, P76; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; RINTOUL SR, 1991, J GEOPHYS RES-OCEANS, V96, P2675, DOI 10.1029/90JC02422; Roberts CN, 2010, GLOBAL PLANET CHANGE, V71, P135, DOI 10.1016/j.gloplacha.2010.01.024; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Smith JA, 2011, QUATERNARY SCI REV, V30, P488, DOI 10.1016/j.quascirev.2010.11.020; Smith JA, 2010, EARTH PLANET SC LETT, V296, P287, DOI 10.1016/j.epsl.2010.05.008; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Timmermann R, 2009, OCEAN MODEL, V27, P114, DOI 10.1016/j.ocemod.2008.10.009; van Ommen T.D., 2011, CLIMATE DISCUSSIONS, V7, P397, DOI DOI 10.5194/CPD-7-397-2011; Weber ME, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002611; WEBER ME, 1994, PALEOCEANOGRAPHY, V9, P1027, DOI 10.1029/94PA01443; WUNSCH C, 1984, J PHYS OCEANOGR, V14, P1712, DOI 10.1175/1520-0485(1984)014<1712:AEAOCM>2.0.CO;2; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	50	52	52	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1265	1269		10.1126/science.1209299	http://dx.doi.org/10.1126/science.1209299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144623				2022-12-28	WOS:000297553600047
J	Gugelmann, HM; Perrone, J				Gugelmann, Hallam M.; Perrone, Jeanmarie			Can Prescription Drug Monitoring Programs Help Limit Opioid Abuse?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OVERDOSE; RATES		[Gugelmann, Hallam M.; Perrone, Jeanmarie] Hosp Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Perrone, Jeanmarie] Hosp Univ Penn, Div Med Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Gugelmann, HM (corresponding author), Hosp Univ Penn, Dept Emergency Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	hallamg@gmail.com						[Anonymous], 2011, EPIDEMIC RESPONDING; Baehren DF, 2010, ANN EMERG MED, V56, P19, DOI 10.1016/j.annemergmed.2009.12.011; *CDCP, UN DRUG POIS US; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Martyres RF, 2004, MED J AUSTRALIA, V180, P211, DOI 10.5694/j.1326-5377.2004.tb05887.x; National Alliance for Model State Drug Laws (NAMSDL), 2011, PRESCR DRUG MON PROG; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Simeone R.H., 2006, EVALUATION PRESCRIPT; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401	10	86	86	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2258	2259		10.1001/jama.2011.1712	http://dx.doi.org/10.1001/jama.2011.1712			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851GD	22110107				2022-12-28	WOS:000297255500026
J	Mechtler, TP; Stary, S; Metz, TF; De Jesus, VR; Greber-Platzer, S; Pollak, A; Herkner, KR; Streubel, B; Kasper, DC				Mechtler, Thomas P.; Stary, Susanne; Metz, Thomas F.; De Jesus, Victor R.; Greber-Platzer, Susanne; Pollak, Arnold; Herkner, Kurt R.; Streubel, Berthold; Kasper, David C.			Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria	LANCET			English	Article							TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; FABRY-DISEASE; INBORN-ERRORS; POMPE-DISEASE; NEWBORN; METABOLISM; DIAGNOSIS; ASSAY; REPLACEMENT	Background The interest in neonatal screening for lysosomal storage disorders has increased substantially because of newly developed enzyme replacement therapies, the need for early diagnosis, and technical advances. We tested for Gaucher's disease, Pompe's disease, Fabry's disease, and Niemann-Pick disease types A and B in an anonymous prospective nationwide screening study that included genetic mutation analysis to assess the practicality and appropriateness of including these disorders in neonatal screening panels. Methods Specimens from dried blood spots of 34 736 newborn babies were collected consecutively from January, 2010 to July, 2010, as part of the national routine Austrian newborn screening programme. Anonymised samples were analysed for enzyme activities of acid beta-glucocerebrosidase, alpha-galactosidase, alpha-glucosidase, and acid sphingomyelinase by electrospray ionisation tandem mass spectrometry. Genetic mutation analyses were done in samples with suspected enzyme deficiency. Findings All 34 736 samples were analysed successfully by the multiplex screening assay. Low enzyme activities were detected in 38 babies. Mutation analysis confirmed lysosomal storage disorders in 15 of them. The most frequent mutations were found for Fabry's disease (1 per 3859 births), followed by Pompe's disease (1 per 8684), and Gaucher's disease (1 per 17 368). The positive predictive values were 32% (95% CI 16-52), 80% (28-99), and 50% (7-93), respectively. Mutational analysis detected predominantly missense mutations associated with a late-onset phenotype. Interpretation The combined overall proportion of infants carrying a mutation for lysosomal storage disorders was higher than expected. Neonatal screening for lysosomal storage disorders is likely to raise challenges for primary health-care providers. Furthermore, the high frequency of late-onset mutations makes lysosomal storage disorders a broad health problem beyond childhood.	[Mechtler, Thomas P.; Metz, Thomas F.; Greber-Platzer, Susanne; Pollak, Arnold; Herkner, Kurt R.; Kasper, David C.] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Stary, Susanne; Streubel, Berthold] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [De Jesus, Victor R.] Ctr Dis Control & Prevent, Newborn Screening & Mol Biol Branch, Atlanta, GA USA	Medical University of Vienna; Medical University of Vienna; Centers for Disease Control & Prevention - USA	Streubel, B (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria.	berthold.streubel@meduniwien.ac.at	Greber-Platzer, Susanne/AAT-1972-2021; Kasper, David/B-9054-2012	Greber-Platzer, Susanne/0000-0002-3706-8370; 	Austrian Ministry of Health, Family, and Women; Austrian Ministry of Health, Family, and Women [GZ 20.501/40-3 IV/A/2007]	Austrian Ministry of Health, Family, and Women; Austrian Ministry of Health, Family, and Women	This work was supported by grants from the Austrian Ministry of Health, Family, and Women (GZ 20.501/40-3 IV/A/2007). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Beck M, 2001, J INHERIT METAB DIS, V24, P47, DOI 10.1023/A:1012463605992; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bombard Y, 2010, EUR J HUM GENET, V18, P751, DOI 10.1038/ejhg.2010.13; CHACE DH, 1993, CLIN CHEM, V39, P66; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CLSI, 2009, NEWB SCREEN PRET LOW; Dajnoki A, 2008, CLIN CHEM, V54, P1624, DOI 10.1373/clinchem.2008.107722; Dajnoki A, 2010, CLIN CHIM ACTA, V411, P1428, DOI 10.1016/j.cca.2010.03.009; De Jesus VR, 2010, SEMIN PERINATOL, V34, P125, DOI 10.1053/j.semperi.2009.12.003; De Jesus VR, 2009, CLIN CHEM, V55, P158, DOI 10.1373/clinchem.2008.111864; Duffey TA, 2010, CLIN CHEM, V56, P1854, DOI 10.1373/clinchem.2010.152009; Duffner PK, 2009, PEDIATR NEUROL, V40, P245, DOI 10.1016/j.pediatrneurol.2008.11.010; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fletcher JM, 2006, J INHERIT METAB DIS, V29, P405, DOI 10.1007/s10545-006-0246-7; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hwu WL, 2010, J INHERIT METAB DIS, V33, P381, DOI 10.1007/s10545-010-9130-6; Kasper DC, 2010, WIEN KLIN WOCHENSCHR, V122, P607, DOI 10.1007/s00508-010-1457-3; Kasper DC, 2010, RAPID COMMUN MASS SP, V24, P986, DOI 10.1002/rcm.4496; Legini E, 2011, CLIN CHIM ACTA, V412, P343, DOI 10.1016/j.cca.2010.11.006; Li YJ, 2004, CLIN CHEM, V50, P638, DOI 10.1373/clinchem.2003.028381; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Mehta A, 2010, QJM-INT J MED, V103, P641, DOI 10.1093/qjmed/hcq117; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Metz TF, 2011, CLIN CHEM, V57, P1286, DOI 10.1373/clinchem.2011.164640; Millington DS, 2010, SEMIN PERINATOL, V34, P163, DOI 10.1053/j.semperi.2009.12.008; Moammar H, 2010, ANN SAUDI MED, V30, P271, DOI 10.4103/0256-4947.65254; Monserrat L, 2007, J AM COLL CARDIOL, V50, P2399, DOI 10.1016/j.jacc.2007.06.062; Park JK, 2002, CLIN GENET, V61, P32, DOI 10.1034/j.1399-0004.2002.610106.x; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; Wang RY, 2011, GENET MED, V13, P457, DOI 10.1097/GIM.0b013e318211a7e1; Wenger DA, 2003, ARCH NEUROL-CHICAGO, V60, P322, DOI 10.1001/archneur.60.3.322; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang XK, 2008, CLIN CHEM, V54, P1725, DOI 10.1373/clinchem.2008.104711; Zhou H, 2011, J PEDIAT, V159, P7	44	189	207	2	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					335	341		10.1016/S0140-6736(11)61266-X	http://dx.doi.org/10.1016/S0140-6736(11)61266-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22133539				2022-12-28	WOS:000300047300040
J	Thompson, BT				Thompson, B. Taylor			beta-agonists for ARDS: the dark side of adrenergic stimulation?	LANCET			English	Editorial Material							ACUTE LUNG INJURY; CONTROLLED CLINICAL-TRIAL		[Thompson, B. Taylor] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Thompson, B. Taylor] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Thompson, BT (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA.	tthompson1@partners.org						Folkesson HG, 2006, AM J RESP CELL MOL, V35, P10, DOI 10.1165/rcmb.2006-0080SF; Gonzalez-Munoz C, 2011, LIFE SCI, V88, P1095, DOI 10.1016/j.lfs.2011.04.015; Grant AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Novotny NM, 2009, SHOCK, V31, P113, DOI 10.1097/SHK.0b013e318180ffb6; Papazian L, 2011, AM J RESP CRIT CARE, V184, P504, DOI 10.1164/rccm.201105-0852ED; Perkins GD, 2011, AM J RESP CRIT CARE, V184, P503, DOI 10.1164/rccm.201106-1115ED; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Schmittinger CA, 2010, MED HYPOTHESES, V74, P460, DOI 10.1016/j.mehy.2009.10.012; Singer M, 2005, PLOS MED, V2, P497, DOI 10.1371/journal.pmed.0020167; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	14	4	5	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					196	198		10.1016/S0140-6736(11)61845-X	http://dx.doi.org/10.1016/S0140-6736(11)61845-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22166901				2022-12-28	WOS:000299316100012
J	Huang, CS; Ge, P; Zhou, ZH; Tong, L				Huang, Christine S.; Ge, Peng; Zhou, Z. Hong; Tong, Liang			An unanticipated architecture of the 750-kDa alpha(6)beta(6) holoenzyme of 3-methylcrotonyl-CoA carboxylase	NATURE			English	Article							AUREUS PYRUVATE-CARBOXYLASE; COENZYME-A; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; COA CARBOXYLASES; MOLECULAR-BASIS; MCCB MUTATIONS; DEFICIENCY; MECHANISM; SOFTWARE	3-Methylcrotonyl-CoA carboxylase (MCC), a member of the biotin-dependent carboxylase superfamily, is essential for the metabolism of leucine, and deficient mutations in this enzyme are linked to methylcrotonylglycinuria (MCG) and other serious diseases in humans(1-8). MCC has strong sequence conservation with propionyl-CoA carboxylase (PCC), and their holoenzymes are both 750-kilodalton (kDa) alpha(6)beta(6) dodecamers. Therefore the architecture of the MCC holoenzyme is expected to be highly similar to that of PCC9. Here we report the crystal structures of the Pseudomonas aeruginosa MCC (PaMCC) holoenzyme, alone and in complex with coenzyme A. Surprisingly, the structures show that the architecture and overall shape of PaMCC are markedly different when compared to PCC. The alpha-subunits show trimeric association in the PaMCC holoenzyme, whereas they have no contacts with each other in PCC. Moreover, the positions of the two domains in the beta-subunit of PaMCC are swapped relative to those in PCC. This structural information establishes a foundation for understanding the disease-causing mutations of MCC and provides new insights into the catalytic mechanism and evolution of biotin-dependent carboxylases. The large structural differences between MCC and PCC also have general implications for the relationship between sequence conservation and structural similarity.	[Huang, Christine S.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Columbia University; University of California System; University of California Los Angeles	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Zhou, Z Hong/HDN-0747-2022	Huang, Christine/0000-0003-4082-3880; Tong, Liang/0000-0002-0563-6468	National Institutes of Health (NIH) [DK067238, GM071940, GM08281]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Shen for carrying out initial studies on MCC; N. Whalen and S. Myers for setting up the X29A beamline at the National Synchrotron Light Source. This research was supported in part by National Institutes of Health (NIH) grants DK067238 (to L. T.) and GM071940 (to Z. H. Z.). C. S. H. was also supported by an NIH training program in molecular biophysics (GM08281).	Aguilar JA, 2008, J BACTERIOL, V190, P4888, DOI 10.1128/JB.00454-08; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Desviat LR, 2003, MOL GENET METAB, V80, P315, DOI 10.1016/S1096-7192(03)00130-6; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forster-Fromme K, 2010, APPL MICROBIOL BIOT, V87, P859, DOI 10.1007/s00253-010-2644-x; Gallardo ME, 2001, AM J HUM GENET, V68, P334, DOI 10.1086/318202; Holzinger A, 2001, HUM MOL GENET, V10, P1299, DOI 10.1093/hmg/10.12.1299; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kress D, 2009, J BIOL CHEM, V284, P28401, DOI 10.1074/jbc.M109.037762; Lasso G, 2010, STRUCTURE, V18, P1300, DOI 10.1016/j.str.2010.07.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen KV, 2011, MOL GENET METAB, V102, P218, DOI 10.1016/j.ymgme.2010.10.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Stadler SC, 2006, HUM MUTAT, V27, P748, DOI 10.1002/humu.20349; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Uematsu M, 2007, J HUM GENET, V52, P1040, DOI 10.1007/s10038-007-0211-9; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008	33	30	31	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					219	+		10.1038/nature10691	http://dx.doi.org/10.1038/nature10691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22158123	Green Submitted, Green Accepted			2022-12-28	WOS:000298981200043
J	Deweerdt, S				Deweerdt, Sarah			ANIMAL MODELS Towards a myeloma mouse	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; CELLS											Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	6	18	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S38	S39		10.1038/480S38a	http://dx.doi.org/10.1038/480S38a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169799	Bronze			2022-12-28	WOS:000298033000004
J	Holzbaur, ELF; Scherer, SS				Holzbaur, Erika L. F.; Scherer, Steven S.			Microtubules, Axonal Transport, and Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEINS		[Holzbaur, Erika L. F.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scherer, Steven S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712, R01NS055284] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS055284, U54 NS065712] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993	5	31	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2330	2332		10.1056/NEJMcibr1112481	http://dx.doi.org/10.1056/NEJMcibr1112481			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168648	Green Accepted			2022-12-28	WOS:000298031800017
J	Giardina, TD; Singh, H				Giardina, Traber Davis; Singh, Hardeep			Should Patients Get Direct Access to Their Laboratory Test Results? An Answer With Many Questions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOLLOW-UP; RECORDS; MAIL		Houston Vet Affairs Hlth Serv Res & Dev, Ctr Excellence, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA; Baylor Coll Med, Sect Hlth Serv Res, Dept Med, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine	Singh, H (corresponding author), VA Med Ctr 152, 2002 Holcombe Blvd, Houston, TX 77030 USA.	hardeeps@bcm.edu	Giardina, Traber D./Y-1176-2019	Giardina, Traber D./0000-0002-7694-103X; /0000-0002-9184-6524	AHRQ HHS [R18HS17820] Funding Source: Medline; NCI NIH HHS [K23CA125585] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017820] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA125585] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldwin Donna M, 2005, BMC Fam Pract, V6, P11, DOI 10.1186/1471-2296-6-11; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Christensen K, 2009, ARCH INTERN MED, V169, P1816, DOI 10.1001/archinternmed.2009.369; Cram P, 2006, J CLIN DENSITOM, V9, P393, DOI 10.1016/j.jocd.2006.09.002; DELMAR CB, 1995, AUST J PUBLIC HEALTH, V19, P211; Grimes GC, 2009, J AM BOARD FAM MED, V22, P670, DOI 10.3122/jabfm.2009.06.090078; Halamka JD, 2008, J AM MED INFORM ASSN, V15, P1, DOI 10.1197/jamia.M2562; Patient Access: Centers for Medicare & Medicaid Services, 2011, FED REGISTER, V76, p[56, 56]; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Sung S, 2006, J GEN INTERN MED, V21, P1075, DOI 10.1111/j.1525-1497.2006.00553.x	10	24	24	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2502	2503		10.1001/jama.2011.1797	http://dx.doi.org/10.1001/jama.2011.1797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	860YB	22122864				2022-12-28	WOS:000297983300025
J	Pavel, ME; Hainsworth, JD; Baudin, E; Peeters, M; Horsch, D; Klimovsky, J; Lebwohl, D; Jehl, V; Wolin, EM; Oberg, K; Van Cutsem, E; Yao, JC				Pavel, Marianne E.; Hainsworth, John D.; Baudin, Eric; Peeters, Marc; Hoersch, Dieter; Klimovsky, Judith; Lebwohl, David; Jehl, Valentine; Wolin, Edward M.; Oberg, Kjell; Van Cutsem, Eric; Yao, James C.		RADIANT 2 Study Grp	Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study	LANCET			English	Article							PROGRESSION-FREE SURVIVAL; PROGNOSTIC-FACTORS; CANCER-THERAPY; NEOPLASMS; PATHWAY; AGENTS; AKT	Background Everolimus, an oral inhibitor of the mammalian target of rapamycin (mTOR), has shown antitumour activity in patients with advanced pancreatic neuroendocrine tumours. We aimed to assess the combination of everolimus plus octreotide long-acting repeatable (LAR) in patients with low-grade or intermediate-grade neuroendocrine tumours (carcinoid). Methods We did a randomised, double-blind, placebo-controlled, phase 3 study comparing 10 mg per day oral everolimus with placebo, both in conjunction with 30 mg intramuscular octreotide LAR every 28 days. Randomisation was by interactive voice response systems. Participants were aged 18 years or older, with low-grade or intermediate-grade advanced (unresectable locally advanced or distant metastatic) neuroendocrine tumours, and disease progression established by radiological assessment within the past 12 months. Our primary endpoint was progression-free survival. Adjusted for two interim analyses, the prespecified boundary at final analysis was p <= 0.0246. This study is registered at ClinicalTrials.gov, number NCT00412061. Findings 429 individuals were randomly assigned to study groups; 357 participants discontinued study treatment and one was lost to follow-up. Median progression-free survival by central review was 16.4 (95% CI 13.7-21.2) months in the everolimus plus octreotide LAR group and 11.3 (8.4-14.6) months in the placebo plus octreotide LAR group (hazard ratio 0.77, 95% CI 0.59-1.00; one-sided log-rank test p=0.026). Drug-related adverse events (everolimus plus octreotide LAR vs placebo plus octreotide LAR) were mostly grade 1 or 2, and adverse events of all grades included stomatitis (62% vs 14%), rash (37% vs 12%), fatigue (31% vs 23%), and diarrhoea (27% vs 16%). Interpretation Everolimus plus octreotide LAR, compared with placebo plus octreotide LAR, improved progression-free survival in patients with advanced neuroendocrine tumours associated with carcinoid syndrome.	[Yao, James C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pavel, Marianne E.] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Hainsworth, John D.] Sarah Cannon Res Inst, Nashville, TN USA; [Baudin, Eric] Inst Gustave Roussy, Villejuif, France; [Peeters, Marc] Univ Antwerp Hosp, Dept Oncol, Edegem, Belgium; [Hoersch, Dieter] Zent Klin Bad Berka GmbH, Zentrum Neuroendokrine Tumore, Klin Innere Med Gastroenterol & Endokrinol, Bad Berka, Germany; [Hoersch, Dieter] Ochsner Kenner Med Ctr, Kenner, LA USA; [Jehl, Valentine] Novartis Pharma AG, Basel, Switzerland; [Wolin, Edward M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Oberg, Kjell] Univ Uppsala Hosp, Dept Endocrine Oncol, Uppsala, Sweden; [Van Cutsem, Eric] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium	University of Texas System; UTMD Anderson Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sarah Cannon Research Institute; UNICANCER; Gustave Roussy; University of Antwerp; Zentralklinik Bad Berka; Ochsner Health System; Novartis; Cedars Sinai Medical Center; Uppsala University; Uppsala University Hospital; KU Leuven; University Hospital Leuven	Yao, JC (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Box 426, Houston, TX 77030 USA.	jyao@mdanderson.org	Van+Cutsem, Eric/ABE-1762-2021; Peeters, Marc/C-5525-2013; Oberg, Kjell/AAG-7118-2019; Wyld, David/B-8893-2015	Peeters, Marc/0000-0003-4969-2303; Wyld, David/0000-0001-9523-4333; de Vries, Elisabeth/0000-0002-8949-7425	Novartis Pharmaceuticals; Novartis	Novartis Pharmaceuticals(Novartis); Novartis(Novartis)	Novartis Pharmaceuticals.; MEP has served as a consultant and has received honoraria and research funding from Novartis. EB has received honoraria or research funding from Novartis. MP has received research funding and is on the speaker's bureau for Novartis. DH is a consultant to and has received honoraria and research funding from Novartis. REW, JK, DL, and VJ are employees of and own shares in Novartis. EMW is a consultant to Novartis. KO serves on advisory boards of and receives honoraria from Novartis, Pfizer, and Ipsen. EVC has received research funding from Novartis. JCY is a consultant to Novartis and has received research funding from Novartis. JDH declares no conflicts of interest.	Asamura H, 2006, J CLIN ONCOL, V24, P70, DOI 10.1200/JCO.2005.04.1202; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Dodd LE, 2008, J CLIN ONCOL, V26, P3791, DOI 10.1200/JCO.2008.16.1711; Durante C, 2009, ENDOCR-RELAT CANCER, V16, P585, DOI 10.1677/ERC-08-0301; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fleming TR, 2009, J CLIN ONCOL, V27, P2874, DOI 10.1200/JCO.2008.20.4107; Kulke MH, 2011, J CLIN ONCOL, V29, P934, DOI 10.1200/JCO.2010.33.2056; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Moreno A, 2008, ENDOCR-RELAT CANCER, V15, P257, DOI 10.1677/ERC-07-0202; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; POLLAK MN, 1989, ANTICANCER RES, V9, P889; Rindi G., 2010, WHO CLASSIFICATION T, P13; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; SALTZ L, 1993, CANCER, V72, P244, DOI 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; von Wichert G, 2000, CANCER RES, V60, P4573; Yao JC, 2008, J CLIN ONCOL, V26, P4311, DOI 10.1200/JCO.2008.16.7858; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Zatelli MC, 2010, ENDOCR-RELAT CANCER, V17, P719, DOI 10.1677/ERC-10-0097	24	748	765	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					2005	2012		10.1016/S0140-6736(11)61742-X	http://dx.doi.org/10.1016/S0140-6736(11)61742-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22119496				2022-12-28	WOS:000298144200024
J	Hatziapostolou, M; Polytarchou, C; Aggelidou, E; Drakaki, A; Poultsides, GA; Jaeger, SA; Ogata, H; Karin, M; Struhl, K; Hadzopoulou-Cladaras, M; Iliopoulos, D				Hatziapostolou, Maria; Polytarchou, Christos; Aggelidou, Eleni; Drakaki, Alexandra; Poultsides, George A.; Jaeger, Savina A.; Ogata, Hisanobu; Karin, Michael; Struhl, Kevin; Hadzopoulou-Cladaras, Margarita; Iliopoulos, Dimitrios			An HNF4 alpha-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis	CELL			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; INTESTINAL EPITHELIAL-CELLS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; STAT3 ACTIVATION; ELEGANS GENOME; CANCER; CARCINOMA; EXPRESSION; MICRORNA	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is essential for liver development and hepatocyte function. Here, we show that transient inhibition of HNF4 alpha initiates hepatocellular transformation through a microRNA-inflammatory feedback loop circuit consisting of miR-124, IL6R, STAT3, miR-24, and miR-629. Moreover, we show that, once this circuit is activated, it maintains suppression of HNF4 alpha and sustains oncogenesis. Systemic administration of miR-124, which modulates inflammatory signaling, prevents and suppresses hepatocellular carcinogenesis by inducing tumor-specific apoptosis without toxic side effects. As we also show that this HNF4 alpha circuit is perturbed in human hepatocellular carcinomas, our data raise the possibility that manipulation of this microRNA feedback-inflammatory loop has therapeutic potential for treating liver cancer.	[Hatziapostolou, Maria; Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; [Hatziapostolou, Maria; Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Aggelidou, Eleni; Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, Dev Biol Lab, Sch Biol, Thessaloniki 54124, Greece; [Drakaki, Alexandra] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Poultsides, George A.] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA; [Jaeger, Savina A.] Novartis Inst Biomed Res, Dept Dev Mol Pathways, Cambridge, MA 02139 USA; [Ogata, Hisanobu; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Sch Med, La Jolla, CA 92093 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Aristotle University of Thessaloniki; Harvard University; Beth Israel Deaconess Medical Center; Stanford University; Novartis; University of California System; University of California San Diego	Iliopoulos, D (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	dimitrios_iliopoulos@dfci.harvard.edu	Aggelidou, Eleni/GQZ-2215-2022; Hatziapostolou, Maria/N-1820-2015; Iliopoulos, Dimitrios/AAE-9106-2019	Hatziapostolou, Maria/0000-0003-2493-7028; 	DFCI CIA; National Institutes of Health [RO1-CA118165, P42-ES0100337]; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER	DFCI CIA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DFCI CIA start-up funds to D.I. and research grants to M.K. from the National Institutes of Health (RO1-CA118165 and P42-ES0100337). We would like to thank the Nikon Imaging Center at Harvard Medical School for their help with light microscopy. Also, we would like to thank Hye-Jung Kim for her assistance with the flow cytometry analysis and Virgilio Garcia for his technical support.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jiang R., 2011, 22 PROMOTES HUMAN HE; Kardassis D, 1997, ARTERIOSCL THROM VAS, V17, P222, DOI 10.1161/01.ATV.17.1.222; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Xu L, 2001, CANCER RES, V61, P3176; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; ZHONG WM, 1993, EMBO J, V12, P537, DOI 10.1002/j.1460-2075.1993.tb05685.x; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	44	372	397	2	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1233	1247		10.1016/j.cell.2011.10.043	http://dx.doi.org/10.1016/j.cell.2011.10.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153071	Green Accepted, Bronze			2022-12-28	WOS:000298148100014
J	Levy, S; Kafri, M; Carmi, M; Barkai, N				Levy, Sagi; Kafri, Moshe; Carmi, Miri; Barkai, Naama			The Competitive Advantage of a Dual-Transporter System	SCIENCE			English	Article							HIGH-AFFINITY TRANSPORT; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSPORTERS; PROLINE TRANSPORT; TRANSCRIPTION; ARABIDOPSIS; YEAST	Cells use transporters of different affinities to regulate nutrient influx. When nutrients are depleted, low-affinity transporters are replaced by high-affinity ones. High-affinity transporters are helpful when concentrations of nutrients are low, but the advantage of reducing their abundance when nutrients are abundant is less clear. When we eliminated such reduced production of the Saccharomyces cerevisiae high-affinity transporters for phosphate and zinc, the elapsed time from the initiation of the starvation program until the lack of nutrients limited growth was shortened, and recovery from starvation was delayed. The latter phenotype was rescued by constitutive activation of the starvation program. Dual-transporter systems appear to prolong preparation for starvation and to facilitate subsequent recovery, which may optimize sensing of nutrient depletion by integrating internal and external information about nutrient availability.	[Levy, Sagi; Kafri, Moshe; Carmi, Miri; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il	Levy, Sagi/AAG-1593-2019	Kafri, Moshe/0000-0002-9416-5513	European Research Council (IDEAS); NIH [P50GM068763]; Helen and Martin Kimmel Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	European Research Council (IDEAS)(European Research Council (ERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen and Martin Kimmel Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Fialkov and S. Meizel for the technical help; D. Ben-Zvi, I. Soifer, and our lab members for helpful discussions; and E. O'Shea for the EB1264 plasmid. Microarrays data have been deposited in Gene Expression Omnibus (accession no. GSE32067). Supported by the European Research Council (IDEAS), NIH grant P50GM068763, and the Helen and Martin Kimmel Award for innovative investigations.	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Levy S, 2009, FEBS LETT, V583, P3974, DOI 10.1016/j.febslet.2009.10.071; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; TOWNSEND DE, 1992, J BACTERIOL, V174, P2702, DOI 10.1128/jb.174.8.2702-2710.1992; Wykoff DD, 2001, GENETICS, V159, P1491; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; YAMAMURA HI, 1973, J NEUROCHEM, V21, P1355, DOI 10.1111/j.1471-4159.1973.tb06022.x; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	27	54	54	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1408	1412		10.1126/science.1207154	http://dx.doi.org/10.1126/science.1207154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158820	Green Accepted			2022-12-28	WOS:000297787700055
J	Liu, X; Bushnell, DA; Kornberg, RD				Liu, Xin; Bushnell, David A.; Kornberg, Roger D.			Lock and Key to Transcription: sigma-DNA Interaction	CELL			English	Editorial Material							RNA; INITIATION; MECHANISM; COMPLEX		[Liu, Xin; Bushnell, David A.; Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu						AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398	10	14	16	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1218	1219		10.1016/j.cell.2011.11.033	http://dx.doi.org/10.1016/j.cell.2011.11.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153066	Bronze			2022-12-28	WOS:000298148100009
J	Paul, WE				Paul, William E.			Bridging Innate and Adaptive Immunity	CELL			English	Editorial Material							PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELLS; IN-VIVO; MICE; UNRESPONSIVENESS; IDENTIFICATION; GENE		NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wpaul@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Metchnikoff E., 1891, PHAGOCYTOSIS IMMUNIT; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323	15	39	40	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1212	1215		10.1016/j.cell.2011.11.036	http://dx.doi.org/10.1016/j.cell.2011.11.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153065	Bronze			2022-12-28	WOS:000298148100007
J	King, JR; Bekinschtein, T; Dehaene, S				King, Jean-Remi; Bekinschtein, Tristan; Dehaene, Stanislas			Comment on "Preserved Feedforward But Impaired Top-Down Processes in the Vegetative State"	SCIENCE			English	Editorial Material							POTENTIALS; COMA		[King, Jean-Remi; Dehaene, Stanislas] Commissariat Energie Atom & Energies Alternat, Div Life Sci, Inst Bioimaging, F-91191 Gif Sur Yvette, France; [King, Jean-Remi] Univ Paris 06, Ecole Doctorale Cerveau Cognit Comportement, F-75005 Paris, France; [King, Jean-Remi; Dehaene, Stanislas] INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [King, Jean-Remi] Inst Cerveau & Moelle Epiniere, INSERM, UMRS 975, F-75013 Paris, France; [Bekinschtein, Tristan] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Dehaene, Stanislas] Univ Paris 11, F-91400 Orsay, France; [Dehaene, Stanislas] Coll France, F-75005 Paris, France	CEA; UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	King, JR (corresponding author), Commissariat Energie Atom & Energies Alternat, Div Life Sci, Inst Bioimaging, F-91191 Gif Sur Yvette, France.	jeanremi.king@gmail.com			European Research Council [249830] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4	15	18	20	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060								10.1126/science.1210012	http://dx.doi.org/10.1126/science.1210012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144601	Green Accepted			2022-12-28	WOS:000297553600022
J	Lipworth, W; Kerridge, I; Brett, J; Day, R				Lipworth, Wendy; Kerridge, Ian; Brett, Jonathan; Day, Richard			How clinical and research failures lead to suboptimal prescribing: the example of chronic gout	BRITISH MEDICAL JOURNAL			English	Editorial Material							ASYMPTOMATIC HYPERURICEMIA; ALLOPURINOL; MANAGEMENT; BENZBROMARONE; INDICATORS; GUIDELINES; COLCHICINE; ADHERENCE		[Lipworth, Wendy] Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia; [Lipworth, Wendy; Kerridge, Ian] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Brett, Jonathan; Day, Richard] St Vincents Hosp, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney; University of Sydney; St Vincents Hospital Sydney	Lipworth, W (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW 2052, Australia.	w.lipworth@unsw.edu.au	Day, Richard/D-8699-2011	Day, Richard/0000-0002-6045-6937; Brett, Jonathan/0000-0003-3065-7495; Kerridge, Ian/0000-0001-7445-4660; Lipworth, Wendy/0000-0002-0234-657X				Becker MA, 2008, CURR OPIN RHEUMATOL, V20, P167, DOI 10.1097/BOR.0b013e3282f54d03; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Flaker GC, 2004, J INTERV CARD ELECTR, V10, P21, DOI 10.1023/B:JICE.0000011342.26830.5f; Gutierrez-Macias A, 2005, BMJ-BRIT MED J, V331, P623, DOI 10.1136/bmj.331.7517.623; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Harrold LR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2659; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kesselheim AS, 2010, NEW ENGL J MED, V362, P2045, DOI 10.1056/NEJMp1003126; Krishnan E, 2008, J RHEUMATOL, V35, P498; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Lindsay K, 2011, JCR-J CLIN RHEUMATOL, V17, P1, DOI 10.1097/RHU.0b013e318204a8f9; Lipworth WL, 2011, MED J AUSTRALIA, V195, P371, DOI 10.5694/mja11.10708; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Mikuls TR, 2004, ARTHRITIS RHEUM-US, V50, P937, DOI 10.1002/art.20102; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Perry ME, 2010, RHEUMATOLOGY, V49, P2233, DOI 10.1093/rheumatology/keq143; Reinders MK, 2009, ANN RHEUM DIS, V68, P892, DOI 10.1136/ard.2008.091462; Reinders MK, 2009, ANN RHEUM DIS, V68, P51, DOI 10.1136/ard.2007.083071; Reinders MK, 2010, CLIN INTERV AGING, V5, P7; Riedel AA, 2004, J RHEUMATOL, V31, P1575; Roddy E, 2007, ANN RHEUM DIS, V66, P1311, DOI 10.1136/ard.2007.070755; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Singh JA, 2009, ANN RHEUM DIS, V68, P1265, DOI 10.1136/ard.2008.092619; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; *UK CLIN PHARM ASS, 2011, UKCPA POS STAT INTR	28	9	11	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2011	343								d7459	10.1136/bmj.d7459	http://dx.doi.org/10.1136/bmj.d7459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RV	22134968	Green Submitted			2022-12-28	WOS:000298037800001
J	Spence, D				Spence, Des			FROM THE FRONTLINE The gender agenda	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						2009, BRIT MED J, V339, pB2587, DOI DOI 10.1136/BMJ.B2587	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7753	10.1136/bmj.d7753	http://dx.doi.org/10.1136/bmj.d7753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131208				2022-12-28	WOS:000298037300009
J	Hermans, EJ; van Marle, HJF; Ossewaarde, L; Henckens, MJAG; Qin, SZ; van Kesteren, MTR; Schoots, VC; Cousijn, H; Rijpkema, M; Oostenveld, R; Fernandez, G				Hermans, Erno J.; van Marle, Hein J. F.; Ossewaarde, Lindsey; Henckens, Marloes J. A. G.; Qin, Shaozheng; van Kesteren, Marlieke T. R.; Schoots, Vincent C.; Cousijn, Helena; Rijpkema, Mark; Oostenveld, Robert; Fernandez, Guillen			Stress-Related Noradrenergic Activity Prompts Large-Scale Neural Network Reconfiguration	SCIENCE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; LOCUS-COERULEUS; PREFRONTAL CORTEX; SYSTEM; BRAIN; MEMORY; ARCHITECTURE; MODULATION; ACTIVATION; AMYGDALA	Acute stress shifts the brain into a state that fosters rapid defense mechanisms. Stress-related neuromodulators are thought to trigger this change by altering properties of large-scale neural populations throughout the brain. We investigated this brain-state shift in humans. During exposure to a fear-related acute stressor, responsiveness and interconnectivity within a network including cortical (frontoinsular, dorsal anterior cingulate, inferotemporal, and temporoparietal) and subcortical (amygdala, thalamus, hypothalamus, and midbrain) regions increased as a function of stress response magnitudes. beta-adrenergic receptor blockade, but not cortisol synthesis inhibition, diminished this increase. Thus, our findings reveal that noradrenergic activation during acute stress results in prolonged coupling within a distributed network that integrates information exchange between regions involved in autonomic-neuroendocrine control and vigilant attentional reorienting.	[Hermans, Erno J.; van Marle, Hein J. F.; Qin, Shaozheng; van Kesteren, Marlieke T. R.; Schoots, Vincent C.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Hermans, Erno J.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Hermans, Erno J.] NYU, Dept Psychol, New York, NY 10003 USA; [van Marle, Hein J. F.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1100 DD Amsterdam, Netherlands; [Ossewaarde, Lindsey; Henckens, Marloes J. A. G.; Cousijn, Helena; Rijpkema, Mark; Oostenveld, Robert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Henckens, Marloes J. A. G.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Qin, Shaozheng] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [van Kesteren, Marlieke T. R.] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6500 HB Nijmegen, Netherlands; [Schoots, Vincent C.] Erasmus Univ, Rotterdam Sch Management, NL-3000 DR Rotterdam, Netherlands; [Cousijn, Helena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	Radboud University Nijmegen; Radboud University Nijmegen; New York University; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Stanford University; Radboud University Nijmegen; Erasmus University Rotterdam; University of Oxford	Hermans, EJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.	erno.hermans@donders.ru.nl	Fernandez, Guillen/B-3771-2009; van Marle, Hein/L-8791-2013; Hermans, Erno J./B-1610-2010; Qin, Shaozheng/AAD-2107-2019; Schoots, Vincent/A-9264-2012; van Kesteren, Marlieke/F-2723-2011; Oostenveld, Robert/D-3259-2009; Rijpkema, Mark/D-1974-2010; van Kesteren, Marlieke/J-5809-2014; Henckens, Marloes J.A.G./J-7132-2015	Fernandez, Guillen/0000-0002-5522-0604; Qin, Shaozheng/0000-0002-1859-2150; Schoots, Vincent/0000-0002-8838-6029; Oostenveld, Robert/0000-0002-1974-1293; Rijpkema, Mark/0000-0002-8495-4703; van Kesteren, Marlieke/0000-0001-6765-7881; Henckens, Marloes J.A.G./0000-0002-2375-1611; Cousijn, Helena/0000-0001-6660-6214; van Marle, Hein/0000-0003-3543-4135	Netherlands Organisation for Scientific Research (NWO) [451.07.019, 918.66.613]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	E.J.H. (451.07.019) and G. F. (918.66.613) received grants from the Netherlands Organisation for Scientific Research (NWO). We thank W. Seeley, V. Menon, C. Beckmann, and E. Phelps.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043	29	377	381	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1151	1153		10.1126/science.1209603	http://dx.doi.org/10.1126/science.1209603			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116887				2022-12-28	WOS:000297313900056
J	Dixon, J; Smith, P; Gravelle, H; Martin, S; Bardsley, M; Rice, N; Georghiou, T; Dusheiko, M; Billings, J; De Lorenzo, M; Sanderson, C				Dixon, Jennifer; Smith, Peter; Gravelle, Hugh; Martin, Steve; Bardsley, Martin; Rice, Nigel; Georghiou, Theo; Dusheiko, Mark; Billings, John; De Lorenzo, Michael; Sanderson, Colin			A person based formula for allocating commissioning funds to general practices in England: development of a statistical model	BRITISH MEDICAL JOURNAL			English	Article							RISK ADJUSTMENT; CARE	Objectives To develop a formula for allocating resources for commissioning hospital care to all general practices in England based on the health needs of the people registered in each practice Design Multivariate prospective statistical models were developed in which routinely collected electronic information from 2005-6 and 2006-7 on individuals and the areas in which they lived was used to predict their costs of hospital care in the next year, 2007-8. Data on individuals included all diagnoses recorded at any inpatient admission. Models were developed on a random sample of 5 million people and validated on a second random sample of 5 million people and a third sample of 5 million people drawn from a random sample of practices. Setting All general practices in England as of 1 April 2007. All NHS inpatient admissions and outpatient attendances for individuals registered with a general practice on that date. Subjects All individuals registered with a general practice in England at 1 April 2007. Main outcome measures Power of the statistical models to predict the costs of the individual patient or each practice's registered population for 2007-8 tested with a range of metrics (R(2) reported here). Comparisons of predicted costs in 2007-8 with actual costs incurred in the same year were calculated by individual and by practice. Results Models including person level information (age, sex, and ICD-10 codes diagnostic recorded) and a range of area level information (such as socioeconomic deprivation and supply of health facilities) were most predictive of costs. After accounting for person level variables, area level variables added little explanatory power. The best models for resource allocation could predict upwards of 77% of the variation in costs at practice level, and about 12% at the person level. With these models, the predicted costs of about a third of practices would exceed or undershoot the actual costs by 10% or more. Smaller practices were more likely to be in these groups. Conclusions A model was developed that performed well by international standards, and could be used for allocations to practices for commissioning. The best formulas, however, could predict only about 12% of the variation in next year's costs of most inpatient and outpatient NHS care for each individual. Person-based diagnostic data significantly added to the predictive power of the models.	[Dixon, Jennifer; Bardsley, Martin; Georghiou, Theo] Nuffield Trust, London W1G 7LP, England; [Smith, Peter] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England; [Smith, Peter] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London SW7 2AZ, England; [Gravelle, Hugh; Rice, Nigel; Dusheiko, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Martin, Steve] Univ York, Dept Econ, York YO10 5DD, N Yorkshire, England; [Billings, John] NYU, Grad Sch Publ Serv, New York, NY 10012 USA; [De Lorenzo, Michael] Hlth Dialog, Portland, ME 04101 USA; [Sanderson, Colin] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England	Imperial College London; Imperial College London; University of York - UK; University of York - UK; New York University; University of London; London School of Hygiene & Tropical Medicine	Dixon, J (corresponding author), Nuffield Trust, London W1G 7LP, England.	jennifer.dixon@nuffieldtrust.org.uk	Sanderson, Colin F/O-9877-2014	Sanderson, Colin/0000-0002-4838-6112; Gravelle, Hugh/0000-0002-7753-4233; Bardsley, Martin/0000-0002-9853-6019; Smith, Peter/0000-0003-0058-7588	Department of Health	Department of Health	The study was entirely funded by a grant from the Department of Health commissioned by the NHS Commissioning Arm of the DoH.	Ashworth M, 2005, FAM PRACT, V22, P529, DOI 10.1093/fampra/cmi057; *AUD COMM, 2007, PUTT COMM PRACT; BEVAN G, 2008, REV WEIGHTED CAPITAT; BEVAN G, 2008, REV WEIGHTED CAPIT S; *DEP HLTH, SUPP PRACT BAS COMM; *DEP HLTH, 2010, LIB NHS COMM PAT; Department of Health, 2008, NHS REF COSTS 2007 0; Department of Health, 2010, EQ EXC LIB NHS; DIXON J, 1995, BRIT MED J, V311, P727, DOI 10.1136/bmj.311.7007.727; DIXON J, 1994, BRIT MED J, V306, P30; Gravelle H, 2003, HEALTH ECON, V12, P985, DOI 10.1002/hec.830; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; *INF CTR HLTH SOC, HES ONL HOSP EP STAT; Martin S, 1998, SOC SCI MED, V47, P1547, DOI 10.1016/S0277-9536(98)00231-7; MAYS N, 1997, BRIT MED J, V315, P612; MORRIS S, 2007, COMBINING AGE RELATE; *NHS INF CTR, 2011, QUAL OUTC FRAM QOF 2; *NHS INF CTR, HESONLINE HOSP EP ST; *NHS INF CTR CAS S, HRG V3 5 TOOLK; PBRA Team, 2010, DEV PERS BAS RES ALL; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; SHELDON MTA, 1994, BRIT MED J, V309, P1059; van de Ven WPMM, 2003, HEALTH POLICY, V65, P75, DOI 10.1016/S0168-8510(02)00118-5; *WESTM CIT COUNC, 2007, WESTM HIDD POP; 2010, COMMUNITIES LOCAL GO	25	45	45	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 22	2011	343								d6608	10.1136/bmj.d6608	http://dx.doi.org/10.1136/bmj.d6608			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857ND	22110252	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000297724300001
J							Ministers Foreign Affairs Brazil F	Why we need a Commission on Global Governance for Health	LANCET			English	Editorial Material									[Ministers Foreign Affairs Brazil F] Royal Norwegian Minist Foreign Affairs, N-0032 Oslo, Norway									Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; [Anonymous], 2010, FOREIGN POLICY GLOBA; Ottersen OP, 2011, LANCET, V378, P1612, DOI 10.1016/S0140-6736(11)61617-6; United Nations General Assembly, 2011, ARES6595 UN GEN ASS; World Health Organization, 2011, RIO POL DECL SOC DET	5	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 21	2012	379	9825					1470	1471		10.1016/S0140-6736(11)61854-0	http://dx.doi.org/10.1016/S0140-6736(11)61854-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930BJ	22169106				2022-12-28	WOS:000303110200008
J	Meyer, RM; Gospodarowicz, MK; Connors, JM; Pearcey, RG; Wells, WA; Winter, JN; Horning, SJ; Dar, AR; Shustik, C; Stewart, DA; Crump, M; Djurfeldt, MS; Chen, BSE; Shepherd, LE				Meyer, Ralph M.; Gospodarowicz, Mary K.; Connors, Joseph M.; Pearcey, Robert G.; Wells, Woodrow A.; Winter, Jane N.; Horning, Sandra J.; Dar, A. Rashid; Shustik, Chaim; Stewart, Douglas A.; Crump, Michael; Djurfeldt, Marina S.; Chen, Bingshu E.; Shepherd, Lois E.		NCIC Clinical Trials Grp; Eastern Cooperative Oncology Grp	ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; COOPERATIVE-ONCOLOGY-GROUP; FIELD RADIOTHERAPY; RANDOMIZED-TRIALS; INTERGROUP TRIAL; DISEASE; CHEMOTHERAPY; VINBLASTINE; DOXORUBICIN; BLEOMYCIN	Background Chemotherapy plus radiation treatment is effective in controlling stage IA or IIA nonbulky Hodgkin's lymphoma in 90% of patients but is associated with late treatment-related deaths. Chemotherapy alone may improve survival because it is associated with fewer late deaths. Methods We randomly assigned 405 patients with previously untreated stage IA or IIA nonbulky Hodgkin's lymphoma to treatment with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone or to treatment with subtotal nodal radiation therapy, with or without ABVD therapy. Patients in the ABVD-only group, both those with a favorable risk profile and those with an unfavorable risk profile, received four to six cycles of ABVD. Among those assigned to subtotal nodal radiation therapy, patients who had a favorable risk profile received subtotal nodal radiation therapy alone and patients with an unfavorable risk profile received two cycles of ABVD plus subtotal nodal radiation therapy. The primary end point was 12-year overall survival. Results The median length of follow-up was 11.3 years. At 12 years, the rate of overall survival was 94% among those receiving ABVD alone, as compared with 87% among those receiving subtotal nodal radiation therapy (hazard ratio for death with ABVD alone, 0.50; 95% confidence interval [CI], 0.25 to 0.99; P=0.04); the rates of freedom from disease progression were 87% and 92% in the two groups, respectively (hazard ratio for disease progression, 1.91; 95% CI, 0.99 to 3.69; P=0.05); and the rates of event-free survival were 85% and 80%, respectively (hazard ratio for event, 0.88; 95% CI, 0.54 to 1.43; P=0.60). Among the patients randomly assigned to ABVD alone, 6 patients died from Hodgkin's lymphoma or an early treatment complication and 6 died from another cause; among those receiving radiation therapy, 4 deaths were related to Hodgkin's lymphoma or early toxic effects from the treatment and 20 were related to another cause. Conclusions Among patients with Hodgkin's lymphoma, ABVD therapy alone, as compared with treatment that included subtotal nodal radiation therapy, was associated with a higher rate of overall survival owing to a lower rate of death from other causes. (Funded by the Canadian Cancer Society and the National Cancer Institute; HD.6ClinicalTrials.govnumber, NCT00002561.)	[Meyer, Ralph M.] Queens Univ, Canc Res Inst, Kingston, ON K7L 3N6, Canada; [Meyer, Ralph M.; Djurfeldt, Marina S.; Chen, Bingshu E.; Shepherd, Lois E.] NCIC Clin Trials Grp, Kingston, ON, Canada; [Gospodarowicz, Mary K.; Wells, Woodrow A.; Crump, Michael] Univ Toronto, Toronto, ON, Canada; [Connors, Joseph M.] British Columbia Canc Agcy Ctr Lymphoid Canc, Vancouver, BC, Canada; [Pearcey, Robert G.] Univ Alberta, Edmonton, AB, Canada; [Dar, A. Rashid] Univ Western Ontario, London, ON, Canada; [Shustik, Chaim] McGill Univ, Montreal, PQ, Canada; [Stewart, Douglas A.] Univ Calgary, Calgary, AB, Canada; [Winter, Jane N.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Horning, Sandra J.] Stanford Univ, Stanford, CA 94305 USA	Queens University - Canada; Queens University - Canada; Canadian Cancer Trials Group; University of Toronto; University of Alberta; Western University (University of Western Ontario); McGill University; University of Calgary; Northwestern University; Feinberg School of Medicine; Stanford University	Meyer, RM (corresponding author), Queens Univ, Canc Res Inst, 10 Stuart St, Kingston, ON K7L 3N6, Canada.	rmeyer@ctg.queensu.ca	Connors, Joseph/AAF-5284-2019	Connors, Joseph/0000-0002-1361-7531; Chen, Bingshu/0000-0001-6139-0696; Winter, Jane/0000-0001-7542-3305	Canadian Cancer Society from the National Cancer Institute of Canada [015469]; Canadian Cancer Society Research Institute [21039]; National Cancer Institute, National Institutes of Health [CA077202]; National Cancer Institute [CA17145, CA21115]; Amgen Canada; Ariad Pharmaceuticals; Astex Therapeutics; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Ortho; Lilly; Merck Frosst Canada; Novartis; Oncothyreon; Ortho Biotech; Pfizer; Roche; SBIO; Sanofi; Schering Canada; ZymoGenetics; Imedex; Physicians' Education Resource; Lundbeck; Millennium; Janssen; NATIONAL CANCER INSTITUTE [U10CA077202, U10CA021115, U10CA017145] Funding Source: NIH RePORTER	Canadian Cancer Society from the National Cancer Institute of Canada; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen Canada(Amgen); Ariad Pharmaceuticals; Astex Therapeutics; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Celgene(Bristol-Myers SquibbCelgene Corporation); GlaxoSmithKline(GlaxoSmithKline); Janssen-Ortho; Lilly(Eli Lilly); Merck Frosst Canada; Novartis(Novartis); Oncothyreon; Ortho Biotech; Pfizer(Pfizer); Roche(Roche Holding); SBIO; Sanofi; Schering Canada; ZymoGenetics; Imedex; Physicians' Education Resource; Lundbeck(Lundbeck Corporation); Millennium(Takeda Pharmaceutical Company Ltd); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NCIC Clinical Trials Group was supported by funds from the Canadian Cancer Society, through grants from the National Cancer Institute of Canada (015469) and the Canadian Cancer Society Research Institute (21039), and by the National Cancer Institute, National Institutes of Health (CA077202); the Eastern Cooperative Oncology Group was supported by grants (CA17145 and CA21115) from the National Cancer Institute.; Dr. Meyer reports receiving honoraria from Lilly for serving on a data and safety monitoring committee and from Celgene for serving on an independent response assessment committee. In addition, the NCIC Clinical Trials Group, of which he is the director, has received research funding from Amgen Canada, Ariad Pharmaceuticals, Astex Therapeutics, AstraZeneca, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen-Ortho, Lilly, Merck Frosst Canada, Novartis, Oncothyreon, Ortho Biotech, Pfizer, Roche, SBIO, Sanofi, Schering Canada, and ZymoGenetics. Dr. Winter reports having research grants pending with Novartis, Millennium, Seattle Genetics, Pfizer, and Lilly, receiving lecture fees from Imedex and Physicians' Education Resource, and holding stock options with GlaxoSmithKline; Dr. Horning, being employed by Genentech and holding stock options with Roche; Dr. Shustik, receiving consulting and lecture fees from Janssen-Ortho, Roche, and Celgene; and Dr. Crump, receiving consulting fees from Celgene, Lundbeck, Millennium, and Janssen and lecture fees from Roche. No other potential conflict of interest relevant to this article was reported.	Canellos GP, 2005, J CLIN ONCOL, V23, P4574, DOI 10.1200/JCO.2005.01.911; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; CARDE P, 1988, J CLIN ONCOL, V6, P239, DOI 10.1200/JCO.1988.6.2.239; CARDE P, 1993, J CLIN ONCOL, V11, P2258, DOI 10.1200/JCO.1993.11.11.2258; Diehl V, 2007, NEW ENGL J MED, V357, P1968, DOI 10.1056/NEJMe078173; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2010, ANN ONCOL, V21, pv168, DOI 10.1093/annonc/mdq181; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Ferme C, 2007, NEW ENGL J MED, V357, P1916, DOI 10.1056/NEJMoa064601; Gallamini A, 2011, LEUKEMIA LYMPHOMA, V52, P583, DOI 10.3109/10428194.2010.551162; Hagenbeek A, 2000, BLOOD, V96, p575A; Herbst C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007110.pub2; Hoppe RT, 2011, J NATL COMPR CANC NE, V9, P1020, DOI 10.6004/jnccn.2011.0086; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Laskar S, 2004, J CLIN ONCOL, V22, P62, DOI 10.1200/JCO.2004.01.021; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Lister TA, 1990, J CLIN ONCOL, V8, P1602; Longo DL, 2009, CANCER J, V15, P114, DOI 10.1097/PPO.0b013e3181a2dc07; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyer R, 2003, BLOOD, V102, p26A; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Meyer RM, 2004, HEMATOLOGY, V1, P184; Nachman JB, 2002, J CLIN ONCOL, V20, P3765, DOI 10.1200/JCO.2002.12.007; Ng AK, 2011, J CLIN ONCOL, V29, P1885, DOI 10.1200/JCO.2010.32.8427; Press OW, 2001, J CLIN ONCOL, V19, P4238, DOI 10.1200/JCO.2001.19.22.4238; Radford J, 2008, HEMATOLOGY AM SOC HE, V1, P321; Straus DJ, 2004, BLOOD, V104, P3483, DOI 10.1182/blood-2004-04-1311; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Terasawa T, 2009, J CLIN ONCOL, V27, P1906, DOI 10.1200/JCO.2008.16.0861; Tomlinson G, 2010, JAMA-J AM MED ASSOC, V303, P267, DOI 10.1001/jama.2009.2017	32	280	291	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2012	366	5					399	408		10.1056/NEJMoa1111961	http://dx.doi.org/10.1056/NEJMoa1111961			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884QX	22149921	Green Accepted, Bronze			2022-12-28	WOS:000299724400005
J	Aldridge, BB; Fernandez-Suarez, M; Heller, D; Ambravaneswaran, V; Irimia, D; Toner, M; Fortune, SM				Aldridge, Bree B.; Fernandez-Suarez, Marta; Heller, Danielle; Ambravaneswaran, Vijay; Irimia, Daniel; Toner, Mehmet; Fortune, Sarah M.			Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility	SCIENCE			English	Article							BACILLUS-SUBTILIS; SIZE CONTROL; DIVISION; PROTEINS; LOCALIZATION; TUBERCULOSIS; CYCLE; SPORULATION; PERSISTENCE; SWITCH	Cells use both deterministic and stochastic mechanisms to generate cell-to-cell heterogeneity, which enables the population to better withstand environmental stress. Here we show that, within a clonal population of mycobacteria, there is deterministic heterogeneity in elongation rate that arises because mycobacteria grow in an unusual, unipolar fashion. Division of the asymmetrically growing mother cell gives rise to daughter cells that differ in elongation rate and size. Because the mycobacterial cell division cycle is governed by time, not cell size, rapidly elongating cells do not divide more frequently than slowly elongating cells. The physiologically distinct subpopulations of cells that arise through asymmetric growth and division are differentially susceptible to clinically important classes of antibiotics.	[Aldridge, Bree B.; Fernandez-Suarez, Marta; Heller, Danielle; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Fernandez-Suarez, Marta; Ambravaneswaran, Vijay; Irimia, Daniel; Toner, Mehmet] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Fortune, Sarah M.] MIT, Ragon Inst MGH, Boston, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Heller, Danielle/0000-0002-6581-1256; Fortune, Sarah/0000-0001-7565-9975; Aldridge, Bree/0000-0003-2236-1424	National Institute of Health [1DP20D001378]; Doris Duke Charitable Foundation [2010054]; United States Army Medical Research Acquisition Activity [W81XWH-10-2-0161]; National Institute of Biomedical Imaging and Bioengineering [P41 EB002503]; Massachusetts General Hospital Executive Committee on Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); United States Army Medical Research Acquisition Activity; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Massachusetts General Hospital Executive Committee on Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Rubin, B. Bloom, C. Sassetti, D. Lauffenburger, E. Liu, and J. Model for helpful discussions; P. Sorger for access to his live-cell imaging systems; A. J. Aranyosi for assistance with microfabrication; J. Goldstein for help with image annotation; and J. Sinn-Hanlon for the device illustration. We thank R. Husson and M. Mir for the gift of Van-Alexa. B. B. A. and S. M. F. designed the experiments and wrote the initial manuscript. B. B. A. performed the experiments, annotated images, and developed the analysis programs. M.F.-S., V. A., D. I., and M. T. designed the microfluidic devices that were built by M.F.-S. D. H. performed the initial pulse-chase experiment and annotated images. This work was partially supported by a National Institute of Health Director's New Innovator Award 1DP20D001378, Doris Duke Charitable Foundation under grant 2010054, and United States Army Medical Research Acquisition Activity under grant W81XWH-10-2-0161 to S. M. F., the National Institute of Biomedical Imaging and Bioengineering under grant P41 EB002503 to M. T. (BioMEMS Resource Center), and by the Massachusetts General Hospital Executive Committee on Research through a postdoctoral fellowship to M.F.S.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bordes P, 2011, P NATL ACAD SCI USA, V108, P8438, DOI 10.1073/pnas.1101189108; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Farnia P, 2010, INT J CLIN EXP MED, V3, P308; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; Mentinova M, 2010, J AM CHEM SOC, V132, P18248, DOI 10.1021/ja107286p; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Singh B, 2010, ANTON LEEUW INT J G, V98, P165, DOI 10.1007/s10482-010-9446-0; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Sveiczer A, 1996, J CELL SCI, V109, P2947; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999	29	265	271	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					100	104		10.1126/science.1216166	http://dx.doi.org/10.1126/science.1216166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174129	Bronze, Green Accepted			2022-12-28	WOS:000298846200060
J	Duan, S; Cermak, L; Pagan, JK; Rossi, M; Martinengo, C; di Celle, PF; Chapuy, B; Shipp, M; Chiarle, R; Pagano, M				Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Rossi, Mario; Martinengo, Cinzia; di Celle, Paola Francia; Chapuy, Bjoern; Shipp, Margaret; Chiarle, Roberto; Pagano, Michele			FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas	NATURE			English	Article							SCF UBIQUITIN LIGASE; GENE-EXPRESSION; PATHOGENESIS	BCL6 is the product of a proto-oncogene implicated in the pathogenesis of human B-cell lymphomas(1,2). By binding specific DNA sequences, BCL6 controls the transcription of a variety of genes involved in B-cell development, differentiation and activation. BCL6 is overexpressed in the majority of patients with aggressive diffuse large B-cell lymphoma (DLBCL), the most common lymphoma in adulthood, and transgenic mice constitutively expressing BCL6 in B cells develop DLBCLs similar to the human disease(3,4). In many DLBCL patients, BCL6 overexpression is achieved through translocation (similar to 40%) or hypermutation of its promoter (similar to 15%). However, many other DLBCLs overexpress BCL6 through an unknown mechanism. Here we show that BCL6 is targeted for ubiquitylation and proteasomal degradation by a SKP1-CUL1-F-box protein (SCF) ubiquitin ligase complex that contains the orphan F-box protein FBXO11 (refs 5, 6). The gene encoding FBXO11 was found to be deleted or mutated in multiple DLBCL cell lines, and this inactivation of FBXO11 correlated with increased levels and stability of BCL6. Similarly, FBXO11 was either deleted or mutated in primary DLBCLs. Notably, tumour-derived FBXO11 mutants displayed an impaired ability to induce BCL6 degradation. Reconstitution of FBXO11 expression in FBXO11-deleted DLBCL cells promoted BCL6 ubiquitylation and degradation, inhibited cell proliferation, and induced cell death. FBXO11-deleted DLBCL cells generated tumours in immunodeficient mice, and the tumorigenicity was suppressed by FBXO11 reconstitution. We reveal a molecular mechanism controlling BCL6 stability and propose that mutations and deletions in FBXO11 contribute to lymphomagenesis through BCL6 stabilization. The deletions/mutations found in DLBCLs are largely monoallelic, indicating that FBXO11 is a haplo-insufficient tumour suppressor gene.	[Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Rossi, Mario; Pagano, Michele] NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Duan, Shanshan; Cermak, Lukas; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Martinengo, Cinzia; Chiarle, Roberto] Univ Turin, CERMS, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [di Celle, Paola Francia] San Giovanni Battista Hosp, I-10126 Turin, Italy; [Chapuy, Bjoern; Shipp, Margaret] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; Howard Hughes Medical Institute; New York University; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Harvard University; Dana-Farber Cancer Institute	Pagano, M (corresponding author), NYU, Sch Med, NYU Canc Inst, Dept Pathol, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	roberto.chiarle@unito.it; michele.pagano@nyumc.org	Pagan, Julia/O-1929-2016; Cermak, Lukas/N-2254-2016; Rossi, Mario/E-7666-2012	Pagan, Julia/0000-0002-7079-6388; Cermak, Lukas/0000-0002-8777-3692; Rossi, Mario/0000-0001-6349-8895; CHIARLE, Roberto/0000-0003-1564-8531; pagano, michele/0000-0003-3210-2442	National Institutes of Health [R01-GM57587, R37-CA76584, R21-CA161108, PO1-CA092625]; Susan G. Komen for the Cure; Lymphoma Research Foundation; AIRC; ERC [ERC-2009-StG-Proposal No242965-LUNELY]; NATIONAL CANCER INSTITUTE [P01CA092625, R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Lymphoma Research Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Carroll, S. Shaham and L. Staudt for sharing unpublished results; A. Melnick, Y. Sun and Y. Xiong for reagents; L. Cerchietti, Y. Cheng, E. Dehan, V. Donato, N. V. Dorello, S. N. Yang and Z. Yao for advice and/or contributions to this work. M. P. is grateful to T. M. Thor and K. E. Davidson, and L. C. to Zuzana S. for continuous support. This work was supported by grants from the National Institutes of Health to M. P. (R01-GM57587, R37-CA76584 and R21-CA161108) and M. S. (PO1-CA092625), a grant from Susan G. Komen for the Cure to S. D., a Lymphoma Research Foundation Fellowship to J.K.P. and grants from AIRC and ERC (ERC-2009-StG-Proposal No242965-LUNELY) to R. C. M. P. is an Investigator with the Howard Hughes Medical Institute.	Baron BW, 2004, P NATL ACAD SCI USA, V101, P14198, DOI 10.1073/pnas.0406138101; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462	19	202	214	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					90	U100		10.1038/nature10688	http://dx.doi.org/10.1038/nature10688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22113614	Green Accepted			2022-12-28	WOS:000298836900035
J	Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Linch, DC; Chowdary, P; Riddell, A; Pie, AJ; Harrington, C; O'Beirne, J; Smith, K; Pasi, J; Glader, B; Rustagi, P; Ng, CYC; Kay, MA; Zhou, JF; Spence, Y; Morton, CL; Allay, J; Coleman, J; Sleep, S; Cunningham, JM; Srivastava, D; Basner-Tschakarjan, E; Mingozzi, F; High, KA; Gray, JT; Reiss, UM; Nienhuis, AW; Davidoff, AM				Nathwani, Amit C.; Tuddenham, Edward G. D.; Rangarajan, Savita; Rosales, Cecilia; McIntosh, Jenny; Linch, David C.; Chowdary, Pratima; Riddell, Anne; Pie, Arnulfo Jaquilmac; Harrington, Chris; O'Beirne, James; Smith, Keith; Pasi, John; Glader, Bertil; Rustagi, Pradip; Ng, Catherine Y. C.; Kay, Mark A.; Zhou, Junfang; Spence, Yunyu; Morton, Christopher L.; Allay, James; Coleman, John; Sleep, Susan; Cunningham, John M.; Srivastava, Deokumar; Basner-Tschakarjan, Etiena; Mingozzi, Federico; High, Katherine A.; Gray, John T.; Reiss, Ulrike M.; Nienhuis, Arthur W.; Davidoff, Andrew M.			Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENOASSOCIATED VIRAL VECTOR; HUMAN-FACTOR IX; CLINICAL-TRIAL; EFFICIENT TRANSDUCTION; IMMUNE-RESPONSE; HUMAN FIX; LIVER; EXPRESSION; THERAPY; EXERCISE	BACKGROUND Hemophilia B, an X-linked disorder, is ideally suited for gene therapy. We investigated the use of a new gene therapy in patients with the disorder. METHODS We infused a single dose of a serotype-8-pseudotyped, self-complementary adenovirus-associated virus (AAV) vector expressing a codon-optimized human factor IX (FIX) transgene (scAAV2/8-LP1-hFIXco) in a peripheral vein in six patients with severe hemophilia B (FIX activity, <1% of normal values). Study participants were enrolled sequentially in one of three cohorts (given a high, intermediate, or low dose of vector), with two participants in each group. Vector was administered without immunosuppressive therapy, and participants were followed for 6 to 16 months. RESULTS AAV-mediated expression of FIX at 2 to 11% of normal levels was observed in all participants. Four of the six discontinued FIX prophylaxis and remained free of spontaneous hemorrhage; in the other two, the interval between prophylactic injections was increased. Of the two participants who received the high dose of vector, one had a transient, asymptomatic elevation of serum aminotransferase levels, which was associated with the detection of AAV8-capsid-specific T cells in the peripheral blood; the other had a slight increase in liver-enzyme levels, the cause of which was less clear. Each of these two participants received a short course of glucocorticoid therapy, which rapidly normalized aminotransferase levels and maintained FIX levels in the range of 3 to 11% of normal values. CONCLUSIONS Peripheral-vein infusion of scAAV2/8-LP1-hFIXco resulted in FIX transgene expression at levels sufficient to improve the bleeding phenotype, with few side effects. Although immune-mediated clearance of AAV-transduced hepatocytes remains a concern, this process may be controlled with a short course of glucocorticoids without loss of transgene expression. (Funded by the Medical Research Council and others; ClinicalTrials.gov number, NCT00979238.)	[Nathwani, Amit C.; Rosales, Cecilia; McIntosh, Jenny; Linch, David C.] UCL, Inst Canc, Dept Haematol, London WC1E 6BT, England; [Nathwani, Amit C.; Tuddenham, Edward G. D.; Chowdary, Pratima; Riddell, Anne; Pie, Arnulfo Jaquilmac; Harrington, Chris] Royal Free Natl Hlth Serv NHS Trust, Katharine Dormandy Haemophilia Ctr, London, England; [Nathwani, Amit C.; Tuddenham, Edward G. D.; Chowdary, Pratima; Riddell, Anne; Pie, Arnulfo Jaquilmac; Harrington, Chris] Royal Free Natl Hlth Serv NHS Trust, Thrombosis Unit, London, England; [O'Beirne, James] Royal Free Natl Hlth Serv NHS Trust, Liver Unit, London, England; [Nathwani, Amit C.; Rosales, Cecilia; McIntosh, Jenny; Smith, Keith] NHS Blood & Transplant, London, England; [Pasi, John] Barts & London Queen Marys Sch Med & Dent, Ctr Haematol, London, England; [Rangarajan, Savita] Basingstoke & N Hampshire NHS Fdn Trust, Basingstoke, Hants, England; [Glader, Bertil; Rustagi, Pradip; Kay, Mark A.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Ng, Catherine Y. C.; Zhou, Junfang; Spence, Yunyu; Morton, Christopher L.; Davidoff, Andrew M.] St Jude Childrens Hosp, Dept Surg, Memphis, TN 38105 USA; [Srivastava, Deokumar] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Gray, John T.; Reiss, Ulrike M.; Nienhuis, Arthur W.] St Jude Childrens Hosp, Dept Hematol, Memphis, TN 38105 USA; [Allay, James; Coleman, John; Sleep, Susan] Childrens GMP, Memphis, TN USA; [Cunningham, John M.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Basner-Tschakarjan, Etiena; Mingozzi, Federico; High, Katherine A.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [High, Katherine A.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of London; University College London; University of London; Queen Mary University London; Stanford University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute	Nathwani, AC (corresponding author), UCL, UCL Canc Inst, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.	a.nathwani@ucl.ac.uk	O'Beirne, James/I-8251-2019; Tuddenham, Edward/AAS-6196-2020; mingozzi, federico/I-2332-2013; High, Katherine A./AAB-9322-2020; Wilson, Matthew H/K-3193-2013; o'beirne, james p/C-5701-2009; Chowdary, P/I-2623-2012; Gray, John T/D-2916-2016	O'Beirne, James/0000-0003-3400-2816; Tuddenham, Edward/0000-0001-8955-2909; o'beirne, james p/0000-0001-8590-396X; Chowdary, P/0000-0002-6690-8586; Gray, John T/0000-0002-1888-4612; High, Katherine/0000-0002-0805-6223; Rangarajan, Savita/0000-0001-7367-133X; Kay, Mark/0000-0002-2799-2615	Medical Research Council; Medical Research Council [G0502121] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10370] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073838, R01HL094396] Funding Source: NIH RePORTER; MRC [G0502121] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Medical Research Council and others; ClinicalTrials.gov number, NCT00979238.	Allay JA, 2011, HUM GENE THER, V22, P595, DOI 10.1089/hum.2010.202; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P17606, DOI 10.1073/pnas.0910387106; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435; den Uijl IEM, 2011, HAEMOPHILIA, V17, P41, DOI 10.1111/j.1365-2516.2010.02383.x; Fagone P, 2011, HUM GENE THER   0923; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P875, DOI 10.1055/s-0038-1651380; Li CW, 2009, P NATL ACAD SCI USA, V106, P10770, DOI 10.1073/pnas.0902269106; Manno CS, 2006, NAT MED, V12, P592, DOI 10.1038/nm0506-592b; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Nathwani AC, 2004, HAEMOPHILIA, V10, P309, DOI 10.1111/j.1365-2516.2004.00926.x; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; NATHWANI AC, 1992, BAILLIERE CLIN HAEM, V5, P383, DOI 10.1016/S0950-3536(11)80025-9; Nathwani A, 2010, BLOOD, V116, P114, DOI 10.1182/blood.V116.21.248.248; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Snyder RO, 1999, NAT MED, V5, P64, DOI 10.1038/4751	25	1251	1370	6	161	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2357	2365		10.1056/NEJMoa1108046	http://dx.doi.org/10.1056/NEJMoa1108046			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865OM	22149959	Green Accepted, Green Published			2022-12-28	WOS:000298320200002
J	Gadalla, SM; Lund, M; Pfeiffer, RM; Gortz, S; Mueller, CM; Moxley, RT; Kristinsson, SY; Bjorkholm, M; Shebl, FM; Hilbert, JE; Landgren, O; Wohlfahrt, J; Melbye, M; Greene, MH				Gadalla, Shahinaz M.; Lund, Marie; Pfeiffer, Ruth M.; Gortz, Sanne; Mueller, Christine M.; Moxley, Richard T., III; Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus; Shebl, Fatma M.; Hilbert, James E.; Landgren, Ola; Wohlfahrt, Jan; Melbye, Mads; Greene, Mark H.			Cancer Risk Among Patients With Myotonic Muscular Dystrophy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRIPLET REPEAT EXPANSION; BASAL-CELL CARCINOMA; HUNTINGTON-DISEASE; TRUE ASSOCIATION; MISMATCH-REPAIR; CTG REPEAT; TYPE-2; GENE; RNA; INSTABILITY	Context Myotonic muscular dystrophy (MMD) is an autosomal-dominant multisystem neuromuscular disorder characterized by unstable nucleotide repeat expansions. Case reports have suggested that MMD patients may be at increased risk of malignancy, putative risks that have never been quantified. Objective To quantitatively evaluate cancer risk in patients with MMD, overall and by sex and age. Design, Setting, and Participants We identified 1658 patients with an MMD discharge diagnosis in the Swedish Hospital Discharge Register or Danish National Patient Registry between 1977 and 2008. We linked these patients to their corresponding cancer registry. Patients were followed up from date of first MMD-related inpatient or outpatient contact to first cancer diagnosis, death, emigration, or completion of cancer registration. Main Outcome Measures Risks of all cancers combined and by anatomic site, stratified by sex and age. Results One hundred four patients with an inpatient or outpatient discharge diagnosis of MMD developed cancer during postdischarge follow-up. This corresponds to an observed cancer rate of 73.4 per 10 000 person-years in MMD vs an expected rate of 36.9 per 10 000 person-years in the general Swedish and Danish populations combined (standardized incidence ratio [SIR], 2.0; 95% CI, 1.6-2.4). Specifically, we observed significant excess risks of cancers of the endometrium (n=11; observed rate, 16.1/10 000 person-years; SIR, 7.6; 95% CI, 4.0-13.2), brain (n=7; observed rate, 4.9/10 000 person-years; SIR, 5.3; 95% CI, 2.3-10.4), ovary (n=7; observed rate, 10.3/10 000 person-years; SIR, 5.2; 95% CI, 2.3-10.2), and colon (n=10; observed rate, 7.1/10 000 person-years; SIR, 2.9; 95% CI, 1.5-5.1). Cancer risks were similar in women and men after excluding genital organ tumors (SIR, 1.9; 95% CI, 1.4-2.5, vs SIR, 1.8; 95% CI, 1.3-2.5, respectively; P=.81 for heterogeneity; observed rates, 64.5 and 47.7 per 10 000 person-years in women and men, respectively). The same pattern of cancer excess was observed first in the Swedish and then in the Danish cohorts, which were studied sequentially and initially analyzed independently. Conclusion Patients with MMD identified from the Swedish and Danish patient registries were at increased risk of cancer both overall and for selected anatomic sites. JAMA. 2011;306(22):2480-2486	[Gadalla, Shahinaz M.; Mueller, Christine M.; Greene, Mark H.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Shebl, Fatma M.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Landgren, Ola] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Gadalla, Shahinaz M.] NCI, Ctr Canc Res, Canc Prevent Fellowship Program, NIH, Bethesda, MD 20892 USA; [Lund, Marie; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Div Epidemiol, Dept Epidemiol Res, Copenhagen, Denmark; [Moxley, Richard T., III; Hilbert, James E.] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Ctr, Rochester, NY 14642 USA; [Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Kristinsson, Sigurdur Y.; Bjoerkholm, Magnus] Karolinska Inst, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut; University of Rochester; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Greene, MH (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, 6120 Execut Blvd,EPS 7023, Bethesda, MD 20892 USA.	greenem@mail.nih.gov	Lund, Marie/GRJ-0350-2022; Gadalla, Shahinaz M/C-4005-2015; Gadalla, Shahinaz/U-2848-2019; Kristinsson, Sigurdur Y/M-2910-2015	Lund, Marie/0000-0001-7417-8889; Gadalla, Shahinaz M/0000-0002-3255-8143; Kristinsson, Sigurdur Y/0000-0002-4964-7476; melbye, mads/0000-0001-8264-6785	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet Foundations; Danish Medical Research Council; US National Cancer Institute [N02CP31003-3]; University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NIH/U54/NS048843]; National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members [NIH/N01-AR-50-227450]; Clinical and Translational Science Institute and Clinical Research Center (National Center for Research Resources) [NIH UL1 RR024160]; NATIONAL CANCER INSTITUTE [ZIABC011205] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members; Clinical and Translational Science Institute and Clinical Research Center (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the Swedish Cancer Society, Stockholm County Council, Karolinska Institutet Foundations, Danish Medical Research Council, Intramural Research Program of the US National Cancer Institute (including contract N02CP31003-3 to Westat), University of Rochester Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (NIH/U54/NS048843), National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members (NIH/N01-AR-50-227450), and Clinical and Translational Science Institute and Clinical Research Center (NIH UL1 RR024160; National Center for Research Resources).	Akiyama M, 2008, PEDIATR BLOOD CANCER, V51, P563, DOI 10.1002/pbc.21654; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1998, PATIENTREGISTRET 198; Azurdia RM, 1999, BRIT J DERMATOL, V141, P941, DOI 10.1046/j.1365-2133.1999.03184.x; BROOK, 1992, CELL, V69, P385; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goellner GM, 1997, AM J HUM GENET, V60, P879; Goolamali SI, 2009, CLIN EXP DERMATOL, V34, pe370, DOI 10.1111/j.1365-2230.2009.03321.x; Greenland S, 2008, MODERN EPIDEMIOLOGY, P213; Harper PS, 2001, MYOTONIC DYSTROPHY; Itin PH, 2001, HAUTARZT, V52, P244, DOI 10.1007/s001050051298; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Mueller CM, 2009, CANCER CAUSE CONTROL, V20, P2009, DOI 10.1007/s10552-009-9395-y; Nilsson A C, 1994, Lakartidningen, V91, P603; Osanai R, 2000, MUSCLE NERVE, V23, P804, DOI 10.1002/(SICI)1097-4598(200005)23:5<804::AID-MUS19>3.0.CO;2-E; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Storm HH, 1997, DAN MED BULL, V44, P535; Sund R, 2009, J INTELL DISABIL RES, V53, P85, DOI 10.1111/j.1365-2788.2008.01116.x; Suominen T, 2011, EUR J HUM GENET, V19, P776, DOI 10.1038/ejhg.2011.23; Survey of Nordic Cancer Registries, 2000, SURV NORD CANC REG; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Turesson I, 2007, INT J CANCER, V121, P2260, DOI 10.1002/ijc.22912; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; Zemtsov A, 2010, ARCH DERMATOL RES, V302, P169, DOI 10.1007/s00403-009-0997-8	41	67	69	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2480	2486		10.1001/jama.2011.1796	http://dx.doi.org/10.1001/jama.2011.1796			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166607	Green Accepted			2022-12-28	WOS:000297983300021
J	Bartal, IBA; Decety, J; Mason, P				Bartal, Inbal Ben-Ami; Decety, Jean; Mason, Peggy			Empathy and Pro-Social Behavior in Rats	SCIENCE			English	Article							BIOMEDICAL-RESEARCH; RESTRAINT STRESS; ALTRUISM; PAIN; FEAR	Whereas human pro-social behavior is often driven by empathic concern for another, it is unclear whether nonprimate mammals experience a similar motivational state. To test for empathically motivated pro-social behavior in rodents, we placed a free rat in an arena with a cagemate trapped in a restrainer. After several sessions, the free rat learned to intentionally and quickly open the restrainer and free the cagemate. Rats did not open empty or object-containing restrainers. They freed cagemates even when social contact was prevented. When liberating a cagemate was pitted against chocolate contained within a second restrainer, rats opened both restrainers and typically shared the chocolate. Thus, rats behave pro-socially in response to a conspecific's distress, providing strong evidence for biological roots of empathically motivated helping behavior.	[Bartal, Inbal Ben-Ami; Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Mason, Peggy] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Decety, Jean; Mason, Peggy] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Bartal, IBA (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.		Ben Ami Bartal, Inbal/AGA-2614-2022	Ben Ami Bartal, Inbal/0000-0001-6823-2770	National Institute on Drug Abuse [DA022978, DA022429]; NSF [BCS-0718480]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022978, R21DA022429] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse (DA022978 and DA022429) to P. M. and from NSF (BCS-0718480) to J.D. The assistance of I. Boni, A. Brimmer, U. Fonio, K. Hellman, A. Logli, J. Peralta, K. Ragsdale, D. Rodgers, M. Sales, J. Wang, A. Weiss, and K. Yuan is gratefully acknowledged.	Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609; LAVERY JJ, 1963, SCIENCE, V140, P172, DOI 10.1126/science.140.3563.172; LUCKE JF, 1980, J EXP SOC PSYCHOL, V16, P214, DOI 10.1016/0022-1031(80)90065-7; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Preston S., 2004, ENCY ANIMAL BEHAV, V2; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; RICE GE, 1964, PSYCHOL REC, V14, P165, DOI 10.1007/BF03393574; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Silk JB., 2012, OXFORD HDB EVOLUTION, P115; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; WILLS GD, 1983, NEUROSCI BIOBEHAV R, V7, P315, DOI 10.1016/0149-7634(83)90035-0; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R	26	433	452	14	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1427	1430		10.1126/science.1210789	http://dx.doi.org/10.1126/science.1210789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158823	Green Accepted			2022-12-28	WOS:000297787700060
J	Guettler, S; LaRose, J; Petsalaki, E; Gish, G; Scotter, A; Pawson, T; Rottapel, R; Sicheri, F				Guettler, Sebastian; LaRose, Jose; Petsalaki, Evangelia; Gish, Gerald; Scotter, Andy; Pawson, Tony; Rottapel, Robert; Sicheri, Frank			Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease	CELL			English	Article							REPEAT-BINDING FACTOR-1; HUMAN TELOMERIC PROTEIN; POLY(ADP-RIBOSE) POLYMERASE; TRF1; INHIBITION; MOTIF; IRAP; IDENTIFICATION; DEGRADATION; MAINTENANCE	The poly(ADP-ribose)polymerases Tankyrase 1/2 (TNKS/TNKS2) catalyze the covalent linkage of ADP-ribose polymer chains onto target proteins, regulating their ubiquitylation, stability, and function. Dysregulation of substrate recognition by Tankyrases underlies the human disease cherubism. Tankyrases recruit specific motifs (often called RxxPDG "hexapeptides") in their substrates via an N-terminal region of ankyrin repeats. These ankyrin repeats form five domains termed ankyrin repeat clusters (ARCs), each predicted to bind substrate. Here we report crystal structures of a representative ARC of TNKS2 bound to targeting peptides from six substrates. Using a solution-based peptide library screen, we derive a rule-based consensus for Tankyrase substrates common to four functionally conserved ARCs. This 8-residue consensus allows us to rationalize all known Tankyrase substrates and explains the basis for cherubism-causing mutations in the Tankyrase substrate 3BP2. Structural and sequence information allows us to also predict and validate other Tankyrase targets, including Disc1, Striatin, Fat4, RAD54, BCR, and MERIT40.	[Guettler, Sebastian; Petsalaki, Evangelia; Gish, Gerald; Pawson, Tony; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Guettler, Sebastian; Petsalaki, Evangelia; Pawson, Tony; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Kings Coll Circle 1, Toronto, ON M5S 1A8, Canada; [LaRose, Jose; Scotter, Andy; Rottapel, Robert] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [LaRose, Jose; Scotter, Andy; Rottapel, Robert] Univ Toronto, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca; rottapel@uhnres.utoronto.ca; sicheri@lunenfeld.ca	Petsalaki, Evangelia/ABC-3561-2020; Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017; Sicheri, Frank/F-8856-2013	Petsalaki, Evangelia/0000-0002-8294-2995; Guettler, Sebastian/0000-0002-3135-1546; Rottapel, Robert/0000-0002-6024-5558	National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; Human Frontier Science Program (HFSP); European Molecular Biology Organization (EMBO); Canadian Institutes of Health Research [MOP-36399, MOP-6849]; Ontario Research Fund [GL2-01-025]; Terry Fox Program [20003]; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Terry Fox Program; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Mario Sanches, Elton Zeqiraj, Stephen Orlicky, and Hong Han for technical and computational help, Kay Perry, Kanagalaghatta Rajashankar, and Igor Kourinov at the Advanced Photon Source for assistance with data collection, Alessandro Datti, Frederick Vizeacoumar, and Thomas Sun (SLRI Robotics) for providing robotics, Rey Interior and Li Zhang (SickKids APTC) for N-terminal sequencing and mass spectrometry, Robert Weatheritt and Norman Davey for providing relative conservation scores for Table S4, Sachdev Sidhu for the recombinant antibody against 3BP2, Gregg Morin, Guy Poirer, John Roder, Anne-Claude Gingras, Marilyn Goudreault, Helen McNeill, Richelle Sopko, Rick Bagshaw, Roger Greenberg, Karen Colwill, Marina Olhovsky, and Bernard Liu for cDNAs and plasmids, Thomas Guttler for helpful comments on the manuscript, and members of the Sicheri and Pawson laboratories for fruitful discussions. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. S.G. was supported by postdoctoral fellowships from the Human Frontier Science Program (HFSP) and the European Molecular Biology Organization (EMBO). This work was supported by grants from the Canadian Institutes of Health Research (MOP-36399 and MOP-6849, to F.S. and T.P.), the Ontario Research Fund (#GL2-01-025, to T.P.), and the Terry Fox Program (#20003, to R.R.). F.S. is supported by a Canada Research Chair in Structural Biology.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Deng Z, 2005, J VIROL, V79, P4640, DOI 10.1128/JVI.79.8.4640-4650.2005; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; Fuchs U, 2003, FEBS LETT, V554, P10, DOI 10.1016/S0014-5793(03)01063-9; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; McCabe N, 2009, ONCOGENE, V28, P1465, DOI 10.1038/onc.2008.483; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	37	174	179	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1340	1354		10.1016/j.cell.2011.10.046	http://dx.doi.org/10.1016/j.cell.2011.10.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153077	Bronze			2022-12-28	WOS:000298148100022
J	Rhee, HS; Pugh, BF				Rhee, Ho Sung; Pugh, B. Franklin			Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution	CELL			English	Article							FACTOR-BINDING SITES; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; CHIP-SEQ; IN-VIVO; CTCF; REGIONS; YEAST; IDENTIFICATION; SPECIFICITY	Chromatin immunoprecipitation (ChIP-chip and ChIP-seq) assays identify where proteins bind throughout a genome. However, DNA contamination and DNA fragmentation heterogeneity produce false positives (erroneous calls) and imprecision in mapping. Consequently, stringent data filtering produces false negatives (missed calls). Here we describe ChIP-exo, where an exonuclease trims ChIP DNA to a precise distance from the crosslinking site. Bound locations are detectable as peak pairs by deep sequencing. Contaminating DNA is degraded or fails to form complementary peak pairs. With the single bp accuracy provided by ChIP-exo, we show an unprecedented view into genome-wide binding of the yeast transcription factors Reb1, Gal4, Phd1, Rap1, and human CTCF. Each of these factors was chosen to address potential limitations of ChIP-exo. We found that binding sites become unambiguous and reveal diverse tendencies governing in vivo DNA-binding specificity that include sequence variants, functionally distinct motifs, motif clustering, secondary interactions, and combinatorial modules within a compound motif.	[Rhee, Ho Sung; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu			NIH [ES13768]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Gue Su Chang and Cizhong Jiang for bioinformatic support, Mark Biggin (Lawrence-Berkeley Laboratory) for discussions on the concept of continuous networks, and members of the Pugh lab and the Penn State Center for Eukaryotic Gene Regulation for scientific discussions. Sequencing was performed at the Penn State Genomics Core Facility. This work was supported by NIH grant ES13768.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Peng SY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-219; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; von Hippel P H, 1974, Proc Natl Acad Sci U S A, V71, P4808; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Walter J, 1996, P NATL ACAD SCI USA, V93, P2680, DOI 10.1073/pnas.93.7.2680; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	49	513	532	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1408	1419		10.1016/j.cell.2011.11.013	http://dx.doi.org/10.1016/j.cell.2011.11.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153082	Bronze, Green Accepted			2022-12-28	WOS:000298148100027
J	Corless, CL				Corless, Christopher L.			Personalized Cancer Diagnostics	SCIENCE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Corless, CL (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	corlessc@ohsu.edu						Beadling C, 2011, J MOL DIAGN, V13, P504, DOI 10.1016/j.jmoldx.2011.04.003; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	5	18	19	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1217	1218		10.1126/science.1216427	http://dx.doi.org/10.1126/science.1216427			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144608				2022-12-28	WOS:000297553600029
J	Larson, EJ				Larson, Edward J.			Turning the world upside down	NATURE			English	Editorial Material									Pepperdine Univ, Malibu, CA 90263 USA	Pepperdine University	Larson, EJ (corresponding author), Pepperdine Univ, Malibu, CA 90263 USA.	ed.larson@pepperdine.edu							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					29	31		10.1038/480029a	http://dx.doi.org/10.1038/480029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PO	22129706	Bronze			2022-12-28	WOS:000298031900014
J	Shah, JR				Shah, Julian R.			Should we treat lower urinary tract symptoms without a definitive diagnosis? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URODYNAMIC EVALUATION; MEN; DYSFUNCTION		[Shah, Julian R.] Inst Urol, London, England; [Shah, Julian R.] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Shah, JR (corresponding author), Inst Urol, London, England.	pjrshah@hotmail.com						Coyne KS, 2009, BJU INT, V103, P24, DOI 10.1111/j.1464-410X.2009.08438.x; Dib PT, 2008, UROL INT, V80, P378, DOI 10.1159/000132695; Dowling C M, 2008, Ir Med J, V101, P203; Gomes CM, 2008, UROL INT, V81, P129, DOI 10.1159/000144049; Harding C, 2007, EUR UROL, V52, P186, DOI 10.1016/j.eururo.2006.11.009; Nitti VW, 1996, J UROLOGY, V155, P263, DOI 10.1016/S0022-5347(01)66614-X; Parsons BA, 2011, WORLD J UROL, V29, P191, DOI 10.1007/s00345-009-0488-8; Parsons JK, 2010, CURR BLADDER DYSFUNC, V5, P212, DOI 10.1007/s11884-010-0067-2; Patel NS, 2009, INT J CLIN PRACT, V63, P1734, DOI 10.1111/j.1742-1241.2009.02138.x; Rodrigues P, 2009, UROL INT, V83, P404, DOI 10.1159/000251179; Sexton CC, 2011, INT J CLIN PRACT, V65, P567, DOI 10.1111/j.1742-1241.2010.02626.x; Sriplakich Supon, 2007, Journal of the Medical Association of Thailand, V90, P2326; Steele GS, 2000, J UROLOGY, V164, P344, DOI 10.1016/S0022-5347(05)67356-9; Thomas AW, 2005, BJU INT, V96, P1301, DOI 10.1111/j.1464-410X.2005.05815.x; Toh KL, 2006, INT J UROL, V13, P520, DOI 10.1111/j.1442-2042.2006.01347.x	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2011	343								d6058	10.1136/bmj.d6058	http://dx.doi.org/10.1136/bmj.d6058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EO	22134966				2022-12-28	WOS:000298938400004
J	Brewer, C				Brewer, Colin			PERSONAL VIEW Secularism needs a distinctive medical voice	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.	brewerismo@gmail.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7658	10.1136/bmj.d7658	http://dx.doi.org/10.1136/bmj.d7658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131205				2022-12-28	WOS:000298037300007
J	Horvat, M				Horvat, Manfred			The New Framework for EU Research and Innovation	SCIENCE			English	Editorial Material									Vienna Univ Technol, A-1040 Vienna, Austria	Technische Universitat Wien	Horvat, M (corresponding author), Vienna Univ Technol, A-1040 Vienna, Austria.	manfred.horvat@tuwien.ac.at						ANNERBERG R, 2010, INTERIM EVALUATION 7, P53; Archibugi D., 2008, OPENING WORLD INT CO; *COM, COM2011572, P9; Council of the European Union, 2010, CONCL INN UN EUR; DEUTSCHE FORSCHUNGSMEINSCHAFT (DFG) GERMAN RESEARCH FOUNDATION, 2011, EXC IN GLANC PROGR G; *EC, 2011, 4 FP7 MON REP, P20; *EC, 2011, LEG PROP EU COH POL; *EC, 2010, COM2010187 EC; EC, 2007, COM2007161 EC, p[161, 412]; *EC, 2010, COM2010700 EC; *EC, 2011, FIN REP HIGH LEV EXP; EC, 2011, COM2011500 EC; *EC, 2011, GREEN PAP COMM STRAT, P3; *EC, 2011, COM2011572 EC; EC, 2010, COM20102020; *ECORYS, 2011, EXT EV EUR I INN TEC; *ERC, ERC GRANTS; European Commission (EC), 2010, COM2010546 EC; GEOGHEGANQUINN M, 2011, LAUNCH SCI EUROPE, P6; Gilbert N, 2011, NATURE, V470, P450, DOI 10.1038/470450a; HORVAT M, 2009, REV SCI TECHNOLOGY C, P23; *JTI SHERP GROUP, 2010, ETP 2010 C 11 12 MAY, P3; Linsinger T., 2010, APPLICATION NOTE 1 C, P1; Macilwain C, 2011, SCIENCE, V333, P1090, DOI 10.1126/science.333.6046.1090; PAIN E, 2011, SCIENCEINSIDER  1014; *PHOTONICS21, 2011, PHOT IND COMM MOR 5; Rubiralta M., 2010, DEV INT CAMPUSES EXC; *SEC, SEC20111072, P9; *US COUNC COMP, 2008, COMP AG NEW CHALL NE, P9; Van Vught F., 2011, FINAL REPORT SYNERGI; Vanhaverbeke W., 2008, OPEN INNOVATION RES, P258; *WALL AC, WALL AC FELL; 2010, OFFICIAL J EUROPEA C, V83, P128; FP7 JTIS; JPIS; 7 FRAMEWORK PROGRAMM; NATL SUPPORT UNFUNDE	37	5	5	5	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1066	1068		10.1126/science.1214295	http://dx.doi.org/10.1126/science.1214295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852AF	22116869				2022-12-28	WOS:000297313900030
J	Walter, P; Ron, D				Walter, Peter; Ron, David			The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation	SCIENCE			English	Review							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR ATF6; ER-STRESS; MESSENGER-RNA; SENSOR IRE1; FACTOR XBP-1; B-CELLS; ACTIVATION; KINASE; REVEALS	The vast majority of proteins that a cell secretes or displays on its surface first enter the endoplasmic reticulum (ER), where they fold and assemble. Only properly assembled proteins advance from the ER to the cell surface. To ascertain fidelity in protein folding, cells regulate the protein-folding capacity in the ER according to need. The ER responds to the burden of unfolded proteins in its lumen (ER stress) by activating intracellular signal transduction pathways, collectively termed the unfolded protein response (UPR). Together, at least three mechanistically distinct branches of the UPR regulate the expression of numerous genes that maintain homeostasis in the ER or induce apoptosis if ER stress remains unmitigated. Recent advances shed light on mechanistic complexities and on the role of the UPR in numerous diseases.	[Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ron, David] Univ Cambridge, Metab Res Lab, Cambridge CB2 0QQ, England; [Ron, David] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu; dr360@medschl.cam.ac.uk		Ron, David/0000-0002-3014-5636	Howard Hughes Medical Institute; Wellcome Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Korrenykh, A. Goke, and members of the Walter lab for helpful comments on the manuscript; K. Gotthardt for help in preparing the structural models; and D. Pincus and H. Li for contributing the fluorescence micrographs in Fig. 3. Supported by funds from the Howard Hughes Medical Institute and the Wellcome Trust. P. W. is an Investigator of the Howard Hughes Medical Institute and D. R. is a Principal Research Fellow of the Wellcome Trust.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chawla A, 2011, J CELL BIOL, V193, P41, DOI 10.1083/jcb.201008071; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; Kawaguchi S, 2011, SCIENCE, V333, P1830, DOI 10.1126/science.1212840; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-48; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	49	3703	3854	30	790	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1081	1086		10.1126/science.1209038	http://dx.doi.org/10.1126/science.1209038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116877				2022-12-28	WOS:000297313900038
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN "How can I avoid being sued?"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						CAMERON C, 2007, CLIN NEGLIGENCE PRAC	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d7827	10.1136/bmj.d7827	http://dx.doi.org/10.1136/bmj.d7827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171348				2022-12-28	WOS:000298317800003
J	Ansari, AZ; Peterson-Kaufman, KJ				Ansari, Aseem Z.; Peterson-Kaufman, Kimberly J.			A Partner Evokes Latent Differences between Hox Proteins	CELL			English	Editorial Material							SPECIFICITY; RECOGNITION		[Ansari, Aseem Z.; Peterson-Kaufman, Kimberly J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ansari, Aseem Z.; Peterson-Kaufman, Kimberly J.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ansari, AZ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ansari@biochem.wisc.edu	Ansari, Aseem/AAF-4945-2019		NATIONAL CANCER INSTITUTE [R01CA133508] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069420] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA133508] Funding Source: Medline; NHLBI NIH HHS [U01 HL099773] Funding Source: Medline; NIGMS NIH HHS [R01 GM069420] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Galant R, 2002, DEVELOPMENT, V129, P3115; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Merabet S, 2007, P NATL ACAD SCI USA, V104, P16946, DOI 10.1073/pnas.0705832104; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; PTASHNE M, 2002, GENES SIGNALS; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102	10	7	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1220	1221		10.1016/j.cell.2011.11.046	http://dx.doi.org/10.1016/j.cell.2011.11.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153067	Bronze			2022-12-28	WOS:000298148100010
J	Reber, S; Hyman, AA				Reber, Simone; Hyman, Anthony A.			Samurai Sword Sets Spindle Size	CELL			English	Editorial Material							MITOTIC SPINDLE; XENOPUS; ELEGANS		[Reber, Simone; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; 				Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Marshall WF, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-57; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092	11	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1224	1225		10.1016/j.cell.2011.11.039	http://dx.doi.org/10.1016/j.cell.2011.11.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153069	Bronze			2022-12-28	WOS:000298148100012
J	Mitchell, AE; Eastwood, TA; Mitchell, IM				Mitchell, Annelies E.; Eastwood, Thomas A.; Mitchell, Ian M.			PERSONAL VIEW We can learn much from the air force	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mitchell, Annelies E.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Eastwood, Thomas A.] RAF Benson, Wallingford OX10 6AA, Oxon, England; [Mitchell, Ian M.] City Hosp Nottingham, Dept Cardiac Surg, Nottingham NG5 1PB, England	Cardiff University; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Mitchell, AE (corresponding author), Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.								0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2011	343								d6464	10.1136/bmj.d6464	http://dx.doi.org/10.1136/bmj.d6464			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874EX	22162500				2022-12-28	WOS:000298939300003
J	Carlo, WA; McDonald, SA; Fanaroff, AA; Vohr, BR; Stoll, BJ; Ehrenkranz, RA; Andrews, WW; Wallace, D; Das, A; Bell, EF; Walsh, MC; Laptook, AR; Shankaran, S; Poindexter, BB; Hale, EC; Newman, NS; Davis, AS; Schibler, K; Kennedy, KA; Sanchez, PJ; Van Meurs, KP; Goldberg, RN; Watterberg, KL; Faix, RG; Frantz, ID; Higgins, RD				Carlo, Waldemar A.; McDonald, Scott A.; Fanaroff, Avroy A.; Vohr, Betty R.; Stoll, Barbara J.; Ehrenkranz, Richard A.; Andrews, William W.; Wallace, Dennis; Das, Abhik; Bell, Edward F.; Walsh, Michele C.; Laptook, Abbot R.; Shankaran, Seetha; Poindexter, Brenda B.; Hale, Ellen C.; Newman, Nancy S.; Davis, Alexis S.; Schibler, Kurt; Kennedy, Kathleen A.; Sanchez, Pablo J.; Van Meurs, Krisa P.; Goldberg, Ronald N.; Watterberg, Kristi L.; Faix, Roger G.; Frantz, Ivan D., III; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst C	Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; EXTREMELY PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; SURVIVAL; AGE; EPICURE; CARE	Context Current guidelines, initially published in 1995, recommend antenatal corticosteroids for mothers with preterm labor from 24 to 34 weeks' gestational age, but not before 24 weeks due to lack of data. However, many infants born before 24 weeks' gestation are provided intensive care. Objective To determine if use of antenatal corticosteroids is associated with improvement in major outcomes for infants born at 22 and 23 weeks' gestation. Design, Setting, and Participants Cohort study of data collected prospectively on inborn infants with a birth weight between 401 g and 1000 g (N=10 541) born at 22 to 25 weeks' gestation between January 1, 1993, and December 31, 2009, at 23 academic perinatal centers in the United States. Certified examiners unaware of exposure to antenatal corticosteroids performed follow-up examinations on 4924 (86.5%) of the infants born between 1993 and 2008 who survived to 18 to 22 months. Logistic regression models generated adjusted odds ratios (AORs), controlling for maternal and neonatal variables. Main Outcome Measures Mortality and neurodevelopmental impairment at 18 to 22 months' corrected age. Results Death or neurodevelopmental impairment at 18 to 22 months was significantly lower for infants who had been exposed to antenatal corticosteroids and were born at 23 weeks' gestation (83.4% with exposure to antenatal corticosteroids vs 90.5% without exposure; AOR, 0.58 [95% CI, 0.42-0.80]), at 24 weeks' gestation (68.4% with exposure to antenatal corticosteroids vs 80.3% without exposure; AOR, 0.62 [95% CI, 0.49-0.78]), and at 25 weeks' gestation (52.7% with exposure to antenatal corticosteroids vs 67.9% without exposure; AOR, 0.61 [95% CI, 0.50-0.74]) but not in those infants born at 22 weeks' gestation (90.2% with exposure to antenatal corticosteroids vs 93.1% without exposure; AOR, 0.80 [95% CI, 0.29-2.21]). If the mothers had received antenatal corticosteroids, the following events occurred significantly less in infants born at 23, 24, and 25 weeks' gestation: death by 18 to 22 months; hospital death; death, intraventricular hemorrhage, or periventricular leukomalacia; and death or necrotizing enterocolitis. For infants born at 22 weeks' gestation, the only outcome that occurred significantly less was death or necrotizing enterocolitis (73.5% with exposure to antenatal corticosteroids vs 84.5% without exposure; AOR, 0.54 [95% CI, 0.30-0.97]). Conclusion Among infants born at 23 to 25 weeks' gestation, antenatal exposure to corticosteroids compared with nonexposure was associated with a lower rate of death or neurodevelopmental impairment at 18 to 22 months. JAMA. 2011;306(21):2348-2358	[Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Women & Infants Ctr 9380, Birmingham, AL 35249 USA; [Carlo, Waldemar A.; Andrews, William W.] Childrens Hosp Alabama, Birmingham, AL USA; [McDonald, Scott A.; Wallace, Dennis] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Fanaroff, Avroy A.; Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Vohr, Betty R.; Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Stoll, Barbara J.; Hale, Ellen C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Stoll, Barbara J.; Hale, Ellen C.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Shankaran, Seetha] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Davis, Alexis S.; Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Davis, Alexis S.; Van Meurs, Krisa P.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Schibler, Kurt] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Kennedy, Kathleen A.] Univ Texas Med Sch, Dept Pediat, Houston, TX USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Goldberg, Ronald N.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Dept Pediat, Albuquerque, NM 87131 USA; [Faix, Roger G.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Frantz, Ivan D., III] Tufts Med Ctr, Floating Hosp Children, Div Newborn Med, Dept Pediat, Boston, MA USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	University of Alabama System; University of Alabama Birmingham; Research Triangle Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Brown University; Women & Infants Hospital Rhode Island; Emory University; Children's Healthcare of Atlanta (CHOA); Yale University; Research Triangle Institute; University of Iowa; Wayne State University; Indiana University System; Indiana University Bloomington; Stanford University; Lucile Packard Children's Hospital (LPCH); University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; University of New Mexico; University of New Mexico's Health Sciences Center; Utah System of Higher Education; University of Utah; Floating Hospital For Children; Tufts Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Carlo, WA (corresponding author), Univ Alabama Birmingham, Dept Pediat, Women & Infants Ctr 9380, 1700 6th Ave S, Birmingham, AL 35249 USA.	wcarlo@peds.uab.edu	Wallace, Dennis/AAR-7005-2021; Das, Abhik/AAF-1883-2020; Myers, Gary J/I-4901-2013	Das, Abhik/0000-0003-2722-0479; Myers, Gary J/0000-0003-4317-015X; Bell, Edward/0000-0002-5568-0889; McDonald, Scott/0000-0002-0054-1099	F. Hoffman-LaRoche Ltd; Astellas; Ikaria; Ikaria Biosynexus; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021385, UG1HD034216, U10HD040461, U10HD027851, U10HD040492, U01HD040636, UG1HD053089, U10HD027871, U10HD021364, U10HD040689, U10HD027880, U10HD027856, U10HD021373, U10HD036790, U10HD053124, U10HD027904, U10HD034216, U10HD053119, U10HD053089, U10HD027853, U10HD053109] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD034167, U10HD040521, U10HD021415, U10HD021397, U10HD040498] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR008084, UL1RR025761, UL1RR025764, M01RR002635, UL1RR024979, M01RR002172, UL1RR025744, UL1RR024160, M01RR006022, M01RR007122, UL1RR025008, UL1RR024139] Funding Source: NIH RePORTER	F. Hoffman-LaRoche Ltd; Astellas(Astellas Pharmaceuticals); Ikaria; Ikaria Biosynexus; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Carlo reported that he is a board member of Mednax. Dr Sanchez reported that he received study funding from F. Hoffman-LaRoche Ltd and Astellas for his work on the Collaborative Antiviral Study Group. Dr van Meurs reported that she received consulting fees, honorarium, and equipment support from Ikaria; travel, accommodations, and meeting expenses paid for by Actelion and Ikaria; and payment from legal firms for expert testimony for various lawsuits. Dr Faix reported that he serves on a data and safety monitoring board and receives funding from Ikaria Biosynexus. No other authors reported disclosures.; The National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provided grant support for the Neonatal Research Network's Generic Database and Follow-up Studies.	Abbasi S, 2010, AM J PERINAT, V27, P61, DOI 10.1055/s-0029-1223269; [Anonymous], 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bottoms SF, 1997, AM J OBSTET GYNECOL, V176, P960, DOI 10.1016/S0002-9378(97)70386-7; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Figueras-Aloy J, 2005, AM J PERINAT, V22, P441, DOI 10.1055/s-2005-916332; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Hofmeyr GJ., ANTENATAL ADM CORTIC; Kollee LAA, 2009, BJOG-INT J OBSTET GY, V116, P1481, DOI 10.1111/j.1471-0528.2009.02235.x; Lee BH, 2008, PEDIATRICS, V121, P289, DOI 10.1542/peds.2007-1103; Lockwood CJ, 2007, GUIDELINES PERINATAL; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; MORI R, 2011, J PEDIAT, V159, pE1; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Stephens BE, 2010, PEDIATRICS, V125, P1152, DOI 10.1542/peds.2009-1922; Stiles AD, 2007, NEW ENGL J MED, V357, P1248, DOI 10.1056/NEJMe078161; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	30	238	246	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2348	2358		10.1001/jama.2011.1752	http://dx.doi.org/10.1001/jama.2011.1752			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147379	Bronze, Green Accepted			2022-12-28	WOS:000297680300020
J	Moscrop, A				Moscrop, Andrew			MEDICINE AND THE MEDIA Scans, misogyny, and miscarriage	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England	University of Oxford	Moscrop, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	andrewmoscrop@yahoo.com							0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7960	10.1136/bmj.d7960	http://dx.doi.org/10.1136/bmj.d7960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874EV	22162503				2022-12-28	WOS:000298939100006
J	Trivedi, NS; Tess, AV				Trivedi, Neha S.; Tess, Anjala V.			Update: A 52-Year-Old Woman With Obesity Review of Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Wee CC, 2009, JAMA-J AM MED ASSOC, V302, P1097, DOI 10.1001/jama.2009.1197	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2375	2375		10.1001/jama.2011.1793	http://dx.doi.org/10.1001/jama.2011.1793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147381				2022-12-28	WOS:000297680300023
J	Prieto-Alhambra, D; Javaid, MK; Judge, A; Murray, D; Carr, A; Cooper, C; Arden, NK				Prieto-Alhambra, Daniel; Javaid, M. Kassim; Judge, Andrew; Murray, David; Carr, Andy; Cooper, Cyrus; Arden, Nigel K.			Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; REPLACEMENT; PROSTHESES; MIGRATION; FRACTURE; OSTEOARTHRITIS; THERAPIES; EFFICACY; DATABASE	Objectives To test whether bisphosphonate use is related to improved implant survival after total arthroplasty of the knee or hip. Design Population based retrospective cohort study. Setting Primary care data from the United Kingdom. Participants All patients undergoing primary total arthroplasty of the knee (n=18 726) or hip (n=23 269) in 1986-2006 within the United Kingdom's General Practice Research Database. We excluded patients with a history of hip fracture before surgery or rheumatoid arthritis, and individuals younger than 40 years at surgery. Intervention Bisphosphonate users were classified as patients with at least six prescriptions of bisphosphonates or at least six months of prescribed bisphosphonate treatment with more than 80% adherence before revision surgery. Outcome measures Revision arthroplasties occurring after surgery, identified by READ and OXMIS codes. Parametric survival models were used to determine effects on implant survival with propensity score adjustment to account for confounding by indication. Results Of 41 995 patients undergoing primary hip or knee arthroplasty, we identified 1912 bisphosphonate users, who had a lower rate of revision at five years than non-users (0.93% (95% confidence interval 0.52% to 1.68%) v 1.96% (1.80% to 2.14%)). Implant survival was significantly longer in bisphosphonate users than in non-users in propensity adjusted models (hazard ratio 0.54 (0.29 to 0.99); P=0.047) and had an almost twofold increase in time to revision after hip or knee arthroplasty (time ratio 1.96 (1.01 to 3.82)). Assuming 2% failure over five years, we estimated that the number to treat to avoid one revision was 107 for oral bisphosphonates. Conclusions In patients undergoing lower limb arthroplasty, bisphosphonate use was associated with an almost twofold increase in implant survival time. These findings require replication and testing in experimental studies for confirmation.	[Prieto-Alhambra, Daniel; Javaid, M. Kassim; Judge, Andrew; Murray, David; Carr, Andy; Cooper, Cyrus; Arden, Nigel K.] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel] Inst Catalat Salut, Barcelona, Spain; [Prieto-Alhambra, Daniel] IMIM, URFOA, Barcelona, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Prieto-Alhambra, Daniel] IDIAP, Primary Care Res Inst, Barcelona, Spain; [Arden, Nigel K.] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Oxford; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; University of Southampton	Arden, NK (corresponding author), Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	nigel.arden@ndorms.ox.ac.uk		Prieto-Alhambra, Daniel/0000-0002-3950-6346; Javaid, Muhammad/0000-0001-7985-0048; Cooper, Cyrus/0000-0003-3510-0709; Judge, Andrew/0000-0003-3015-0432	National Institute for Health Research (NIHR) [RP-PG-0407-10064]; NIHR Biomedical Research Unit; Nuffield Orthopaedic Centre; University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol via the Institut Municipal d'Investigacio Medica; Merck, Sharpe and Dohme; Novartis; Southampton Rheumatology Trust; Alliance for Better Bone Health; Amgen; Merck Sharp and Dohme; Servier; Eli Lilly; GlaxoSmithKline; National Institute for Health Research [RP-PG-0407-10064] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit(National Institute for Health Research (NIHR)); Nuffield Orthopaedic Centre; University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol via the Institut Municipal d'Investigacio Medica; Merck, Sharpe and Dohme(Merck & Company); Novartis(Novartis); Southampton Rheumatology Trust; Alliance for Better Bone Health; Amgen(Amgen); Merck Sharp and Dohme(Merck & Company); Servier(Servier); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10064). The study also received funding from the NIHR Biomedical Research Unit into Musculoskeletal Disease, Nuffield Orthopaedic Centre, and University of Oxford; Institut Catala de la Salut-IDIAP Jordi Gol (via a grant for a research fellowship at the Institut Municipal d'Investigacio Medica); and Merck, Sharpe and Dohme, Novartis, and Southampton Rheumatology Trust (via unrestricted educational grants).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: DP-A, AJ, and AC have no conflicts of interest; MKJ, NKA, and CC have received honorariums, held advisory board positions (which involved receipt of fees), and received consortium research grants, respectively, from: Novartis and Alliance for Better Health and Lilly; Merck, Merck Sharp and Dohme, Roche, Novartis, Smith and Nephew, Q-MED, Nicox, Servier, GlaxoSmithKline, Schering-Plough, Pfizer, and Rottapharm; and Alliance for Better Bone Health, Amgen, Novartis, Merck Sharp and Dohme, Servier, Eli Lilly, and GlaxoSmithKline; they have no other relationships or activities that could appear to have influenced the submitted work.	Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971, DOI 10.1302/0301-620X.72B6.2246300; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Brankin E, 2006, CURR MED RES OPIN, V22, P1249, DOI 10.1185/030079906X112688; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Curtis JR, 2008, OSTEOPOROSIS INT, V19, P1613, DOI 10.1007/s00198-008-0604-4; de Steiger RN, 2010, ACTA ORTHOP, V81, P72, DOI 10.3109/17453671003667176; Felsenberg D, 2006, NAT CLIN PRACT ENDOC, V2, P662, DOI 10.1038/ncpendmet0348; Friedl G, 2009, J BONE JOINT SURG AM, V91A, P274, DOI 10.2106/JBJS.G.01193; Goodship AE, 2008, J ORTHOP RES, V26, P693, DOI 10.1002/jor.20533; Hansson U, 2009, ACTA ORTHOP, V80, P41, DOI 10.1080/17453670902804968; HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106; Hilding M, 2007, ACTA ORTHOP, V78, P795, DOI 10.1080/17453670710014572; Hilding M, 2006, ACTA ORTHOP, V77, P912, DOI 10.1080/17453670610013213; Hossain F, 2010, CLIN ORTHOP RELAT R, V468, P1221, DOI 10.1007/s11999-009-1204-0; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Lin T, 2011, OSTEOPOROS INT; Lloyd BD, 2009, J GERONTOL A-BIOL, V64, P599, DOI 10.1093/gerona/glp003; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; National Joint Registry, 2009, 6 NAT JOINT REG; National Joint Registry, 2010, 7 NAT JOINT REG; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Prieto-Alhambra D, 2011, OSTEOPOROSIS INT, V22, P1555, DOI 10.1007/s00198-010-1368-1; Prieto-Alhambra D, 2011, ANN RHEUM DIS, V70, P134, DOI 10.1136/ard.2010.131110; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Sambrook Philip, 2006, Aust Fam Physician, V35, P801; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Sibanda N, 2008, PLOS MED, V5, P1398, DOI 10.1371/journal.pmed.0050179; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Thillemann TM, 2010, BONE, V46, P946, DOI 10.1016/j.bone.2010.01.377; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Zeng Y, 2011, ORTHOPEDICS, V34	34	70	78	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2011	343								d7222	10.1136/bmj.d7222	http://dx.doi.org/10.1136/bmj.d7222			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EU	22147909	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000298939000006
J	Meisel, C; Meisel, A				Meisel, Christian; Meisel, Andreas			Suppressing Immunosuppression after Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIONS; CELLS		[Meisel, Christian] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Meisel, Andreas] Charite, Dept Neurol, Neurocure Clin Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meisel, C (corresponding author), Charite, Inst Med Immunol, D-13353 Berlin, Germany.			Meisel, Christian/0000-0003-0222-991X; Meisel, Andreas/0000-0001-7233-5342				Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	5	71	74	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2134	2136		10.1056/NEJMcibr1112454	http://dx.doi.org/10.1056/NEJMcibr1112454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129259				2022-12-28	WOS:000297499000016
J	Seddon, N				Seddon, Nick			HINCHINGBROOKE HOSPITAL Why shouldn't private companies run failing hospitals?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nick.seddon@reform.co.uk						2011, BRIT MED J, V343, pD7341, DOI DOI 10.1136/BMJ.D7341	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7770	10.1136/bmj.d7770	http://dx.doi.org/10.1136/bmj.d7770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131210				2022-12-28	WOS:000298037300004
J	Friedl, P; Alexander, S				Friedl, Peter; Alexander, Stephanie			Cancer Invasion and the Microenvironment: Plasticity and Reciprocity	CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; COLLECTIVE CELL-MIGRATION; CIRCULATING TUMOR-CELLS; E-CADHERIN; EXTRACELLULAR-MATRIX; TGF-BETA; LEUKOCYTE MIGRATION; ADHERENS JUNCTIONS; CARCINOMA-CELLS; DRIVES INVASION	Cancer invasion is a cell- and tissue-driven process for which the physical, cellular, and molecular determinants adapt and react throughout the progression of the disease. Cancer invasion is initiated and maintained by signaling pathways that control cytoskeletal dynamics in tumor cells and the turnover of cell-matrix and cell-cell junctions, followed by cell migration into the adjacent tissue. Here, we describe the cell-matrix and cell-cell adhesion, protease, and cytokine systems that underlie tissue invasion by cancer cells. We explain how the reciprocal reprogramming of both the tumor cells and the surrounding tissue structures not only guides invasion, but also generates diverse modes of dissemination. The resulting "plasticity" contributes to the generation of diverse cancer invasion routes and programs, enhanced tumor heterogeneity, and ultimately sustained metastatic dissemination.	[Friedl, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HC Nijmegen, Netherlands; [Friedl, Peter; Alexander, Stephanie] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Friedl, Peter; Alexander, Stephanie] Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; [Friedl, Peter; Alexander, Stephanie] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97080 Wurzburg, Germany	Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	Friedl, P (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HC Nijmegen, Netherlands.	p.friedl@ncmls.ru.nl	Alexander, Stephanie/B-7150-2012; Friedl, Peter/A-8961-2010	Alexander, Stephanie/0000-0002-8308-3977; Friedl, Peter/0000-0002-0119-4041	Netherlands' Science Foundation [NWO-VICI 918.11.626]; Dutch Cancer Foundation [KWF 2008-4031]; European Union [TH-15-2008-208142, FP7-T3Net-237946, FP7-PEOPLE-2010-IEF-276443]; Deutsche Forschungsgemeinschaft [SPP1190/FR1155/8-3]	Netherlands' Science Foundation(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Foundation(KWF Kankerbestrijding); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge Bettina Weigelin, Antoine Khalil, and Vaishnavi Narasimhan for helpful comments and corrections on the manuscript. The work of the laboratory is supported by grants from the Netherlands' Science Foundation (NWO-VICI 918.11.626), the Dutch Cancer Foundation (KWF 2008-4031), the European Union (ENCITE HEALTH TH-15-2008-208142; FP7-T3Net-237946; FP7-PEOPLE-2010-IEF-276443), and the Deutsche Forschungsgemeinschaft (SPP1190/FR1155/8-3).	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Bornstein P., 1982, PATHOBIOLOGY ENDOTHE, V1 ed., P215, DOI DOI 10.1016/B978-0-12-521980-8.50020-1; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi YP, 2011, CANCER LETT, V307, P62, DOI 10.1016/j.canlet.2011.03.018; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; El Haibi CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-85; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 1997, CANCER RES, V57, P2061; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; He KJ, 2011, MOL CANCER THER, V10, P938, DOI 10.1158/1535-7163.MCT-10-1120; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Hung SC, 2010, MOL PHARMACEUT, V7, P2312, DOI 10.1021/mp1002834; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iguchi T, 2008, AM J SURG PATHOL, V32, P1675, DOI 10.1097/PAS.0b013e31817a8ed5; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Ishizaki M, 2001, VIRCHOWS ARCH, V438, P574, DOI 10.1007/s004280000391; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Kulesa PM, 2010, DEV BIOL, V344, P566, DOI 10.1016/j.ydbio.2010.05.005; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li ZY, 2008, CLIN EXP METASTAS, V25, P265, DOI 10.1007/s10585-007-9140-4; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lopes FF, 2009, ANN DIAGN PATHOL, V13, P22, DOI 10.1016/j.anndiagpath.2008.07.006; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Maaser K, 1999, MOL BIOL CELL, V10, P3067, DOI 10.1091/mbc.10.10.3067; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nannuru Kalyan C, 2010, Curr Osteoporos Rep, V8, P105, DOI 10.1007/s11914-010-0011-6; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; Neuhaus B, 2011, CELL MOL LIFE SCI, V68, P3757, DOI 10.1007/s00018-011-0676-8; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Picchio M, 2008, J NUCL MED, V49, P597, DOI 10.2967/jnumed.107.046870; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reynolds AB, 2010, CELL, V141, P20, DOI 10.1016/j.cell.2010.03.022; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693; Ryschich E, 2009, PANCREAS, V38, P804, DOI 10.1097/MPA.0b013e3181b9dfda; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Sounni NE, 2010, DIS MODEL MECH, V3, P317, DOI 10.1242/dmm.003863; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsuji K, 2006, CANCER RES, V66, P303, DOI 10.1158/0008-5472.CAN-05-2958; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van den Brand M, 2010, ORAL ONCOL, V46, P393, DOI 10.1016/j.oraloncology.2010.03.001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Walch A, 2008, MODERN PATHOL, V21, P544, DOI 10.1038/modpathol.2008.3; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang XH, 2009, ORAL SURG ORAL MED O, V107, P547, DOI 10.1016/j.tripleo.2008.11.021; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yao HR, 2011, TRANSL ONCOL, V4, P282, DOI 10.1593/tlo.11133; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	177	1341	1381	13	458	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					992	1009		10.1016/j.cell.2011.11.016	http://dx.doi.org/10.1016/j.cell.2011.11.016			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118458	Bronze			2022-12-28	WOS:000297376600013
J	Montavon, T; Soshnikova, N; Mascrez, B; Joye, E; Thevenet, L; Splinter, E; de Laat, W; Spitz, F; Duboule, D				Montavon, Thomas; Soshnikova, Natalia; Mascrez, Benedicte; Joye, Elisabeth; Thevenet, Laurie; Splinter, Erik; de Laat, Wouter; Spitz, Francois; Duboule, Denis			A Regulatory Archipelago Controls Hox Genes Transcription in Digits	CELL			English	Article							VERTEBRATE LIMB DEVELOPMENT; EMBRYONIC STEM-CELLS; CHROMOSOME CONFORMATION; IN-VIVO; DEVELOPMENTAL REGULATORS; HISTONE MODIFICATIONS; HOMEOTIC GENE; MOUSE; EXPRESSION; ENHANCERS	The evolution of digits was an essential step in the success of tetrapods. Among the key players, Hoxd genes are coordinately regulated in developing digits, where they help organize growth and patterns. We identified the distal regulatory sites associated with these genes by probing the three-dimensional architecture of this regulatory unit in developing limbs. This approach, combined with in vivo deletions of distinct regulatory regions, revealed that the active part of the gene cluster contacts several enhancer-like sequences. These elements are dispersed throughout the nearby gene desert, and each contributes either quantitatively or qualitatively to Hox gene transcription in presumptive digits. We propose that this genetic system, which we call a "regulatory archipelago," provides an inherent flexibility that may partly underlie the diversity in number and morphology of digits across tetrapods, as well as their resilience to drastic variations.	[Montavon, Thomas; Joye, Elisabeth; Duboule, Denis] Ecole Polytech Fed Lausanne, Natl Res Ctr, Sch Life Sci, Lausanne, Switzerland; [Soshnikova, Natalia; Mascrez, Benedicte; Thevenet, Laurie; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva 4, Switzerland; [Splinter, Erik; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Spitz, Francois] EMBL, Dev Biol Unit, Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Ecole Polytech Fed Lausanne, Natl Res Ctr, Sch Life Sci, Lausanne, Switzerland.	denis.duboule@unige.ch		de Laat, Wouter/0000-0002-6393-595X; duboule, denis/0000-0001-9961-2960; Spitz, Francois/0000-0002-1960-829X; Montavon, Thomas/0000-0001-8247-1399	Ecole Polytechnique Fe de rale, Lausanne; University of Geneva; Swiss National Research Fund; National Research Center "Frontiers in Genetics,"; EU; ERC	Ecole Polytechnique Fe de rale, Lausanne; University of Geneva; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center "Frontiers in Genetics,"; EU(European Commission); ERC(European Research Council (ERC)European Commission)	We thank N. Jones and W. Breitwieser for mice; P. Descombes and the staff of the NCCR genomic platform; I. Barde and members of the EPFL transgenic core facility; S. Ruf for help with the SB mice; and G. Andrey, M. Friedli, P. Schorderet, and members of the Duboule laboratories for discussions and reagents. This work was supported by funds from the Ecole Polytechnique Fe de rale, Lausanne, the University of Geneva, the Swiss National Research Fund, the National Research Center "Frontiers in Genetics," the EU program "Crescendo," and the ERC grants "SystemsHox.ch" (to D. D.) and "4C" (to W. D.-L). T. M. and D. D. designed all the experiments except the rel5 allele (F. S. and D. D.). T. M., N. S., and F. S. performed the experiments, with the assistance of E.J. B. M., L. T., and F. S. provided mutant mice. W. D.-L. and E. S. assisted with the 3C technology. T. M. and D. D. wrote the manuscript with inputs from coauthors.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dlugaszewska B, 2006, J MED GENET, V43, P111, DOI 10.1136/jmg.2005.033555; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Gerard M, 1996, GENE DEV, V10, P2326, DOI 10.1101/gad.10.18.2326; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hinchliffe JR, 1991, DEV PATTERNING VERTE, P313; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Mitter D, 2010, AM J MED GENET A, V152A, P1213, DOI 10.1002/ajmg.a.33344; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tschopp P, 2011, DEV BIOL, V351, P288, DOI 10.1016/j.ydbio.2010.12.034; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	56	348	356	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1132	1145		10.1016/j.cell.2011.10.023	http://dx.doi.org/10.1016/j.cell.2011.10.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118467	Bronze			2022-12-28	WOS:000297376600023
J	Vargas, DY; Shah, K; Batish, M; Levandoski, M; Sinha, S; Marras, SAE; Schedl, P; Tyagi, S				Vargas, Diana Y.; Shah, Khyati; Batish, Mona; Levandoski, Michael; Sinha, Sourav; Marras, Salvatore A. E.; Schedl, Paul; Tyagi, Sanjay			Single-Molecule Imaging of Transcriptionally Coupled and Uncoupled Splicing	CELL			English	Article							RNA-POLYMERASE-II; SEX-LETHAL AUTOREGULATION; MESSENGER-RNA; IN-VIVO; BINDING PROTEINS; NUCLEUS; TRANSPORT; SWITCH; GENE; EXON	Introns are removed from pre-mRNAs during transcription while the pre-mRNA is still tethered to the gene locus via RNA polymerase. However, during alternative splicing, it is important that splicing be deferred until all of the exons and introns involved in the choice have been synthesized. We have developed an in situ RNA imaging method with single-molecule sensitivity to define the intracellular sites of splicing. Using this approach, we found that the normally tight coupling between transcription and splicing is broken in situations where the intron's polypyrimidine tract is sequestered within strong secondary structures. We also found that in two cases of alternative splicing, in which certain exons are skipped due to the activity of the RNA-binding proteins Sxl and PTB, splicing is uncoupled from transcription. This uncoupling occurs only on the perturbed introns, whereas the preceding and succeeding introns are removed cotranscriptionally.	[Vargas, Diana Y.; Shah, Khyati; Batish, Mona; Levandoski, Michael; Sinha, Sourav; Marras, Salvatore A. E.; Tyagi, Sanjay] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Batish, Mona; Levandoski, Michael; Marras, Salvatore A. E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Shah, Khyati] New Jersey Inst Technol, Newark, NJ 07102 USA; [Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; New Jersey Institute of Technology; Princeton University	Tyagi, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA.	tyagisa@umdnj.edu	Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Tyagi, Sanjay/0000-0001-7303-5827; Marras, Salvatore/0000-0003-2040-0354	National Institutes of Health [MH 079197, GM 043432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043432, R56GM043432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ben Gold and Fred Russell Kramer for their contributions. This work was supported by National Institutes of Health grants MH 079197 (S. T.) and GM 043432 (P. S.).	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Graham PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002185; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Penalva LOF, 2001, MOL CELL BIOL, V21, P1986, DOI 10.1128/MCB.21.6.1986-1996.2001; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZHANG GH, 1994, NATURE, V372, P809	45	159	161	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1054	1065		10.1016/j.cell.2011.10.024	http://dx.doi.org/10.1016/j.cell.2011.10.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118462	Green Accepted, Bronze			2022-12-28	WOS:000297376600017
J	Libert, S; Pointer, K; Bell, EL; Das, A; Cohen, DE; Asara, JM; Kapur, K; Bergmann, S; Preisig, M; Otowa, T; Kendler, KS; Chen, XN; Hettema, JM; van den Oord, EJ; Rubio, JP; Guarente, L				Libert, Sergiy; Pointer, Kelli; Bell, Eric L.; Das, Abhirup; Cohen, Dena E.; Asara, John M.; Kapur, Karen; Bergmann, Sven; Preisig, Martin; Otowa, Takeshi; Kendler, Kenneth S.; Chen, Xiangning; Hettema, John M.; van den Oord, Edwin J.; Rubio, Justin P.; Guarente, Leonard			SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive	CELL			English	Article							INTERNATIONAL HAPMAP PROJECT; CALORIE RESTRICTION; PSYCHIATRIC-DISORDERS; ASSOCIATION; CONTRIBUTES; PLASTICITY; PHENOTYPES; RATIONALE; INTERVIEW; COGNITION	SIRT1 is a NAD(+)-dependent deacetylase that governs a number of genetic programs to cope with changes in the nutritional status of cells and organisms. Behavioral responses to food abundance are important for the survival of higher animals. Here we used mice with increased or decreased brain SIRT1 to show that this sirtuin regulates anxiety and exploratory drive by activating transcription of the gene encoding the monoamine oxidase A (MAO-A) to reduce serotonin levels in the brain. Indeed, treating animals with MAO-A inhibitors or selective serotonin reuptake inhibitors (SSRIs) normalized anxiety differences between wild-type and mutant animals. SIRT1 deacetylates the brain-specific helix-loop-helix transcription factor NHLH2 on lysine 49 to increase its activation of the MAO-A promoter. Both common and rare variations in the SIRT1 gene were shown to be associated with risk of anxiety in human population samples. Together these data indicate that SIRT1 mediates levels of anxiety, and this regulation may be adaptive in a changing environment of food availability.	[Libert, Sergiy; Pointer, Kelli; Bell, Eric L.; Das, Abhirup; Cohen, Dena E.; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Cohen, Dena E.] HHMI Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Asara, John M.] Dept Med, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kapur, Karen; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Preisig, Martin] CHU Vaudois, Dept Psychiat, CH-1011 Lausanne, Switzerland; [Otowa, Takeshi; Kendler, Kenneth S.; Chen, Xiangning; Hettema, John M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [van den Oord, Edwin J.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Dept Pharm, Richmond, VA 23298 USA; [Rubio, Justin P.] GlaxoSmithKline R&D, Quantitat Sci, Stevenage SG1 2NY, Herts, England	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Virginia Commonwealth University; Virginia Commonwealth University; GlaxoSmithKline	Guarente, L (corresponding author), MIT, Dept Biol, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	Libert, Sergiy/D-8136-2016; Colaus, PsyColaus/K-6607-2013; Das, Abhirup/AAF-5129-2019; Kendler, Kenneth/AAF-2876-2019; Bell, Eric/F-6368-2012	Libert, Sergiy/0000-0003-2497-5390; Pointer, Kelli/0000-0001-9383-0000; Das, Abhirup/0000-0003-1866-457X; RUBIO, JUSTIN/0000-0003-3750-917X; Preisig, Martin/0000-0001-5689-4259; Bergmann, Sven/0000-0002-6785-9034	Leukemia and Lymphoma Society [5089-09]; NIH; Glenn Foundation for Medical Research; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSC0-122661, 31003A_130691]; GlaxoSmithKline; Swiss Institute of Bioinformatics; European Framework Project 6; National Center for Research Resources [UL1RR031990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049492, R01MH040828] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Swiss Institute of Bioinformatics; European Framework Project 6; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to acknowledge Vincent Mooser, Federica Tozzi, Kijuong Song, James Ellis, Enrique Castelao, and Carol Prescott for their contribution to the provision, analysis, and interpretation of human genetic data; and Xuemei Yang for help with mass spectrometry. This work was supported by the fellowship from Leukemia and Lymphoma Society (5089-09) to S. L. and grants from the NIH and a gift from the Glenn Foundation for Medical Research to L. G. The PsyCoLaus study was supported by grants from the Swiss National Science Foundation (#3200B0-105993, #3200B0-118308, #33CSC0-122661) and from GlaxoSmithKline. S. B. was supported by the Swiss National Science Foundation (#31003A_130691), the Swiss Institute of Bioinformatics, and the European Framework Project 6. We are grateful to Mid-Atlantic Twin Registry (MATR) for the ascertainment of VATSPSUD subjects for the replication study. The MATR was supported by grant UL1RR031990 from the National Center for Research Resources. J.R. works for GlaxoSmithKline. L. G. consults for Sirtris (GSK company).	Abe N, 2011, J PSYCHIATR RES, V45, P1106, DOI 10.1016/j.jpsychires.2011.01.016; Aklillu E, 2009, PHARMACOGENET GENOM, V19, P267, DOI 10.1097/FPC.0b013e328328d4d3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blehar MC, 1994, ARCH GEN PSYCHIAT, V51, P63; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; BROWN L, 1992, P NATL ACAD SCI USA, V89, P8492, DOI 10.1073/pnas.89.18.8492; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, EXP GERONTOL, V43, P1086, DOI 10.1016/j.exger.2008.08.050; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; CUNHA JM, 1978, PHARMACOLOGY, V16, P259, DOI 10.1159/000136777; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; FRANKOVA S, 1968, J NUTR, V96, P477; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Good DJ, 2008, EXERC SPORT SCI REV, V36, P187, DOI 10.1097/JES.0b013e31818782dd; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hettema JM, 2008, BIOL PSYCHIAT, V64, P302, DOI 10.1016/j.biopsych.2008.03.014; Kendler KS, 2001, PSYCHOL MED, V31, P989, DOI 10.1017/S0033291701004226; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Minor RK, 2008, BEHAV BRAIN RES, V189, P202, DOI 10.1016/j.bbr.2007.12.030; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Spielberger CD, 1970, MANUAL STATE TRAIT A; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	40	157	165	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2011	147	7					1459	1472		10.1016/j.cell.2011.10.054	http://dx.doi.org/10.1016/j.cell.2011.10.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	866SP	22169038	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000298403400012
J	Letzkus, JJ; Wolff, SBE; Meyer, EMM; Tovote, P; Courtin, J; Herry, C; Luthi, A				Letzkus, Johannes J.; Wolff, Steffen B. E.; Meyer, Elisabeth M. M.; Tovote, Philip; Courtin, Julien; Herry, Cyril; Luethi, Andreas			A disinhibitory microcircuit for associative fear learning in the auditory cortex	NATURE			English	Article							GABAERGIC CELL SUBTYPES; LAYER-I INTERNEURONS; RAT NEOCORTEX; GABA RELEASE; PLASTICITY; NEURONS; MODULATION; INHIBITION; RECEPTORS; AMYGDALA	Learning causes a change in how information is processed by neuronal circuits. Whereas synaptic plasticity, an important cellular mechanism, has been studied in great detail, we know much less about how learning is implemented at the level of neuronal circuits and, in particular, how interactions between distinct types of neurons within local networks contribute to the process of learning. Here we show that acquisition of associative fear memories depends on the recruitment of a disinhibitory microcircuit in the mouse auditory cortex. Fear-conditioning-associated disinhibition in auditory cortex is driven by foot-shock-mediated cholinergic activation of layer 1 interneurons, in turn generating inhibition of layer 2/3 parvalbumin-positive interneurons. Importantly, pharmacological or optogenetic block of pyramidal neuron disinhibition abolishes fear learning. Together, these data demonstrate that stimulus convergence in the auditory cortex is necessary for associative fear learning to complex tones, define the circuit elements mediating this convergence and suggest that layer-1-mediated disinhibition is an important mechanism underlying learning and information processing in neocortical circuits.	[Letzkus, Johannes J.; Wolff, Steffen B. E.; Meyer, Elisabeth M. M.; Tovote, Philip; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wolff, Steffen B. E.; Meyer, Elisabeth M. M.] Univ Basel, CH-4003 Basel, Switzerland; [Courtin, Julien; Herry, Cyril] INSERM, U862, F-33077 Bordeaux, France	Friedrich Miescher Institute for Biomedical Research; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Letzkus, JJ (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	johannes.letzkus@fmi.ch; andreas.luthi@fmi.ch	courtin, julien/AAH-2380-2022; Herry, Cyril/AAP-9902-2020; courtin, julien/AEN-1402-2022; Tovote, Philip/AAC-5668-2019	courtin, julien/0000-0002-6454-3245; Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; Meyer, Elisabeth/0000-0001-9750-865X; Tovote, Philip/0000-0002-4598-722X; Letzkus, Johannes/0000-0001-5678-3030	Swiss National Science Foundation; National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders; French National Research Agency [ANR-2010-BLAN-1442-01]; Marie-Curie fellowship; Schering Foundation; Fonds AXA pour la Recherche; Aquitaine Regional Council; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders(Swiss National Science Foundation (SNSF)); French National Research Agency(French National Research Agency (ANR)); Marie-Curie fellowship(European Commission); Schering Foundation; Fonds AXA pour la Recherche(AXA Research Fund); Aquitaine Regional Council(Region Nouvelle-Aquitaine); Novartis Research Foundation	We thank all members of the Luthi laboratory for discussions and comments. We thank B. Kampa and T. Oertner for advice on two-photon imaging, R. Friedrich and J. Grundemann for comments on the manuscript, P. Argast, J. Ludke and C. Muller for excellent technical assistance, H. Zielinska for preparation of artwork and S. Arber, Y. Yanagawa and K. Deisseroth for generously sharing materials. This work was supported by grants from the Swiss National Science Foundation (J. J. L. Ambizione; A.L.), the National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders, the French National Research Agency (C. H., ANR-2010-BLAN-1442-01), a Marie-Curie fellowship (J. J. L.), a Schering Foundation fellowship (S. B. E. W.), a Fonds AXA pour la Recherche fellowship (J. C.), the Aquitaine Regional Council (C. H.) and the Novartis Research Foundation.	Acquas E, 1996, J NEUROSCI, V16, P3089; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Chu ZG, 2003, J NEUROSCI, V23, P96; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Foehring RC, 2002, J NEUROSCI, V22, P8238; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Ji WQ, 2005, J NEUROPHYSIOL, V94, P1199, DOI 10.1152/jn.00112.2005; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mechawar N, 2000, J COMP NEUROL, V428, P305, DOI 10.1002/1096-9861(20001211)428:2<305::AID-CNE9>3.0.CO;2-Y; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weinberger NM, 2007, HEARING RES, V229, P54, DOI 10.1016/j.heares.2007.01.004; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wu JP, 2005, J NEUROSCI, V25, P6322, DOI 10.1523/JNEUROSCI.1405-05.2005; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou FM, 1996, J COMP NEUROL, V376, P198, DOI 10.1002/(SICI)1096-9861(19961209)376:2<198::AID-CNE3>3.0.CO;2-Z	47	542	544	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					331	U76		10.1038/nature10674	http://dx.doi.org/10.1038/nature10674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22158104				2022-12-28	WOS:000298033000043
J	Srivastava, R				Srivastava, Ranjana			Dealing with Uncertainty in a Time of Plenty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2252	2253		10.1056/NEJMp1109456	http://dx.doi.org/10.1056/NEJMp1109456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861PN	22168641				2022-12-28	WOS:000298031800004
J	Brawley, O; Byers, T; Chen, A; Pignone, M; Ransohoff, D; Schenk, M; Smith, R; Sox, H; Thorson, AG; Wender, R				Brawley, Otis; Byers, Tim; Chen, Amy; Pignone, Michael; Ransohoff, David; Schenk, Maryjean; Smith, Robert; Sox, Harold; Thorson, Alan G.; Wender, Richard			New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; COLORECTAL-CANCER; PHYSICIANS	Guidelines for cancer screening written by different organizations often differ, even when they are based on the same evidence. Those dissimilarities can create confusion among health care professionals, the general public, and policy makers. The Institute of Medicine (IOM) recently released 2 reports to establish new standards for developing more trustworthy clinical practice guidelines and conducting systematic evidence reviews that serve as their basis. Because the American Cancer Society (ACS) is an important source of guidance about cancer screening for both health care practitioners and the general public, it has revised its methods to create a more transparent, consistent, and rigorous process for developing and communicating guidelines. The new ACS methods align with the IOM principles for trustworthy clinical guideline development by creating a single generalist group for writing the guidelines, commissioning independent systematic evidence reviews, and clearly articulating the benefits, limitations, and harms associated with a screening test. This new process should ensure that ACS cancer screening guidelines will continue to be a trustworthy source of information for both health care practitioners and the general public to guide clinical practice, personal choice, and public policy about cancer screening. JAMA. 2011;306(22):2495-2499	[Brawley, Otis; Smith, Robert] Amer Canc Soc, Atlanta, GA 30329 USA; [Byers, Tim] Colorado Sch Publ Hlth, Aurora, CO USA; [Chen, Amy] Emory Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Atlanta, GA USA; [Pignone, Michael] Univ N Carolina, Sch Med, Dept Gen Internal Med, Chapel Hill, NC USA; [Ransohoff, David] Univ N Carolina, Sch Med, Clin Res Curriculum, Chapel Hill, NC USA; [Schenk, Maryjean] Wayne State Univ, Sch Med, Detroit, MI USA; [Sox, Harold] Dartmouth Med Sch, Dartmouth Inst, W Lebanon, NH USA; [Thorson, Alan G.] Creighton Univ, Dept Surg, Omaha, NE 68178 USA; [Thorson, Alan G.] Univ Nebraska, Omaha, NE 68182 USA; [Wender, Richard] Thomas Jefferson Univ, Jefferson Med Coll, Dept Family Med, Philadelphia, PA 19107 USA	American Cancer Society; Colorado School of Public Health; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wayne State University; Dartmouth College; Creighton University; University of Nebraska System; Jefferson University	Byers, T (corresponding author), Mail Stop B-119,13001 E 17th Pl, Aurora, CO 80045 USA.	Tim.Byers@ucdenver.edu	Smith, Robert/AAB-6682-2020	Pignone, Michael/0000-0002-6657-7342				Agency for Healthcare Research and Quality, NAT GUID CLEAR; Burda BU, 2011, J CLIN EPIDEMIOL, V64, P968, DOI 10.1016/j.jclinepi.2010.12.005; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Han PKJ, 2011, MED CARE, V49, P139, DOI 10.1097/MLR.0b013e318202858e; Institute of Medicine, 2011, CLIN PRACT GUID WE C; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; National Cancer Institute, STAT CANC LEG DAT; Nonprofit Brand Institute, 2011, 2 HLTH CHAR RANK AM; Zapka JM, 2011, CANCER EPIDEM BIOMAR, V20, P509, DOI 10.1158/1055-9965.EPI-10-0749	10	71	72	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2495	2499		10.1001/jama.2011.1800	http://dx.doi.org/10.1001/jama.2011.1800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166609				2022-12-28	WOS:000297983300023
J	Alexander, M; Christia, F				Alexander, Marcus; Christia, Fotini			Context Modularity of Human Altruism	SCIENCE			English	Article							STRONG RECIPROCITY; ETHNIC DIVERSITY; EVOLUTION; COOPERATION	Whereas altruism drives the evolution of human cooperation, ethno-religious diversity has been considered to obstruct it, leading to poverty, corruption, and war. We argue that current research has failed to properly account for the institutional environment and how it affects the role diversity plays. The emergence of thriving, diverse communities throughout human history suggests that diversity does not always lead to cooperation breakdown. We conducted experiments in Mostar, Bosnia-Herzegovina with Catholic Croats and Muslim Bosniaks at a critical historic moment in the city's postwar history. Using a public goods game, we found that the ability to sanction is key to achieving cooperation in ethno-religiously diverse groups, but that sanctions succeed only in integrated institutional environments and fail in segregated ones. Hence, we show experimentally for the first time in a real-life setting that institutions of integration can unleash human altruism and restore cooperation in the presence of diversity.	[Alexander, Marcus] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Christia, Fotini] MIT, Dept Polit Sci, Cambridge, MA 02139 USA; [Christia, Fotini] Harvard Acad Int & Area Studies, Weatherhead Ctr, Cambridge, MA 02138 USA	Stanford University; Massachusetts Institute of Technology (MIT); Harvard University	Alexander, M (corresponding author), Stanford Univ, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA.	cfotini@mit.edu; marcalex@stanford.edu		Alexander, Marcus/0000-0001-8627-7534	Russell Sage Foundation; Harvard Davis Center for Russian and Eurasian Studies; Harvard Weatherhead Center for International Affairs	Russell Sage Foundation; Harvard Davis Center for Russian and Eurasian Studies; Harvard Weatherhead Center for International Affairs	We acknowledge funding from the Russell Sage Foundation, Harvard Davis Center for Russian and Eurasian Studies, and the Harvard Weatherhead Center for International Affairs. The authors declare that they have no competing financial interests. Informed consent was obtained after the nature and possible consequences of the study were explained. We thank the editor and two anonymous referees for their consideration and excellent feedback. We also thank R. H. Bates, N. Christakis, E. Fehr, M. C. Harding, and G. King. We are grateful to the directors and students of the three participating high schools in the city of Mostar in Bosnia-Herzegovina. Our thanks go to C. Hazlett for outstanding research assistance and to D. Sekulic for advice in the field.	Alesina A, 1999, Q J ECON, V114, P1243, DOI 10.1162/003355399556269; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Alesina A, 2000, Q J ECON, V115, P847, DOI 10.1162/003355300554935; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bowles S, 2004, J ECON BEHAV ORGAN, V55, P1, DOI 10.1016/j.jebo.2003.06.005; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 1999, J POLIT ECON, V107, P106, DOI 10.1086/250052; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Habyarimana James, 2009, COETHNICITY DIVERSIT; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Miguel E, 2005, J PUBLIC ECON, V89, P2325, DOI 10.1016/j.jpubeco.2004.09.004; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wade R., 1994, VILLAGE REPUBLICS EC	17	49	51	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1392	1394		10.1126/science.1202599	http://dx.doi.org/10.1126/science.1202599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858HW	22158815				2022-12-28	WOS:000297787700050
J	Feinmann, J; Gwande, A				Feinmann, Jane; Gwande, Atul			BMJ CHRISTMAS APPEAL Unsafe surgery: make it zero	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7773	10.1136/bmj.d7773	http://dx.doi.org/10.1136/bmj.d7773			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131262				2022-12-28	WOS:000298037300003
J	Pittet, MJ; Weissleder, R				Pittet, Mikael J.; Weissleder, Ralph			Intravital Imaging	CELL			English	Article							IN-VIVO; DENDRITIC CELLS; LYMPH-NODE; T-CELLS; FLUORESCENT PROTEINS; 2-PHOTON MICROSCOPY; HEMATOPOIETIC STEM; SINGLE CELLS; LIVING CELLS; BONE-MARROW	Until recently, the idea of observing life deep within the tissues of a living mouse, at a resolution sufficient to pick out cellular behaviors and molecular signals underlying them, remained a much-coveted dream. Now, a new era of intravital fluorescence microscopy has dawned. In this Primer, we review the technologies that made this revolution possible and demonstrate how intravital imaging is beginning to provide quantitative and dynamic insights into cell biology, immunology, tumor biology, and neurobiology.	[Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pittet, Mikael J.; Weissleder, Ralph] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Pittet, Mikael/ABD-6300-2021	/0000-0003-0828-4143	US National Institutes of Health (NIH) [R01-AI084880, P50-CA086355, U54-CA126515]; NIH [P50-CA086355, R01-CA164448]; NATIONAL CANCER INSTITUTE [P50CA086355, R01CA164448, U54CA126515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to the authors whose work we could not cite because of the limit on the number of references. We would like to thank Drs. Claudio Vinegoni, Rainer Kohler, Misha Pivovarov, and Martin Etzrodt for valuable comments and data generation; Drs. Thomas Reiner, Sarah Earley, and Katy Yang for some of the examples in Figures 1 and 3; and Dr. Yvonna Fisher-Jeffes for review. Special thanks go to Drs. Charles Lin, Timothy Mitchison, Peter Sorger, and Gaudenz Danuser for helpful discussions. The work of M.J.P. is supported by US National Institutes of Health (NIH) grants R01-AI084880, P50-CA086355, and U54-CA126515. The work of R. W. is supported by NIH grants R01-CA164448 and P50-CA086355.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Andresen V, 2009, CURR OPIN BIOTECH, V20, P54, DOI 10.1016/j.copbio.2009.02.008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Beuneu H, 2010, IMMUNITY, V33, P412, DOI 10.1016/j.immuni.2010.08.016; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Boutrus S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2722733; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Budin G, 2011, ANGEW CHEM INT EDIT, V50, P9378, DOI 10.1002/anie.201103273; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dutrochet H, 1824, RECHERCHES ANATOMIQU; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; EVANS CL, 2005, RAMAN SCATTERING, V102, P16807; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giesen U, 2011, RADIAT PROT DOSIM, V143, P349, DOI 10.1093/rpd/ncq477; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hickman H.D., 2011, J EXP MED; Hoole S., 1800, SELECT WORKS A VANLE; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Paramsothy S, 2010, NAT REV GASTRO HEPAT, V7, P366, DOI 10.1038/nrgastro.2010.83; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Reiner T, 2010, CHEMBIOCHEM, V11, P2374, DOI 10.1002/cbic.201000477; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tian FF, 2010, AUTOPHAGY, V6, P1107, DOI 10.4161/auto.6.8.13427; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Wagner R., 1839, ERLAUTERUNGSTAFELN P; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Weber K, 2011, NAT MED, V17, P504, DOI 10.1038/nm.2338; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449	75	333	340	2	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					983	991		10.1016/j.cell.2011.11.004	http://dx.doi.org/10.1016/j.cell.2011.11.004			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118457	Bronze, Green Accepted			2022-12-28	WOS:000297376600012
J	Yamazaki, S; Ema, H; Karlsson, G; Yamaguchi, T; Miyoshi, H; Shioda, S; Taketo, MM; Karlsson, S; Iwama, A; Nakauchi, H				Yamazaki, Satoshi; Ema, Hideo; Karlsson, Goran; Yamaguchi, Tomoyuki; Miyoshi, Hiroyuki; Shioda, Seiji; Taketo, Makoto M.; Karlsson, Stefan; Iwama, Atsushi; Nakauchi, Hiromitsu			Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche	CELL			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PERIPHERAL-NERVE; IN-VIVO; ACTIVATION; INTEGRIN; RECEPTOR; PROLIFERATION; MAINTENANCE; QUIESCENCE	Hematopoietic stem cells (HSCs) reside and self-renew in the bone marrow (BM) niche. Overall, the signaling that regulates stem cell dormancy in the HSC niche remains controversial. Here, we demonstrate that TGF-beta type II receptor-deficient HSCs show low-level Smad activation and impaired long-term repopulating activity, underlining the critical role of TGF-beta/Smad signaling in HSC maintenance. TGF-b is produced as a latent form by a variety of cells, so we searched for those that express activator molecules for latent TGF-beta. Nonmyelinating Schwann cells in BM proved responsible for activation. These glial cells ensheathed autonomic nerves, expressed HSC niche factor genes, and were in contact with a substantial proportion of HSCs. Autonomic nerve denervation reduced the number of these active TGF-beta-producing cells and led to rapid loss of HSCs from BM. We propose that glial cells are components of a BM niche and maintain HSC hibernation by regulating activation of latent TGF-beta.	[Yamazaki, Satoshi; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Chiyoda Ku, Tokyo 1020075, Japan; [Ema, Hideo; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Med, Tokyo 1088639, Japan; [Karlsson, Goran; Karlsson, Stefan] Univ Lund Hosp, Lund Stem Cell Ctr, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden; [Miyoshi, Hiroyuki; Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Iwama, Atsushi] CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan	Japan Science & Technology Agency (JST); University of Tokyo; Lund University; Skane University Hospital; Kyoto University; Showa University; Japan Science & Technology Agency (JST); Chiba University	Nakauchi, H (corresponding author), Japan Sci & Technol Agcy, ERATO, Chiyoda Ku, Tokyo 1020075, Japan.	nakauchi@ims.u-tokyo.ac.jp		Miyoshi, Hiroyuki/0000-0001-7400-0714; Karlsson, Goran/0000-0001-8197-754X	JST; Ministry of Education, Culture, Sport, Science, and Technology, Japan	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Yamazaki, Y. Ishii, and Y. Koyama for excellent technical support, Drs. T. Saito and S. Uchida for valuable discussions, and Dr. N. Watanabe, Dr. R. Yamamoto, Dr. T. Kobayashi, N. Suzuki, F. Lin, and Dr. A. Knisely for critical reading of the manuscript. This work was supported by grants from JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. H. N. is a founder and shareholder of ReproCELL, Inc.	Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bradford GB, 1997, EXP HEMATOL, V25, P445; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CALVO W, 1970, BLOOD-J HEMATOL, V36, P180, DOI 10.1182/blood.V36.2.180.180; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Chernousov MA, 2003, EXP CELL RES, V291, P514, DOI 10.1016/S0014-4827(03)00409-9; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006; Fernando FS, 2002, GENE, V284, P23, DOI 10.1016/S0378-1119(02)00394-3; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Noguchi E, 1999, J AUTONOM NERV SYST, V75, P78, DOI 10.1016/S0165-1838(98)00144-1; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Rosendahl A, 2003, INT IMMUNOL, V15, P1401, DOI 10.1093/intimm/dxg139; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Suzuki R, 2003, MOL BRAIN RES, V115, P10, DOI 10.1016/S0169-328X(03)00172-4; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Utsugisawa T, 2006, STEM CELLS, V24, P1128, DOI 10.1634/stemcells.2005-0263; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	55	511	528	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1146	1158		10.1016/j.cell.2011.09.053	http://dx.doi.org/10.1016/j.cell.2011.09.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118468	Bronze			2022-12-28	WOS:000297376600024
J	Bochukova, E; Schoenmakers, N; Agostini, M; Schoenmakers, E; Rajanayagam, O; Keogh, JM; Henning, E; Reinemund, J; Gevers, E; Sarri, M; Downes, K; Offiah, A; Albanese, A; Halsall, D; Schwabe, JWR; Bain, M; Lindley, K; Muntoni, F; Khadem, FV; Dattani, M; Farooqi, IS; Gurnell, M; Chatterjee, K				Bochukova, Elena; Schoenmakers, Nadia; Agostini, Maura; Schoenmakers, Erik; Rajanayagam, Odelia; Keogh, Julia M.; Henning, Elana; Reinemund, Jana; Gevers, Evelien; Sarri, Margarita; Downes, Kate; Offiah, Amaka; Albanese, Assunta; Halsall, David; Schwabe, John W. R.; Bain, Murray; Lindley, Keith; Muntoni, Francesco; Khadem, Faraneh Vargha; Dattani, Mehul; Farooqi, I. Sadaf; Gurnell, Mark; Chatterjee, Krishna			A Mutation in the Thyroid Hormone Receptor Alpha Gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTNATAL-DEVELOPMENT; MICE; HYPOTHYROIDISM; RESISTANCE; DOMAIN; BETA	Thyroid hormones exert their effects through alpha (TR alpha 1) and beta (TR beta 1 and TR beta 2) receptors. Here we describe a child with classic features of hypothyroidism (growth retardation, developmental retardation, skeletal dysplasia, and severe constipation) but only borderline-abnormal thyroid hormone levels. Using whole-exome sequencing, we identified a de novo heterozygous nonsense mutation in a gene encoding thyroid hormone receptor alpha (THRA) and generating a mutant protein that inhibits wild-type receptor action in a dominant negative manner. Our observations are consistent with defective human TR alpha-mediated thyroid hormone resistance and substantiate the concept of hormone action through distinct receptor subtypes in different target tissues.	[Farooqi, I. Sadaf; Chatterjee, Krishna] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Bochukova, Elena; Schoenmakers, Nadia; Agostini, Maura; Schoenmakers, Erik; Rajanayagam, Odelia; Keogh, Julia M.; Henning, Elana; Reinemund, Jana; Halsall, David; Farooqi, I. Sadaf; Gurnell, Mark; Chatterjee, Krishna] Addenbrookes Hosp, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Inst Metab Sci, Cambridge, England; [Downes, Kate] Addenbrookes Hosp, Diabet & Inflammat Lab, Cambridge Inst Med Res, Cambridge, England; [Offiah, Amaka] Univ Sheffield, Acad Unit Child Hlth, Sheffield, S Yorkshire, England; [Schwabe, John W. R.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Gevers, Evelien; Dattani, Mehul] Great Ormond St Hosp Sick Children, Dept Endocrinol, London, England; [Sarri, Margarita; Khadem, Faraneh Vargha] Great Ormond St Hosp Sick Children, Dept Neuropsychol, London, England; [Lindley, Keith] Great Ormond St Hosp Sick Children, Dept Gastroenterol, London, England; [Albanese, Assunta; Bain, Murray] St George Hosp, Dept Paediat Endocrinol, London, England; [Muntoni, Francesco] Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield; University of Leicester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; St Georges University London; University of London; University College London	Chatterjee, K (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Box 289,Hills Rd, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; kkc1@mole.bio.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Offiah, Amaka/G-2911-2010; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Schwabe, John WR/A-9132-2008; Gevers, Evelien/AAJ-9885-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Offiah, Amaka/0000-0001-8991-5036; Schwabe, John WR/0000-0003-2865-4383; Gevers, Evelien/0000-0002-4397-4126; Farooqi, Sadaf/0000-0001-7609-3504; Schoenmakers, Nadia/0000-0002-0847-2884; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Bochukova, Elena/0000-0003-0275-1548	Wellcome Trust; National Institutes of Health Research Cambridge Biomedical Research Centre; Medical Research Council Centre for Obesity and Related Metabolic Disease; Great Ormond Street Children's Charity; MRC [G0900756] Funding Source: UKRI; Medical Research Council [G0900756] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10198] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1229] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Research Cambridge Biomedical Research Centre; Medical Research Council Centre for Obesity and Related Metabolic Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Children's Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity; Muscular Dystrophy UK	Supported by grants from the Wellcome Trust, the National Institutes of Health Research Cambridge Biomedical Research Centre, the Medical Research Council Centre for Obesity and Related Metabolic Disease (to Drs. Farooqi, Gurnell, and Chatterjee), and the Great Ormond Street Children's Charity (to Drs. Muntoni and Dattani).	Barca-Mayo O, 2011, MOL ENDOCRINOL, V25, P575, DOI 10.1210/me.2010-0213; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BEIERWALTES WH, 1954, J CLIN ENDOCR METAB, V14, P1551, DOI 10.1210/jcem-14-12-1551; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Ebert EC, 2010, J CLIN GASTROENTEROL, V44, P402, DOI 10.1097/MCG.0b013e3181d6bc3e; Esaki T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1149, DOI 10.1152/ajpendo.00078.2004; Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412; Horlein AJ., 1996, CURR OPIN ENDOCRINOL, V3, P412, DOI [10.1097/00060793-199610000-00009, DOI 10.1097/00060793-199610000-00009]; Huffmeier U, 2007, EUR J MED GENET, V50, P209, DOI 10.1016/j.ejmg.2007.02.002; Kaneshige M, 2001, P NATL ACAD SCI USA, V98, P15095, DOI 10.1073/pnas.261565798; Kapelari Klaus, 2008, BMC Endocr Disord, V8, P15, DOI 10.1186/1472-6823-8-15; KRISHNA V, 1991, J CLIN INVEST, V87, P1977, DOI 10.1172/JCI115225; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; LaFranchi SH, 2003, J PEDIATR-US, V143, P296, DOI 10.1067/S0022-3476(03)00184-7; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; O'Shea PJ, 2005, MOL ENDOCRINOL, V19, P3045, DOI 10.1210/me.2005-0224; Ocasio CA, 2006, ACS CHEM BIOL, V1, P585, DOI 10.1021/cb600311v; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; Refetoff S, 2007, BEST PRACT RES CL EN, V21, P277, DOI 10.1016/j.beem.2007.03.005; Rovet JF, 2009, CLIN MANAGEMENT THYR, P123; Tinnikov A, 2002, EMBO J, V21, P5079, DOI 10.1093/emboj/cdf523; Vennstrom B, 2008, ACTA PAEDIATR, V97, P1605, DOI 10.1111/j.1651-2227.2008.01031.x; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455	24	248	261	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2012	366	3					243	249		10.1056/NEJMoa1110296	http://dx.doi.org/10.1056/NEJMoa1110296			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	877RZ	22168587	Green Published, Green Submitted			2022-12-28	WOS:000299201400010
J	Fritz, JH; Rojas, OL; Simard, N; McCarthy, DD; Hapfelmeier, S; Rubino, S; Robertson, SJ; Larijani, M; Gosselin, J; Ivanov, II; Martin, A; Casellas, R; Philpott, DJ; Girardin, SE; McCoy, KD; Macpherson, AJ; Paige, CJ; Gommerman, JL				Fritz, Joerg H.; Rojas, Olga Lucia; Simard, Nathalie; McCarthy, Douglas D.; Hapfelmeier, Siegfried; Rubino, Stephen; Robertson, Susan J.; Larijani, Mani; Gosselin, Jean; Ivanov, Ivaylo I.; Martin, Alberto; Casellas, Rafael; Philpott, Dana J.; Girardin, Stephen E.; McCoy, Kathy D.; Macpherson, Andrew J.; Paige, Christopher J.; Gommerman, Jennifer L.			Acquisition of a multifunctional IgA(+) plasma cell phenotype in the gut	NATURE			English	Article							B-CELLS; DENDRITIC CELLS; BACTERIAL-INFECTION; AID EXPRESSION; STROMAL CELLS; BONE-MARROW; HOMEOSTASIS; MICROBIOTA; PROGENITORS; MATURATION	The largest mucosal surface in the body is in the gastrointestinal tract, a location that is heavily colonized by microbes that are normally harmless. A key mechanism required for maintaining a homeostatic balance between this microbial burden and the lymphocytes that densely populate the gastrointestinal tract is the production and transepithelial transport of poly-reactive IgA (ref. 1). Within the mucosal tissues, B cells respond to cytokines, sometimes in the absence of T-cell help, undergo class switch recombination of their immunoglobulin receptor to IgA, and differentiate to become plasma cells(2). However, IgA-secreting plasma cells probably have additional attributes that are needed for coping with the tremendous bacterial load in the gastrointestinal tract. Here we report that mouse IgA(+) plasma cells also produce the antimicrobial mediators tumour-necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS), and expressmany molecules that are commonly associated with monocyte/granulocytic cell types. The development of iNOS-producing IgA(+) plasma cells can be recapitulated in vitro in the presence of gut stroma, and the acquisition of this multifunctional phenotype in vivo and in vitro relies on microbial co-stimulation. Deletion of TNF-a and iNOS in B-lineage cells resulted in a reduction in IgA production, altered diversification of the gut microbiota and poor clearance of a gut-tropic pathogen. These findings reveal a novel adaptation to maintaining homeostasis in the gut, and extend the repertoire of protective responses exhibited by some B-lineage cells.	[Fritz, Joerg H.; Rojas, Olga Lucia; Simard, Nathalie; McCarthy, Douglas D.; Robertson, Susan J.; Larijani, Mani; Martin, Alberto; Philpott, Dana J.; Paige, Christopher J.; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Simard, Nathalie; Paige, Christopher J.] Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Hapfelmeier, Siegfried; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Klin Forsch Gastroenterol, CH-3010 Bern, Switzerland; [Rubino, Stephen; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Gosselin, Jean] Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada; [Ivanov, Ivaylo I.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA; [Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bern; University of Toronto; Laval University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Gommerman, JL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	jen.gommerman@utoronto.ca	McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011	Hapfelmeier, Siegfried/0000-0002-6913-7932; Martin, Alberto/0000-0002-0795-0418; Gommerman, Jennifer/0000-0003-4576-6168	CIHR [9862, 89783, 114972, 67157]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NIH [R00 DK085329-02]; CCFA [2388]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041149, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. White in the Faculty of Medicine Flow Cytometry core facility and H. Singh for critical reading of the manuscript. We thank E. Verdu for providing additional germ-free mice at short notice, and we also thank C. Guidos for numerous Rag22/ 2 mice for mixed bone marrow chimeras. C. J. P. is supported by a CIHR operating grant MOP number 9862. R. C. is supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. I. I. I. is supported by NIH (R00 DK085329-02) and CCFA (CDA # 2388). A. M. is supported by a CIHR operating grant MOP number 89783. J. H. F. acknowledges support by an APART-fellowship of the Austrian Academy of Sciences, McGill start-up funds and a CIHR operating grant MOP number 114972. N. S. acknowledges the support of a CIHR Doctoral Award. J. L. G. is funded by the Canadian Institutes of Health Research (CIHR) and acknowledges the support of CIHR operating grant MOP number 67157 as well as infrastructure support from the Ontario Research Fund and that Canadian Foundation for Innovation. All authors have reviewed and agree with the content of the manuscript.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Johnson BA, 2010, P NATL ACAD SCI USA, V107, P10644, DOI 10.1073/pnas.0914347107; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kelly-Scumpia KM, 2011, J EXP MED, V208, P1673, DOI 10.1084/jem.20101715; Lee MR, 2011, BIOCHEM BIOPH RES CO, V410, P602, DOI 10.1016/j.bbrc.2011.06.035; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Marshall AJ, 1997, J IMMUNOL, V158, P4282; Milne CD, 2004, EUR J IMMUNOL, V34, P2647, DOI 10.1002/eji.200425400; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177	29	137	148	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					199	+		10.1038/nature10698	http://dx.doi.org/10.1038/nature10698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22158124	Green Accepted			2022-12-28	WOS:000298981200039
J	Pascoli, V; Turiault, M; Luscher, C				Pascoli, Vincent; Turiault, Marc; Luescher, Christian			Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour	NATURE			English	Article							RAT NUCLEUS-ACCUMBENS; AMPA RECEPTORS; PLASTICITY; DOPAMINE; ACTIVATION; ADDICTION; ERK; SENSITIZATION; CASCADE; RESPONSES	Drug-evoked synaptic plasticity is observed at many synapses and may underlie behavioural adaptations in addiction(1). Mechanistic investigations start with the identification of the molecular drug targets. Cocaine, for example, exerts its reinforcing(2) and early neuroadaptive effects(3) by inhibiting the dopamine transporter, thus causing a strong increase in mesolimbic dopamine. Among the many signalling pathways subsequently engaged, phosphorylation of the extracellular signal-regulated kinase (ERK) in the nucleus accumbens(4) is of particular interest because it has been implicated in NMDA-receptor and type 1 dopamine (D1)-receptor-dependent synaptic potentiation(5) as well as in several behavioural adaptations(6-8). A causal link between drug-evoked plasticity at identified synapses and behavioural adaptations, however, is missing, and the benefits of restoring baseline transmission have yet to be demonstrated. Here we find that cocaine potentiates excitatory transmission in D1-receptor-expressing medium-sized spiny neurons (D1R-MSNs) in mice via ERK signalling with a time course that parallels locomotor sensitization. Depotentiation of cortical nucleus accumbens inputs by optogenetic stimulation in vivo efficiently restored normal transmission and abolished cocaine-induced locomotor sensitization. These findings establish synaptic potentiation selectively in D1R-MSNs as a mechanism underlying a core component of addiction, probably by creating an imbalance between distinct populations of MSNs in the nucleus accumbens. Our data also provide proof of principle that reversal of cocaine-evoked synaptic plasticity can treat behavioural alterations caused by addictive drugs and may inspire novel therapeutic approaches involving deep brain stimulation or transcranial magnetic stimulation.	[Pascoli, Vincent; Turiault, Marc; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Core, Vector/CAF-4832-2022; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596	Swiss National Science Foundation; "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders	We thank P. Kalivas and the members of the Luscher laboratory for suggestions on the manuscript. This work is supported by the Swiss National Science Foundation (C. L.) and "Synapsy", a National Competence Center in Research (NCCR) of the Swiss Confederation on the synaptic basis of mental disorders.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; LaLumiere RT, 2010, LEARN MEMORY, V17, P168, DOI 10.1101/lm.1576810; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Pascoli V, 2011, BIOL PSYCHIAT, V69, P218, DOI 10.1016/j.biopsych.2010.08.031; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Pierce RC, 1999, J NEUROSCI, V19, P8685; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Xie GQ, 2009, ALCOHOL CLIN EXP RES, V33, P121, DOI 10.1111/j.1530-0277.2008.00818.x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	34	269	271	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					71	U76		10.1038/nature10709	http://dx.doi.org/10.1038/nature10709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22158102	Green Accepted			2022-12-28	WOS:000298836900031
J	Kim, Y; Sharov, AA; McDole, K; Cheng, M; Hao, H; Fan, CM; Gaiano, N; Ko, MSH; Zheng, Y				Kim, Youngjo; Sharov, Alexei A.; McDole, Katie; Cheng, Melody; Hao, Haiping; Fan, Chen-Ming; Gaiano, Nicholas; Ko, Minoru S. H.; Zheng, Yixian			Mouse B-Type Lamins Are Required for Proper Organogenesis But Not by Embryonic Stem Cells	SCIENCE			English	Article							NUCLEAR LAMINA; DIFFERENTIATION; ORGANIZATION; EXPRESSION; GENE; PROLIFERATION; PERIPHERY; DEFECTS	B-type lamins, the major components of the nuclear lamina, are believed to be essential for cell proliferation and survival. We found that mouse embryonic stem cells (ESCs) do not need any lamins for self-renewal and pluripotency. Although genome-wide lamin-B binding profiles correlate with reduced gene expression, such binding is not directly required for gene silencing in ESCs or trophectoderm cells. However, B-type lamins are required for proper organogenesis. Defects in spindle orientation in neural progenitor cells and migration of neurons probably cause brain disorganizations found in lamin-B null mice. Thus, our studies not only disprove several prevailing views of lamin-Bs but also establish a foundation for redefining the function of the nuclear lamina in the context of tissue building and homeostasis.	[Sharov, Alexei A.; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Kim, Youngjo; Fan, Chen-Ming; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Kim, Youngjo; McDole, Katie; Zheng, Yixian] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [McDole, Katie; Fan, Chen-Ming; Zheng, Yixian] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Cheng, Melody; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hao, Haiping] Johns Hopkins Univ, Sch Med, Microarray Core Facil, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA.	kom@grc.nia.nih.gov; zheng@ciwemb.edu	Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Hao, Haiping/0000-0002-8826-1568	National Institute on Aging; Howard Hughes Medical Institute;  [R01 GM056312]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662, ZIAAG000655] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Van Steensel and H. Niwa for reagents, M. Sepanski for electron microscopy, O. Martin for technical support, C. Liu (National Heart, Lung, and Blood Institute) for mouse targeting, and the members of the Zheng lab for critical comments. Supported in part by the Intramural Research Program of National Institute on Aging (A. A. S. and M. S. H. K.) and R01 GM056312 (Y.Z.). Y.Z. is supported by the Howard Hughes Medical Institute. A patent (7510850) regarding the use of Xenopus egg extracts to isolate and study the lamin-B spindle matrix is held by The Carnegie Institution for Science.	Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Cohen TV, 2008, CURR TOP DEV BIOL, V84, P351, DOI 10.1016/S0070-2153(08)00607-8; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; ROBER RA, 1989, DEVELOPMENT, V105, P365; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Yamada M, 2010, CELL ADHES MIGR, V4, P180, DOI 10.4161/cam.4.2.10715; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	26	178	186	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1706	1710		10.1126/science.1211222	http://dx.doi.org/10.1126/science.1211222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22116031	Green Accepted			2022-12-28	WOS:000298344000068
J	Gravitz, L				Gravitz, Lauren			DIAGNOSTICS The early bird	NATURE			English	Editorial Material																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S36	S37		10.1038/480S36a	http://dx.doi.org/10.1038/480S36a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169798	Bronze			2022-12-28	WOS:000298033000003
J	McDonald, F				McDonald, Frank			Watching the players at the climate poker table	NATURE			English	Editorial Material												fmcd@eircom.net							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					293	293		10.1038/480293a	http://dx.doi.org/10.1038/480293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22170643	Bronze			2022-12-28	WOS:000298033000018
J	Taira, T; Hatoyama, Y				Taira, Tomoyuki; Hatoyama, Yukio			Nationalize the Fukushima Daiichi atomic plant	NATURE			English	Editorial Material												g11426@shugiin.go.jp; g03629@shugiin.go.jp							0	18	18	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					313	314		10.1038/480313a	http://dx.doi.org/10.1038/480313a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22170662	Bronze			2022-12-28	WOS:000298033000027
J	Taberlay, PC; Kelly, TK; Liu, CC; You, JS; De Carvalho, DD; Miranda, TB; Zhou, XJ; Liang, GN; Jones, PA				Taberlay, Phillippa C.; Kelly, Theresa K.; Liu, Chun-Chi; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Zhou, Xianghong J.; Liang, Gangning; Jones, Peter A.			Polycomb-Repressed Genes Have Permissive Enhancers that Initiate Reprogramming	CELL			English	Article							HISTONE MODIFICATIONS; CHROMATIN SIGNATURES; CELL-LINES; MYOD GENE; EXPRESSION; FIBROBLASTS; TRANSCRIPTION; TRANSFECTION; METHYLATIONS; ACTIVATION	Key regulatory genes, suppressed by Polycomb and H3K27me3, become active during normal differentiation and induced reprogramming. Using the well-characterized enhancer/promoter pair of MYOD1 as a model, we have identified a critical role for enhancers in reprogramming. We observed an unexpected nucleosome-depleted region (NDR) at the H3K4me1-enriched enhancer at which transcriptional regulators initially bind, leading to subsequent changes in the chromatin at the cognate promoter. Exogenous Myod1 activates its own transcription by binding first at the enhancer, leading to an NDR and transcription-permissive chromatin at the associated MYOD1 promoter. Exogenous OCT4 also binds first to the permissive MYOD1 enhancer but has a different effect on the cognate promoter, where the monovalent H3K27me3 marks are converted to the bivalent state characteristic of stem cells. Genome-wide, a high percentage of Polycomb targets are associated with putative enhancers in permissive states, suggesting that they may provide a widespread avenue for the initiation of cell-fate reprogramming.	[Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Urol, Los Angeles, CA 90033 USA; [Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA; [Taberlay, Phillippa C.; Kelly, Theresa K.; You, Jueng Soo; De Carvalho, Daniel D.; Miranda, Tina B.; Liang, Gangning; Jones, Peter A.] Univ So Calif, Dept Biol Mol, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Liu, Chun-Chi; Zhou, Xianghong J.] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; [Liu, Chun-Chi] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 402, Taiwan	University of Southern California; University of Southern California; University of Southern California; University of Southern California; National Chung Hsing University	Liang, GN (corresponding author), Univ So Calif, Dept Urol, Los Angeles, CA 90033 USA.	gliang@usc.edu; pjones@med.usc.edu	De Carvalho, Daniel/F-4794-2011; kelly, theresa/E-3624-2010; Taberlay, Phillippa C/C-9616-2010; De Carvalho, Daniel D/J-5503-2014	De Carvalho, Daniel/0000-0003-0771-2265; Taberlay, Phillippa C/0000-0002-5298-8730; De Carvalho, Daniel D/0000-0002-8572-5259; Liang, Gangning/0000-0001-8664-922X	NIH [R37 CA-082422, R01 CA-124518, 5T32 CA-009320-27]; NSF [0747475]; ARCS; NATIONAL CANCER INSTITUTE [T32CA009320, R01CA124518, R37CA082422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ARCS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Adele Murrell for helpful advice and suggestions. We thank Dr. C. Andreu-Vieyra and Fides Lay for critical review of the manuscript. Funding for this work to P.A.J. was provided by NIH R37 CA-082422 and G.L. by R01 CA-124518. X.J.Z. was supported by an NSF Career Award 0747475. T.K.K. was funded by NIH 5T32 CA-009320-27 and an ARCS fellowship.	ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; ATCHISON ML, 1988, EMBO J, V7, P4213, DOI 10.1002/j.1460-2075.1988.tb03318.x; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOUKAMP P, 1992, J CELL BIOL, V116, P1257, DOI 10.1083/jcb.116.5.1257; CARNAC G, 1992, MOL ENDOCRINOL, V6, P1185, DOI 10.1210/me.6.8.1185; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daley GQ, 2011, CELL, V145, P811; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; FAERMAN A, 1995, DEV BIOL, V171, P27, DOI 10.1006/dbio.1995.1257; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miele Adriana, 2008, V464, P105; PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108	48	136	141	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1283	1294		10.1016/j.cell.2011.10.040	http://dx.doi.org/10.1016/j.cell.2011.10.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153073	Bronze, Green Accepted			2022-12-28	WOS:000298148100018
J	Vojvodic, A; Norskov, JK				Vojvodic, Aleksandra; Norskov, Jens K.			Optimizing Perovskites for the Water-Splitting Reaction	SCIENCE			English	Editorial Material							CATALYSIS		[Vojvodic, Aleksandra; Norskov, Jens K.] Stanford Univ, Dept Chem Engn, Stanford, CA 94035 USA; [Vojvodic, Aleksandra; Norskov, Jens K.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94205 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Vojvodic, A (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94035 USA.	alevoj@slac.stanford.edu; norskov@stan-ford.edu	Norskov, Jens K/D-2539-2017; Vojvodic, Aleksandra/C-3383-2014	Norskov, Jens K/0000-0002-4427-7728; Vojvodic, Aleksandra/0000-0002-5584-6711				Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; Man IC, 2011, CHEMCATCHEM, V3, P1159, DOI 10.1002/cctc.201000397; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Sabatier P, 1911, BER DTSCH CHEM GES, V44, P1984, DOI 10.1002/cber.19110440303; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Vojvodic A, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3602323; Vojvodic A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.146103	7	285	287	13	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1355	1356		10.1126/science.1215081	http://dx.doi.org/10.1126/science.1215081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158809				2022-12-28	WOS:000297787700037
J	Feldman, S				Feldman, Sarah			Making Sense of the New Cervical-Cancer Screening Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Feldman, S (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.		FELDMAN, SARAH/F-8423-2013; Feldman, Sarah/AAJ-2457-2020	FELDMAN, SARAH/0000-0002-1671-9365; 				*AM SOC COLP CERV, CERV CANC SCREEN PRE; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; *PREV SERV TASK FO, OPP PUBL COMM; VESCO KK, 2011, ANN INTERN MED  1017	4	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2145	2147		10.1056/NEJMp1112532	http://dx.doi.org/10.1056/NEJMp1112532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857PQ	22111669				2022-12-28	WOS:000297731400012
J	Welfare, M				Welfare, Mark			NICE's recommendations for thromboembolism are not evidence based	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Welfare, Mark] Northumbria Healthcare NHS Fdn Trust, N Shields NE29 8NH, Tyne & Wear, England; [Welfare, Mark] Univ Newcastle, N Tyneside Gen Hosp, N Shields NE29 8NH, Tyne & Wear, England	Newcastle University - UK	Welfare, M (corresponding author), Northumbria Healthcare NHS Fdn Trust, N Shields NE29 8NH, Tyne & Wear, England.	mark.welfare@nhct.nhs.uk						2007, ANN INT MED, V146, P278	1	18	18	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d6452	10.1136/bmj.d6452	http://dx.doi.org/10.1136/bmj.d6452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SP	22162381				2022-12-28	WOS:000298039800007
J	Blumenthal, D				Blumenthal, David			2012-A Watershed Election for Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blumenthal, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2047	2049		10.1056/NEJMp1111239	http://dx.doi.org/10.1056/NEJMp1111239			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	854MO	22129250				2022-12-28	WOS:000297499000003
J	Wang, G; Yu, HY; Cong, WX; Katsevich, A				Wang, Ge; Yu, Hengyong; Cong, Wenxiang; Katsevich, Alexander			Non-uniqueness and instability of 'ankylography'	NATURE			English	Letter							PHASE RETRIEVAL; UNIQUENESS		[Wang, Ge; Yu, Hengyong; Cong, Wenxiang] Virginia Tech, VT WFU Sch Biomed Engn & Sci, SBES Biomed Imaging Div, Blacksburg, VA 24060 USA; [Katsevich, Alexander] Univ Cent Florida, Dept Math, Orlando, FL 32816 USA	Virginia Polytechnic Institute & State University; State University System of Florida; University of Central Florida	Wang, G (corresponding author), Virginia Tech, VT WFU Sch Biomed Engn & Sci, SBES Biomed Imaging Div, Blacksburg, VA 24060 USA.	wangg@vt.edu	Yu, Hengyong/AAH-5726-2019; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705				Anderson NG, 2010, EUR RADIOL, V20, P2126, DOI 10.1007/s00330-010-1768-9; CRIMMINS TR, 1983, J OPT SOC AM, V73, P218, DOI 10.1364/JOSA.73.000218; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; FOLEY JT, 1981, J OPT SOC AM, V71, P1008, DOI 10.1364/JOSA.71.001008; HAMAKER C, 1980, ROCKY MOUNTAIN J MAT, V10, P253; Inouye T., 1979, IEEE T NUCL SCI, V26, P2665; Raines KS, 2010, NATURE, V463, P214, DOI 10.1038/nature08705; Thibault P., 2009, FEASIBILITY 3D RECON; Ye Y., 2010, BIOMEDICAL MATH PROM, P543; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; [No title captured]	12	16	18	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					E2	E3		10.1038/nature10635	http://dx.doi.org/10.1038/nature10635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129733				2022-12-28	WOS:000298031900002
J	Cohen, D				Cohen, Deborah			New image for the drug industry	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						*MHRA, 2004, SAN AV ASHF NURS INC, pD6063	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2011	343								d7713	10.1136/bmj.d7713	http://dx.doi.org/10.1136/bmj.d7713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RP	22127772				2022-12-28	WOS:000298037200008
J	Fischer, G; Bradford, J				Fischer, Gayle; Bradford, Jennifer			Persistent vaginitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DESQUAMATIVE INFLAMMATORY VAGINITIS; VULVO-VAGINAL CANDIDIASIS; FIXED DRUG ERUPTION; LICHEN-PLANUS; CANDIDOSIS; DIAGNOSIS; DISEASE		[Fischer, Gayle] Univ Sydney, Royal N Shore Hosp, Sydney Med Sch, LPO, St Leonards, NSW 2065, Australia; [Bradford, Jennifer] Univ Western Sydney, Campbelltown, NSW, Australia	Royal North Shore Hospital; University of Sydney; Western Sydney University	Fischer, G (corresponding author), Univ Sydney, Royal N Shore Hosp, Sydney Med Sch, LPO, POB 4028, St Leonards, NSW 2065, Australia.	gayle.fischer@sydney.edu.au						Anderson MR, 2004, JAMA-J AM MED ASSOC, V291, P1368, DOI 10.1001/jama.291.11.1368; Andreani SM, 2010, INT J SURG, V8, P2, DOI 10.1016/j.ijsu.2009.09.012; Batta K, 1999, BRIT J DERMATOL, V140, P945, DOI 10.1046/j.1365-2133.1999.02832.x; Bradford J, 2010, J LOW GENIT TRACT DI, V14, P306, DOI 10.1097/LGT.0b013e3181d737d0; Lara LAD, 2010, J SEX MED, V7, P3216, DOI 10.1111/j.1743-6109.2010.01885.x; Donders GGG, 2010, GYNECOL OBSTET INVES, V70, P306, DOI 10.1159/000314022; Drummond C, 2009, AUSTRALAS J DERMATOL, V50, P118, DOI 10.1111/j.1440-0960.2009.00519.x; Edwards L, 2010, DERMATOL CLIN, V28, P727, DOI 10.1016/j.det.2010.07.004; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fischer G, 2000, J REPROD MED, V45, P493; Fischer G, 2010, VULVA CLIN PRACTICAL, V4; Fischer G, 2007, J REPROD MED, V52, P81; Jang N, 2008, AUSTRALAS J DERMATOL, V49, P216, DOI 10.1111/j.1440-0960.2008.00472.x; McPherson T, 2010, DERMATOL THER, V23, P523, DOI 10.1111/j.1529-8019.2010.01355.x; Moraes PSA, 2000, ANN ALLERG ASTHMA IM, V85, P253, DOI 10.1016/S1081-1206(10)62527-6; Murphy R, 2008, J REPROD MED, V53, P124; Oduyebo OO, 2009, COCHRANE DB SYST REV, V8; Santegoets LAM, 2010, J LOW GENIT TRACT DI, V14, P323, DOI 10.1097/LGT.0b013e3181d73622; Schlosser BJ, 2010, DERMATOL CLIN, V28, P697, DOI 10.1016/j.det.2010.08.006; Shah AN, 2003, INT J GYNECOL OBSTET, V81, P221, DOI 10.1016/S0020-7292(03)00035-3; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2004, NEW ENGL J MED, V351, P876, DOI 10.1056/NEJMoa033114	22	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2011	343								d7314	10.1136/bmj.d7314	http://dx.doi.org/10.1136/bmj.d7314			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861RP	22127139				2022-12-28	WOS:000298037200024
J	McNally, A; Prier, CK; MacMillan, DWC				McNally, Andrew; Prier, Christopher K.; MacMillan, David W. C.			Discovery of an alpha-Amino C-H Arylation Reaction Using the Strategy of Accelerated Serendipity	SCIENCE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ALIPHATIC-AMINES; PHOTOCHEMICAL-REACTIONS; COORDINATION-COMPOUNDS; CHEMICAL-REACTIONS; BOND ACTIVATION; CATION RADICALS; TRANSFER PET; DEPROTONATION; GENERATION	Serendipity has long been a welcome yet elusive phenomenon in the advancement of chemistry. We sought to exploit serendipity as a means of rapidly identifying unanticipated chemical transformations. By using a high-throughput, automated workflow and evaluating a large number of random reactions, we have discovered a photoredox-catalyzed C-H arylation reaction for the construction of benzylic amines, an important structural motif within pharmaceutical compounds that is not readily accessed via simple substrates. The mechanism directly couples tertiary amines with cyanoaromatics by using mild and operationally trivial conditions.	[McNally, Andrew; Prier, Christopher K.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu	kitajima, showa/AAP-7593-2020		Marie-Curie Actions for an International Outgoing Fellowship; NIH General Medical Sciences (NIHGMS) [NIHGMS R01 01 GM093213-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	Marie-Curie Actions for an International Outgoing Fellowship; NIH General Medical Sciences (NIHGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.M. thanks the Marie-Curie Actions for an International Outgoing Fellowship. Financial support was provided by the NIH General Medical Sciences (NIHGMS) (grant NIHGMS R01 01 GM093213-01) and gifts from Merck, Amgen, Abbott, and Bristol-Myers Squibb. We would also like to thank J. C. Conrad for assistance.	Aubele DL, 2004, ADV SYNTH CATAL, V346, P359, DOI 10.1002/adsc.200303173; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; Beeler AB, 2007, J AM CHEM SOC, V129, P1413, DOI 10.1021/ja0674744; BELLAS M, 1977, J CHEM SOC PERK T 1, P2571, DOI 10.1039/p19770002571; Campos KR, 2006, J AM CHEM SOC, V128, P3538, DOI 10.1021/ja0605265; Chen YY, 2011, NAT CHEM, V3, P146, DOI 10.1038/NCHEM.932; Cossy J, 2006, TETRAHEDRON, V62, P6459, DOI 10.1016/j.tet.2006.03.062; DINNOCENZO JP, 1989, J AM CHEM SOC, V111, P8646, DOI 10.1021/ja00205a014; Dixon IM, 2000, CHEM SOC REV, V29, P385, DOI 10.1039/b000704h; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; Giera DS, 2009, SYNTHESIS-STUTTGART, P3797, DOI 10.1055/s-0029-1217026; Goodell JR, 2009, J ORG CHEM, V74, P6169, DOI 10.1021/jo901073v; HIRAI Y, 1988, CHEM PHARM BULL, V36, P1343; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Lednicer D., 1998, STRATEGIES ORGANIC D; Li ZP, 2005, J AM CHEM SOC, V127, P6968, DOI 10.1021/ja0516054; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; OHASHI M, 1977, CHEM LETT, P615, DOI 10.1246/cl.1977.615; OHASHI M, 1980, B CHEM SOC JPN, V53, P1683, DOI 10.1246/bcsj.53.1683; Ohta M, 2009, CHEM-ASIAN J, V4, P1416, DOI 10.1002/asia.200900157; PANDEY G, 1993, TOP CURR CHEM, V168, P175; PANTELEEVA EV, 1995, TETRAHEDRON LETT, V36, P8465, DOI 10.1016/0040-4039(95)01685-B; Pastine SJ, 2006, J AM CHEM SOC, V128, P14220, DOI 10.1021/ja064481j; Robbins DW, 2011, SCIENCE, V333, P1423, DOI 10.1126/science.1207922; Roberts R. M., 1989, SERENDIPITY ACCIDENT; Rossi R. A., 2004, CRC HDB ORGANIC PHOT, P47; Rozenman MM, 2007, J AM CHEM SOC, V129, P14933, DOI 10.1021/ja074155j; Szewczyk JW, 2001, ANGEW CHEM INT EDIT, V40, P216, DOI 10.1002/1521-3773(20010105)40:1<216::AID-ANIE216>3.0.CO;2-K; Weber L, 1999, SYNLETT, P366, DOI 10.1055/s-1999-2612; Yoshikai N, 2010, J AM CHEM SOC, V132, P5568, DOI 10.1021/ja100651t; ZHANG XM, 1994, J AM CHEM SOC, V116, P4211, DOI 10.1021/ja00089a010	33	651	653	12	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1114	1117		10.1126/science.1213920	http://dx.doi.org/10.1126/science.1213920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116882	Green Accepted			2022-12-28	WOS:000297313900045
J	Ellis, J; Mavromatos, NE				Ellis, John; Mavromatos, Nick E.			Does gravity correct gauge couplings?	NATURE			English	Letter							GRAVITATIONAL CONTRIBUTIONS		[Ellis, John] CERN, Div Theory, CH-1211 Geneva 23, Switzerland; [Mavromatos, Nick E.] Kings Coll London, Dept Phys, London WC2R 2LS, England	European Organization for Nuclear Research (CERN); University of London; King's College London	Ellis, J (corresponding author), CERN, Div Theory, CH-1211 Geneva 23, Switzerland.	john.ellis@cern.ch	Ellis, John/J-2222-2012	Ellis, John/0000-0002-7399-0813				Anber M. M., 2010, RUNNING COUPLINGS OP; Antoniadis I, 1997, NUCL PHYS B, V489, P160, DOI 10.1016/S0550-3213(96)00514-7; Kallosh R. E., 1973, YAD FIZ, V17, P190; KIRITSIS E, 1995, NUCL PHYS B, V442, P472, DOI 10.1016/0550-3213(95)00156-M; Pietrykowski AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.061801; Robinson SP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.231601; Salam A., 1970, Physical Review D (Particles and Fields), V2, P2869, DOI 10.1103/PhysRevD.2.2869; Tang Y, 2010, COMMUN THEOR PHYS, V54, P1040, DOI 10.1088/0253-6102/54/6/15; Toms DJ, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.045015; TSEYTLIN AA, 1986, PHYS LETT B, V176, P92, DOI 10.1016/0370-2693(86)90930-5	11	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					E5	E6		10.1038/nature10619	http://dx.doi.org/10.1038/nature10619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113695				2022-12-28	WOS:000297285600001
J	Fribourg, M; Moreno, JL; Holloway, T; Provasi, D; Baki, L; Mahajan, R; Park, G; Adney, SK; Hatcher, C; Eltit, JM; Ruta, JD; Albizu, L; Li, Z; Umali, A; Shim, J; Fabiato, A; MacKerell, AD; Brezina, V; Sealfon, SC; Filizola, M; Gonzalez-Maeso, J; Logothetis, DE				Fribourg, Miguel; Moreno, Jose L.; Holloway, Terrell; Provasi, Davide; Baki, Lia; Mahajan, Rahul; Park, Gyu; Adney, Scott K.; Hatcher, Candice; Eltit, Jose M.; Ruta, Jeffrey D.; Albizu, Laura; Li, Zheng; Umali, Adrienne; Shim, Jihyun; Fabiato, Alexandre; MacKerell, Alexander D., Jr.; Brezina, Vladimir; Sealfon, Stuart C.; Filizola, Marta; Gonzalez-Maeso, Javier; Logothetis, Diomedes E.			Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; MU-OPIOID RECEPTORS; BETA-GAMMA-SUBUNITS; 5-HYDROXYTRYPTAMINE(2A) RECEPTOR; CRYSTAL-STRUCTURE; SCHIZOPHRENIA; IDENTIFICATION; ACTIVATION; AGONIST; PHARMACOLOGY	Atypical antipsychotic drugs, such as clozapine and risperidone, have a high affinity for the serotonin 5-HT2A G protein-coupled receptor (GPCR), the 2AR, which signals via a G(q) heterotrimeric G protein. The closely related non-antipsychotic drugs, such as ritanserin and methysergide, also block 2AR function, but they lack comparable neuropsychological effects. Why some but not all 2AR inhibitors exhibit antipsychotic properties remains unresolved. We now show that a heteromeric complex between the 2AR and the Gi-linked GPCR, metabotropic glutamate 2 receptor (mGluR2), integrates ligand input, modulating signaling output and behavioral changes. Serotonergic and glutamatergic drugs bind the mGluR2/2AR heterocomplex, which then balances Gi- and Gq-dependent signaling. We find that the mGluR2/2AR-mediated changes in Gi and Gq activity predict the psychoactive behavioral effects of a variety of pharmocological compounds. These observations provide mechanistic insight into antipsychotic action that may advance therapeutic strategies for disorders including schizophrenia and dementia.	[Moreno, Jose L.; Holloway, Terrell; Ruta, Jeffrey D.; Umali, Adrienne; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Fribourg, Miguel; Provasi, Davide; Li, Zheng; Brezina, Vladimir; Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Albizu, Laura; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Fribourg, Miguel; Brezina, Vladimir; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Brezina, Vladimir; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [MacKerell, Alexander D., Jr.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Baki, Lia; Mahajan, Rahul; Park, Gyu; Adney, Scott K.; Hatcher, Candice; Eltit, Jose M.; Fabiato, Alexandre; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; Virginia Commonwealth University	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	javier.maeso@mssm.edu; delogothetis@vcu.edu	Mahajan, Rahul/AAS-5971-2021; MacKerell, Alex/AAA-2560-2020; MacKerell, Alex/Y-2469-2019; Moreno, Jose L/L-8981-2017; Fribourg, Miguel/AAO-2186-2020	Mahajan, Rahul/0000-0002-9613-2870; MacKerell, Alex/0000-0001-8287-6804; Filizola, Marta/0000-0002-4382-8276; Provasi, Davide/0000-0002-2868-303X; Adney, Scott/0000-0001-8743-5944; Fribourg, Miguel/0000-0003-1804-8136; SEALFON, Stuart/0000-0001-5791-1217	NIH [HL59949, 5R01MH084894, MH084894, MH091360, DA026434, F30HL097582, SRC1DA02811202, 1R01DA02694702]; NARSAD; Dainippon Sumitomo Pharma; Maltz Family Foundation; National Science Foundation [TG-MCB080109N]; Ministerio de Ciencia e Innovacion, Spain; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, F30HL097582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091360, R01MH084894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Maltz Family Foundation; National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Sophia Gruszecki, Heikki Vaananen, Dr. Jian Yang, and Dr. Basil Hanss for Xenopus oocyte isolation and are grateful to Dr. Kurt Hauser for his support with the cortical primary neuronal cultures and Dr. J.A. Gingrich for his gift of 5HT2A-KO mice. The authors are also thankful to Drs. M. Scott Bowers, Louis J. De Felice, Frank Guarnieri (Virginia Commonwealth University), Lakshmi Devi (Mount Sinai School of Medicine), Jonathan Javitch (Columbia University), George Liapakis (University of Crete, Greece), and Herbert Meltzer (Vanderbilt University) for critical feedback on the manuscript and to members of the Logothetis lab for useful feedback throughout this project. D. E. L. was partly supported for this work by NIH grant HL59949. J. G.-M. was supported by NIH grant 5R01MH084894, as well as NARSAD, Dainippon Sumitomo Pharma, and the Maltz Family Foundation Award. M. F. was supported by NIH grants MH084894, MH091360, and DA026434. The computations were supported in part by the National Science Foundation through TeraGrid advanced computing resources provided by the Texas Advanced Computing Center under grant TG-MCB080109N. J. L. M. was the recipient of a postdoctoral fellowship from Ministerio de Ciencia e Innovacion, Spain. R. M. was supported by NIH grant F30HL097582. J. M. E. was supported by NIH grants SRC1DA02811202 and 1R01DA02694702.	Aloyo VJ, 2009, PHARMACOL THERAPEUT, V121, P160, DOI 10.1016/j.pharmthera.2008.10.010; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Bespalov A, 2007, J PHARMACOL EXP THER, V320, P944, DOI 10.1124/jpet.106.110684; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Egan CT, 1998, J PHARMACOL EXP THER, V286, P85; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Gonzalez-Maeso J, 2002, EUR J PHARMACOL, V452, P21, DOI 10.1016/S0014-2999(02)02242-2; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hof PR., 2000, COMP CYTOARCHITECTON; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Meltzer HY, 2008, PROG BRAIN RES, V172, P177, DOI 10.1016/S0079-6123(08)00909-6; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Moreno JL, 2009, CELL MOL LIFE SCI, V66, P3777, DOI 10.1007/s00018-009-0130-3; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pichon X, 2010, MOL THER, V18, P1462, DOI 10.1038/mt.2010.101; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; REIMHERR FW, 1986, PSYCHOPHARMACOL BULL, V22, P237; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Uslaner JM, 2009, PSYCHOPHARMACOLOGY, V206, P641, DOI 10.1007/s00213-009-1644-y; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	50	206	226	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1011	1023		10.1016/j.cell.2011.09.055	http://dx.doi.org/10.1016/j.cell.2011.09.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118459	Green Accepted, Bronze			2022-12-28	WOS:000297376600014
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX Communities of practice	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7609	10.1136/bmj.d7609	http://dx.doi.org/10.1136/bmj.d7609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113839				2022-12-28	WOS:000297724400012
J	Buller, HR; Gallus, AS; Pillion, G; Prins, MH; Raskob, GE				Buller, Harry R.; Gallus, Alex S.; Pillion, Gerard; Prins, Martin H.; Raskob, Gary E.		Cassiopea Investigators	Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial	LANCET			English	Article							DEEP-VEIN THROMBOSIS; ANTITHROMBOTIC THERAPY	Background Treatment of pulmonary embolism with low-molecular-weight heparin and vitamin K antagonists, such as warfarin, is not ideal. We aimed to assess non-inferiority of idrabiotaparinux, a reversible longlasting indirect inhibitor of activated factor X, to warfarin in patients with acute symptomatic pulmonary embolism. Methods In our randomised, double-blind, double-dummy, non-inferiority trial, we enrolled adults with objectively documented acute symptomatic pulmonary embolism attending 291 centres in 37 countries. We excluded patients who were pregnant, had active bleeding, kidney failure, or malignant hypertension, or were at high risk of death, bleeding, or adverse reactions to study drugs. We randomly allocated patients to receive 5-10 days' enoxaparin 1.0 mg/kg twice daily followed by subcutaneous idrabiotaparinux (starting dose 3.0 mg) or adjusted-dose warfarin (target international normalised ratio 2.0-3.0); regimens lasted 3 months or 6 months dependent on clinical presentation. Block randomisation was done with a central interactive computerised system, stratified by study centre and intended treatment duration. The primary efficacy outcome was recurrent venous thromboembolism at 99 days after randomisation. We estimated the odds ratio and 95% CI with a Mantel-Haenzsel chi(2) analysis (non-inferiority margin 2.0) in the intention-to-treat population. The main safety outcome was clinically relevant bleeding (major or non-major) in all patients at day 99. This study is registered with ClinicalTrials.gov, number NCT00345618. Findings Between Aug 1, 2006, and Jan 31, 2010, we enrolled 3202 patients aged 18-96 years. 34 (2%) of 1599 patients randomly allocated to receive enoxaparin-idrabiotaparinux and 43 (3%) of 1603 patients randomly allocated to receive enoxaparin-warfarin had recurrent venous thromboembolism (odds ratio 0.79, 95% CI 0.50-1.25; p(non-inferiority)=0.0001). 72 (5%) of 1599 patients in the enoxaparin-idrabiotaparinux group and 106 (7%) of 1603 patients in the enoxaparin-warfarin group had clinically relevant bleeding (0.67, 0.49-0.91; p(superiority)=0.0098). We noted similar differences in outcomes in those patients treated to 6 months. Interpretation Idrabiotaparinux could provide an attractive alternative to warfarin for the long-term treatment of pulmonary embolism, and seems to be associated with reduced bleeding.	[Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Gallus, Alex S.] Flinders Med Ctr, SA Pathol, Adelaide, SA, Australia; [Gallus, Alex S.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Pillion, Gerard] Sanofi Aventis, Antony, France; [Prins, Martin H.] Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA	University of Amsterdam; Academic Medical Center Amsterdam; Flinders Medical Centre; SA Pathology; Flinders University South Australia; Sanofi-Aventis; Maastricht University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Ferrari, Emile/R-2917-2016; Lodigiani, Corrado/AAW-1964-2020	Lodigiani, Corrado/0000-0002-9152-9385; Dennis, Rodolfo J/0000-0003-3215-9721; Gallus, Alexander/0000-0001-7347-9989; Lanas, Fernando/0000-0003-3595-9759	Sanofi-Aventis (Paris, France); Sanofi-Aventis	Sanofi-Aventis (Paris, France)(Sanofi-Aventis); Sanofi-Aventis(Sanofi-Aventis)	Sanofi-Aventis (Paris, France).; HRB, ASG, GER, and MHP have received consultancy fees from Sanofi-Aventis for their contributions, execution, and writing of the report. GP was an employee of Sanofi-Aventis.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2010.04100.x; Hull RD, 1997, ARCH INTERN MED, V157, P2317, DOI 10.1001/archinte.157.20.2317; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Leguet P, 2007, J THROMB HAEMOST S, V5; Paty I, 2010, J THROMB HAEMOST, V8, P722, DOI 10.1111/j.1538-7836.2010.03746.x; Raskob GE, 2010, AM J PREV MED, V38, pS502, DOI 10.1016/j.amepre.2010.01.010; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; The Matisse Investigators, 2004, NEW ENGL J MED, V140, P867; Veyrat-Follet C, 2009, J THROMB HAEMOST, V7, P559, DOI 10.1111/j.1538-7836.2009.03298.x	15	53	55	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					123	129		10.1016/S0140-6736(11)61505-5	http://dx.doi.org/10.1016/S0140-6736(11)61505-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22130488				2022-12-28	WOS:000299317700033
J	Baselga, J; Cortes, J; Kim, SB; Im, SA; Hegg, R; Im, YH; Roman, L; Pedrini, JL; Pienkowski, T; Knott, A; Clark, E; Benyunes, MC; Ross, G; Swain, SM				Baselga, Jose; Cortes, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Young-Hyuck; Roman, Laslo; Pedrini, Jose Luiz; Pienkowski, Tadeusz; Knott, Adam; Clark, Emma; Benyunes, Mark C.; Ross, Graham; Swain, Sandra M.		CLEOPATRA Study Grp	Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; MONOCLONAL-ANTIBODY; RECEPTOR; ERBB2; INHIBITOR; TOXICITY; EFFICACY; PROTEINS; THERAPY; HER2	BACKGROUND The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive metastatic breast cancer. However, most cases of advanced disease eventually progress. Pertuzumab, an anti-HER2 humanized monoclonal antibody that inhibits receptor dimerization, has a mechanism of action that is complementary to that of trastuzumab, and combination therapy with the two antibodies has shown promising activity and an acceptable safety profile in phase 2 studies involving patients with HER2-positive breast cancer. METHODS We randomly assigned 808 patients with HER2-positive metastatic breast cancer to receive placebo plus trastuzumab plus docetaxel (control group) or pertuzumab plus trastuzumab plus docetaxel (pertuzumab group) as first-line treatment until the time of disease progression or the development of toxic effects that could not be effectively managed. The primary end point was independently assessed progression-free survival. Secondary end points included overall survival, progression-free survival as assessed by the investigator, the objective response rate, and safety. RESULTS The median progression-free survival was 12.4 months in the control group, as compared with 18.5 months in the pertuzumab group (hazard ratio for progression or death, 0.62; 95% confidence interval, 0.51 to 0.75; P<0.001). The interim analysis of overall survival showed a strong trend in favor of pertuzumab plus trastuzumab plus docetaxel. The safety profile was generally similar in the two groups, with no increase in left ventricular systolic dysfunction; the rates of febrile neutropenia and diarrhea of grade 3 or above were higher in the pertuzumab group than in the control group. CONCLUSIONS The combination of pertuzumab plus trastuzumab plus docetaxel, as compared with placebo plus trastuzumab plus docetaxel, when used as first-line treatment for HER2-positive metastatic breast cancer, significantly prolonged progression-free survival, with no increase in cardiac toxic effects. (Funded by F. Hoffmann-La Roche/Genentech; ClinicalTrials.gov number, NCT00567190.)	[Baselga, Jose] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Baselga, Jose] Harvard Univ, Sch Med, Boston, MA USA; [Cortes, Javier] Vall dHebron Inst Oncol, Barcelona, Spain; [Kim, Sung-Bae] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Im, Seock-Ah] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol, Seoul 151, South Korea; [Im, Young-Hyuck] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Med Oncol,Dept Internal Med, Seoul, South Korea; [Hegg, Roberto] Univ Sao Paulo, Hosp Perola Byington, Sao Paulo, Brazil; [Hegg, Roberto] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Roman, Laslo] Leningrad Reg Oncol Dispensary, St Petersburg, Russia; [Pedrini, Jose Luiz] Conceicao Hosp, Mastol Unit, Ctr Pesquisas Med & Ensaios Clin, Porto Alegre, RS, Brazil; [Pienkowski, Tadeusz] Ctr Onkol, Warsaw, Poland; [Knott, Adam; Clark, Emma; Ross, Graham] Roche, Welwyn Garden City, England; [Benyunes, Mark C.] Genentech Inc, San Francisco, CA 94080 USA; [Swain, Sandra M.] MedStar Washington Hosp Ctr, Washington Canc Inst, Washington, DC USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vall d'Hebron Institut d'Oncologia (VHIO); University of Ulsan; Asan Medical Center; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Roche Holding; Roche Holding; Genentech; MedStar Washington Hospital Center	Baselga, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St,Lawrence House 108, Boston, MA 02114 USA.	jbaselga@partners.org	Calvo, Lourdes/M-2352-2014; Andrade, Jurandyr M/B-2025-2013; MORALES, SERAFIN/L-7216-2019; Aktas, Bahriye/F-1019-2014; de Azevedo, Sergio Jobim/P-5115-2015; Im, Seock-Ah/J-5620-2012	Andrade, Jurandyr M/0000-0003-3619-0582; MORALES, SERAFIN/0000-0001-7445-4193; Hegg, Roberto/0000-0002-6453-8155; Pienkowski, Tadeusz/0000-0002-0110-5950; Ciruelos, Eva/0000-0002-2796-1042; Biganzoli, Laura/0000-0001-7989-8658; Cortes, Javier/0000-0001-7623-1583; Di Leo, Angelo/0000-0002-3665-9056; Coudert, Bruno/0000-0001-9445-2216; Swain, Sandra/0000-0002-1320-3830	F. Hoffmann-La Roche/Genentech, a member of the Roche Group; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	F. Hoffmann-La Roche/Genentech, a member of the Roche Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by F. Hoffmann-La Roche/Genentech, a member of the Roche Group. Support for writing assistance by a third party (Vilma Graupner, Ph.D.) was provided by F. Hoffmann-La Roche.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Burstein HJ, 2011, SEMIN ONCOL, V38, pS17, DOI 10.1053/j.seminoncol.2011.04.002; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Geyer CE, 2007, NEW ENGL J MED, V356, P1487; Gianni L, 2010, 33 ANN SAN ANT BREAS; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Molina MA, 2001, CANCER RES, V61, P4744; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Portera CC, 2008, CLIN CANCER RES, V14, P3641, DOI 10.1158/1078-0432.CCR-14-11-COR; Portera CC, 2008, CLIN CANCER RES, V14, P2710, DOI 10.1158/1078-0432.CCR-07-4636; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Valero V, 2011, J CLIN ONCOL, V29, P149, DOI 10.1200/JCO.2010.28.6450; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	28	1717	1794	7	222	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					109	119		10.1056/NEJMoa1113216	http://dx.doi.org/10.1056/NEJMoa1113216			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874VA	22149875	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000298985000005
J	Beck, PG; Montalban, J; Kallinger, T; De Ridder, J; Aerts, C; Garcia, RA; Hekker, S; Dupret, MA; Mosser, B; Eggenberger, P; Stello, D; Elsworth, Y; Frandsen, S; Carrier, F; Hillen, M; Gruberbauer, M; Christensen-Dalsgaard, J; Miglio, A; Valentini, M; Bedding, TR; Kjeldsen, H; Girouard, FR; Hall, JR; Ibrahim, KA				Beck, Paul G.; Montalban, Josefina; Kallinger, Thomas; De Ridder, Joris; Aerts, Conny; Garcia, Rafael A.; Hekker, Saskia; Dupret, Marc-Antoine; Mosser, Benoit; Eggenberger, Patrick; Stello, Dennis; Elsworth, Yvonne; Frandsen, Soren; Carrier, Fabien; Hillen, Michel; Gruberbauer, Michael; Christensen-Dalsgaard, Jorgen; Miglio, Andrea; Valentini, Marica; Bedding, Timothy R.; Kjeldsen, Hans; Girouard, Forrest R.; Hall, Jennifer R.; Ibrahim, Khadeejah A.			Fast core rotation in red-giant stars as revealed by gravity-dominated mixed modes	NATURE			English	Article							ASTEROSEISMOLOGY; OSCILLATIONS; CIRCULATION	When the core hydrogen is exhausted during stellar evolution, the central region of a star contracts and the outer envelope expands and cools, giving rise to a red giant. Convection takes place overmuch of the star's radius. Conservation of angular momentum requires that the cores of these stars rotate faster than their envelopes; indirect evidence supports this(1,2). Information about the angular-momentum distribution is inaccessible to direct observations, but it can be extracted from the effect of rotation on oscillation modes that probe the stellar interior. Here we report an increasing rotation rate from the surface of the star to the stellar core in the interiors of red giants, obtained using the rotational frequency splitting of recently detected 'mixed modes'(3,4). By comparison with theoretical stellar models, we conclude that the core must rotate at least ten times faster than the surface. This observational result confirms the theoretical prediction of a steep gradient in the rotation profile towards the deep stellar interior(1,5,6).	[Beck, Paul G.; Kallinger, Thomas; De Ridder, Joris; Aerts, Conny; Carrier, Fabien; Hillen, Michel] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Montalban, Josefina; Dupret, Marc-Antoine; Valentini, Marica] Univ Liege, Inst Astrophys Geophys, B-4000 Liege, Belgium; [Kallinger, Thomas] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Aerts, Conny] Radboud Univ Nijmegen, IMAPP, NL-6500 GL Nijmegen, Netherlands; [Garcia, Rafael A.] Univ Paris Diderot, CNRS, IRFU Sap, Ctr Saclay,CEA DSM,Lab Astrophys Instrumentat & M, F-91191 Gif Sur Yvette, France; [Hekker, Saskia] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Hekker, Saskia; Elsworth, Yvonne; Miglio, Andrea] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Mosser, Benoit] Univ Paris 07, Univ Paris 06, CNRS, Observ Paris,Lab Etudes Spatiales & Instrumentat, F-92195 Meudon, France; [Eggenberger, Patrick] Univ Geneva, Observ Geneve, CH-1290 Sauverny, Switzerland; [Stello, Dennis; Bedding, Timothy R.] Univ Sydney, Sch Phys, Sydney Inst Astron SIfA, Sydney, NSW 2006, Australia; [Frandsen, Soren; Christensen-Dalsgaard, Jorgen; Kjeldsen, Hans] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Gruberbauer, Michael] St Marys Univ, Dept Phys & Astron, Halifax, NS B3H 3C3, Canada; [Girouard, Forrest R.; Hall, Jennifer R.; Ibrahim, Khadeejah A.] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA	KU Leuven; University of Liege; University of Vienna; Radboud University Nijmegen; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Amsterdam; University of Birmingham; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Geneva; University of Sydney; Aarhus University; Saint Marys University - Canada; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Beck, PG (corresponding author), Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium.	paul.beck@ster.kuleuven.be	Miglio, Andrea/M-5789-2018; Bedding, Timothy/AAU-9400-2021; Stello, Dennis/Q-9754-2019; Kallinger, Thomas/N-7501-2019; miglio, andrea/O-9594-2019	Miglio, Andrea/0000-0001-5998-8533; Bedding, Timothy/0000-0001-5222-4661; Stello, Dennis/0000-0002-4879-3519; Kallinger, Thomas/0000-0003-3627-2561; miglio, andrea/0000-0001-5998-8533; Bedding, Timothy/0000-0001-5943-1460; Aerts, Conny/0000-0003-1822-7126; Hillen, Michel/0000-0001-9086-4766; Hekker, Saskia/0000-0002-1463-726X; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Garcia, Rafael A./0000-0002-8854-3776; Mosser, Benoit/0000-0002-7547-1208; Valentini, Marica/0000-0003-0974-4148; Beck, Paul G./0000-0003-4745-2242	NASA's Science Mission Directorate; European Community; Fund for Scientific Research, Flanders; Netherlands Organisation for Scientific Research; Belgian Science Policy Office	NASA's Science Mission Directorate; European Community(European Commission); Fund for Scientific Research, Flanders(FWO); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Belgian Science Policy Office(Belgian Federal Science Policy Office)	We acknowledge the work of the team behind Kepler. Funding for the Kepler Mission is provided by NASA's Science Mission Directorate. P. G. B. and C. A. were supported by the European Community's Seventh Framework Programme (ERC grant PROSPERITY); J.D.R. and T.K. were supported by the Fund for Scientific Research, Flanders. S. H. was supported by the Netherlands Organisation for Scientific Research. J.M. and M. V. were supported by the Belgian Science Policy Office. The work is partly based on observations with the High Efficiency and Resolution Mercator Echelle Spectrograph at the Mercator Telescope, which is operated at La Palma in Spain by the Flemish Community.	Aerts C, 2003, SCIENCE, V300, P1926, DOI 10.1126/science.1084993; Aerts C., 2010, ASTRON ASTROPHYS LIB; Beck PG, 2011, SCIENCE, V332, P205, DOI 10.1126/science.1201939; Bedding TR, 2010, ASTROPHYS J LETT, V713, pL176, DOI 10.1088/2041-8205/713/2/L176; Bedding TR, 2011, NATURE, V471, P608, DOI 10.1038/nature09935; Chaplin WJ, 1999, MON NOT R ASTRON SOC, V308, P405, DOI 10.1046/j.1365-8711.1999.02691.x; Christensen-Dalsgaard J, 2004, SOL PHYS, V220, P137, DOI 10.1023/B:SOLA.0000031392.43227.7d; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Dupret MA, 2009, ASTRON ASTROPHYS, V506, P57, DOI 10.1051/0004-6361/200911713; Dziembowski WA, 2001, MON NOT R ASTRON SOC, V328, P601, DOI 10.1046/j.1365-8711.2001.04894.x; Eggenberger P, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912897; ELSWORTH Y, 1995, NATURE, V376, P669, DOI 10.1038/376669a0; Garcia RA, 2011, MON NOT R ASTRON SOC, V414, pL6, DOI 10.1111/j.1745-3933.2011.01042.x; Garcia RA, 2007, SCIENCE, V316, P1591, DOI 10.1126/science.1140598; Kallinger T, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015263; Kawaler SD, 1999, ASTROPHYS J, V516, P349, DOI 10.1086/307087; LEDOUX P, 1951, ASTROPHYS J, V114, P373, DOI 10.1086/145477; Montalban J, 2010, ASTROPHYS J LETT, V721, pL182, DOI 10.1088/2041-8205/721/2/L182; Mosser B, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015440; Pamyatnykh AA, 2004, MON NOT R ASTRON SOC, V350, P1022, DOI 10.1111/j.1365-2966.2004.07721.x; Sills A, 2000, ASTROPHYS J, V540, P489, DOI 10.1086/309306; SWEIGART AV, 1979, ASTROPHYS J, V229, P624, DOI 10.1086/156996; Thompson MJ, 2003, ANNU REV ASTRON ASTR, V41, P599, DOI 10.1146/annurev.astro.41.011802.094848; ZAHN JP, 1992, ASTRON ASTROPHYS, V265, P115	24	348	348	0	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					55	57		10.1038/nature10612	http://dx.doi.org/10.1038/nature10612			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22158105	Green Published, Green Submitted			2022-12-28	WOS:000298836900027
J	Amaravadi, RK				Amaravadi, Ravi K.			Autophagy in Tumor Immunity	SCIENCE			English	Editorial Material							METASTATIC MELANOMA; CANCER; TUMORIGENESIS; CHEMOTHERAPY		Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Amaravadi, RK (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	ravi.amaravadi@uphs.upenn.edu						ALGAZY SL, 2011, P 102 ANN M AACR ORL; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Lazova R, 2012, CLIN CANCER RES, V18, P370, DOI 10.1158/1078-0432.CCR-11-1282; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Margolin K, 2005, CANCER-AM CANCER SOC, V104, P1045, DOI 10.1002/cncr.21265; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111	16	26	28	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1501	1502		10.1126/science.1216428	http://dx.doi.org/10.1126/science.1216428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174234				2022-12-28	WOS:000298091400033
J	Dolgin, E				Dolgin, Elie			STEM CELLS Transplants on trial	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; THERAPY											Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Bjorkstrand B, 2011, J CLIN ONCOL, V29, P3016, DOI 10.1200/JCO.2010.32.7312; Fermand JP, 1998, BLOOD, V92, P3131, DOI 10.1182/blood.V92.9.3131.421k30_3131_3136; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620	6	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S46	S47		10.1038/480S46a	http://dx.doi.org/10.1038/480S46a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169802				2022-12-28	WOS:000298033000007
J	Vize, R				Vize, Richard			NHS REFORMS Reality of the NHS budget squeeze	BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 12	2011	343								d8027	10.1136/bmj.d8027	http://dx.doi.org/10.1136/bmj.d8027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NJ	22155790				2022-12-28	WOS:000298317300003
J	Shetty, P				Shetty, Priya			Profile Anand Grover: leading the defence of human rights	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					1991	1991		10.1016/S0140-6736(11)61863-1	http://dx.doi.org/10.1016/S0140-6736(11)61863-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22153193				2022-12-28	WOS:000298144200014
J	Bhattacharjee, S; Halane, MK; Kim, SH; Gassmann, W				Bhattacharjee, Saikat; Halane, Morgan K.; Kim, Sang Hee; Gassmann, Walter			Pathogen Effectors Target Arabidopsis EDS1 and Alter Its Interactions with Immune Regulators	SCIENCE			English	Article							DISEASE RESISTANCE; INNATE IMMUNITY; PLANT IMMUNITY; REPEAT PROTEIN; RECEPTORS; SYSTEM; GENES; SRFR1	Plant resistance proteins detect the presence of specific pathogen effectors and initiate effector-triggered immunity. Few immune regulators downstream of resistance proteins have been identified, none of which are known virulence targets of effectors. We show that Arabidopsis ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1), a positive regulator of basal resistance and of effector-triggered immunity specifically mediated by Toll-interleukin-1 receptor-nucleotide binding-leucine-rich repeat (TIR-NB-LRR) resistance proteins, forms protein complexes with the TIR-NB-LRR disease resistance proteins RPS4 and RPS6 and with the negative immune regulator SRFR1 at a cytoplasmic membrane. Further, the cognate bacterial effectors AvrRps4 and HopA1 disrupt these EDS1 complexes. Tight association of EDS1 with TIR-NB-LRR-mediated immunity may therefore derive mainly from being guarded by TIR-NB-LRR proteins, and activation of this branch of effector-triggered immunity may directly connect to the basal resistance signaling pathway via EDS1.	[Bhattacharjee, Saikat; Kim, Sang Hee; Gassmann, Walter] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Bhattacharjee, Saikat; Kim, Sang Hee; Gassmann, Walter] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Halane, Morgan K.] Univ Missouri, Dept English, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Gassmann, W (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA.	gassmannw@missouri.edu		BHATTACHARJEE, SAIKAT/0000-0003-1369-7700; Gassmann, Walter/0000-0002-7527-0385; Halane, Morgan/0000-0001-6357-6232; Kim, Sang Hee/0000-0003-1831-4633	NSF [IOS-0715926, IOS-1121114]	NSF(National Science Foundation (NSF))	We thank J. Parker for providing seed of eds1-2 and EDS1-YFP plants, F. Gao and J. C. Nam for technical assistance, and the University of Missouri Molecular Cytology Core for assistance with confocal fluorescence microscopy. This work was supported by the NSF Integrative Organismal Systems Program (grants IOS-0715926 and IOS-1121114) (W.G.).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kim MG, 2009, PLANT J, V57, P645, DOI 10.1111/j.1365-313X.2008.03716.x; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Kim SH, 2009, PLANT PHYSIOL, V150, P1723, DOI 10.1104/pp.109.139238; Kwon SI, 2009, PLANT J, V57, P109, DOI 10.1111/j.1365-313X.2008.03669.x; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Shen QH, 2007, EMBO J, V26, P4293, DOI 10.1038/sj.emboj.7601854; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	28	221	239	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1405	1408		10.1126/science.1211592	http://dx.doi.org/10.1126/science.1211592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158819				2022-12-28	WOS:000297787700054
J	Torres, JZ; Summers, MK; Peterson, D; Brauer, MJ; Lee, J; Senese, S; Gholkar, AA; Lo, YC; Lei, XY; Jung, K; Anderson, DC; Davis, DP; Belmont, L; Jackson, PK				Torres, Jorge Z.; Summers, Matthew K.; Peterson, David; Brauer, Matthew J.; Lee, James; Senese, Silvia; Gholkar, Ankur A.; Lo, Yu-Chen; Lei, Xingye; Jung, Kenneth; Anderson, David C.; Davis, David P.; Belmont, Lisa; Jackson, Peter K.			The STARD9/Kif16a Kinesin Associates with Mitotic Microtubules and Regulates Spindle Pole Assembly	CELL			English	Article							SMALL-MOLECULE INHIBITOR; ANTIMITOTIC DRUGS; CELL-DIVISION; PROTEIN; CENTROSOMES; GENE; IDENTIFICATION; MECHANISMS; TRANSPORT; DATABASE	During cell division, cells form the microtubule-based mitotic spindle, a highly specialized and dynamic structure that mediates proper chromosome transmission to daughter cells. Cancer cells can show perturbed mitotic spindles and an approach in cancer treatment has been to trigger cell killing by targeting microtubule dynamics or spindle assembly. To identify and characterize proteins necessary for spindle assembly, and potential antimitotic targets, we performed a proteomic and genetic analysis of 592 mitotic microtubule copurifying proteins (MMCPs). Screening for regulators that affect both mitosis and apoptosis, we report the identification and characterization of STARD9, a kinesin-3 family member, which localizes to centrosomes and stabilizes the pericentriolar material (PCM). STARD9-depleted cells have fragmented PCM, form multipolar spindles, activate the spindle assembly checkpoint (SAC), arrest in mitosis, and undergo apoptosis. Interestingly, STARD9-depletion synergizes with the chemotherapeutic agent taxol to increase mitotic death, demonstrating that STARD9 is a mitotic kinesin and a potential antimitotic target.	[Torres, Jorge Z.; Summers, Matthew K.; Jackson, Peter K.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Torres, Jorge Z.; Summers, Matthew K.; Peterson, David; Belmont, Lisa; Jackson, Peter K.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA; [Brauer, Matthew J.; Jung, Kenneth] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Lee, James; Davis, David P.] Genentech Inc, Dept Biol Mol, San Francisco, CA 94080 USA; [Lei, Xingye] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Torres, Jorge Z.; Senese, Silvia; Gholkar, Ankur A.; Lo, Yu-Chen] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Anderson, David C.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Stanford University; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Los Angeles; University of Oregon	Torres, JZ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	torres@chem.ucla.edu		Jackson, Peter/0000-0002-1742-2539; Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X	Genetech Inc, NIH [RO1 GM054811, RO1 GM063023]; Stanford Cancer Biology Postdoctoral Fellowship; Leukemia and Lymphoma Society; V Foundation for cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063023, R01GM054811] Funding Source: NIH RePORTER	Genetech Inc, NIH; Stanford Cancer Biology Postdoctoral Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); V Foundation for cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Brinkley, D. Compton, Q. Gao, W. Jiang, J. Salisbury, and H. Yu for antibodies; A. Ribas, F. Mortazavi, G. Miranda-Carboni, C. Miceli, R. Gatti, and B. Gomperts for cell lines; M. White for sharing data prior to publication; members of the Torres and Jackson labs for helpful discussions. This work was supported by Genetech Inc, NIH grants RO1 GM054811 and RO1 GM063023 (P.K.J.), Stanford Cancer Biology Postdoctoral Fellowship (J.Z.T), The Leukemia and Lymphoma Society Postdoctoral Fellowship (J.Z.T), and The V Foundation for cancer Research V Scholar Award (J.Z.T)	Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Blangy A, 1998, CELL MOTIL CYTOSKEL, V40, P174, DOI 10.1002/(SICI)1097-0169(1998)40:2<174::AID-CM6>3.0.CO;2-F; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Funk CJ, 2004, ANAL BIOCHEM, V329, P68, DOI 10.1016/j.ab.2004.02.032; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Halama N, 2006, INT J MOL MED, V18, P653; Hart RK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P403; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Loughlin R, 2008, CELL, V134, P548, DOI 10.1016/j.cell.2008.07.038; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Manning AL, 2008, CELL, V134, P694, DOI 10.1016/j.cell.2008.08.001; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	47	55	59	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1309	1323		10.1016/j.cell.2011.11.020	http://dx.doi.org/10.1016/j.cell.2011.11.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153075	Bronze, Green Accepted			2022-12-28	WOS:000298148100020
J	Zanette, LY; White, AF; Allen, MC; Clinchy, M				Zanette, Liana Y.; White, Aija F.; Allen, Marek C.; Clinchy, Michael			Perceived Predation Risk Reduces the Number of Offspring Songbirds Produce per Year	SCIENCE			English	Article							SONG SPARROWS; NEST PREDATION; NUTRITIONAL STRESS; MELOSPIZA-MELODIA; EGG-PRODUCTION; SIBERIAN JAY; CLUTCH SIZE; FOOD; BIRDS; PLASTICITY	Predator effects on prey demography have traditionally been ascribed solely to direct killing in studies of population ecology and wildlife management. Predators also affect the prey's perception of predation risk, but this has not been thought to meaningfully affect prey demography. We isolated the effects of perceived predation risk in a free-living population of song sparrows by actively eliminating direct predation and used playbacks of predator calls and sounds to manipulate perceived risk. We found that the perception of predation risk alone reduced the number of offspring produced per year by 40%. Our results suggest that the perception of predation risk is itself powerful enough to affect wildlife population dynamics, and should thus be given greater consideration in vertebrate conservation and management.	[Zanette, Liana Y.; White, Aija F.; Allen, Marek C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Clinchy, Michael] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	Western University (University of Western Ontario); University of Victoria	Zanette, LY (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	lzanette@uwo.ca	White, Aija F/I-3074-2019	White, Aija/0000-0002-9384-6587	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank T. Golumbia, P. Handford, and C. Payne for assistance; Parks Canada and the Bateman family for access to the islands; and D. Blumstein, N. Davies, C. Krebs, R. Magrath, J. Schulkin, and three anonymous reviewers for help improving the manuscript. This research was approved by the University of Western Ontario Animal Care Committee and funded by the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada.	Bernardo J, 1996, AM ZOOL, V36, P216; Caro T., 2005, ANTIPREDATOR DEFENCE; CHRISTIAN JJ, 1950, J MAMMAL, V31, P247, DOI 10.2307/1375290; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Conway CJ, 2000, EVOLUTION, V54, P670; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Kempster B, 2007, OECOLOGIA, V151, P365, DOI 10.1007/s00442-006-0597-7; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; MacDonald IF, 2006, P ROY SOC B-BIOL SCI, V273, P2559, DOI 10.1098/rspb.2006.3547; Martin TE, 2011, EVOLUTION, V65, P1607, DOI 10.1111/j.1558-5646.2011.01227.x; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; Pereyra ME, 2001, AUK, V118, P116, DOI 10.1642/0004-8038(2001)118[0116:NGATDI]2.0.CO;2; Rastogi AD, 2006, ANIM BEHAV, V72, P933, DOI 10.1016/j.anbehav.2006.03.006; Russell AF, 2007, SCIENCE, V317, P941, DOI 10.1126/science.1146037; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226; Zanette L, 2006, OECOLOGIA, V147, P632, DOI 10.1007/s00442-005-0330-y; Zanette L, 2006, ECOLOGY, V87, P2459, DOI 10.1890/0012-9658(2006)87[2459:FAPAEP]2.0.CO;2; Zanette L, 2009, P R SOC B, V276, P2855, DOI 10.1098/rspb.2009.0450	29	552	563	10	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1398	1401		10.1126/science.1210908	http://dx.doi.org/10.1126/science.1210908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158817				2022-12-28	WOS:000297787700052
J	Junge, C				Junge, Christine			A personal response	NATURE			English	Editorial Material																		DOLIN R, 2009, UNDERSTAND YOUR RISK; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967	4	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S14	S15		10.1038/480S14a	http://dx.doi.org/10.1038/480S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158295	Bronze			2022-12-28	WOS:000297744200009
J	McInnes, IB; Schett, G				McInnes, Iain B.; Schett, Georg			MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTICITRULLINATED PROTEIN ANTIBODIES; FIBROBLAST-LIKE SYNOVIOCYTES; SPLEEN TYROSINE KINASE; C-REACTIVE PROTEIN; T-CELL; SYNOVIAL TISSUE; BONE-MARROW; CARDIOVASCULAR EVENTS; FUNCTIONAL-ROLE; ALPHA-ENOLASE		[McInnes, Iain B.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany	University of Glasgow; University of Erlangen Nuremberg	McInnes, IB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Level 4,Sir Graeme Davis Bldg,120 Univ Pl, Glasgow G12 8QQ, Lanark, Scotland.	innes@glasgow.ac.uk; georg.schett@uk-erlangen.de		McInnes, Iain/0000-0002-6462-4280				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Auger I, 1997, J CLIN INVEST, V99, P1818, DOI 10.1172/JCI119348; Aupperle KR, 1998, AM J PATHOL, V152, P1091; Baecklund E, 2003, ARTHRITIS RHEUM-US, V48, P1543, DOI 10.1002/art.11144; Bajpai M, 2008, EXPERT OPIN INV DRUG, V17, P641, DOI [10.1517/13543784.17.5.641, 10.1517/13543784.17.5.641 ]; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Behrens F, 2007, ANN RHEUM DIS, V66, P1151, DOI 10.1136/ard.2006.068320; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bradfield PF, 2003, ARTHRITIS RHEUM, V48, P2472, DOI 10.1002/art.11219; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantaert T, 2009, ARTHRITIS RHEUM-US, V60, P1944, DOI 10.1002/art.24635; Capellino S, 2010, ANN RHEUM DIS, V69, P1853, DOI 10.1136/ard.2009.119701; Cascao R, 2010, AUTOIMMUN REV, V9, P531, DOI 10.1016/j.autrev.2009.12.013; Chabaud M, 1998, J IMMUNOL, V161, P409; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; De Almeida DE, 2010, J IMMUNOL, V185, P1927, DOI 10.4049/jimmunol.0904002; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Filer A, 2006, ARTHRITIS RHEUM, V54, P2096, DOI 10.1002/art.21930; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; GOUGH AKS, 1994, ANN RHEUM DIS, V53, P14, DOI 10.1136/ard.53.1.14; Gravallese EM, 1998, AM J PATHOL, V152, P943; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Guler-Yuksel M, 2009, ANN RHEUM DIS, V68, P330, DOI 10.1136/ard.2007.086348; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Hetland ML, 2009, ANN RHEUM DIS, V68, P384, DOI 10.1136/ard.2008.088245; Holmqvist ME, 2010, J INTERN MED, V268, P578, DOI 10.1111/j.1365-2796.2010.02260.x; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Jimenez-Boj E, 2005, J IMMUNOL, V175, P2579, DOI 10.4049/jimmunol.175.4.2579; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kraan MC, 1998, ARTHRITIS RHEUM, V41, P1481, DOI 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Kurreeman FAS, 2007, PLOS MED, V4, P2013, DOI 10.1371/journal.pmed.0040358; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lebre MC, 2008, AM J PATHOL, V172, P940, DOI 10.2353/ajpath.2008.070703; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Liew FY, 2002, MOL IMMUNOL, V38, P887, DOI 10.1016/S0161-5890(02)00014-7; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; McGonagle D, 2009, ARTHRITIS RHEUM-US, V60, P1042, DOI 10.1002/art.24417; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2000, ARTHRITIS RES, V2, P374, DOI 10.1186/ar115; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Ohata J, 2005, J IMMUNOL, V174, P864, DOI 10.4049/jimmunol.174.2.864; Panayi GS, 2006, NAT CLIN PRACT RHEUM, V2, P58, DOI 10.1038/ncprheum0094; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Polzer K, 2008, ANN RHEUM DIS, V67, P1610, DOI 10.1136/ard.2007.083394; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Sabeh F, 2010, J IMMUNOL, V184, P6396, DOI 10.4049/jimmunol.0904068; Sattar N, 2005, CURR OPIN RHEUMATOL, V17, P286, DOI 10.1097/01.bor.0000158150.57154.f9; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Scher JU, 2010, ARTHRITIS RHEUM, V62, P1390; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Schett G, 2008, ARTHRITIS RHEUM-US, V58, P2936, DOI 10.1002/art.23951; Schett G, 2006, ARCH INTERN MED, V166, P2495, DOI 10.1001/archinte.166.22.2495; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Seyler TM, 2005, J CLIN INVEST, V115, P3083, DOI 10.1172/JCI25265; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Szekanecz Zoltan, 2009, Front Biosci (Elite Ed), V1, P44; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; VanderHeijde DMFM, 1995, BRIT J RHEUMATOL, V34, P74; Vincent C, 1999, ANN RHEUM DIS, V58, P42, DOI 10.1136/ard.58.1.42; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; WEYAND CM, 1990, J CLIN INVEST, V85, P1051, DOI 10.1172/JCI114535; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	101	2654	2767	16	399	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2205	2219		10.1056/NEJMra1004965	http://dx.doi.org/10.1056/NEJMra1004965			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150039				2022-12-28	WOS:000297731400006
J	Watts, G				Watts, Geoff			RESEARCH Data rising from the East	BRITISH MEDICAL JOURNAL			English	Editorial Material																		*DEP TRAD IND, 2005, 22 DTI, pD6154; HY Y, 2011, LANCET, V377, P124; McMahon DS, 2010, REGEN MED, V5, P35, DOI [10.2217/rme.09.78, 10.2217/RME.09.78]; The Royal Society, 2011, KNOWL NETW NAT GLOB; UNESCO, 2010, SCI REP	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 5	2011	343								d7480	10.1136/bmj.d7480	http://dx.doi.org/10.1136/bmj.d7480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RZ	22144409				2022-12-28	WOS:000298038200004
J	Serrano, M				Serrano, Manuel			CANCER Final act of senescence	NATURE			English	Editorial Material									Spanish Natl Canc Res Ctr CNIO, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, E-28029 Madrid, Spain.	mserrano@cnio.es	Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Acosta JC, 2009, CANCER RES, V69, P2167, DOI 10.1158/0008-5472.CAN-08-3772; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	10	18	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					481	482		10.1038/479481a	http://dx.doi.org/10.1038/479481a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113687				2022-12-28	WOS:000297285600037
J	Hecht, R; Kaddar, M; Schmitt, S				Hecht, Robert; Kaddar, Miloud; Schmitt, Sarah			PERSONAL VIEW Transparent pricing of vaccines would help poor as well as rich countries	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hecht, Robert] Results Dev Inst, Washington, DC USA; [Kaddar, Miloud] World Hlth Org, Immunizat Vaccines & Biol Dept, Geneva, Switzerland	World Health Organization	Hecht, R (corresponding author), Results Dev Inst, Washington, DC USA.	rhecht@resultsfordevelopment.org						Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; KENNEDY R, 2011, NEW GLOBAL FRAMEWORK; PAHO, PAHO REV FUND; *UNICEF, UNICEF PROM VACC PRI; WHO, GLOB PRIC REP MECH; 2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D6239	6	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7414	10.1136/bmj.d7414	http://dx.doi.org/10.1136/bmj.d7414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113835				2022-12-28	WOS:000297724400002
J	MacGurn, JA; Hsu, PC; Smolka, MB; Emr, SD				MacGurn, Jason A.; Hsu, Pi-Chiang; Smolka, Marcus B.; Emr, Scott D.			TORC1 Regulates Endocytosis via Npr1-Mediated Phosphoinhibition of a Ubiquitin Ligase Adaptor	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; AMINO-ACIDS; PHOSPHORYLATION; COMPLEX; YEAST; MTOR; NPR1; IDENTIFICATION; TRANSPORTERS	The TORC1 kinase signaling complex is a key determinant of cell growth that senses nutritional status and responds by coordinating diverse cellular processes including transcription, translation, and autophagy. Here, we demonstrate that TORC1 modulates the composition of plasma membrane (PM) proteins by regulating ubiquitin-mediated endocytosis. The mechanism involves the Npr1 kinase, a negative regulator of endocytosis that is itself negatively regulated by TORC1. We show that Npr1 inhibits the activity of Art1, an arrestin-like adaptor protein that promotes endocytosis by targeting the Rsp5 ubiquitin ligase to specific PM cargoes. Npr1 antagonizes Art1-mediated endocytosis via N-terminal phosphorylation, a modification that prevents Art1 association with the PM. Thus, our study adds ubiquitin ligase targeting and control of endocytosis to the known effector mechanisms of TORC1, underscoring how TORC1 coordinates ubiquitin-mediated endocytosis with protein synthesis and autophagy in order to regulate cell growth.	[MacGurn, Jason A.; Hsu, Pi-Chiang; Smolka, Marcus B.; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu			Fleming Research Fellowship; Taiwanese Ministry of Education	Fleming Research Fellowship; Taiwanese Ministry of Education	We thank M. N. Hall, R. Loewith, and J. Thorner for helpful advice and discussion. We also thank Patrice Ohouo and Sunil Adige for technical advice and assistance. We are grateful to E. MacGurn for assistance with graphic design, and to Shu-Bing Qian and W. Michael Henne for critical reading of the manuscript. We also thank members of the Emr lab for helpful discussions, especially Chris Stefan. J. A. M. is supported by a Fleming Research Fellowship. P. H. is supported by a fellowship from the Taiwanese Ministry of Education.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonenfant D, 2003, P NATL ACAD SCI USA, V100, P880, DOI 10.1073/pnas.232735599; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Gander S, 2009, J PROTEOME RES, V8, P5305, DOI 10.1021/pr9005469; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198	25	156	157	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1104	1117		10.1016/j.cell.2011.09.054	http://dx.doi.org/10.1016/j.cell.2011.09.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118465	Bronze			2022-12-28	WOS:000297376600021
J	Spence, D				Spence, Des			FROM THE FRONTLINE Too much emotion?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7568	10.1136/bmj.d7568	http://dx.doi.org/10.1136/bmj.d7568			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113837				2022-12-28	WOS:000297724400007
J	Barnett, BE; Ciocca, ML; Goenka, R; Barnett, LG; Wu, JM; Laufer, TM; Burkhardt, JK; Cancro, MP; Reiner, SL				Barnett, Burton E.; Ciocca, Maria L.; Goenka, Radhika; Barnett, Lisa G.; Wu, Junmin; Laufer, Terri M.; Burkhardt, Janis K.; Cancro, Michael P.; Reiner, Steven L.			Asymmetric B Cell Division in the Germinal Center Reaction	SCIENCE			English	Article							T-LYMPHOCYTE DIVISION; BCL-6; ANTIGEN; DIFFERENTIATION; INFLAMMATION; EXPRESSION; RESPONSES	Lifelong antibody responses to vaccination require reorganization of lymphoid tissue and dynamic intercellular communication called the germinal center reaction. B lymphocytes undergo cellular polarization during antigen stimulation, acquisition, and presentation, which are critical steps for initiating humoral immunity. Here, we show that germinal center B lymphocytes asymmetrically segregate the transcriptional regulator Bcl6, the receptor for interleukin-21, and the ancestral polarity protein atypical protein kinase C to one side of the plane of division, generating unequal inheritance of fate-altering molecules by daughter cells. Germinal center B lymphocytes from mice with a defect in leukocyte adhesion fail to divide asymmetrically. These results suggest that motile cells lacking constitutive attachment can receive provisional polarity cues from the microenvironment to generate daughter cell diversity and self-renewal.	[Barnett, Burton E.; Ciocca, Maria L.; Wu, Junmin; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Goenka, Radhika; Burkhardt, Janis K.; Cancro, Michael P.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Barnett, Burton E.; Ciocca, Maria L.; Barnett, Lisa G.; Wu, Junmin; Laufer, Terri M.; Reiner, Steven L.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Burkhardt, Janis K.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@columbia.edu		Cancro, Michael/0000-0002-8659-3227; Burkhardt, Janis/0000-0002-8176-1375	NIH [AI042370, AI076458, T32GM07229, T32HD007516, 3T32GM007170-36S1, T32AI055428, AI065644]; U.S. Department of Defense [W81WWXWH1010185]; Veterans Administration [BX000435]; Abramson family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI042370, R01AI061699, R01AI076458, R56AI076458, T32AI055428, R01AI065644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170, T32GM007229] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Veterans Administration(US Department of Veterans Affairs); Abramson family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank J. Chaix, S. Gordon, M. Paley, and L. Rupp for assistance. We are grateful for funding from the NIH (grants AI042370 and AI076458 to S. L. R., T32GM07229 to B. E. B., T32HD007516 and 3T32GM007170-36S1 to M. L. C., T32AI055428 to R. G., and AI065644 to J.K.B.), the U.S. Department of Defense (grant W81WWXWH1010185 to M. P. C.), Veterans Administration (grant BX000435 to T. M. L.), and the Abramson family (to S. L. R.). The data reported in this paper are tabulated in the main paper and in the supporting online material. The authors declare no conflicts of interest.	Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; FISCHER A, 1986, J IMMUNOL, V136, P3198; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008	19	68	71	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					342	344		10.1126/science.1213495	http://dx.doi.org/10.1126/science.1213495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22174128	Green Accepted, Green Submitted			2022-12-28	WOS:000299273400049
J	Carson, JL; Terrin, ML; Noveck, H; Sanders, DW; Chaitman, BR; Rhoads, GG; Nemo, G; Dragert, K; Beaupre, L; Hildebrand, K; Macaulay, W; Lewis, C; Cook, DR; Dobbin, G; Zakriya, KJ; Apple, FS; Horney, RA; Magaziner, J				Carson, Jeffrey L.; Terrin, Michael L.; Noveck, Helaine; Sanders, David W.; Chaitman, Bernard R.; Rhoads, George G.; Nemo, George; Dragert, Karen; Beaupre, Lauren; Hildebrand, Kevin; Macaulay, William; Lewis, Courtland; Cook, Donald Richard; Dobbin, Gwendolyn; Zakriya, Khwaja J.; Apple, Fred S.; Horney, Rebecca A.; Magaziner, Jay		FOCUS Investigators	Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL; TRIAL	BACKGROUND The hemoglobin threshold at which postoperative red-cell transfusion is warranted is controversial. We conducted a randomized trial to determine whether a higher threshold for blood transfusion would improve recovery in patients who had undergone surgery for hip fracture. METHODS We enrolled 2016 patients who were 50 years of age or older, who had either a history of or risk factors for cardiovascular disease, and whose hemoglobin level was below 10 g per deciliter after hip-fracture surgery. We randomly assigned patients to a liberal transfusion strategy (a hemoglobin threshold of 10 g per deciliter) or a restrictive transfusion strategy (symptoms of anemia or at physician discretion for a hemoglobin level of <8 g per deciliter). The primary outcome was death or an inability to walk across a room without human assistance on 60-day follow-up. RESULTS A median of 2 units of red cells were transfused in the liberal-strategy group and none in the restrictive-strategy group. The rates of the primary outcome were 35.2% in the liberal-strategy group and 34.7% in the restrictive-strategy group (odds ratio in the liberal-strategy group, 1.01; 95% confidence interval [CI], 0.84 to 1.22), for an absolute risk difference of 0.5 percentage points (95% CI, -3.7 to 4.7). The rates of in-hospital acute coronary syndrome or death were 4.3% and 5.2%, respectively (absolute risk difference, -0.9%; 99% CI, -3.3 to 1.6), and rates of death on 60-day follow-up were 7.6% and 6.6%, respectively (absolute risk difference, 1.0%; 99% CI, -1.9 to 4.0). The rates of other complications were similar in the two groups. CONCLUSIONS A liberal transfusion strategy, as compared with a restrictive strategy, did not reduce rates of death or inability to walk independently on 60-day follow-up or reduce in-hospital morbidity in elderly patients at high cardiovascular risk. (Funded by the National Heart, Lung, and Blood Institute; FOCUS ClinicalTrials.gov number, NCT00071032.)	[Carson, Jeffrey L.; Noveck, Helaine; Dragert, Karen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Gen Internal Med, New Brunswick, NJ 08903 USA; [Terrin, Michael L.; Magaziner, Jay] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Zakriya, Khwaja J.] Johns Hopkins Bayview Med Ctr, Baltimore, MD USA; [Sanders, David W.] Univ Western Ontario, Div Orthopaed Surg, London, ON, Canada; [Beaupre, Lauren] Univ Alberta, Dept Phys Therapy & Surg, Edmonton, AB, Canada; [Beaupre, Lauren] Univ Alberta, Div Orthopaed Surg, Edmonton, AB, Canada; [Hildebrand, Kevin] Univ Calgary, Div Orthoped Surg, Calgary, AB, Canada; [Cook, Donald Richard] Univ Calgary, Dept Med, Calgary, AB, Canada; [Dobbin, Gwendolyn] QEII Hlth Sci Ctr, Dept Orthoped Surg, Halifax, NS, Canada; [Chaitman, Bernard R.] St Louis Univ, Sch Med, Dept Med, St Louis, MO 63103 USA; [Rhoads, George G.] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ 08854 USA; [Nemo, George] NHLBI, Transfus Med & Cellular Therapeut Branch, Div Blood Dis & Resources, Bethesda, MD 20892 USA; [Horney, Rebecca A.] Vet Affairs Med Ctr, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA; [Macaulay, William] Columbia Univ, Dept Orthoped Surg, New York Presbyterian Hosp, New York, NY USA; [Lewis, Courtland] Hartford Hosp, Hartford, CT 06115 USA; [Apple, Fred S.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Apple, Fred S.] Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Minneapolis, MN USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; Western University (University of Western Ontario); University of Alberta; University of Alberta; University of Calgary; University of Calgary; Queen Elizabeth II Health Sciences Centre; Saint Louis University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Columbia University; NewYork-Presbyterian Hospital; Hartford Hospital; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Minneapolis Medical Research Foundation	Carson, JL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Gen Internal Med, 125 Paterson St, New Brunswick, NJ 08903 USA.	carson@umdnj.edu	Hug, Balthasar L./G-1568-2010; Naudie, Douglas D.R./B-5779-2015; Hildebrand, Kevin/N-8394-2015	Hildebrand, Kevin/0000-0001-8786-9021; /0000-0001-6570-3290; Macaulay, William/0000-0003-2684-0676; Coles, Chad/0000-0003-0454-3507	National Heart, Lung, and Blood Institute [U01 HL073958, U01 HL074815]; Amgen; Orthopaedic Associates of Hartford; Abbott Diagnostics; Ortho Clinical Diagnostics; Instrumentation Laboratories; Siemens; Roche Diagnostics; BioRad; Response Biomedical; Radiometer; BRAHMS; Alere; Eli Lily; Sanofi-Aventis; Novartis; Merck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL073958, U01HL074815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028747] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Amgen(Amgen); Orthopaedic Associates of Hartford; Abbott Diagnostics(Abbott Laboratories); Ortho Clinical Diagnostics; Instrumentation Laboratories; Siemens(Siemens AG); Roche Diagnostics; BioRad; Response Biomedical; Radiometer; BRAHMS; Alere; Eli Lily; Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Merck(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by grants from the National Heart, Lung, and Blood Institute (U01 HL073958 and U01 HL074815).; Dr. Carson reports receiving grant support to his institution from Amgen; Dr. Lewis, receiving a salary from the Orthopaedic Associates of Hartford, receiving a stipend for serving as president of the Hartford County Medical Association, and providing expert testimony representing the American Academy of Orthopaedic Surgery on the Medicare Evidence Development and Coverage Advisory Committee; Dr. Apple, serving as a scientific advisory board member for Abbott Laboratories, Alere, Beckman Coulter, Ortho Clinical Diagnostics, and Instrumentation Laboratories, receiving consulting fees from Abbott Diagnostics, Ortho Clinical Diagnostics, and Instrumentation Laboratories, receiving grant support to his institution from Abbott Diagnostics, Siemens, Ortho Clinical Diagnostics, Roche Diagnostics, BioRad, Response Biomedical, Radiometer, and BRAHMS, and receiving lecture fees and travel expenses from Abbott Diagnostics and Alere; Dr. Magazine, serving as a board member for Amgen, Novartis, and GlaxoSmithKline and receiving consulting fees from Eli Lily, Sanofi-Aventis, and Amgen, grant support to his institution from Novartis, Merck, and Eli Lilly, and lecture fees from Novartis. No other potential conflict of interest relevant to this article was reported.	Alpert JS, 2001, J AM COLL CARDIOL, V37, P973; Anderson SA, 2007, TRANSFUSION, V47, P582, DOI 10.1111/j.1537-2995.2007.01159.x; [Anonymous], 2011, REP DEP HLTH HUM SER; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Carson JL, 2006, TRANSFUSION, V46, P2192, DOI 10.1111/j.1537-2995.2006.01056.x; Cobain TJ, 2007, COCHRANE DB SYST REV, V17, P1; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HOSMER DW, 1989, APPL LOGISTIC REGRES; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011	14	875	908	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2453	2462		10.1056/NEJMoa1012452	http://dx.doi.org/10.1056/NEJMoa1012452			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22168590	Green Accepted			2022-12-28	WOS:000298544600006
J	Lamia, KA; Papp, SJ; Yu, RT; Barish, GD; Uhlenhaut, NH; Jonker, JW; Downes, M; Evans, RM				Lamia, Katja A.; Papp, Stephanie J.; Yu, Ruth T.; Barish, Grant D.; Uhlenhaut, N. Henriette; Jonker, Johan W.; Downes, Michael; Evans, Ronald M.			Cryptochromes mediate rhythmic repression of the glucocorticoid receptor	NATURE			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; PERIPHERAL-TISSUES; TRANSCRIPTION; LIVER; COMPONENT; BINDING; MOUSE; MICE; TIME	Mammalian metabolism is highly circadian and major hormonal circuits involving nuclear hormone receptors display interlinked diurnal cycling(1,2). However, mechanisms that logically explain the coordination of nuclear hormone receptors and the clock are poorly understood. Here we show that two circadian co-regulators, cryptochromes 1 and 2, interact with the glucocorticoid receptor in a ligand-dependent fashion and globally alter the transcriptional response to glucocorticoids in mouse embryonic fibroblasts: cryptochrome deficiency vastly decreases gene repression and approximately doubles the number of dexamethasone-induced genes, suggesting that cryptochromes broadly oppose glucocorticoid receptor activation and promote repression. In mice, genetic loss of cryptochrome 1 and/or 2 results in glucose intolerance and constitutively high levels of circulating corticosterone, suggesting reduced suppression of the hypothalamic-pituitary-adrenal axis coupled with increased glucocorticoid transactivation in the liver. Genomically, cryptochromes 1 and 2 associate with a glucocorticoid response element in the phosphoenolpyruvate carboxykinase 1 promoter in a hormone-dependent manner, and dexamethasone-induced transcription of the phosphoenolpyruvate carboxykinase 1 gene was strikingly increased in cryptochrome-deficient livers. These results reveal a specific mechanism through which cryptochromes couple the activity of clock and receptor target genes to complex genomic circuits underpinning normal metabolic homeostasis.	[Lamia, Katja A.; Yu, Ruth T.; Barish, Grant D.; Uhlenhaut, N. Henriette; Jonker, Johan W.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Lamia, Katja A.; Papp, Stephanie J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klamia@scripps.edu; evans@salk.edu	Uhlenhaut, Henriette/AFR-1141-2022; Uhlenhaut, Nina Henriette/C-6288-2014; Evans, Ronald/AAF-4001-2019; Uhlenhaut, Henriette/AAP-5400-2020; Jonker, Johan W./ABE-6853-2020	Evans, Ronald/0000-0002-9986-5965; Jonker, Johan W./0000-0002-3919-5437; Yu, Ruth/0000-0002-9527-9627; Uhlenhaut, Henriette/0000-0002-4220-4779	National Institutes of Health [DK057978, DK062434, DK090188]; Glenn Foundation for Aging Research; Helmsley Trust; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, K01DK090188, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Aging Research; Helmsley Trust; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kaufman for assistance with glucose tolerance tests, J. Alvarez for RNA sample preparation, H. Juguilon for luciferase assays, J. Vaughan for corticosterone and ACTH measurements, antigenic peptide design and peptide-KLH coupling reactions, H. Cho for sharing unpublished plasmids and R. Shaw for comments on the manuscript. This work was supported by National Institutes of Health grants DK057978 and DK062434 (to R. M. E.) and DK090188 (to K. A. L.), by support from the Glenn Foundation for Aging Research (to R. M. E. and K. A. L.), from the Helmsley Trust (to R. M. E.) and by a Merck fellowship from the Life Sciences Research Foundation (to K.A.L.).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	29	378	410	3	61	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					552	556		10.1038/nature10700	http://dx.doi.org/10.1038/nature10700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22170608	Green Accepted			2022-12-28	WOS:000298318000067
J	Schmittner, A; Urban, NM; Shakun, JD; Mahowald, NM; Clark, PU; Bartlein, PJ; Mix, AC; Rosell-Mele, A				Schmittner, Andreas; Urban, Nathan M.; Shakun, Jeremy D.; Mahowald, Natalie M.; Clark, Peter U.; Bartlein, Patrick J.; Mix, Alan C.; Rosell-Mele, Antoni			Climate Sensitivity Estimated from Temperature Reconstructions of the Last Glacial Maximum	SCIENCE			English	Article							MODEL; CO2	Assessing the impact of future anthropogenic carbon emissions is currently impeded by uncertainties in our knowledge of equilibrium climate sensitivity to atmospheric carbon dioxide doubling. Previous studies suggest 3 kelvin (K) as the best estimate, 2 to 4.5 K as the 66% probability range, and nonzero probabilities for much higher values, the latter implying a small chance of high-impact climate changes that would be difficult to avoid. Here, combining extensive sea and land surface temperature reconstructions from the Last Glacial Maximum with climate model simulations, we estimate a lower median (2.3 K) and reduced uncertainty (1.7 to 2.6 K as the 66% probability range, which can be widened using alternate assumptions or data subsets). Assuming that paleoclimatic constraints apply to the future, as predicted by our model, these results imply a lower probability of imminent extreme climatic change than previously thought.	[Schmittner, Andreas; Mix, Alan C.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Urban, Nathan M.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Shakun, Jeremy D.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Mahowald, Natalie M.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA; [Clark, Peter U.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; [Bartlein, Patrick J.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Rosell-Mele, Antoni] Autonomous Univ Barcelona, Inst Catalana Recerca & Estudis Avancats, Bellaterra, Spain; [Rosell-Mele, Antoni] Autonomous Univ Barcelona, Inst Environm Sci & Technol, Bellaterra, Spain	Oregon State University; Princeton University; Harvard University; Cornell University; Oregon State University; University of Oregon; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona	Schmittner, A (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	aschmitt@coas.oregonstate.edu	Rosell-Melé, Antoni/B-3433-2013; Bartlein, Patrick J./E-4643-2011; Mahowald, Natalie M/D-8388-2013; Schmittner, Andreas/O-9647-2015	Rosell-Melé, Antoni/0000-0002-5513-2647; Bartlein, Patrick J./0000-0001-7657-5685; Mahowald, Natalie M/0000-0002-2873-997X; Schmittner, Andreas/0000-0002-8376-0843; Urban, Nathan/0000-0002-2264-3512	National Science Foundation [06023950-ATM]; Directorate For Geosciences [0932946] Funding Source: National Science Foundation; ICREA Funding Source: Custom	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICREA(ICREA)	This work was supported by the Paleoclimate Program of the National Science Foundation through project PALEOVAR (06023950-ATM). Thanks to S. Harrison and two anonymous reviewers for thoughtful and constructive comments that led to substantial improvements in the paper.	Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Ballantyne AP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021217; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Bintanja R, 2005, CLIM DYNAM, V24, P197, DOI 10.1007/s00382-004-0486-x; BUDYKO MI, 1969, TELLUS, V21, P611, DOI 10.3402/tellusa.v21i5.10109; Charney J., 1979, CARBON DIOXIDE CLIMA; Crucifix M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027137; Forest CE, 2008, TELLUS A, V60, P911, DOI 10.1111/j.1600-0870.2008.00346.x; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Harrison SP, 2001, EARTH-SCI REV, V54, P43, DOI 10.1016/S0012-8252(01)00041-1; Knutti R, 2003, CLIM DYNAM, V21, P257, DOI 10.1007/s00382-003-0345-1; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Maher BA, 2010, EARTH-SCI REV, V99, P61, DOI 10.1016/j.earscirev.2009.12.001; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; MANABE S, 1992, J CLIMATE, V5, P105, DOI 10.1175/1520-0442(1992)005<0105:TROACO>2.0.CO;2; Masson-Delmotte V, 2006, CLIM DYNAM, V26, P513, DOI [10.1007/s00382-005-0081-9, 10.1007/S00382-005-0081-9]; Roe GH, 2007, SCIENCE, V318, P629, DOI 10.1126/science.1144735; Royer DL, 2007, NATURE, V446, P530, DOI 10.1038/nature05699; Schneider von Deimling T, 2006, CLIM DYNAM, V27, P149, DOI 10.1007/s00382-006-0126-8; Solomon S., 2007, PHYS SCI BASIS WORKI; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Sutton RT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028164; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686	27	164	165	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1385	1388		10.1126/science.1203513	http://dx.doi.org/10.1126/science.1203513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22116027				2022-12-28	WOS:000297787700048
J	Jaworski, T; Dewachter, I; Lechat, B; Gees, M; Kremer, A; Demedts, D; Borghgraef, P; Devijver, H; Kugler, S; Patel, S; Woodgett, JR; Van Leuven, F				Jaworski, Tomasz; Dewachter, Ilse; Lechat, Benoit; Gees, Maarten; Kremer, Anna; Demedts, David; Borghgraef, Peter; Devijver, Herman; Kuegler, Seb; Patel, Satish; Woodgett, Jim R.; Van Leuven, Fred			GSK-3 alpha/beta kinases and amyloid production in vivo	NATURE			English	Letter							GLYCOGEN-SYNTHASE KINASE-3-BETA; PRECURSOR PROTEIN; TAU; DEFICIENCY		[Jaworski, Tomasz; Dewachter, Ilse; Lechat, Benoit; Gees, Maarten; Kremer, Anna; Demedts, David; Borghgraef, Peter; Devijver, Herman; Van Leuven, Fred] Katholieke Univ Leuven, Expt Genet Grp, Louvain, Belgium; [Kuegler, Seb] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Patel, Satish; Woodgett, Jim R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	KU Leuven; University of Gottingen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Jaworski, T (corresponding author), Katholieke Univ Leuven, Expt Genet Grp, Louvain, Belgium.	fred.vanleuven@med.kuleuven.be	Dewachter, Ilse/AAZ-5661-2020; Woodgett, Jim/F-1087-2010	Dewachter, Ilse/0000-0001-7202-515X; Woodgett, Jim/0000-0003-3731-5797; Jaworski, Tomasz/0000-0002-6387-9249				De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dewachter I, 2002, J NEUROSCI, V22, P3445; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jaworski T, 2010, BBA-MOL BASIS DIS, V1802, P808, DOI 10.1016/j.bbadis.2010.03.005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Perez-Costas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008911; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Tanghe A., 2010, INT J ALZHEIMERS DIS, V2010, DOI DOI 10.4061/2010/417314; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904	13	64	67	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					E4	E5		10.1038/nature10615	http://dx.doi.org/10.1038/nature10615			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158250				2022-12-28	WOS:000297744200001
J	Paterson, JR; Garcia-Bellido, DC; Lee, MSY; Brock, GA; Jago, JB; Edgecombe, GD				Paterson, John R.; Garcia-Bellido, Diego C.; Lee, Michael S. Y.; Brock, Glenn A.; Jago, James B.; Edgecombe, Gregory D.			Acute vision in the giant Cambrian predator Anomalocaris and the origin of compound eyes	NATURE			English	Article							BAY SHALE LAGERSTATTE; BURGESS SHALE; SOUTH-AUSTRALIA; ARTHROPOD; EVOLUTION; ANIMALS; CHINA; BIOTA	Until recently(1), intricate details of the optical design of non-biomineralized arthropod eyes remained elusive in Cambrian Burgess-Shale-type deposits, despite exceptional preservation of soft-part anatomy in such Konservat-Lagerstatten(2,3). The structure and development of ommatidia in arthropod compound eyes support a single origin some time before the latest common ancestor of crown-group arthropods(4), but the appearance of compound eyes in the arthropod stem group has been poorly constrained in the absence of adequate fossils. Here we report 2-3-cm paired eyes from the early Cambrian (approximately 515 million years old) Emu Bay Shale of South Australia, assigned to the Cambrian apex predator Anomalocaris. Their preserved visual surfaces are composed of at least 16,000 hexagonally packed ommatidial lenses (in a single eye), rivalling the most acute compound eyes in modern arthropods. The specimens show two distinct taphonomic modes, preserved as iron oxide (after pyrite) and calcium phosphate, demonstrating that disparate styles of early diagenetic mineralization can replicate the same type of extracellular tissue (that is, cuticle) within a single Burgess-Shale-type deposit. These fossils also provide compelling evidence for the arthropod affinities of anomalocaridids, push the origin of compound eyes deeper down the arthropod stem lineage, and indicate that the compound eye evolved before such features as a hardened exoskeleton. The inferred acuity of the anomalocaridid eye is consistent with other evidence that these animals were highly mobile visual predators in the water column(5,6). The existence of large, macrophagous nektonic predators possessing sharp vision-such as Anomalocaris-within the early Cambrian ecosystem probably helped to accelerate the escalatory 'arms race' that began over half a billion years ago(7,8).	[Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Div Earth Sci, Armidale, NSW 2351, Australia; [Garcia-Bellido, Diego C.] Inst Geociencias CSIC UCM, Dept Geol Sedimentaria & Cambio Ambiental, Madrid 28040, Spain; [Lee, Michael S. Y.; Jago, James B.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Brock, Glenn A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Jago, James B.] Univ S Australia, Sch Nat & Built Environm, Mawson Lakes, SA 5095, Australia; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	University of New England; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); University of Adelaide; Macquarie University; University of South Australia; Natural History Museum London	Paterson, JR (corresponding author), Univ New England, Sch Environm & Rural Sci, Div Earth Sci, Armidale, NSW 2351, Australia.	jpater20@une.edu.au	Garcia-Bellido, Diego/AAF-9043-2021	Jago, James/0000-0002-3059-1572; Edgecombe, Gregory/0000-0002-9591-8011; Brock, Glenn/0000-0002-2277-7350; Paterson, John/0000-0003-2947-3912; Garcia-Bellido, Diego/0000-0003-1922-9836	Australian Research Council [LP0774959]; South Australian Museum; University of Adelaide; MICINN-Spanish Ministry of Science [RYC2007-00090, CGL2009-07073]; Beach Energy; Sealink Pty Ltd	Australian Research Council(Australian Research Council); South Australian Museum; University of Adelaide; MICINN-Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Beach Energy; Sealink Pty Ltd	We thank P. and C. Buck for access to and assistance at the fossil site; R. Atkinson, M. Gemmell, N. Schroeder, M. Binnie, J. Gehling, B. McHenry and others (Supplementary table 3 in ref. 1) for assistance with excavations and curation; A. Daley and J. Gehling for comments and advice; D. Birch and N. Vella for help with SEM-EDS analyses; and the Australian Research Council (grant LP0774959), South Australian Museum, University of Adelaide, MICINN-Spanish Ministry of Science (RYC2007-00090 and grant CGL2009-07073), Beach Energy and Sealink Pty Ltd for funding.	BERGSTROM J, 2010, DARWINS HERITAGE TOD, P29; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; BRIGGS DEG, 1994, SCIENCE, V264, P1283, DOI 10.1126/science.264.5163.1283; Bush AM, 2011, ANNU REV EARTH PL SC, V39, P241, DOI 10.1146/annurev-earth-040809-152556; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; CHEN JY, 1994, SCIENCE, V264, P1304, DOI 10.1126/science.264.5163.1304; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cronin Thomas W., 2008, Evolution Education and Outreach, V1, P463, DOI 10.1007/s12052-008-0085-0; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; McKirdy DM, 2011, AUST J EARTH SCI, V58, P259, DOI 10.1080/08120099.2011.557439; Nedin C, 1999, GEOLOGY, V27, P987, DOI 10.1130/0091-7613(1999)027<0987:APONAM>2.3.CO;2; Nedin Christopher, 1995, Memoir of the Association of Australasian Palaeontologists, V18, P31; Usami Y, 2006, J THEOR BIOL, V238, P11, DOI 10.1016/j.jtbi.2005.05.008; Van Roy P, 2011, NATURE, V473, P510, DOI 10.1038/nature09920; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; WEHNER R, 1981, COMP PHYSL EVOLUTION, P287; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	30	126	129	3	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					237	240		10.1038/nature10689	http://dx.doi.org/10.1038/nature10689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158247				2022-12-28	WOS:000297744200050
J	Centola, D				Centola, Damon			An Experimental Study of Homophily in the Adoption of Health Behavior	SCIENCE			English	Article							SOCIAL NETWORK; DIFFUSION; DISPARITIES; INEQUALITY; FEATHER; SPREAD; BIRDS; TIES	How does the composition of a population affect the adoption of health behaviors and innovations? Homophily-similarity of social contacts-can increase dyadic-level influence, but it can also force less healthy individuals to interact primarily with one another, thereby excluding them from interactions with healthier, more influential, early adopters. As a result, an important network-level effect of homophily is that the people who are most in need of a health innovation may be among the least likely to adopt it. Despite the importance of this thesis, confounding factors in observational data have made it difficult to test empirically. We report results from a controlled experimental study on the spread of a health innovation through fixed social networks in which the level of homophily was independently varied. We found that homophily significantly increased overall adoption of a new health behavior, especially among those most in need of it.	MIT, Sloan Sch, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Centola, D (corresponding author), MIT, Sloan Sch, Cambridge, MA 02142 USA.	dcentola@mit.edu			James S. McDonnell Foundation; Center for the Study of Social Organization at Princeton University; Institute for Research in the Social Sciences at Stanford University	James S. McDonnell Foundation; Center for the Study of Social Organization at Princeton University; Institute for Research in the Social Sciences at Stanford University	I thank A. van de Rijt for helpful discussion, and N. Christakis, S. Levin, J. Freese, R. Reagans, E. Zuckerman, J. Fowler, F. Garip, and P. DiMaggio for useful comments and suggestions; W. Pan for programming assistance; A. Wagner, T. Groves, and A. Michal for website development; and K. Schive, M. Kirkbride, and MIT Medical for assistance with site design and participant recruitment. Supported by the James S. McDonnell Foundation, and by time in residence at the Center for the Study of Social Organization at Princeton University, and the Institute for Research in the Social Sciences at Stanford University. Data on population characteristics and adoption behavior are provided in (28).	Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Blau P. M., 1984, CROSSCUTTING SOCIAL; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2007, J CONFLICT RESOLUT, V51, P905, DOI 10.1177/0022002707307632; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Correll S.J., 2003, HDB SOCIAL PSYCHOL, P29, DOI DOI 10.1007/0-387-36921-X_2; Crosnoe R, 2008, SOC FORCES, V86, P1189; DiMaggio P, 2011, AM J SOCIOL, V116, P1887, DOI 10.1086/659653; Freese J, 2011, HANDB SOCIOL SOC RES, P67, DOI 10.1007/978-1-4419-7261-3_4; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; McPherson M., 1987, AM SOCIOL REV, V52, P370; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pampel FC, 2002, SOC PROBL, V49, P35, DOI 10.1525/sp.2002.49.1.35; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; RAO AG, 1980, IND J EXT ED, V16, P19; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Rostila M, 2010, SOCIOL HEALTH ILL, V32, P382, DOI 10.1111/j.1467-9566.2009.01196.x; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Strang D, 1998, ANNU REV SOCIOL, V24, P265, DOI 10.1146/annurev.soc.24.1.265; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Valente TW, 2009, J ADOLESCENT HEALTH, V45, P202, DOI 10.1016/j.jadohealth.2009.01.007; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406	31	371	383	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1269	1272		10.1126/science.1207055	http://dx.doi.org/10.1126/science.1207055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HD	22144624				2022-12-28	WOS:000297553600048
J	Coulson, T; MacNulty, DR; Stahler, DR; Vonholdt, B; Wayne, RK; Smith, DW				Coulson, Tim; MacNulty, Daniel R.; Stahler, Daniel R.; vonHoldt, Bridgett; Wayne, Robert K.; Smith, Douglas W.			Modeling Effects of Environmental Change on Wolf Population Dynamics, Trait Evolution, and Life History	SCIENCE			English	Article							ECOLOGICAL DYNAMICS; YELLOWSTONE; WOLVES; PREDATION; SIZE; SELECTION; CLIMATE; GROWTH; RATES; ELK	Environmental change has been observed to generate simultaneous responses in population dynamics, life history, gene frequencies, and morphology in a number of species. But how common are such eco-evolutionary responses to environmental change likely to be? Are they inevitable, or do they require a specific type of change? Can we accurately predict eco-evolutionary responses? We address these questions using theory and data from the study of Yellowstone wolves. We show that environmental change is expected to generate eco-evolutionary change, that changes in the average environment will affect wolves to a greater extent than changes in how variable it is, and that accurate prediction of the consequences of environmental change will probably prove elusive.	[Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [MacNulty, Daniel R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Stahler, Daniel R.; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [vonHoldt, Bridgett] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	Imperial College London; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	MacNulty, Dan/L-3965-2016; Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	European Research Council; Wellcome Trust; Royal Society; Natural Environment Research Council; Wolfson Foundation; NSF; Natural Environment Research Council [NE/I023783/1] Funding Source: researchfish; NERC [NE/I023783/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wolfson Foundation; NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	T.C. acknowledges the European Research Council, the Wellcome Trust, the Royal Society, the Natural Environment Research Council, and the Wolfson Foundation for funding that supported the development of theory. D. R. M., R. K. W., and D. W. S. thank NSF for support (separate grants to R. K. W. and D. W. S.). Thanks to T. Ezard, J.-M. Gaillard, A. Malo, A. Ozgul, S. Schindler, I. Smallegange, and four anonymous reviewers for comments on an earlier version of the manuscript. D. W. S. and D. R. S. run the Yellowstone wolf project and along with D. R. M. conducted or oversaw all data collection. B. V. conducted genotyping under the supervision of R. K. W. D. R. M. and D. R. S. compiled the data file, and along with T. C. and D. W. S. planned model structure and statistical analyses. T. C. conducted analysis and modeling. T. C. and D. R. M. wrote the paper with input from all coauthors. Functional forms and parameter values for the model on which this paper is based are available in the SOM; data, results, and the R code to run simulations are available on Dryad (http://datadryad.org, doi:10.5061/dryad.bp23483h).	Adler PB, 2010, ECOL LETT, V13, P1019, DOI 10.1111/j.1461-0248.2010.01496.x; Almberg ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007042; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Caswell H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020809; Childs DZ, 2004, P ROY SOC B-BIOL SCI, V271, P425, DOI 10.1098/rspb.2003.2597; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P1924, DOI 10.2193/2006-200; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; Miller DA, 2011, ECOLOGY, V92, P1658; Pinheiro J, 2001, MIXED EFFECTS MODELS; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; SCHMITZ OJ, 1985, CAN J ZOOL, V63, P1130, DOI 10.1139/z85-171; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x	30	150	150	0	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1275	1278		10.1126/science.1209441	http://dx.doi.org/10.1126/science.1209441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144626				2022-12-28	WOS:000297553600050
J	Duan, LM				Duan, L. -M.			Quantum Correlation Between Distant Diamonds	SCIENCE			English	Editorial Material							ATOMIC ENSEMBLES; LINEAR OPTICS; ENTANGLEMENT		[Duan, L. -M.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Duan, L. -M.] Tsinghua Univ, IIIS, Ctr Quantum Informat, Beijing 100084, Peoples R China	University of Michigan System; University of Michigan; Tsinghua University	Duan, LM (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	lmduan@umich.edu						Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Clausen C, 2011, NATURE, V469, P508, DOI 10.1038/nature09662; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256	9	2	2	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1213	1214		10.1126/science.1215444	http://dx.doi.org/10.1126/science.1215444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144605				2022-12-28	WOS:000297553600026
J	Lee, KC; Sprague, MR; Sussman, BJ; Nunn, J; Langford, NK; Jin, XM; Champion, T; Michelberger, P; Reim, KF; England, D; Jaksch, D; Walmsley, IA				Lee, K. C.; Sprague, M. R.; Sussman, B. J.; Nunn, J.; Langford, N. K.; Jin, X. -M.; Champion, T.; Michelberger, P.; Reim, K. F.; England, D.; Jaksch, D.; Walmsley, I. A.			Entangling Macroscopic Diamonds at Room Temperature	SCIENCE			English	Article							QUANTUM GROUND-STATE; ATOMIC ENSEMBLES; ENTANGLEMENT; LIGHT	Quantum entanglement in the motion of macroscopic solid bodies has implications both for quantum technologies and foundational studies of the boundary between the quantum and classical worlds. Entanglement is usually fragile in room-temperature solids, owing to strong interactions both internally and with the noisy environment. We generated motional entanglement between vibrational states of two spatially separated, millimeter-sized diamonds at room temperature. By measuring strong nonclassical correlations between Raman-scattered photons, we showed that the quantum state of the diamonds has positive concurrence with 98% probability. Our results show that entanglement can persist in the classical context of moving macroscopic solids in ambient conditions.	[Lee, K. C.; Sprague, M. R.; Nunn, J.; Langford, N. K.; Jin, X. -M.; Champion, T.; Michelberger, P.; Reim, K. F.; England, D.; Jaksch, D.; Walmsley, I. A.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Sussman, B. J.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Jin, X. -M.; Jaksch, D.] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117548, Singapore	University of Oxford; National Research Council Canada; National University of Singapore	Walmsley, IA (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	walmsley@physics.ox.ac.uk	Langford, Nathan K/A-5699-2012; Jin, Xian-Min/E-7283-2011; Jaksch, Dieter/F-1964-2010	Langford, Nathan K/0000-0003-4338-3059; Jin, Xian-Min/0000-0002-2809-7882; Walmsley, Ian/0000-0002-4714-0575	Royal Society; Engineering and Physical Sciences Research Council [GR/S82176/01]; EU IP Q-ESSENCE [248095]; EU ITN FASTQUAST; U.S. European Office of Aerospace Research and Development [093020]; Clarendon Fund; St. Edmund Hall; Natural Sciences and Engineering Research Council of Canada	Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU IP Q-ESSENCE; EU ITN FASTQUAST; U.S. European Office of Aerospace Research and Development; Clarendon Fund; St. Edmund Hall; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank V. Vedral, A. Datta, and L. Zhang for valuable insights. This work was supported by the Royal Society, Engineering and Physical Sciences Research Council (grant GR/S82176/01), EU IP Q-ESSENCE (grant 248095), EU ITN FASTQUAST, U.S. European Office of Aerospace Research and Development (grant 093020), Clarendon Fund, St. Edmund Hall, and Natural Sciences and Engineering Research Council of Canada.	Abbott B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073032; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Gerlich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1263; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Greentree AD, 2008, MATER TODAY, V11, P22, DOI 10.1016/S1369-7021(08)70176-7; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Lee KC, 2010, DIAM RELAT MATER, V19, P1289, DOI 10.1016/j.diamond.2010.06.002; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Milburn GJ, 2007, J OPT SOC AM B, V24, P167, DOI 10.1364/JOSAB.24.000167; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Penrose R., 2000, WAVEFUNCTION COLLAPS, P266; Prechtel L, 2011, NANO LETT, V11, P269, DOI 10.1021/nl1036897; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Thompson JD, 2008, NATURE, V452, P900, DOI 10.1038/nature06898; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245	24	222	223	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1253	1256		10.1126/science.1211914	http://dx.doi.org/10.1126/science.1211914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144620				2022-12-28	WOS:000297553600044
J	Thone, CC; Postigo, AD; Fryer, CL; Page, KL; Gorosabel, J; Aloy, MA; Perley, DA; Kouveliotou, C; Janka, HT; Mimica, P; Racusin, JL; Krimm, H; Cummings, J; Oates, SR; Holland, ST; Siegel, MH; De Pasquale, M; Sonbas, E; Im, M; Park, WK; Kann, DA; Guziy, S; Garcia, LH; Llorente, A; Bundy, K; Choi, C; Jeong, H; Korhonen, H; Kubanek, P; Lim, J; Moskvitin, A; Munoz-Darias, T; Pak, S; Parrish, I				Thoene, C. C.; Postigo, A. de Ugarte; Fryer, C. L.; Page, K. L.; Gorosabel, J.; Aloy, M. A.; Perley, D. A.; Kouveliotou, C.; Janka, H. T.; Mimica, P.; Racusin, J. L.; Krimm, H.; Cummings, J.; Oates, S. R.; Holland, S. T.; Siegel, M. H.; De Pasquale, M.; Sonbas, E.; Im, M.; Park, W. -K.; Kann, D. A.; Guziy, S.; Hernandez Garcia, L.; Llorente, A.; Bundy, K.; Choi, C.; Jeong, H.; Korhonen, H.; Kubanek, P.; Lim, J.; Moskvitin, A.; Munoz-Darias, T.; Pak, S.; Parrish, I.			The unusual gamma-ray burst GRB 101225A from a helium star/neutron star merger at redshift 0.33	NATURE			English	Article							SUPERNOVA; GRB-060218; GALAXY; SWIFT; HOLE	Long gamma-ray bursts (GRBs) are the most dramatic examples of massive stellar deaths, often associated with supernovae(1). They release ultra-relativistic jets, which produce non-thermal emission through synchrotron radiation as they interact with the surrounding medium(2). Here we report observations of the unusual GRB 101225A. Its gamma-ray emission was exceptionally long-lived and was followed by a bright X-ray transient with a hot thermal component and an unusual optical counterpart. During the first 10 days, the optical emission evolved as an expanding, cooling black body, after which an additional component, consistent with a faint supernova, emerged. We estimate its redshift to be z = 0.33 by fitting the spectral-energy distribution and light curve of the optical emission with a GRB-supernova template. Deep optical observations may have revealed a faint, unresolved host galaxy. Our proposed progenitor is a merger of a helium star with a neutron star that underwent a common envelope phase, expelling its hydrogen envelope. The resulting explosion created a GRB-like jet which became thermalized by interacting with the dense, previously ejected material, thus creating the observed black body, until finally the emission from the supernova dominated. An alternative explanation is a minor body falling onto a neutron star in the Galaxy(3).	[Thoene, C. C.; Gorosabel, J.; Guziy, S.; Hernandez Garcia, L.; Kubanek, P.] IAA CSIC, Granada 18008, Spain; [Thoene, C. C.] Niels Bohr Int Acad, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Postigo, A. de Ugarte] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Fryer, C. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Page, K. L.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Aloy, M. A.; Mimica, P.] Univ Valencia, Dept Astron & Astrofis, E-46100 Burjassot, Spain; [Perley, D. A.; Bundy, K.; Parrish, I.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, Sci & Technol Off, Huntsville, AL 35812 USA; [Janka, H. T.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Racusin, J. L.; Krimm, H.; Cummings, J.; Holland, S. T.; Sonbas, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Krimm, H.; Holland, S. T.; Sonbas, E.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Krimm, H.; Holland, S. T.] CRESST, Columbia, MD 21044 USA; [Oates, S. R.; De Pasquale, M.] Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Siegel, M. H.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 104, University Pk, PA 16802 USA; [Sonbas, E.] Univ Adiyaman, Dept Phys, TR-02040 Adiyaman, Turkey; [Im, M.; Park, W. -K.; Choi, C.] Seoul Natl Univ, Dept Phys & Astron, Ctr Explorat Origin Universe, Seoul, South Korea; [Kann, D. A.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Guziy, S.] Nikolaev Natl Univ, UA-54030 Nikolayev, Ukraine; [Llorente, A.] ESAC, INSA, Herschel Sci Operat Ctr, Madrid 28080, Spain; [Jeong, H.; Pak, S.] Kyung Hee Univ, Sch Space Res, Yongin 446701, Gyeonggi Do, South Korea; [Korhonen, H.] Univ Turku, Finnish Ctr Astron ESO FINCA, Piikkio 21500, Finland; [Kubanek, P.] Inst Phys, Prague 18000 8, Czech Republic; [Lim, J.] Kyung Hee Univ, Dept Astron & Space Sci, Yongin 446701, Gyeonggi Do, South Korea; [Moskvitin, A.] Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Russia; [Munoz-Darias, T.] INAF Osservatorio Astron Brera, I-23807 Merate, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Leicester; University of Valencia; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Adiyaman University; Seoul National University (SNU); V.O. Sukhomlynskyi Mykolaiv National University; European Space Agency; Kyung Hee University; University of Turku; Kyung Hee University; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Istituto Nazionale Astrofisica (INAF)	Thone, CC (corresponding author), IAA CSIC, Glorieta Astron S-N, Granada 18008, Spain.	cthoene@iaa.es	Korhonen, Heidi H./E-3065-2016; Muñoz-Darias, Teo/AAE-1950-2019; Pak, Soojong/E-2360-2013; Im, Myungshin/B-3436-2013; Guziy, Sergiy/HGC-0149-2022; De Pasquale, Massimiliano/AAC-5695-2020; Aloy, Miguel-Ángel/ABC-1245-2021; Korhonen, Heidi/AAZ-5747-2020; Bundy, Kevin/ABE-6356-2021; Kubánek, Petr/G-7209-2014; Aloy, Miguel A/K-9941-2014; Racusin, Judith L/D-2935-2012; Sonbas, Eda/AAJ-5517-2021; Thone, Christina/Q-3938-2017	Korhonen, Heidi H./0000-0003-0529-1161; Muñoz-Darias, Teo/0000-0002-3348-4035; Pak, Soojong/0000-0002-2548-238X; Im, Myungshin/0000-0002-8537-6714; Aloy, Miguel-Ángel/0000-0002-5552-7681; Korhonen, Heidi/0000-0003-0529-1161; Kubánek, Petr/0000-0002-1877-1386; Aloy, Miguel A/0000-0002-5552-7681; Siegel, Michael/0000-0003-1817-3009; Kann, David Alexander/0000-0003-2902-3583; de Ugarte Postigo, Antonio/0000-0001-7717-5085; Thone, Christina/0000-0002-7978-7648; Sonbas, Eda/0000-0002-6909-192X; Hernandez-Garcia, Lorena/0000-0002-8606-6961	DNRF; UK Space Agency; MICINN; ERC; DFG; CRI/NRF/MEST of Korea; Russian government; Science and Technology Facilities Council [ST/H00260X/1, ST/G009465/1] Funding Source: researchfish; STFC [ST/G009465/1, ST/H00260X/1] Funding Source: UKRI	DNRF; UK Space Agency; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); CRI/NRF/MEST of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Russian government; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This Letter is based on observations collected at CAHA/Calar Alto, GTC/La Palma, the Liverpool Telescope at ORM/La Palma, the McDonald Observatory at the University of Texas at Austin, and Gemini-North and Keck on Hawaii. We thank J. S. Bloom for helping with the Keck observations. The Dark Cosmology Centre is funded by the DNRF. K. L. P., S.R.O. and M.D.P. acknowledge the support of the UK Space Agency. J. G., S. G. and P. K. are partially supported by MICINN. M. A. A. and P. M. are supported by an ERC starting grant. H. T. J. acknowledges support by a DFG grant. M. I., W.-K.P., C. C., J. L. and S. P. acknowledge support from CRI/NRF/MEST of Korea. A. M. acknowledges support from the Russian government.	Barkov MV, 2011, MON NOT R ASTRON SOC, V415, P944, DOI 10.1111/j.1365-2966.2011.18762.x; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Cano Z, 2011, MON NOT R ASTRON SOC, V413, P669, DOI 10.1111/j.1365-2966.2010.18164.x; Frail D. A., 2011, 11550 GCN, V11550; Fryer CL, 1998, ASTROPHYS J, V502, pL9, DOI 10.1086/311493; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Kann DA, 2010, ASTROPHYS J, V720, P1513, DOI 10.1088/0004-637X/720/2/1513; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Mazzali PA, 2006, NATURE, V442, P1018, DOI 10.1038/nature05081; Page KL, 2011, MON NOT R ASTRON SOC, V416, P2078, DOI 10.1111/j.1365-2966.2011.19183.x; Pian E, 2006, NATURE, V442, P1011, DOI 10.1038/nature05082; Sakamoto T, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/2; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Soderberg AM, 2006, ASTROPHYS J, V636, P391, DOI 10.1086/498009; Starling RLC, 2011, MON NOT R ASTRON SOC, V411, P2792, DOI 10.1111/j.1365-2966.2010.17879.x; Wiersema K, 2008, ASTRON ASTROPHYS, V481, P319, DOI 10.1051/0004-6361:20078050; Wiersema K, 2007, ASTRON ASTROPHYS, V464, P529, DOI 10.1051/0004-6361:20066273; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; Zauderer A., 2011, 11770 GCN, V11770; Zhang B, 2004, INT J MOD PHYS A, V19, P2385, DOI 10.1142/S0217751X0401746X	21	86	86	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					72	74		10.1038/nature10611	http://dx.doi.org/10.1038/nature10611			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129726	Green Accepted, Green Submitted			2022-12-28	WOS:000298031900035
J	Wei, HQ				Wei, Haiqing			Fundamental limits of 'ankylography' due to dimensional deficiency	NATURE			English	Letter									Ambow Res Inst, Ambow Educ Grp, Beijing 100088, Peoples R China		Wei, HQ (corresponding author), Ambow Res Inst, Ambow Educ Grp, Beijing 100088, Peoples R China.	davidhwei@yahoo.com						Bhatia R, 2007, CLASS APPL MATH, V53, P1, DOI 10.1137/1.9780898719079; Gallager R. G., 1968, INFORM THEORY RELIAB; HANSEN RC, 1981, P IEEE, V69, P170, DOI 10.1109/PROC.1981.11950; LANDAU HJ, 1980, J MATH ANAL APPL, V77, P469, DOI 10.1016/0022-247X(80)90241-3; Miao J., 2009, 2 RESPONSE FEASIBILI; Miao J., 2009, RESPONSE FEASIBILITY; Miller DAB, 1998, OPT LETT, V23, P1645, DOI 10.1364/OL.23.001645; Raines KS, 2010, NATURE, V463, P214, DOI 10.1038/nature08705; Thibault P, 2010, FEASIBILITY 3D RECON; Wei H., 2010, FUNDAMENTAL LIMITS A	10	14	14	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					E1	E1		10.1038/nature10634	http://dx.doi.org/10.1038/nature10634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129732	Bronze, Green Submitted			2022-12-28	WOS:000298031900001
J	White, A; Mckee, M; Richardson, N; de Visser, R; Madsen, SA; de Sousa, BC; Hogston, R; Zatonski, W; Makara, P				White, Alan; McKee, Martin; Richardson, Noel; de Visser, Richard; Madsen, Svend Aage; de Sousa, Bruno C.; Hogston, Richard; Zatonski, Witold; Makara, Peter			Europe's men need their own health strategy	BRITISH MEDICAL JOURNAL			English	Editorial Material							HELP-SEEKING; PARTICIPATION; PROGRAMS; BEHAVIOR; BARRIERS		[White, Alan; Hogston, Richard] Leeds Metropolitan Univ, Fac Hlth & Social Sci, Inst Hlth & Wellbeing, Ctr Mens Hlth, Leeds LS2 8NU, W Yorkshire, England; [McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Richardson, Noel] Inst Technol Carlow, Ctr Mens Hlth, Carlow, Ireland; [de Visser, Richard] Univ Sussex, Sch Psychol, Falmer, England; [Madsen, Svend Aage] Rigshosp, Copenhagen Univ Hosp, Dept Psychol, DK-2100 Copenhagen, Denmark; [de Sousa, Bruno C.] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Doencas Trop, P-1200 Lisbon, Portugal; [Zatonski, Witold] Ctr Canc, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Zatonski, Witold] Inst Oncol, Warsaw, Poland; [Makara, Peter] Semmelweiss Univ, Inst Publ Hlth, Budapest, Hungary	Leeds Beckett University; University of London; London School of Hygiene & Tropical Medicine; South East Technological University (SETU); University of Sussex; Rigshospitalet; University of Copenhagen; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Maria Sklodowska-Curie National Research Institute of Oncology; Semmelweis University	White, A (corresponding author), Leeds Metropolitan Univ, Fac Hlth & Social Sci, Inst Hlth & Wellbeing, Ctr Mens Hlth, Leeds LS2 8NU, W Yorkshire, England.	a.white@leedsmet.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Richardson, Noel/Q-2943-2016; de Sousa, Bruno/A-1654-2012; de Sousa, Bruno/S-2600-2019	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Richardson, Noel/0000-0002-2060-2338; de Sousa, Bruno/0000-0001-9918-8100; de Visser, Richard/0000-0003-1174-1499; White, Alan/0000-0001-8054-7783				Andreev EM, 2003, B WORLD HEALTH ORGAN, V81, P778; Bates LM, 2009, SOC SCI MED, V69, P1002, DOI 10.1016/j.socscimed.2009.07.021; *COMM WORK UN, BT WORKF, pD6063; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; *DAN NAT BOARD HLT, 2010, MAENDS SUNDH OV OV S, pD6063; De Visser RO, 2007, PSYCHOL HEALTH, V22, P595, DOI 10.1080/14768320600941772; De Visser RO, 2009, J HEALTH PSYCHOL, V14, P1047, DOI 10.1177/1359105309342299; Department of Health, 2011, IMPR OUTC STRAT CANC; Department of Health and Children, 2008, NAT MENS HLTH POL WO; Douglas FAM, 2008, EVALUATION WELL MEN; European Commision, 2011, STAT MENS HLTH EUR R; European Commission, 2011, STAT MENS HLTH EUR E; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gough B, 2006, SOC SCI MED, V62, P387, DOI 10.1016/j.socscimed.2005.05.032; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; Hammarstrom A, 2002, J EPIDEMIOL COMMUN H, V56, P624, DOI 10.1136/jech.56.8.624; Leishman J, 2003, MENS HLTH J, V2; LLOYD T, 2001, BOYS YOUNG MENS HLTH; Lohan M, 2007, SOC SCI MED, V65, P493, DOI 10.1016/j.socscimed.2007.04.020; Marcell AV, 2007, PEDIATRICS, V119, pE966, DOI 10.1542/peds.2006-1683; MARSDEN D, 2008, VALUE RUDE HLTH REPO, pD6063; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Meryn S, 2001, BMJ-BRIT MED J, V323, P1013, DOI 10.1136/bmj.323.7320.1013; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Ormsby J, 2010, HEALTH SOC CARE COMM, V18, P607, DOI 10.1111/j.1365-2524.2010.00932.x; Pringle A, 2011, PUBLIC HEALTH, V125, P411, DOI 10.1016/j.puhe.2011.04.013; Richardson N, 2011, PUBLIC HEALTH, V125, P424, DOI 10.1016/j.puhe.2011.04.015; Robertson LM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-141; Robroek SJW, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-26; Settersten RA, 2010, RES HUM DEV, V7, P83, DOI 10.1080/15427609.2010.481520; Virtanen P, 2002, J EPIDEMIOL COMMUN H, V56, P569, DOI 10.1136/jech.56.8.569; White A, 2011, PUBLIC HEALTH, V125, P407, DOI 10.1016/j.puhe.2011.04.012; White A, 2011, J MENS HEALTH, V8, P192, DOI 10.1016/j.jomh.2011.08.113; WHO, 2011, HLTH ALL DAT; Wilkinson RG, 2003, SOCIAL DETERMINANTS; World Health Organization, 2007, FATH HLTH OUTC EUR; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	37	40	40	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2011	343								d7397	10.1136/bmj.d7397	http://dx.doi.org/10.1136/bmj.d7397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RP	22127516	Green Accepted			2022-12-28	WOS:000298037200010
J	Lawrence, DJ; Eke, VR; Elphic, RC; Feldman, WC; Funsten, HO; Prettyman, TH; Teodoro, LFA				Lawrence, David J.; Eke, Vincent R.; Elphic, Richard C.; Feldman, William C.; Funsten, Herbert O.; Prettyman, Thomas H.; Teodoro, Luis F. A.			Technical Comment on "Hydrogen Mapping of the Lunar South Pole Using the LRO Neutron Detector Experiment LEND"	SCIENCE			English	Editorial Material									[Lawrence, David J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Eke, Vincent R.] Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; [Teodoro, Luis F. A.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Feldman, William C.; Prettyman, Thomas H.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Funsten, Herbert O.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Durham University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Los Alamos National Laboratory	Lawrence, DJ (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	david.j.lawrence@jhuapl.edu	Lawrence, David J/E-7463-2015; Funsten, Herbert O/A-5702-2015	Lawrence, David J/0000-0002-7696-6667; Funsten, Herbert O/0000-0002-6817-1039; Eke, Vincent/0000-0001-5416-8675; Prettyman, Thomas/0000-0003-0072-2831				Gasnault O, 2001, GEOPHYS RES LETT, V28, P3797, DOI 10.1029/2001GL013072; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2010, ASTROBIOLOGY, V10, P183, DOI 10.1089/ast.2009.0401; Lawrence DJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002050; Maurice S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002208; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; Mitrofanov IG, 2010, SPACE SCI REV, V150, P183, DOI 10.1007/s11214-009-9608-4; National Nuclear Data Center, EV NUCL DAT FIL ENDF; Pelowitz D.B., 2008, LACP071473 LOS AL NA	9	22	22	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059								10.1126/science.1203341	http://dx.doi.org/10.1126/science.1203341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116865				2022-12-28	WOS:000297313900027
J	Sheeran, J				Sheeran, Josette			Preventing hunger: Sustainability not aid	NATURE			English	Editorial Material									United Nations World Food Programme, I-00148 Rome, Italy		Sheeran, J (corresponding author), United Nations World Food Programme, I-00148 Rome, Italy.	wfpinfo@wfp.org							0	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					469	470		10.1038/479469a	http://dx.doi.org/10.1038/479469a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	851QI	22113674	Bronze			2022-12-28	WOS:000297285600025
J	Johnson, S				Johnson, Sonia			Has the closure of psychiatric beds gone too far? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; MENTAL-ILLNESS; SCHIZOPHRENIA; PEOPLE; PSYCHOSIS; CRISIS; RATES; CARE; UK		[Johnson, Sonia] UCL, London, England; [Johnson, Sonia] Camden & Islington NHS Fdn Trust, London, England	University of London; University College London	Johnson, S (corresponding author), UCL, London, England.	s.johnson@ucl.ac.uk	Johnson, Sonia/A-5220-2008; Johnson, Sonia/ABF-1457-2020	Johnson, Sonia/0000-0002-2219-1384; Johnson, Sonia/0000-0002-2219-1384				[Anonymous], EUR HLTH ALL DAT; Appleby L, 2011, NATL CONFIDENTIAL IN; Berry K, 2008, PSYCHOL PSYCHOTHER-T, V81, P419, DOI 10.1348/147608308X329540; Bowers L, 2009, J MENT HEALTH, V18, P316, DOI 10.1080/09638230802053359; Carra G, 2009, SOC PSYCH PSYCH EPID, V44, P429, DOI 10.1007/s00127-008-0458-2; Gafoor R, 2010, BRIT J PSYCHIAT, V196, P372, DOI 10.1192/bjp.bp.109.066050; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; Holloway F, 2011, OXFORD TXB COMMUNITY, P167; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Johnson S, 2010, BRIT J PSYCHIAT, V197, pS52, DOI 10.1192/bjp.bp.110.081125; Kallert TW, 2007, J CLIN PSYCHIAT, V68, P278, DOI 10.4088/JCP.v68n0214; Leff J, 2001, BRIT J PSYCHIAT, V179, P381, DOI 10.1192/bjp.179.5.381; Marwaha S, 2007, BRIT J PSYCHIAT, V191, P30, DOI 10.1192/bjp.bp.105.020982; Mueser KT, 2011, OXFORD TXB COMMUNITY, P211; National Audit Office, 2007, HELP PEOPL MENT HLTH; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Slade M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-26; Thornicroft G, 2004, SCHIZOPHR RES, V69, P125, DOI 10.1016/S0920-9964(03)00191-9; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Tulloch AD, 2011, SOC PSYCHIAT PS 0714	21	7	7	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 22	2011	343								d7410	10.1136/bmj.d7410	http://dx.doi.org/10.1136/bmj.d7410			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857ND	22110254	Green Submitted			2022-12-28	WOS:000297724300004
J	Kashuba, ADM; Patterson, KB; Dumond, JB; Cohen, MS				Kashuba, Angela D. M.; Patterson, Kristine B.; Dumond, Julie B.; Cohen, Myron S.			Pre-exposure prophylaxis for HIV prevention: how to predict success	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; ADHERENCE; MARAVIROC; TISSUE		[Kashuba, Angela D. M.; Dumond, Julie B.] Univ N Carolina, UNC Ctr AIDS Res Clin Pharmacol & Analyt Chem Cor, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Patterson, Kristine B.; Cohen, Myron S.] Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kashuba, ADM (corresponding author), Univ N Carolina, UNC Ctr AIDS Res Clin Pharmacol & Analyt Chem Cor, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	akashuba@unc.edu			NIAID NIH HHS [U01 AI095031, P30 AI050410] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095031, P30AI050410] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baeton J., 2011, 6 IAS C JUL 17 20 RO; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Brown KC, 2011, J INFECT DIS, V203, P1484, DOI 10.1093/infdis/jir059; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dumond JB, 2009, JAIDS-J ACQ IMM DEF, V51, P546, DOI 10.1097/QAI.0b013e3181ae69c5; FEMem-PrEP Project, FHI360 FEMEM PREP PR; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V43, pS104, DOI 10.1097/01.qai.0000245888.97003.a3; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Thigpen M., 2011, 6 IAS C JUL 17 20 RO	14	51	52	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2409	2411		10.1016/S0140-6736(11)61852-7	http://dx.doi.org/10.1016/S0140-6736(11)61852-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22153566	Green Accepted			2022-12-28	WOS:000305915900007
J	Wood, AJJ; Drazen, JM; Greene, MF				Wood, Alastair J. J.; Drazen, Jeffrey M.; Greene, Michael F.			The Politics of Emergency Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wood, Alastair J. J.] Symphony Capital, New York, NY USA		Wood, AJJ (corresponding author), Symphony Capital, New York, NY USA.		Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Department of Health and Human Services, 2011, COMMUNICATION   1207; Food and Drug Administration, 2011, COMMUNICATION   1207; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wood AJJ, 2005, NEW ENGL J MED, V353, P1197, DOI 10.1056/NEJMp058222	4	15	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					101	102		10.1056/NEJMp1114439	http://dx.doi.org/10.1056/NEJMp1114439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874VA	22168588				2022-12-28	WOS:000298985000001
J	Berglund, J				Berglund, Jennifer			ORTHOPAEDICS Structural support	NATURE			English	Editorial Material																		Berenson J, 2011, LANCET ONCOL, V12, P225, DOI 10.1016/S1470-2045(11)70008-0; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Francis M. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P2	3	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S56	S57		10.1038/480S56a	http://dx.doi.org/10.1038/480S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169807				2022-12-28	WOS:000298033000013
J	RajBhandary, UL				RajBhandary, Uttam L.			Har Gobind Khorana (1922-2011) OBITUARY	NATURE			English	Biographical-Item									MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	RajBhandary, UL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bhandary@mit.edu						KHORANA HG, PUBLICATION LIST	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					322	322		10.1038/480322a	http://dx.doi.org/10.1038/480322a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170673	Bronze			2022-12-28	WOS:000298033000037
J	Benson, O				Benson, Oliver			Assembly of hybrid photonic architectures from nanophotonic constituents	NATURE			English	Review							ATOMIC-FORCE MICROSCOPE; CONTROLLED QUANTUM DOTS; CRYSTAL NANOCAVITY; OPTICAL PLASMONS; SINGLE PHOTONS; EMITTING DIODE; DIAMOND; CAVITY; SURFACE; MANIPULATION	The assembly of hybrid nanophotonic devices from different fundamental photonic entities-such as single molecules, nanocrystals, semiconductor quantum dots, nanowires and metal nanoparticles-can yield functionalities that exceed those of the individual subunits. Combining these photonic elements requires nanometre-scale fabrication precision and potentially involves a material diversity that is incompatible with standard nanotechnological processes. Although merging these different systems on a single hybrid platform is at present challenging, it promises improved performance and novel devices. Particularly rapid progress is seen in the combination of plasmonic-dielectric constituents with quantum emitters that can be assembled on demand into fundamental model systems for future optical elements.	Humboldt Univ, D-12489 Berlin, Germany	Humboldt University of Berlin	Benson, O (corresponding author), Humboldt Univ, Newtonstr 15, D-12489 Berlin, Germany.	oliver.benson@physik.hu-berlin.de	Benson, Oliver/C-1953-2012		Deutsche Forschungsgemeinschaft [BE2224/9, Sfb 951]; Bundesministerium fur Bildung und Forschung (KEPHOSI)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (KEPHOSI)(Federal Ministry of Education & Research (BMBF))	I acknowledge financial supported by the Deutsche Forschungsgemeinschaft (BE2224/9, Sfb 951) and the Bundesministerium fur Bildung und Forschung (KEPHOSI).	Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Ampem-Lassen E, 2009, OPT EXPRESS, V17, P11287, DOI 10.1364/OE.17.011287; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Arcizet O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133601; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Barclay PE, 2009, OPT EXPRESS, V17, P8081, DOI 10.1364/OE.17.008081; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Barth M, 2010, NANO LETT, V10, P891, DOI 10.1021/nl903555u; Bennett AJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1921332; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Bozhevolnyi S, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/105001; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chang DE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.053002; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Chen J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133603; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; DECHER G, 2003, MULTILAYER THIN FILM; Dietl T, 2008, SEMICONDUCT SEMIMET, V82, P371, DOI 10.1016/S0080-8784(08)00009-4; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Englund D, 2007, OPT EXPRESS, V15, P5550, DOI 10.1364/OE.15.005550; Englund D, 2010, NANO LETT, V10, P3922, DOI 10.1021/nl101662v; Erb RM, 2009, NATURE, V457, P999, DOI 10.1038/nature07766; Falk AL, 2009, NAT PHYS, V5, P475, DOI 10.1038/NPHYS1284; Fan HJ, 2006, SMALL, V2, P700, DOI 10.1002/smll.200500495; Faraon A, 2008, OPT EXPRESS, V16, P12154, DOI 10.1364/OE.16.012154; Faraon A, 2008, NAT PHYS, V4, P859, DOI 10.1038/nphys1078; Folman R, 2002, ADV ATOM MOL OPT PHY, V48, P263; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; GRANGIER P, 2004, N J PHYS, V6; Harel E, 2005, NANO LETT, V5, P2624, DOI 10.1021/nl0342592; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hennessy K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1992656; Hofmann HF, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024308; Hsieh SC, 2002, J PHYS CHEM B, V106, P231, DOI 10.1021/jp012747x; Huang TJ, 2008, MRS BULL, V33, P226, DOI 10.1557/mrs2008.48; Hwang J, 2009, NATURE, V460, P76, DOI 10.1038/nature08134; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Jelezko F, 2006, PHYS STATUS SOLIDI A, V203, P3207, DOI 10.1002/pssa.200671403; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Jonas U, 2002, P NATL ACAD SCI USA, V99, P5034, DOI 10.1073/pnas.082634799; JUNNO T, 1995, APPL PHYS LETT, V66, P3627, DOI 10.1063/1.113809; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Klein DL, 1997, NATURE, V389, P699, DOI 10.1038/39535; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Koller DM, 2008, NAT PHOTONICS, V2, P684, DOI 10.1038/nphoton.2008.200; Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; Laux E, 2008, NAT PHOTONICS, V2, P161, DOI 10.1038/nphoton.2008.1; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Lippitz M, 2005, NANO LETT, V5, P799, DOI 10.1021/nl0502571; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; MEIJER J, 2008, PHYS, V91, P567; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Moerland RJ, 2008, NANO LETT, V8, P606, DOI 10.1021/nl073026y; Mohan A, 2010, NAT PHOTONICS, V4, P302, DOI 10.1038/NPHOTON.2010.2; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Park HG, 2008, NAT PHOTONICS, V2, P622, DOI 10.1038/nphoton.2008.180; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; POTHIER H, 1991, PHYSICA B, V169, P573, DOI 10.1016/0921-4526(91)90332-9; PR Berman, 1993, CAVITY QUANTUM ELECT; Prasad P. N., 2004, NANOPHOTONICS; Prawer S, 2008, SCIENCE, V320, P1601, DOI 10.1126/science.1158340; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; PURCELL EM, 1946, PHYS REV, V69, P681; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Rivoire K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232233; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Sangu S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115334; Schietinger S, 2009, NANO LETT, V9, P1694, DOI 10.1021/nl900384c; Schroder T, 2011, NANO LETT, V11, P198, DOI 10.1021/nl103434r; Shen Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033201; Sirbuly DJ, 2005, P NATL ACAD SCI USA, V102, P7800, DOI 10.1073/pnas.0408641102; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Song BS, 2003, SCIENCE, V300, P1537, DOI 10.1126/science.1083066; Sonnefraud Y, 2008, OPT LETT, V33, P611, DOI 10.1364/OL.33.000611; Sunner T, 2008, OPT LETT, V33, P1759, DOI 10.1364/OL.33.001759; Thelander C, 2002, NANOTECHNOLOGY, V13, P108, DOI 10.1088/0957-4484/13/1/323; Tong L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2822418; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; van der Sar T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3571437; van der Sar T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120558; Vasa P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.116801; Waks E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.153601; Wang CF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2813023; Wang Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2714287; Wolters J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499300; Yan RX, 2009, P NATL ACAD SCI USA, V106, P21045, DOI 10.1073/pnas.0902064106; Yan RX, 2009, NAT PHOTONICS, V3, P569, DOI 10.1038/NPHOTON.2009.184; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; You CC, 2006, SOFT MATTER, V2, P190, DOI 10.1039/b517354j	98	288	295	4	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					193	199		10.1038/nature10610	http://dx.doi.org/10.1038/nature10610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158243				2022-12-28	WOS:000297744200042
J	Gross, C; Strobel, H; Nicklas, E; Zibold, T; Bar-Gill, N; Kurizki, G; Oberthaler, MK				Gross, C.; Strobel, H.; Nicklas, E.; Zibold, T.; Bar-Gill, N.; Kurizki, G.; Oberthaler, M. K.			Atomic homodyne detection of continuous-variable entangled twin-atom states	NATURE			English	Article							PODOLSKY-ROSEN PARADOX; QUANTUM; TELEPORTATION; BEAMS; LIMIT	Historically, the completeness of quantum theory has been questioned using the concept of bipartite continuous-variable entanglement(1). The non-classical correlations (entanglement) between the two subsystems imply that the observables of one subsystem are determined by the measurement choice on the other, regardless of the distance between the subsystems. Nowadays, continuous-variable entanglement is regarded as an essential resource, allowing for quantum enhanced measurement resolution(2), the realization of quantum teleportation(3-5) and quantum memories(3,6), or the demonstration of the Einstein-Podolsky-Rosen paradox(1,7-9). These applications rely on techniques to manipulate and detect coherences of quantum fields, the quadratures. Whereas in optics coherent homodyne detection(10) of quadratures is a standard technique, for massive particles a corresponding method was missing. Here we report the realization of an atomic analogue to homodyne detection for the measurement of matter-wave quadratures. The application of this technique to a quantum state produced by spin-changing collisions in a Bose-Einstein condensate(11,12) reveals continuous-variable entanglement, as well as the twin-atom character of the state(13). Our results provide a rare example of continuous-variable entanglement of massive particles(6,14). The direct detection of atomic quadratures has applications not only in experimental quantum atom optics, but also for the measurement of fields in many-body systems of massive particles(15).	[Gross, C.; Strobel, H.; Nicklas, E.; Zibold, T.; Oberthaler, M. K.] Univ Heidelberg, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany; [Bar-Gill, N.; Kurizki, G.] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Ruprecht Karls University Heidelberg; Weizmann Institute of Science	Oberthaler, MK (corresponding author), Univ Heidelberg, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	homodyning@matterwave.de	Gross, Christian/P-5475-2014	Gross, Christian/0000-0003-2292-5234; Zibold, Tilman/0000-0003-0266-6650	Deutsche Forschungsgemeinschaft; German-Israeli Foundation; Heidelberg Center for Quantum Dynamics; Landesstiftung Baden-Wurttemberg; ExtreMe Matter Institute; European Commission; Humboldt-Meitner Award; Deutsche-Israelische Projektgruppe (DIP);  [Forschergruppe FOR760]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Heidelberg Center for Quantum Dynamics; Landesstiftung Baden-Wurttemberg; ExtreMe Matter Institute; European Commission(European CommissionEuropean Commission Joint Research Centre); Humboldt-Meitner Award; Deutsche-Israelische Projektgruppe (DIP); 	We acknowledge discussions with P. Grangier, A. Aspect, A. J. Ferris, M. J. Davis and B. C. Sanders. This work was supported by the Forschergruppe FOR760, the Deutsche Forschungsgemeinschaft, the German-Israeli Foundation, the Heidelberg Center for Quantum Dynamics, Landesstiftung Baden-Wurttemberg, the ExtreMe Matter Institute and the European Commission Future and Emerging Technologies Open Scheme project MIDAS (Macroscopic Interference Devices for Atomic and Solid-State Systems). G. K. acknowledges support from the Humboldt-Meitner Award and the Deutsche-Israelische Projektgruppe (DIP).	Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; BOOKJANS EM, 2011, STRONG QUANTUM SPIN; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Bucker R, 2011, NAT PHYS, V7, P608, DOI [10.1038/NPHYS1992, 10.1038/nphys1992]; CAVES CM, 1985, PHYS REV A, V31, P3068, DOI 10.1103/PhysRevA.31.3068; Chang MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.140403; DIENER RB, 2006, QUANTUM SPIN DYNAMIC; Duan LM, 2000, PHYS REV LETT, V85, P3991, DOI 10.1103/PhysRevLett.85.3991; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ferris AJ, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.060104; Gerbier F, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041602; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Jaskula JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190402; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Klempt C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195303; Kronjager J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110404; Law CK, 1998, PHYS REV LETT, V81, P5257, DOI 10.1103/PhysRevLett.81.5257; Leslie SR, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043631; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Opatrny T, 2001, PHYS REV LETT, V86, P3180, DOI 10.1103/PhysRevLett.86.3180; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Pu H, 2000, PHYS REV LETT, V85, P3987, DOI 10.1103/PhysRevLett.85.3987; Raymer MG, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052104; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Schmaljohann H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040402; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8	30	154	154	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					219	223		10.1038/nature10654	http://dx.doi.org/10.1038/nature10654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22139418	Green Submitted			2022-12-28	WOS:000297744200046
J	Reuter, M; Berninger, P; Chuma, S; Shah, H; Hosokawa, M; Funaya, C; Antony, C; Sachidanandam, R; Pillai, RS				Reuter, Michael; Berninger, Philipp; Chuma, Shinichiro; Shah, Hardik; Hosokawa, Mihoko; Funaya, Charlotta; Antony, Claude; Sachidanandam, Ravi; Pillai, Ramesh S.			Miwi catalysis is required for piRNA amplification-independent LINE1 transposon silencing	NATURE			English	Article							PIWI-INTERACTING RNAS; MALE GERM-CELLS; DNA METHYLATION; CHROMATOID BODIES; FAMILY-MEMBERS; PATHWAY; PROTEIN; MICE; GENE; SPERMATOGENESIS	Repetitive-element-derived Piwi-interacting RNAs (piRNAs)(1,2) act together with Piwi proteins Mili (also known as Piwil2) and Miwi2 (also known as Piwil4) in a genome defence mechanism that initiates transposon silencing via DNA methylation in the mouse male embryonic germ line. This silencing depends on the participation of the Piwi proteins in a slicer-dependent piRNA amplification pathway and is essential for male fertility(3,4). A third Piwi family member, Miwi (also known as Piwil1), is expressed in specific postnatal germ cells and associates with a unique set of piRNAs of unknown function(5-7). Here we show that Miwi is a small RNA-guided RNase (slicer) that requires extensive complementarity for target cleavage in vitro. Disruption of its catalytic activity in mice by a single point mutation causes male infertility, and mutant germ cells show increased accumulation of LINE1 retrotransposon transcripts. We provide evidence for Miwi slicer activity directly cleaving transposon messenger RNAs, offering an explanation for the continued maintenance of repeat-derived piRNAs long after transposon silencing is established in germline stem cells. Furthermore, our study supports a slicer-dependent silencing mechanism that functions without piRNA amplification. Thus, Piwi proteins seem to act in a two-pronged mammalian transposon silencing strategy: one promotes transcriptional repression in the embryo, the other reinforces silencing at the post-transcriptional level after birth.	[Reuter, Michael; Berninger, Philipp; Pillai, Ramesh S.] European Mol Biol Lab, F-38042 Grenoble, France; [Reuter, Michael; Berninger, Philipp; Pillai, Ramesh S.] CNRS, UJF, EMBL Int Unit, UMI Virus Host Cell Interact UVHCI 3265, F-38042 Grenoble, France; [Chuma, Shinichiro; Hosokawa, Mihoko] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Chuma, Shinichiro; Hosokawa, Mihoko] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068501, Japan; [Shah, Hardik; Sachidanandam, Ravi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Antony, Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Kyoto University; Kyoto University; Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL)	Pillai, RS (corresponding author), European Mol Biol Lab, 6 Rue Jules Horowitz,BP 181, F-38042 Grenoble, France.	pillai@embl.fr	sachidanandam, ravi/Q-6916-2019; antony, claude/K-5342-2013	sachidanandam, ravi/0000-0001-9844-4459; Fredriksson Funaya, Charlotta/0000-0003-1375-1287	Deutsche Forschungsgemeinschaft (DFG); Agence National de la Recherche (ANR) (piRmachines); European Union (European Research Council, ERC); EMBL	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence National de la Recherche (ANR) (piRmachines)(French National Research Agency (ANR)); European Union (European Research Council, ERC)(European Research Council (ERC)); EMBL	We thank S. Cusack for initial support for the project and discussions. We thank D. O'Carroll and S. Khochbin for help with mouse experiments; J. Xiol and N. Nakatsuji for helpful discussions; D. O'Carroll, S. Martin, S. Kistler and R. Balhorn for antibodies. We thank the Mouse Biology Unit, European Molecular Biology Laboratory (EMBL) Monterotondo and EMBL facilities (Gene, Proteomics, Protein Expression and Purification). This work was supported by a Deutsche Forschungsgemeinschaft (DFG) postdoctoral fellowship to M. R. and grants to R. S. P. from Agence National de la Recherche (ANR) (piRmachines) and the European Union (European Research Council, ERC Starting Grant, pisilence). The R. S. P. laboratory is supported by the EMBL.	Ahmed EA, 2007, DNA REPAIR, V6, P1243, DOI 10.1016/j.dnarep.2007.02.011; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Berninger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-46; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Caron C, 2005, PROG MOLEC, V38, P65; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; HEIDARAN MA, 1988, J CELL BIOL, V106, P1427, DOI 10.1083/jcb.106.5.1427; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Olson A J, 2008, Pac Symp Biocomput, P126; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; STANKER LH, 1987, HYBRIDOMA, V6, P293, DOI 10.1089/hyb.1987.6.293; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514	47	274	285	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					264	U154		10.1038/nature10672	http://dx.doi.org/10.1038/nature10672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22121019				2022-12-28	WOS:000297744200056
J	Templeton, A; Grimes, DA				Templeton, Allan; Grimes, David A.			A Request for Abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL VACUUM ASPIRATION; EARLY MEDICAL ABORTION; BREAST-CANCER; 1ST-TRIMESTER ABORTION; MIFEPRISTONE; MISOPROSTOL; ACCEPTABILITY; TRIAL; RATES; RISK	A 22-year-old student presents to her primary care physician with an unintended pregnancy at 9 weeks of gestation and requests an abortion. She is aware of both medical (drug-induced) and surgical methods of terminating a pregnancy and wants to know which approach would be recommended. She also asks whether either method will affect her future reproductive health. What would you advise?	[Templeton, Allan] Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland; [Grimes, David A.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of Aberdeen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Templeton, A (corresponding author), Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland.	allan.templeton@abdn.ac.uk			Nordic Pharma UK; World Health Organization	Nordic Pharma UK; World Health Organization(World Health Organization)	Dr. Templeton reports receiving travel fees from Nordic Pharma UK. Dr. Grimes reports being an unpaid plaintiff in a challenge to the new North Carolina abortion law (Stuart et al. v. Huff et al.), serving as a paid expert witness in malpractice cases regarding abortion practice, receiving royalties from John Wiley & Sons as an editor of the National Abortion Federation textbook on abortion, and receiving per diem and travel fees from the World Health Organization for a meeting on the guidelines for the safe practice of abortion. No other potential conflict of interest relevant to this article was reported.	Achilles Sharon L, 2011, Contraception, V83, P295, DOI 10.1016/j.contraception.2010.11.006; American Psychological Association. Task force on mental health and abortion, 2008, REP TASK FORC MENT H; [Anonymous], 2010, AB STAT YEAR END DEC; [Anonymous], SAF AB TECH IN PRESS; Ashok PW, 2002, BJOG-INT J OBSTET GY, V109, P1281, DOI 10.1016/S1470-0328(02)02956-7; Ashok PW, 2002, HUM REPROD, V17, P92, DOI 10.1093/humrep/17.1.92; Baird DT, 2002, BEST PRACT RES CL OB, V16, P221, DOI 10.1053/beog.2001.0272; Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2; Bruce FC, 2008, OBSTET GYNECOL, V111, P1089, DOI 10.1097/AOG.0b013e31816c441a; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Clark WH, 2005, EUR J CONTRACEP REPR, V10, P184, DOI 10.1080/13625180500284581; Coles MS, 2010, J ADOLESCENT HEALTH, V47, P160, DOI 10.1016/j.jadohealth.2010.01.003; Creinin MD, 2000, CONTRACEPTION, V62, P117, DOI 10.1016/S0010-7824(00)00151-7; Department of Health, 2011, AB STAT ENGL WAL 201; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; Fjerstad M, 2009, NEW ENGL J MED, V361, P145, DOI 10.1056/NEJMoa0809146; Goodman S, 2008, CONTRACEPTION, V78, P136, DOI 10.1016/j.contraception.2008.03.008; Grimes D, 2003, COCHRANE DB SYST REV, V1, pCD003036; GRIMES DA, 1984, JAMA-J AM MED ASSOC, V251, P2108, DOI 10.1001/jama.251.16.2108; GRIMES DA, 1979, AM J OBSTET GYNECOL, V135, P1030, DOI 10.1016/0002-9378(79)90731-2; Hamoda H, 2005, BJOG-INT J OBSTET GY, V112, P1102, DOI 10.1111/j.1471-0528.2005.00638.x; Heikinheimo O, 2008, CONTRACEPTION, V78, P149, DOI 10.1016/j.contraception.2008.03.013; HENSHAW RC, 1993, BRIT MED J, V307, P714, DOI 10.1136/bmj.307.6906.714; Howie FL, 1997, BRIT J OBSTET GYNAEC, V104, P829, DOI 10.1111/j.1471-0528.1997.tb12028.x; Jones RK, 2011, OBSTET GYNECOL, V117, P1358, DOI 10.1097/AOG.0b013e31821c405e; Kapp N, 2010, COCHRANE DB SYST REV, V2; Kulier R, 2011, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002855.PUB3; Kulier R, 2011, CONTRACEPTION, V83, P30, DOI 10.1016/j.contraception.2010.06.014; Lang EV, 2000, LANCET, V355, P1486, DOI 10.1016/S0140-6736(00)02162-0; Luk J, 2007, CONTRACEPTION, V76, P331, DOI 10.1016/j.contraception.2007.06.001; Michels KB, 2007, ARCH INTERN MED, V167, P814, DOI 10.1001/archinte.167.8.814; Middleton T, 2005, CONTRACEPTION, V72, P328, DOI 10.1016/j.contraception.2005.05.017; Munk-Olsen T, 2011, NEW ENGL J MED, V364, P332, DOI 10.1056/NEJMoa0905882; National Abortion Federation, 2011, 2011 CLIN POL GUID; National Collaborating Centre for Mental Health, 2011, IND AB MENT HLTH SYS; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Niinimaki M, 2009, OBSTET GYNECOL, V114, P795, DOI 10.1097/AOG.0b013e3181b5ccf9; Penney GC, 1998, BRIT J OBSTET GYNAEC, V105, P599, DOI 10.1111/j.1471-0528.1998.tb10173.x; RCOG, 2010, TERM PREGN FET ABN E; Reeves GK, 2006, INT J CANCER, V119, P1741, DOI 10.1002/ijc.22001; Renner RM, 2009, COCHRANE DB SYST REV, V2; Roberts H, 2010, CONTRACEPTION, V82, P260, DOI 10.1016/j.contraception.2010.03.003; Robson SC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13530; Royal College of obstetricians and gynaecologists, 2011, CAR WOM REQ IND AB E; Sawaya GF, 1996, OBSTET GYNECOL, V87, P884; Say L, 2005, COCHRANE DB SYST REV, V1; von Hertzen H, 2010, BJOG-INT J OBSTET GY, V117, P1186, DOI 10.1111/j.1471-0528.2010.02636.x; Wen J, 2008, BJOG-INT J OBSTET GY, V115, P5, DOI 10.1111/j.1471-0528.2007.01572.x; Wu YM, 2000, BRIT J OBSTET GYNAEC, V107, P524	50	20	25	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2198	2204		10.1056/NEJMcp1103639	http://dx.doi.org/10.1056/NEJMcp1103639			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150038				2022-12-28	WOS:000297731400005
J	Hendrick, R				Hendrick, Rachel			REPORTING OF RESEARCH Ghosts in the machine	BRITISH MEDICAL JOURNAL			English	Editorial Material							GOOD PUBLICATION PRACTICE; GUIDELINES		[Hendrick, Rachel] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Hendrick, Rachel] BMJ, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hendrick, R (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	rachelhendrick@gmail.com		Hendrick, Rachel/0000-0001-6894-1040				*AM MED WRIT ASS, CAN I LEARN SKILLS N, pD185; Applbaum K., 2004, MARKETING ERA PROFES; *DESIGNWRITE, 1997, PREMARIN PUBL PROGR, pD185; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; *ISMPP, ISMPP COD ETH, pD185; Jacobs A, 2005, CURR MED RES OPIN, V21, P317, DOI 10.1185/030079905X25578; Jacobs A, 2009, WRITE STUFF, V18, P118; Krimsky S., 2004, SCI PRIVATE INTEREST; Rasmussen N, 2005, B HIST MED, V79, P50, DOI 10.1353/bhm.2005.0036; Sismondo S, 2010, BIOETHICS, V24, P273, DOI 10.1111/j.1467-8519.2008.01702.x; *SMITHKLINE BEECH, PAR00057054659 SMITH, pD185; Tierney WM, 2005, J GEN INTERN MED, V20, P550, DOI 10.1111/j.1525-1497.2005.41008.x; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767	14	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2011	343								d7860	10.1136/bmj.d7860	http://dx.doi.org/10.1136/bmj.d7860			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SM	22146647				2022-12-28	WOS:000298039500006
J	Nguyen, USDT; Zhang, YQ; Zhu, YY; Niu, JB; Zhang, B; Felson, DT				Nguyen, Uyen-Sa D. T.; Zhang, Yuqing; Zhu, Yanyan; Niu, Jingbo; Zhang, Bin; Felson, David T.			Increasing Prevalence of Knee Pain and Symptomatic Knee Osteoarthritis: Survey and Cohort Data	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; FRAMINGHAM OSTEOARTHRITIS; REPLACEMENT; BURDEN; TRENDS; HIP; US; DISABILITY; OBESITY; ADULTS	Background: A recent surge in knee replacements is assumed to be due to aging and increased obesity of the U.S. population. Objective: To assess whether age, obesity, and change in radiographic knee osteoarthritis explain the trend in knee pain and osteoarthritis. Design: Cross-sectional, using data from 6 NHANES (National Health and Nutrition Examination Survey) surveys between 1971 and 2004 and from 3 examination periods in the FOA (Framingham Osteoarthritis) Study between 1983 through 2005. Setting: U.S. population. Participants: NHANES participants (white or African American; aged 60 to 74 years) and FOA Study participants (mostly white; aged >= 70 years) were included. Measurements: NHANES participants were asked about pain in or around the knee on most days. In the FOA Study, participants were asked about knee pain and had bilateral weight-bearing anteroposterior knee radiography to define radiographic knee osteoarthritis. Radiographic evidence and self-reported pain were used to define symptomatic knee osteoarthritis. The age- and age- and body mass index (BMI)-adjusted prevalences of knee pain and osteoarthritis at later examinations were compared with that of earlier examinations by using the ratio of the prevalence estimates. Results: Age- and BMI-adjusted prevalence of knee pain increased by about 65% in NHANES from 1974 to 1994 among non-Hispanic white and Mexican American men and women and among African American women. In the FOA Study, the age- and BMI-adjusted prevalence of knee pain and symptomatic knee osteoarthritis approximately doubled in women and tripled in men over 20 years. No such trend was observed in the prevalence of radiographic knee osteoarthritis in FOA Study participants. After age adjustment, additional adjustment for BMI resulted in a 10% to 25% decrease in the prevalence ratios for knee pain and symptomatic knee osteoarthritis. Limitations: Differences in sampling of FOA Study participants over time or birth cohort effects cannot be ruled out as possible explanations of the increased reporting of knee pain. Increases in prevalence at the last interval in the FOA Study might be due to differences in cohort membership by interval. Conclusion: Results suggest that the prevalence of knee pain has increased substantially over 20 years, independent of age and BMI. Obesity accounted for only part of this increase. Symptomatic knee osteoarthritis increased but radiographic knee osteoarthritis did not.	[Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital	Felson, DT (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Suite X200, Boston, MA 02118 USA.			Zhang, Yuqing/0000-0001-7954-1149; Niu, Jingbo/0000-0002-6170-1965; Nguyen, Uyen-Sa/0000-0003-2715-9073; Felson, David/0000-0002-2668-2447	National Institutes of Health (NIH) [AR47785, AG18393]; American College of Rheumatology Research and Education Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH) [N01-HC-25195]; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health; National Heart, Lung, and Blood Institute; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institutes of Health (NIH AR47785 and AG18393) and an American College of Rheumatology Research and Education Foundation Rheumatology Scientist Development Award (Dr. Nguyen). The Framingham Heart Study was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH contract N01-HC-25195), and the FOA Study was funded by the National Institute on Aging and National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.; American College of Rheumatology Research and Education Foundation and National Institutes of Health. The FOA Study was funded by the National Heart, Lung, and Blood Institute (for the parent Framingham Heart Study), National Institute on Aging, and National Institute of Arthritis and Musculoskeletal and Skin Diseases (FOA Study), National Institutes of Health.	[Anonymous], NATL HLTH NUTR EXAMI; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2005, MMWR-MORBID MORTAL W, V54, P179; Centers for Disease Control and Prevention National Center for Health Statistics, 1971, NATL HLTH NUTR EX SU; Cisternas M. G., 2009, Morbidity and Mortality Weekly Report, V58, P133; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Grotle M, 2008, J RHEUMATOL, V35, P677; Hunter DJ, 2008, ANN RHEUM DIS, V67, P1545, DOI 10.1136/ard.2007.076810; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525; Kopec JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P929, DOI 10.1002/art.23827; Leijon O, 2009, OCCUP ENVIRON MED, V66, P137, DOI 10.1136/oem.2008.040337; Leveille SG, 2005, AM J PUBLIC HEALTH, V95, P1607, DOI 10.2105/AJPH.2004.060418; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Marks R, 2007, OBESITY, V15, P1867, DOI 10.1038/oby.2007.221; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Zeni JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-86	25	318	331	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					725	U135		10.7326/0003-4819-155-11-201112060-00004	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147711	Green Accepted			2022-12-28	WOS:000297988400001
J	Wolpaw, DR				Wolpaw, Daniel R.			Seeing Eye to Eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATIENT		[Wolpaw, Daniel R.] Case Western Reserve Sch Med, Cleveland, OH USA; [Wolpaw, Daniel R.] Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Wolpaw, DR (corresponding author), Case Western Reserve Sch Med, Cleveland, OH USA.							Levinson W, 2011, JAMA-J AM MED ASSOC, V305, P1802, DOI 10.1001/jama.2011.556; NYE NS, 1995, WORDS WORDS SELECTED; Shapiro Dan, 2001, MOMS MARIJUANA LIFE; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Williams William Carlos, 1967, AUTOBIOGRAPHY WC WIL	5	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2052	2053		10.1056/NEJMp1108469	http://dx.doi.org/10.1056/NEJMp1108469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129251				2022-12-28	WOS:000297499000005
J	Coller, HA				Coller, Hilary A.			The Essence of Quiescence	SCIENCE			English	Editorial Material							CELLULAR QUIESCENCE; CONTACT INHIBITION; CYCLE		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Coller, HA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu			NIGMS NIH HHS [R01 GM081686, R01 GM086465] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081686, R01GM086465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gos M, 2005, CELL PROLIFERAT, V38, P107, DOI 10.1111/j.1365-2184.2005.00334.x; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; WILLIAMS JG, 1975, CELL, V6, P197, DOI 10.1016/0092-8674(75)90010-0	15	59	59	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1074	1075		10.1126/science.1216242	http://dx.doi.org/10.1126/science.1216242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116874	Green Accepted			2022-12-28	WOS:000297313900035
J	Hannisdal, B; Peters, SE				Hannisdal, Bjarte; Peters, Shanan E.			Phanerozoic Earth System Evolution and Marine Biodiversity	SCIENCE			English	Article							SEA-LEVEL CHANGES; FOSSIL RECORD; ORGANIC-CARBON; SULFUR; ORIGINATION; EXTINCTIONS; DIVERSITY; SEDIMENTS; HISTORY; CLIMATE	The Phanerozoic fossil record of marine animal diversity covaries with the amount of marine sedimentary rock. The extent to which this covariation reflects a geologically controlled sampling bias remains unknown. We show that Phanerozoic records of seawater chemistry and continental flooding contain information on the diversity of marine animals that is independent of sedimentary rock quantity and sampling. Interrelationships among variables suggest long-term interactions among continental flooding, sulfur and carbon cycling, and macroevolution. Thus, mutual responses to interacting Earth systems, not sampling biases, explain much of the observed covariation between Phanerozoic patterns of sedimentation and fossil biodiversity. Linkages between biodiversity and environmental records likely reflect complex biotic responses to changing ocean redox conditions and long-term sea-level fluctuations driven by plate tectonics.	[Hannisdal, Bjarte] Univ Bergen, Dept Earth Sci, Ctr Geobiol, N-5007 Bergen, Norway; [Peters, Shanan E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Bergen; University of Wisconsin System; University of Wisconsin Madison	Hannisdal, B (corresponding author), Univ Bergen, Dept Earth Sci, Ctr Geobiol, Allegaten 41, N-5007 Bergen, Norway.	bjarte.hannisdal@geo.uib.no	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317	NSF [EAR-0819931]	NSF(National Science Foundation (NSF))	We thank J. Alroy, B. Wilkinson, M. Foote, and two anonymous reviewers for helpful comments, and J. Alroy for his suggestion to use SQS and for the generous contribution he made by executing the Paleobiology Database download and analysis at http://paleodb.org. All data used herein are archived in (23). Supported by NSF grant EAR-0819931 (S. E. P.). This is Paleobiology Database publication 146.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Cardenas AL, 2010, NAT GEOSCI, V3, P430, DOI 10.1038/NGEO869; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; Finnegan S, 2011, SCIENCE, V331, P903, DOI 10.1126/science.1200803; GARRELS RM, 1974, MAR CHEM, P303; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hannisdal B, 2011, AM J SCI, V311, P315, DOI 10.2475/04.2011.02; Hannisdal B, 2010, J GEOL, V118, P111, DOI 10.1086/650180; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; Heim NA, 2011, GEOL SOC AM BULL, V123, P620, DOI 10.1130/B30215.1; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Meyers SR, 2011, EARTH PLANET SC LETT, V303, P174, DOI 10.1016/j.epsl.2010.12.044; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Prokoph A, 2008, EARTH-SCI REV, V87, P113, DOI 10.1016/j.earscirev.2007.12.003; RAUP D M, 1976, Paleobiology, V2, P289; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; Smith AB, 2005, BIOL LETT-UK, V1, P443, DOI 10.1098/rsbl.2005.0345; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; VEIZER J, 1980, GEOCHIM COSMOCHIM AC, V44, P579, DOI 10.1016/0016-7037(80)90250-1; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012	30	146	152	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1121	1124		10.1126/science.1210695	http://dx.doi.org/10.1126/science.1210695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116884				2022-12-28	WOS:000297313900047
J	Smith, MH; Ploegh, HL; Weissman, JS				Smith, Melanie H.; Ploegh, Hidde L.; Weissman, Jonathan S.			Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum	SCIENCE			English	Review							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; MISFOLDED GLYCOPROTEINS; MEMBRANE-PROTEIN; QUALITY-CONTROL; MUTANT ALPHA-1-ANTITRYPSIN; RETRO-TRANSLOCATION; N-GLYCANASE; DISLOCATION; HRD1P	Some nascent proteins that fold within the endoplasmic reticulum (ER) never reach their native state. Misfolded proteins are removed from the folding machinery, dislocated from the ER into the cytosol, and degraded in a series of pathways collectively referred to as ER-associated degradation (ERAD). Distinct ERAD pathways centered on different E3 ubiquitin ligases survey the range of potential substrates. We now know many of the components of the ERAD machinery and pathways used to detect substrates and target them for degradation. Much less is known about the features used to identify terminally misfolded conformations and the broader role of these pathways in regulating protein half-lives.	[Smith, Melanie H.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Grad Grp Biophys, San Francisco, CA 94158 USA; [Smith, Melanie H.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Grad Grp Biophys, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Smith, Melanie/0000-0003-2464-8429	Howard Hughes Medical Institute; Hertz Foundation; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Hertz Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. G. Fujimori, C. Jan, M. Larson, Y. C. Liu, and E. Q. Toyama for critical reading of the manuscript. This work was supported by the Howard Hughes Medical Institute (J.S.W.), the Hertz Foundation Peter Strauss Fellowship (M.H.S.), and the National Institutes of Health (J.S.W. and H.L.P.).	Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; Brodsky JL, 2008, TRENDS ENDOCRIN MET, V19, P254, DOI 10.1016/j.tem.2008.07.002; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Walter MJ, 2011, SCIENCE, V334, P54, DOI 10.1126/science.1209300; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	51	460	469	5	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1086	1090		10.1126/science.1209235	http://dx.doi.org/10.1126/science.1209235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116878	Green Accepted, Green Published			2022-12-28	WOS:000297313900039
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING US Supreme Court considers Obama's health reform law	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Abelson R., NY TIMES; [Anonymous], NY TIMES; [Anonymous], LOS ANGELES TIMES; ELHAUGE E, NY TIMES; *KAIS FAM FDN, 2011, KAIS TRACK POLL; Tanne JH, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7415	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7579	10.1136/bmj.d7579	http://dx.doi.org/10.1136/bmj.d7579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113569				2022-12-28	WOS:000297724400008
J	Smith, FG; Perkins, GD; Gates, S; Young, D; McAuley, DF; Tunnicliffe, W; Khan, Z; Lamb, SE				Smith, Fang Gao; Perkins, Gavin D.; Gates, Simon; Young, Duncan; McAuley, Daniel F.; Tunnicliffe, William; Khan, Zahid; Lamb, Sarah E.		BALTI-2 Study Investigators	Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial	LANCET			English	Article							ACUTE LUNG INJURY; QUALITY-OF-LIFE; IN-VITRO; SALBUTAMOL; DYSFUNCTION; SURVIVORS; ARDS; VIVO	Background In a previous randomised controlled phase 2 trial, intravenous infusion of salbutamol for up to 7 days in patients with acute respiratory distress syndrome (ARDS) reduced extravascular lung water and plateau airway pressure. We assessed the effects of this intervention on mortality in patients with ARDS. Methods We did a multicentre, placebo-controlled, parallel-group, randomised trial at 46 UK intensive-care units between December, 2006, and March, 2010. Intubated and mechanically ventilated patients (aged >= 16 years) within 72 h of ARDS onset were randomly assigned to receive either salbutamol (15 mu g/kg ideal bodyweight per h) or placebo for up to 7 days. Randomisation was done by a central telephone or web-based randomisation service with minmisation by centre, pressure of arterial oxygen to fractional inspired oxygen concentration (PaO(2)/F(I)O(2)) ratio, and age. All participants, caregivers, and investigators were masked to group allocation. The primary outcome was death within 28 days of randomisation. Analysis was by intention-to-treat. This trial is registered, ISRCTN38366450 and EudraCT number 2006-002647-86. Findings We randomly assigned 162 patients to the salbutamol group and 164 to the placebo group. One patient in each group withdrew consent. Recruitment was stopped after the second interim analysis because of safety concerns. Salbutamol increased 28-day mortality (55 [34%] of 161 patients died in the salbutamol group vs 38 (23%) of 163 in the placebo group; risk ratio [RR] 1.47, 95% CI 1.03-2.08). Interpretation Treatment with intravenous salbutamol early in the course of ARDS was poorly tolerated. Treatment is unlikely to be beneficial, and could worsen outcomes. Routine use of beta-2 agonist treatment in ventilated patients with this disorder cannot be recommended.	[Smith, Fang Gao; Perkins, Gavin D.; Gates, Simon; Lamb, Sarah E.] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Smith, Fang Gao; Perkins, Gavin D.] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Acad Dept Anaesthesia Crit Care Pain & Resuscitat, Birmingham, W Midlands, England; [Young, Duncan; Lamb, Sarah E.] John Radcliffe Hosp, Kadoorie Crit Care Res Ctr, Oxford OX3 9DU, England; [McAuley, Daniel F.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Royal Victoria Hosp, UK & Reg Intens Care Unit, Belfast BT12 6BA, Antrim, North Ireland; [Tunnicliffe, William] Queen Elizabeth Hosp, Crit Care Unit, Birmingham B15 2TH, W Midlands, England; [Khan, Zahid] Birmingham City Hosp, Crit Care Unit, Birmingham, W Midlands, England	University of Warwick; Heart of England NHS Foundation Trust; University of Birmingham; University of Oxford; Queens University Belfast; University of Birmingham	Smith, FG (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Perioperat Crit Care & Trauma Trials Grp, Birmingham B15 2TT, W Midlands, England.	f.gaosmith@bham.ac.uk	Young, John D/M-9756-2016; Laha, Shondipon/AAN-9181-2020; Grocott, Michael/C-4394-2008; Perkins, Gavin/E-7613-2010; Smith, Fang G/H-8451-2018	Laha, Shondipon/0000-0001-8748-9766; Grocott, Michael/0000-0002-9484-7581; Bion, Julian/0000-0003-0344-5403; Perkins, Gavin/0000-0003-3027-7548; Young, John Duncan/0000-0002-6838-4835; McAuley, Daniel/0000-0002-3283-1947; Danbury, Chris/0000-0001-7807-0541; Lamb, Sarah/0000-0003-4349-7195; Smith, Fang G/0000-0002-8095-0609	UK Medical Research Council [84730]; UK Department of Health; UK Intensive Care Foundation; GlaxoSmithKline; AstraZeneca; National Institute for Health Research; MRC [G0700478] Funding Source: UKRI; Medical Research Council [G0700478] Funding Source: researchfish; National Institute for Health Research [DHCS/06/06/010] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; UK Intensive Care Foundation; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Medical Research Council, UK Department of Health, UK Intensive Care Foundation.; FGS and GDP have received an investigator-led research grant from GlaxoSmithKline. GDP and DFM have consulted for, sat on advisory boards for, and received lecture fees from GlaxoSmithKline, and have received lecture fees from AstraZeneca for educational meetings (all unrelated to beta agonists). All other authors declare that they have no conflicts of interest.; The drug supply was funded by the Department of Health, UK, and the internal pilot was funded by the Intensive Care Foundation, UK. GDP was funded by a Clinician Scientist Award from the National Institute for Health Research. We thank all patients and their legal representatives who participated in the beta-2 agonist lung injury trial (BALTI-2), all research nurses and the pharmacists in all participating centres for their help, and medical and nursing staff in participating centres who cared for patients and collected data. This trial was funded by the Medical Research Council (UK, number 84730).	[Anonymous], 2001, OFF J EUR COMMUNITIE, V121, P34; Au DH, 2002, CHEST, V121, P846, DOI 10.1378/chest.121.3.846; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Briot R, 2009, CRIT CARE, V13, DOI 10.1186/cc8137; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Felton Tim W, 2009, BMC Res Notes, V2, P77, DOI 10.1186/1756-0500-2-77; Frank JA, 2007, AM J PHYSIOL-LUNG C, V293, pL52, DOI 10.1152/ajplung.00256.2006; Heyland DK, 2005, CRIT CARE MED, V33, P1549, DOI 10.1097/01.CCM.0000168609.98847.50; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; Linden VB, 2009, ACTA ANAESTH SCAND, V53, P489, DOI 10.1111/j.1399-6576.2008.01808.x; Maak CA, 2011, J EMERG MED, V40, P135, DOI 10.1016/j.jemermed.2007.11.056; Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Matthay MA, 2011, AM J RESP CRIT CARE, V342, P1301; Millar EA, 1997, CHEST, V111, P71, DOI 10.1378/chest.111.1.71; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Perkins GD, 2008, THORAX, V63, P215, DOI 10.1136/thx.2007.080382; Perkins GD, 2007, THORAX, V62, P36, DOI 10.1136/thx.2006.059410; Perkins GD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-113; Perkins GD, 2004, CRIT CARE, V8, P25, DOI 10.1186/cc2417; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SAKUMA T, 1994, AM J RESP CRIT CARE, V150, P305, DOI 10.1164/ajrccm.150.2.8049807; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	29	215	217	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					229	235		10.1016/S0140-6736(11)61623-1	http://dx.doi.org/10.1016/S0140-6736(11)61623-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22166903	Green Published, Bronze			2022-12-28	WOS:000299316100037
J	Hofmann, LV; Kuo, WT				Hofmann, Lawrence V.; Kuo, William T.			Catheter-directed thrombolysis for acute DVT	LANCET			English	Editorial Material							DEEP VENOUS THROMBOSIS; LOWER-EXTREMITIES; VEIN THROMBOSIS; UROKINASE; ALTEPLASE		[Hofmann, Lawrence V.; Kuo, William T.] Stanford Univ, Sch Med, Div Intervent Radiol, Stanford, CA 94305 USA	Stanford University	Hofmann, LV (corresponding author), Stanford Univ, Sch Med, Div Intervent Radiol, Stanford, CA 94305 USA.	lhofmann@stanfordmed.org						Chan KT, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.100; Chung JW, 2004, J VASC INTERV RADIOL, V15, P249, DOI 10.1097/01.RIV.0000109402.52762.8D; DUPAS B, 1995, LANCET, V346, P17, DOI 10.1016/S0140-6736(95)92650-X; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Grunwald MR, 2004, J VASC INTERV RADIOL, V15, P347, DOI 10.1097/01.RVI.0000121407.46920.15; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kwak HS, 2005, J VASC INTERV RADIOL, V16, P815, DOI 10.1097/01.RVI.0000157690.91690.38; LEWIS BD, 1994, RADIOLOGY, V192, P651, DOI 10.1148/radiology.192.3.8058929; Sugimoto K, 2003, J VASC SURG, V37, P512, DOI 10.1067/mva.2003.41; Vedantham S, 2009, J VASC INTERV RADIOL, V20, pS227, DOI 10.1016/j.jvir.2009.04.016; Yoshida S, 2001, BRIT J RADIOL, V74, P1013, DOI 10.1259/bjr.74.887.741013	11	15	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					3	4		10.1016/S0140-6736(11)61875-8	http://dx.doi.org/10.1016/S0140-6736(11)61875-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	22172245				2022-12-28	WOS:000298913000006
J	Koch, P; Breuer, P; Peitz, M; Jungverdorben, J; Kesavan, J; Poppe, D; Doerr, J; Ladewig, J; Mertens, J; Tuting, T; Hoffmann, P; Klockgether, T; Evert, BO; Wullner, U; Brustle, O				Koch, Philipp; Breuer, Peter; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Tueting, Thomas; Hoffmann, Per; Klockgether, Thomas; Evert, Bernd O.; Wuellner, Ullrich; Bruestle, Oliver			Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease	NATURE			English	Article							POLYGLUTAMINE-EXPANDED ATAXIN-3; IN-VITRO; CLEAVAGE; EXPANSION; MODEL; NEURODEGENERATION; PROTEOLYSIS; INCLUSIONS; DISORDERS; PROTEINS	Machado-Joseph disease (MJD; also called spinocerebellar ataxia type 3) is a dominantly inherited late-onset neurodegenerative disorder caused by expansion of polyglutamine (polyQ)-encoding CAG repeats in the MJD1 gene (also known as ATXN3). Proteolytic liberation of highly aggregation-prone polyQ fragments from the protective sequence of the MJD1 gene product ataxin 3 (ATXN3) has been proposed to trigger the formation of ATXN3-containing aggregates, the neuropathological hallmark of MJD(1-5). ATXN3 fragments are detected in brain tissue of MJD patients and transgenic mice expressing mutant human ATXN3(Q71)(6), and their amount increases with disease severity, supporting a relationship between ATXN3 processing and disease progression. The formation of early aggregation intermediates is thought to have a critical role in disease initiation(7,8), but the precise pathogenic mechanism operating in MJD has remained elusive(9). Here we show that L-glutamate-induced excitation of patient-specific induced pluripotent stem cell (iPSC)-derived neurons initiates Ca2+-dependent proteolysis of ATXN3 followed by the formation of SDS-insoluble aggregates. This phenotype could be abolished by calpain inhibition, confirming a key role of this protease in ATXN3 aggregation. Aggregate formation was further dependent on functional Na+ and K+ channels as well as ionotropic and voltage-gated Ca2+ channels, and was not observed in iPSCs, fibroblasts or glia, thereby providing an explanation for the neuron-specific phenotype of this disease. Our data illustrate that iPSCs enable the study of aberrant protein processing associated with late-onset neurodegenerative disorders in patient-specific neurons.	[Koch, Philipp; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-53127 Bonn, Germany; [Koch, Philipp; Peitz, Michael; Jungverdorben, Johannes; Kesavan, Jaideep; Poppe, Daniel; Doerr, Jonas; Ladewig, Julia; Mertens, Jerome; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Breuer, Peter; Klockgether, Thomas; Evert, Bernd O.; Wuellner, Ullrich] Univ Bonn, Med Ctr, Dept Neurol, D-53105 Bonn, Germany; [Tueting, Thomas] Univ Bonn, Med Ctr, Dept Dermatol, D-53127 Bonn, Germany; [Hoffmann, Per] Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-53127 Bonn, Germany; [Hoffmann, Per] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Klockgether, Thomas] German Ctr Neurodegenerat Dis, DZNE, D-53175 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Brustle, O (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-53127 Bonn, Germany.	brustle@uni-bonn.de	Mertens, Jerome/P-1931-2015; Koch, Philipp/M-1186-2016; Wüllner, Ullrich/R-6790-2019; Tüting, Thomas/AAJ-3610-2021; Hoffmann, Per/A-5149-2010; Koch, Philipp/AAZ-3751-2020; Peitz, Michael/AHB-0741-2022	Mertens, Jerome/0000-0002-4291-4121; Tüting, Thomas/0000-0001-7146-0934; Hoffmann, Per/0000-0002-6573-983X; Koch, Philipp/0000-0003-3713-8786; Poppe, Daniel/0000-0002-6674-8420; Kesavan, Jaideep/0000-0003-1933-1187	German Federal Ministry for Education and Research (BMBF) [01GNO813, 01GS0860]; European Union [LSHG-CT-2006-018739, HEALTH-F5-2010-266753]; Deutsche Forschungsgemeinschaft [WU 184/6-1, EV143/1-1]; BONFOR; Hertie Foundation	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR; Hertie Foundation	We thank S. Auel, D. Kuhne, M. Segschneider and V. Dobberahn for technical support, A. Leinhaas for conducting the teratoma assays and H. L. Paulson for providing the polyclonal ATXN3 antibody used for immunocytochemistry. The human embryonic stem cell lines H9 and I3 (used as control for quantitative PCR) and I6 (originally used to derive the lt-NES cells) were provided by J. Itskovitz-Eldor (Technion, Israel Institute of Technology, Haifa, Israel). The work was supported by the German Federal Ministry for Education and Research (BMBF; grants 01GNO813, 01GS0860), the European Union (LSHG-CT-2006-018739, ESTOOLS; HEALTH-F5-2010-266753, SCR&Tox), the Deutsche Forschungsgemeinschaft (WU 184/6-1, EV143/1-1), BONFOR and the Hertie Foundation.	Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jung J, 2009, HUM MOL GENET, V18, P4843, DOI 10.1093/hmg/ddp456; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Rubinsztein DC, 1999, J MED GENET, V36, P265; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P149; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X	25	233	245	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					543	U170		10.1038/nature10671	http://dx.doi.org/10.1038/nature10671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22113611				2022-12-28	WOS:000298318000065
J	Li, WD; Bloom, JS; Podsiadlowski, P; Miller, AA; Cenko, SB; Jha, SW; Sullivan, M; Howell, DA; Nugent, PE; Butler, NR; Ofek, EO; Kasliwal, MM; Richards, JW; Stockton, A; Shih, HY; Bildsten, L; Shara, MM; Bibby, J; Filippenko, AV; Ganeshalingam, M; Silverman, JM; Kulkarni, SR; Law, NM; Poznanski, D; Quimby, RM; McCully, C; Patel, B; Maguire, K; Shen, KJ				Li, Weidong; Bloom, Joshua S.; Podsiadlowski, Philipp; Miller, Adam A.; Cenko, S. Bradley; Jha, Saurabh W.; Sullivan, Mark; Howell, D. Andrew; Nugent, Peter E.; Butler, Nathaniel R.; Ofek, Eran O.; Kasliwal, Mansi M.; Richards, Joseph W.; Stockton, Alan; Shih, Hsin-Yi; Bildsten, Lars; Shara, Michael M.; Bibby, Joanne; Filippenko, Alexei V.; Ganeshalingam, Mohan; Silverman, Jeffrey M.; Kulkarni, S. R.; Law, Nicholas M.; Poznanski, Dovi; Quimby, Robert M.; McCully, Curtis; Patel, Brandon; Maguire, Kate; Shen, Ken J.			Exclusion of a luminous red giant as a companion star to the progenitor of supernova SN 2011fe	NATURE			English	Article							WHITE-DWARF MODELS; IA SUPERNOVAE; X-RAY; RECURRENT NOVAE; EVOLUTION; MASS; BINARIES; CHANNEL; DISTANCE; SYSTEM	Type Ia supernovae are thought to result from a thermonuclear explosion of an accreting white dwarf in a binary system(1,2), but little is known of the precise nature of the companion star and the physical properties of the progenitor system. There are two classes of models(1,3): double-degenerate (involving two white dwarfs in a close binary system(2,4)) and single-degenerate models(5,6). In the latter, the primary white dwarf accretes material from a secondary companion until conditions are such that carbon ignites, at a mass of 1.38 times the mass of the Sun. The type Ia supernova SN 2011fe was recently detected in a nearby galaxy(7). Here we report an analysis of archival images of the location of SN 2011fe. The luminosity of the progenitor system (especially the companion star) is 10-100 times fainter than previous limits on other type Ia supernova progenitor systems(8-10), allowing us to rule out luminous red giants and almost all helium stars as the mass-donating companion to the exploding white dwarf.	[Li, Weidong; Bloom, Joshua S.; Miller, Adam A.; Cenko, S. Bradley; Nugent, Peter E.; Richards, Joseph W.; Filippenko, Alexei V.; Ganeshalingam, Mohan; Silverman, Jeffrey M.; Shen, Ken J.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Podsiadlowski, Philipp; Sullivan, Mark; Maguire, Kate] Univ Oxford, Dept Phys Astrophys, Oxford OX1 3RH, England; [Jha, Saurabh W.; McCully, Curtis; Patel, Brandon] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Howell, D. Andrew] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Howell, D. Andrew; Bildsten, Lars] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Nugent, Peter E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Computat Cosmol Ctr, Berkeley, CA 94720 USA; [Butler, Nathaniel R.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Ofek, Eran O.; Kulkarni, S. R.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Ofek, Eran O.] Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Kasliwal, Mansi M.] Carnegie Inst Sci, Pasadena, CA 91101 USA; [Richards, Joseph W.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Stockton, Alan; Shih, Hsin-Yi] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Bildsten, Lars] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Shara, Michael M.; Bibby, Joanne] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Law, Nicholas M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Quimby, Robert M.] Univ Tokyo, IPMU, Kashiwa, Chiba, Japan; [Poznanski, Dovi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	University of California System; University of California Berkeley; University of Oxford; Rutgers State University New Brunswick; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; California Institute of Technology; Weizmann Institute of Science; Carnegie Institution for Science; University of California System; University of California Berkeley; University of Hawaii System; University of California System; University of California Santa Barbara; American Museum of Natural History (AMNH); University of Toronto; University of Tokyo; Tel Aviv University	Li, WD (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	weidong@berkeley.edu	Howell, Andy/ABE-6446-2020; Nugent, Peter Edward/AGG-8472-2022; Maguire, Kate/HHN-6122-2022	Maguire, Kate/0000-0002-9770-3508; Shen, Ken/0000-0002-9632-6106; Poznanski, Dovi/0000-0003-1470-7173; Kasliwal, Tamay/0000-0001-5634-7167; Nugent, Peter/0000-0002-3389-0586; Jha, Saurabh/0000-0001-8738-6011; Bloom, Joshua/0000-0002-7777-216X; Sullivan, Mark/0000-0001-9053-4820	NASA; Carnegie-Princeton Fellowship; US National Science Foundation; Richard & Rhoda Goldman Fund; Sylvia and Jim Katzman Foundation; Gary and Cynthia Bengier; TABASGO Foundation; Hilary Lipsitz; American Museum of Natural History; Royal Society; W. M. Keck Foundation; STFC [ST/H002456/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H002456/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1009987, 1109174] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1009991] Funding Source: National Science Foundation; Office Of The Director [0941742] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Carnegie-Princeton Fellowship; US National Science Foundation(National Science Foundation (NSF)); Richard & Rhoda Goldman Fund; Sylvia and Jim Katzman Foundation; Gary and Cynthia Bengier; TABASGO Foundation; Hilary Lipsitz; American Museum of Natural History; Royal Society(Royal Society of London); W. M. Keck Foundation(W.M. Keck Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Maoz and S. Starrfield for comments, and the staff of the W. M. Keck Observatory, especially J. Lyke and R. Campbell, for their assistance in obtaining the NIRC adaptive optics imaging. P. P. acknowledges discussions on symbiotic binaries with J. Mikolajewska. M. M. K. acknowledges support by NASA's Hubble Fellowship and the Carnegie-Princeton Fellowship. J.S.B.'s group was partially supported by NASA. J. S. B., A. V. F., L. B. and S. W. J. acknowledge support from the US National Science Foundation. A.V.F.'s group at UC Berkeley, and the Katzman Automatic Imaging Telescope (KAIT) and its ongoing operation, have received financial assistance from NASA, Gary and Cynthia Bengier, the Richard & Rhoda Goldman Fund, the Sylvia and Jim Katzman Foundation, and the TABASGO Foundation. E.O.O. is supported by an Einstein Fellowship from NASA. M. M. S. and J. B. acknowledge the support of Hilary Lipsitz and the American Museum of Natural History for essential funding. M. S. acknowledges support from the Royal Society. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; the observatory was made possible by the generous financial support of the W. M. Keck Foundation. Observations were obtained with the Samuel Oschin Telescope at the Palomar Observatory as part of the Palomar Transient Factory project, a scientific collaboration between the California Institute of Technology, Columbia University, La Cumbres Observatory, the Lawrence Berkeley National Laboratory, the National Energy Research Scientific Computing Center, the University of Oxford, and the Weizmann Institute of Science. The National Energy Research Scientific Computing Center, provided staff, computational resources, and data storage for this project.	Di Stefano R, 2010, ASTROPHYS J, V719, P474, DOI 10.1088/0004-637X/719/1/474; Di Stefano R, 2010, ASTROPHYS J, V712, P728, DOI 10.1088/0004-637X/712/1/728; Fryer CL, 2010, ASTROPHYS J, V725, P296, DOI 10.1088/0004-637X/725/1/296; Greiner J, 2000, NEW ASTRON, V5, P137, DOI 10.1016/S1384-1076(00)00018-X; Hachisu I, 2001, ASTROPHYS J, V558, P323, DOI 10.1086/321601; Hachisu I, 1999, ASTROPHYS J, V519, P314, DOI 10.1086/307370; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Liu WM, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014180; Maoz D, 2008, MON NOT R ASTRON SOC, V388, P421, DOI 10.1111/j.1365-2966.2008.13403.x; MUNARI U, 1992, ASTROPHYS J, V397, pL87, DOI 10.1086/186551; Nelemans G, 2008, MON NOT R ASTRON SOC, V388, P487, DOI 10.1111/j.1365-2966.2008.13416.x; NOMOTO K, 1982, ASTROPHYS J, V253, P798, DOI 10.1086/159682; Nomoto K, 1997, SCIENCE, V276, P1378, DOI 10.1126/science.276.5317.1378; Podsiadlowski P, 2008, NEW ASTRON REV, V52, P381, DOI 10.1016/j.newar.2008.06.020; Schaefer BE, 2010, ASTROPHYS J SUPPL S, V187, P275, DOI 10.1088/0067-0049/187/2/275; Shappee BJ, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/124; Shen K. J., 2011, LONG TERM EVOLUTION; Stetson PB, 1998, ASTROPHYS J, V508, P491, DOI 10.1086/306443; Thoroughgood TD, 2001, MON NOT R ASTRON SOC, V327, P1323, DOI 10.1046/j.1365-8711.2001.04828.x; Torres G, 2010, ASTRON J, V140, P1158, DOI 10.1088/0004-6256/140/5/1158; VANDENHEUVEL EPJ, 1992, ASTRON ASTROPHYS, V262, P97; Voss R, 2008, NATURE, V451, P802, DOI 10.1038/nature06602; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Wizinowich PL, 2006, PUBL ASTRON SOC PAC, V118, P297, DOI 10.1086/499290; Woudt PA, 2009, ASTROPHYS J, V706, P738, DOI 10.1088/0004-637X/706/1/738; Yoon SC, 2007, MON NOT R ASTRON SOC, V380, P933, DOI 10.1111/j.1365-2966.2007.12161.x; Yoon SC, 2003, ASTRON ASTROPHYS, V412, pL53, DOI 10.1051/0004-6361:20034607	29	242	244	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					348	350		10.1038/nature10646	http://dx.doi.org/10.1038/nature10646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170681	Green Submitted			2022-12-28	WOS:000298033000046
J	Kohli, P; Cannon, CP				Kohli, Payal; Cannon, Christopher P.			Statins and safety: can we finally be reassured?	LANCET			English	Editorial Material							RISK; CHOLESTEROL; CANCER		[Kohli, Payal; Cannon, Christopher P.] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Kohli, P (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791; Kohli, Payal/0000-0002-1049-5233				Alsheikh-Ali AA, 2007, J AM COLL CARDIOL, V50, P409, DOI 10.1016/j.jacc.2007.02.073; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Heart Protection Study Collaborative Group, 2011, Lancet, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; OLIVER MF, 1991, LANCET, V337, P1529, DOI 10.1016/0140-6736(91)93208-Q; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Sever PS, 2011, EUR HEART J, V32, P2525, DOI 10.1093/eurheartj/ehr333; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; SMITH GD, 1992, BMJ-BRIT MED J, V304, P431, DOI 10.1136/bmj.304.6824.431	13	11	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					1980	1981		10.1016/S0140-6736(11)61544-4	http://dx.doi.org/10.1016/S0140-6736(11)61544-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863DY	22115875				2022-12-28	WOS:000298144200008
J	Jasny, BR; Chin, G; Chong, L; Vignieri, S				Jasny, Barbara R.; Chin, Gilbert; Chong, Lisa; Vignieri, Sacha			Again, and Again, and Again ... INTRODUCTION	SCIENCE			English	Editorial Material																			0	144	150	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1225	1225		10.1126/science.334.6060.1225	http://dx.doi.org/10.1126/science.334.6060.1225			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144612				2022-12-28	WOS:000297553600033
J	Kacprzak, GG				Kacprzak, Glenn G.			The Pristine Universe	SCIENCE			English	Editorial Material							STAR-FORMATION		Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Kacprzak, GG (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia.	gkacprzak@astro.swin.edu.au		Kacprzak, Glenn/0000-0003-1362-9302				BATTISTI AJ, 2011, ARXIV11104557; Coc A, 2004, ASTROPHYS J, V600, P544, DOI 10.1086/380121; Fumagalli M, 2011, SCIENCE, V334, P1245, DOI 10.1126/science.1213581; Hernquist L, 2003, MON NOT R ASTRON SOC, V341, P1253, DOI 10.1046/j.1365-8711.2003.06499.x; Hosokawa T, 2011, SCIENCE, V334, P1250, DOI 10.1126/science.1207433; Larson D, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/16; Mackey J, 2003, ASTROPHYS J, V586, P1, DOI 10.1086/367613; Prochaska JX, 2003, ASTROPHYS J, V595, pL9, DOI 10.1086/378945; Wise J.H., 2010, ARXIV10112632; Wise JH, 2008, ASTROPHYS J, V685, P40, DOI 10.1086/590417; Yoshida N, 2004, ASTROPHYS J, V605, P579, DOI 10.1086/382499	12	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1216	1217		10.1126/science.1215355	http://dx.doi.org/10.1126/science.1215355			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144607				2022-12-28	WOS:000297553600028
J	Tomasello, M; Call, J				Tomasello, Michael; Call, Josep			Methodological Challenges in the Study of Primate Cognition	SCIENCE			English	Editorial Material								Laboratory studies of primate cognition face the problem that captive populations of a species are not always comparable, and generalizations to natural populations are never certain. Studies of primate cognition in the field face the problem that replications are expensive and difficult, and again different populations are not always comparable. To help remedy these problems, we recommend the creation of data banks where primary data and videotapes may be deposited (perhaps as a requirement of publication) to facilitate cross-examination, replication, and, eventually, the pooling of data across investigators.	[Tomasello, Michael; Call, Josep] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Tomasello, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	tomas@eva.mpg.de; call@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336				Cheney D. L., 1990, MONKEYS SEE WORLD IN; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; MCGREW WC, 1989, COMP SOCIOECOLOGY BE, P457; MENZEL CR, 1991, ANIM BEHAV, V41, P397, DOI 10.1016/S0003-3472(05)80840-1; Miller G, 2010, SCIENCE, V329, P890, DOI 10.1126/science.329.5994.890-b; Ryan MJ, 2011, SCIENCE, V334, P1229, DOI 10.1126/science.1214532; SAVAGERUMBAUGH ES, 1993, MONOGRAFS SOC RES CH, V233, P3; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	9	35	37	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1227	1228		10.1126/science.1213443	http://dx.doi.org/10.1126/science.1213443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144614				2022-12-28	WOS:000297553600035
J	Brocklehurst, P; Hardy, P; Hollowell, J; Linsell, L; Macfarlane, A; McCourt, C; Marlow, N; Miller, A; Newburn, M; Petrou, S; Puddicombe, D; Redshaw, M; Rowe, R; Sandall, J; Silverton, L; Stewart, M				Brocklehurst, P.; Hardy, Pollyanna; Hollowell, Jennifer; Linsell, Louise; Macfarlane, Alison; McCourt, Christine; Marlow, Neil; Miller, Alison; Newburn, Mary; Petrou, Stavros; Puddicombe, David; Redshaw, Maggie; Rowe, Rachel; Sandall, Jane; Silverton, Louise; Stewart, Mary		Birthplace England Collaborative	Perinatal and maternal outcomes by planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BOOKED HOME BIRTHS; MORTALITY RATES	Objective To compare perinatal outcomes, maternal outcomes, and interventions in labour by planned place of birth at the start of care in labour for women with low risk pregnancies. Design Prospective cohort study. Setting England: all NHS trusts providing intrapartum care at home, all freestanding midwifery units, all alongside midwifery units (midwife led units on a hospital site with an obstetric unit), and a stratified random sample of obstetric units. Participants 64 538 eligible women with a singleton, term (>= 37 weeks gestation), and "booked" pregnancy who gave birth between April 2008 and April 2010. Planned caesarean sections and caesarean sections before the onset of labour and unplanned home births were excluded. Main outcome measure A composite primary outcome of perinatal mortality and intrapartum related neonatal morbidities (stillbirth after start of care in labour, early neonatal death, neonatal encephalopathy, meconium aspiration syndrome, brachial plexus injury, fractured humerus, or fractured clavicle) was used to compare outcomes by planned place of birth at the start of care in labour (at home, freestanding midwifery units, alongside midwifery units, and obstetric units). Results There were 250 primary outcome events and an overall weighted incidence of 4.3 per 1000 births (95% CI 3.3 to 5.5). Overall, there were no significant differences in the adjusted odds of the primary outcome for any of the non-obstetric unit settings compared with obstetric units. For nulliparous women, the odds of the primary outcome were higher for planned home births (adjusted odds ratio 1.75, 95% CI 1.07 to 2.86) but not for either midwifery unit setting. For multiparous women, there were no significant differences in the incidence of the primary outcome by planned place of birth. Interventions during labour were substantially lower in all non-obstetric unit settings. Transfers from non-obstetric unit settings were more frequent for nulliparous women (36% to 45%) than for multiparous women (9% to 13%). Conclusions The results support a policy of offering healthy women with low risk pregnancies a choice of birth setting. Women planning birth in a midwifery unit and multiparous women planning birth at home experience fewer interventions than those planning birth in an obstetric unit with no impact on perinatal outcomes. For nulliparous women, planned home births also have fewer interventions but have poorer perinatal outcomes.	[Brocklehurst, P.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Brocklehurst, P.] UCL, Inst Womens Hlth, London WC1E 6BT, England; [Macfarlane, Alison; McCourt, Christine] City Univ London, London, England; [Miller, Alison] CEMACH, London, England; [Newburn, Mary] Natl Childbirth Trust, London, England; [Petrou, Stavros] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Stewart, Mary] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London, England; [Silverton, Louise] Royal Coll Midwives, London, England	University of Oxford; University of London; University College London; City University London; University of Warwick; University of London; King's College London	Brocklehurst, P (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	peter.brocklehurst@npeu.ox.ac.uk	Petrou, Stavros/ABD-8323-2021; Hollowell, Jennifer/B-5052-2009; Puddicombe, David M/F-1354-2011; Marlow, Neil/D-2918-2009; Sandall, Jane/D-4146-2009; Rowe, Rachel E/F-1430-2011	Petrou, Stavros/0000-0003-3121-6050; Hollowell, Jennifer/0000-0002-4041-5732; Puddicombe, David M/0000-0003-4343-4522; Marlow, Neil/0000-0001-5890-2953; Sandall, Jane/0000-0003-2000-743X; Rowe, Rachel E/0000-0003-2994-3240; McCourt, Christine/0000-0003-4765-5795	National Institute for Health Research Service Delivery and Organisation (NIHR SDO); Department of Health Policy Research Programme (DH PRP); National Institute for Health Research [08/1604/140, 10/1008/35] Funding Source: researchfish	National Institute for Health Research Service Delivery and Organisation (NIHR SDO)(National Institute for Health Research (NIHR)); Department of Health Policy Research Programme (DH PRP); National Institute for Health Research(National Institute for Health Research (NIHR))	This study combines the Evaluation of Maternity Units in England study, funded by the National Institute for Health Research Service Delivery and Organisation (NIHR SDO) programme, and the Birth at Home in England study funded by the Department of Health Policy Research Programme (DH PRP). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The views expressed are not necessarily those of the funders.	Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Gyte G, 2009, BJOG-INT J OBSTET GY, V116, P933, DOI 10.1111/j.1471-0528.2009.02147.x; Hodnett ED, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000012.pub3, 10.1002/14651858.CD000012.pub4]; Hollowell J, 2011, BIRTHPLACE NATL PROS; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Lindelow M, 2008, MULTIVARIATE ANAL HL; Lindgren HE, 2008, ACTA OBSTET GYN SCAN, V87, P751, DOI 10.1080/00016340802199903; Maternity Care Working Party, 2007, MAK NORM BIRTH REAL; Mori R, 2008, BJOG-INT J OBSTET GY, V115, P554, DOI 10.1111/j.1471-0528.2008.01669.x; National Perinatal Epidemiology Unit (NPEU), 2007, BIRTHPL ENGL RES PRO; NICE, 2007, INTR CAR HLTH WOM TH; Redshaw M, 2011, MAPPING MATERNITY CA; ROBERTSON CMT, 1993, CLIN PERINATOL, V20, P483, DOI 10.1016/S0095-5108(18)30405-6; Schroeder L, 2011, BIRTHPLACE COST EFFE; StataCorp, 2021, STATA STAT SOFTWARE; Wax JR, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.028; Werkmeister G, 2008, MIDWIFERY, V24, P256, DOI 10.1016/j.midw.2008.06.001	19	452	460	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2011	343								d7400	10.1136/bmj.d7400	http://dx.doi.org/10.1136/bmj.d7400			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875FI	22117057	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000299015400007
J	Moore, EB; Molinero, V				Moore, Emily B.; Molinero, Valeria			Structural transformation in supercooled water controls the crystallization rate of ice	NATURE			English	Article							MOLECULAR-DYNAMICS; GLASSY WATER; STABILITY; SINGULARITY; NUCLEATION; BEHAVIOR; DENSITY; GROWTH; LIQUID; PHASE	One of water's unsolved puzzles is the question of what determines the lowest temperature to which it can be cooled before freezing to ice. The supercooled liquid has been probed experimentally to near the homogeneous nucleation temperature, T approximate to 232 K, yet the mechanism of ice crystallization-including the size and structure of critical nuclei-has not yet been resolved. The heat capacity and compressibility of liquid water anomalously increase on moving into the supercooled region, according to power laws that would diverge ( that is, approach infinity) at similar to 225K (refs 1, 2), so there may be a link between water's thermodynamic anomalies and the crystallization rate of ice. But probing this link is challenging because fast crystallization prevents experimental studies of the liquid below T-H. And although atomistic studies have captured water crystallization(3), high computational costs have so far prevented an assessment of the rates and mechanism involved. Here we report coarse-grained molecular simulations with the mW water model(4) in the supercooled regime around TH which reveal that a sharp increase in the fraction of four-coordinated molecules in supercooled liquid water explains its anomalous thermodynamics and also controls the rate and mechanisms of ice formation. The results of the simulations and classical nucleation theory using experimental data suggest that the crystallization rate of water reaches a maximum around 225 K, below which ice nuclei form faster than liquid water can equilibrate. This implies a lower limit of metastability of liquid water just below TH and well above its glass transition temperature, 136 K. By establishing a relationship between the structural transformation in liquid water and its anomalous thermodynamics and crystallization rate, our findings also provide mechanistic insight into the observed(5) dependence of homogeneous ice nucleation rates on the thermodynamics of water.	[Moore, Emily B.; Molinero, Valeria] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Molinero, V (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	Valeria.Molinero@utah.edu			Arnold and Mabel Beckman Foundation	Arnold and Mabel Beckman Foundation	This work was supported by the Arnold and Mabel Beckman Foundation through a Young Investigator Award to V. M. We thank P. G. Debenedetti for discussions and D. P. Fernandez for criticism of the manuscript.	Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; de la Llave E, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3462964; Finney JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225503; Huang CC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3495974; Jacobson LC, 2009, J PHYS CHEM B, V113, P10298, DOI 10.1021/jp903439a; Jahnert S, 2008, PHYS CHEM CHEM PHYS, V10, P6039, DOI 10.1039/b809438c; JOHARI GP, 1994, J PHYS CHEM-US, V98, P4719, DOI 10.1021/j100068a038; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kiselev SB, 2001, INT J THERMOPHYS, V22, P1421, DOI 10.1023/A:1012893020651; Kohl I, 2000, PHYS CHEM CHEM PHYS, V2, P1579, DOI 10.1039/a908688i; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Liu J, 2007, LANGMUIR, V23, P7286, DOI 10.1021/la063650a; Liu Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3229892; Mallamace F, 2007, P NATL ACAD SCI USA, V104, P18387, DOI 10.1073/pnas.0706504104; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; Mishima O, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2085144; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Molinero V, 2009, J PHYS CHEM B, V113, P4008, DOI 10.1021/jp805227c; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Moore EB, 2010, PHYS CHEM CHEM PHYS, V12, P4124, DOI 10.1039/b919724a; Moore EB, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3158470; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P982, DOI 10.1021/j100395a030; Stevenson JD, 2011, J PHYS CHEM A, V115, P3713, DOI 10.1021/jp1060057; Tanaka H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011505; Tombari E, 1999, CHEM PHYS LETT, V300, P749, DOI 10.1016/S0009-2614(98)01392-X; Wedekind J, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2713401; Xu LM, 2009, NAT PHYS, V5, P565, DOI 10.1038/NPHYS1328	32	488	492	11	527	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					506	U226		10.1038/nature10586	http://dx.doi.org/10.1038/nature10586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113691	Green Submitted			2022-12-28	WOS:000297285600045
J	Senecal, EL; Rosenfield, K; Caldera, AE; Passeri, JJ				Senecal, Emily L.; Rosenfield, Kenneth; Caldera, Angel E.; Passeri, Jonathan J.			Case 36-2011: A 93-Year-Old Woman with Shortness of Breath and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; ST ELEVATION; ELECTROCARDIOGRAM; ASSOCIATION		[Senecal, Emily L.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Rosenfield, Kenneth; Caldera, Angel E.; Passeri, Jonathan J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Senecal, Emily L.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Rosenfield, Kenneth; Caldera, Angel E.; Passeri, Jonathan J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Senecal, EL (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.		Caldera, Angel/AAH-9798-2019					[Anonymous], 1986, LANCET, V1, P397; Bonacchi M, 2009, EUR J HEART FAIL, V11, P721, DOI 10.1093/eurjhf/hfp068; Brady WJ, 1999, J EMERG MED, V17, P473, DOI 10.1016/S0736-4679(99)00010-4; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; HIRATA K, 1995, AM J CARDIOL, V76, P1207, DOI 10.1016/S0002-9149(99)80342-7; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; LH Cohn, 2008, CARDIAC SURG ADULT, P803; Lin JF, 2009, CIRC J, V73, P1157, DOI 10.1253/circj.CJ-08-0474; MEIZLISH JL, 1984, NEW ENGL J MED, V311, P1001, DOI 10.1056/NEJM198410183111601; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Ryan TJ, 1996, CIRCULATION, V94, P2341, DOI 10.1161/01.CIR.94.9.2341; Sarda L, 2001, J AM COLL CARDIOL, V37, P786, DOI 10.1016/S0735-1097(00)01201-8; Sato H, 1990, CLIN ASPECT MYOCARDI, P56; SHARKEY SW, 1994, AM J CARDIOL, V73, P550, DOI 10.1016/0002-9149(94)90331-X; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001	19	2	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					2021	2028		10.1056/NEJMcpc1103565	http://dx.doi.org/10.1056/NEJMcpc1103565			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851PF	22111721				2022-12-28	WOS:000297282600013
J	Lo, B; Barnes, M				Lo, Bernard; Barnes, Mark			Protecting Research Participants While Reducing Regulatory Burdens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS		[Lo, Bernard] Univ Calif San Francisco, Dept Med, Program Med Eth, San Francisco, CA 94143 USA; [Barnes, Mark] Harvard Univ, Harvard Sch Publ Hlth, Harvard Law Sch, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health	Lo, B (corresponding author), Univ Calif San Francisco, Dept Med, Program Med Eth, 521 Parnassus Ave,Room C126, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu						Boga M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001089; Department of Health and Human Services Office of the Secretary of Food and Drug Administration, HUM SUBJ RES PROT EN; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Jesus JE, 2009, PREHOSP DISASTER MED, V24, P109, DOI 10.1017/S1049023X00006634; Lo B, 2005, ETHICAL CONSIDERATIO; National Bioethics Advisory Commission, 2001, ETH POL ISS RES INV; Sharkey S, 2011, J MED ETHICS; Stunkel Leanne, 2010, IRB, V32, P1; Sunstein CR, 1995, CALIF LAW REV, V83, P953, DOI 10.2307/3480896; Woodsong C, 2005, AM J PUBLIC HEALTH, V95, P412, DOI 10.2105/AJPH.2004.041624	10	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2260	2261		10.1001/jama.2011.1727	http://dx.doi.org/10.1001/jama.2011.1727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851GD	22110108				2022-12-28	WOS:000297255500027
J	Agarwal, R; Teoh, S; Short, D; Harvey, R; Savage, PM; Seckl, MJ				Agarwal, Roshan; Teoh, Suliana; Short, Delia; Harvey, Richard; Savage, Philip M.; Seckl, Michael J.			Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study	LANCET			English	Article							GESTATIONAL-TROPHOBLASTIC-DISEASE; COMPLETE HYDATIDIFORM MOLE; RISK; DIAGNOSIS; TUMORS; METHOTREXATE; MANAGEMENT; NEOPLASIA	Background Indications for chemotherapy in gestational trophoblastic disease include raised human chorionic gonadotropin (hCG) concentrations 6 months after uterine evacuation of hydatidiform mole, even when values are falling. We aimed to establish whether chemotherapy is always necessary in these patients. Methods We retrospectively identified women registered between January, 1993, and May, 2008, at Charing Cross Hospital, London, UK, who had persistently high hCG concentrations 6 months after evacuation of hydatidiform mole. Rates of hCG normalisation, relapse, and death were assessed in patients continued under surveillance and those who received chemotherapy after 6 months. We postulated that a surveillance policy would be clinically acceptable if hCG values returned to normal in 75% of patients or more. Findings 76 (<1%) of 13 960 patients with hydatidiform moles had persistently high hCG concentrations of more than 5 IU/L 6 months after evacuation. 66 (87%) patients continued under surveillance and hCG values spontaneously returned to normal without chemotherapy in 65 (98%) of these patients. Values in one patient did not become normal because of chronic renal failure, but she remains healthy. Ten patients received chemotherapy, and hCG concentrations returned to normal in eight (80%) of these individuals (surveillance vs chemotherapy groups p=0.044) and remained slightly high (6-11 IU/L) in two without any associated clinical problems off treatment. We noted no significant differences between individuals in the surveillance and chemotherapy groups, apart from lower median hCG concentrations 6 months after evacuation in those under surveillance than in those given chemotherapy (13 IU/L, range 5-887, vs 157 IU/L, range 6-6438; p=0.004). Overall, there were no deaths in this series. Interpretation A surveillance policy seems to be clinically acceptable in patients with low and declining concentrations of hCG 6 months after evacuation of hydatidiform mole.	[Seckl, Michael J.] Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, London W6 8RF, England; [Agarwal, Roshan; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Seckl, MJ (corresponding author), Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, Charing Cross Hosp Campus, London W6 8RF, England.	m.seckl@imperial.ac.uk		Savage, Philip/0000-0002-4792-6869; Teoh, Suliana/0000-0002-5456-9273	National Commissioning Group; Imperial Experimental Cancer Medicine Centre; Imperial Biomedical Research Centre; Cancer Research UK; Imperial College Experimental Cancer Medicine Centre; Department of Health; Imperial College Biomedical Research Centre	National Commissioning Group; Imperial Experimental Cancer Medicine Centre; Imperial Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Imperial College Experimental Cancer Medicine Centre; Department of Health; Imperial College Biomedical Research Centre	National Commissioning Group, Imperial Experimental Cancer Medicine Centre, Imperial Biomedical Research Centre, and Cancer Research UK.; MJS thanks the National Commissioning Group and Department of Health for continuing support of the GTD service. MJS is supported by the Imperial College Experimental Cancer Medicine Centre grant from Cancer Research UK, the Department of Health, and the Imperial College Biomedical Research Centre. RA is supported by a Clinician Scientist Fellowship from Cancer Research UK.	Alazzam M, 2009, COCHRANE DB SYST REV, V1; BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E; BAGSHAWE KD, 1986, LANCET, V2, P673; Bower M, 1997, J CLIN ONCOL, V15, P2636, DOI 10.1200/JCO.1997.15.7.2636; Cole LA, 2006, GYNECOL ONCOL, V102, P151, DOI 10.1016/j.ygyno.2005.12.045; FISHER RA, 1987, PLACENTA, V8, P249, DOI 10.1016/0143-4004(87)90048-8; Fisher RA, 1998, J REPROD MED, V43, P87; Fowler DJ, 2006, ULTRASOUND OBST GYN, V27, P56, DOI 10.1002/uog.2592; Gillespie AM, 2000, BRIT J CANCER, V82, P1393, DOI 10.1054/bjoc.1999.1124; Hancock BW, 2006, J REPROD MED, V51, P764; Harvey RA, 2010, J REPROD MED, V55, P285; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kim SJ, 1998, INT J GYNECOL OBSTET, V60, pS85, DOI 10.1016/S0020-7292(98)80010-6; Kohorn EI, 2001, INT J GYNECOL CANCER, V11, P73, DOI 10.1046/j.1525-1438.2001.011001073.x; LAGE JM, 1992, OBSTET GYNECOL, V79, P403, DOI 10.1097/00006250-199203000-00016; Lurain JR, 2005, GYNECOL ONCOL, V97, P618, DOI 10.1016/j.ygyno.2005.02.004; McNeish IA, 2002, J CLIN ONCOL, V20, P1838, DOI 10.1200/JCO.2002.07.166; Ngan HYS, 2003, INT J GYNECOL OBSTET, V83, P175, DOI 10.1016/S0020-7292(03)90120-2; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; PALMER JR, 1994, J REPROD MED, V39, P155; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Palmieri C, 2007, GYNECOL ONCOL, V106, P35, DOI 10.1016/j.ygyno.2007.01.053; Powles T, 2006, BRIT J CANCER, V95, P1145, DOI 10.1038/sj.bjc.6603416; Rustin GJS, 1996, J CLIN ONCOL, V14, P2769, DOI 10.1200/JCO.1996.14.10.2769; Savage P, 2010, J REPROD MED, V55, P341; Schmid P, 2009, LANCET, V374, P48, DOI 10.1016/S0140-6736(09)60618-8; Sebire NJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1193; Sebire NJ, 2007, BJOG-INT J OBSTET GY, V114, P760, DOI 10.1111/j.1471-0528.2007.01320.x; Sebire NJ, 2002, LANCET, V359, P2165, DOI 10.1016/S0140-6736(02)09085-2; Sebire NJ, 2002, BJOG-INT J OBSTET GY, V109, P99, DOI 10.1111/j.1471-0528.2002.t01-1-01037.x; Seckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6; Seckl MJ, 2004, J REPROD MED, V49, P527; STONE M, 1976, BRIT J OBSTET GYNAEC, V83, P913, DOI 10.1111/j.1471-0528.1976.tb00774.x	34	32	34	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					130	135		10.1016/S0140-6736(11)61265-8	http://dx.doi.org/10.1016/S0140-6736(11)61265-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22130490	Green Published			2022-12-28	WOS:000299317700034
J	Yuan, P; Leonetti, MD; Hsiung, YC; MacKinnon, R				Yuan, Peng; Leonetti, Manuel D.; Hsiung, Yichun; MacKinnon, Roderick			Open structure of the Ca2+ gating ring in the high-conductance Ca2+-activated K+ channel	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; HUMAN BK CHANNEL; SMOOTH-MUSCLE; RCK DOMAIN; QUATERNARY AMMONIUM; CRYSTAL-STRUCTURE; CALCIUM; BLOCK; MECHANISM; COMPLEX	High-conductance voltage-and Ca2+-activated K+ channels function in many physiological processes that link cell membrane voltage and intracellular Ca2+ concentration, including neuronal electrical activity, skeletal and smooth muscle contraction, and hair cell tuning(1-8). Like other voltage-dependent K+ channels, Ca2+-activated K+ channels open when the cell membrane depolarizes, but in contrast to other voltage-dependent K+ channels, they also open when intracellular Ca2+ concentrations rise. Channel opening by Ca2+ is made possible by a structure called the gating ring, which is located in the cytoplasm. Recent structural studies have defined the Ca2+-free, closed, conformation of the gating ring, but the Ca2+-bound, open, conformation is not yet known(9). Here we present the Ca2+-bound conformation of the gating ring. This structure shows how one layer of the gating ring, in response to the binding of Ca2+, opens like the petals of a flower. The degree to which it opens explains how Ca2+ binding can open the transmembrane pore. These findings present a molecular basis for Ca2+ activation of K+ channels and suggest new possibilities for targeting the gating ring to treat conditions such as asthma and hypertension.	[Yuan, Peng; Leonetti, Manuel D.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu	Yuan, Peng/A-7643-2012	Yuan, Peng/0000-0002-5660-225X; Leonetti, Manuel/0000-0002-4881-405X	American Asthma Foundation [07-0127]	American Asthma Foundation	We thank staff members at NSLS X29, Brookhaven National Laboratory, for beamline assistance, and members of the MacKinnon laboratory for discussion. We thank P. Hoff and members of the Gadsby laboratory for help with oocyte preparation. R. M. is an investigator in the Howard Hughes Medical Institute. The research is supported by the American Asthma Foundation grant 07-0127.	Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1987, J BACTERIOL, V169, P3743, DOI 10.1128/jb.169.8.3743-3749.1987; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TR, 1993, J APPL PHYSIOL, V74, P1879, DOI 10.1152/jappl.1993.74.4.1879; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li WY, 2006, J GEN PHYSIOL, V128, P423, DOI 10.1085/jgp.200609521; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MIURA M, 1992, AM REV RESPIR DIS, V146, P132, DOI 10.1164/ajrccm/146.1.132; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Pico A. R., 2003, THESIS ROCKEFELLER U; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	38	103	108	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					94	U105		10.1038/nature10670	http://dx.doi.org/10.1038/nature10670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22139424	Green Accepted			2022-12-28	WOS:000298836900036
J	Chowdhury, BA; Seymour, SM; Michele, TM; Durmowicz, AG; Liu, DM; Rosebraugh, CJ				Chowdhury, Badrul A.; Seymour, Sally M.; Michele, Theresa M.; Durmowicz, Anthony G.; Liu, Dongmei; Rosebraugh, Curtis J.			The Risks and Benefits of Indacaterol - The FDA's Review	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chowdhury, Badrul A.; Seymour, Sally M.; Michele, Theresa M.; Durmowicz, Anthony G.] US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Liu, Dongmei] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rosebraugh, Curtis J.] US FDA, Off Drug Evaluat 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Barnes PJ, 2010, PULM PHARMACOL THER, V23, P165, DOI 10.1016/j.pupt.2010.01.003; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; European Medicines Agency, HUM MED ONBR BREEZH; Food and Drug Administration, DRUGS FDA FDA APPR D; *FOOD DRUG ADM, M MAT MARCH 8 2011 M	5	34	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2247	2249		10.1056/NEJMp1109621	http://dx.doi.org/10.1056/NEJMp1109621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168640				2022-12-28	WOS:000298031800002
J	Graves, JA; Curtis, R; Gruber, J				Graves, John A.; Curtis, Rick; Gruber, Jonathan			Balancing Coverage Affordability and Continuity under a Basic Health Program Option	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Graves, John A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Curtis, Rick] Inst Hlth Policy Solut, Washington, DC USA; [Gruber, Jonathan] MIT, Cambridge, MA 02139 USA	Vanderbilt University; Massachusetts Institute of Technology (MIT)	Graves, JA (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.							Short PF, 2011, REALIZING HLTH REFOR; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000	2	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					E44	U107		10.1056/NEJMp1111863	http://dx.doi.org/10.1056/NEJMp1111863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861PN	22129219				2022-12-28	WOS:000298031800005
J	Wineland, D				Wineland, David			Norman Ramsey (1915-2011) OBITUARY	NATURE			English	Biographical-Item									NIST, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Wineland, D (corresponding author), NIST, Div Time & Frequency, Boulder, CO 80305 USA.	david.wineland@nist.gov							0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					182	182		10.1038/480182a	http://dx.doi.org/10.1038/480182a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158235	Bronze			2022-12-28	WOS:000297744200034
J	Spangler, JG				Spangler, John G.			His Patients. My Patients.	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Spangler, JG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27103 USA.	jspangle@wakehealth.edu						Fuller A, 2011, WINSTON SALEM J 0709	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2305	2306		10.1001/jama.2011.1747	http://dx.doi.org/10.1001/jama.2011.1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147372				2022-12-28	WOS:000297680300001
J	Palfrey, J; Zittrain, J				Palfrey, John; Zittrain, Jonathan			Better Data for a Better Internet	SCIENCE			English	Editorial Material									[Zittrain, Jonathan] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Zittrain, J (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.	zittrain@law.harvard.edu		Zittrain, Jonathan/0000-0002-3122-0298				Benkler Y., 2009, NEXT GENERATION CONN; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Deibert R., 2010, ACCESS CONTROLLED SH; Mayer-Schonberger V, 2009, SCIENCE, V325, P396, DOI 10.1126/science.1178418; Palfrey J, 2008, ENHANCING CHILD SAFE; Taylor J., 2011, WEB SCI TRUST REV 20; The Framework for Global Electronic Commerce, 1997, FRAM GLOB EL COMM	7	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1210	1211		10.1126/science.1210737	http://dx.doi.org/10.1126/science.1210737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HD	22144603				2022-12-28	WOS:000297553600024
J	Subbaraman, R; Tripkovic, D; Strmcnik, D; Chang, KC; Uchimura, M; Paulikas, AP; Stamenkovic, V; Markovic, NM				Subbaraman, Ram; Tripkovic, Dusan; Strmcnik, Dusan; Chang, Kee-Chul; Uchimura, Masanobu; Paulikas, Arvydas P.; Stamenkovic, Vojislav; Markovic, Nenad M.			Enhancing Hydrogen Evolution Activity in Water Splitting by Tailoring Li+-Ni(OH)(2)-Pt Interfaces	SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; SINGLE-CRYSTAL SURFACES; ELECTROLYTIC HYDROGEN; CO ELECTROOXIDATION; PLATINUM MONOLAYER; SOLID-SURFACES; ADSORPTION; ELECTRODES; OXIDATION; ELECTROCHEMISTRY	Improving the sluggish kinetics for the electrochemical reduction of water to molecular hydrogen in alkaline environments is one key to reducing the high overpotentials and associated energy losses in water-alkali and chlor-alkali electrolyzers. We found that a controlled arrangement of nanometer-scale Ni (OH)(2) clusters on platinum electrode surfaces manifests a factor of 8 activity increase in catalyzing the hydrogen evolution reaction relative to state-of-the-art metal and metal-oxide catalysts. In a bifunctional effect, the edges of the Ni(OH)(2) clusters promoted the dissociation of water and the production of hydrogen intermediates that then adsorbed on the nearby Pt surfaces and recombined into molecular hydrogen. The generation of these hydrogen intermediates could be further enhanced via Li+-induced destabilization of the HO-H bond, resulting in a factor of 10 total increase in activity.	[Subbaraman, Ram; Tripkovic, Dusan; Strmcnik, Dusan; Chang, Kee-Chul; Uchimura, Masanobu; Paulikas, Arvydas P.; Stamenkovic, Vojislav; Markovic, Nenad M.] Argonne Natl Lab, Div Mat Sci, Lemont, IL 60559 USA; [Subbaraman, Ram] Argonne Natl Lab, Nucl Engn Div, Lemont, IL 60559 USA; [Uchimura, Masanobu] Nissan Res Ctr, Adv Mat Lab, Kanagawa 2378523, Japan	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Nissan Motor Company	Markovic, NM (corresponding author), Argonne Natl Lab, Div Mat Sci, Lemont, IL 60559 USA.	nmmarkovic@anl.gov	Chang, Kee-Chul/O-9938-2014; Stamenkovic, Vojislav/AAF-1435-2019; Stamenkovic, Vojislav/ABD-5466-2021	Chang, Kee-Chul/0000-0003-1775-2148; Stamenkovic, Vojislav/0000-0002-1149-3563	Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences, U.S. Department of Energy [DE-AC02-06CH11357]	Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Supported by the Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences, U.S. Department of Energy, under contract DE-AC02-06CH11357. A patent application related to the materials and design presented here has been submitted.	Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; Arenz M, 2005, J AM CHEM SOC, V127, P6819, DOI 10.1021/ja043602h; Balasubramanian M, 1999, J ELECTROCHEM SOC, V146, P607, DOI 10.1149/1.1391651; Beck F., 1987, ULLMANNS ENCY IND A, V9, P183; Birry L, 2004, J APPL ELECTROCHEM, V34, P735, DOI 10.1023/B:JACH.0000031161.26544.6a; CAMPBELL CT, 1990, ANNU REV PHYS CHEM, V41, P775; Chlistunoff J, 2004, ADV CHLOR ALKALI TEC; CONWAY BE, 1986, J ELECTROANAL CHEM, V198, P149, DOI 10.1016/0022-0728(86)90033-1; Conway BE, 2002, ELECTROCHIM ACTA, V47, P3571, DOI 10.1016/S0013-4686(02)00329-8; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Gandia LM, 2007, ENERG FUEL, V21, P1699, DOI 10.1021/ef060491u; Gerischer H., 1958, B SOC CHIM BELG, V67, P506, DOI [10.1002/bscb.19580670714, DOI 10.1002/BSCB.19580670714]; Gileadi, 2011, PHYS ELECTROCHEMISTR; Greeley J, 2006, NAT MATER, V5, P909, DOI 10.1038/nmat1752; Greeley J, 2006, CHEMPHYSCHEM, V7, P1032, DOI 10.1002/cphc.200500663; Han Q, 2003, INT J HYDROGEN ENERG, V28, P1345, DOI 10.1016/S0360-3199(03)00043-0; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; Henrich V. E., 1994, SURFACE SCI METAL OX; Jaksic M. M., 1987, International Journal of Hydrogen Energy, V12, P727, DOI 10.1016/0360-3199(87)90090-5; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kinoshita K., 1992, ELECTROCHEMICAL OXYG; Knudsen J, 2010, ACS NANO, V4, P4380, DOI 10.1021/nn101241c; Lasia A, 2003, HDB FUEL CELLS FUNDA, P416; LOS P, 1993, J APPL ELECTROCHEM, V23, P135; MARINKOVIC NS, 1992, J ELECTROANAL CHEM, V330, P433, DOI 10.1016/0022-0728(92)80323-V; Markovic NM, 1996, J CHEM SOC FARADAY T, V92, P3719, DOI 10.1039/ft9969203719; Markovic NM, 1997, J PHYS CHEM B, V101, P5405, DOI 10.1021/jp970930d; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; Merte LR, 2009, SURF SCI, V603, pL15, DOI 10.1016/j.susc.2008.11.014; Miousse D, 1999, J NEW MAT ELECT SYST, V2, P71; Moorhouse J., 2001, MODERN CHLOR ALKALI, V8; O'Brien T., 2005, HDB CHLOR ALKALI TEC, V4; PARSONS R, 1958, T FARADAY SOC, V54, P1053, DOI 10.1039/tf9585401053; Pletcher D., 1993, IND ELECTROCHEMISTRY; ROBINSON IK, 1986, PHYS REV B, V33, P3830, DOI 10.1103/PhysRevB.33.3830; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Russell AE, 2004, CHEM REV, V104, P4613, DOI 10.1021/cr020708r; SETO K, 1987, J ELECTROANAL CHEM, V226, P351, DOI 10.1016/0022-0728(87)80057-8; Stoffelsma C, 2010, J AM CHEM SOC, V132, P16127, DOI 10.1021/ja106389k; Strmcnik D, 2009, NAT CHEM, V1, P466, DOI [10.1038/NCHEM.330, 10.1038/nchem.330]; Strmcnik D, 2010, NAT CHEM, V2, P880, DOI [10.1038/nchem.771, 10.1038/NCHEM.771]; Strmcnik DS, 2008, J AM CHEM SOC, V130, P15332, DOI 10.1021/ja8032185; Subbaraman R, 2010, J PHYS CHEM C, V114, P8414, DOI 10.1021/jp100814x; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X; TIDSWELL IM, 1994, SURF SCI, V317, P241, DOI 10.1016/0039-6028(94)90271-2; TRASATTI S, 1972, J ELECTROANAL CHEM, V39, P163, DOI 10.1016/0368-1874(72)85118-9; Trinidad P, 1996, ELECTROCHIM ACTA, V41, P493, DOI 10.1016/0013-4686(95)00335-5; Zhang J, 2005, J PHYS CHEM B, V109, P22701, DOI 10.1021/jp055634c	48	1874	1896	105	1724	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1256	1260		10.1126/science.1211934	http://dx.doi.org/10.1126/science.1211934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144621				2022-12-28	WOS:000297553600045
J	Tsokos, GC				Tsokos, George C.			MECHANISMS OF DISEASE Systemic Lupus Erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPSTEIN-BARR-VIRUS; ALPHA-ACTININ ANTIBODIES; PLACEBO-CONTROLLED TRIAL; B-CELL DEPLETION; FC-GAMMA-RIIB; DOUBLE-BLIND; T-CELLS; PRONE MICE; COMPLEMENT ACTIVATION; AUTOIMMUNE-DISEASE		Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol, 330 Brookline Ave,CLS 937, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360				Alarcon-Segovia D, 2003, ARTHRITIS RHEUM, V48, P442, DOI 10.1002/art.10763; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Battafarano DF, 1998, ARTHRITIS RHEUM, V41, P1828, DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boumpas DT, 2010, ANN RHEUM DIS, V69, P2059, DOI 10.1136/ard.2010.139683; Brodsky RA, 2008, BLOOD REV, V22, P65, DOI 10.1016/j.blre.2007.10.002; Brucato A, 2011, CLIN REV ALLERG IMMU, V40, P27, DOI 10.1007/s12016-009-8190-6; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Chang DM, 2002, ARTHRITIS RHEUM, V46, P2924, DOI 10.1002/art.10615; Cohen PL, 2004, RHEUM DIS CLIN N AM, V30, P473, DOI 10.1016/j.rdc.2004.04.003; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Decker P, 2005, J IMMUNOL, V174, P3326, DOI 10.4049/jimmunol.174.6.3326; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; Deng GM, 2010, J IMMUNOL, V184, P7154, DOI 10.4049/jimmunol.0902514; Doria A, 2002, ARTHRIT RHEUM-ARTHR, V47, P202, DOI 10.1002/art.10248; Duarte C, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P673; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; Gorman CL, 2008, J IMMUNOL, V180, P1060, DOI 10.4049/jimmunol.180.2.1060; Hahn BH, 2005, ANN NY ACAD SCI, V1051, P433, DOI 10.1196/annals.1361.085; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; Hedberg A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3281; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ichinose K, 2011, ARTHRITIS RHEUM-US, V63, P523, DOI 10.1002/art.30085; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Jacobi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005776; Juang YT, 2011, LUPUS, V20, P243, DOI 10.1177/0961203310383072; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Kelley J, 2007, ARTHRITIS RHEUM, V56, P3375, DOI 10.1002/art.22916; KIMBERLY RP, 1987, RHEUM DIS CLIN N AM, V13, P583; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kyttaris VC, 2011, ARTHRITIS RHEUM-US, V63, P2058, DOI 10.1002/art.30353; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; LEIJH PCJ, 1979, J CLIN INVEST, V63, P772, DOI 10.1172/JCI109362; Li X, 2009, GENES IMMUN, V10, P380, DOI 10.1038/gene.2009.35; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Liu K, 2009, J CLIN INVEST, V119, P911, DOI 10.1172/JCI36728; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Lu TYT, 2009, ARTHRIT RHEUM-ARTHR, V61, P482, DOI 10.1002/art.24341; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manson JJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2831; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Niederer HA, 2010, ANN NY ACAD SCI, V1183, P69, DOI 10.1111/j.1749-6632.2009.05132.x; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Radhakrishnan J, 2010, KIDNEY INT, V77, P152, DOI 10.1038/ki.2009.412; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Ramos-Casals M, 2009, LUPUS, V18, P767, DOI 10.1177/0961203309106174; Renaudineau Y, 2007, AUTOIMMUN REV, V6, P464, DOI 10.1016/j.autrev.2007.02.001; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; Simard JF, 2009, LUPUS, V18, P431, DOI 10.1177/0961203308098186; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan W, 2011, ARTHRITIS RHEUM 0516; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Tsai CY, 2000, NEPHRON, V85, P207, DOI 10.1159/000045663; Tsokos GC, 2000, MOL MED TODAY, V6, P418, DOI 10.1016/S1357-4310(00)01798-6; TSOKOS GC, 1983, J IMMUNOL, V131, P1797; Tsokos GC, 2004, CURR DIRECT AUTOIMMU, V7, P149; Urowitz MB, 2007, LUPUS, V16, P731, DOI 10.1177/0961203307081113; Urowitz MB, 2010, ARTHRIT CARE RES, V62, P881, DOI 10.1002/acr.20122; UROWITZ MB, 1993, ARTHRITIS RHEUM, V36, P1392, DOI 10.1002/art.1780361011; Valdivielso P, 2008, CLIN EXP RHEUMATOL, V26, P827; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385	100	653	695	8	259	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2110	2121		10.1056/NEJMra1100359	http://dx.doi.org/10.1056/NEJMra1100359			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129255				2022-12-28	WOS:000297499000011
J	Delaugerre, C; De Oliveira, F; Lascoux-Combe, C; Plantier, JC; Simon, F				Delaugerre, Constance; De Oliveira, Fabienne; Lascoux-Combe, Caroline; Plantier, Jean-Christophe; Simon, Francois			HIV-1 group N: travelling beyond Cameroon	LANCET			English	Editorial Material							IDENTIFICATION		[Delaugerre, Constance; Simon, Francois] CHU St Louis, Microbiol Serv, INSERM, Fac Med Paris Diderot,U941, F-75475 Paris, France; [Lascoux-Combe, Caroline] CHU St Louis, Serv Malad Infect & Trop, INSERM, Fac Med Paris Diderot,U941, F-75475 Paris, France; [De Oliveira, Fabienne; Plantier, Jean-Christophe] CHU Charles Nicolle, Serv Virol, Lab Associe Ctr Natl Reference VIH, Rouen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen	Simon, F (corresponding author), CHU St Louis, Microbiol Serv, INSERM, Fac Med Paris Diderot,U941, 1 Ave Claude Vellefaux, F-75475 Paris, France.	francois.simon@sls.aphp.fr		PLANTIER, Jean-Christophe/0000-0001-6417-4083				Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Roques P, 2004, AIDS, V18, P1371, DOI 10.1097/01.aids.0000125990.86904.28; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83	5	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 26	2011	378	9806					1894	1894		10.1016/S0140-6736(11)61457-8	http://dx.doi.org/10.1016/S0140-6736(11)61457-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	22118443				2022-12-28	WOS:000297695800034
J	Daniel, SB; Lovegrove, MC; Shehab, N; Richards, CL				Budnitz, Daniel S.; Lovegrove, Maribeth C.; Shehab, Nadine; Richards, Chesley L.			Emergency Hospitalizations for Adverse Drug Events in Older Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPARTMENT VISITS; MEDICATION USE; ADMISSIONS; SURVEILLANCE; SAFETY	BACKGROUND Adverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse drug events that result in hospitalization in this population have been limited. METHODS We used adverse-event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2007 through 2009) to estimate the frequency and rates of hospitalization after emergency department visits for adverse drug events in older adults and to assess the contribution of specific medications, including those identified as high-risk or potentially inappropriate by national quality measures. RESULTS On the basis of 5077 cases identified in our sample, there were an estimated 99,628 emergency hospitalizations (95% confidence interval [CI], 55,531 to 143,724) for adverse drug events in U. S. adults 65 years of age or older each year from 2007 through 2009. Nearly half of these hospitalizations were among adults 80 years of age or older (48.1%; 95% CI, 44.6 to 51.6). Nearly two thirds of hospitalizations were due to unintentional overdoses (65.7%; 95% CI, 60.1 to 71.3). Four medications or medication classes were implicated alone or in combination in 67.0% (95% CI, 60.0 to 74.1) of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). High-risk medications were implicated in only 1.2% (95% CI, 0.7 to 1.7) of hospitalizations. CONCLUSIONS Most emergency hospitalizations for recognized adverse drug events in older adults resulted from a few commonly used medications, and relatively few resulted from medications typically designated as high-risk or inappropriate. Improved management of antithrombotic and antidiabetic drugs has the potential to reduce hospitalizations for adverse drug events in older adults.	[Budnitz, Daniel S.; Lovegrove, Maribeth C.; Shehab, Nadine] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Richards, Chesley L.] Ctr Dis Control & Prevent, Off Prevent Healthcare, Atlanta, GA 30333 USA; [Richards, Chesley L.] Emory Univ, Sch Med, Div Geriatr & Gerontol, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Daniel, SB (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.	dbudnitz@cdc.gov	Hug, Balthasar L./G-1568-2010	Budnitz, Daniel/0000-0002-0136-2623; Shehab, Nadine/0000-0001-8700-8539				Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; [Anonymous], HEALTHC EFF DAT INF; [Anonymous], PATT MED US US 2006; [Anonymous], 2002, NAT EL INJ SURV SYST; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Buie VC, 2010, VITAL HLTH STAT, V13, P168; Burt CW, 2002, HEALTH AFFAIR, V21, P206, DOI 10.1377/hlthaff.21.4.206; Centers for Disease Control and Prevention, BRIDG RAC POP EST US; Centers for Disease Control and Prevention, AMB HLTH CAR DAT; Curtiss FR, 2011, J MANAGE CARE PHARM, V17, P60, DOI 10.18553/jmcp.2011.17.1.60; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Fick, 2004, ARCH INTERN MED, V164, P298; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Gage BF, 2009, NEW ENGL J MED, V361, P1200, DOI 10.1056/NEJMe0906886; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; HealthCare. gov, PARTN PAT BETT CAR L; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Jha AK, 2001, PHARMACOEPIDEM DR S, V10, P113, DOI 10.1002/pds.568; Jhung MA, 2007, MED CARE, V45, pS96, DOI 10.1097/MLR.0b013e318041f737; Kim MM, 2010, PHARMACOEPIDEM DR S, V19, P731, DOI 10.1002/pds.1953; Kish L, 1995, SCI 1995; Kocher R, 2010, ANN INTERN MED, V153, P536, DOI 10.7326/0003-4819-153-8-201010190-00274; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; National Quality Forum, NQF END STAND; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Pogach L, 2010, JAMA-J AM MED ASSOC, V303, P2076, DOI 10.1001/jama.2010.655; Shehab N, 2010, ARCH INTERN MED, V170, P1926, DOI 10.1001/archinternmed.2010.407; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Spinler SA, 2009, PHARMACOTHERAPY, V29, P812, DOI 10.1592/phco.29.7.812; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Streiff MB, 2010, ANN PHARMACOTHER, V44, P733, DOI 10.1345/aph.1M666; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785; Wears RL, 2010, ANN EMERG MED, V55, P511, DOI 10.1016/j.annemergmed.2010.01.018; Wu WK, 2003, AM J HEALTH-SYST PH, V60, P253, DOI 10.1093/ajhp/60.3.253; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	41	1084	1113	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					2002	2012		10.1056/NEJMsa1103053	http://dx.doi.org/10.1056/NEJMsa1103053			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22111719	Bronze			2022-12-28	WOS:000297282600010
J	Rouhe, H				Rouhe, Hanna			Should women be able to request a caesarean section? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL REQUEST; FEAR; BIRTH		Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Rouhe, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland.	hanna.rouhe@helsinki.fi						Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Bewley S, 2002, LANCET, V359, P2128, DOI 10.1016/S0140-6736(02)09113-4; Fisher J, 1997, AUST NZ J PSYCHIAT, V31, P728, DOI 10.3109/00048679709062687; Gilliam M, 2006, SEMIN PERINATOL, V30, P257, DOI 10.1053/j.semperi.2006.07.005; Nerum H, 2006, BIRTH-ISS PERINAT C, V33, P221, DOI 10.1111/j.1523-536X.2006.00107.x; Rouhe H, 2011, BJOG, V118, P1105; Saisto T, 2006, ACTA OBSTET GYN SCAN, V85, P1315, DOI 10.1080/00016340600756920; Salmela-Aro K, 2011, J HLTH PSYCHOL  0929; Wagner M, 2000, LANCET, V356, P1677, DOI 10.1016/S0140-6736(00)03169-X; Wiklund I, 2007, ACTA OBSTET GYN SCAN, V86, P451, DOI 10.1080/00016340701217913; Zelop C, 2004, CLIN OBSTET GYNECOL, V47, P386, DOI 10.1097/00003081-200406000-00012	11	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2011	343								d7565	10.1136/bmj.d7565	http://dx.doi.org/10.1136/bmj.d7565			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875FH	22113836				2022-12-28	WOS:000299015300008
J	Gilbert, R; Fluke, J; O'Donnell, M; Gonzalez-Izquierdo, A; Brownell, M; Gulliver, P; Janson, S; Sidebotham, P				Gilbert, Ruth; Fluke, John; O'Donnell, Melissa; Gonzalez-Izquierdo, Arturo; Brownell, Marni; Gulliver, Pauline; Janson, Staffan; Sidebotham, Peter			Child maltreatment: variation in trends and policies in six developed countries	LANCET			English	Review							POSITIVE PARENTING PROGRAM; CORPORAL PUNISHMENT; BEHAVIORAL OUTCOMES; ABUSE; PROTECTION; INJURY; PREVENTION; EPIDEMIOLOGY; FRACTURES; VIOLENCE	We explored trends in six developed countries in three types of indicators of child maltreatment for children younger than 11 years, since the inception of modern child protection systems in the 1970s. Despite several policy initiatives for child protection, we recorded no consistent evidence for a decrease in all types of indicators of child maltreatment. We noted falling rates of violent death in a few age and country groups, but these decreases coincided with reductions in admissions to hospital for maltreatment-related injury only in Sweden and Manitoba (Canada). One or more child protection agency indicators increased in five of six countries, particularly in infants, possibly as a result of early intervention policies. Comparisons of mean rates between countries showed five-fold to ten-fold differences in rates of agency indicators, but less than two-fold variation in violent deaths or maltreatment-related injury, apart from high rates of violent child death in the USA. These analyses draw attention to the need for robust research to establish whether the high and rising rates of agency contacts and out-of-home care in some settings are effectively reducing child maltreatment.	[Gilbert, Ruth; Gonzalez-Izquierdo, Arturo] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London WC1N 1EH, England; [Fluke, John] Amer Humane Assoc, Child Protect Res Ctr, Englewood, CO USA; [O'Donnell, Melissa] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Brownell, Marni] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Gulliver, Pauline] Univ Otago, Injury Prevent Res Unit, Dunedin, New Zealand; [Janson, Staffan] Karlstad Univ, Dept Publ Hlth, Karlstad, Sweden; [Janson, Staffan] Univ Orebro, Dept Paediat, Orebro, Sweden; [Sidebotham, Peter] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Western Australia; University of Manitoba; University of Otago; Karlstad University; Orebro University; University of Warwick	Gilbert, R (corresponding author), UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, 30 Guilford St, London WC1N 1EH, England.	r.gilbert@ich.ucl.ac.uk	Gulliver, Pauline/N-1513-2014; Sidebotham, Peter D/E-3011-2010; O'Donnell, Melissa/H-5555-2014	Gulliver, Pauline/0000-0002-7249-5132; Sidebotham, Peter D/0000-0003-4891-6926; Brownell, Marni/0000-0001-7673-4404; Gilbert, Ruth/0000-0001-9347-2709; O'Donnell, Melissa/0000-0003-2440-3667; Gonzalez-Izquierdo, Arturo/0000-0002-0984-5830	Department of Health for England; Manitoba Centre for Health Policy; Child Protection Research Center at the American Humane Association; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546, G0400546B] Funding Source: researchfish	Department of Health for England; Manitoba Centre for Health Policy; Child Protection Research Center at the American Humane Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Researchers funded by The Department of Health for England, The Manitoba Centre for Health Policy, and the Child Protection Research Center at the American Humane Association contributed to the analyses or to the writing of the report, or both. We thank Pernilla Fagerstrom and Marika Holmqvist (The National Board of Health and Welfare, Stockholm, Sweden), Sarah Wolstenholme (Department for Education, London, UK), Francesco Mitis (WHO European Centre for Environment and Health, Rome, Italy), and Kaija Pay (Department for Child Protection, Government of Western Australia, Australia) and the Western Australian Data Linkage Unit (West Perth, Australia) for assisting with data extraction; Okechukwu Ekuma (Manitoba Centre for Health Policy, Department of Community Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada) and Kim Wittenstrom (Child Protection Research Center, American Humane Association, Englewood, CO, USA) for assisting with analyses; James Mansell (Ministry of Development, Wellington, New Zealand) for providing guidance about interpretation of agency indicators; Mario Cortina-Borja (UCL Institute of Child Health, London, UK) for providing advice about the time-trend analyses; Des Runyan (Kempe Center for the Prevention and Treatment of Child Abuse and Neglect, School of Medicine, University of Colorado, Denver, CO, USA) for helpful advice in the early stages of the project; James Mansell (Ministry of Development, Wellington, New Zealand) for comments on the study design and results of analyses; Fiona Stanley (Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, WA, Australia) and John Langley (Injury Prevention research Unit, University of Otago, Dunedin, New Zealand) for helping to conceptualise the project and for commenting on drafts of the report; Jenny Woodman (UCL Institute of Child Health, London, UK) for comments on the report; Colin Pritchard (School of Health and Social Care, Bournemouth University, Bournemouth, UK) for discussions at the start of the project; and June Thoburn (Faculty of Social Sciences, School of Social Work and psychology, University of East Anglia, Norwich, UK) and Danya Glaser (Department of Child and Adolescent Mental Health, Great Ormond Street Hospital for Children, London, UK) for comments on the analyses and report. This article does not necessarily reflect the views of the government departments who provided data for this research or of the funding bodies.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1984, 5 STANF U LAB COMP S; Australian Institute of Health and Welfare, 1999, COMP CHILD PROT DAT; Ayre P, 2001, BRIT J SOC WORK, V31, P887, DOI 10.1093/bjsw/31.6.887; Baumann DJ, 2011, MONOGRAPH AM HUMANE; Bullock R., 1995, CHILD PROTECTION MES; Casey Family Programs: 2020 strategy, 2010, CAS FAM PROGR 2020 S; Cawson P., 2000, CHILD MALTREATMENT U; Cross TP, 2009, CHILD MALTREATMENT, V14, P38, DOI 10.1177/1077559508318400; Department for Health Home Office Department of education and employment, 1999, WORK TOG SAF CHILDR, P1; Devaney J, 2009, CHILD YOUTH SERV REV, V31, P635, DOI 10.1016/j.childyouth.2008.12.003; Doyle JJ, 2008, J POLIT ECON, V116, P746, DOI 10.1086/590216; Drake B, 2007, CHILD ABUSE NEGLECT, V31, P343, DOI 10.1016/j.chiabu.2006.08.009; Fallon B, 2010, CHILD ABUSE NEGLECT, V34, P70, DOI 10.1016/j.chiabu.2009.08.008; Finkelhor D, 2010, ARCH PEDIAT ADOL MED, V164, P238, DOI 10.1001/archpediatrics.2009.283; Finkelhor D, 2009, J INTERPERS VIOLENCE, V24, P711, DOI 10.1177/0886260508317185; Flaherty Emalee G, 2008, Pediatrics, V122 Suppl 1, pS1, DOI 10.1542/peds.2008-0715c; Franzen E, 2008, BRIT J SOC WORK, V38, P1043, DOI 10.1093/bjsw/bcl380; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Gonzalez-Izquierdo A, 2010, ARCH DIS CHILD, V95, P918, DOI 10.1136/adc.2009.180216; HCUP Kids' Inpatient Database (KID), 1997, HCUP KIDS INP DAT KI; Healthcare Cost and Utilization Project (HCUP), 2000, HCUP KIDS INP DAT KI; Healthcare Cost and Utilization Project (HCUP), 2011, HCUP KIDS INP DAT KI; Healthcare Cost and Utilization Project (HCUP), 2003, HCUP KIDS INP DAT KI; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP KIDS INP DAT KI; Hirte C., 2008, CONTACT S AUSTR CHIL; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Janson S., 2007, VIOLENCE CHILDREN SW; Jones LM, 2006, CHILD MALTREATMENT, V11, P107, DOI 10.1177/1077559505284375; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Keller M, 2010, ACTA PAEDIATR, V99, P1624, DOI 10.1111/j.1651-2227.2010.01894.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lawrence CR, 2006, DEV PSYCHOPATHOL, V18, P57, DOI 10.1017/S0954579406060044; Laws PJ, 2007, PERINATAL STAT SERIE, V20; Leventhal JM, 2007, CHILD ABUSE NEGLECT, V31, P311, DOI 10.1016/j.chiabu.2006.07.004; Louwers ECFM, 2011, ARCH DIS CHILD, V96, P422, DOI 10.1136/adc.2010.202358; Macdonald GM, 2008, COCHRANE DB SYST REV, V1; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; Mansell J, 2007, SOC POLICY J N Z, V18, P97; Mathews B, 2009, ARCH DIS CHILD, V94, P329, DOI 10.1136/adc.2008.154997; Melton GB, 2005, CHILD ABUSE NEGLECT, V29, P9, DOI 10.1016/j.chiabu.2004.05.005; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Moss E, 2011, DEV PSYCHOPATHOL, V23, P195, DOI 10.1017/S0954579410000738; Munro E, 2005, CHILD YOUTH SERV REV, V27, P375, DOI 10.1016/j.childyouth.2004.11.006; Munro E., 2010, MUNRO REV CHILD PROT; NCANDS. National Child Abuse and Neglect Data System, 2011, NAT DAT ARCH CHILD A; New Zealand Health Information Service, 2007, REP MAT MAT NEWB INF; Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0; Nygren P, 2004, ANN FAM MED, V2, P161, DOI 10.1370/afm.113; O'Donnell M, J PAEDIAT C IN PRESS; O'Donnell M, 2008, AUST NZ J PUBL HEAL, V32, P325, DOI 10.1111/j.1753-6405.2008.00249.x; Oecd, 2021, MAIN EC IND, V2021, DOI [10.1787/07fb6059-en, DOI 10.1787/07FB6059-EN]; Parton N, 2011, BRIT J SOC WORK, V41, P854, DOI 10.1093/bjsw/bcq119; Paxson C, 2003, J POLICY ANAL MANAG, V22, P85, DOI 10.1002/pam.10097; Plummer CA, 2007, J INTERPERS VIOLENCE, V22, P775, DOI 10.1177/0886260507300753; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Putnam-Hornstein E, 2011, CHILD MALTREATMENT, V16, P163, DOI 10.1177/1077559511411179; Radford L., 2011, MALTREATMENT VICTIMI; Reading R, 2009, LANCET, V373, P332, DOI 10.1016/S0140-6736(08)61709-2; Roberts JV, 2000, CHILD ABUSE NEGLECT, V24, P1027, DOI 10.1016/S0145-2134(00)00155-1; Runyan DK, 2010, PEDIATRICS, V126, pE701, DOI 10.1542/peds.2008-2374; Runyan DK, 2011, INT ISSUES CHILD MAL, P617; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sedlak A. J., 2010, US DEP HLTH HUM SERV; Sidebotham P, 2006, CHILD ABUSE NEGLECT, V30, P497, DOI 10.1016/j.chiabu.2005.11.005; Sidebotham P, 2012, ARCH DIS CHILD, V97, P193, DOI 10.1136/adc.2010.207647; Skellern C, 2008, J PAEDIATR CHILD H, V44, P736, DOI 10.1111/j.1440-1754.2008.01423.x; Smith AB., 2010, GLOBAL PATHWAYS ABOL, P241; Sonderegger DL, 2009, FRONT ECOL ENVIRON, V7, P190, DOI 10.1890/070179; Taitz J, 2004, J PAEDIATR CHILD H, V40, P170, DOI 10.1111/j.1440-1754.2004.00332.x; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Thoburn J., 2010, INT J CHILD FAMILY W, V12, P34; Thoburn J., 2008, GLOBALISATION CHILD; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Trocme N, 2003, OVERVIEW DIFFERENTIA, V1; Trocme NM, 2003, CHILD ABUSE NEGLECT, V27, P1427, DOI 10.1016/j.chiabu.2003.07.003; UNICEF, 2007, REP CARD 7 CHILD POV; Venables WN., 2002, MODERN APPL STAT S; Waldegrave C, 2006, SOC POLICY J N Z, V27, P57; Waldegrave S, 2005, SOC POLICY J N Z, V25, P48; Waldfogel J, 2004, CHILD YOUTH SERV REV, V26, P919, DOI 10.1016/j.childyouth.2004.04.002; Waldfogel J, 2009, FUTURE CHILD, V19, P195; Winokur M, 2009, COCHRANE DB SYST REV, V1; Wulczyn F, 2009, FUTURE CHILD, V19, P39; Zolotor AJ, 2011, CHILD ABUSE REV, V20, P57, DOI 10.1002/car.1128; Zolotor AJ, 2009, CHILD ABUSE NEGLECT, V33, P833, DOI 10.1016/j.chiabu.2009.09.004	89	206	206	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					758	772		10.1016/S0140-6736(11)61087-8	http://dx.doi.org/10.1016/S0140-6736(11)61087-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	22169108				2022-12-28	WOS:000300792600032
J	Castets, M; Broutier, L; Molin, Y; Brevet, M; Chazot, G; Gadot, N; Paquet, A; Mazelin, L; Jarrosson-Wuilleme, L; Scoazec, JY; Bernet, A; Mehlen, P				Castets, Marie; Broutier, Laura; Molin, Yann; Brevet, Marie; Chazot, Guillaume; Gadot, Nicolas; Paquet, Armelle; Mazelin, Laetitia; Jarrosson-Wuilleme, Loraine; Scoazec, Jean-Yves; Bernet, Agnes; Mehlen, Patrick			DCC constrains tumour progression via its dependence receptor activity	NATURE			English	Article							COLORECTAL TUMORIGENESIS; CANCER; GENE; ACTIVATION; APOPTOSIS; IDENTIFICATION; MECHANISM; MODEL; GAPS; MICE	The role of deleted in colorectal carcinoma (DCC) as a tumour suppressor has been a matter of debate for the past 15 years. DCC gene expression is lost or markedly reduced in the majority of advanced colorectal cancers(1) and, by functioning as a dependence receptor, DCC has been shown to induce apoptosis unless engaged by its ligand, netrin-1 (ref. 2). However, so far no animal model has supported the view that the DCC loss-of-function is causally implicated as predisposing to aggressive cancer development(3). To investigate the role of DCC-induced apoptosis in the control of tumour progression, here we created a mouse model in which the pro-apoptotic activity of DCC is genetically silenced. Although the loss of DCC-induced apoptosis in this mouse model is not associated with a major disorganization of the intestines, it leads to spontaneous intestinal neoplasia at a relatively low frequency. Loss of DCC-induced apoptosis is also associated with an increase in the number and aggressiveness of intestinal tumours in a predisposing APC mutant context, resulting in the development of highly invasive adenocarcinomas. These results demonstrate that DCC functions as a tumour suppressor via its ability to trigger tumour cell apoptosis.	[Castets, Marie; Broutier, Laura; Molin, Yann; Chazot, Guillaume; Mazelin, Laetitia; Jarrosson-Wuilleme, Loraine; Bernet, Agnes; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard,Ctr Cancerol Lyon,INSERM,U1052, Equipe Labellise La Ligue,LabEX DEVweCAN,CNRS,UMR, F-69008 Lyon, France; [Brevet, Marie; Gadot, Nicolas; Paquet, Armelle; Scoazec, Jean-Yves] Univ Lyon, Hop Edouard Herriot, Endocrine Differentiat Lab,CNRS,UMR5286, Hosp Civils Lyon,Ctr Cancerol Lyon,INSERM,U1052, F-69437 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mehlen, P (corresponding author), Univ Lyon, Apoptosis Canc & Dev Lab, Ctr Leon Berard,Ctr Cancerol Lyon,INSERM,U1052, Equipe Labellise La Ligue,LabEX DEVweCAN,CNRS,UMR, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr	Bernet, Agnes/GSN-2702-2022; Castets, Marie/L-2059-2018; Mazelin, Laetitia/AAD-9319-2020; BROUTIER, Laura/X-8536-2019	Mazelin, Laetitia/0000-0002-4001-2132; BROUTIER, Laura/0000-0001-5163-5573; BREVET, Marie/0000-0003-2275-691X	Ligue Contre le Cancer; INCA; ANR; IP ApoSys; LabEX DEVweCAN [ANR-10-LABX-61]	Ligue Contre le Cancer(Ligue nationale contre le cancer); INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); IP ApoSys; LabEX DEVweCAN	We wish to thank D. E. Bredesen and J.-G. Delcros for critical reading of the manuscript. We thank C. H. Herbreteau and C. Bonod-Bidaud for their initial involvement in this work and the animal facility staff for animal care. We thank the ICS for the generation of the DCC mutant mice. We thank the LMT (Laboratoire des Modeles Tumoraux) and AniPath for the analysis of animal models. This work was supported by institutional grants from the Ligue Contre le Cancer, INCA, ANR, IP ApoSys and the LabEX DEVweCAN (ANR-10-LABX-61).	Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P1769, DOI 10.1053/j.gastro.2007.09.011; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Roush W, 1997, SCIENCE, V276, P534, DOI 10.1126/science.276.5312.534; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015	18	76	77	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					534	U259		10.1038/nature10708	http://dx.doi.org/10.1038/nature10708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22158121				2022-12-28	WOS:000300770500052
J	Iglehart, JK				Iglehart, John K.			Expanding Eligibility, Cutting Costs - A Medicaid Update	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2011, REP C EV MAN CAR MED; Gifford K, PROFILE MEDICAID MAN; Keehan SP, 2011, HEALTH AFFAIR, V30, P1594, DOI 10.1377/hlthaff.2011.0662; Rosenbaum S, 2011, NEW ENGL J MED, V365, P2245, DOI 10.1056/NEJMp1111428; Smith VK, MOVING AHEAD FISCAL	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					105	107		10.1056/NEJMp1113561	http://dx.doi.org/10.1056/NEJMp1113561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874VA	22149734				2022-12-28	WOS:000298985000003
J	Habibzadeh, F				Habibzadeh, Farrokh			The control of non-communicable diseases in rural Iran	LANCET			English	Editorial Material							HEALTH		Shiraz NIOC Med Educ & Res Ctr, Shiraz 71955, Iran		Habibzadeh, F (corresponding author), Shiraz NIOC Med Educ & Res Ctr, POB 71955-575, Shiraz 71955, Iran.	farrokh.habibzadeh@theijoem.com	Habibzadeh, Farrokh/ABA-5286-2021	Habibzadeh, Farrokh/0000-0001-5360-2900				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Beaglehole R, 2011, LANCET, V378, P1283, DOI 10.1016/S0140-6736(11)61559-6; Bristol N, 2010, LANCET, V375, P625, DOI 10.1016/S0140-6736(10)60250-4; Dusing R, 2006, CURR MED RES OPIN, V22, P1545, DOI 10.1185/030079906X120995; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Hatmi Z N, 2007, BMC Cardiovasc Disord, V7, P32, DOI 10.1186/1471-2261-7-32; Kelishadi R, 2008, PUBLIC HEALTH NUTR, V11, P246, DOI 10.1017/S1368980007000262; Khosravi A, 2007, B WORLD HEALTH ORGAN, V85, P607, DOI 10.2471/BLT.06.038802; Naderi T, 2003, J OBSTET GYNAECOL RE, V29, P59, DOI 10.1046/j.1341-8076.2003.00082.x; Ooms G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-17; United Nations, 2011, A66L1 UN; WHO, 2011, GLOB STAT REP NONC D	12	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					6	7		10.1016/S0140-6736(11)61678-4	http://dx.doi.org/10.1016/S0140-6736(11)61678-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22169104				2022-12-28	WOS:000298913000008
J	Ng, EP; Chateigner, D; Bein, T; Valtchev, V; Mintova, S				Eng-Poh Ng; Chateigner, Daniel; Bein, Thomas; Valtchev, Valentin; Mintova, Svetlana			Capturing Ultrasmall EMT Zeolite from Template-Free Systems	SCIENCE			English	Article							CROWN-ETHERS; RICH FAUJASITE; FAU; MECHANISM; SIZE	Small differences between the lattice energies of different zeolites suggest that kinetic factors are of major importance in controlling zeolite nucleation. Thus, it is critical to control the nucleation kinetics in order to obtain a desired microporous material. Here, we demonstrate how careful investigation of the very early stages of zeolite crystallization in colloidal systems can provide access to important nanoscale zeolite phases while avoiding the use of expensive organic templates. We report the effective synthesis of ultrasmall (6- to 15-nanometer) crystals of the large-pore zeolite EMT from template-free colloidal precursors at low temperature (30 degrees C) and very high yield.	[Eng-Poh Ng; Valtchev, Valentin; Mintova, Svetlana] Univ Caen, Lab Catalyse & Spectrochim, ENSICAEN, CNRS, F-14050 Caen, France; [Eng-Poh Ng] Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Malaysia; [Chateigner, Daniel] Univ Caen, CRISMAT, ENSICAEN, F-14050 Caen, France; [Bein, Thomas] Univ Munich LMU, Dept Chem, D-81377 Munich, Germany; [Bein, Thomas] Univ Munich LMU, Ctr NanoSci, D-81377 Munich, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Universiti Sains Malaysia; Universite de Caen Normandie; University of Munich; University of Munich	Mintova, S (corresponding author), Univ Caen, Lab Catalyse & Spectrochim, ENSICAEN, CNRS, 6 Blvd Marechal Juin, F-14050 Caen, France.	svetlana.mintova@ensicaen.fr	Bein, Thomas/G-7686-2014; Ng, Eng-Poh/A-6899-2011; Mintova, Svetlana/N-7933-2018; Chateigner, Daniel/A-7654-2008	Bein, Thomas/0000-0001-7248-5906; Ng, Eng-Poh/0000-0002-1260-4552; Mintova, Svetlana/0000-0002-0738-5244; Chateigner, Daniel/0000-0001-7792-8702	FEDER of Down Normandy, NIM (Nano-Initiative-Munich);  [SRIF-ANR-06-NANO-007-01]	FEDER of Down Normandy, NIM (Nano-Initiative-Munich); 	We thank S. Schmidt (LMU) for collecting the TEM data and SRIF-ANR-06-NANO-007-01 Region and FEDER of Down Normandy, NIM (Nano-Initiative-Munich), for financial support.	Baerlocher C, 2007, ATLAS ZEOLITE FRAMEW, P123; BARRETT MG, 1981, Patent No. 2076793; Breck D., 1974, ZEOLITES MOL SIEVES; BURKETT SL, 1993, MICROPOROUS MATER, V1, P265, DOI 10.1016/0927-6513(93)80070-B; Casci JL, 2005, MICROPOR MESOPOR MAT, V82, P217, DOI 10.1016/j.micromeso.2005.01.035; Chateigner D, 2010, WILEY-ISTE, P41; CHATELAIN T, 1995, ZEOLITES, V15, P90, DOI 10.1016/0144-2449(94)00021-J; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DOUGNIER F, 1992, ZEOLITES, V12, P160, DOI 10.1016/0144-2449(92)90078-4; Dougnier F, 1996, MICROPOROUS MATER, V6, P79, DOI 10.1016/0927-6513(95)00082-8; Gonzalez G, 2007, MICROPOR MESOPOR MAT, V101, P30, DOI 10.1016/j.micromeso.2006.11.008; Haas A, 1999, MICROPOR MESOPOR MAT, V28, P325, DOI 10.1016/S1387-1811(98)00247-9; KOKOTAILO GT, 1971, ADV CHEM SER, P109; LEBAIL A, 1995, J NON-CRYST SOLIDS, V183, P39, DOI 10.1016/0022-3093(94)00664-4; Liu SZ, 2008, J POROUS MAT, V15, P295, DOI 10.1007/s10934-006-9078-y; Luo YF, 2002, CHEM MATER, V14, P1906, DOI 10.1021/cm0106567; Lutterotti L., 2002, MAUD MAT ANAL USING, P1599; MARTENS JA, 1989, ZEOLITES, V9, P423, DOI 10.1016/0144-2449(89)90097-3; Matsukata M, 2001, CRYST GROWTH DES, V1, P509, DOI 10.1021/cg015546r; Mintova S, 1999, SCIENCE, V283, P958, DOI 10.1126/science.283.5404.958; Mintova S, 2003, CHEM COMMUN, P326, DOI 10.1039/b210767h; Newsam J. M., 1989, CHEM COMMUN, V493; Popa NC, 1998, J APPL CRYSTALLOGR, V31, P176, DOI 10.1107/S0021889897009795; Snyder MA, 2007, ANGEW CHEM INT EDIT, V46, P7560, DOI 10.1002/anie.200604910; Sun J., 1999, J CHEM SOC CHEM COMM, P2459; Tosheva L, 2005, CHEM MATER, V17, P2494, DOI 10.1021/cm047908z; VAUGHAN DEW, 1980, PROPERTIES APPL ZEOL, P294; VAUGHAN DEW, 1989, Patent No. 0351461; Wendelbo R, 1999, MICROPOR MESOPOR MAT, V28, P361, DOI 10.1016/S1387-1811(98)00304-7; Wendelbo R., 2001, Norwegian Patent Application No, Patent No. 964988; Zhan BZ, 2002, CHEM MATER, V14, P3636, DOI 10.1021/cm011635f	32	223	229	19	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					70	73		10.1126/science.1214798	http://dx.doi.org/10.1126/science.1214798			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22157080	Green Submitted			2022-12-28	WOS:000298846200051
J	Niven, JE				Niven, Jeremy E.			How Honeybees Break a Decision-Making Deadlock	SCIENCE			English	Editorial Material							INHIBITION		Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Niven, JE (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	jen23@sussex.ac.uk						Barlow H. B., 1961, SENS COMMUN, P782; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gilley DC, 1998, APIDOLOGIE, V29, P229, DOI 10.1051/apido:19980303; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550	12	12	12	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					43	44		10.1126/science.1216563	http://dx.doi.org/10.1126/science.1216563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	872YA	22157084				2022-12-28	WOS:000298846200040
J	Casanueva, MO; Burga, A; Lehner, B				Olivia Casanueva, M.; Burga, Alejandro; Lehner, Ben			Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; DELETERIOUS MUTATIONS; MOLECULAR CHAPERONES; NATURAL-SELECTION; LIFE-SPAN; HSP90; EVOLUTION; BACTERIA	Mutations often have consequences that vary across individuals. Here, we show that the stimulation of a stress response can reduce mutation penetrance in Caenorhabditis elegans. Moreover, this induced mutation buffering varies across isogenic individuals because of interindividual differences in stress signaling. This variation has important consequences in wild-type animals, producing some individuals with higher stress resistance but lower reproductive fitness and other individuals with lower stress resistance and higher reproductive fitness. This may be beneficial in an unpredictable environment, acting as a "bet-hedging" strategy to diversify risk. These results illustrate how transient environmental stimuli can induce protection against mutations, how environmental responses can underlie variable mutation buffering, and how a fitness trade-off may make variation in stress signaling advantageous.	[Olivia Casanueva, M.; Lehner, Ben] CRG, European Mol Biol Lab, Ctr Genom Regulat EMBL CRG, Syst Biol Unit, Barcelona, Spain; [Olivia Casanueva, M.; Burga, Alejandro; Lehner, Ben] Univ Pompeu Fabra, Barcelona, Spain; [Burga, Alejandro; Lehner, Ben] CRG, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), CRG, European Mol Biol Lab, Ctr Genom Regulat EMBL CRG, Syst Biol Unit, Barcelona, Spain.	ben.lehner@crg.eu	Burga, Alejandro/AAJ-8745-2020; Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	Burga, Alejandro/0000-0002-0211-4357; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	European Research Council (ERC); ICREA; Spanish Ministry of Science and Innovation (MICINN) [BFU2008-00365]; University and Research Grant Management Agency of Catalonia (AGAUR); ERASysBio+; ERA-NET SysBio+; EMBL-CRG; Beatriu de Pinos Fellowship; Formacion de Personal Investigador (FPI)-MICINN; NIH National Center for Research Resources (NCRR); ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); ICREA(ICREA); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University and Research Grant Management Agency of Catalonia (AGAUR); ERASysBio+; ERA-NET SysBio+; EMBL-CRG; Beatriu de Pinos Fellowship; Formacion de Personal Investigador (FPI)-MICINN(National Health and Medical Research Council (NHMRC) of Australia); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ICREA(ICREA)	We thank the European Research Council (ERC), ICREA, Spanish Ministry of Science and Innovation (MICINN) Plan Nacional grant BFU2008-00365, University and Research Grant Management Agency of Catalonia (AGAUR), ERASysBio+, ERA-NET SysBio+, and the EMBL-CRG Systems Biology Program for funding. O.C. was supported by a Beatriu de Pinos Fellowship and A. B by a Formacion de Personal Investigador (FPI)-MICINN fellowship. Some nematode strains and bacterial clones were provided by T. Gidalevitz, C. Silva, A. Chisholm, A. Rougvie, and the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We thank R. Jelier for assistance with statistical analyses and M. Isalan and members of our laboratory for comments on the manuscript.	Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; GILLESPIE JH, 1974, GENETICS, V76, P601; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Marden JH, 2001, J EXP BIOL, V204, P3457; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	33	104	105	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					82	85		10.1126/science.1213491	http://dx.doi.org/10.1126/science.1213491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174126				2022-12-28	WOS:000298846200055
J	Seeley, TD; Visscher, PK; Schlegel, T; Hogan, PM; Franks, NR; Marshall, JAR				Seeley, Thomas D.; Visscher, P. Kirk; Schlegel, Thomas; Hogan, Patrick M.; Franks, Nigel R.; Marshall, James A. R.			Stop Signals Provide Cross Inhibition in Collective Decision-Making by Honeybee Swarms	SCIENCE			English	Article							NEST-SITE SELECTION; VIBRATIONAL SIGNALS; BEE SWARMS; NEUROBIOLOGY; CHOICE; DANCE	Honeybee swarms and complex brains show many parallels in how they make decisions. In both, separate populations of units (bees or neurons) integrate noisy evidence for alternatives, and, when one population exceeds a threshold, the alternative it represents is chosen. We show that a key feature of a brain-cross inhibition between the evidence-accumulating populations-also exists in a swarm as it chooses its nesting site. Nest-site scouts send inhibitory stop signals to other scouts producing waggle dances, causing them to cease dancing, and each scout targets scouts' reporting sites other than her own. An analytic model shows that cross inhibition between populations of scout bees increases the reliability of swarm decision-making by solving the problem of deadlock over equal sites.	[Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Visscher, P. Kirk] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Schlegel, Thomas; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Hogan, Patrick M.; Marshall, James A. R.] Univ Sheffield, Kroto Res Inst, Sheffield S1 4DP, S Yorkshire, England	Cornell University; University of California System; University of California Riverside; University of Bristol; University of Sheffield; University of Sheffield	Seeley, TD (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	tds5@cornell.edu	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; Marshall, James/0000-0002-1506-167X	Cornell Agriculture Experiment Station [NYC-191522]; University of California-Riverside [CA-R*-ENT-6892-H]; UK Biotechnology and Biological Sciences Research Council [BB/G02166X/1]; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [E19832, BB/G02166X/1, BB/G02166X/2] Funding Source: researchfish	Cornell Agriculture Experiment Station; University of California-Riverside(University of California System); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the staff of the Shoals Marine Laboratory for general assistance and D. Pais for useful discussions on dynamical systems theory. This work was supported by Cornell Agriculture Experiment Station grant NYC-191522 (T. D. S.), University of California-Riverside grant CA-R*-ENT-6892-H (P. K. V.), and UK Biotechnology and Biological Sciences Research Council grant BB/G02166X/1 (J.A.R.M. and N.R.F.). The data on how scouts performing waggle dances receive stop signals are tabulated in the supporting online material (SOM). The data on who produces stop signals and when they are produced are shown in Fig. 2.	Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; KIRCHNER WH, 1993, BEHAV ECOL SOCIOBIOL, V33, P169, DOI 10.1007/BF00216597; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; NIEH JC, 1993, BEHAV ECOL SOCIOBIOL, V33, P51, DOI 10.1007/BF00164346; Passino KM, 2008, BEHAV ECOL SOCIOBIOL, V62, P401, DOI 10.1007/s00265-007-0468-1; Pastor KA, 2005, ETHOLOGY, V111, P775, DOI 10.1111/j.1439-0310.2005.01116.x; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V54, P511, DOI 10.1007/s00265-003-0664-6; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; Seeley TD, 2001, J COMP PHYSIOL A, V187, P667, DOI 10.1007/s00359-001-0243-0; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9	23	221	225	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					108	111		10.1126/science.1210361	http://dx.doi.org/10.1126/science.1210361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22157081				2022-12-28	WOS:000298846200062
J	Malanchi, I; Santamaria-Martinez, A; Susanto, E; Peng, H; Lehr, HA; Delaloye, JF; Huelsken, J				Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Lehr, Hans-Anton; Delaloye, Jean-Francois; Huelsken, Joerg			Interactions between cancer stem cells and their niche govern metastatic colonization	NATURE			English	Article							TUMOR-INITIATING CELLS; PERIOSTIN-NULL MICE; BREAST-CANCER; MAMMARY-TUMORS; BETA-CATENIN; MOUSE MODEL; LONG-TERM; EXPRESSION; IDENTIFICATION; DISSEMINATION	Metastatic growth in distant organs is the major cause of cancer mortality. The development of metastasis is a multistage process with several rate-limiting steps(1). Although dissemination of tumour cells seems to be an early and frequent event(2), the successful initiation of metastatic growth, a process termed 'metastatic colonization', is inefficient for many cancer types and is accomplished only by a minority of cancer cells that reach distant sites(3,4). Prevalent target sites are characteristic of many tumour entities(5), suggesting that inadequate support by distant tissues contributes to the inefficiency of the metastatic process. Here we show that a small population of cancer stem cells is critical for metastatic colonization, that is, the initial expansion of cancer cells at the secondary site, and that stromal niche signals are crucial to this expansion process. We find that periostin (POSTN), a component of the extracellular matrix, is expressed by fibroblasts in the normal tissue and in the stroma of the primary tumour. Infiltrating tumour cells need to induce stromal POSTN expression in the secondary target organ (in this case lung) to initiate colonization. POSTN is required to allow cancer stem cell maintenance, and blocking its function prevents metastasis. POSTN recruits Wnt ligands and thereby increases Wnt signalling in cancer stem cells. We suggest that the education of stromal cells by infiltrating tumour cells is an important step in metastatic colonization and that preventing de novo niche formation may be a novel strategy for the treatment of metastatic disease.	[Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Huelsken, Joerg] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Malanchi, Ilaria; Santamaria-Martinez, Albert; Susanto, Evelyn; Peng, Hong; Huelsken, Joerg] Natl Ctr Competence Res Mol Oncol, CH-1015 Lausanne, Switzerland; [Peng, Hong] So Med Univ, Nanfang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510515, Guangdong, Peoples R China; [Lehr, Hans-Anton] Univ Lausanne, CHUV, Univ Inst Pathol, CH-1011 Lausanne, Switzerland; [Delaloye, Jean-Francois] CHU Vaudois, Dept Obstet & Gynecol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Southern Medical University - China; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Huelsken, J (corresponding author), Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	joerg.huelsken@epfl.ch	Peng, Hongjuan/GYV-5462-2022; Santamaria-Martínez, Albert/X-1411-2018; Huelsken, Joerg/AAC-9581-2021	Santamaria-Martínez, Albert/0000-0001-5436-9207; Huelsken, Joerg/0000-0003-3105-9606	Swiss League against Cancer; SNF; NCCR in Molecular Oncology; Anna Fuller Fund; Debiopharm	Swiss League against Cancer; SNF; NCCR in Molecular Oncology; Anna Fuller Fund; Debiopharm	We are grateful to U. Koch for advice on FACS, to M. Moniatte for advice on mass spectrometry and to S. Leuba for technical assistance with histology. I. M., E. S., A.S.-M. and J.H. were supported in part by the Swiss League against Cancer, the SNF, the NCCR in Molecular Oncology and the Anna Fuller Fund. J.H. holds the EPFL chair for Signal Transduction in Oncogenesis sponsored by Debiopharm.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimazaki M, 2008, BIOCHEM BIOPH RES CO, V367, P736, DOI 10.1016/j.bbrc.2008.01.009; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhao WL, 2002, CANCER IMMUNOL IMMUN, V51, P381, DOI 10.1007/s00262-002-0290-6	34	932	972	3	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					85	U95		10.1038/nature10694	http://dx.doi.org/10.1038/nature10694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22158103	Green Submitted, Green Published			2022-12-28	WOS:000298836900034
J	Panksepp, J				Panksepp, Jaak			Empathy and the Laws of Affect	SCIENCE			English	Editorial Material									Washington State Univ, Coll Vet Med, Dept Comparat Anat Physiol & Pharmacol, Ctr Study Anim Well Being, Pullman, WA 99164 USA	Washington State University	Panksepp, J (corresponding author), Washington State Univ, Coll Vet Med, Dept Comparat Anat Physiol & Pharmacol, Ctr Study Anim Well Being, Pullman, WA 99164 USA.	jpanksepp@vetmed.wsu.edu						Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Cromwell H. C., 2011, NEUROSCI BIOBEHAV R, V35, P1789; Decety J, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P1; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Pansepp J., 1997, ANN NY ACAD SCI, V807, P78; Rizzolati G., 2007, MIRRORS BRAIN; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; WATT D, 2007, NEUROPSYCHOANALYSIS, V9, P119	13	34	36	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1358	1359		10.1126/science.1216480	http://dx.doi.org/10.1126/science.1216480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158811				2022-12-28	WOS:000297787700039
J	Murdin, L; Golding, J; Bronstein, A				Murdin, Louisa; Golding, John; Bronstein, Adolfo			Managing motion sickness	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SCOPOLAMINE; PREVENTION; MIGRAINE; AIRSICKNESS; SYMPTOMS; VERTIGO; GINGER		[Murdin, Louisa] Natl Hosp Neurol & Neurosurg, Dept Neurootol, London WC1N 3BG, England; [Golding, John] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Bronstein, Adolfo] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci Neurootol, London SW7 2AZ, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Westminster; Imperial College London	Murdin, L (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neurootol, Queen Sq, London WC1N 3BG, England.	louisa@murdin.com	Hug, Balthasar L./G-1568-2010		MRC [G0600183, MC_U950770497] Funding Source: UKRI; Medical Research Council [MC_U950770497, G0600183] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Afridi Shazia K, 2006, Curr Pain Headache Rep, V10, P221, DOI 10.1007/s11916-006-0049-4; Albert EG, 2003, MED J AUSTRALIA, V178, P575, DOI 10.5694/j.1326-5377.2003.tb05362.x; Balaban CD, 1999, CURR OPIN NEUROL, V12, P29, DOI 10.1097/00019052-199902000-00005; Bar R, 2009, PHARMACOTHERAPY, V29, P1082, DOI 10.1592/phco.29.9.1082; Benson AJ, 2002, MED ASPECTS HARSH EN, V2; Boldingh MI, 2011, CEPHALALGIA, V31, P1211, DOI 10.1177/0333102411409074; Bos JE, 2005, AVIAT SPACE ENVIR MD, V76, P1111; Buckey JC, 2007, J VESTIBUL RES-EQUIL, V17, P301; Cha YH, 2009, SEMIN NEUROL, V29, P520, DOI 10.1055/s-0029-1241038; CHEUNG BSK, 1991, AVIAT SPACE ENVIR MD, V62, P527; Cowings PS, 2000, AVIAT SPACE ENVIR MD, V71, P1013; DOWECK I, 1994, AVIAT SPACE ENVIR MD, V65, P606; Estrada A, 2007, AVIAT SPACE ENVIR MD, V78, P408; Furman JM, 2011, J HEADACHE PAIN, V12, P81, DOI 10.1007/s10194-010-0250-z; GOLDING JF, 1995, AVIAT SPACE ENVIR MD, V66, P1046; Golding JF, 1997, BRIT J CLIN PHARMACO, V43, P633, DOI 10.1046/j.1365-2125.1997.00606.x; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Grunfeld E, 1998, BRAIN RES BULL, V47, P433, DOI 10.1016/S0361-9230(98)00099-9; Guedry FE, 1998, BRAIN RES BULL, V47, P475, DOI 10.1016/S0361-9230(98)00087-2; Howarth PA, 2008, DISPLAYS, V29, P117, DOI 10.1016/j.displa.2007.09.009; Klocker N, 2001, EUR J PHARM SCI, V13, P227, DOI 10.1016/S0928-0987(01)00107-5; LAWTHER A, 1988, AVIAT SPACE ENVIR MD, V59, P399; Lien HC, 2003, AM J PHYSIOL-GASTR L, V284, pG481, DOI 10.1152/ajpgi.00164.2002; Murdin L, 2009, NEUROLOGY, V73, P638, DOI 10.1212/WNL.0b013e3181b38a04; Muth ER, 2007, AVIAT SPACE ENVIR MD, V78, P686; Otto B, 2006, BRIT J CLIN PHARMACO, V61, P27, DOI 10.1111/j.1365-2125.2005.02505.x; Sang FDYP, 2003, J TRAVEL MED, V10, P108, DOI 10.2310/7060.2003.31768; Sang FYP, 2005, PERCEPT MOTOR SKILL, V101, P244, DOI 10.2466/PMS.101.5.244-256; Simmons RG, 2010, AVIAT SPACE ENVIR MD, V81, P405, DOI 10.3357/ASEM.2668.2010; Spinks A., 2011, COCHRANE DB SYST REV, V6, P1; STEWART JJ, 1991, PHARMACOLOGY, V42, P111, DOI 10.1159/000138781; Turner M, 2000, AVIAT SPACE ENVIR MD, V71, P1181; Turner M, 1999, BRIT J PSYCHOL, V90, P519, DOI 10.1348/000712699161594; VANMARION WF, 1985, CLIN PHARMACOL THER, V38, P301, DOI 10.1038/clpt.1985.175; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Ziavra NV, 2003, MAYO CLIN PROC, V78, P574, DOI 10.4065/78.5.574	36	23	26	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2011	343								d7430	10.1136/bmj.d7430	http://dx.doi.org/10.1136/bmj.d7430			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861RX	22138695				2022-12-28	WOS:000298038000003
J	Shelton, JD				Shelton, James D.			Twenty criteria to make the best of scarce health resources in developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV PREVENTION; MALE CIRCUMCISION; ACCEPTABILITY; AFRICA; KENYA; NETS		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, 1300 Penn Ave, Washington, DC 20523 USA.	jshelton@usaid.gov						ABDULLAH M, 1985, AM J CLIN NUTR, V41, P1305, DOI 10.1093/ajcn/41.6.1305; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Calmy A, 2004, AIDS, V18, P2353; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; FOEGE WH, 1975, B WORLD HEALTH ORGAN, V52, P209; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Kyritsi A, 2011, LWT-FOOD SCI TECHNOL, V44, P312, DOI 10.1016/j.lwt.2010.06.001; Linehan M, 2011, AM J TROP MED HYG, V84, P5, DOI 10.4269/ajtmh.2011.10-0411; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Ministry of Health Uganda and Macro International Inc, 2008, UG SERV PROV ASS SUR; Moran M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000411; National Bureau of Statistics Tanzania and Macro International, 2007, TANZ SERV PROV ASS S; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Saenz-de-Miera B, 2010, TOB CONTROL, V19, P481, DOI 10.1136/tc.2009.032177; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Shelton JD, 2001, INT FAM PLAN PERSPEC, V27, P152, DOI 10.2307/2673838; Snow RW, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P195; The PLoS Medicine, 2010, PLOS MED, V7; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Trussell J, 2011, CONTRACEPTION, V83, P387; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; Walllinga J, 2005, PLOS MED, V2, P1152, DOI 10.1371/journal.pmed.0020316; Warren C, 2010, INT J QUAL HEALTH C, V22, P24, DOI 10.1093/intqhc/mzp050; Weiss HA, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000390708.66136.f4; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Wolkon A, 2010, AM J TROP MED HYG, V83, P1014, DOI 10.4269/ajtmh.2010.09-0599	34	7	7	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2011	343								d7023	10.1136/bmj.d7023	http://dx.doi.org/10.1136/bmj.d7023			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875FJ	22121163				2022-12-28	WOS:000299015500001
J	Rosset, P				Rosset, Peter			Preventing hunger: Change economic policy	NATURE			English	Editorial Material							FOOD; AGRICULTURE; MOVEMENT		[Rosset, Peter] Ctr Study Rural Change Mexico CECCAM, Oaxaca, Mexico		Rosset, P (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	rosset@globalalternatives.org	Rosset, Peter M./G-5317-2014	Rosset, Peter M./0000-0002-1253-1066				Badgley C, 2007, RENEW AGR FOOD SYST, V22, P86, DOI 10.1017/S1742170507001640; Martinez-Torres ME, 2010, J PEASANT STUD, V37, P149, DOI 10.1080/03066150903498804; Food and Agriculture Organization of the United Nations (FAO), 2011, STATE FOOD INSECURIT; Ghosh J, 2010, J AGRAR CHANGE, V10, P72, DOI 10.1111/j.1471-0366.2009.00249.x; Rosset PM, 2011, J PEASANT STUD, V38, P161, DOI 10.1080/03066150.2010.538584; Rosset P., 2011, Development (London), V54, P21, DOI 10.1057/dev.2010.102; Rosset P., 2009, Bulletin of Science, Technology and Society, V29, P189, DOI 10.1177/0270467609333733; ROSSET PM, 2006, FOOD IS DIFFERENT	8	15	17	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					472	473		10.1038/479472a	http://dx.doi.org/10.1038/479472a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	851QI	22113676	Bronze			2022-12-28	WOS:000297285600027
J	Altevogt, BM; Pankevich, DE; Pope, AM; Kahn, JP				Altevogt, Bruce M.; Pankevich, Diana E.; Pope, Andrew M.; Kahn, Jeffrey P.			Guiding Limited Use of Chimpanzees in Research	SCIENCE			English	Editorial Material									[Altevogt, Bruce M.; Pankevich, Diana E.; Pope, Andrew M.] Natl Acad, Inst Med, Washington, DC 20001 USA; [Kahn, Jeffrey P.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	National Academies of Sciences, Engineering & Medicine; Johns Hopkins University	Altevogt, BM (corresponding author), Natl Acad, Inst Med, Washington, DC 20001 USA.	baltevogt@nas.edu		Kahn, Jeffrey/0000-0003-2493-2016				Chapman K, 2009, MABS-AUSTIN, V1, P505, DOI 10.4161/mabs.1.5.9676; European Union, 2010, OFFICIAL J EUROPEA L; Institute of Medicine (IOM), 2011, CHIMP BIOM BEH RES A; U.S. Department of Health and Human Services, COSTS MAINT HUM CAR; VandeBerg JL, 2005, NATURE, V437, P30, DOI 10.1038/437030a; Vogel G., 2001, SCIENCENOW      0501	6	13	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					41	42		10.1126/science.1217521	http://dx.doi.org/10.1126/science.1217521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174127				2022-12-28	WOS:000298846200039
J	Soon, FF; Ng, LM; Zhou, XE; West, GM; Kovach, A; Tan, MHE; Suino-Powell, KM; He, YZ; Xu, Y; Chalmers, MJ; Brunzelle, JS; Zhang, HM; Yang, HY; Jiang, HL; Li, J; Yong, EL; Cutler, S; Zhu, JK; Griffin, PR; Melcher, K; Xu, HE				Soon, Fen-Fen; Ng, Ley-Moy; Zhou, X. Edward; West, Graham M.; Kovach, Amanda; Tan, M. H. Eileen; Suino-Powell, Kelly M.; He, Yuanzheng; Xu, Yong; Chalmers, Michael J.; Brunzelle, Joseph S.; Zhang, Huiming; Yang, Huaiyu; Jiang, Hualiang; Li, Jun; Yong, Eu-Leong; Cutler, Sean; Zhu, Jian-Kang; Griffin, Patrick R.; Melcher, Karsten; Xu, H. Eric			Molecular Mimicry Regulates ABA Signaling by SnRK2 Kinases and PP2C Phosphatases	SCIENCE			English	Article							2C PROTEIN PHOSPHATASES; ABSCISIC-ACID; GUARD-CELLS; ACTIVATION; PHOSPHORYLATION; ARABIDOPSIS; MECHANISMS; CHANNEL; OST1; PAIR	Abscisic acid (ABA) is an essential hormone for plants to survive environmental stresses. At the center of the ABA signaling network is a subfamily of type 2C protein phosphatases (PP2Cs), which form exclusive interactions with ABA receptors and subfamily 2 Snfl-related kinase (SnRK2s). Here, we report a SnRK2-PP2C complex structure, which reveals marked similarity in PP2C recognition by SnRK2 and ABA receptors. In the complex, the kinase activation loop docks into the active site of PP2C, while the conserved ABA-sensing tryptophan of PP2C inserts into the kinase catalytic cleft, thus mimicking receptor-PP2C interactions. These structural results provide a simple mechanism that directly couples ABA binding to SnRK2 kinase activation and highlight a new paradigm of kinase-phosphatase regulation through mutual packing of their catalytic sites.	[Soon, Fen-Fen; Ng, Ley-Moy; Zhou, X. Edward; Kovach, Amanda; Tan, M. H. Eileen; Suino-Powell, Kelly M.; He, Yuanzheng; Xu, Yong; Li, Jun; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Soon, Fen-Fen; Ng, Ley-Moy; Tan, M. H. Eileen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Hosp, Singapore 119228, Singapore; [West, Graham M.; Chalmers, Michael J.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Translat Res Inst, Jupiter, FL 33458 USA; [Brunzelle, Joseph S.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Zhang, Huiming; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Ctr Drug Discovery & Design, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Cutler, Sean] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Xu, H. Eric] Chinese Acad Sci, VARI SIMM Ctr, Ctr Struct & Funct Drug Targets, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Van Andel Institute; National University of Singapore; Scripps Research Institute; Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of California System; University of California Riverside; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Karsten.Melcher@vai.org; eric.xu@vai.org	Zhu, Jian-Kang/F-7658-2011; Cutler, Sean R/D-6617-2011; Zhang, Huiming/G-9083-2015; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Zhu, Jian-Kang/0000-0001-5134-731X; Melcher, Karsten/0000-0002-9125-4027; He, Yuanzheng/0000-0001-9131-140X; Yong, Eu-Leong/0000-0001-6511-770X; Zhang, Huiming/0000-0003-0695-3593; Xu, H. Eric/0000-0002-6829-8144; Chalmers, Michael/0000-0002-2139-6089	Michigan Economic Development Corporation; Office of Science of the U.S. Department of Energy; Jay and Betty Van Andel Foundation; Amway (China) Limited; NIH; NSF [IOS-0820508]; Singapore Biomedical Research Council; NUS Graduate School for Integrative Sciences and Engineering (NGS); National Institute for General Medical Studies [GM084041]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM084041] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; Amway (China) Limited; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering (NGS); National Institute for General Medical Studies; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Protein Data Bank (PDB) code for SnRK2.6-HAB1 is 3UJG, for ABI2 is 3UJK, and for PYL2-ABA-ABI2 is 3UJL. We thank the staff of LS-CAT for assistance in data collection at the beam lines of sector 21, which is in part funded by Michigan Economic Development Corporation. Use of the Advanced Photon Source was supported by the Office of Science of the U.S. Department of Energy. This work was supported by the Jay and Betty Van Andel Foundation and Amway (China) Limited (H. E. X.), NIH (H. E. X., P. R. G., and J.-K.Z.), NSF (S. C. and J.-K.Z.), and the Singapore Biomedical Research Council (E.-L.Y.). L.-M.N., F.-F.S., and M. H. E. T. were supported by an overseas Ph.D. scholarship from the NUS Graduate School for Integrative Sciences and Engineering (NGS). S. C. received funding from the NSF (grant IOS-0820508), and P. R. G. received funding from National Institute for General Medical Studies (grant GM084041). Author contributions: J.L., E.-L.Y., J.-K.Z., P. R. G., K. M., and H. E. X. conceived the project and designed research; F.-F.S., L.-M.N., X.E.Z., G. W., A. K., M. H. E. T., K.M.S.-P., Y.H., Y.X., M. C., J.S.B., H.Z., H.Y., H.J., K. M., and H. E. X. performed research; F.-F.S., L.-M.N., X.E.Z., G. W., A. K., M. H. E. T., K.M.S.-P., M. C., J.S.B., P. R. G., K. M., and H. E. X. analyzed data; and K. M. and H. E. X. wrote the paper with contributions from all authors.	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Burza AM, 2006, J BIOL CHEM, V281, P34299, DOI 10.1074/jbc.M601977200; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2010, CURR OPIN STRUC BIOL, V20, P722, DOI 10.1016/j.sbi.2010.09.007; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	21	336	373	19	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					85	88		10.1126/science.1215106	http://dx.doi.org/10.1126/science.1215106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22116026	Green Accepted			2022-12-28	WOS:000298846200056
J	Nakashima, R; Sakurai, K; Yamasaki, S; Nishino, K; Yamaguchi, A				Nakashima, Ryosuke; Sakurai, Keisuke; Yamasaki, Seiji; Nishino, Kunihiko; Yamaguchi, Akihito			Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket	NATURE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; TRANSPORTER; TOLC; MECHANISM; COMPLEX; SITE	AcrB and its homologues are the principal multidrug transporters in Gram-negative bacteria(1-6) and are important in antibiotic drug tolerance(7,8). AcrB is a homotrimer that acts as a tripartite complex(9,10) with the outer membrane channel TolC(11,12) and the membrane fusion protein AcrA(13,14). Minocycline and doxorubicin have been shown to bind to the phenylalanine cluster region of the binding monomer(15). Here we report the crystal structures of AcrB bound to the high-molecular-mass drugs rifampicin and erythromycin. These drugs bind to the access monomer, and the binding sites are located in the proximal multisite binding pocket, which is separated from the phenylalanine cluster region (distal pocket) by the Phe-617 loop. Our structures indicate that there are two discrete multisite binding pockets along the intramolecular channel. High-molecular-mass drugs first bind to the proximal pocket in the access state and are then forced into the distal pocket in the binding state by a peristaltic mechanism involving subdomain movements that include a shift of the Phe-617 loop. By contrast, low-molecular-mass drugs, such as minocycline and doxorubicin, travel through the proximal pocket without specific binding and immediately bind to the distal pocket. The presence of two discrete, high-volume multisite binding pockets contributes to the remarkably broad substrate recognition of AcrB.	[Nakashima, Ryosuke; Sakurai, Keisuke; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; [Yamasaki, Seiji; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Osaka 5670047, Japan	Osaka University; Osaka University; Osaka University	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp	Yamasaki, Seiji/GRF-3261-2022		Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Tsukihara for advice on the crystallographic analysis. We also thank N. Kato for discussion about the organic chemistry of the drugs that were investigated in this study. Our diffraction data were collected using Osaka University's beamline BL44XU at SPring-8, which was equipped with an MX225-HE detector (Rayonix) and was financially supported by the Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We are also grateful to the technical staff of the Comprehensive Analysis Center of the Institute of Scientific and Industrial Research for their assistance. This work was supported by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Medek P, 2007, JOURNAL WSCG, V15, P107; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Pos KM, 2004, FEBS LETT, V564, P333, DOI 10.1016/S0014-5793(04)00272-8; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	38	241	252	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					565	U199		10.1038/nature10641	http://dx.doi.org/10.1038/nature10641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121023				2022-12-28	WOS:000298318000070
J	Speed, T				Speed, Terry			A Correlation for the 21st Century	SCIENCE			English	Editorial Material									[Speed, Terry] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Speed, Terry] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Walter & Eliza Hall Institute; University of California System; University of California Berkeley	Speed, T (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia.	terry@stat.berkeley.edu						Delicado P, 2009, STAT COMPUT, V19, P255, DOI 10.1007/s11222-008-9090-y; DIACONIS P, 1983, SCI AM, V248, P116, DOI 10.1038/scientificamerican0583-116; FISHER RA, 1925, STAT METHODS RES WOR, P34; Galton F., 1886, J ANTHR I, V15, P246, DOI 10.2307%2F2841583; Hirschfeld H.O., 1935, MATH P CAMBRIDGE PHI, V31, P520, DOI DOI 10.1017/S0305004100013517; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Linfoot EH, 1957, INFORM CONTR, V1, P85, DOI DOI 10.1016/S0019-9958(57)90116-X; Renyi A, 1959, ACTA MATH ACAD SCI H, V10, P441, DOI DOI 10.1007/BF02024507; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stigler S.M., 1989, STAT SCI, V4, P73, DOI [10.1214/ss/1177012580, DOI 10.1214/SS/1177012580]; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312	12	92	104	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1502	1503		10.1126/science.1215894	http://dx.doi.org/10.1126/science.1215894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174235				2022-12-28	WOS:000298091400034
J	Brody, H				Brody, Herb			MULTIPLE MYELOMA	NATURE			English	Editorial Material																			0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S33	S33		10.1038/480S33a	http://dx.doi.org/10.1038/480S33a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169796	Bronze			2022-12-28	WOS:000298033000001
J	Matsui, W				Matsui, William			PERSPECTIVE A model disease	NATURE			English	Editorial Material							MULTIPLE-MYELOMA; CELLS		Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Matsui, W (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	matsuwi@jhmi.edu		Matsui, William/0000-0002-3088-0964	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Munshi NC, 2011, CLIN CANCER RES, V17, P1234, DOI 10.1158/1078-0432.CCR-10-1843; Rasheed ZA, 2011, STEM CELLS, V29, P883, DOI 10.1002/stem.648	4	10	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S58	S58		10.1038/480S58a	http://dx.doi.org/10.1038/480S58a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169808	Green Accepted			2022-12-28	WOS:000298033000014
J	Ott, HC; Mathisen, DJ				Ott, Harald C.; Mathisen, Douglas J.			Bioartificial tissues and organs: are we ready to translate?	LANCET			English	Editorial Material							MATRIX; LUNGS		[Ott, Harald C.; Mathisen, Douglas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Thorac Surg,Dept Surg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Ott, HC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Thorac Surg,Dept Surg, Boston, MA 02114 USA.	hott@partners.org						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Dohmen PM, 2011, ANN THORAC SURG, V92, P1308, DOI 10.1016/j.athoracsur.2011.06.009; Grillo HC, 2004, SURG TRACHEA BRONCHI, P599; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Song JJ, 2011, ANN THORAC SURG, V92, P998, DOI 10.1016/j.athoracsur.2011.05.018; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170	12	6	8	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					1977	1978		10.1016/S0140-6736(11)61791-1	http://dx.doi.org/10.1016/S0140-6736(11)61791-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22119608				2022-12-28	WOS:000298144200006
J	Ovseiko, PV; Buchan, AM				Ovseiko, Pavel V.; Buchan, Alastair M.			Postgraduate medical education in England: 100 years of solitude	LANCET			English	Editorial Material									[Ovseiko, Pavel V.; Buchan, Alastair M.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford OX3 9DU, England	University of Oxford	Buchan, AM (corresponding author), Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford OX3 9DU, England.	alastair.buchan@medsci.ox.ac.uk	Ovseiko, Pavel/E-1824-2013; Buchan, Alastair M/B-9095-2009	Ovseiko, Pavel/0000-0002-3504-2177; Buchan, Alastair M/0000-0002-2918-5200	National Institute for Health Research [NF-SI-0508-10213] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*AC MED ROYAL COLL, 2011, AC MED ROYAL COLL SP; *AC MED ROYAL COLL, 2011, DEV HEALTHC WORKF CO; *AC MED SCI, 2011, AC MED SCI RESP GOV; [Anonymous], 2011, TIMES HIGHER ED 1027; Clover B, 2011, HLTH SERV J; *DEP HLTH, 2010, LIB NHS DEV HEALTHC; *GEN MED COUNC, 2011, LIB NHS DEV HEALTHC; *HLTH COMM, ED TRAIN WORKF PLANN; *MED SCH COUNC, 2011, DEV HEALTHC WORKF RE; *NHS FUT FOR, 2011, ED TRAIN REP NHS FUT; Osler W., 1911, LANCET, V177, P211	11	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					1984	1985		10.1016/S0140-6736(11)61844-8	http://dx.doi.org/10.1016/S0140-6736(11)61844-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863DY	22153191				2022-12-28	WOS:000298144200010
J	Martin, TE				Martin, Thomas E.			The Cost of Fear	SCIENCE			English	Editorial Material							NEST-PREDATION; RISK; BIRDS; FOOD		Univ Montana, US Geol Survey, Montana Cooperat Wildlife Res Unit, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Martin, TE (corresponding author), Univ Montana, US Geol Survey, Montana Cooperat Wildlife Res Unit, Missoula, MT 59812 USA.	tom.martin@umontana.edu	Martin, Thomas E/F-6016-2011	Martin, Thomas E/0000-0002-4028-4867				Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Chalfoun AD, 2010, CONDOR, V112, P701, DOI 10.1525/cond.2010.090242; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Doligez B, 2003, ECOLOGY, V84, P2582, DOI 10.1890/02-3116; Eggers S, 2008, BEHAV ECOL, V19, P1056, DOI 10.1093/beheco/arn063; Lack D., 1954, P343; Lloyd P, 2005, ECOL APPL, V15, P1504, DOI 10.1890/04-1243; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Martin TE, 2004, AUK, V121, P289, DOI 10.1642/0004-8038(2004)121[0289:ALEHAE]2.0.CO;2; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; MARZLUFF JM, 1985, CONDOR, V87, P559, DOI 10.2307/1367966; SLAGSVOLD T, 1984, J ANIM ECOL, V53, P945, DOI 10.2307/4669; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	15	20	22	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1353	1354		10.1126/science.1216109	http://dx.doi.org/10.1126/science.1216109			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158807				2022-12-28	WOS:000297787700035
J	McDowell, JM				McDowell, John M.			Beleaguered Immunity	SCIENCE			English	Editorial Material							PLANT; RESISTANCE; EFFECTORS; SYSTEM; EDS1		Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	McDowell, JM (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	johnmcd@vt.edu		McDowell, John/0000-0002-9070-4874				Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042	12	4	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1354	1355		10.1126/science.1216482	http://dx.doi.org/10.1126/science.1216482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158808				2022-12-28	WOS:000297787700036
J	Vaidyanathan, G				Vaidyanathan, Gayathri			Virus Hunters: Catching Bugs in the Field	CELL			English	Editorial Material																			0	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1209	1211		10.1016/j.cell.2011.11.037	http://dx.doi.org/10.1016/j.cell.2011.11.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153064	Bronze, Green Published			2022-12-28	WOS:000298148100006
J	Halavais, A				Halavais, Alexander			Open up online research	NATURE			English	Editorial Material									[Halavais, Alexander] Assoc Internet Researchers, Hamden, CT 06518 USA; [Halavais, Alexander] Quinnipiac Univ, Hamden, CT 06518 USA	Quinnipiac University	Halavais, A (corresponding author), Assoc Internet Researchers, Hamden, CT 06518 USA.	alex@halavais.net		Halavais, Alexander/0000-0002-7164-9208					0	7	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					174	175		10.1038/480174a	http://dx.doi.org/10.1038/480174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158224	Bronze			2022-12-28	WOS:000297744200023
J	Park, YH; Kim, KS				Park, Young-Hoon; Kim, Kyu Seop			Blindness after Fat Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Park, Young-Hoon; Kim, Kyu Seop] Seoul St Marys Hosp, Seoul, South Korea	Seoul St. Mary's Hospital	Park, YH (corresponding author), Seoul St Marys Hosp, Seoul, South Korea.	parkyh@catholic.ac.kr							0	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2220	2220		10.1056/NEJMicm1100804	http://dx.doi.org/10.1056/NEJMicm1100804			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150040				2022-12-28	WOS:000297731400007
J	Dorsey, R; Graham, G				Dorsey, Rashida; Graham, Garth			New HHS Data Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dorsey, Rashida] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Graham, Garth] US Dept HHS, Off Assistant Secretary Hlth, Washington, DC 20201 USA; [Graham, Garth] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida	Dorsey, R (corresponding author), US Dept HHS, Off Assistant Secretary Planning & Evaluat, 200 Independence Ave SW,Hubert Humphrey Bldg,Room, Washington, DC 20201 USA.	rashida.dorsey@hhs.gov						[Anonymous], 1997, FED REGISTER, V62, P36873; Department of Health and Human Services, 2011, FED REG, V76, P38396; Heckler M., 1985, REPORT SECRETARYS TA; Institute of Medicine (IOM) Subcommittee on Standardized Collection of Race /Ethnicity Data for Healthcare Quality, 2009, RAC ETH LANG DAT STA; IOM, 2002, UN TREATM CONFR RAC; Office of Minority Health, EXPL DAT STAND RAC E; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612	7	41	41	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2378	2379		10.1001/jama.2011.1789	http://dx.doi.org/10.1001/jama.2011.1789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147383				2022-12-28	WOS:000297680300025
J	Fujiwara, T; Kodaira, S; No, T; Kaiho, Y; Takahashi, N; Kaneda, Y				Fujiwara, Toshiya; Kodaira, Shuichi; No, Tetsuo; Kaiho, Yuka; Takahashi, Narumi; Kaneda, Yoshiyuki			The 2011 Tohoku-Oki Earthquake: Displacement Reaching the Trench Axis	SCIENCE			English	Article									[Fujiwara, Toshiya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Res Earth Evolut IFREE, Yokosuka, Kanagawa 2370061, Japan; [Kodaira, Shuichi; No, Tetsuo; Kaiho, Yuka] JAMSTEC, IFREE, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Takahashi, Narumi; Kaneda, Yoshiyuki] JAMSTEC, Earthquake & Tsunami Res Project Disaster Prevent, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Fujiwara, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Res Earth Evolut IFREE, Natsushima Cho 2-15, Yokosuka, Kanagawa 2370061, Japan.	toshi@jamstec.go.jp	Kodaira, Shuichi/G-8746-2016; Fujiwara, Toshiya/HDM-4404-2022	Kodaira, Shuichi/0000-0002-5774-2561; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the crew of R/V Kairei and the technicians of Nippon Marine Enterprises for their dedication. The 2011 survey, part of the program launched following the earthquake, was supported by a Grant-in-Aid for Special Purposes of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and a contribution from JAMSTEC.	Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ito A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022307; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; Kido M., 2011, JAP GEOSC UN M 2011; Maeda T, 2011, EARTH PLANETS SPACE, V63, P803, DOI 10.5047/eps.2011.06.005; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Tsuru T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001664	7	307	314	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1240	1240		10.1126/science.1211554	http://dx.doi.org/10.1126/science.1211554			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144619				2022-12-28	WOS:000297553600040
J	Ice, GE; Budai, JD; Pang, JWL				Ice, Gene E.; Budai, John D.; Pang, Judy W. L.			The Race to X-ray Microbeam and Nanobeam Science	SCIENCE			English	Review							GRAINS; DIFFRACTION; ELEMENTS; DISEASE; STATE	X-ray microbeams are an emerging characterization tool with broad implications for science, ranging from materials structure and dynamics, to geophysics and environmental science, to biophysics and protein crystallography. We describe how submicrometer hard x-ray beams with the ability to penetrate tens to hundreds of micrometers into most materials and with the ability to determine local composition, chemistry, and (crystal) structure can characterize buried sample volumes and small samples in their natural or extreme environments. Beams less than 10 nanometers have already been demonstrated, and the practical limit for hard x-ray beam size, the limit to trace-element sensitivity, and the ultimate limitations associated with near-atomic structure determinations are the subject of ongoing research.	[Ice, Gene E.; Budai, John D.; Pang, Judy W. L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Ice, GE (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	icege@ornl.gov	Budai, John/R-9276-2016	Budai, John/0000-0002-7444-1306	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC05-00OR22725]; UT-Battelle, LLC	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); UT-Battelle, LLC	Research sponsored by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Materials Sciences and Engineering Division under contract DE-AC05-00OR22725 with UT-Battelle, LLC. Research included use of beamline 34-ID at the Advanced Photon Source, a U. S. DOE Office of Science User Facility.	Ahn KH, 2004, NATURE, V428, P401, DOI 10.1038/nature02364; Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Barrea RA, 2009, J SYNCHROTRON RADIAT, V16, P76, DOI 10.1107/S0909049508039782; Bilderback DH, 2004, AIP CONF PROC, V705, P1271, DOI 10.1063/1.1758032; Bleuet P, 2010, TRAC-TREND ANAL CHEM, V29, P518, DOI 10.1016/j.trac.2010.02.011; Budai J. D., 2004, FORUM, V467-470, P1373; Cao J, 2010, NANO LETT, V10, P2667, DOI 10.1021/nl101457k; Chwiej J, 2008, J TRACE ELEM MED BIO, V22, P183, DOI 10.1016/j.jtemb.2008.03.006; Collingwood JF, 2005, J ALZHEIMERS DIS, V7, P267; Courtin-Nomade A, 2010, AM MINERAL, V95, P582, DOI 10.2138/am.2010.3331; Evans-Lutterodt K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.134801; Ice GE, 2009, MAT SCI ENG A-STRUCT, V524, P3, DOI 10.1016/j.msea.2009.06.001; Jark W, 2001, APPL PHYS LETT, V78, P1192, DOI 10.1063/1.1350956; Kashiv Y, 2010, ASTROPHYS J, V713, P212, DOI 10.1088/0004-637X/713/1/212; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; Larson BC, 2008, J ENG MATER-T ASME, V130, DOI 10.1115/1.2884336; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Leon Y, 2010, APPL PHYS A-MATER, V99, P419, DOI 10.1007/s00339-010-5628-x; Letard I, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2209961; Lienert U, 2007, MATER SCI FORUM, V539-543, P2353, DOI 10.4028/www.scientific.net/MSF.539-543.2353; Liu CA, 2010, AIP CONF PROC, V1234, P47, DOI 10.1063/1.3463245; Matsuyama S, 2009, X-RAY SPECTROM, V38, P89, DOI 10.1002/xrs.1123; Mimura H, 2010, NAT PHYS, V6, P122, DOI 10.1038/NPHYS1457; Moukhametzianov R, 2008, ACTA CRYSTALLOGR D, V64, P158, DOI 10.1107/S090744490705812X; Murray CE, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079656; Naghedolfeizi M, 2003, J NUCL MATER, V312, P146, DOI 10.1016/S0022-3115(02)01681-1; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Pang JWL, 2010, MAT SCI ENG A-STRUCT, V528, P28, DOI 10.1016/j.msea.2010.05.031; Poulsen H. H., 2004, 3 DIMENSIONAL XRAY D; Poulsen HF, 2001, J APPL CRYSTALLOGR, V34, P751, DOI 10.1107/S0021889801014273; Qazilbash MM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165108; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt S, 2004, SCIENCE, V305, P229, DOI 10.1126/science.1098627; Schroer CG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090801; Schroer CG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2053350; Schroer CG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.054802; Schulze C, 1998, J SYNCHROTRON RADIAT, V5, P77, DOI 10.1107/S0909049597014568; Silversmit G, 2009, ANAL CHEM, V81, P6107, DOI 10.1021/ac900507x; Snigirev A, 1996, NATURE, V384, P49, DOI 10.1038/384049a0; Sobiech M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147864; SPARKS CJ, 1978, PHYS REV LETT, V40, P507, DOI 10.1103/PhysRevLett.40.507; Specht ED, 2010, J SYNCHROTRON RADIAT, V17, P250, DOI 10.1107/S0909049509052078; Takahashi Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214102; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Tselev A, 2010, NANO LETT, V10, P2003, DOI 10.1021/nl1008794; Vincze L, 2004, ANAL CHEM, V76, P6786, DOI 10.1021/ac049274l; Wang L, 2011, METALL MATER TRANS A, V42A, P626, DOI 10.1007/s11661-010-0249-8; Wang L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.095701; Zaiser M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195507	52	205	209	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1234	1239		10.1126/science.1202366	http://dx.doi.org/10.1126/science.1202366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144618				2022-12-28	WOS:000297553600039
J	Ioannidis, JPA; Khoury, MJ				Ioannidis, John P. A.; Khoury, Muin J.			Improving Validation Practices in "Omics" Research	SCIENCE			English	Editorial Material							BIOINFORMATICS; PROTEOMICS	"Omics" research poses acute challenges regarding how to enhance validation practices and eventually the utility of this rich information. Several strategies may be useful, including routine replication, public data and protocol availability, funding incentives, reproducibility rewards or penalties, and targeted repeatability checks.	[Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA; [Khoury, Muin J.] NCI, Div Canc Control & Populat Sci, NIH, Rockville, MD 20852 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University; Stanford University	Khoury, MJ (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA.	muk1@cdc.gov	Ioannidis, John P. A./G-9836-2011		Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Andre F, 2011, NAT REV CLIN ONCOL, V8, P171, DOI 10.1038/nrclinonc.2011.4; Baggerly K, 2010, NATURE, V467, P401, DOI 10.1038/467401b; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Castaldi PJ, 2011, BRIEF BIOINFORM, V12, P189, DOI 10.1093/bib/bbq073; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Dupuy A., 2007, J NATL CANCER I, V17, P99; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jelizarow M, 2010, BIOINFORMATICS, V26, P1990, DOI 10.1093/bioinformatics/btq323; Johnson AD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002269; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Mann M, 2009, NAT METHODS, V6, P717, DOI 10.1038/nmeth1009-717; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Ransohoff DF, 2010, CLIN CHEM, V56, P172, DOI 10.1373/clinchem.2009.126698; Riley R D, 2003, Health Technol Assess, V7, P1; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c	21	160	164	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1230	1232		10.1126/science.1211811	http://dx.doi.org/10.1126/science.1211811			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144616	Green Accepted			2022-12-28	WOS:000297553600037
J	Koreth, J; Matsuoka, K; Kim, HT; McDonough, SM; Bindra, B; Alyea, EP; Armand, P; Cutler, C; Ho, VT; Treister, NS; Bienfang, DC; Prasad, S; Tzachanis, D; Joyce, RM; Avigan, DE; Antin, JH; Ritz, J; Soiffer, RJ				Koreth, John; Matsuoka, Ken-ichi; Kim, Haesook T.; McDonough, Sean M.; Bindra, Bhavjot; Alyea, Edwin P., III; Armand, Philippe; Cutler, Corey; Ho, Vincent T.; Treister, Nathaniel S.; Bienfang, Don C.; Prasad, Sashank; Tzachanis, Dmitrios; Joyce, Robin M.; Avigan, David E.; Antin, Joseph H.; Ritz, Jerome; Soiffer, Robert J.			Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSENSUS DEVELOPMENT PROJECT; LOW-DOSE INTERLEUKIN-2; CLINICAL-TRIALS; TRANSPLANTATION; EXPRESSION; INFUSION; TOLERANCE; CRITERIA; RELAPSE; FOXP3	Background Dysfunction of regulatory T (Treg) cells has been detected in diverse inflammatory disorders, including chronic graft-versus-host disease (GVHD). Interleukin-2 is critical for Treg cell growth, survival, and activity. We hypothesized that low-dose interleukin-2 could preferentially enhance Treg cells in vivo and suppress clinical manifestations of chronic GVHD. Methods In this observational cohort study, patients with chronic GVHD that was refractory to glucocorticoid therapy received daily low-dose subcutaneous interleukin-2 (0.3x10(6), 1x10(6), or 3x10(6) IU per square meter of body-surface area) for 8 weeks. The end points were safety and clinical and immunologic response. After a 4-week hiatus, patients with a response could receive interleukin-2 for an extended period. Results A total of 29 patients were enrolled. None had progression of chronic GVHD or relapse of a hematologic cancer. The maximum tolerated dose of interleukin-2 was 1x106 IU per square meter. The highest dose level induced unacceptable constitutional symptoms. Of the 23 patients who could be evaluated for response, 12 had major responses involving multiple sites. The numbers of CD4+ Treg cells were preferentially increased in all patients, with a peak median value, at 4 weeks, that was more than eight times the baseline value (P<0.001), without affecting CD4+ conventional T (Tcon) cells. The Treg: Tcon ratio increased to a median of more than five times the baseline value (P<0.001). The Treg cell count and Treg: Tcon ratio remained elevated at 8 weeks (P<0.001 for both comparisons with baseline values), then declined when the patients were not receiving interleukin-2. The increased numbers of Treg cells expressed the transcription factor forkhead box P3 (FOXP3) and could inhibit autologous Tcon cells. Immunologic and clinical responses were sustained in patients who received interleukin-2 for an extended period, permitting the glucocorticoid dose to be tapered by a mean of 60% (range, 25 to 100). Conclusions Daily low-dose interleukin-2 was safely administered in patients with active chronic GVHD that was refractory to glucocorticoid therapy. Administration was associated with preferential, sustained Treg cell expansion in vivo and amelioration of the manifestations of chronic GVHD in a substantial proportion of patients. (Funded by a Dana-Farber Dunkin' Donuts Rising Star award and others.)	[Koreth, John; Matsuoka, Ken-ichi; McDonough, Sean M.; Bindra, Bhavjot; Alyea, Edwin P., III; Armand, Philippe; Cutler, Corey; Ho, Vincent T.; Antin, Joseph H.; Ritz, Jerome; Soiffer, Robert J.] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02215 USA; [Kim, Haesook T.] Dana Farber Canc Inst, Div Biostat & Computat Biol, Boston, MA 02215 USA; [Treister, Nathaniel S.] Brigham & Womens Hosp, Div Oral Med & Dent, Boston, MA 02115 USA; [Bienfang, Don C.; Prasad, Sashank] Brigham & Womens Hosp, Neurol Ophthalmol Sect, Boston, MA 02215 USA; [Tzachanis, Dmitrios; Joyce, Robin M.; Avigan, David E.] Beth Israel Deaconess Med Ctr, Hematol Oncol Div, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Koreth, J (corresponding author), Dana Farber Canc Inst, Div Hematol Malignancies, 450 Brookline Ave, Boston, MA 02215 USA.	john_koreth@dfci.harvard.edu	Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669; Treister, Nathaniel/0000-0002-5596-7222	Dana-Farber Dunkin' Donuts Rising Star award; American Society of Blood; Marrow Transplantation/Pharmion New Investigator award; National Cancer Institute [P01 CA142106]; Jock and Bunny Adams Research and Education Endowment; National Institute of Allergy and Infectious Diseases [AI29530]; NATIONAL CANCER INSTITUTE [P01CA142106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI029530, U19AI029530] Funding Source: NIH RePORTER	Dana-Farber Dunkin' Donuts Rising Star award; American Society of Blood; Marrow Transplantation/Pharmion New Investigator award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jock and Bunny Adams Research and Education Endowment; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by a Dana-Farber Dunkin' Donuts Rising Star award and an American Society of Blood and Marrow Transplantation/Pharmion New Investigator award (to Dr. Koreth); a grant from the National Cancer Institute (P01 CA142106, to Dr. Antin); and grants from the Jock and Bunny Adams Research and Education Endowment and the National Institute of Allergy and Infectious Diseases (AI29530, to Dr. Soiffer).	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Azuma T, 2003, CANCER RES, V63, P4516; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flowers MED, 2008, BLOOD, V112, P2667, DOI 10.1182/blood-2008-03-141481; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Kahl C, 2007, BLOOD, V110, P2744, DOI 10.1182/blood-2007-03-078592; Koreth J, 2008, EXPERT REV HEMATOL, V1, P111, DOI 10.1586/17474086.1.1.111; Ladenstein R, 2011, J CLIN ONCOL, V29, P441, DOI 10.1200/JCO.2009.23.5465; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Olivieri A, 2009, BLOOD, V114, P709, DOI 10.1182/blood-2009-02-204156; Pavletic SZ, 2006, BIOL BLOOD MARROW TR, V12, P252, DOI 10.1016/j.bbmt.2006.01.008; Perez-Simon JA, 2008, BIOL BLOOD MARROW TR, V14, P1163, DOI 10.1016/j.bbmt.2008.07.015; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Rizzieri DA, 2011, CANCER INVEST, V29, P56, DOI 10.3109/07357907.2010.535055; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; SOIFFER RJ, 1992, BLOOD, V79, P517; SOIFFER RJ, 1994, BLOOD, V84, P964; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang XH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001819; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	41	762	794	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2055	2066		10.1056/NEJMoa1108188	http://dx.doi.org/10.1056/NEJMoa1108188			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129252	Bronze, Green Accepted			2022-12-28	WOS:000297499000006
J	Saadoun, D; Rosenzwajg, M; Joly, F; Six, A; Carrat, F; Thibault, V; Sene, D; Cacoub, P; Klatzmann, D				Saadoun, David; Rosenzwajg, Michelle; Joly, Florence; Six, Adrien; Carrat, Fabrice; Thibault, Vincent; Sene, Damien; Cacoub, Patrice; Klatzmann, David			Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; ADAPTIVE IMMUNE-RESPONSES; MIXED CRYOGLOBULINEMIA; RITUXIMAB; EXPANSION; INNATE	Background Patients with vasculitis induced by the hepatitis C virus (HCV) have reduced levels of regulatory T cells (Tregs). Resolution of HCV infection correlates with cure of vasculitis and the recovery of Treg levels. We reasoned that interleukin-2, a cytokine that promotes Treg survival and function, could be beneficial for patients with vasculitis that is resistant to HCV therapy. Methods We investigated the safety and immunologic effects of the administration of low-dose interleukin-2 in a prospective open-label, phase 1-phase 2a study. Ten patients with HCV-induced vasculitis that was refractory to conventional antiviral therapy, rituximab therapy, or both and who were not receiving glucocorticoid or immunosuppressant therapy, received one course of interleukin-2 (1.5 million IU per day) for 5 days, followed by three 5-day courses of 3 million IU per day at weeks 3, 6, and 9. Both the safety of the treatment and its effectiveness were evaluated, the latter by monitoring the Treg response and the clinical signs of HCV vasculitis. Results No adverse events reached a level higher than grade 1. The treatment did not induce effector T-cell activation, vasculitis flare, or increased HCV viremia. We observed a reduction in cryoglobulinemia in 9 of 10 patients and improvement of vasculitis in 8 of 10. Administration of low-dose interleukin-2 was followed by an increase in the percentage of CD4+, CD25(high), forkhead box P3 (FOXP3+) Tregs [E-max (maximum value) divided by baseline value x 100 = 420%] with potent suppressive activity in all subjects and by a concomitantly decreased proportion of marginal-zone B cells. Transcriptome studies of peripheral-blood mononuclear cells revealed that interleukin-2 induced a global attenuation of the signatures for inflammation and oxidative stress mediators. Conclusions The trial showed that low-dose interleukin-2 was not associated with adverse effects and led to Treg recovery and concomitant clinical improvement in patients with HCV-induced vasculitis, an autoimmune condition. (Funded by the French Agency for Research on AIDS and Viral Hepatitis [ANRS] and others.)	[Saadoun, David; Cacoub, Patrice] Hop La Pitie Salpetriere, Dept Internal Med, Reference Ctr Autoimmune Dis, F-75651 Paris 13, France; [Rosenzwajg, Michelle; Six, Adrien; Klatzmann, David] Hop La Pitie Salpetriere, Clin Invest Ctr Biotherapy, F-75651 Paris 13, France; [Thibault, Vincent] Hop La Pitie Salpetriere, Dept Virol, F-75651 Paris 13, France; [Saadoun, David; Rosenzwajg, Michelle; Six, Adrien; Cacoub, Patrice; Klatzmann, David] Univ Paris 06, Paris, France; [Saadoun, David; Rosenzwajg, Michelle; Six, Adrien; Sene, Damien; Cacoub, Patrice; Klatzmann, David] CNRS, Unite Mixte Rech 7211, Paris, France; [Rosenzwajg, Michelle; Cacoub, Patrice; Klatzmann, David] INSERM, U S959, Paris, France; [Carrat, Fabrice] INSERM, U 707, Paris, France; [Carrat, Fabrice] Hop St Antoine, Dept Publ Hlth, F-75571 Paris, France; [Joly, Florence] PrediGuard, Marseilles, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Cacoub, P (corresponding author), Hop La Pitie Salpetriere, Dept Internal Med, Reference Ctr Autoimmune Dis, 83 Bd Hop, F-75651 Paris 13, France.	patrice.cacoub@psl.aphp.fr; david.klatzmann@upmc.fr	THIBAULT, Vincent/J-7193-2015; Carrat, Fabrice/AAU-8480-2020; sene, damien/R-3970-2017; joly, florence/AAF-9191-2020; JOLY, Florence/L-7752-2015; Rosenzwajg, Michelle/AAF-6276-2019; THIBAULT, Vincent/AAB-5241-2020	THIBAULT, Vincent/0000-0001-6517-2901; Carrat, Fabrice/0000-0002-8672-7918; sene, damien/0000-0001-8640-4580; Rosenzwajg, Michelle/0000-0001-5312-6203; THIBAULT, Vincent/0000-0001-6517-2901; Six, Adrien/0000-0001-5898-555X; Klatzmann, David/0000-0002-0054-3422; Cacoub, Patrice/0000-0002-6727-4992; saadoun, david/0000-0003-3628-9996	ANRS	ANRS(ANRSFrench National Research Agency (ANR))	Supported by the ANRS, with additional support from the authors' institutions.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Boyer O, 2004, BLOOD, V103, P3428, DOI 10.1182/blood-2003-07-2598; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; CHANG AE, 1989, SEMIN SURG ONCOL, V5, P385, DOI 10.1002/ssu.2980050604; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2009, J CLIN INVEST, V119, P2648, DOI 10.1172/JCI36628; Giedlin Martin A., 1993, Current Opinion in Biotechnology, V4, P722, DOI 10.1016/0958-1669(93)90056-3; GOREVIC PD, 1980, AM J MED, V69, P287, DOI 10.1016/0002-9343(80)90390-3; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Landau DA, 2008, ARTHRITIS RHEUM-US, V58, P2897, DOI 10.1002/art.23759; Lemoine FM, 2009, INT J ONCOL, V35, P569, DOI 10.3892/ijo_00000368; Lenzi M, 1998, BLOOD, V91, P2062, DOI 10.1182/blood.V91.6.2062.2062_2062_2066; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Saadoun D, 2007, RHEUMATOLOGY, V46, P1234, DOI 10.1093/rheumatology/kem132; Saadoun D, 2008, BLOOD, V111, P5334, DOI 10.1182/blood-2007-11-122713; Saadoun D, 2010, BLOOD, V116, P326, DOI 10.1182/blood-2009-10-248518; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Terrier B, 2009, ARTHRITIS RHEUM-US, V60, P2531, DOI 10.1002/art.24703; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818	29	553	584	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2067	2077		10.1056/NEJMoa1105143	http://dx.doi.org/10.1056/NEJMoa1105143			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129253				2022-12-28	WOS:000297499000007
J	Tyc, T; Zhang, X				Tyc, Tomas; Zhang, Xiang			Positive thinking	NATURE			English	Editorial Material									[Tyc, Tomas] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Tyc, Tomas] Masaryk Univ, Fac Informat, CS-61137 Brno, Czech Republic; [Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA	Masaryk University Brno; Masaryk University Brno; National Science Foundation (NSF); University of California System; University of California Berkeley	Tyc, T (corresponding author), Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic.	tomtyc@physics.muni.cz; xiang@berkeley.edu	Zhang, Xiang/F-6905-2011	Tyc, Tomas/0000-0002-7565-6958; Zhang, Xiang/0000-0002-3272-894X				Blaikie RJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/058001; de Rosny J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.124301; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Leonhardt U, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093040; Lerosey G, 2007, SCIENCE, V315, P1120, DOI 10.1126/science.1134824; Ma YG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033016; Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188; Merlin R, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.057801; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Stockman MI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177404	10	29	30	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					42	42		10.1038/480042a	http://dx.doi.org/10.1038/480042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PO	22129719	Bronze			2022-12-28	WOS:000298031900025
J	Mills, EJ; Kanters, S; Hagopian, A; Bansback, N; Nachega, J; Alberton, M; Au-Yeung, CG; Mtambo, A; Bourgeault, IL; Luboga, S; Hogg, RS; Ford, N				Mills, Edward J.; Kanters, Steve; Hagopian, Amy; Bansback, Nick; Nachega, Jean; Alberton, Mark; Au-Yeung, Christopher G.; Mtambo, Andy; Bourgeault, Ivy L.; Luboga, Samuel; Hogg, Robert S.; Ford, Nathan			The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH WORKER MIGRATION; BRAIN-DRAIN; PROFESSIONALS; PHYSICIANS; NEEDS; HIV/AIDS	Objective To estimate the lost investment of domestically educated doctors migrating from sub-Saharan African countries to Australia, Canada, the United Kingdom, and the United States. Design Human capital cost analysis using publicly accessible data. Settings Sub-Saharan African countries. Participants Nine sub-Saharan African countries with an HIV prevalence of 5% or greater or with more than one million people with HIV/AIDS and with at least one medical school (Ethiopia, Kenya, Malawi, Nigeria, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe), and data available on the number of doctors practising in destination countries. Main outcome measures The financial cost of educating a doctor (through primary, secondary, and medical school), assuming that migration occurred after graduation, using current country specific interest rates for savings converted to US dollars; cost according to the number of source country doctors currently working in the destination countries; and savings to destination countries of receiving trained doctors. Results In the nine source countries the estimated government subsidised cost of a doctor's education ranged from $ 21 000 ( pound 13 000; (sic) 15 000) in Uganda to $ 58 700 in South Africa. The overall estimated loss of returns from investment for all doctors currently working in the destination countries was $ 2.17bn (95% confidence interval 2.13bn to 2.21bn), with costs for each country ranging from $ 2.16m (1.55m to 2.78m) for Malawi to $ 1.41bn (1.38bn to 1.44bn) for South Africa. The ratio of the estimated compounded lost investment over gross domestic product showed that Zimbabwe and South Africa had the largest losses. The benefit to destination countries of recruiting trained doctors was largest for the United Kingdom ($ 2.7bn) and United States ($ 846m). Conclusions Among sub-Saharan African countries most affected by HIV/AIDS, lost investment from the emigration of doctors is considerable. Destination countries should consider investing in measurable training for source countries and strengthening of their health systems.	[Mills, Edward J.; Kanters, Steve; Alberton, Mark; Bourgeault, Ivy L.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; [Mills, Edward J.; Kanters, Steve] Ctr Evaluat & Clin Epidemiol, Vancouver, BC, Canada; [Hagopian, Amy] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Bansback, Nick] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Nachega, Jean] Univ Stellenbosch, Fac Hlth Sci, Ctr Infect Dis, Cape Town, South Africa; [Au-Yeung, Christopher G.; Mtambo, Andy; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Luboga, Samuel] Makerere Univ, Sch Med, Off Dean, Kampala, Uganda; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7700 Rondebosch, South Africa	University of Ottawa; University of Washington; University of Washington Seattle; University of British Columbia; Stellenbosch University; B.C. Centre for Excellence in HIV/AIDS; Makerere University; Simon Fraser University; University of Cape Town	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada.	Edward.mills@uottawa.ca	Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Bansback, Nick/0000-0002-1510-3462; Nachega, Jean/0000-0002-2862-4443; Bourgeault, Ivy/0000-0002-5113-9243				American Medical Association, 2010, INT MED GRAD AM MED; AusAID, 2010, STAT SUMM 2005 2008; Australian Age Pension, 2006, AUSTR RET AG; Australian Doctor, 2006, NEV SAY RET; Australian Institute of Health and Welfare, 2009, MED LAB FORC 2007; Awases M., 2004, MIGRATION HLTH PROFE; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; BCCFE, 2010, GLOB ACC HLTH IND AR; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; British Medical Association, 2010, UK MED WORKF 2008; Buchan J., 2010, BMJ-BRIT MED J, V340, P791; Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; Canadian Medical Association, 2009, NUMB PHYS SPEC AG CA; Chen LC, 2005, NEW ENGL J MED, V353, P1850, DOI 10.1056/NEJMe058188; Clemons MA, 2011, FINANCIAL EFFECTS HI; Connell J, 2007, SOC SCI MED, V64, P1876, DOI 10.1016/j.socscimed.2006.12.013; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; DFID, 2010, STAT INT DEV; Eastwood JB, 2005, LANCET, V365, P1893, DOI 10.1016/S0140-6736(05)66623-8; Enright A, 2007, CAN J ANAESTH, V54, P935, DOI 10.1007/BF03026799; Hagopian A, 2005, SOC SCI MED, V61, P1750, DOI 10.1016/j.socscimed.2005.03.027; Hagopian A, 2007, ANN FAM MED, V5, P483, DOI 10.1370/afm.787; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Harries AD, 2002, T ROY SOC TROP MED H, V96, P34, DOI 10.1016/S0035-9203(02)90231-2; Huddart J., 2003, HLTH SECTOR HUMAN RE; International Development and Research Canada, 2010, INT DEV RES CAN ANN; Katz JD, 2001, ANESTH ANALG, V92, P1487; Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-89; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Magoha GAO, 1999, E AFR MED J, V76, P462; Martin S, 2000, CAN MED ASSOC J, V163, P1499; Medecins sans Frontieres, 2007, HELP WANT CONFR HLTH; Mensah K, 2005, SKILLS DRAIN HLTH PR; Mills EJ, 2008, LANCET, V371, P685, DOI 10.1016/S0140-6736(08)60308-6; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2002, HEALTH AFFAIR, V21, P158, DOI 10.1377/hlthaff.21.1.158; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Mullan F, 2007, NEW ENGL J MED, V356, P440, DOI 10.1056/NEJMp068267; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Muula A S, 2007, Tanzan Health Res Bull, V9, P61; Onyebuchi AUO, 2008, AM J PUBLIC HEALTH, V98, P148; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Plaza S, 2011, DIASPORA FOR DEVELOPMENT IN AFRICA, P1; Pond B, 2006, LANCET, V367, P1448, DOI 10.1016/S0140-6736(06)68346-3; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Scheffler RM, 2008, B WORLD HEALTH ORGAN, V86, P516, DOI 10.2471/BLT.07.046474; Snyder J, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160802654152; Stilwell B, 2005, MIGRATION HLTH WORKE; *UNAIDS, 2008, 2008 REP GLOB AIDS E; WHO, 2006, WORLD HLTH REP; World Health Organization, 2010, GLOB HLTH OBS; World Health Organization, 2010, WHO GLOB COD PRACT I; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	54	51	51	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2011	343								d7031	10.1136/bmj.d7031	http://dx.doi.org/10.1136/bmj.d7031			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875FI	22117056	Green Published, Green Submitted			2022-12-28	WOS:000299015400005
J	Zoller, B; Li, XJ; Sundquist, J; Sundquist, K				Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina			Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; VENOUS THROMBOEMBOLISM; THROMBOSIS	Background Some autoimmune disorders have been linked to venous thromboembolism. We examined whether there is an association between autoimmune disorders and risk of pulmonary embolism. Methods We followed up all individuals in Sweden without previous hospital admission for venous thromboembolism and with a primary or secondary diagnosis of an autoimmune disorder between Jan 1, 1964, and Dec 31, 2008, for hospital admission for pulmonary embolism. We obtained data from the MigMed2 database, which has individual-level information about all registered residents of Sweden. The reference population was the total population of Sweden. We calculated standardised incidence ratios (SIRs) for pulmonary embolism, adjusted for individual variables, including age and sex. Findings 535 538 individuals were admitted to hospital because of an autoimmune disorder. Overall risk of pulmonary embolism during the first year after admission for an autoimmune disorder was 6.38 (95% CI 6.19-6.57). All the 33 autoimmune disorders were associated with a significantly increased risk of pulmonary embolism during the first year after admission. However, some had a particularly high risk-eg, immune thrombocytopenic purpura (10.79, 95% CI 7.98-14.28), polyarteritis nodosa (13.26, 9.33-18.29), polymyositis or dermatomyositis (16.44, 11.57-22.69), and systemic lupus erythematosus (10.23, 8.31-12.45). Overall risk decreased over time, from 1.53 (1.48-1.57) at 1-5 years, to 1.15 (1.11-1.20) at 5-10 years, and 1.04 (1.00-1.07) at 10 years and later. The risk was increased for both sexes and all age groups. Interpretation Autoimmune disorders are associated with a high risk of pulmonary embolism in the first year after hospital admission. Our findings suggest that these disorders in general should be regarded as hypercoagulable disorders.	[Zoller, Bengt] Lund Univ Reg Skane, Malmo Univ Hosp, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Skane University Hospital; Stanford University	Zoller, B (corresponding author), Lund Univ Reg Skane, Malmo Univ Hosp, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden.	bengt.zoller@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Swedish Research Council Formas [2006-4255-6596-99, 2007-1352]; Region Skane [REGSKANE-124611]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Region Skane	We thank Stephen Gilliver for his useful comments about the text. The registers used in this study are maintained by Statistics Sweden and the National Board of Health and Welfare. KS and JS received grant support from the Swedish Research Council (grant numbers 2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754, and 2007-1962), and Swedish Research Council Formas (2006-4255-6596-99 and 2007-1352). BZ received grant support from Region Skane (REGSKANE-124611).	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Bergqvist D, 2002, PREVENTION DIAGNOSIS; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grip O, 2000, SCAND J GASTROENTERO, V35, P619, DOI 10.1080/003655200750023589; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lin HC, 2010, J THROMB HAEMOST, V8, P2176, DOI 10.1111/j.1538-7836.2010.03993.x; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Ludvigsson JF, 2007, BRIT J HAEMATOL, V139, P121, DOI 10.1111/j.1365-2141.2007.06766.x; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; Merkel PA, 2005, ANN INTERN MED, V142, P620, DOI 10.7326/0003-4819-142-8-200505030-00011; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; National Board of Health and Welfare, 2000, VAL DIAGN SWED IN CA; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Rosengren A, 2008, J THROMB HAEMOST, V6, P558, DOI 10.1111/j.1538-7836.2007.02857.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sjalander Anders, 2007, Lakartidningen, V104, P1585; Statistics Sweden, 2008, POP HOUS CENS 1960 9; Statistics Sweden, 2010, MULT REG 2009 DESCR; Stein PD, 2009, AM J MED SCI, V337, P259, DOI 10.1097/MAJ.0b013e31818bbb8b; Wang JY, 2009, WORLD J GASTROENTERO, V15, P927, DOI 10.3748/wjg.15.927; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Yazici Yusuf, 2010, Curr Rheumatol Rep, V12, P429, DOI 10.1007/s11926-010-0132-z	29	248	256	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					244	249		10.1016/S0140-6736(11)61306-8	http://dx.doi.org/10.1016/S0140-6736(11)61306-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879FW	22119579				2022-12-28	WOS:000299316100039
J	Cheung, ANY; Chan, KKL				Cheung, Annie N. Y.; Chan, Karen K. L.			Perplexing hCG profile after evacuation of hydatidiform mole	LANCET			English	Editorial Material							GESTATIONAL TROPHOBLASTIC NEOPLASIA; HUMAN CHORIONIC-GONADOTROPIN; DISEASES		[Cheung, Annie N. Y.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Karen K. L.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cheung, ANY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	anycheun@hku.hk	Chan, Karen/E-4041-2015; Cheung, Annie Nga Yin/C-4231-2009	Chan, Karen/0000-0001-9947-4713; Cheung, Annie Nga Yin/0000-0002-1584-7568				Agarwal R, 2012, LANCET, V379, P130, DOI 10.1016/S0140-6736(11)61265-8; Butler SA, 2002, OBSTET GYNECOL, V99, P516, DOI 10.1016/S0029-7844(01)01774-4; Chan KKL, 2006, AM J OBSTET GYNECOL, V195, P1282, DOI 10.1016/j.ajog.2006.03.048; Cole LA, 2004, J REPROD MED, V49, P423; Cole LA, 2006, GYNECOL ONCOL, V102, P145, DOI 10.1016/j.ygyno.2005.12.047; Cole LA, 2010, GYNECOL ONCOL, V116, P3, DOI 10.1016/j.ygyno.2009.09.028; Khanlian SA, 2003, AM J OBSTET GYNECOL, V188, P1254, DOI 10.1067/mob.2003.271; Kohorn EI, 2002, GYNECOL ONCOL, V85, P315, DOI 10.1006/gyno.2002.6622; Ngan HYS, 2006, J REPROD MED, V51, P829; Ngan HYS, 2004, INT J GYNECOL CANCER, V14, P202, DOI 10.1111/j.1048-891X.2004.014236.x; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Zhang HJ, 2008, PLACENTA, V29, P549, DOI 10.1016/j.placenta.2008.03.003	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					98	100		10.1016/S0140-6736(11)61518-3	http://dx.doi.org/10.1016/S0140-6736(11)61518-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22130489				2022-12-28	WOS:000299317700012
J	DeWitt, MA; Chang, AY; Combs, PA; Yildiz, A				DeWitt, Mark A.; Chang, Amy Y.; Combs, Peter A.; Yildiz, Ahmet			Cytoplasmic Dynein Moves Through Uncoordinated Stepping of the AAA plus Ring Domains	SCIENCE			English	Article							HAND-OVER-HAND; MYOSIN VI; KINESIN; PROCESSIVITY; MOTOR; COORDINATION; MECHANISM; BEHAVIOR; SITES	Cytoplasmic dynein is a homodimeric AAA+ motor that transports a multitude of cargos toward the microtubule minus end. How the two catalytic head domains interact and move relative to each other during processive movement is unclear. Here, we tracked the relative positions of both heads with nanometer precision and directly observed the heads moving independently along the microtubule. The heads remained widely separated, and their stepping behavior varied as a function of interhead separation. One active head was sufficient for processive movement, and an active head could drag an inactive partner head forward. Thus, dynein moves processively without interhead coordination, a mechanism fundamentally distinct from the hand-over-hand stepping of kinesin and myosin.	[Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	yildiz@berkeley.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X; Combs, Peter/0000-0003-2835-5623	NIH [GM094522, GM08295]; NSF [MCB-1055017]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM094522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. D. Vale and A. P. Carter for providing yeast strains; T. Bilyard, F. B. Cleary, and S. Shih for critical evaluation of the manuscript; and K. Schimert for technical assisstance. This work is supported by NIH [GM094522 (A.Y.), GM08295 ( M. A. D. and P. A. C.)], NSF [MCB-1055017 (A.Y.)], and Burroughs Wellcome Foundation (A.Y.).	Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kamei T, 2005, BIOPHYS J, V88, P2068, DOI 10.1529/biophysj.104.049759; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Liao JC, 2009, J MOL BIOL, V392, P862, DOI 10.1016/j.jmb.2009.07.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Tsygankov D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050098; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	23	136	137	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2012	335	6065					221	225		10.1126/science.1215804	http://dx.doi.org/10.1126/science.1215804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875LZ	22157083	Green Accepted			2022-12-28	WOS:000299033100054
J	Kump, LR; Junium, C; Arthur, MA; Brasier, A; Fallick, A; Melezhik, V; Lepland, A; Crne, AE; Luo, GM				Kump, Lee R.; Junium, Christopher; Arthur, Michael A.; Brasier, Alex; Fallick, Anthony; Melezhik, Victor; Lepland, Aivo; Crne, Alenka E.; Luo, Genming			Isotopic Evidence for Massive Oxidation of Organic Matter Following the Great Oxidation Event	SCIENCE			English	Article							CARBON; CONSTRAINTS; DEPOSITS; NITROGEN; PROVINCE; RISE	The stable isotope record of marine carbon indicates that the Proterozoic Eon began and ended with extreme fluctuations in the carbon cycle. In both the Paleoproterozoic [2500 to 1600 million years ago (Ma)] and Neoproterozoic (1000 to 542 Ma), extended intervals of anomalously high carbon isotope ratios (delta C-13) indicate high rates of organic matter burial and release of oxygen to the atmosphere; in the Neoproterozoic, the high delta C-13 interval was punctuated by abrupt swings to low delta C-13, indicating massive oxidation of organic matter. We report a Paleoproterozoic negative delta C-13 excursion that is similar in magnitude and apparent duration to the Neoproterozoic anomaly. This Shunga-Francevillian anomaly may reflect intense oxidative weathering of rocks as the result of the initial establishment of an oxygen-rich atmosphere.	[Kump, Lee R.; Junium, Christopher; Arthur, Michael A.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Junium, Christopher] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Brasier, Alex; Fallick, Anthony] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Melezhik, Victor; Lepland, Aivo; Crne, Alenka E.] Norwegian Geol Survey, N-7491 Trondheim, Norway; [Melezhik, Victor] Univ Bergen, Ctr Geobiol SFF, N-5020 Bergen, Norway; [Lepland, Aivo] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia; [Crne, Alenka E.] ZRC SAZU, Ivan Rakovec Inst Paleontol, SI-1000 Ljubljana, Slovenia; [Luo, Genming] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Scottish Universities Research & Reactor Center; Geological Survey of Norway; University of Bergen; Tallinn University of Technology; Slovenian Academy of Sciences & Arts (SASA); China University of Geosciences	Kump, LR (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu	Kump, Lee/H-8287-2012; Arthur, Michael A/E-2872-2014; Brasier, Alexander T./E-7412-2010	Arthur, Michael A/0000-0002-3028-6279; Brasier, Alexander T./0000-0001-6103-2848; Fallick, Anthony/0000-0002-7649-6167; Lepland, Aivo/0000-0002-0248-1405	International Continental Drilling Program; NSF; NASA Astrobiology Institute; Natural Environment Research Council [NE/G00398X/1]; Norwegian Research Council [191530/V30]; Geological Survey of Norway; NERC [NE/G00398X/1] Funding Source: UKRI	International Continental Drilling Program; NSF(National Science Foundation (NSF)); NASA Astrobiology Institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Geological Survey of Norway; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the International Continental Drilling Program and by NSF, NASA Astrobiology Institute, Natural Environment Research Council grant NE/G00398X/1, Norwegian Research Council grant 191530/V30, and Geological Survey of Norway. Thanks to the FAR-DEEP drilling team, especially D. V. Rychanchik and A. E. Romashkin, Karelian Science Centre, for assistance during the drilling and archiving operations. The data reported in this paper are tabulated in the SOM.	Aharon P, 2005, PRECAMBRIAN RES, V137, P207, DOI 10.1016/j.precamres.2005.03.008; [Anonymous], 1968, GEOCHEMISTRY-GERMANY; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Derry LA, 2010, EARTH PLANET SC LETT, V294, P152, DOI 10.1016/j.epsl.2010.03.022; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; Gauthier-Lafaye F, 2003, PRECAMBRIAN RES, V120, P81, DOI 10.1016/S0301-9268(02)00163-8; Godfrey LV, 2009, NAT GEOSCI, V2, P725, DOI 10.1038/NGEO633; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Hannah J. L., 2008, 33 INT GEOL C OSL NO; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Horie K., 2005, 15 VM GOLDSCHM C MAY, pA11; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Melezhik V. A., 1994, MINERAL MAG A, V85A, P593; Melezhik VA, 1999, EARTH-SCI REV, V47, P1, DOI 10.1016/S0012-8252(99)00027-6; Melezhik VA, 2007, GEOLOGY, V35, P655, DOI 10.1130/G23764A.1; Muller SG, 2005, GEOLOGY, V33, P577, DOI 10.1130/G21482.1; Murakami T, 2011, GEOCHIM COSMOCHIM AC, V75, P3982, DOI 10.1016/j.gca.2011.04.023; Ovchinnikova G. V., 2007, STRATIGR GEOL CORREL, V4, P20; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Preat A, 2011, PRECAMBRIAN RES, V189, P212, DOI 10.1016/j.precamres.2011.05.013; PUKHTEL IS, 1992, DOKL AKAD NAUK+, V326, P706; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; SCHIDLOWSKI M, 1976, GEOCHIM COSMOCHIM AC, V40, P449, DOI 10.1016/0016-7037(76)90010-7; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266	29	138	148	9	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2011	334	6063					1694	1696		10.1126/science.1213999	http://dx.doi.org/10.1126/science.1213999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865XK	22144465				2022-12-28	WOS:000298344000064
J	Meeks, JC				Meeks, John C.			Closing the Cycle	SCIENCE			English	Editorial Material							BLUE-GREEN ALGAE; HETEROTROPHIC GROWTH; CYANOBACTERIA; ANABAENA		Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Meeks, JC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	jcmeeks@ucdavis.edu						BOTHE H, 1974, ARCH MICROBIOL, V96, P291, DOI 10.1007/BF00590185; BOTTOMLEY PJ, 1978, J GEN MICROBIOL, V107, P309, DOI 10.1099/00221287-107-2-309; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; KHOJA T, 1971, ARCH MIKROBIOL, V79, P280, DOI 10.1007/BF00408790; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; ONEILL GP, 1988, J BACTERIOL, V170, P3810, DOI 10.1128/jb.170.9.3810-3816.1988; Pearce C. K., 1967, BIOCHEM J, V105, p45P; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Ungerer JL, 2008, J BACTERIOL, V190, P8115, DOI 10.1128/JB.00886-08; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	15	3	3	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1508	1509		10.1126/science.1215655	http://dx.doi.org/10.1126/science.1215655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174240				2022-12-28	WOS:000298091400039
J	Sharma, SK; Agrawal, S; Damodaran, D; Sreenivas, V; Kadhiravan, T; Lakshmy, R; Jagia, P; Kumar, A				Sharma, Surendra K.; Agrawal, Swastik; Damodaran, Deepak; Sreenivas, Vishnubhatla; Kadhiravan, Tamilarasu; Lakshmy, Ramakrishnan; Jagia, Priya; Kumar, Atin			RETRACTED: CPAP for the Metabolic Syndrome in Patients with Obstructive Sleep Apnea (Retracted article. See vol. 369, pg. 1770, 2013)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Retracted Publication							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; HYPERTENSION; PREVALENCE; ABNORMALITIES; OBESITY; LEPTIN	BACKGROUND Obstructive sleep apnea is associated with an increased prevalence of the metabolic syndrome and its components. It is unclear whether treatment of obstructive sleep apnea syndrome with continuous positive airway pressure (CPAP) would modify these outcomes. METHODS In our double-blind, placebo-controlled trial, we randomly assigned patients with obstructive sleep apnea syndrome to undergo 3 months of therapeutic CPAP followed by 3 months of sham CPAP, or vice versa, with a washout period of 1 month in between. Before and after each intervention, we obtained measurements of anthropometric variables, blood pressure, fasting blood glucose levels, insulin resistance (with the use of homeostasis model assessment), fasting blood lipid profile, glycated hemoglobin levels, carotid intima-media thickness, and visceral fat. The metabolic syndrome was defined according to National Cholesterol Education Program Adult Treatment Panel III criteria, with Asian cutoff values for abdominal obesity. RESULTS A total of 86 patients completed the study, 75 (87%) of whom had the metabolic syndrome. CPAP treatment (vs. sham CPAP) was associated with significant mean decreases in systolic blood pressure (3.9 mm Hg; 95% confidence interval [CI], 1.4 to 6.4; P=0.001), diastolic blood pressure (2.5 mm Hg; 95% CI, 0.9 to 4.1; P < 0.001), serum total cholesterol (13.3 mg per deciliter; 95% CI, 5.3 to 21.3; P=0.005), non-high-density lipoprotein cholesterol (13.3 mg per deciliter; 95% CI, 4.8 to 21.8; P=0.009), low-density lipoprotein cholesterol (9.6 mg per deciliter; 95% CI, 2.5 to 16.7; P=0.008), triglycerides (18.7 mg per deciliter; 95% CI, 4.3 to 41.6; P=0.02), and glycated hemoglobin (0.2%; 95% CI, 0.1 to 0.4; P=0.003). The frequency of the metabolic syndrome was reduced after CPAP therapy (reversal found in 11 of 86 patients [13%] undergoing CPAP therapy vs. 1 of 86 [1%] undergoing sham CPAP). Accelerated hypertension developed 1 patient receiving CPAP therapy first, intolerance to CPAP developed in 2 others, and another patient declined to continue sham CPAP. CONCLUSIONS In patients with moderate-to-severe obstructive sleep apnea syndrome, 3 months of CPAP therapy lowers blood pressure and partially reverses metabolic abnormalities. (Funded by Pfizer; ClinicalTrials.gov number, NCT00694616.)	[Sharma, Surendra K.; Agrawal, Swastik; Damodaran, Deepak] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India; [Lakshmy, Ramakrishnan] All India Inst Med Sci, Dept Cardiac Biochem, New Delhi 110029, India; [Jagia, Priya] All India Inst Med Sci, Dept Cardiac Radiol, New Delhi 110029, India; [Kumar, Atin] All India Inst Med Sci, Dept Radiodiag, New Delhi 110029, India; [Kadhiravan, Tamilarasu] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Pondicherry, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Institute of Postgraduate Medical Education & Research	Sharma, SK (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	sksharma.aiims@gmail.com		Agrawal, Swastik/0000-0002-5671-5174	Pfizer	Pfizer(Pfizer)	Supported by Pfizer through an investigator-initiated research grant.	Baigent C, 2008, LANCET, V371, P2084; Bairaktari E, 2000, CLIN BIOCHEM, V33, P549, DOI 10.1016/S0009-9120(00)00162-4; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basta M, 2007, SLEEP MED, V8, P5, DOI 10.1016/j.sleep.2006.10.001; Borgel J, 2006, EUR RESPIR J, V27, P121, DOI 10.1183/09031936.06.00131304; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Cuhadaroglu C, 2009, LUNG, V187, P75, DOI 10.1007/s00408-008-9131-5; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Dorkova Z, 2008, CHEST, V134, P686, DOI 10.1378/chest.08-0556; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, pc5991; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; Harsch IA, 2003, EUR RESPIR J, V22, P251, DOI 10.1183/09031936.03.00010103; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mota PC, 2010, SLEEP BREATH    0924; Nieto F. Javier, 2002, JAMA (Journal of the American Medical Association), V288, P1985; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Robinson GV, 2004, THORAX, V59, P777, DOI 10.1136/thx.2003.018739; SALONEN JT, 1993, CIRCULATION, V87, P56; Sharma SK, 2007, SLEEP MED, V8, P12, DOI 10.1016/j.sleep.2006.06.014; Sharma SK, 2004, SLEEP MED, V5, P351, DOI 10.1016/j.sleep.2004.03.004; Sharma SK, 2010, SLEEP MED, V11, P562, DOI 10.1016/j.sleep.2010.02.008; Sharma SK, 2006, CHEST, V130, P149, DOI 10.1378/chest.130.1.149; Steiropoulos P, 2007, CHEST, V132, P843, DOI 10.1378/chest.07-0074; Tatsumi K, 2005, CHEST, V127, P716, DOI 10.1378/chest.127.3.716; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	36	239	250	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2277	2286		10.1056/NEJMoa1103944	http://dx.doi.org/10.1056/NEJMoa1103944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168642				2022-12-28	WOS:000298031800008
J	Singh, M; Holmes, DR; Dehmer, GJ; Lennon, RJ; Wharton, TP; Kutcher, MA; Aversano, T; Rihal, CS				Singh, Mandeep; Holmes, David R., Jr.; Dehmer, Gregory J.; Lennon, Ryan J.; Wharton, Thomas P.; Kutcher, Michael A.; Aversano, Thomas; Rihal, Charanjit S.			Percutaneous Coronary Intervention at Centers With and Without On-site Surgery A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ELEVATION MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; CARDIAC-SURGERY; OUTCOMES; HOSPITALS; ANGIOPLASTY; ASSOCIATION; GUIDELINES; REGISTRY; BACKUP	Context Percutaneous coronary interventions are performed at centers without on-site surgery, despite current guidelines discouraging this. Objective To assess literature comparing rates of in-hospital mortality and emergency coronary artery bypass grafting surgery at centers with and without on-site surgery. Data Sources A systematic search of studies published between January 1990 and May 2010 was conducted using MEDLINE, EMBASE, and Cochrane Review databases. Study Selection English-language studies of percutaneous coronary intervention performed at centers with and without on-site surgery providing data on in-hospital mortality and emergency bypass were identified. Two study authors independently reviewed the 1029 articles originally identified and selected 40 for analysis. Data Extraction Study title, time period, indication for angioplasty, and outcomes were extracted manually from all selected studies, and quality of each study was assessed using the strengthening the reporting of observational studies in epidemiology(STROBE) checklist. Data Synthesis High-quality studies of percutaneous coronary interventions performed at centers with and without on-site surgery were included. Pooled-effect estimates were calculated with random-effects models. Analyses of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction of 124 074 patients demonstrated no increase in in-hospital mortality (no on-site surgery vs on-site surgery: observed risk, 4.6% vs 7.2%; odds ratio [OR], 0.96; 95% CI, 0.88-1.05; I-2=0%) or emergency bypass (observed risk, 0.22% vs 1.03%; OR, 0.53; 95% CI, 0.35-0.79; I-2=20%) at centers without on-site surgery. For nonprimary percutaneous coronary interventions (elective and urgent, n=914 288), the rates of in-hospital mortality (observed risk, 1.4% vs 2.1%; OR, 1.15; 95% CI, 0.93-1.41; I-2=46%) and emergency bypass (observed risk, 0.17% vs 0.29%; OR, 1.21; 95% CI, 0.52-2.85; I-2=5%) were not significantly different at centers without or with on-site surgery. Conclusion Percutaneous coronary interventions performed at centers without on-site surgery, compared with centers with on-site surgery, were not associated with a higher incidence of in-hospital mortality or emergency bypass surgery. JAMA. 2011;306(22):2487-2494	[Singh, Mandeep; Holmes, David R., Jr.; Rihal, Charanjit S.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Lennon, Ryan J.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Dehmer, Gregory J.] Scott & White Healthcare, Div Cardiol, Temple, TX USA; [Wharton, Thomas P.] Exeter Hosp, Exeter, NH USA; [Kutcher, Michael A.] Wake Forest Univ, Baptist Med Ctr, Dept Cardiol, Winston Salem, NC 27109 USA; [Aversano, Thomas] Johns Hopkins Univ Hosp, Dept Cardiol, Baltimore, MD 21287 USA	Mayo Clinic; Mayo Clinic; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins Medicine	Singh, M (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	singh.mandeep@mayo.edu	Dehmer, Gregory/AAQ-9380-2021					Anis A, 2009, CIRCULATION, V120, pS959; Carlsson J, 2007, HEART, V93, P335, DOI 10.1136/hrt.2006.098061; DELLAVALLE A, 1995, CORONARY ARTERY DIS, V6, P513; Frutkin AD, 2008, AM J CARDIOL, V101, P53, DOI 10.1016/j.amjcard.2007.07.047; Giuliani Gabriele, 2008, EuroIntervention, V4, P365, DOI 10.4244/EIJV4I3A65; Hannan EL, 2009, CIRC-CARDIOVASC INTE, V2, P519, DOI 10.1161/CIRCINTERVENTIONS.109.894048; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038; Loubeyre C, 1999, CATHETER CARDIO INTE, V47, P441, DOI 10.1002/(SICI)1522-726X(199908)47:4<441::AID-CCD12>3.0.CO;2-S; Malenka DJ, 1999, J AM COLL CARDIOL, V34, P1471, DOI 10.1016/S0735-1097(99)00393-9; Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026; Peels HO, 2007, AM J CARDIOL, V100, P1353, DOI 10.1016/j.amjcard.2007.06.022; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pride YB, 2009, JACC-CARDIOVASC INTE, V2, P944, DOI 10.1016/j.jcin.2009.07.008; Pride YB, 2009, CIRC-CARDIOVASC QUAL, V2, P574, DOI 10.1161/CIRCOUTCOMES.108.841296; Sanborn TA, 2004, AM J CARDIOL, V93, P1335, DOI 10.1016/j.amjcard.2004.02.026; Seshadri N, 2002, CIRCULATION, V106, P2346, DOI 10.1161/01.CIR.0000036595.92742.69; Shiraishi J, 2007, CIRC J, V71, P1208, DOI 10.1253/circj.71.1208; Singh M, 2009, MAYO CLIN PROC, V84, P501, DOI 10.1016/S0025-6196(11)60581-8; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tebbe U, 2009, CLIN RES CARDIOL, V98, P701, DOI 10.1007/s00392-009-0045-x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weaver WD, 1995, J INVASIVE CARDIOL, V7, pF34; Wennberg DE, 2004, JAMA-J AM MED ASSOC, V292, P1961, DOI 10.1001/jama.292.16.1961; Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083	26	48	50	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2487	2494		10.1001/jama.2011.1790	http://dx.doi.org/10.1001/jama.2011.1790			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166608				2022-12-28	WOS:000297983300022
J	Hegerl, GC; Russon, T				Hegerl, Gabriele C.; Russon, Tom			Using the Past to Predict the Future?	SCIENCE			English	Editorial Material							CLIMATE SENSITIVITY; EARTHS TEMPERATURE; SIMULATIONS; ENSEMBLE		[Hegerl, Gabriele C.; Russon, Tom] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh	Hegerl, GC (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland.	gabi.hegerl@ed.ac.uk		Hegerl, Gabriele/0000-0002-4159-1295	NERC [NE/G019819/1] Funding Source: UKRI; Natural Environment Research Council [NE/G019819/1, ncas10009, NER/T/S/2002/00982] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Annan JD, 2005, SOLA, V1, P181, DOI 10.2151/sola.2005-047; CROWLEY TJ, 1990, J CLIMATE, V3, P1282, DOI 10.1175/1520-0442(1990)003<1282:ATASGA>2.0.CO;2; Hargreaves JC, 2007, CLIM PAST, V3, P77, DOI 10.5194/cp-3-77-2007; Holden PB, 2010, CLIM DYNAM, V35, P785, DOI 10.1007/s00382-009-0630-8; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Otto-Bliesner BL, 2009, CLIM DYNAM, V32, P799, DOI 10.1007/s00382-008-0509-0; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Schneider von Deimling T, 2006, CLIM DYNAM, V27, P149, DOI 10.1007/s00382-006-0126-8; Solomon S., 2011, CLIMATE STABILIZATIO; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224	12	11	11	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1360	1361		10.1126/science.1214828	http://dx.doi.org/10.1126/science.1214828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22116029				2022-12-28	WOS:000297787700041
J	Shibata, K; Watanabe, T; Sasaki, Y; Kawato, M				Shibata, Kazuhisa; Watanabe, Takeo; Sasaki, Yuka; Kawato, Mitsuo			Perceptual Learning Incepted by Decoded fMRI Neurofeedback Without Stimulus Presentation	SCIENCE			English	Article							REAL-TIME FMRI; BRAIN ACTIVATION; V1 NEURONS; CORTEX; RESPONSES; AREA	It is controversial whether the adult primate early visual cortex is sufficiently plastic to cause visual perceptual learning (VPL). The controversy occurs partially because most VPL studies have examined correlations between behavioral and neural activity changes rather than cause-and-effect relationships. With an online-feedback method that uses decoded functional magnetic resonance imaging (fMRI) signals, we induced activity patterns only in early visual cortex corresponding to an orientation without stimulus presentation or participants' awareness of what was to be learned. The induced activation caused VPL specific to the orientation. These results suggest that early visual areas are so plastic that mere inductions of activity patterns are sufficient to cause VPL. This technique can induce plasticity in a highly selective manner, potentially leading to powerful training and rehabilitative protocols.	[Shibata, Kazuhisa; Watanabe, Takeo; Sasaki, Yuka; Kawato, Mitsuo] Adv Telecommun Res Inst, Int Computat Neurosci Labs, Keihanna Sci City, Kyoto 6190288, Japan	Advanced Telecommunications Research Institute International	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	takeo@bu.edu	Jovicich, Jorge/D-2293-2010	Sasaki, Yuka/0000-0002-0061-0250	NIH [R01 AG031941, R01 EY015980, R01 MH091801]; NSF [0964776]; NATIONAL EYE INSTITUTE [R01EY015980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was conducted in "Brain Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. T. W. was partially supported by NIH grants R01 AG031941 and R01 EY015980 and Y.S. by grants R01 MH091801 and NSF 0964776. We thank J. Dobres, M. Fukuda, G. Ganesh, H. Imamizu, A. R. Seitz, and K. Tanaka for their comments on a draft of this manuscript and M. Fukuda, Y. Furukawa, S. Hirose, M. Sato, and ATR BAIC for technical assistances.	Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Censor N, 2009, J VISION, V9, DOI 10.1167/9.4.12; Corthout E, 2000, NEUROREPORT, V11, P1565, DOI 10.1097/00001756-200005150-00039; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Giovannelli F, 2010, NEUROPSYCHOLOGIA, V48, P1807, DOI 10.1016/j.neuropsychologia.2010.02.031; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Huxlin KR, 2009, J NEUROSCI, V29, P3981, DOI 10.1523/JNEUROSCI.4882-08.2009; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kawato M, 2008, PHILOS T R SOC B, V363, P2201, DOI 10.1098/rstb.2008.2272; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	20	287	298	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1413	1415		10.1126/science.1212003	http://dx.doi.org/10.1126/science.1212003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158821	Green Accepted			2022-12-28	WOS:000297787700056
J	Atmar, RL; Bernstein, DI; Harro, CD; Al-Ibrahim, MS; Chen, WH; Ferreira, J; Estes, MK; Graham, DY; Opekun, AR; Richardson, C; Mendelman, PM				Atmar, Robert L.; Bernstein, David I.; Harro, Clayton D.; Al-Ibrahim, Mohamed S.; Chen, Wilbur H.; Ferreira, Jennifer; Estes, Mary K.; Graham, David Y.; Opekun, Antone R.; Richardson, Charles; Mendelman, Paul M.			Norovirus Vaccine against Experimental Human Norwalk Virus Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELLULAR IMMUNE-RESPONSES; HOST SUSCEPTIBILITY; GASTROENTERITIS; INFECTION; DISEASE; PARTICLES; VOLUNTEERS; PROTECTION; MUCOSAL; ADJUVANTS	BACKGROUND Noroviruses cause epidemic and sporadic acute gastroenteritis. No vaccine is available to prevent norovirus illness or infection. METHODS We conducted a randomized, double-blind, placebo-controlled, multicenter trial to assess the safety, immunogenicity, and efficacy of an investigational, intranasally delivered norovirus viruslike particle (VLP) vaccine (with chitosan and monophosphoryl lipid A as adjuvants) to prevent acute viral gastroenteritis after challenge with a homologous viral strain, Norwalk virus (genotype GI.1). Healthy adults 18 to 50 years of age received two doses of either vaccine or placebo and were subsequently inoculated with Norwalk virus and monitored for infection and gastroenteritis symptoms. RESULTS Ninety-eight persons were enrolled and randomly assigned to receive vaccine (50 participants) or placebo (48 participants), and 90 received both doses (47 participants in the vaccine group and 43 in the placebo group). The most commonly reported symptoms after vaccination were nasal stuffiness, nasal discharge, and sneezing. Adverse events occurred with similar frequency among vaccine and placebo recipients. A Norwalk virus-specific IgA seroresponse (defined as an increase by a factor of 4 in serum antibody levels) was detected in 70% of vaccine recipients. Seventy-seven of 84 participants inoculated with Norwalk virus were included in the per-protocol analysis. Vaccination significantly reduced the frequencies of Norwalk virus gastroenteritis (occurring in 69% of placebo recipients vs. 37% of vaccine recipients, P = 0.006) and Norwalk virus infection (82% of placebo recipients vs. 61% of vaccine recipients, P = 0.05). CONCLUSIONS This norovirus VLP vaccine provides protection against illness and infection after challenge with a homologous virus. (Funded by LigoCyte Pharmaceuticals and the National Institutes of Health; ClinicalTrials.gov number, NCT00973284.)	[Atmar, Robert L.; Estes, Mary K.; Graham, David Y.; Opekun, Antone R.] Baylor Coll Med, Houston, TX 77030 USA; [Bernstein, David I.] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati, OH USA; [Harro, Clayton D.] Johns Hopkins Univ, Baltimore, MD USA; [Al-Ibrahim, Mohamed S.] Shin Nippon Biomed Labs, Clin Pharmacol Ctr, Baltimore, MD USA; [Chen, Wilbur H.] Univ Maryland, Baltimore, MD 21201 USA; [Ferreira, Jennifer] EMMES, Rockville, MD USA; [Richardson, Charles; Mendelman, Paul M.] LigoCyte Pharmaceut, Bozeman, MT USA	Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Shin Nippon Biomedical Laboratories Ltd.; University System of Maryland; University of Maryland Baltimore	Atmar, RL (corresponding author), Baylor Coll Med, 1 Baylor Plaza,MS BCM280, Houston, TX 77030 USA.	ratmar@bcm.edu	Atmar, Robert/AFQ-5392-2022; Graham, David/AAL-2165-2021	Atmar, Robert/0000-0001-9989-6772; 	LigoCyte Pharmaceuticals; National Institutes of Health [M01 RR-000188]; Baylor College of Medicine; Cincinnati Children's Hospital; Johns Hopkins University; SNBL; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER	LigoCyte Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; Cincinnati Children's Hospital; Johns Hopkins University(Johns Hopkins University); SNBL; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by LigoCyte Pharmaceuticals and a grant from the National Institutes of Health to the Baylor College of Medicine General Clinical Research Center (M01 RR-000188).; We thank the staff at each of the clinical sites for recruiting and providing care for the study participants; the clinical and laboratory personnel who supported this study (Baylor College of Medicine: Mark A. Gilger and Frederick H. Neill; Cincinnati Children's Hospital: Susan Parker, Michele Dickey, and Colleen Fitzpatrick; Johns Hopkins University: Barbara DeNearing and Alicia Marcum-Cage; and SNBL: Thuy Anderson and Will Leslie); the members of the Safety Monitoring Committee (Drs. Philip C. Johnson, Nancy Browning, and Robert B. Belshe); staff at EMMES for their help with data management and analysis; Julie Cordova and Robin Mertens for their operational expertise; and Dr. Robert Bargatze and Robert Goodwin of LigoCyte Pharmaceuticals for their review of a draft of the manuscript.	Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Atmar RL, 2011, ANN M INF DIS SOC AM; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Ball JM, 1998, J VIROL, V72, P1345, DOI 10.1128/JVI.72.2.1345-1353.1998; Ball JM, 1999, GASTROENTEROLOGY, V117, P40, DOI 10.1016/S0016-5085(99)70548-2; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; COUCH RB, 1984, MOL VIROLOGY EPIDEMI, P119; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; El-Kamary SS, 2011, J INFECT DIS, V203, P1036, DOI 10.1093/infdis/jiq151; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Guerrero RA, 2001, J VIROL, V75, P9713, DOI 10.1128/JVI.75.20.9713-9722.2001; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Iritani N, 2008, J VIROL, V82, P7336, DOI 10.1128/JVI.02371-07; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; Joura EA, 2008, VACCINE, V26, P6844, DOI 10.1016/j.vaccine.2008.09.073; Kavanagh O, 2011, CLIN VACCINE IMMUNOL, V18, P1187, DOI 10.1128/CVI.00039-11; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Le Guyader FS, 2010, J CLIN MICROBIOL, V48, P915, DOI 10.1128/JCM.01664-09; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2010, J VIROL, V84, P1800, DOI 10.1128/JVI.02179-09; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992	38	350	367	0	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2178	2187		10.1056/NEJMoa1101245	http://dx.doi.org/10.1056/NEJMoa1101245			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150036	Green Accepted			2022-12-28	WOS:000297731400003
J	Graham-Rowe, D				Graham-Rowe, Duncan			Racing against the flu	NATURE			English	Editorial Material																			0	12	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S2	S3		10.1038/480S2a	http://dx.doi.org/10.1038/480S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158296	Bronze			2022-12-28	WOS:000297744200004
J	Coombes, R				Coombes, Rebecca			Nominations open for BMJ Group awards 2012	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7958	10.1136/bmj.d7958	http://dx.doi.org/10.1136/bmj.d7958			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861SP	22162293				2022-12-28	WOS:000298039800002
J	Czupryn, A; Zhou, YD; Chen, X; McNay, D; Anderson, MP; Flier, JS; Macklis, JD				Czupryn, Artur; Zhou, Yu-Dong; Chen, Xi; McNay, David; Anderson, Matthew P.; Flier, Jeffrey S.; Macklis, Jeffrey D.			Transplanted Hypothalamic Neurons Restore Leptin Signaling and Ameliorate Obesity in db/db Mice	SCIENCE			English	Article							ARCUATE NUCLEUS; GLUCOSE-HOMEOSTASIS; PROOPIOMELANOCORTIN NEURONS; ENERGY-BALANCE; POMC NEURONS; BODY-WEIGHT; RECEPTOR; NEUROGENESIS; CHANNELS; PROGENITORS	Evolutionarily old and conserved homeostatic systems in the brain, including the hypothalamus, are organized into nuclear structures of heterogeneous and diverse neuron populations. To investigate whether such circuits can be functionally reconstituted by synaptic integration of similarly diverse populations of neurons, we generated physically chimeric hypothalami by microtransplanting small numbers of embryonic enhanced green fluorescent protein-expressing, leptin-responsive hypothalamic cells into hypothalami of postnatal leptin receptor-deficient (db/db) mice that develop morbid obesity. Donor neurons differentiated and integrated as four distinct hypothalamic neuron subtypes, formed functional excitatory and inhibitory synapses, partially restored leptin responsiveness, and ameliorated hyperglycemia and obesity in db/db mice. These experiments serve as a proof of concept that transplanted neurons can functionally reconstitute complex neuronal circuitry in the mammalian brain.	[Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; [Zhou, Yu-Dong; Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02215 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Dept Neurol, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Dept Neurosurg, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA; [Czupryn, Artur; Macklis, Jeffrey D.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Czupryn, Artur] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Chen, Xi; McNay, David; Flier, Jeffrey S.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Harvard University; Beth Israel Deaconess Medical Center	Anderson, MP (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	matthew_anderson@bidmc.harvard.edu; jeffrey_flier@hms.harvard.edu; jeffrey_macklis@hms.harvard.edu	Flier, jeffrey/AAG-6223-2019	McNay, David/0000-0002-4747-0136; Zhou, Yu-Dong/0000-0002-6364-3869; Anderson, Matthew/0000-0003-4602-1811	NIH [NS41590]; Jane and Lee Seidman Fund for Central Nervous System Research; Emily and Robert Pearlstein Fund for Nervous System Repair; National Institute of Neurological Disorders and Stroke (NINDS) [NS057444, NS054674, NS070295]; Ministerstwa Nauki i Szkolnictwa Wyzszego [N303 298437]; Foundation for Polish Science;  [DKR37-28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK028082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS041590, K02NS054674, R01NS049553, R01NS045523, R01NS041590, R21NS070295, R01NS057444] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane and Lee Seidman Fund for Central Nervous System Research; Emily and Robert Pearlstein Fund for Nervous System Repair; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministerstwa Nauki i Szkolnictwa Wyzszego; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Yamamoto, K. Billmers, A. Palmer, L. Pasquina, K. Quinn, A. Wheeler, and P. Davis (J.D.M. laboratory), and H. Yin (J.S.F. laboratory) for excellent technical assistance. We thank O.K. Ronnekleiv at Oregon Health and Science University for providing antibody to beta-endorphin. We thank M. McKee of the MGH Microscopy Core for excellent EM assistance. This study was partially supported by NIH grant NS41590 (to J.D.M.), with additional infrastructure supported by NS45523 and NS49553 (to J.D.M.), and with additional support from the Jane and Lee Seidman Fund for Central Nervous System Research and the Emily and Robert Pearlstein Fund for Nervous System Repair (to J.D.M.), grant DKR37-28082 (to J.S.F.), the Picower Foundation (to J.S.F. and M. P. A.), National Institute of Neurological Disorders and Stroke (NINDS) grants NS057444, NS054674, and NS070295 (to M. P. A.), and the Nancy Lurie Marks Family Foundation (to M. P. A.). A. C. was partially supported by Ministerstwa Nauki i Szkolnictwa Wyzszego grant N303 298437 and by the Foundation for Polish Science.	Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bayer S.A., 1991, NEOCORTICAL DEV; Burdakov D, 2002, J NEUROSCI, V22, P6380; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Mcnay DEG, 2006, MOL ENDOCRINOL, V20, P1623, DOI 10.1210/me.2005-0518; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Shin JJ, 2000, J NEUROSCI, V20, P7404; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	33	43	45	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1133	1137		10.1126/science.1209870	http://dx.doi.org/10.1126/science.1209870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116886	Green Submitted, Green Accepted			2022-12-28	WOS:000297313900051
J	Huang, HJ; Fei, YW; Cai, LC; Jing, FQ; Hu, XJ; Xie, HS; Zhang, LM; Gong, ZZ				Huang, Haijun; Fei, Yingwei; Cai, Lingcang; Jing, Fuqian; Hu, Xiaojun; Xie, Hongsen; Zhang, Lianmeng; Gong, Zizheng			Evidence for an oxygen-depleted liquid outer core of the Earth	NATURE			English	Article							SHOCK COMPRESSION; HUGONIOT DATA; IRON; STATE; CONSTRAINTS; EQUATIONS	On the basis of geophysical observations, cosmochemical constraints, and high-pressure experimental data, the Earth's liquid outer core consists of mainly liquid iron alloyed with about ten per cent (by weight) of light elements(1,2). Although the concentrations of the light elements are small, they nevertheless affect the Earth's core: its rate of cooling, the growth of the inner core, the dynamics of core convection, and the evolution of the geodynamo(3,4). Several light elements-including sulphur, oxygen, silicon, carbon and hydrogen-have been suggested(2), but the precise identity of the light elements in the Earth's core is still unclear. Oxygen has been proposed as a major light element in the core on the basis of cosmochemical arguments and chemical reactions during accretion(5,6). Its presence in the core has direct implications for Earth accretion conditions of oxidation state, pressure and temperature. Here we report new shockwave data in the Fe-S-O system that are directly applicable to the outer core. The data include both density and sound velocity measurements, which we compare with the observed density and velocity profiles of the liquid outer core. The results show that we can rule out oxygen as a major light element in the liquid outer core because adding oxygen into liquid iron would not reproduce simultaneously the observed density and sound velocity profiles of the outer core. An oxygen-depleted core would imply a more reduced environment during early Earth accretion.	[Fei, Yingwei] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Huang, Haijun; Jing, Fuqian; Hu, Xiaojun] Wuhan Univ Technol, Sch Sci, Wuhan 430070, Hubei, Peoples R China; [Fei, Yingwei] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Cai, Lingcang; Jing, Fuqian] China Acad Engn Phys, Inst Fluid Phys, Natl Key Lab Shock Wave & Detonat Phys, Mianyang 621900, Sichuan, Peoples R China; [Xie, Hongsen] Chinese Acad Sci, Inst Geochem, Guiyang 550002, Guizhou, Peoples R China; [Zhang, Lianmeng] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Hubei, Peoples R China; [Gong, Zizheng] Beijing Inst Spacecraft Environm Engn, Natl Key Lab Sci & Technol Reliabil & Environm En, Beijing 100094, Peoples R China	Carnegie Institution for Science; Wuhan University of Technology; Peking University; Chinese Academy of Engineering Physics; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Wuhan University of Technology	Fei, YW (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	fei@gl.ciw.edu	Fei, Yingwei/F-3709-2011	Fei, Yingwei/0000-0001-9955-5353	National Natural Science Foundation of China [41074056, 40604007]; Fundamental Research Funds for the Central Universities; National Basic Research of China [2010CB731600]; National Science Foundation [EAR-0809539]; Carnegie Institution of Washington; Directorate For Geosciences [0809539] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research of China(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Carnegie Institution of Washington; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. D. Dai, J. D. Weng and Q. S. Wang from the Institute of Fluid Physics for help with the experiments, and Q. Shen from the Sate Key Lab of Advanced Technology for Materials Synthesis and Processing and C. H. Shen from the Materials Research and Testing Center for the preparation of the samples. We also thank C. Seagle, L. Zhang and V. Hillgren for comments. This work was supported by the National Natural Science Foundation of China ( grant numbers 41074056 and 40604007), the Fundamental Research Funds for the Central Universities, and the National Basic Research of China ( grant number 2010CB731600). Support by the National Science Foundation ( grant number EAR-0809539 to Y. F.) and the Carnegie Institution of Washington is also acknowledged.	AHRENS TJ, 1979, J GEOPHYS RES, V84, P985, DOI 10.1029/JB084iB03p00985; Alfe D, 2002, EARTH PLANET SC LETT, V195, P91, DOI 10.1016/S0012-821X(01)00568-4; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; Brown JM, 2000, J APPL PHYS, V88, P5496, DOI 10.1063/1.1319320; BROWN JM, 1984, J GEOPHYS RES, V89, P6041, DOI 10.1029/JB089iB07p06041; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; DUFFY TS, 1995, J GEOPHYS RES-SOL EA, V100, P529, DOI 10.1029/94JB02065; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Helffrich G, 2004, SCIENCE, V306, P2239, DOI 10.1126/science.1101109; Hillgren V.J., 2000, ORIGIN EARTH MOON PP, P245, DOI DOI 10.2307/J.CTV1V7ZDRP.20; Hu JB, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898891; Huang HJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006514; [黄海军 HUANG HaiJun], 2006, [高压物理学报, Chinese Journal of High Pressure Physics], V20, P139; JEANLOZ R, 1980, GEOPHYS J ROY ASTR S, V62, P505, DOI 10.1111/j.1365-246X.1980.tb02588.x; Jing F. Q., 1986, INTRO EXPT EQUATION, P1; Komabayashi T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006442; Li J., 2007, TREATISE GEOCHEMISTR, V2, P1; Lin JF, 2005, SCIENCE, V308, P1892, DOI 10.1126/science.1111724; Mao HK, 2001, SCIENCE, V292, P914, DOI 10.1126/science.1057670; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MITCHELL AC, 1981, J APPL PHYS, V52, P3363, DOI 10.1063/1.329160; Nguyen JH, 2004, NATURE, V427, P339, DOI 10.1038/nature02248; OHTANI E, 1984, EARTH PLANET SC LETT, V71, P85, DOI 10.1016/0012-821X(84)90054-2; RINGWOOD AE, 1977, GEOCHEM J, V11, P111, DOI 10.2343/geochemj.11.111; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; WALLACE DC, 1991, P R SOC-MATH PHYS SC, V433, P615, DOI 10.1098/rspa.1991.0067; Weng JD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335948; Wood BJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1415, DOI 10.1016/j.gca.2007.11.036; YAGI T, 1988, GEOPHYS RES LETT, V15, P816, DOI 10.1029/GL015i008p00816	30	82	95	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					513	U236		10.1038/nature10621	http://dx.doi.org/10.1038/nature10621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113693				2022-12-28	WOS:000297285600047
J	Zeiger, RS; Mauger, D; Bacharier, LB; Guilbert, TW; Martinez, FD; Lemanske, RF; Strunk, RC; Covar, R; Szefler, SJ; Boehmer, S; Jackson, DJ; Sorkness, CA; Gern, JE; Kelly, HW; Friedman, NJ; Mellon, MH; Schatz, M; Morgan, WJ; Chinchilli, VM; Raissy, HH; Bade, E; Malka-Rais, J; Beigelman, A; Taussig, LM				Zeiger, Robert S.; Mauger, David; Bacharier, Leonard B.; Guilbert, Theresa W.; Martinez, Fernando D.; Lemanske, Robert F., Jr.; Strunk, Robert C.; Covar, Ronina; Szefler, Stanley J.; Boehmer, Susan; Jackson, Daniel J.; Sorkness, Christine A.; Gern, James E.; Kelly, H. William; Friedman, Noah J.; Mellon, Michael H.; Schatz, Michael; Morgan, Wayne J.; Chinchilli, Vernon M.; Raissy, Hengameh H.; Bade, Elizabeth; Malka-Rais, Jonathan; Beigelman, Avraham; Taussig, Lynn M.		CARE Network Natl Heart Lung	Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED FLUTICASONE PROPIONATE; 2 YEARS OLD; INHALATION SUSPENSION; YOUNG-CHILDREN; PERSISTENT ASTHMA; ORAL PREDNISOLONE; DOUBLE-BLIND; CORTICOSTEROIDS; INFANTS; EFFICACY	BACKGROUND Daily inhaled glucocorticoids are recommended for young children at risk for asthma exacerbations, as indicated by a positive value on the modified asthma predictive index (API) and an exacerbation in the preceding year, but concern remains about daily adherence and effects on growth. We compared daily therapy with intermittent therapy. METHODS We studied 278 children between the ages of 12 and 53 months who had positive values on the modified API, recurrent wheezing episodes, and at least one exacerbation in the previous year but a low degree of impairment. Children were randomly assigned to receive a budesonide inhalation suspension for 1 year as either an intermittent high-dose regimen (1 mg twice daily for 7 days, starting early during a predefined respiratory tract illness) or a daily low-dose regimen (0.5 mg nightly) with corresponding placebos. The primary outcome was the frequency of exacerbations requiring oral glucocorticoid therapy. RESULTS The daily regimen of budesonide did not differ significantly from the intermittent regimen with respect to the frequency of exacerbations, with a rate per patient-year for the daily regimen of 0.97 (95% confidence interval [CI], 0.76 to 1.22) versus a rate of 0.95 (95% CI, 0.75 to 1.20) for the intermittent regimen (relative rate in the intermittent-regimen group, 0.99; 95% CI, 0.71 to 1.35; P = 0.60). There were also no significant between-group differences in several other measures of asthma severity, including the time to the first exacerbation, or adverse events. The mean exposure to budesonide was 104 mg less with the intermittent regimen than with the daily regimen. CONCLUSIONS A daily low-dose regimen of budesonide was not superior to an intermittent high-dose regimen in reducing asthma exacerbations. Daily administration led to greater exposure to the drug at 1 year. (Funded by the National Heart, Lung, and Blood Institute and others; MIST ClinicalTrials.gov number, NCT00675584.)	[Zeiger, Robert S.; Friedman, Noah J.; Mellon, Michael H.; Schatz, Michael] Kaiser Permanente So Calif, Dept Allergy, San Diego, CA USA; [Zeiger, Robert S.; Schatz, Michael] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Mauger, David; Boehmer, Susan; Chinchilli, Vernon M.] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA; [Bacharier, Leonard B.; Strunk, Robert C.; Beigelman, Avraham] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Bacharier, Leonard B.; Strunk, Robert C.; Beigelman, Avraham] St Louis Childrens Hosp, St Louis, MO USA; [Guilbert, Theresa W.; Lemanske, Robert F., Jr.; Jackson, Daniel J.; Sorkness, Christine A.; Gern, James E.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Guilbert, Theresa W.; Lemanske, Robert F., Jr.; Jackson, Daniel J.; Sorkness, Christine A.; Gern, James E.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Guilbert, Theresa W.; Lemanske, Robert F., Jr.; Jackson, Daniel J.; Sorkness, Christine A.; Gern, James E.] Univ Wisconsin Madison, Sch Pharm, Madison, WI USA; [Martinez, Fernando D.; Morgan, Wayne J.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Covar, Ronina; Szefler, Stanley J.; Malka-Rais, Jonathan; Taussig, Lynn M.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO USA; [Covar, Ronina; Szefler, Stanley J.; Malka-Rais, Jonathan; Taussig, Lynn M.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO USA; [Covar, Ronina; Szefler, Stanley J.; Malka-Rais, Jonathan; Taussig, Lynn M.] Univ Colorado, Sch Med, Denver, CO USA; [Kelly, H. William; Raissy, Hengameh H.] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Bade, Elizabeth] Univ Wisconsin Milwaukee, Sch Med & Publ Hlth, Dept Family Med, Milwaukee, WI USA	Kaiser Permanente; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of New Mexico; University of Wisconsin System; University of Wisconsin Milwaukee	Zeiger, RS (corresponding author), Kaiser Permanente, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.	robert.s.zeiger@kp.org		Bacharier, Leonard/0000-0003-0432-2704; Zeiger, Robert/0000-0001-5788-5063; Szefler, Stanley/0000-0002-6911-3199; Guilbert, Theresa/0000-0002-6932-712X	National Heart, Lung, and Blood Institute [5U10HL064287, 5U10HL064288, 5U10HL064295, 5U10HL064307, 5U10HL064305, 5U10HL064313]; Washington University School of Medicine [5UL1RR02499204]; Madison CTSA [1UL1RR025011]; National Center for Research Resources, National Institutes of Health [UL1RR025780];  [M01 RR00036];  [M01 RR00051];  [5M01 RR00997]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000997, M01RR000036, UL1RR025011, UL1RR024992, UL1RR025780, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064288, U10HL064295, U10HL064307, U10HL064287, U10HL064313, U10HL064305] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington University School of Medicine; Madison CTSA; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (5U10HL064287, 5U10HL064288, 5U10HL064295, 5U10HL064307, 5U10HL064305, and 5U10HL064313) from the National Heart, Lung, and Blood Institute; a grant (5UL1RR02499204) from the Washington University School of Medicine Clinical and Translational Science Awards (CTSA) Infrastructure for Pediatric Research; a grant (1UL1RR025011) from the Madison CTSA; a grant (UL1RR025780) to the Colorado CTSA from the National Center for Research Resources, National Institutes of Health; and grants to the General Clinical Research Centers at Washington University School of Medicine (M01 RR00036), National Jewish Health (M01 RR00051), and the University of New Mexico (5M01 RR00997).	Bacharier LB, 2007, J ALLERGY CLIN IMMUN, V119, P604, DOI 10.1016/j.jaci.2006.12.607; Bacharier LB, 2009, J ALLERGY CLIN IMMUN, V123, P1077, DOI 10.1016/j.jaci.2008.12.1120; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Baker JW, 1999, PEDIATRICS, V103, P414, DOI 10.1542/peds.103.2.414; Beigelman A, 2009, ANN ALLERG ASTHMA IM, V103, P108, DOI 10.1016/S1081-1206(10)60162-7; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P126, DOI 10.1164/ajrccm.160.1.9811024; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2009, PEDIATRICS, V123, pe519, DOI 10.1542/peds.2008-2867; CONNETT G, 1993, ARCH DIS CHILD, V68, P85, DOI 10.1136/adc.68.1.85; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Getahun D, 2005, J ASTHMA, V42, P373, DOI 10.1081/JAS-200062995; Global Initiative for Asthma, GLOB STRAT DIAGN MAN; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Horner CC, 2007, CURR OPIN ALLERGY CL, V7, P180, DOI 10.1097/ACI.0b013e32807fafd2; Kemp JP, 1999, ANN ALLERG ASTHMA IM, V83, P231, DOI 10.1016/S1081-1206(10)62646-4; Leflein JG, 2002, PEDIATRICS, V109, P866, DOI 10.1542/peds.109.5.866; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; National Asthma Education and Prevention Program, EXP PAN REP 3 GUID D; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Pao CS, 2002, AM J RESP CRIT CARE, V166, P945, DOI 10.1164/rccm.200203-265OC; Papi A, 2009, ALLERGY, V64, P1463, DOI 10.1111/j.1398-9995.2009.02134.x; Raat H, 2007, QUAL LIFE RES, V16, P445, DOI 10.1007/s11136-006-9134-8; Rivera-Spoljaric K, 2009, J PEDIATR-US, V154, P877, DOI 10.1016/j.jpeds.2008.12.029; Roorda RJ, 2001, J ALLERGY CLIN IMMUN, V108, P540, DOI 10.1067/mai.2001.118789; Santanello NC, 2000, J ALLERGY CLIN IMMUN, V106, P861, DOI 10.1067/mai.2000.110478; Scott MB, 2001, ANN ALLERG ASTHMA IM, V87, P488, DOI 10.1016/S1081-1206(10)62262-4; Shapiro G, 1998, J ALLERGY CLIN IMMUN, V102, P789, DOI 10.1016/S0091-6749(98)70019-3; Shapiro G, 1999, DRUGS, V58, P43, DOI 10.2165/00003495-199958004-00006; Svedmyr J, 1999, ACTA PAEDIATR, V88, P42; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P730, DOI 10.1067/mai.2002.122712; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1043, DOI 10.1016/j.jaci.2007.08.063; Teper AM, 2005, AM J RESP CRIT CARE, V171, P587, DOI 10.1164/rccm.200408-1088OC; Teper AM, 2004, PEDIATR PULM, V37, P111, DOI 10.1002/ppul.10400; Wasserman RL, 2006, ANN ALLERG ASTHMA IM, V96, P808, DOI 10.1016/S1081-1206(10)61343-9	39	160	179	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1990	2001		10.1056/NEJMoa1104647	http://dx.doi.org/10.1056/NEJMoa1104647			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851PF	22111718	Green Accepted			2022-12-28	WOS:000297282600009
J	Hombauer, H; Campbell, CS; Smith, CE; Desai, A; Kolodner, RD				Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.			Visualization of Eukaryotic DNA Mismatch Repair Reveals Distinct Recognition and Repair Intermediates	CELL			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI MUTS; REPLICATION FACTORIES; POLYMERASE-DELTA; YEAST; PCNA; PROTEINS; COMPLEX; ALPHA	DNA mismatch repair (MMR) increases replication fidelity by eliminating mispaired bases resulting from replication errors. In Saccharomyces cerevisiae, mispairs are primarily detected by the Msh2-Msh6 complex and corrected following recruitment of the Mlh1-Pms1 complex. Here, we visualized functional fluorescent versions of Msh2-Msh6 and Mlh1-Pms1 in living cells. We found that the Msh2-Msh6 complex is an S phase component of replication centers independent of mispaired bases; this localized pool accounted for 10%-15% of MMR in wildtype cells but was essential for MMR in the absence of Exo1. Unexpectedly, Mlh1-Pms1 formed nuclear foci that, although dependent on Msh2-Msh6 for formation, rarely colocalized with Msh2-Msh6 replication-associated foci. Mlh1-Pms1 foci increased when the number of mispaired bases was increased; in contrast, Msh2-Msh6 foci were unaffected. These findings suggest the presence of replication machinery-coupled and -independent pathways for mispair recognition by Msh2-Msh6, which direct formation of superstoichiometric Mlh1-Pms1 foci that represent sites of active MMR.	[Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Hombauer, Hans; Smith, Catherine E.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Hombauer, Hans; Campbell, Christopher S.; Smith, Catherine E.; Desai, Arshad; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	; Hombauer, Hans/B-9712-2019	Campbell, Christopher/0000-0002-3927-344X; Hombauer, Hans/0000-0002-2100-564X; Smith, Catherine/0000-0001-6779-8035	NIH [GM50006, GM085764, GM074215, CA23100]; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, P50GM085764, R01GM050006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Kolodner and Desai Lab members for discussions; T. Kunkel, S. Martinez, M. Mendillo, L. Reha-Krantz, E. Schiebel, S. Shell, R. Tsien, and the Yeast Resource Center for providing plasmids/strains; S. Sandall for initial technical microscopy support; and C. Putnam and R. Fishel for discussions and comments on the manuscript. This work was supported by NIH grants GM50006 and GM085764 (R. D. K.), GM074215 (A. D.), and CA23100 (A. D., R. D. K.) and a Damon Runyon Cancer Research Foundation Fellowship (C. S. C.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 1996, MOL CELL BIOL, V16, P5604; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 2000, J MOL BIOL, V302, P327, DOI 10.1006/jmbi.2000.4081; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Datta A, 1996, MOL CELL BIOL, V16, P1085; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Elez M, 2010, CURR BIOL, V20, P1432, DOI 10.1016/j.cub.2010.06.071; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; FANG WH, 1993, J BIOL CHEM, V268, P11838; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Huang SYN, 2008, J MOL BIOL, V384, P31, DOI 10.1016/j.jmb.2008.08.052; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015496; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Zanders S, 2010, GENETICS, V186, P493, DOI 10.1534/genetics.110.120105; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	73	145	148	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1040	1053		10.1016/j.cell.2011.10.025	http://dx.doi.org/10.1016/j.cell.2011.10.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118461	Bronze, Green Accepted			2022-12-28	WOS:000297376600016
J	Kiefer, T; Park, L; Tribouilloy, C; Cortes, C; Casillo, R; Chu, V; Delahaye, F; Durante-Mangoni, E; Edathodu, J; Falces, C; Logar, M; Miro, JM; Naber, C; Tripodi, MF; Murdoch, DR; Moreillon, P; Utili, R; Wang, A				Kiefer, Todd; Park, Lawrence; Tribouilloy, Christophe; Cortes, Claudia; Casillo, Roberta; Chu, Vivian; Delahaye, Francois; Durante-Mangoni, Emanuele; Edathodu, Jameela; Falces, Carlos; Logar, Mateja; Miro, Jose M.; Naber, Christophe; Tripodi, Marie Francoise; Murdoch, David R.; Moreillon, Philippe; Utili, Riccardo; Wang, Andrew			Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIVE VALVE ENDOCARDITIS; STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; IN-HOSPITAL MORTALITY; PROPENSITY-SCORE; INTERNATIONAL COLLABORATION; PROGNOSTIC-FACTORS; MULTICENTER; GUIDELINES; MANAGEMENT; DIAGNOSIS	Context Heart failure (HF) is the most common complication of infective endocarditis. However, clinical characteristics of HF in patients with infective endocarditis, use of surgical therapy, and their associations with patient outcome are not well described. Objectives To determine the clinical, echocardiographic, and microbiological variables associated with HF in patients with definite infective endocarditis and to examine variables independently associated with in-hospital and 1-year mortality for patients with infective endocarditis and HF, including the use and association of surgery with outcome. Design, Setting, and Patients The International Collaboration on Endocarditis-Prospective Cohort Study, a prospective, multicenter study enrolling 4166 patients with definite native- or prosthetic-valve infective endocarditis from 61 centers in 28 countries between June 2000 and December 2006. Main Outcome Measures In-hospital and 1-year mortality. Results Of 4075 patients with infective endocarditis and known HF status enrolled, 1359 (33.4% [95% CI, 31.9%-34.8%]) had HF, and 906 (66.7% [95% CI, 64.2%-69.2%]) were classified as having New York Heart Association class III or IV symptom status. Within the subset with HF, 839 (61.7% [95% CI, 59.2%-64.3%]) underwent valvular surgery during the index hospitalization. In-hospital mortality was 29.7%(95% CI, 27.2%-32.1%) for the entire HF cohort, with lower mortality observed in patients undergoing valvular surgery compared with medical therapy alone (20.6%[95% CI, 17.9%-23.4%] vs 44.8% [95% CI, 40.4%-49.0%], respectively; P < .001). One-year mortality was 29.1% (95% CI, 26.0%-32.2%) in patients undergoing valvular surgery vs 58.4% (95% CI, 54.1%-62.6%) in those not undergoing surgery (P < .001). Cox proportional hazards modeling with propensity score adjustment for surgery showed that advanced age, diabetes mellitus, health care-associated infection, causative microorganism (Staphylococcus aureus or fungi), severe HF (New York Heart Association class III or IV), stroke, and paravalvular complications were independently associated with 1-year mortality, whereas valvular surgery during the initial hospitalization was associated with lower mortality. Conclusion In this cohort of patients with infective endocarditis complicated by HF, severity of HF was strongly associated with surgical therapy and subsequent mortality, whereas valvular surgery was associated with lower in-hospital and 1-year mortality. JAMA. 2011;306(20):2239-2247	[Wang, Andrew] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA; [Chu, Vivian] Duke Clin Res Inst, Durham, NC USA; [Tribouilloy, Christophe] S Hosp Amiens, Amiens, France; [Cortes, Claudia] Fdn Favaloro, Univ Hosp, Buenos Aires, DF, Argentina; [Casillo, Roberta; Durante-Mangoni, Emanuele; Tripodi, Marie Francoise; Utili, Riccardo] Univ Naples SUN, Naples, Italy; [Delahaye, Francois] Hosp Louis Pradel, Bron, France; [Edathodu, Jameela] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Falces, Carlos; Miro, Jose M.] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Logar, Mateja] Med Ctr Ljublijana, Ljubljana, Slovenia; [Naber, Christophe] Univ Essen Gesamthsch, Essen, Germany; [Murdoch, David R.] Univ Otago, Christchurch, New Zealand; [Moreillon, Philippe] Univ Lausanne, Lausanne, Switzerland	Duke University; Duke University; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Buenos Aires; CHU Lyon; King Faisal Specialist Hospital & Research Center; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Duisburg Essen; University of Otago; University of Lausanne	Wang, A (corresponding author), Duke Univ, Med Ctr, Div Cardiovasc Med, DUMC 3428, Durham, NC 27710 USA.	a.wang@duke.edu	Murdoch, David/A-2012-2009	Falces, Carlos/0000-0002-3483-3786; Durante-Mangoni, Emanuele/0000-0002-5381-3537; Wang, Andrew/0000-0001-8729-0933; Rizk, Hussien/0000-0001-5791-2359	American Heart Association [0675027N]; Novartis; Federation francaise de cardiologie; Wyeth; Edwards Life-sciences; Abbott Vascular; Gilead Sciences; National Institutes of Health [2 T32 GM008600]; Instituto de Salud Carlos III, Madrid, Spain [INT10/219]; Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008600] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Novartis(Novartis); Federation francaise de cardiologie; Wyeth(Wyeth); Edwards Life-sciences; Abbott Vascular(Abbott Laboratories); Gilead Sciences(Gilead Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain(Generalitat de Catalunya); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chu reported receiving a grant from the American Heart Association (0675027N). Dr Delahaye reported receiving grants from Novartis and the Federation francaise de cardiologie. Dr Utili reported serving on the board of Novartis; receiving grants or grants pending from Wyeth; receiving payment for lectures, including service of speakers bureaus, from Novartis; receiving payment for manuscript preparation from Pfizer; and receiving travel/accommodations/meeting expenses from Pfizer, Wyeth, and Novartis. Dr Wang reported receiving grants or grants pending from Edwards Life-sciences, Abbott Vascular, and Gilead Sciences; receiving payment for lectures, including service on speakers bureaus, from American Physician Inc; receiving payment for development of educational presentations from the American Board of Internal Medicine and the American College of Cardiology Foundation; and serving as a defense reviewer (no expert testimony) for a legal case related to endocarditis.; This work was supported in part by National Institutes of Health grant 2 T32 GM008600 to Dr Kiefer. Dr Miro was a recipient of an INT10/219 Intensification Research Grant (I3SNS & PRICS programs) from the Instituto de Salud Carlos III, Madrid, Spain, and the Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain. Hospital Clinic of Barcelona (Spain) data were supported in part by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, and the Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008), Madrid, Spain. No compensation for participation in the International Collaboration on Endocarditis-Prospective Cohort Study was provided to the investigators for their contributions.	Aksoy O, 2007, CLIN INFECT DIS, V44, P364, DOI 10.1086/510583; Anguera I, 2005, AM J CARDIOL, V96, P976, DOI 10.1016/j.amjcard.2005.05.056; Anguera I, 2005, EUR HEART J, V26, P288, DOI 10.1093/eurheartj/ehi034; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Cabell Christopher H., 2003, Cardiology Clinics, V21, P147, DOI 10.1016/S0733-8651(03)00033-X; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Delahaye F, 2007, SCAND J INFECT DIS, V39, P849, DOI 10.1080/00365540701393088; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Gaca JG, 2011, J THORAC CARDIOV SUR, V141, P98, DOI 10.1016/j.jtcvs.2010.09.016; Gaca JG, 2011, J THORAC CARDIOVASC, V141, pe1; Galvez-Acebal J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-17; Habib G, 2005, HEART, V91, P954, DOI 10.1136/hrt.2004.046177; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Kahveci G, 2007, AM J CARDIOL, V99, P1429, DOI 10.1016/j.amjcard.2006.12.071; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Nadji G, 2009, EUR J HEART FAIL, V11, P668, DOI 10.1093/eurjhf/hfp077; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; Shiue AB, 2010, AM J CARDIOL, V106, P1011, DOI 10.1016/j.amjcard.2010.05.034; Thuny F, 2010, HEART, V96, P892, DOI 10.1136/hrt.2008.151936; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001	30	147	157	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2239	2247		10.1001/jama.2011.1701	http://dx.doi.org/10.1001/jama.2011.1701			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22110106	Green Accepted, Bronze			2022-12-28	WOS:000297255500023
J	Mehta, MR				Mehta, Mayank R.			Contribution of I-h to LTP, Place Cells, and Grid Cells	CELL			English	Editorial Material							ENTORHINAL CORTEX; OSCILLATIONS; EXPERIENCE; NEURONS; FIELDS; MICE; CA1	The brain's grid and place cells, which contribute to spatial representations of the external environment, are thought to be modulated by the hyperpolarization-activated cation current (I-h). Giocomo et al. and Hussaini et al. now provide new insights into these cells' unique activity patterns by studying transgenic mice lacking I-h.	Univ Calif Los Angeles, Keck Ctr Neurophys, Dept Phys & Astron,Dept Neurol, Integrat Ctr Learning & Memory,Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, Keck Ctr Neurophys, Dept Phys & Astron,Dept Neurol, Integrat Ctr Learning & Memory,Dept Neurobiol, Los Angeles, CA 90095 USA.	mayankmehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468				Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hussaini SA, 2011, NEURON, V72, P643, DOI 10.1016/j.neuron.2011.09.007; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					968	970		10.1016/j.cell.2011.11.005	http://dx.doi.org/10.1016/j.cell.2011.11.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118453	Bronze			2022-12-28	WOS:000297376600008
J	Cohen, IG; Blumstein, JF				Cohen, I. Glenn; Blumstein, James F.			The Constitutionality of the ACA's Medicaid-Expansion Mandate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Blumstein, James F.] Vanderbilt Law Sch, Nashville, TN USA	Harvard University; Vanderbilt University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.								0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2012	366	2					103	104		10.1056/NEJMp1113416	http://dx.doi.org/10.1056/NEJMp1113416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	874VA	22149737				2022-12-28	WOS:000298985000002
J	Outterson, K				Outterson, Kevin			Smoking and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Law, Boston, MA 02215 USA	Boston University	Outterson, K (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Outterson, Kevin/0000-0003-2513-3216				Outterson Kevin, 2011, N Engl J Med, V365, pe13, DOI 10.1056/NEJMp1107614; 2011, FED REG         0622, V76, P36628	2	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2011	365	25					2351	2353		10.1056/NEJMp1113011	http://dx.doi.org/10.1056/NEJMp1113011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865OM	22149735	Green Published			2022-12-28	WOS:000298320200013
J	Bi, DP; Zhang, J; Chakraborty, B; Behringer, RP				Bi, Dapeng; Zhang, Jie; Chakraborty, Bulbul; Behringer, R. P.			Jamming by shear	NATURE			English	Article								A broad class of disordered materials including foams, glassy molecular systems, colloids and granular materials can form jammed states. A jammed system can resist small stresses without deforming irreversibly, whereas unjammed systems flow under any applied stresses. The broad applicability of the Liu-Nagel jamming concept(1,2) has attracted intensive theoretical and modelling interest but has prompted less experimental effort(1-6). In the Liu-Nagel framework, jammed states of athermal systems exist only above a certain critical density. Although numerical simulations for particles that do not experience friction broadly support this idea(7-13), the nature of the jamming transition for frictional grains is less clear(14-17). Here we show that jamming of frictional, disk-shaped grains can be induced by the application of shear stress at densities lower than the critical value, at which isotropic (shear-free) jamming occurs. These jammed states have a much richer phenomenology than the isotropic jammed states: for small applied shear stresses, the states are fragile, with a strong force network that percolates only in one direction. A minimum shear stress is needed to create robust, shear-jammed states with a strong force network percolating in all directions. The transitions from unjammed to fragile states and from fragile to shear-jammed states are controlled by the fraction of force-bearing grains. The fractions at which these transitions occur are statistically independent of the density. Jammed states with densities lower than the critical value have an anisotropic fabric (contact network). The minimum anisotropy of shear-jammed states vanishes as the density approaches the critical value from below, in a manner reminiscent of an order-disorder transition.	[Zhang, Jie; Behringer, R. P.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Zhang, Jie] Indiana Univ Purdue Univ, Dept Phys, Ft Wayne, IN 46805 USA; [Zhang, Jie] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China; [Zhang, Jie] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200240, Peoples R China; [Bi, Dapeng; Chakraborty, Bulbul] Brandeis Univ, Martin Fisher Sch Phys, Waltham, MA 02454 USA	Duke University; Purdue University System; Indiana University Purdue University Fort Wayne; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brandeis University	Behringer, RP (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	bob@phy.duke.edu	Bi, Dapeng/AHD-0930-2022; Bi, Dapeng/K-3642-2013; Zhang, Jie/O-2127-2015	Bi, Dapeng/0000-0003-4850-8666; Bi, Dapeng/0000-0003-4850-8666; 	US NSF [DMR-0905880, DMR-0906908, NSF-0835571]; US ARO [W911NF-07-1-1031]	US NSF(National Science Foundation (NSF)); US ARO	D. B. and B. C. acknowledge support from US NSF grant DMR-0905880. R. P. B. and J.Z. acknowledge support from US NSF grants DMR-0906908 and NSF-0835571, and from US ARO grant W911NF-07-1-1031. B. C. and R. P. B. acknowledge the hospitality of the Aspen Center for Physics and discussions with S. Teitel, H. Hayakawa and M. Otsuki. D. B. and B. C. acknowledge discussions with M. Mailman.	Alonso-Marroquin F, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051304; Candelier R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128001; Cates ME, 1998, PHYS REV LETT, V81, P1841, DOI 10.1103/PhysRevLett.81.1841; Ciamarra MP, 2010, SOFT MATTER, V6, P2871, DOI 10.1039/b926810c; Goddard J. D., 1998, CONTINUUM MODELING G, P1; Goncu F, 2010, CR MECANIQUE, V338, P570, DOI 10.1016/j.crme.2010.10.004; Hatano T, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.123002; Henkes S, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/14003; Heussinger C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218303; Lechenault F, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46003; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Liu AJ, 2010, SOFT MATTER, V6, P2869, DOI 10.1039/c005388k; Majmudar TS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058001; Majmudar TS, 2005, NATURE, V435, P1079, DOI 10.1038/nature03805; Makse HA, 2000, PHYS REV LETT, V84, P4160, DOI 10.1103/PhysRevLett.84.4160; Nedderman R.M., 1992, STATICS KINEMATICS G; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; Olsson P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178001; Olsson P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.030302; Otsuki M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051301; Pastore R, 2011, PHILOS MAG, V91, P2006, DOI 10.1080/14786435.2010.540457; Peyneau PE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011307; Radjai F, 1998, PHYS REV LETT, V80, P61, DOI 10.1103/PhysRevLett.80.61; Silbert LE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098301; Silbert LE, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041304; Silbert LE, 2010, SOFT MATTER, V6, P2918, DOI 10.1039/c001973a; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Walker DM, 2011, GRANUL MATTER, V13, P233, DOI 10.1007/s10035-011-0250-y; Wyart M, 2005, ANN PHYS-PARIS, V30, P1, DOI 10.1051/anphys:2006003; Zhang J, 2010, GRANUL MATTER, V12, P159, DOI 10.1007/s10035-010-0170-2	30	431	442	14	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					355	358		10.1038/nature10667	http://dx.doi.org/10.1038/nature10667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170683				2022-12-28	WOS:000298033000048
J	Poulikakos, PI; Persaud, Y; Janakiraman, M; Kong, XJ; Ng, C; Moriceau, G; Shi, HB; Atefi, M; Titz, B; Gabay, MT; Salton, M; Dahlman, KB; Tadi, M; Wargo, JA; Flaherty, KT; Kelley, MC; Misteli, T; Chapman, PB; Sosman, JA; Graeber, TG; Ribas, A; Lo, RS; Rosen, N; Solit, DB				Poulikakos, Poulikos I.; Persaud, Yogindra; Janakiraman, Manickam; Kong, Xiangju; Ng, Charles; Moriceau, Gatien; Shi, Hubing; Atefi, Mohammad; Titz, Bjoern; Gabay, May Tal; Salton, Maayan; Dahlman, Kimberly B.; Tadi, Madhavi; Wargo, Jennifer A.; Flaherty, Keith T.; Kelley, Mark C.; Misteli, Tom; Chapman, Paul B.; Sosman, Jeffrey A.; Graeber, Thomas G.; Ribas, Antoni; Lo, Roger S.; Rosen, Neal; Solit, David B.			RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)	NATURE			English	Article							BRAF; PATHWAY; MEK	Activated RAS promotes dimerization of members of the RAF kinase family(1-3). ATP-competitive RAF inhibitors activate ERK signalling(4-7) by transactivating RAF dimers(4). In melanomas with mutant BRAF(V600E), levels of RAS activation are low and these drugs bind to BRAF(V600E) monomers and inhibit their activity. This tumour-specific inhibition of ERK signalling results in a broad therapeutic index and RAF inhibitors have remarkable clinical activity in patients with melanomas that harbour mutant BRAF(V600E)(8). However, resistance invariably develops. Here, we identify a new resistance mechanism. We find that a subset of cells resistant to vemurafenib (PLX4032, RG7204) express a 61-kDa variant form of BRAF(V600E), p61BRAF(V600E), which lacks exons 4-8, a region that encompasses the RAS-binding domain. p61BRAF(V600E) shows enhanced dimerization in cells with low levels of RAS activation, as compared to full-length BRAF(V600E). In cells in which p61BRAF(V600E) is expressed endogenously or ectopically, ERK signalling is resistant to the RAF inhibitor. Moreover, a mutation that abolishes the dimerization of p61BRAF(V600E) restores its sensitivity to vemurafenib. Finally, we identified BRAF(V600E) splicing variants lacking the RAS-binding domain in the tumours of six of nineteen patients with acquired resistance to vemurafenib. These data support the model that inhibition of ERK signalling by RAF inhibitors is dependent on levels of RAS-GTP too low to support RAF dimerization and identify a novel mechanism of acquired resistance in patients: expression of splicing isoforms of BRAF(V600E) that dimerize in a RAS-independent manner.	[Persaud, Yogindra; Janakiraman, Manickam; Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Poulikakos, Poulikos I.; Gabay, May Tal; Tadi, Madhavi; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA; [Kong, Xiangju; Moriceau, Gatien; Shi, Hubing; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Ng, Charles; Atefi, Mohammad; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Titz, Bjoern; Graeber, Thomas G.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Salton, Maayan; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Dahlman, Kimberly B.; Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Boston, MA 02114 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Kelley, Mark C.] Vanderbilt Ingram Canc Ctr, Dept Surg, Nashville, TN 37232 USA; [Chapman, Paul B.; Rosen, Neal; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Vanderbilt University; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	solitd@mskcc.org	Persaud, Yogindra/AAZ-7032-2021; Titz, Björn/B-9516-2008; Solit, David B./AAC-5309-2019; Titz, Bjoern/G-6317-2017; Shi, Hubing/B-8445-2014; Rosen, Neal/ABF-2677-2020	Persaud, Yogindra/0000-0001-8266-9434; Titz, Bjoern/0000-0003-4414-4105; Salton, Maayan/0000-0001-8812-5577; Shi, Hubing/0000-0002-2926-3440; Graeber, Thomas/0000-0001-8574-9181; Janakiraman, Manickam/0000-0003-4423-6237	Vanderbilt-Ingram Cancer Center; T. J. Martell Foundation; National Institutes of Health (NIH); Beene Foundation; Melanoma Research Alliance; STARR Foundation; Burroughs Wellcome Fund; American Skin Association; Joint Center for Translational Medicine; Sidney Kimmel Foundation; Stand Up to Cancer; NIH, NCI, Center for Cancer Research; Danny Federici Melanoma Fund;  [T32 CACA062948-15]; NATIONAL CANCER INSTITUTE [R01CA127240, K22CA151638, P30CA008748, ZIABC010309] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; T. J. Martell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beene Foundation; Melanoma Research Alliance; STARR Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Skin Association; Joint Center for Translational Medicine; Sidney Kimmel Foundation; Stand Up to Cancer; NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danny Federici Melanoma Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Baccarini and C. Pritchard for the RAF knockout mouse embryonic fibroblasts. We would like to thank K. Shokat, C. Zhang, S. Chandarlapaty, C. Pratilas and K. Robzyk for useful discussions, C. Liu for her technical expertise and T. J. Riley. We also thank D. Hucks for technical assistance, P. L. Lyle for scoring the tumour sections, and T. Chodon for assistance with tumour procurement. The ITR is supported by the Vanderbilt-Ingram Cancer Center and the T. J. Martell Foundation. This work has been funded by the National Institutes of Health (NIH; R. S. L., N.R., D. B. S.), the Beene Foundation (D. B. S.), the Melanoma Research Alliance (K. T. F., J. A. S. P. B. C., R. S. L., N.R., D. B. S.) and the STARR Foundation (N.R., D. B. S.). R. S. L. was supported by the Burroughs Wellcome Fund, American Skin Association, Joint Center for Translational Medicine, Sidney Kimmel Foundation, and Stand Up to Cancer. T. M. was supported in part by the Intramural Research Program of the NIH, NCI, Center for Cancer Research and P. B. C. was supported in part by the Danny Federici Melanoma Fund. P. I. P. was supported by T32 CACA062948-15.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; McArthur GA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8502; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758	22	1055	1091	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					387	U144		10.1038/nature10662	http://dx.doi.org/10.1038/nature10662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22113612	Green Accepted, Green Submitted			2022-12-28	WOS:000298033000056
J	Drife, JO				Drife, James Owen			IN AND OUT OF HOSPITAL A Christmas lecture	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2011	343								d8021	10.1136/bmj.d8021	http://dx.doi.org/10.1136/bmj.d8021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NM	22167793				2022-12-28	WOS:000298317600030
J	Spence, D				Spence, Des			FROM THE FRONTLINE All a-Twitter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2011	343								d8122	10.1136/bmj.d8122	http://dx.doi.org/10.1136/bmj.d8122			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NM	22167796				2022-12-28	WOS:000298317600029
J	Jungebluth, P; Alici, E; Baiguera, S; Le Blanc, K; Blomberg, P; Bozoky, B; Crowley, C; Einarsson, O; Grinnemo, KH; Gudbjartsson, T; Le Guyader, S; Henriksson, G; Hermanson, O; Juto, JE; Leidner, B; Lilja, T; Liska, J; Luedde, T; Lundin, V; Moll, G; Nilsson, B; Roderburg, C; Stromblad, S; Sutlu, T; Teixeira, AI; Watz, E; Seifalian, A; Macchiarini, P				Jungebluth, Philipp; Alici, Evren; Baiguera, Silvia; Le Blanc, Katarina; Blomberg, Pontus; Bozoky, Bela; Crowley, Claire; Einarsson, Oskar; Grinnemo, Karl-Henrik; Gudbjartsson, Tomas; Le Guyader, Sylvie; Henriksson, Gert; Hermanson, Ola; Juto, Jan Erik; Leidner, Bertil; Lilja, Tobias; Liska, Jan; Luedde, Tom; Lundin, Vanessa; Moll, Guido; Nilsson, Bo; Roderburg, Christoph; Stromblad, Staffan; Sutlu, Tolga; Teixeira, Ana Isabel; Watz, Emma; Seifalian, Alexander; Macchiarini, Paolo			RETRACTED: Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study (Publication with Expression of Concern. See vol. 387, pg. 1359, 2016) (Retracted article. See vol. 392, pg. 11, 2018)	LANCET			English	Article; Retracted Publication							AIRWAY COMPLICATIONS; MOBILIZATION; MANAGEMENT	Background Tracheal tumours can be surgically resected but most are an inoperable size at the time of diagnosis; therefore, new therapeutic options are needed. We report the clinical transplantation of the tracheobronchial airway with a stem-cell-seeded bioartificial nanocomposite. Methods A 36-year-old male patient, previously treated with debulking surgery and radiation therapy, presented with recurrent primary cancer of the distal trachea and main bronchi. After complete tumour resection, the airway was replaced with a tailored bioartificial nanocomposite previously seeded with autologous bone-marrow mononuclear cells via a bioreactor for 36 h. Postoperative granulocyte colony-stimulating factor filgrastim (10 mu g/kg) and epoetin beta (40 000 UI) were given over 14 days. We undertook flow cytometry, scanning electron microscopy, confocal microscopy epigenetics, multiplex, miRNA, and gene expression analyses. Findings We noted an extracellular matrix-like coating and proliferating cells including a CD105+ subpopulation in the scaffold after the reseeding and bioreactor process. There were no major complications, and the patient was asymptomatic and tumour free 5 months after trans plantation. The bioartificial nanocomposite has patent anastomoses, lined with a vascularised neomucosa, and was partly covered by nearly healthy epithelium. Post-operatively, we detected a mobilisation of peripheral cells displaying increased mesenchymal stromal cell phenotype, and upregulation of epoetin receptors, antiapoptotic genes, and miR-34 and miR-449 biomarkers. These findings, together with increased levels of regenerative-associated plasma factors, strongly suggest stem-cell homing and cell-mediated wound repair, extracellular matrix remodelling, and neovascularisation of the graft. Interpretation Tailor-made bioartificial scaffolds can be used to replace complex airway defects. The bioreactor reseeding process and pharmacological-induced site-specific and graft-specific regeneration and tissue protection are key factors for successful clinical outcome.	[Jungebluth, Philipp; Baiguera, Silvia; Grinnemo, Karl-Henrik; Macchiarini, Paolo] Karolinska Inst, Adv Ctr Translat Regenerat Med, SE-14186 Stockholm, Sweden; [Alici, Evren; Sutlu, Tolga] Karolinska Inst, Cell & Gene Therapy Ctr, Dept Med, Div Hematol, SE-14186 Stockholm, Sweden; [Le Blanc, Katarina; Moll, Guido; Watz, Emma] Karolinska Inst, Lab Med, SE-14186 Stockholm, Sweden; [Le Guyader, Sylvie; Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14186 Stockholm, Sweden; [Hermanson, Ola; Lilja, Tobias] Karolinska Inst, Linnaeus Ctr Dev Biol Regenerat Med, Dept Neurosci, SE-14186 Stockholm, Sweden; [Leidner, Bertil] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden; [Lundin, Vanessa; Teixeira, Ana Isabel] Karolinska Inst, Dept Cell & Mol Biol, SE-14186 Stockholm, Sweden; [Jungebluth, Philipp; Henriksson, Gert; Juto, Jan Erik; Macchiarini, Paolo] Karolinska Univ Hosp, Div Ear Nose & Throat, Stockholm, Sweden; [Blomberg, Pontus] Karolinska Univ Hosp, Clin Res Ctr, Stockholm, Sweden; [Bozoky, Bela] Karolinska Univ Hosp, Div Pathol, Stockholm, Sweden; [Grinnemo, Karl-Henrik; Liska, Jan] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Leidner, Bertil] Karolinska Univ Hosp, Dept Radiol Huddinge, Stockholm, Sweden; [Watz, Emma] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Crowley, Claire; Seifalian, Alexander] UCL, Ctr Nanotechnol & Regenerat Med, London, England; [Einarsson, Oskar] Univ Iceland, Landspitali Univ Hosp, Fac Med, Dept Pulmonol, Reykjavik, Iceland; [Gudbjartsson, Tomas] Univ Iceland, Landspitali Univ Hosp, Fac Med, Dept Cardiothorac Surg, Reykjavik, Iceland; [Luedde, Tom; Roderburg, Christoph] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of London; University College London; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; University of Iceland; RWTH Aachen University; RWTH Aachen University Hospital; Uppsala University	Macchiarini, P (corresponding author), Karolinska Inst, Adv Ctr Translat Regenerat Med ACTREM, European Airway Inst, Div Ear Nose & Throat CLINTEC, Alfred Nobels Alle 8, SE-14186 Stockholm, Sweden.	paolo.macchiarini@ki.se	Le Blanc, Katarina/L-4631-2019; Roderburg, Christoph/AHC-8101-2022; Sutlu, Tolga/E-1190-2012; Seifalian, Alexander M/I-6028-2013; Moll, Guido/L-6321-2019; Alici, Evren/A-4696-2010; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022; Macchiarini, Paolo/E-6878-2013; Baiguera, Silvia/AAC-4738-2022	Roderburg, Christoph/0000-0002-1409-7697; Sutlu, Tolga/0000-0002-7813-8734; Seifalian, Alexander M/0000-0002-1180-3322; Luedde, Tom/0000-0002-6288-8821; Baiguera, Silvia/0000-0002-6669-7061; Alici, Evren/0000-0001-5307-6648; Grinnemo, Karl-Henrik/0000-0001-6717-3393; Le Guyader, Sylvie/0000-0002-8812-8046	European Commission [280584-2BIOtracheaCP-FPFP7-NMP-2011-SMALL-5]; Knut and Alice Wallenberg Foundation; Swedish Research Council; StratRegen; Vinnova Foundation; Radiumhemmet; Clinigene EU Network of Excellence; Swedish Cancer Society; Centre for Biosciences (The Live Cell imaging Unit); UCL Business; Centre for Biosciences;  [ERC-2007-Stg/208237-Luedde-Med3-Aachen]	European Commission(European CommissionEuropean Commission Joint Research Centre); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); StratRegen; Vinnova Foundation(Vinnova); Radiumhemmet; Clinigene EU Network of Excellence(European Commission); Swedish Cancer Society(Swedish Cancer Society); Centre for Biosciences (The Live Cell imaging Unit); UCL Business; Centre for Biosciences; 	European Commission, Knut and Alice Wallenberg Foundation, Swedish Research Council, StratRegen, Vinnova Foundation, Radiumhemmet, Clinigene EU Network of Excellence, Swedish Cancer Society, Centre for Biosciences (The Live Cell imaging Unit), and UCL Business.; The European Commission (FP7 EU Project: 280584-2BIOtracheaCP-FPFP7-NMP-2011-SMALL-5), the Knut and Alice Wallenberg Foundation, Swedish Research Council, and the StratRegen funded preclinical and postoperative in-vitro studies, gene expression, cell characterisation, and imaging. The Vinnova Foundation, Radiumhemmet, and Clinigene EU Network of Excellence funded multiplex and flow cytometric analyses. The Swedish Cancer Society supported the epigenetic studies. The Centre for Biosciences, the Knut and Alice Wallenberg Foundation, and the Swedish Research Council supported the Live Cell imaging Unit at the Department of Biosciences and Nutrition, Karolinska Institutet, used for live cell imaging. ERC-2007-Stg/208237-Luedde-Med3-Aachen funded the miRNA studies. The UCL Business supported the development of the three-dimensional nanocomposite scaffold. We thank all the health professionals of the Karolinska University Hospital in Huddinge, Stockholm, Sweden, without whom the transplantation could not have been done; Harvard Apparatus (Hollison, MA, USA) and Hugo Sachs Elektronik-Harvard Apparatus GmbH (March-Hugstetten, Germany) for supporting us with the bioreactor and the supervision of its use; Peter Guntner, for image analysis and measurements for scaffold production, and Anders Svensson, for three-dimensional volume image rendering, both from the Department of Radiology, Karolinska University Hospital Huddinge, Stockholm, Sweden; all the staff of the Landspitali University Hospital in Reykjavik, for the excellent support with the preoperative and postoperative care of the patient; Alessandra Bianco and Costantino Del Gaudio from Department of Science and Chemical Technologies, Intrauniversitary Consortium for Material Science Technology (INSTM), Research Unit Tor Vergata, Rome, Italy, for bi-dimensional and three-dimensional mathematical model for tracheal lateral area assessment; Iyadh Douagi from the Center of Hematology and Regenerative Medicine, Department of Medicine, Karolinska Insitutet for his assistance with flow cytometry; and Ulrika Felldin from ACTREM, Karolinska Institutet for her assistance with cell isolation.	Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bader A, 2010, J CELL MOL MED, V14, P1877, DOI 10.1111/j.1582-4934.2010.01073.x; Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005; Behrend M, 2002, J INVEST SURG, V15, P227, DOI 10.1080/08941930290086010; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597; Gaissert HA, 2010, SURG CLIN N AM, V90, P1065, DOI 10.1016/j.suc.2010.06.004; Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071; Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002; Grillo HC, 2004, SURG TRACHEA BRONCHI, P791; Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380; Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b; Kshettry VR, 1997, ANN THORAC SURG, V63, P1576, DOI 10.1016/S0003-4975(97)83852-0; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Macchiarini P, 2006, LANCET ONCOL, V7, P83, DOI 10.1016/S1470-2045(05)70541-6; Macchiarini P, 2006, ANN THORAC SURG, V82, P1989, DOI 10.1016/j.athoracsur.2006.07.016; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mansilla E, 2006, TRANSPL P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053; Marquez-Curtis LA, 2011, STEM CELL REV REP, V7, P590, DOI 10.1007/s12015-010-9212-8; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Puchalski J, 2011, CLIN CHEST MED, V32, P357, DOI 10.1016/j.ccm.2011.03.001; Santacruz Jose Fernando, 2009, Proc Am Thorac Soc, V6, P79, DOI 10.1513/pats.200808-094GO; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7; Sigurdsson MI, 2011, AM J RESP CRIT CARE, V183, P681, DOI 10.1164/ajrccm.183.5.681b	28	339	362	1	184	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					1997	2004		10.1016/S0140-6736(11)61715-7	http://dx.doi.org/10.1016/S0140-6736(11)61715-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22119609	Bronze			2022-12-28	WOS:000298144200023
J	Jepson, P; Jennings, S; Jones, KE; Hodgetts, T				Jepson, Paul; Jennings, Steve; Jones, Kate E.; Hodgetts, Timothy			Entertainment Value: Should the Media Pay for Nature Conservation?	SCIENCE			English	Editorial Material									[Jepson, Paul; Hodgetts, Timothy] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Jennings, Steve] Oxfam GB, Oxford OX4 2JY, England; [Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Oxford; Zoological Society of London	Jepson, P (corresponding author), Univ Oxford, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	paul.jepson@ouce.ox.ac.uk	Jones, Kate E/G-4768-2010; Jones, Kate/Y-3317-2019	Jones, Kate E/0000-0001-5231-3293; Jones, Kate/0000-0001-5231-3293				Andrews A., 2010, DAILY TELEGRAPH 1116, P4; [Anonymous], 2007, DISCOVERY COMMU 0501; Bouse Derek, 2000, WILDLIFE FILMS; Crutzen PJ, 2002, J PHYS IV, V12, P1, DOI 10.1051/jp4:20020447; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; PALMER C, 2010, SHOOTING WILD; Robinson J., 2006, OBSERVER        0409, P11; Sukhdev P., 2010, TEEB EC ECOSYSTEMS B; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; UN Millennium Project, 2005, INV DEV PRACT PLAN A	13	12	12	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1351	1352		10.1126/science.1213189	http://dx.doi.org/10.1126/science.1213189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858HW	22158806				2022-12-28	WOS:000297787700034
J	Loughlin, R; Wilbur, JD; McNally, FJ; Nedelec, FJ; Heald, R				Loughlin, Rose; Wilbur, Jeremy D.; McNally, Francis J.; Nedelec, Francois J.; Heald, Rebecca			Katanin Contributes to Interspecies Spindle Length Scaling in Xenopus	CELL			English	Article							EGG EXTRACTS; MITOTIC SPINDLE; MEIOTIC SPINDLE; AURORA-B; STABLE MICROTUBULES; METAPHASE SPINDLE; ORGANIZATION; INHIBITION; CHROMOSOMES; ATTACHMENT	Bipolar spindles must separate chromosomes by the appropriate distance during cell division, but mechanisms determining spindle length are poorly understood. Based on a 2D model of meiotic spindle assembly, we predicted that higher localized microtubule (MT) depolymerization rates could generate the shorter spindles observed in egg extracts of X. tropicalis compared to X. laevis. We found that katanin-dependent MT severing was increased in X. tropicalis, which, unlike X. laevis, lacks an inhibitory phosphorylation site in the katanin p60 catalytic subunit. Katanin inhibition lengthened spindles in both species. In X. tropicalis, k-fiber MT bundles that connect to chromosomes at their kinetochores extended through spindle poles, disrupting them. In both X. tropicalis extracts and the spindle simulation, a balance between k-fiber number and MT depolymerization is required to maintain spindle morphology. Thus, mechanisms have evolved in different species to scale spindle size and coordinate regulation of multiple MT populations in order to generate a robust steady-state structure.	[Nedelec, Francois J.] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Loughlin, Rose; Wilbur, Jeremy D.; Heald, Rebecca] Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; [Loughlin, Rose] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [McNally, Francis J.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis	Nedelec, FJ (corresponding author), EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de; bheald@berkeley.edu	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Heald, Rebecca/0000-0001-6671-6528	NIH [DP1 OD000818]; Miller Institute for Basic Research in Science; National Science Foundation; Cancer Research Coordinating Committee; BioMS (Center for Modeling and Simulation in the Biosciences); EU [241548]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079421] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miller Institute for Basic Research in Science; National Science Foundation(National Science Foundation (NSF)); Cancer Research Coordinating Committee; BioMS (Center for Modeling and Simulation in the Biosciences); EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kara Helmke and members of the Heald and Nedelec labs for helpful discussions; and Liam Holt for critical comments on the manuscript. Special thanks to Todd Stukenberg for Nuf2 antibodies; Claire Walczak for Kif2a and MCAK antibodies; Christian Tischer for sharing MATLAB code for image analysis; and David Halpin for PEGylated slides. R. H. was supported by the NIH Director's Pioneer Award (DP1 OD000818) and The Miller Institute for Basic Research in Science. R. L. acknowledges support from the National Science Foundation and the Cancer Research Coordinating Committee. F.J.N. is supported by BioMS (Center for Modeling and Simulation in the Biosciences), EU FP7 contract 241548 Mitosys and the Systems Microscopy network of excellence.	Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Brust-Mascher I, 2009, MOL BIOL CELL, V20, P1749, DOI 10.1091/mbc.E08-10-1033; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Buster D, 2002, J CELL SCI, V115, P1083; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Houghtaling BR, 2009, P NATL ACAD SCI USA, V106, P15338, DOI 10.1073/pnas.0902317106; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Knowlton AL, 2009, CURR BIOL, V19, P758, DOI 10.1016/j.cub.2009.03.018; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maresca Thomas J., 2006, V322, P459; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2002, CELL MOTIL CYTOSKEL, V53, P337, DOI 10.1002/cm.10080; McNally KP, 2000, J CELL SCI, V113, P1623; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	37	137	138	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1397	1407		10.1016/j.cell.2011.11.014	http://dx.doi.org/10.1016/j.cell.2011.11.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153081	Green Accepted, Bronze			2022-12-28	WOS:000298148100026
J	Avorn, J				Avorn, Jerry			Learning about the Safety of Drugs - A Half-Century of Evolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Carpenter D, 2010, PRINC STUD AM POLIT, P1; Food and Drug Administration, APPR RISK EV MIT STR; LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555; MCBRIDE WG, 1961, LANCET, V2, P1358; Yllner N, 2008, JUST LITTLE WHITE SL	5	31	33	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2151	2153		10.1056/NEJMp1110327	http://dx.doi.org/10.1056/NEJMp1110327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857PQ	22150034				2022-12-28	WOS:000297731400015
J	Moltz, JC				Moltz, James Clay			Asia's space race	NATURE			English	Editorial Material									USN, Postgrad Sch, Dept Natl Secur Affairs, Monterey, CA 93943 USA	United States Department of Defense; United States Navy; Naval Postgraduate School	Moltz, JC (corresponding author), USN, Postgrad Sch, Dept Natl Secur Affairs, Monterey, CA 93943 USA.	jcmoltz@nps.edu							0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					171	173		10.1038/480171a	http://dx.doi.org/10.1038/480171a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158223				2022-12-28	WOS:000297744200022
J	Wei, S; Siegal, GP				Wei, Shi; Siegal, Gene P.			A 23-Year-Old Woman With a Right Femoral Neck Fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; MANAGEMENT		[Wei, Shi] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA; UAB Ctr Metab Bone Dis, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wei, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, NP 3542,1802 6th Ave S, Birmingham, AL 35249 USA.	swei@uab.edu						Bhadada SK, 2009, CLIN ENDOCRINOL, V70, P527, DOI 10.1111/j.1365-2265.2008.03346.x; Davies M, 2002, CLIN ENDOCRINOL, V57, P145, DOI 10.1046/j.1365-2265.2002.01581.x; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; HAYES CW, 1991, RADIOL CLIN N AM, V29, P85; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Silverberg SJ, 2006, NAT CLIN PRACT ENDOC, V2, P494, DOI 10.1038/ncpendmet0265; SZABO J, 1995, AM J HUM GENET, V56, P944	9	2	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2385	2386		10.1001/jama.2011.1748	http://dx.doi.org/10.1001/jama.2011.1748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147386				2022-12-28	WOS:000297680300029
J	Sheehan, MJ; Tibbetts, EA				Sheehan, Michael J.; Tibbetts, Elizabeth A.			Specialized Face Learning Is Associated with Individual Recognition in Paper Wasps	SCIENCE			English	Article							IDENTITY SIGNALS; POLISTES WASPS; EVOLUTION; PERCEPTION; BEHAVIOR; SHEEP	We demonstrate that the evolution of facial recognition in wasps is associated with specialized face-learning abilities. Polistes fuscatus can differentiate among normal wasp face images more rapidly and accurately than nonface images or manipulated faces. A close relative lacking facial recognition, Polistes metricus, however, lacks specialized face learning. Similar specializations for face learning are found in primates and other mammals, although P. fuscatus represents an independent evolution of specialization. Convergence toward face specialization in distant taxa as well as divergence among closely related taxa with different recognition behavior suggests that specialized cognition is surprisingly labile and may be adaptively shaped by species-specific selective pressures such as face recognition.	[Sheehan, Michael J.; Tibbetts, Elizabeth A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sheehan, MJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	mic@umich.edu	Sheehan, Michael/F-5612-2012	Tibbetts, Elizabeth/0000-0002-5625-892X; Sheehan, Michael/0000-0002-3949-7873	University of Michigan; E. S. George Reserve Scholarship	University of Michigan(University of Michigan System); E. S. George Reserve Scholarship	We thank J. Klein and J. Jinn for assistance collecting data. J. McCormack, I. Flora, J. Hunt, J. Cronin, and B. Cronin helped collect wasps. O. Pascalis and T. Bergman provided comments on an earlier draft. Funding was provided by the University of Michigan and an E. S. George Reserve Scholarship to M. J. S. The authors have no competing financial interests. All data from these experiments are presented in the main text or supporting online material.	Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Farris SA, 2005, ARTHROPOD STRUCT DEV, V34, P211, DOI 10.1016/j.asd.2005.01.008; HUGHES CR, 1993, BEHAV ECOL, V4, P128, DOI 10.1093/beheco/4.2.128; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1987, SCIENCE, V236, P448, DOI 10.1126/science.3563521; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Papini MR, 2002, PSYCHOL REV, V109, P186, DOI 10.1037//0033-295X.109.1.186; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pascalis O, 2009, PERSPECT PSYCHOL SCI, V4, P200, DOI 10.1111/j.1745-6924.2009.01119.x; Reeve H.K., 1991, P99; Reeve HK, 2000, P ROY SOC B-BIOL SCI, V267, P75, DOI 10.1098/rspb.2000.0969; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Sheehan MJ, 2010, J EVOLUTION BIOL, V23, P570, DOI 10.1111/j.1420-9101.2009.01923.x; Sheehan MJ, 2008, CURR BIOL, V18, pR851, DOI 10.1016/j.cub.2008.07.032; Sheehan MJ, 2009, EVOLUTION, V63, P3106, DOI 10.1111/j.1558-5646.2009.00833.x; Shettleworth S. J., 2010, COGNITION EVOLUTION, pxiii; Tibbetts EA, 2004, P ROY SOC B-BIOL SCI, V271, P1955, DOI 10.1098/rspb.2004.2784; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	24	140	143	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1272	1275		10.1126/science.1211334	http://dx.doi.org/10.1126/science.1211334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144625				2022-12-28	WOS:000297553600049
J	Ibrahim, A; Asuku, ME				Ibrahim, Abdulrasheed; Asuku, Malachy Eneye			Neurofibromatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ibrahim, Abdulrasheed; Asuku, Malachy Eneye] Ahmadu Bello Univ, Teaching Hosp, Kaduna, Nigeria	Ahmadu Bello University	Ibrahim, A (corresponding author), Ahmadu Bello Univ, Teaching Hosp, Kaduna, Nigeria.								0	3	3	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					2020	2020		10.1056/NEJMicm1103859	http://dx.doi.org/10.1056/NEJMicm1103859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851PF	22111720				2022-12-28	WOS:000297282600012
J	Page, D; Cheung, V; Haussler, D; Gibbs, R				Page, David; Cheung, Vivian; Haussler, David; Gibbs, Richard			Human Genome: What's Been Most Surprising?	CELL			English	News Item									[Page, David] MIT, Cambridge, MA 02139 USA; [Cheung, Vivian] Univ Penn, Philadelphia, PA 19104 USA; [Haussler, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Gibbs, Richard] Baylor Coll Med, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of California System; University of California Santa Cruz; Baylor College of Medicine	Page, D (corresponding author), MIT, Cambridge, MA 02139 USA.		Cheung, Vivian G./AAT-3115-2020						0	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					9	10						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	22128372	Bronze			2022-12-28	WOS:000295396700005
J	Baselga, J; Campone, M; Piccart, M; Burris, HA; Rugo, HS; Sahmoud, T; Noguchi, S; Gnant, M; Pritchard, KI; Lebrun, F; Beck, JT; Ito, Y; Yardley, D; Deleu, I; Perez, A; Bachelot, T; Vittori, L; Xu, ZY; Mukhopadhyay, P; Lebwohl, D; Hortobagyi, GN				Baselga, Jose; Campone, Mario; Piccart, Martine; Burris, Howard A., III; Rugo, Hope S.; Sahmoud, Tarek; Noguchi, Shinzaburo; Gnant, Michael; Pritchard, Kathleen I.; Lebrun, Fabienne; Beck, J. Thaddeus; Ito, Yoshinori; Yardley, Denise; Deleu, Ines; Perez, Alejandra; Bachelot, Thomas; Vittori, Luc; Xu, Zhiying; Mukhopadhyay, Pabak; Lebwohl, David; Hortobagyi, Gabriel N.			Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIRST-LINE THERAPY; AROMATASE INHIBITORS; PHASE-III; WOMEN; TAMOXIFEN; TRIAL; ANASTROZOLE; LETROZOLE; SUPERIOR; EFFICACY	Background Resistance to endocrine therapy in breast cancer is associated with activation of the mammalian target of rapamycin (mTOR) intracellular signaling pathway. In early studies, the mTOR inhibitor everolimus added to endocrine therapy showed antitumor activity. Methods In this phase 3, randomized trial, we compared everolimus and exemestane versus exemestane and placebo (randomly assigned in a 2:1 ratio) in 724 patients with hormone-receptor-positive advanced breast cancer who had recurrence or progression while receiving previous therapy with a nonsteroidal aromatase inhibitor in the adjuvant setting or to treat advanced disease (or both). The primary end point was progression-free survival. Secondary end points included survival, response rate, and safety. A preplanned interim analysis was performed by an independent data and safety monitoring committee after 359 progression-free survival events were observed. Results Baseline characteristics were well balanced between the two study groups. The median age was 62 years, 56% had visceral involvement, and 84% had hormone-sensitive disease. Previous therapy included letrozole or anastrozole (100%), tamoxifen (48%), fulvestrant (16%), and chemotherapy (68%). The most common grade 3 or 4 adverse events were stomatitis (8% in the everolimus-plus-exemestane group vs. 1% in the placebo-plus-exemestane group), anemia (6% vs. <1%), dyspnea (4% vs. 1%), hyperglycemia (4% vs. <1%), fatigue (4% vs. 1%), and pneumonitis (3% vs. 0%). At the interim analysis, median progression-free survival was 6.9 months with everolimus plus exemestane and 2.8 months with placebo plus exemestane, according to assessments by local investigators (hazard ratio for progression or death, 0.43; 95% confidence interval [CI], 0.35 to 0.54; P<0.001). Median progression-free survival was 10.6 months and 4.1 months, respectively, according to central assessment (hazard ratio, 0.36; 95% CI, 0.27 to 0.47; P<0.001). Conclusions Everolimus combined with an aromatase inhibitor improved progression-free survival in patients with hormone-receptor-positive advanced breast cancer previously treated with nonsteroidal aromatase inhibitors. (Funded by Novartis; BOLERO-2 ClinicalTrials.gov number, NCT00863655.)	[Baselga, Jose] Harvard Univ, Div Hematol Oncol, Ctr Canc, Massachusetts Gen Hosp,Sch Med, Boston, MA 02114 USA; [Campone, Mario] Inst Cancerol Ouest Rene Gauducheau, St Herblain, France; [Piccart, Martine; Lebrun, Fabienne] Inst Jules Bordet, B-1000 Brussels, Belgium; [Burris, Howard A., III; Yardley, Denise] Sarah Cannon Res Inst, Nashville, TN USA; [Rugo, Hope S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Sahmoud, Tarek; Xu, Zhiying] Novartis, E Hanover, NJ USA; [Noguchi, Shinzaburo] Osaka Univ, Dept Breast & Endocrine Surg, Osaka, Japan; [Gnant, Michael] Med Univ Vienna, Dept Surg, Ctr Comprehens Canc, Vienna, Austria; [Pritchard, Kathleen I.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Pritchard, Kathleen I.] Univ Toronto, Toronto, ON, Canada; [Beck, J. Thaddeus] Highlands Oncol Grp, Fayetteville, AR USA; [Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Deleu, Ines] AZ Nikolass, Ctr Oncol, St Niklaas, Belgium; [Perez, Alejandra] Mem Canc Inst, Hollywood, FL USA; [Bachelot, Thomas] Ctr Leon Berard, F-69373 Lyon, France; [Vittori, Luc] Novartis Pharmaceut, Basel, Switzerland; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut Jules Bordet; Sarah Cannon Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Novartis; Osaka University; Medical University of Vienna; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Japanese Foundation for Cancer Research; UNICANCER; Centre Leon Berard; Novartis; University of Texas System; UTMD Anderson Cancer Center	Baselga, J (corresponding author), Harvard Univ, Div Hematol Oncol, Ctr Canc, Massachusetts Gen Hosp,Sch Med, 55 Fruit St,Lawrence House 108, Boston, MA 02114 USA.	jbaselga@partners.org	de Azevedo, Sergio Jobim/P-5115-2015; Gnant, Michael/AAN-7054-2020	Gnant, Michael/0000-0003-1002-2118	Novartis; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Novartis, including funding for medical editorial assistance with the manuscript.	Bachelot T, 2010, 33 ANN SAN ANT BREAS; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Burstein HJ, 2011, SEMIN ONCOL, V38, pS17, DOI 10.1053/j.seminoncol.2011.04.002; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Chow LWC, 2006, 29 ANN SAN ANT BREAS; Di Leo A, 2011, J CLIN ONCOL, V29, P2293, DOI 10.1200/JCO.2011.36.8522; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Johnston SRD, 2006, CLIN CANCER RES, V12, p1061S, DOI 10.1158/1078-0432.CCR-05-2125; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mauri D, 2006, JNCI-J NATL CANCER I, V98, P1285, DOI 10.1093/jnci/djj357; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Mouridsen, 2001, J CLIN ONCOL, V19, P3302; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200	25	2012	2109	3	169	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					520	529		10.1056/NEJMoa1109653	http://dx.doi.org/10.1056/NEJMoa1109653			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888GH	22149876	Green Accepted			2022-12-28	WOS:000299991300008
J	Deng, X; Mammen, L; Butt, HJ; Vollmer, D				Deng, Xu; Mammen, Lena; Butt, Hans-Juergen; Vollmer, Doris			Candle Soot as a Template for a Transparent Robust Superamphiphobic Coating	SCIENCE			English	Article							SUPER WATER-REPELLENT; SUPERHYDROPHOBIC SURFACES; ROUGHNESS; DROPLETS; LOTUS	Coating is an essential step in adjusting the surface properties of materials. Superhydrophobic coatings with contact angles greater than 150 degrees and roll-off angles below 10 degrees for water have been developed, based on low-energy surfaces and roughness on the nano-and micrometer scales. However, these surfaces are still wetted by organic liquids such as surfactant-based solutions, alcohols, or alkanes. Coatings that are simultaneously superhydrophobic and superoleophobic are rare. We designed an easily fabricated, transparent, and oil-rebounding superamphiphobic coating. A porous deposit of candle soot was coated with a 25-nanometer-thick silica shell. The black coating became transparent after calcination at 600 degrees C. After silanization, the coating was superamphiphobic and remained so even after its top layer was damaged by sand impingement.	[Deng, Xu; Mammen, Lena; Butt, Hans-Juergen; Vollmer, Doris] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Deng, Xu] Tech Univ Darmstadt, Ctr Smart Interfaces, D-64287 Darmstadt, Germany	Max Planck Society; Technical University of Darmstadt	Vollmer, D (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	vollmerd@mpip-mainz.mpg.de	Deng, Xu/G-4589-2011; Vollmer, Doris/I-3721-2014; Butt, Hans-Jürgen/C-4811-2011	Deng, Xu/0000-0002-9659-0417; Vollmer, Doris/0000-0001-9599-5589; Butt, Hans-Jürgen/0000-0001-5391-2618	Deutsche Forschungsgemeinschaft [SPP 1273, SPP 1420, SPP 1486]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to G. Glaser, K. Kirchhoff, G. Schafer, S. Pinnells, J. Ally, and P. Papadopoulos for technical support and stimulating discussions. We acknowledge financial support from Deutsche Forschungsgemeinschaft grants SPP 1273 (D. V.), SPP 1420 (H.J.B.), and SPP 1486 (L.M.).	Ahuja A, 2008, LANGMUIR, V24, P9, DOI 10.1021/la702327z; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bartolo D, 2006, EUROPHYS LETT, V74, P299, DOI 10.1209/epl/i2005-10522-3; Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856; Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f; Cao LL, 2008, LANGMUIR, V24, P1640, DOI 10.1021/la703401f; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Deng X, 2011, ADV MATER, V23, P2962, DOI 10.1002/adma.201100410; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Gao LC, 2006, LANGMUIR, V22, P2966, DOI 10.1021/la0532149; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Genzer J, 2000, SCIENCE, V290, P2130, DOI 10.1126/science.290.5499.2130; Herminghaus S, 2000, EUROPHYS LETT, V52, P165, DOI 10.1209/epl/i2000-00418-8; Joly L, 2009, SOFT MATTER, V5, P2549, DOI 10.1039/b821214g; Kim SH, 2010, ANGEW CHEM INT EDIT, V49, P2535, DOI 10.1002/anie.201000108; Kumar RTR, 2010, J PHYS CHEM C, V114, P2936, DOI 10.1021/jp9066422; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Manukyan G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014501; McHale G, 2010, SOFT MATTER, V6, P714, DOI 10.1039/b917861a; MEGARIDIS CM, 1990, COMBUST SCI TECHNOL, V71, P95, DOI 10.1080/00102209008951626; Nosonovsky M, 2007, LANGMUIR, V23, P3157, DOI 10.1021/la062301d; Richard D, 2002, NATURE, V417, P811, DOI 10.1038/417811a; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Singh S, 2006, NATURE, V442, P526, DOI 10.1038/442526a; Steele A, 2009, NANO LETT, V9, P501, DOI 10.1021/nl8037272; Tuteja A, 2008, MRS BULL, V33, P752, DOI 10.1557/mrs2008.161; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Xie QD, 2004, ADV MATER, V16, P302, DOI 10.1002/adma.200306281; Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p	31	1522	1588	140	1979	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					67	70		10.1126/science.1207115	http://dx.doi.org/10.1126/science.1207115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22144464				2022-12-28	WOS:000298846200050
J	Feklistov, A; Darst, SA				Feklistov, Andrey; Darst, Seth A.			Structural Basis for Promoter-10 Element Recognition by the Bacterial RNA Polymerase sigma Subunit	CELL			English	Article							ESCHERICHIA-COLI SIGMA(70); OPEN COMPLEX-FORMATION; SINGLE-STRANDED-DNA; TRANSCRIPTION INITIATION; NONTEMPLATE STRAND; CONSERVED REGION-2; BACILLUS-SUBTILIS; MELTING REGION; SEQUENCE LOGOS; AMINO-ACIDS	The key step in bacterial promoter opening is recognition of the -10 promoter element (T(-12)A(-11)T(-10)A(-9) A(-8)T(-7) consensus sequence) by the RNA polymerase sigma subunit. We determined crystal structures of sigma domain 2 bound to single-stranded DNA bearing -10 element sequences. Extensive interactions occur between the protein and the DNA backbone of every -10 element nucleotide. Base-specific interactions occur primarily with A(-11) and T-7, which are flipped out of the single-stranded DNA base stack and buried deep in protein pockets. The structures, along with biochemical data, support a model where the recognition of the -10 element sequence drives initial promoter opening as the bases of the nontemplate strand are extruded from the DNA double-helix and captured by sigma. These results provide a detailed structural basis for the critical roles of A(-11) and T-7 in promoter melting and reveal important insights into the initiation of transcription bubble formation.	[Feklistov, Andrey; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Feklistov, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	afeklistov@rockefeller.edu; darst@rockefeller.edu			US Department of Energy, Office of Basic Energy Sciences; NCRR at the NIH [RR-15301]; NIH [RO1 GM053759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NCRR at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Shultzaberger and T. Schneider for providing Figure 1B and for helpful discussions; P. deHaseth, A. Kulbachinskiy, S. Malik, A. Mustaev, R. Saecker, and M. Schapira for helpful discussions; K.R. Rajashankar and F. Murphy at APS NE-CAT beamline 24ID-E and W. Shi at NSLS beamline X29 for support with synchrotron data collection; and R. MacKinnon for use of the fluorescence plate-reader. A.F. is a Merck Postdoctoral Fellow at The Rockefeller University. This work was based, in part, on research conducted at the APS and the NSLS, supported by the US Department of Energy, Office of Basic Energy Sciences. The NE-CAT beamlines at the APS are supported by award RR-15301 from the NCRR at the NIH. This work was supported by NIH RO1 GM053759 to S.A.D.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen J, 2010, P NATL ACAD SCI USA, V107, P12523, DOI 10.1073/pnas.1003533107; CHEN YF, 1995, J MOL BIOL, V249, P743, DOI 10.1006/jmbi.1995.0333; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DREW HR, 1985, EMBO J, V4, P1025, DOI 10.1002/j.1460-2075.1985.tb03734.x; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2001, P NATL ACAD SCI USA, V98, P9020, DOI 10.1073/pnas.161085798; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; Fenton MS, 2003, NUCLEIC ACIDS RES, V31, P2745, DOI 10.1093/nar/gkg400; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; Gueron M, 1995, METHOD ENZYMOL, V261, P383; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Heyduk E, 2006, J BIOL CHEM, V281, P12362, DOI 10.1074/jbc.M601364200; Hoffman MM, 2004, NUCLEIC ACIDS RES, V32, pD174, DOI 10.1093/nar/gkh128; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; JOHNSRUD L, 1978, P NATL ACAD SCI USA, V75, P5314, DOI 10.1073/pnas.75.11.5314; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; KENNEY TJ, 1989, P NATL ACAD SCI USA, V86, P9109, DOI 10.1073/pnas.86.23.9109; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lee HJ, 2004, J BIOL CHEM, V279, P16899, DOI 10.1074/jbc.C400054200; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; MOYLE H, 1991, J BACTERIOL, V173, P1944, DOI 10.1128/jb.173.6.1944-1950.1991; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Niedziela-Majka A, 2005, J BIOL CHEM, V280, P38219, DOI 10.1074/jbc.M507984200; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; SAVINKOVA L K, 1988, Molekulyarnaya Biologiya (Moscow), V22, P807; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; Schroeder LA, 2008, J MOL BIOL, V376, P153, DOI 10.1016/j.jmb.2007.11.070; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Sevostyanova A, 2007, J BIOL CHEM, V282, P22033, DOI 10.1074/jbc.M702495200; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SPASSKY A, 1988, EMBO J, V7, P1871, DOI 10.1002/j.1460-2075.1988.tb03020.x; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P2723, DOI 10.1021/bi00332a019; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tsujikawa L, 2002, BIOCHEMISTRY-US, V41, P15334, DOI 10.1021/bi026539m; WALDBURGER C, 1994, J MOL BIOL, V235, P1489, DOI 10.1006/jmbi.1994.1103; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	71	225	231	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1257	1269		10.1016/j.cell.2011.10.041	http://dx.doi.org/10.1016/j.cell.2011.10.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22136875	Bronze, Green Accepted			2022-12-28	WOS:000298148100016
J	Nagib, DA; MacMillan, DWC				Nagib, David A.; MacMillan, David W. C.			Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis	NATURE			English	Article							FLUORINE; ELECTROCHEMISTRY; COMPLEXES	Modern drug discovery relies on the continual development of synthetic methodology to address the many challenges associated with the design of new pharmaceutical agents(1). One such challenge arises from the enzymatic metabolism of drugs in vivo by cytochrome P450 oxidases, which use single-electron oxidative mechanisms to rapidly modify small molecules to facilitate their excretion(2). A commonly used synthetic strategy to protect against in vivo metabolism involves the incorporation of electron-withdrawing functionality, such as the trifluoromethyl (CF3) group, into drug candidates(3). The CF3 group enjoys a privileged role in the realm of medicinal chemistry because its incorporation into small molecules often enhances efficacy by promoting electrostatic interactions with targets, improving cellular membrane permeability, and increasing robustness towards oxidative metabolism of the drug(4-6). Although common pharmacophores often bear CF3 motifs in an aromatic system, access to such analogues typically requires the incorporation of the CF3 group, or a surrogate moiety, at the start of a multi-step synthetic sequence. Here we report a mild, operationally simple strategy for the direct trifluoromethylation of unactivated arenes and heteroarenes through a radical-mediated mechanism using commercial photocatalysts and a household light bulb. We demonstrate the broad utility of this transformation through addition of CF3 to a number of heteroaromatic and aromatic systems. The benefit to medicinal chemistry and applicability to late-stage drug development is also shown through examples of the direct trifluoromethylation of widely prescribed pharmaceutical agents.	[Nagib, David A.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Frick Lab 192, Princeton, NJ 08540 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Frick Lab 192, Princeton, NJ 08540 USA.	dmacmill@princeton.edu	Nagib, David A/B-6618-2014	Nagib, David/0000-0002-2275-6381	NIH General Medical Sciences [R01 01 GM093213-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	NIH General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by the NIH General Medical Sciences (R01 01 GM093213-01) and gifts from Merck, Amgen, Abbott and Bristol-Myers Squibb. We thank C. Kraml and N. Byrne of Lotus Separations LLC for their development of preparatory supercritical fluid chromatography (SFC) methods and for the separation of all three CF<INF>3</INF>-Lipitor analogues.	ANDRIEUX CP, 1990, J AM CHEM SOC, V112, P3509, DOI 10.1021/ja00165a040; BHATIA K, 1974, J PHYS CHEM-US, V78, P2335; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; DEXTER DL, 1972, CANCER RES, V32, P247; Dolbier WR, 1997, TOP CURR CHEM, V192, P97; Filler R., 1993, ORGANOFLUORINE COMPO; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Heaton C. A., 1989, J FLUORINE CHEM, V45, P86; Heaton CA, 2001, J FLUORINE CHEM, V107, P1, DOI 10.1016/S0022-1139(00)00324-9; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; KAMIGATA N, 1994, J CHEM SOC PERK T 1, P1339, DOI 10.1039/p19940001339; KAMIGATA N, 1990, CHEM LETT, P649, DOI 10.1246/cl.1990.649; LANGLOIS BR, 1991, TETRAHEDRON LETT, V32, P7525, DOI 10.1016/0040-4039(91)80524-A; Li J. J., 2010, MODERN DRUG SYNTHESI; Montellano P. R. O., 2005, CYTOCHROMEP450 STRUC; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Roth BD, 2002, PROGR MED CHEM, V40, P1, DOI 10.1016/S0079-6468(08)70080-8; SKARDA V, 1984, J CHEM SOC PERK T 2, P1309, DOI 10.1039/p29840001309; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Wiehn MS, 2010, J FLUORINE CHEM, V131, P951, DOI 10.1016/j.jfluchem.2010.06.020; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/NCHEM.687, 10.1038/nchem.687]	30	976	994	9	633	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					224	228		10.1038/nature10647	http://dx.doi.org/10.1038/nature10647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158245	Green Accepted			2022-12-28	WOS:000297744200047
J	Palmer, R				Palmer, Roxanne			Lines of defence	NATURE			English	Editorial Material																			0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S9	S10		10.1038/480S9a	http://dx.doi.org/10.1038/480S9a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158299	Bronze			2022-12-28	WOS:000297744200007
J	Evans, JP; Berg, JS				Evans, James P.; Berg, Jonathan S.			Next-Generation DNA Sequencing, Regulation, and the Limits of Paternalism The Next Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LYNCH-SYNDROME; MORTALITY		[Evans, James P.; Berg, Jonathan S.] Univ N Carolina, Dept Genet & Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu		Berg, Jonathan/0000-0003-2360-2664				Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Creighton S, 2003, CLIN GENET, V63, P462, DOI 10.1034/j.1399-0004.2003.00093.x; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Gahl WA, GENET MED, DOI [10.1097/GIM.0b013e318232a005, DOI 10.1097/GIM.0B013E318232A005]; Kutz G, 2010, DIRECT CONSUMER GENE; Stevenson DA, 2004, AM J MED GENET A, V126A, P393, DOI 10.1002/ajmg.a.20409; Vorhous D., DTC GENETIC TESTING	8	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2376	2377		10.1001/jama.2011.1788	http://dx.doi.org/10.1001/jama.2011.1788			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147382				2022-12-28	WOS:000297680300024
J	Tsatsaris, V; Capitant, C; Schmitz, T; Chazallon, C; Bulifon, S; Riethmuller, D; Picone, O; Poulain, P; Lewin, F; Laine, F; Jacqz-Aigrain, E; Aboulker, JP; Launay, O				Tsatsaris, Vassilis; Capitant, Catherine; Schmitz, Thomas; Chazallon, Corine; Bulifon, Sophie; Riethmuller, Didier; Picone, Olivier; Poulain, Patrice; Lewin, Fanny; Laine, Fabrice; Jacqz-Aigrain, Evelyne; Aboulker, Jean-Pierre; Launay, Odile		Inserm C09-33 PREFLUVAC Immunogeni	Maternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine A Single-Group Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PREGNANT-WOMEN; RESPIRATORY ILLNESS; ANTIBODY TRANSFER; IMMUNIZATION; HOSPITALIZATIONS; INFANTS; IMMUNOGENICITY; MOTHERS	Background: Pregnant women and infants who get influenza are at increased risk for severe illness. Objective: To evaluate the immunogenicity and transplacental antibody transfer of 2009 pandemic influenza A(H1N1) vaccine administered during pregnancy. Design: Prospective, multicenter, single-group clinical trial. (Clinical Trials.gov registration number: NCT01024400) Setting: Five level-3 perinatal centers in France. Patients: 107 pregnant women between 22(0/7) and 32(0/7) weeks of gestation. Intervention: An intramuscular dose of a nonadjuvanted H1N1 vaccine that contained 15 mcg of hemagglutinin. Measurements: Proportion of women with an influenza antibody titer of 1:40 or greater at days 21 and 42 after vaccination, delivery, and 3 months after delivery. Seroconversion rate, fold increase in the geometric mean titer 21 days after vaccination, and proportion of neonates with an antibody titer of 1:40 or greater at birth were also assessed. Results: At baseline, 19% of the women had an antibody titer of 1:40 or greater. At day 21, 98% of the women had an antibody titer of 1:40 or greater, the seroconversion rate was 93%, and the fold increase in geometric mean titer was 67.4. At day 42, delivery, and 3 months after delivery, 98%, 92%, and 90% of the women, respectively, had an antibody titer of 1:40 or greater. Ninety-five percent of the cord serum samples obtained from 88 neonates showed an antibody titer of 1:40 or greater. The median neonate-mother antibody titer ratio was 1.4. Limitations: Only healthy pregnant women were selected. Data on hemagglutination inhibition antibody titers of infants were reported only at birth. Conclusion: A single dose of a nonadjuvanted influenza A(H1N1) vaccine with 15 mcg of hemagglutinin triggered a strong immune response in pregnant women and a high rate of neonatal seroprotection.	Univ Paris 11, Hop Cochin,Univ Paris Descartes, AP HP,Paris Diderot Univ,Antoine Beclere Univ Hos, Robert Debre Univ Hosp,PremUP Fdn,Inserm CIC 9202, Paris, France; Inserm CIC CBT505, Paris, France; Inserm SC10, Villejuif, France; Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; Bicetre Univ Hosp, Le Kremlin Bicetre, France; Univ Franche Comte, F-25030 Besancon, France; St Jacques Hosp, Besancon, France; Univ Rennes 1, Rennes Univ Hosp, Rennes, France; Inserm CIC 02 03, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Cochin - APHP; Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Launay, O (corresponding author), Grp Hosp Cochin St Vincent de Paul, CIC Vaccinol Cochin Pasteur, Batiment Lavoisier,27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	odile.launay@cch.aphp.fr	Jacqz-Aigrain, Evelyne/AAW-7089-2021; PICONE, Olivier/ABF-7916-2020	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; PICONE, Olivier/0000-0001-8421-9971; Azria, Elie/0000-0002-6159-6253; GOFFINET, Francois/0000-0001-9643-0299; laine, fabrice/0000-0001-6405-2211; Le Ray, Camille/0000-0003-0891-1063	French National Institute of Health and Medical Research; Aviesan-Institut de Microbiologie et des Maladies Infectieuses	French National Institute of Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aviesan-Institut de Microbiologie et des Maladies Infectieuses	By the French National Institute of Health and Medical Research and a grant from the programme de recherches H1N1 Aviesan-Institut de Microbiologie et des Maladies Infectieuses. Sanofi Pasteur provided the vaccines and performed immunologic tests.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], 1997, FED REGISTER, V62, P27464; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Bland JM, 1996, BRIT MED J, V312, P1079; Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE; Committee for Human Medicinal Products, 2007, GUID INFL VACC PREP; Committee for Medicinal Products for Human Use, 2004, GUID DOSS STRUCT CON; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Coudeville L, 2010, HUM VACCINES, V6, P841, DOI 10.4161/hv.6.10.12636; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Englund JA, 2007, J COMP PATHOL, V137, pS16, DOI 10.1016/j.jcpa.2007.04.006; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; Haut Conseil de la Sante ' Publique, 2008, AV REL VACC GRIPP SA; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kendal AP, 1982, CONCEPTS PROCEDURES; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Mereckiene J, 2008, EURO SURVEILL, V13; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; World Health Organization, 2009, AV CAND REASS VACC V; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729	30	47	47	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					733	U146		10.7326/0003-4819-155-11-201112060-00005	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147712				2022-12-28	WOS:000297988400002
J	Schubert, C				Schubert, Charlotte			TECHNOLOGY FEATURE THE DEEPEST DIFFERENCES	NATURE			English	Editorial Material							SINGLE-CELL; TRANSCRIPTOME; DYNAMICS; REVEALS											Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Chiu DT, 2009, ACCOUNTS CHEM RES, V42, P649, DOI 10.1021/ar8002464; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Hatcher NG, 2008, J NEUROCHEM, V104, P1358, DOI 10.1111/j.1471-4159.2007.05084.x; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Mackler S. A., 1992, J H NEURON, V9, P539; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Urban PL, 2010, LAB CHIP, V10, P3206, DOI 10.1039/c0lc00211a; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663	17	64	65	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					133	137		10.1038/480133a	http://dx.doi.org/10.1038/480133a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129730				2022-12-28	WOS:000298031900050
J	van den Hoek, HL; Bos, WJW; de Boer, A; van de Garde, EMW				van den Hoek, Hester L.; Bos, Willem Jan W.; de Boer, Anthonius; van de Garde, Ewoudt M. W.			Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RENAL-TRANSPLANT RECIPIENTS; CHRONIC-HEMODIALYSIS PATIENTS; COMMUNITY-ACQUIRED PNEUMONIA; CARDIAC OUTCOMES; CARDIOVASCULAR-DISEASE; DOSE ATORVASTATIN; OLDER PATIENTS; HEART-FAILURE; DOUBLE-BLIND; ROSUVASTATIN	Objective To evaluate whether the potential of statins to lower the risk of infections as published in observational studies is causal. Design Systematic review and meta-analysis of randomised placebo controlled trials. Data sources Medline, Embase, and the Cochrane Library. Study selection Randomised placebo controlled trials of statins (up to 10 March 2011) enrolling a minimum of 100 participants, with follow-up for at least one year. Data extraction Infection or infection related death. Results The first study selection yielded 632 trials. After screening of the corresponding abstracts and full text papers, 11 trials totalling 30 947 participants were included. 4655 of the participants (2368 assigned to statins and 2287 assigned to placebo) reported an infection during treatment. Meta-analysis showed no effect of statins on the risk of infections (relative risk 1.00, 95% confidence interval 0.96 to 1.05) or on infection related deaths (0.97, 0.83 to 1.13). Conclusion These findings do not support the hypothesis that statins reduce the risk of infections. Absence of any evidence for a beneficial effect in large placebo controlled trials reduces the likelihood of a causal effect as reported in observational studies.	[van den Hoek, Hester L.; de Boer, Anthonius; van de Garde, Ewoudt M. W.] Univ Utrecht, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Bos, Willem Jan W.] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands; [van den Hoek, Hester L.; van de Garde, Ewoudt M. W.] St Antonius Hosp, Dept Clin Pharm, NL-3430 EM Nieuwegein, Netherlands	Utrecht University; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	van de Garde, EMW (corresponding author), Univ Utrecht, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	e.van.de.garde@antoniusziekenhuis.nl		Bos, Willem Jan W/0000-0002-5062-2567				Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Becker K, 2011, J STROKE CEREBROVASC; Bone HG, 2007, J CLIN ENDOCR METAB, V92, P4671, DOI 10.1210/jc.2006-1909; Chalmers JD, 2010, RESP MED, V104, P1081, DOI 10.1016/j.rmed.2010.04.005; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; ClinicalTrials.gov, 2011, NCT00147602 CLINICAL; ClinicalTrials.gov, 2011, NCT00336336 CLINICAL; ClinicalTrials.gov, 2011, NCT00206310 CLINICAL; ClinicalTrials.gov, 2011, NCT00240331 CLINICAL; Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570; Colhoun HM, 2002, DIABETIC MED, V19, P201, DOI 10.1046/j.1464-5491.2002.00643.x; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fellstrom B, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-9; Fellstrom B, 2007, KIDNEY BLOOD PRESS R, V30, P314, DOI 10.1159/000106803; Fellstrom B, 2006, CLIN TRANSPLANT, V20, P732, DOI 10.1111/j.1399-0012.2006.00555.x; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2001, J CARDIOVASC RISK, V8, P63, DOI 10.1097/00043798-200104000-00002; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Newman CB, 2008, DIABETES VASC DIS RE, V5, P177, DOI 10.3132/dvdr.2008.029; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Serruys Patrick WJC, 2001, Int J Cardiovasc Intervent, V4, P165; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sharp Collaborative Group, 2010, Am Heart J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sillesen H, 2003, CEREBROVASC DIS, V16, P389, DOI 10.1159/000072562; Stegmayr BG, 2005, SCAND J UROL NEPHROL, V39, P489, DOI 10.1080/00365590500329304; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Thompson JN, 2011, MYCOSES, V54, pE481, DOI 10.1111/j.1439-0507.2010.01957.x; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Toh S, 2007, PHARMACOEPIDEM DR S, V16, P627, DOI 10.1002/pds.1363; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Wanner C, 1999, KIDNEY INT, V56, pS222, DOI 10.1046/j.1523-1755.1999.07158.x; Wanner C, 2004, KIDNEY BLOOD PRESS R, V27, P259, DOI 10.1159/000080241; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	58	49	50	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2011	343								d7281	10.1136/bmj.d7281	http://dx.doi.org/10.1136/bmj.d7281			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EL	22127443	Green Published, hybrid			2022-12-28	WOS:000298938100006
J	Vose, JM				Vose, Julie M.			Intensified chemotherapy for diffuse large B-cell lymphomas	LANCET			English	Editorial Material							PLUS RITUXIMAB; STANDARD CHOP		Nebraska Med Ctr, Div Hematol Oncol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Vose, JM (corresponding author), Nebraska Med Ctr, Div Hematol Oncol, Omaha, NE 68198 USA.	jmvose@unmc.edu						Advani RH, 2011, ANN ONCOL, V22, P135; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Casasnovas RO, 2011, BLOOD, V118, P37, DOI 10.1182/blood-2010-12-327767; Nowakowski GS, 2011, LEUKEMIA, V25, P1877, DOI 10.1038/leu.2011.165; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruan J, 2011, J CLIN ONCOL, V29, P690, DOI 10.1200/JCO.2010.31.1142; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Tilly H, 2003, BLOOD, V102, P4284, DOI 10.1182/blood-2003-02-0542; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391	11	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2011	378	9806					1828	1829		10.1016/S0140-6736(11)61269-5	http://dx.doi.org/10.1016/S0140-6736(11)61269-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	22118432				2022-12-28	WOS:000297695800009
J	O'Connor, S; Ono, R; Clarkson, C				O'Connor, Sue; Ono, Rintaro; Clarkson, Chris			Pelagic Fishing at 42,000 Years Before the Present and the Maritime Skills of Modern Humans	SCIENCE			English	Article							ETHNO-ARCHAEOLOGY; SOUTH-AFRICA; EAST TIMOR; EXPLOITATION	By 50,000 years ago, it is clear that modern humans were capable of long-distance sea travel as they colonized Australia. However, evidence for advanced maritime skills, and for fishing in particular, is rare before the terminal Pleistocene/early Holocene. Here we report remains of a variety of pelagic and other fish species dating to 42,000 years before the present from Jerimalai shelter in East Timor, as well as the earliest definite evidence for fishhook manufacture in the world. Capturing pelagic fish such as tuna requires high levels of planning and complex maritime technology. The evidence implies that the inhabitants were fishing in the deep sea.	[O'Connor, Sue] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT 0200, Australia; [Ono, Rintaro] Tokai Univ, Sch Marine Sci & Technol, Dept Maritime Civilizat, Shizuoka 4248610, Japan; [Clarkson, Chris] Univ Queensland, Sch Social Sci, St Lucia, Qld 4072, Australia	Australian National University; Tokai University; University of Queensland	O'Connor, S (corresponding author), Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, GPO Box 4, Canberra, ACT 0200, Australia.		Ono, Rintaro/GPF-4775-2022	Clarkson, Chris/0000-0002-8938-8974; O'Connor, Sue/0000-0001-9381-078X	Australian Research Council [DP0556210, DPl10102864]	Australian Research Council(Australian Research Council)	Australian Research Council Discovery grant DP0556210 funded this project. Australian Research Council Discovery grants DP0556210 and DPl10102864 to C. C. funded the lithics research.	Allen J, 2000, MOD QUAT RE, V16, P139; Allen J., 1993, COMMUNITY CULTURE PE, P139; [Anonymous], 2008, E SCI NEWS; Butler Virginia L., 1994, Archaeology in Oceania, V29, P81; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; FishOnline, 2011, FISHONLINE FISHING M; Haslam M, 2012, QUATERN INT, V258, P148, DOI 10.1016/j.quaint.2011.08.040; Haslam M, 2010, J ARCHAEOL SCI, V37, P3370, DOI 10.1016/j.jas.2010.07.034; Henshilwood C, 1997, CURR ANTHROPOL, V38, P890, DOI 10.1086/204678; KIRCH PV, 1979, J POLYNESIAN SOC, V88, P53; Klein R., 2002, DAWN HUMAN CULTURE; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; LEACH B F, 1988, Micronesica, V21, P1; Leavesley Matthew, 1998, Archaeology in Oceania, V33, P63; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Masse W. B., 1989, ARCHAEOLOGY ECOLOG 1; MASSE WB, 1989, ARCHAEOLOGY ECOLOG 2; O'Connor S, 2005, ANTIQUITY, V79, P249, DOI 10.1017/S0003598X0011405X; O'Connor S., 2006, UNCOVERING SE ASIAS, P74; O'Connor S, 2007, ARCHAEOL OCEAN, V42, P82, DOI 10.1002/j.1834-4453.2007.tb00021.x; O'Connor S, 2007, ANTIQUITY, V81, P523, DOI 10.1017/S0003598X00095569; O'Connor S, 2010, AUST ARCHAEOL, P29; O'Connor S, 2010, ANTIQUITY, V84, P649, DOI 10.1017/S0003598X00100146; Ono R, 2010, J POLYNESIAN SOC, V119, P269; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Szabo K, 2007, CURR ANTHROPOL, V48, P701, DOI 10.1086/520131; Wickler S., 2001, TERRA AUSTRALIS, V16; Wright A., 1985, Asian Marine Biology, V2, P69; Yoneda M, 2010, ASIAN PERSPECT, V48, P318	29	225	226	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1117	1121		10.1126/science.1207703	http://dx.doi.org/10.1126/science.1207703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	852AF	22116883	Green Published			2022-12-28	WOS:000297313900046
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Worst cases of patient care in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D7237	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7592	10.1136/bmj.d7592	http://dx.doi.org/10.1136/bmj.d7592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113570				2022-12-28	WOS:000297724400009
J	Samarasekera, U				Samarasekera, Udani			Salim S Abdool Karim: perseverance pays off	LANCET			English	Biographical-Item																		KARIM SA, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					E7	E7		10.1016/S0140-6736(11)61754-6	http://dx.doi.org/10.1016/S0140-6736(11)61754-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22119495	Bronze			2022-12-28	WOS:000310196500001
J	Heneghan, C; Ward, A; Perera, R; Bankhead, C; Fuller, A; Stevens, R; Bradford, K; Tyndel, S; Alonso-Coello, P; Ansell, J; Beyth, R; Bernardo, A; Christensen, TD; Cromheecke, M; Edson, RG; Fitzmaurice, D; Gadisseur, APA; Garcia-Alamino, JM; Gardiner, C; Hasenkam, M; Jacobson, A; Kaatz, S; Kamali, F; Khan, TI; Knight, E; Kortke, H; Levi, M; Matchar, DB; Menendez-Jandula B; Rakovac, I; Schaefer, C; Siebenhofer, A; Souto, JC; Sunderji, R; Gin, K; Shalansky, K; Voller, H; Wagner, O; Zittermann, A				Heneghan, Carl; Ward, Alison; Perera, Rafael; Bankhead, Clare; Fuller, Alice; Stevens, Richard; Bradford, Kairen; Tyndel, Sally; Alonso-Coello, Pablo; Ansell, Jack; Beyth, Rebecca; Bernardo, Artur; Christensen, Thomas Decker; Cromheecke, Manon; Edson, Robert G; Fitzmaurice, David; Gadisseur, Alain PA; Garcia-Alamino, Josep M; Gardiner, Chris; Hasenkam, Michael; Jacobson, Alan; Kaatz, Scott; Kamali, Farhad; Khan, Tayyaba Irfan; Knight, Eve; Kortke, Heinrich; Levi, Marcel; Matchar, David Bruce; Menendez-Jandula, Barbara; Rakovac, Ivo; Schaefer, Christian; Siebenhofer, Andrea; Souto, Juan Carlos; Sunderji, Rubina; Gin, Kenneth; Shalansky, Karen; Voller, Heinz; Wagner, Otto; Zittermann, Armin		Self-Monitoring Trialist Collabora	Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data	LANCET			English	Article							ATRIAL-FIBRILLATION; PROTHROMBIN TIME; MANAGEMENT PROGRAM; STROKE PREVENTION; WARFARIN THERAPY; RANDOMIZED-TRIAL; OLDER PATIENTS; QUALITY; GUIDELINES; INR	Background Uptake of self-testing and self-management of oral coagulation has remained inconsistent, despite good evidence of their effectiveness. To clarify the value of self-monitoring of oral anticoagulation, we did a meta-analysis of individual patient data addressing several important gaps in the evidence, including an estimate of the effect on time to death, first major haemorrhage, and thromboembolism. Methods We searched Ovid versions of Embase (1980-2009) and Medline (1966-2009), limiting searches to randomised trials with a maximally sensitive strategy. We approached all authors of included trials and requested individual patient data: primary outcomes were time to death, first major haemorrhage, and first thromboembolic event. We did prespecified subgroup analyses according to age, type of control-group care (anticoagulation-clinic care vs primary care), self-testing alone versus self-management, and sex. We analysed patients with mechanical heart valves or atrial fibrillation separately. We used a random-effect model method to calculate pooled hazard ratios and did tests for interaction and heterogeneity, and calculated a time-specific number needed to treat. Findings Of 1357 abstracts, we included 11 trials with data for 6417 participants and 12 800 person-years of follow-up. We reported a significant reduction in thromboembolic events in the self-monitoring group (hazard ratio 0.51; 95% CI 0.31-0.85) but not for major haemorrhagic events (0.88, 0.74-1.06) or death (0.82, 0.62-1.09). Participants younger than 55 years showed a striking reduction in thrombotic events (hazard ratio 0.33, 95% CI 0.17-0.66), as did participants with mechanical heart valve (0.52, 0.35-0.77). Analysis of major outcomes in the very elderly (age >= 85 years, n=99) showed no significant adverse effects of the intervention for all outcomes. Interpretation Our analysis showed that self-monitoring and self-management of oral coagulation is a safe option for suitable patients of all ages. Patients should also be offered the option to self-manage their disease with suitable health-care support as back-up.	[Heneghan, Carl; Ward, Alison; Perera, Rafael; Bankhead, Clare; Fuller, Alice; Stevens, Richard; Bradford, Kairen; Tyndel, Sally; Garcia-Alamino, Josep M] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Alonso-Coello, Pablo] Inst Biomed Res IIB St Pau, Clin Epidemiol & Publ Hlth Dept, Iberoamer Cochrane Ctr, Barcelona 08041, Spain; [Ansell, Jack] Lenox Hill Hosp, Dept Med, New York, NY USA; [Ansell, Jack] New York Univ Sch Med, New York, NY USA; [Beyth, Rebecca] Univ Florida, Div Internal Med, Gainesville, FL 32611 USA; [Beyth, Rebecca] North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA; [Bernardo, Artur] Klin Gais AG, Gais, Switzerland; [Christensen, Thomas Decker; Hasenkam, Michael] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Aarhus, Denmark; [Christensen, Thomas Decker] Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark; [Cromheecke, Manon; Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Cardiopulm Surg, Amsterdam, Netherlands; [Edson, Robert G] VA Cooperat Studies Program Coordinating Ctr, Palo Alto, CA USA; [Fitzmaurice, David] Univ Birmingham, Med Sch Birmingham, Dept Primary Hlth Care & Gen Pract, Birmingham B15 2TT, W Midlands, England; [Gadisseur, Alain PA] Univ Antwerp Hosp, Dept Haematol, Edegem, Belgium; [Gardiner, Chris] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Jacobson, Alan] Loma Linda Univ, Res & Dev Serv, Jerry L Pettis VA Med Ctr, Loma Linda, CA 92350 USA; Loma Linda Univ, Dept Internal Med, Loma Linda, CA 92350 USA; [Kaatz, Scott] Henry Ford Hosp, Dept Internal Med, Detroit, MI USA; [Kamali, Farhad; Khan, Tayyaba Irfan] Univ Newcastle, Inst Cell Med, Newcastle, NSW 2308, Australia; [Knight, Eve] Anticoagulation Europe, Kent, OH USA; [Kortke, Heinrich] Heart & Diabet Ctr N Rhine Westphalia, Inst Appl Telemedicine, Bad Oeynhausen, Germany; [Matchar, David Bruce] Duke Ctr Clin Hlth Policy Research, Durham, NC USA; [Matchar, David Bruce] Duke Univ, Med Ctr, Dept Internal Med, Div Gen Internal Med, Durham, NC USA; [Matchar, David Bruce] Duke NUS Grad Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Menendez-Jandula, Barbara; Souto, Juan Carlos] Hosp Santa Creu & Sant Pau, Unidad Hemostasis & Trombosis, Barcelona, Spain; [Rakovac, Ivo] Joanneum Res Forschungsgesell MBH, Inst Biomed & Hlth Sci, Graz, Austria; [Schaefer, Christian] ISMAAP, Geneva, Switzerland; [Siebenhofer, Andrea] Goethe Univ Frankfurt, Inst Gen Practice, D-60590 Frankfurt, Germany; [Sunderji, Rubina; Shalansky, Karen] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Gin, Kenneth] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Sunderji, Rubina; Gin, Kenneth; Shalansky, Karen] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC, Canada; [Voller, Heinz] Univ Potsdam, Rehabil Res Ctr, Potsdam, Germany; [Wagner, Otto; Zittermann, Armin] Ruhr Univ Bochum, Dept Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany; [Wagner, Otto; Zittermann, Armin] Ruhr Univ Bochum, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany	University of Oxford; Northwell Health; New York University; State University System of Florida; University of Florida; Aarhus University; Aarhus University; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Antwerp; University of Oxford; Loma Linda University; Loma Linda University; Henry Ford Health System; Henry Ford Hospital; University of Newcastle; Ruhr University Bochum; Duke University; National University of Singapore; Hospital of Santa Creu i Sant Pau; Goethe University Frankfurt; University of British Columbia; University of British Columbia; University of British Columbia; University of Potsdam; Ruhr University Bochum; Ruhr University Bochum	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, 23-38 Hythe Bridge St, Oxford OX1 2ET, England.	carl.heneghan@phc.ox.ac.uk	Levi, Marcel/AAZ-8559-2020; Gardiner, Chris/F-1178-2011; Gadisseur, Alain/AAW-9867-2021; Rakovac, Ivo/A-7678-2013; Matchar, David/M-3951-2019	Gardiner, Chris/0000-0002-2318-0062; Rakovac, Ivo/0000-0003-3462-2636; Siebenhofer-Kroitzsch, Andrea/0000-0002-6980-2103; Gadisseur, Alain/0000-0001-9419-8772; Perera, Rafael/0000-0003-2418-2091; Matchar, David/0000-0003-3020-2108; Rakovac, Ivo/0000-0002-6815-5274; Alonso-Coello, Pablo/0000-0002-8001-8504	UK National Institute for Health Research (NIHR); UK NIHR National School for Primary Care Research; National Institute for Health Research Technology Assessment Programme (NIHR HTA; UK); Instituto de Salud Carlos III; Alere ITC; NIHR; University of Florida; Department of Veterans Affairs; US National Institutes of Health; VA Cooperative Studies Program; Roche Diagnostics; Bayer Healthcare and Boehringer Ingelheim; Department of Haemotology, Antwerp University Hospital (Germany); Bayer Healthcare; Johnson Johnson; Edwards Lifesciences; Nycomed; National Board of Health; Anticoagulation Forum; Loma Linda Veterans Association for Research; Biosite Corporation; Boehringer Ingelheim; Daiichi Sankyo; Farallon Medical; Hemosene; Inverness Medical; Pfizer Medical; Quality Assured Services; Sanofi-Aventis; Tapestry Medical; GlaxoSmithKline; THINRS	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK NIHR National School for Primary Care Research; National Institute for Health Research Technology Assessment Programme (NIHR HTA; UK); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Alere ITC; NIHR(National Institute for Health Research (NIHR)); University of Florida(University of Florida); Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Cooperative Studies Program; Roche Diagnostics; Bayer Healthcare and Boehringer Ingelheim; Department of Haemotology, Antwerp University Hospital (Germany); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Edwards Lifesciences; Nycomed; National Board of Health; Anticoagulation Forum; Loma Linda Veterans Association for Research; Biosite Corporation; Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Farallon Medical; Hemosene; Inverness Medical; Pfizer Medical(Pfizer); Quality Assured Services; Sanofi-Aventis(Sanofi-Aventis); Tapestry Medical; GlaxoSmithKline(GlaxoSmithKline); THINRS	Funding UK National Institute for Health Research (NIHR) Technology Assessment Programme, UK NIHR National School for Primary Care Research.; Department of Primary Health Care, Oxford University (UK) received funding from the National Institute for Health Research Technology Assessment Programme (NIHR HTA; UK) and NIHR National School for Primary Care Research (UK); Iberoamerican Cochrane Centre received funding from Instituto de Salud Carlos III; Jack Ansell received funding from Alere ITC; Rebecca Beyth received funding from the 5th International Patient/Physician Conference on Oral Anticoagulant Therapy and the NIHR, University of Florida, Department of Veterans Affairs, and US National Institutes of Health; Robert Edson received funding from VA Cooperative Studies Program; Alain P A Gadisseur received funding from Roche Diagnostics, Bayer Healthcare and Boehringer Ingelheim; Department of Haemotology, Antwerp University Hospital (Germany) received funding from Bayer Healthcare; University College London Hospital (UK) received funding from Roche Diagnostics; J Michael Hasenkam received funding from Roche Diagnostics, Johnson & Johnson, Edwards Lifesciences, and Nycomed; Department of Cardiothoracic Surgery, Aarhus University Hospital (Denmark) received funding from National Board of Health; Alan Jacobson received funding from Anticoagulation Forum, Loma Linda Veterans Association for Research, Biosite Corporation, Boehringer Ingelheim, Daiichi Sankyo, Farallon Medical, Hemosene, Inverness Medical, Pfizer Medical, Quality Assured Services, Roche Diagnostics, Sanofi-Aventis, Tapestry Medical, GlaxoSmithKline, and VA Cooperative Studies Program and was the co-chair of the THINRS study; Department of Internal Medicine, Loma Linda University (USA) received funding from Loma Linda Veterans Association for Research, Biosite Corporation, Boehringer Ingelheim, Farallon Medical, Hemosene, Inverness Medical, and Sanofi-Aventis; Scott Kaatz received funding from Biosite and Vox media; Department of Internal Medicine, Henry Ford Hospital (USA) received funding from Roche Diagnostics; Institute of Cellular Medicine, University of Newcastle (UK) received funding from Heart Research UK; Wolfson Unit of Clinical Pharmacology, School of Clinical and Laboratory Sciences, University of Newcastle (UK) received funding from the BUPA Foundation and Coaguchek; Anticoagulation Europe received funding from Roche Diagnostics; David Matchar received funding from Boerhinger Ingelheim, Roche, and VA Cooperative Studies Program and was the Co-Chair of the THINRS study; Juan Carlos Souto is the Scientific Director of Monitor Medical.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bauman ME, 2010, THROMB RES, V126, pE110, DOI 10.1016/j.thromres.2010.05.024; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Christensen TD, 2007, INT J CARDIOL, V118, P54, DOI 10.1016/j.ijcard.2006.06.018; Christensen TD, 2006, EUR J INTERN MED, V17, P260, DOI 10.1016/j.ejim.2005.11.021; Connock M., 2007, HEALTH TECHNOL ASSES, V11, pix; Cromheecke ME, 2000, LANCET, V356, P97, DOI 10.1016/S0140-6736(00)02470-3; Dauphin C, 2008, ARCH CARDIOVASC DIS, V101, P753, DOI 10.1016/j.acvd.2008.10.007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Dolor RJ, 2010, J THROMB THROMBOLYS, V30, P263, DOI 10.1007/s11239-010-0499-8; Fitzmaurice DA, 2005, BRIT MED J, V331, P1057, DOI 10.1136/bmj.38618.580903.AE; Fitzmaurice DA, 2005, BRIT J HAEMATOL, V131, P156, DOI 10.1111/j.1365-2141.2005.05739.x; Fitzmaurice DA, 2002, J CLIN PATHOL, V55, P845, DOI 10.1136/jcp.55.11.845; Gadisseur APA, 2003, ARCH INTERN MED, V163, P2639, DOI 10.1001/archinte.163.21.2639; Garcia-Alamino Josep M, 2010, Cochrane Database Syst Rev, pCD003839, DOI 10.1002/14651858.CD003839.pub2; Gardiner C, 2006, BRIT J HAEMATOL, V132, P598, DOI 10.1111/j.1365-2141.2005.05899.x; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Hamad MAS, 2009, EUR J CARDIO-THORAC, V35, P265, DOI 10.1016/j.ejcts.2008.10.020; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horstkotte, 1998, J Thromb Thrombolysis, V5 Suppl 1, P19, DOI 10.1023/A:1013228718768; Kaatz S, 2001, J THROMB THROMBOLYS, V12, P111; Khan TI, 2004, BRIT J HAEMATOL, V126, P557, DOI 10.1111/j.1365-2141.2004.05074.x; Kortke H, 2001, Z KARDIOL, V90, P118; Lip GYH, 2007, INT J CLIN PRACT, V61, P9, DOI 10.1111/j.1742-1241.2006.01151.x; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Matchar DB, 2010, NEW ENGL J MED, V363, P1608, DOI 10.1056/NEJMoa1002617; Menendez-Jandula B, 2005, ANN INTERN MED, V142, P1, DOI 10.7326/0003-4819-142-1-200501040-00006; Perera R, 2008, J HEART VALVE DIS, V17, P233; Poller L, 2004, CLIN CHEM, V50, P537, DOI 10.1373/clinchem.2003.019653; Regier DA, 2006, CAN MED ASSOC J, V174, P1847, DOI 10.1503/cmaj.051104; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sidhu P, 2001, ANN THORAC SURG, V72, P1523, DOI 10.1016/S0003-4975(01)03049-1; Siebenhofer A, 2004, THROMB HAEMOSTASIS, V91, P225, DOI 10.1160/TH03-09-0598; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; Sunderji R, 2004, CAN J CARDIOL, V20, P1117; Szucs TD, 2006, J THROMB HAEMOST, V4, P1180, DOI 10.1111/j.1538-7836.2006.01890.x; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tinazzi A, 1998, SYST REV EV ACT INT, V6, P65; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Voller H, 2005, Z KARDIOL, V94, P182, DOI 10.1007/s00392-005-0199-0; WHITE RH, 1989, ANN INTERN MED, V111, P730, DOI 10.7326/0003-4819-111-9-730	49	231	235	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					322	334		10.1016/S0140-6736(11)61294-4	http://dx.doi.org/10.1016/S0140-6736(11)61294-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	22137798	Green Submitted			2022-12-28	WOS:000300047300039
J	Gillessen, S; Genzel, R; Fritz, TK; Quataert, E; Alig, C; Burkert, A; Cuadra, J; Eisenhauer, F; Pfuhl, O; Dodds-Eden, K; Gammie, CF; Ott, T				Gillessen, S.; Genzel, R.; Fritz, T. K.; Quataert, E.; Alig, C.; Burkert, A.; Cuadra, J.; Eisenhauer, F.; Pfuhl, O.; Dodds-Eden, K.; Gammie, C. F.; Ott, T.			A gas cloud on its way towards the supermassive black hole at the Galactic Centre	NATURE			English	Article							SAGITTARIUS-A-ASTERISK; STELLAR ORBITS; CENTRAL PARSEC; ESO VLT; ACCRETION; GALAXY; WINDS; RESOLUTION; EMISSION; SINFONI	Measurements of stellar orbits(1-3) provide compelling evidence(4,5) that the compact radio source Sagittarius A* at the Galactic Centre is a black hole four million times the mass of the Sun. With the exception of modest X-ray and infrared flares(6,7), Sgr A* is surprisingly faint, suggesting that the accretion rate and radiation efficiency near the event horizon are currently very low(3,8). Here we report the presence of a dense gas cloud approximately three times the mass of Earth that is falling into the accretion zone of Sgr A*. Our observations tightly constrain the cloud's orbit to be highly eccentric, with an innermost radius of approach of only similar to 3,100 times the event horizon that will be reached in 2013. Over the past three years the cloud has begun to disrupt, probably mainly through tidal shearing arising from the black hole's gravitational force. The cloud's dynamic evolution and radiation in the next few years will probe the properties of the accretion flow and the feeding processes of the supermassive black hole. The kilo-electronvolt X-ray emission of Sgr A* may brighten significantly when the cloud reaches pericentre. There may also be a giant radiation flare several years from now if the cloud breaks up and its fragments feed gas into the central accretion zone.	[Gillessen, S.; Genzel, R.; Fritz, T. K.; Burkert, A.; Eisenhauer, F.; Pfuhl, O.; Dodds-Eden, K.; Ott, T.] Max Planck Inst Extraterr Phys MPE, D-85748 Garching, Germany; [Genzel, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Quataert, E.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Alig, C.] Univ Munich, D-81679 Munich, Germany; [Cuadra, J.] Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago 7820436, Chile; [Gammie, C. F.] Univ Illinois, Ctr Theoret Astrophys, Dept Astron, Urbana, IL 61801 USA; [Gammie, C. F.] Univ Illinois, Ctr Theoret Astrophys, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Munich; Pontificia Universidad Catolica de Chile; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillessen, S (corresponding author), Max Planck Inst Extraterr Phys MPE, Giessenbachstr 1, D-85748 Garching, Germany.	ste@mpe.mpg.de; genzel@mpe.mpg.de	Cuadra, Jorge/GYV-4257-2022; Fritz, Tobias/AAA-5126-2020	Cuadra, Jorge/0000-0003-1965-3346; Fritz, Tobias/0000-0002-3122-300X; Gammie, Charles/0000-0001-7451-8935	FONDAP; FONDECYT; Basal; VRI-PUC; excellence cluster 'Origin and Structure of the Universe'	FONDAP; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); VRI-PUC; excellence cluster 'Origin and Structure of the Universe'	This paper is based on observations at the Very Large Telescope (VLT) of the European Observatory (ESO) in Chile. We thank C. McKee and R. Klein for discussions on the cloud destruction process. J.C. acknowledges support from FONDAP, FONDECYT, Basal and VRI-PUC. A. B. acknowledges the support of the excellence cluster 'Origin and Structure of the Universe'.	Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; Baganoff FK, 2001, NATURE, V413, P45, DOI 10.1038/35092510; Bartko H, 2009, ASTROPHYS J, V697, P1741, DOI 10.1088/0004-637X/697/2/1741; Blandford RD, 1999, MON NOT R ASTRON SOC, V303, pL1, DOI 10.1046/j.1365-8711.1999.02358.x; Bonnet H, 2003, P SOC PHOTO-OPT INS, V4839, P329, DOI 10.1117/12.457060; Chandrasekhar S., 1961, HYDRODYNAMIC HYDROMA, P428; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Eisenhauer F, 2003, P SOC PHOTO-OPT INS, V4841, P1548, DOI 10.1117/12.459468; Genzel R, 2003, NATURE, V425, P934, DOI 10.1038/nature02065; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Lenzen R, 1998, P SOC PHOTO-OPT INS, V3354, P606, DOI 10.1117/12.317287; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; Martins F, 2007, ASTRON ASTROPHYS, V468, P233, DOI 10.1051/0004-6361:20066688; Martins F, 2006, ASTROPHYS J, V649, pL103, DOI 10.1086/508328; Murray SD, 2004, ASTROPHYS J, V615, P586, DOI 10.1086/424658; Ozernoy LM, 1997, MON NOT R ASTRON SOC, V288, P237, DOI 10.1093/mnras/288.1.237; Reid MJ, 2007, ASTROPHYS J, V659, P378, DOI 10.1086/511744; Sanders RH, 1998, MON NOT R ASTRON SOC, V294, P35, DOI 10.1046/j.1365-8711.1998.01127.x; Scoville NZ, 2003, ASTROPHYS J, V594, P294, DOI 10.1086/376790; Sharma P, 2007, ASTROPHYS J, V667, P714, DOI 10.1086/520800; Xu YD, 2006, ASTROPHYS J, V640, P319, DOI 10.1086/499932; Yuan F, 2003, ASTROPHYS J, V598, P301, DOI 10.1086/378716; Zhao JH, 2009, ASTROPHYS J, V699, P186, DOI 10.1088/0004-637X/699/1/186	28	243	243	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2012	481	7379					51	54		10.1038/nature10652	http://dx.doi.org/10.1038/nature10652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22170607	Green Submitted			2022-12-28	WOS:000298836900026
J	Humphries, C				Humphries, Courtney			GENETICS Profiling a shape-shifter	NATURE			English	Editorial Material																		Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S50	S51		10.1038/480S50a	http://dx.doi.org/10.1038/480S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22169804	Bronze			2022-12-28	WOS:000298033000009
J	Rindi, G; Caplin, M				Rindi, Guido; Caplin, Martyn			mTOR inhibitor therapy for patients with carcinoid	LANCET			English	Editorial Material							NEUROENDOCRINE TUMORS		[Rindi, Guido] Univ Cattolica Policlin A Gemelli, Inst Pathol, I-00168 Rome, Italy; [Caplin, Martyn] Royal Free Hosp, Ctr Gastroenterol, Neuroendocrine Tumour Unit, London NW3 2QG, England	Catholic University of the Sacred Heart; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Rindi, G (corresponding author), Univ Cattolica Policlin A Gemelli, Inst Pathol, I-00168 Rome, Italy.	guido.rindi@rm.unicatt.it		RINDI, Guido/0000-0003-2996-4404				Bosman F., 2010, WHO CLASSIFICATION T, V4th; Caplin ME, 1998, LANCET, V352, P799, DOI 10.1016/S0140-6736(98)02286-7; Edge SB, 2010, AJCC CANC STAGING MA; Oberndorfer S., 1907, FRANKFURT Z PATHOL, V1, P426; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Ramage JK, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2011-300831; Rindi G, 2010, WHO CLASSIFICATION T, P10, DOI DOI 10.1200/JCO.2009.22.8510; Rindi G, 2012, NAT REV ENDOCRINOL, V8, P54, DOI 10.1038/nrendo.2011.120; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	11	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					1978	1980		10.1016/S0140-6736(11)61789-3	http://dx.doi.org/10.1016/S0140-6736(11)61789-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22119494				2022-12-28	WOS:000298144200007
J	Li, QY; Tullis, TE; Goldsby, D; Carpick, RW				Li, Qunyang; Tullis, Terry E.; Goldsby, David; Carpick, Robert W.			Frictional ageing from interfacial bonding and the origins of rate and state friction	NATURE			English	Article							ATOMIC-FORCE MICROSCOPE; DEPENDENT FRICTION; ROCK FRICTION; SLIP; STICK; INDENTATION; CALIBRATION; STABILITY; HUMIDITY	Earthquakes have long been recognized as being the result of stick-slip frictional instabilities(1,2). Over the past few decades, laboratory studies of rock friction have elucidated many aspects of tectonic fault zone processes and earthquake phenomena(3-5). Typically, the static friction of rocks grows logarithmically with time when they are held in stationary contact(6), but the mechanism responsible for this strengthening is not understood. This time-dependent increase of frictional strength, or frictional ageing, is one manifestation of the 'evolution effect' in rate and state friction theory(5). A prevailing view is that the time dependence of rock friction results from increases in contact area caused by creep of contacting asperities(7,8). Here we present the results of atomic force microscopy experiments that instead show that frictional ageing arises from the formation of interfacial chemical bonds, and the large magnitude of ageing at the nanometre scale is quantitatively consistent with what is required to explain observations in macroscopic rock friction experiments. The relative magnitude of the evolution effect compared with that of the 'direct effect'-the dependence of friction on instantaneous changes in slip velocity-determine whether unstable slip, leading to earthquakes, is possible(9,10). Understanding the mechanism underlying the evolution effect would enable us to formulate physically based frictional constitutive laws, rather than the current empirically based 'laws'(11,12), allowing more confident extrapolation to natural faults.	[Li, Qunyang; Carpick, Robert W.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Tullis, Terry E.; Goldsby, David] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Pennsylvania; Brown University	Carpick, RW (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	carpick@seas.upenn.edu	Li, Qunyang/A-2368-2011	Li, Qunyang/0000-0002-6865-3863; Goldsby, David/0000-0002-9004-0086	National Science Foundation [EAR0810088, EAR0810192]	National Science Foundation(National Science Foundation (NSF))	We thank M.O. Robbins, I. Szlufarska and Y. Liu for discussions. We acknowledge support from the National Science Foundation under awards EAR0810088 and EAR0810192.	Ben-David O, 2010, NATURE, V463, P76, DOI 10.1038/nature08676; Bowden F. P., 1958, FRICTION LUBRICATION; BRACE WF, 1966, SCIENCE, V153, P990, DOI 10.1126/science.153.3739.990; DIETERICH JH, 1984, J GEOPHYS RES, V89, P4196, DOI 10.1029/JB089iB06p04196; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; DIETERICH JH, 1994, PURE APPL GEOPHYS, V143, P283, DOI 10.1007/BF00874332; DIETERICH JH, 1972, J GEOPHYS RES, V77, P3690, DOI 10.1029/JB077i020p03690; Frye KM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000654; GRIGGS D, 1967, GEOPHYS J ROY ASTR S, V14, P19; HIRTH JP, 1980, METALL TRANS A, V11, P1501, DOI 10.1007/BF02654514; ILER RK, 1979, CHEM SILICA, pCH1; Kendall K., 2001, MOL ADHESION ITS APP; Li Q, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2209953; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; MICHALSKE TA, 1985, J AM CERAM SOC, V68, P586, DOI 10.1111/j.1151-2916.1985.tb16160.x; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Plossl A, 1999, MAT SCI ENG R, V25, P1, DOI 10.1016/S0927-796X(98)00017-5; Ranjith K, 1999, J MECH PHYS SOLIDS, V47, P1207, DOI 10.1016/S0022-5096(98)00113-6; Rice JR, 2001, J MECH PHYS SOLIDS, V49, P1865, DOI 10.1016/S0022-5096(01)00042-4; Roche A., 2001, ULTRACLEAN PROCESSIN, p[76, 111]; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; SCHOLZ CH, 1976, INT J ROCK MECH MIN, V13, P149, DOI 10.1016/0148-9062(76)90819-6; STAVRINIDIS B, 1983, PHYS CHEM GLASSES, V24, P19; THOMS BD, 1994, APPL PHYS LETT, V65, P2957, DOI 10.1063/1.112503; TULLIS TE, 1988, PURE APPL GEOPHYS, V126, P555, DOI 10.1007/BF00879010; Weeks J. D., 1991, EOS T AGU, V72, P457	29	177	180	8	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					233	U112		10.1038/nature10589	http://dx.doi.org/10.1038/nature10589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22139421				2022-12-28	WOS:000297744200049
J	Whalen, HR; Kidd, GA; O'Dwyer, PJ				Whalen, Henry Robert; Kidd, Gillian A.; O'Dwyer, Patrick J.			EASILY MISSED? Femoral hernias	BRITISH MEDICAL JOURNAL			English	Editorial Material							GROIN HERNIA; STRANGULATION; ULTRASOUND; DIAGNOSIS; SURGERY; REPAIR		[Whalen, Henry Robert; O'Dwyer, Patrick J.] Univ Glasgow, Western Infirm, Univ Dept Surg, Glasgow G11 6NT, Lanark, Scotland; [Kidd, Gillian A.] Midlock Med Ctr, Glasgow, Lanark, Scotland	University of Glasgow	Whalen, HR (corresponding author), Univ Glasgow, Western Infirm, Univ Dept Surg, Glasgow G11 6NT, Lanark, Scotland.	Henry.Whalen@gjnh.scot.nhs.uk						Alvarez J A, 2004, Hernia, V8, P121, DOI 10.1007/s10029-003-0186-1; ANDREWS NJ, 1981, BRIT J SURG, V68, P329, DOI 10.1002/bjs.1800680513; Bradley M, 2003, ANN ROY COLL SURG, V85, P178, DOI 10.1308/003588403321661334; Dahlstrand U, 2009, ANN SURG, V249, P672, DOI 10.1097/SLA.0b013e31819ed943; Djuric-Stefanovic A, 2008, HERNIA, V12, P395, DOI 10.1007/s10029-008-0352-6; GALLEGOS NC, 1991, BRIT J SURG, V78, P1171, DOI 10.1002/bjs.1800781007; GLASSOW F, 1985, AM J SURG, V150, P353, DOI 10.1016/0002-9610(85)90077-7; Hair A, 2001, J ROY COLL SURG EDIN, V46, P117; HJALTASON E, 1981, ACTA CHIR SCAND, V147, P263; Kemler MA, 1997, EUR J SURG, V163, P187; Kitami M, 2009, J COMPUT ASSIST TOMO, V33, P678, DOI 10.1097/RCT.0b013e3181977a0a; Kjaergaard J, 2010, HERNIA, V14, P351, DOI 10.1007/s10029-010-0657-0; Malek S, 2004, INT J CLIN PRACT, V58, P207, DOI 10.1111/j.1368-5031.2004.0097.x; MCENTEE GP, 1989, BRIT J SURG, V76, P725, DOI 10.1002/bjs.1800760724; Nilsson H, 2011, HERNIA, V15, P301, DOI 10.1007/s10029-011-0782-4; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; Tanaka N, 2010, SURG TODAY, V40, P1144, DOI 10.1007/s00595-009-4193-4; van den Berg JC, 1999, INVEST RADIOL, V34, P739, DOI 10.1097/00004424-199912000-00002	18	18	19	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2011	343								d7668	10.1136/bmj.d7668	http://dx.doi.org/10.1136/bmj.d7668			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EX	22162501	Green Accepted			2022-12-28	WOS:000298939300004
J	Leung, ES; Hamilton-Bruce, MA; Stocks, N; Koblar, SA				Leung, Elaine Stephanie; Hamilton-Bruce, Monica Anne; Stocks, Nigel; Koblar, Simon A.			10-MINUTE CONSULTATION Funny turn	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leung, Elaine Stephanie; Hamilton-Bruce, Monica Anne; Koblar, Simon A.] Univ Adelaide, Stroke Res Programme, Adelaide, SA 5005, Australia; [Hamilton-Bruce, Monica Anne; Koblar, Simon A.] Queen Elizabeth Hosp, Dept Neurol, Adelaide, SA, Australia	University of Adelaide	Leung, ES (corresponding author), Univ Adelaide, Stroke Res Programme, Adelaide, SA 5005, Australia.	elaine.leung@adelaide.edu.au	Stocks, Nigel P/I-1083-2012	Koblar, Simon/0000-0002-8667-203X; Stocks, Nigel/0000-0002-9018-0361					0	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 5	2011	343								d7465	10.1136/bmj.d7465	http://dx.doi.org/10.1136/bmj.d7465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RZ	22144408				2022-12-28	WOS:000298038200005
J	Kaberuka, D				Kaberuka, Donald			Africa's health and the Commission on Macroeconomics and Health	LANCET			English	Editorial Material									African Dev Bank Grp, Tunis 1002, Belvedere, Tunisia	African Development Bank Group (AfDB)	Kaberuka, D (corresponding author), African Dev Bank Grp, BP 323, Tunis 1002, Belvedere, Tunisia.	d.kaberuka@afdb.org						[Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2009, WORLD MAL REP 2009; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Organisation for Economic Co-operation and Development African Development Bank Group United Nations Economic Commission for Africa United Nations Development Programme, 2011, AFR EC OUTL 2011; Pierre-Louis A-M, 2011, MALARIA CONTROL SUCC, P417; Sekabaraga C, 2011, INNOVATIVE FINANCING, P403; Sekabaraga C, 2011, HEALTH POLICY PLANN, V26, pII52, DOI 10.1093/heapol/czr070; *UNAIDS, 2007, AIDS EP UPD; UNAIDS, 2011, AFR LEAD DEF SHAR RE; UNICEF, CHILD MON SIT CHILDR; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Bank UNICEF UNFPA Partnership for Maternal newborn and child health, 2009, HLTH SYST MILL DEV G	14	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2011	378	9807					1904	1905		10.1016/S0140-6736(11)61820-5	http://dx.doi.org/10.1016/S0140-6736(11)61820-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863AW	22137833				2022-12-28	WOS:000298136200015
J	Wilson, A; Gallos, ID; Plana, N; Lissauer, D; Khan, KS; Zamora, J; MacArthur, C; Coomarasamy, A				Wilson, Amie; Gallos, Ioannis D.; Plana, Nieves; Lissauer, David; Khan, Khalid S.; Zamora, Javier; MacArthur, Christine; Coomarasamy, Arri			Effectiveness of strategies incorporating training and support of traditional birth attendants on perinatal and maternal mortality: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEONATAL-MORTALITY; CARE; IMPACT; BANGLADESH; SERVICE; TRIAL	Objective To assess the effectiveness of strategies incorporating training and support of traditional birth attendants on the outcomes of perinatal, neonatal, and maternal death in developing countries. Design Systematic review with meta-analysis. Data sources Medline, Embase, the Allied and Complementary Medicine database, British Nursing Index, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, BioMed Central, PsycINFO, Latin American and Caribbean Health Sciences Literature database, African Index Medicus, Web of Science, Reproductive Health Library, and Science Citation Index (from inception to April 2011), without language restrictions. Search terms were "birth attend*", "traditional midwife", "lay birth attendant", "dais", and "comadronas". Review methods We selected randomised and non-randomised controlled studies with outcomes of perinatal, neonatal, and maternal mortality. Two independent reviewers undertook data extraction. We pooled relative risks separately for the randomised and non-randomised controlled studies, using a random effects model. Results We identified six cluster randomised controlled trials (n=138 549) and seven non-randomised controlled studies (n=72 225) that investigated strategies incorporating training and support of traditional birth attendants. All six randomised controlled trials found a reduction in adverse perinatal outcomes; our meta-analysis showed significant reductions in perinatal death (relative risk 0.76, 95% confidence interval 0.64 to 0.88, P<0.001; number needed to treat 35, 24 to 70) and neonatal death (0.79, 0.69 to 0.88, P<0.001; 98, 66 to 170). Meta-analysis of the non-randomised studies also showed a significant reduction in perinatal mortality (0.70, 0.57 to 0.84, p<0.001; 48, 32 to 96) and neonatal mortality (0.61, 0.48 to 0.75, P<0.001; 96, 65 to 168). Six studies reported on maternal mortality and our meta-analysis showed a non-significant reduction (three randomised trials, relative risk 0.79, 0.53 to 1.05, P=0.12; three non-randomised studies, 0.80, 0.44 to 1.15, P=0.26). Conclusion Perinatal and neonatal deaths are significantly reduced with strategies incorporating training and support of traditional birth attendants.	[Wilson, Amie; Gallos, Ioannis D.; Lissauer, David; Coomarasamy, Arri] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Plana, Nieves; Zamora, Javier] Hosp Univ Ramon & Cajal, Clin Biostat Unit, CIBERESP, Madrid, Spain; [Plana, Nieves; Zamora, Javier] Inst Invest Sanitaria IRYCIS, Madrid, Spain; [Khan, Khalid S.] Barts & London Queen Marys Sch Med & Dent, Inst Hlth Sci Educ, London, England; [MacArthur, Christine] Univ Birmingham, Sch Hlth & Populat Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; University of London; Queen Mary University London; University of Birmingham	Coomarasamy, A (corresponding author), Univ Birmingham, Acad Unit, Birmingham Womens Fdn Trust, Birmingham B15 2TG, W Midlands, England.	a.coomarasamy@bham.ac.uk	MASANA, LUIS/M-7002-2019; Khan, Khalid S/AAT-8824-2020; MacArthur, Christine/ABA-8601-2021; Wilson, Amie/HHS-0117-2022; Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022	MASANA, LUIS/0000-0002-0789-4954; Khan, Khalid S/0000-0001-5084-7312; MacArthur, Christine/0000-0003-0434-2158; Wilson, Amie/0000-0002-1015-3786; Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X; Plana, Nuria/0000-0002-4231-7618; Lissauer, David/0000-0002-7878-2327; Gallos, Ioannis/0000-0002-2766-358X; Plana, Maria Nieves/0000-0003-0921-7954	Ammalife [1120236]; research and development department at the Birmingham Women's NHS Foundation Trust; National Institute for Health Research	Ammalife; research and development department at the Birmingham Women's NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Ammalife (www.ammalife.org, UK registered charity no 1120236) and by the research and development department at the Birmingham Women's NHS Foundation Trust.; All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this study was funded by Ammalife and the research and development department at the Birmingham Women's NHS Foundation Trust; CM was partly funded by the National Institute for Health Research through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; no relationships with any institution that might have an interest in the submitted work in the previous 3 years; and no non-financial interests that may be relevant to the submitted work.	ALISJAHBANA A, 1995, INT J GYNECOL OBSTET, V48, pS83, DOI 10.1016/0020-7292(95)02323-5; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Brennan M, 1988, Trop J Obstet Gynaecol, V1, P44; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Fleming J R, 1994, Midwifery, V10, P142, DOI 10.1016/0266-6138(94)90044-2; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Gloyd S, 2001, J MIDWIFERY WOM HEAL, V46, P210, DOI 10.1016/S1526-9523(01)00142-8; GREENWOOD AM, 1990, J TROP MED HYG, V93, P58; Hussein Asia K, 2005, Afr J Reprod Health, V9, P113; Janowitz B., 1988, Health Policy and Planning, V3, P48, DOI 10.1093/heapol/3.1.48; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kafatos A G, 1991, Hygie, V10, P32; Lassi Z, 2010, COCHRANE DB SYST REV, V11; Mba C.J., 2007, POPULATION HLTH DEV; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Ronsmans C, 1997, LANCET, V350, P1810, DOI 10.1016/S0140-6736(97)08012-4; Sibley LM, 2009, COCHRANE DB SYST REV, V3; Wells G., 2000, NEWCASTLEOTTAWA SCAL; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2007, MILL DEV GOALS REP 2; World Health Organization, 1996, COV MAT CAR LIST AV	28	52	52	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2011	343								d7102	10.1136/bmj.d7102	http://dx.doi.org/10.1136/bmj.d7102			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EO	22134967	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000298938400003
J	Davies, P				Davies, Peter			Hinchingbrooke: the shape of things to come?	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2011	343								d7692	10.1136/bmj.d7692	http://dx.doi.org/10.1136/bmj.d7692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RP	22127771				2022-12-28	WOS:000298037200009
J	Crampton, J				Crampton, James			What Drives Biodiversity Changes?	SCIENCE			English	Editorial Material							MARINE; ORIGINATION; EXTINCTION; FALL; RISE		GNS Sci, Lower Hutt, New Zealand	GNS Science - New Zealand	Crampton, J (corresponding author), GNS Sci, POB 30-368, Lower Hutt, New Zealand.	j.crampton@gns.cri.nz	Crampton, James/G-1381-2012	Crampton, James/0000-0003-3270-9981				Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Cardenas AL, 2010, NAT GEOSCI, V3, P430, DOI 10.1038/NGEO869; Crampton JS, 2006, PALEOBIOLOGY, V32, P509, DOI 10.1666/06014.1; Crampton JS, 2011, GEOL SOC SPEC PUBL, V358, P105, DOI 10.1144/SP358.8; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2007, SCIENCE, V318, P1131, DOI 10.1126/science.1146303; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hannisdal B, 2011, AM J SCI, V311, P315, DOI 10.2475/04.2011.02; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461	13	1	1	8	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1073	1074		10.1126/science.1214829	http://dx.doi.org/10.1126/science.1214829			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852AF	22116873				2022-12-28	WOS:000297313900034
J	Nogues-Bravo, D; Rahbek, C				Nogues-Bravo, David; Rahbek, Carsten			Communities Under Climate Change	SCIENCE			English	Editorial Material							MACROECOLOGY; DIVERSITY; PATTERNS; SHIFTS; WEB		[Nogues-Bravo, David; Rahbek, Carsten] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	University of Copenhagen	Nogues-Bravo, D (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	dnogues@bio.ku.dk	Rahbek, Carsten/L-1129-2013; Rahbek, Carsten/D-9372-2013	Rahbek, Carsten/0000-0003-4585-0300; Nogues-Bravo, David/0000-0002-4060-0153				Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Brown JH, 1999, OIKOS, V87, P3, DOI 10.2307/3546991; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752	14	41	41	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1070	1071		10.1126/science.1214833	http://dx.doi.org/10.1126/science.1214833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852AF	22116871				2022-12-28	WOS:000297313900032
J	Novak, MJU; Tabrizi, SJ				Novak, Marianne J. U.; Tabrizi, Sarah J.			A man with deteriorating ability to live independently	BRITISH MEDICAL JOURNAL			English	Editorial Material							HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT		[Novak, Marianne J. U.; Tabrizi, Sarah J.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Novak, Marianne J. U.] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Tabrizi, Sarah J.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Tabrizi, SJ (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	sarah.tabrizi@prion.ucl.ac.uk		Tabrizi, Sarah/0000-0003-2716-2045	MRC [G0700877] Funding Source: UKRI; Medical Research Council [G0700877] Funding Source: Medline; Wellcome Trust [075696/Z/04/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bohanna I, 2008, BRAIN RES REV, V58, P209, DOI 10.1016/j.brainresrev.2008.04.001; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wild E J, 2007, Pract Neurol, V7, P360, DOI 10.1136/pn.2007.134585	8	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2011	343								d7463	10.1136/bmj.d7463	http://dx.doi.org/10.1136/bmj.d7463			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875FI	22115904				2022-12-28	WOS:000299015400008
J	Stensmyr, MC; Hansson, BS				Stensmyr, Marcus C.; Hansson, Bill S.			A Genome Befitting a Monarch	CELL			English	Editorial Material							SUN COMPASS; BUTTERFLIES	The monarch butterfly is famous for its annual fall migration from eastern North America to central Mexico, but it has also been an important model for studies in long-distance migration. Now, Zhang et al. present the genome of the monarch, opening up the detailed characterization of the butterfly's navigational system and unique social life.	[Stensmyr, Marcus C.; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07749 Jena, Germany	Max Planck Society	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoell Str 8, D-07749 Jena, Germany.	mstensmyr@ice.mpg.de; hansson@ice.mpg.de	Hansson, Bill/G-2774-2013	Hansson, Bill/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212				Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Grimaldi David, 2005, pi; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; Holland RA, 2009, J EXP BIOL, V212, P4065, DOI 10.1242/jeb.034504; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	10	2	2	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					970	972		10.1016/j.cell.2011.11.009	http://dx.doi.org/10.1016/j.cell.2011.11.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118454	Bronze			2022-12-28	WOS:000297376600009
J	Jabbour, A; Zaman, S; Ismail, T; Prasad, S; Mohiaddin, R				Jabbour, Andrew; Zaman, Saman; Ismail, Tevfik; Prasad, Sanjay; Mohiaddin, Raad			Profound pectus excavatum in Marfan's syndrome	LANCET			English	Editorial Material									[Jabbour, Andrew; Zaman, Saman; Ismail, Tevfik; Prasad, Sanjay; Mohiaddin, Raad] Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England; [Jabbour, Andrew; Zaman, Saman; Ismail, Tevfik; Prasad, Sanjay; Mohiaddin, Raad] Imperial Coll, Natl Heart & Lung Inst, NIHR Cardiovasc Biomed Res Unit, London, England	Royal Brompton Hospital; Imperial College London	Mohiaddin, R (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Royal Brompton Hosp Sydney St, London SW3 6NP, England.	r.mohiaddin@rbht.nhs.uk	Ismail, Tevfik F/AAG-3303-2020	Ismail, Tevfik F/0000-0002-1691-7599					0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 11	2012	379	9815					557	557		10.1016/S0140-6736(11)60973-2	http://dx.doi.org/10.1016/S0140-6736(11)60973-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AO	22137033				2022-12-28	WOS:000300188800032
J	Kyrle, PA; Eichinger, S				Kyrle, Paul Alexander; Eichinger, Sabine			Vitamin K antagonists: self-determination by self-monitoring?	LANCET			English	Editorial Material							ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; DABIGATRAN; ANTICOAGULATION		[Kyrle, Paul Alexander; Eichinger, Sabine] Med Univ Vienna, Dept Med 1, A-1090 Vienna, Austria	Medical University of Vienna	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Med 1, A-1090 Vienna, Austria.	paul.kyrle@meduniwien.ac.at						Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heneghan C, 2012, LANCET, V379, P322, DOI 10.1016/S0140-6736(11)61294-4; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Singer DE, 2009, CIRC-CARDIOVASC QUAL, V2, P297, DOI 10.1161/CIRCOUTCOMES.108.830232; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					292	293		10.1016/S0140-6736(11)61748-0	http://dx.doi.org/10.1016/S0140-6736(11)61748-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	889BA	22137797				2022-12-28	WOS:000300047300012
J	Hsu, CL; Lin, WY; Seshasayee, D; Chen, YH; Ding, X; Lin, ZH; Suto, E; Huang, ZY; Lee, WP; Park, H; Xu, M; Sun, M; Rangell, L; Lutman, JL; Ulufatu, S; Stefanich, E; Chalouni, C; Sagolla, M; Diehl, L; Fielder, P; Dean, B; Balazs, M; Martin, F				Hsu, Chia-Lin; Lin, Weiyu; Seshasayee, Dhaya; Chen, Yung-Hsiang; Ding, Xiao; Lin, Zhonghua; Suto, Eric; Huang, Zhiyu; Lee, Wyne P.; Park, Hyunjoo; Xu, Min; Sun, Mei; Rangell, Linda; Lutman, Jeff L.; Ulufatu, Sheila; Stefanich, Eric; Chalouni, Cecile; Sagolla, Meredith; Diehl, Lauri; Fielder, Paul; Dean, Brian; Balazs, Mercedesz; Martin, Flavius			Equilibrative Nucleoside Transporter 3 Deficiency Perturbs Lysosome Function and Macrophage Homeostasis	SCIENCE			English	Article							STORAGE DISORDERS; PROTEINS; MUTATIONS; FAMILY; HENT3	Lysosomal storage diseases (LSDs) are a group of heterogeneous disorders caused by defects in lysosomal enzymes or transporters, resulting in accumulation of undegraded macromolecules or metabolites. Macrophage numbers are expanded in several LSDs, leading to histiocytosis of unknown pathophysiology. Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed a spontaneous and progressive macrophage-dominated histiocytosis. In the absence of ENT3, defective apoptotic cell clearance led to lysosomal nucleoside buildup, elevated intralysosomal pH, and altered macrophage function. The macrophage accumulation was partly due to increased macrophage colony-stimulating factor and receptor expression and signaling secondary to the lysosomal defects. These studies suggest a cellular and molecular basis for the development of histiocytosis in several human syndromes associated with ENT3 mutations and potentially other LSDs.	[Hsu, Chia-Lin; Lin, Weiyu; Seshasayee, Dhaya; Martin, Flavius] Genentech Inc, Immunol, San Francisco, CA 94080 USA; [Chen, Yung-Hsiang; Ding, Xiao; Dean, Brian] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Lin, Zhonghua; Suto, Eric; Huang, Zhiyu; Lee, Wyne P.; Park, Hyunjoo; Xu, Min; Balazs, Mercedesz] Genentech Inc, Translat Immunol, San Francisco, CA 94080 USA; [Sun, Mei; Rangell, Linda; Chalouni, Cecile; Sagolla, Meredith; Diehl, Lauri] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Lutman, Jeff L.; Ulufatu, Sheila; Stefanich, Eric; Fielder, Paul] Genentech Inc, Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Martin, F (corresponding author), Genentech Inc, Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	martin.flavius@gene.com	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Hsu, Chia-Lin/0000-0001-9383-6330				Avitan-Hersh E, 2011, AM J DERMATOPATH, V33, P47, DOI 10.1097/DAD.0b013e3181ee547c; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Mancini GMS, 2000, J INHERIT METAB DIS, V23, P278, DOI 10.1023/A:1005640214408; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Spiegel R, 2010, EUR J MED GENET, V53, P309, DOI 10.1016/j.ejmg.2010.06.012; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	21	80	81	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					89	92		10.1126/science.1213682	http://dx.doi.org/10.1126/science.1213682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22174130				2022-12-28	WOS:000298846200057
J	Detsky, AS				Detsky, Allan S.			What Patients Really Want From Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Ackery AD, 2011, CAN MED ASSOC J, V183, P1235, DOI 10.1503/cmaj.110634; Bailey R, 2011, WILL COMP EFFECTIVEN; Detsky ME, 2008, JAMA-J AM MED ASSOC, V300, P954, DOI 10.1001/jama.300.8.954; Dhalla I, 2007, CAN MED ASSOC J, V177, P51, DOI 10.1503/cmaj.061064; Maa J, 2011, NEW ENGL J MED, V364, P2279, DOI 10.1056/NEJMp1101882; Srivastava R, 2010, NEW ENGL J MED, V363, P1786, DOI 10.1056/NEJMp1003221; Wells DA, 2007, JAMA-J AM MED ASSOC, V298, P2785, DOI 10.1001/jama.298.23.2785	7	45	46	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2500	2501		10.1001/jama.2011.1819	http://dx.doi.org/10.1001/jama.2011.1819			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166610				2022-12-28	WOS:000297983300024
J	Smallwood, JA				Smallwood, James A.			PERSONAL VIEW We must reconfigure healthcare providers	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp, Dept Surg, Southampton SO16 6UY, Hants, England		Smallwood, JA (corresponding author), Univ Hosp, Dept Surg, Southampton SO16 6UY, Hants, England.	jamesasmallwood@gmail.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d6997	10.1136/bmj.d6997	http://dx.doi.org/10.1136/bmj.d6997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171343				2022-12-28	WOS:000298317800004
J	Feasey, N; Molyneux, E				Feasey, Nick; Molyneux, Elizabeth			Keep it clean: hospital-acquired infections in children	LANCET			English	Editorial Material							RESISTANCE; IMPACT		[Feasey, Nick; Molyneux, Elizabeth] Queen Elizabeth Cent Hosp, Coll Med, Blantyre, Malawi; [Feasey, Nick] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Feasey, Nick] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Malawi; University of Liverpool	Molyneux, E (corresponding author), Queen Elizabeth Cent Hosp, Coll Med, Box 360, Blantyre, Malawi.	emmolyneux@gmail.com		Feasey, Nicholas/0000-0003-4041-1405				Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bush-Knapp ME, 2007, AM J INFECT CONTROL, V35, P656, DOI 10.1016/j.ajic.2007.03.006; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heyns L, 2004, INDIAN J PEDIATR, V71, P617; ISAACK H, 1992, E AFR MED J, V69, P433; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; National Audit Office, 2009, RED HEALTHC ASS INF; Pittet D, 2003, LANCET INFECT DIS, V3, P269, DOI 10.1016/S1473-3099(03)00601-7; TIKHOMIROV E, 1987, CHEMIOTERAPIA, V6, P148; World Health Organization, BURD HLTH CAR ASS IN; WYKLICKY H, 1983, Infection Control (Thorofare), V4, P367; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	15	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					1982	1983		10.1016/S0140-6736(11)61783-2	http://dx.doi.org/10.1016/S0140-6736(11)61783-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863DY	22133537				2022-12-28	WOS:000298144200009
J	Berendsen, AD; Olsen, BR				Berendsen, Agnes D.; Olsen, Bjorn R.			Tankyrase Loses Its Grip on SH3BP2 in Cherubism	CELL			English	Editorial Material							TELOMERES; PROTEIN		[Berendsen, Agnes D.; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Olsen, BR (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	bjorn_olsen@hms.harvard.edu						CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047	9	7	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1222	1223		10.1016/j.cell.2011.11.035	http://dx.doi.org/10.1016/j.cell.2011.11.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153068	Bronze			2022-12-28	WOS:000298148100011
J	Gonzalez, E; Arbiol, J; Puntes, VF				Gonzalez, Edgar; Arbiol, Jordi; Puntes, Victor F.			Carving at the Nanoscale: Sequential Galvanic Exchange and Kirkendall Growth at Room Temperature	SCIENCE			English	Article							REPLACEMENT REACTION; GOLD NANOCAGES; HOLLOW; NANOPARTICLES; PARTICLES; NANOSTRUCTURES; NANOCRYSTALS; SPHERES	Shape control of inorganic nanocrystals is important for understanding basic size- and shape-dependent scaling laws and is useful in a wide range of applications. With minor modifications in the chemical environment, it is possible to control the reaction and diffusion processes at room temperature, opening up a synthetic route for the production of polymetallic hollow nanoparticles with very different morphology and composition, obtained by the simultaneous or sequential action of galvanic replacement and the Kirkendall effect.	[Gonzalez, Edgar; Puntes, Victor F.] ICN, Bellaterra 08193, Spain; [Gonzalez, Edgar; Puntes, Victor F.] UAB, Bellaterra 08193, Spain; [Arbiol, Jordi] ICMAB CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Spain; [Arbiol, Jordi; Puntes, Victor F.] ICREA, Barcelona 08010, Spain; [Puntes, Victor F.] ICN CSIC, CIN2, Bellaterra 08193, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ICN - Centro de Investigacion en Nanociencia y Nanotecnologia (CIN2)	Puntes, VF (corresponding author), ICN, Campus UAB, Bellaterra 08193, Spain.	victor.puntes@icn.cat	Arbiol, Jordi/B-6048-2008; Puntes, Victor/AAL-6081-2021; Puntes, Víctor F./F-8407-2013	Arbiol, Jordi/0000-0002-0695-1726; Puntes, Victor/0000-0001-8996-9499; Puntes, Víctor F./0000-0001-8996-9499; Gonzalez, Edgar E/0000-0003-3103-3959	NanoAraCat;  [2009 SGR 770];  [CSD2006-00012];  [CSD2009_00013];  [MAT2009-14734-C02-01];  [MAT2010-15138]; ICREA Funding Source: Custom	NanoAraCat; ; ; ; ; ; ICREA(ICREA)	The authors acknowledge funding from grants 2009 SGR 770, NanoAraCat, XaRMAE, CSD2006-00012, CSD2009_00013, MAT2009-14734-C02-01, MAT2010-15138, 2009 SGR 776, and VALTEC09-2-0085. J.A. acknowledges NanoAraCat funding for the use of advanced (S)TEM facilities at Instituto de Nanociencia de Aragon-Laboratorio de Microscopia Avanzada and A. Ibarra for help on STEM alignment. A patent application related to this work was filed 14 March 2011 (European Union application number EP11158024.7).	Bi YP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/27/275306; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Chen JY, 2007, NANO LETT, V7, P1318, DOI 10.1021/nl070345g; Das D, 1999, SCRIPTA MATER, V41, P861, DOI 10.1016/S1359-6462(99)00220-1; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Guisbiers G, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/43/435701; Im SH, 2005, NAT MATER, V4, P671, DOI 10.1038/nmat1448; Kim SW, 2002, J AM CHEM SOC, V124, P7642, DOI 10.1021/ja026032z; Lou XW, 2008, ADV MATER, V20, P1853, DOI 10.1002/adma.200702379; Marinakos SM, 1999, J AM CHEM SOC, V121, P8518, DOI 10.1021/ja990945k; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Perez-Juste J, 2004, ADV FUNCT MATER, V14, P571, DOI 10.1002/adfm.200305068; Shibata T, 2002, J AM CHEM SOC, V124, P11989, DOI 10.1021/ja026764r; Skrabalak SE, 2008, ACCOUNTS CHEM RES, V41, P1587, DOI 10.1021/ar800018v; Sun YG, 2004, J AM CHEM SOC, V126, P3892, DOI 10.1021/ja039734c; Sun YG, 2002, NANO LETT, V2, P481, DOI 10.1021/nl025531v; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Yavuz MS, 2009, NAT MATER, V8, P935, DOI [10.1038/NMAT2564, 10.1038/nmat2564]; Yen CW, 2009, J PHYS CHEM A, V113, P4340, DOI 10.1021/jp811014u; Yin YD, 2006, ADV FUNCT MATER, V16, P1389, DOI 10.1002/adfm.200600256; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Zeng J, 2010, NANO LETT, V10, P30, DOI 10.1021/nl903062e; Zhao QR, 2006, EUR J INORG CHEM, P1643, DOI 10.1002/ejic.200500975	23	517	519	15	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1377	1380		10.1126/science.1212822	http://dx.doi.org/10.1126/science.1212822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158813				2022-12-28	WOS:000297787700045
J	Gieger, C; Radhakrishnan, A; Cvejic, A; Tang, WH; Porcu, E; Pistis, G; Serbanovic-Canic, J; Elling, U; Goodall, AH; Labrune, Y; Lopez, LM; Magi, R; Meacham, S; Okada, Y; Pirastu, N; Sorice, R; Teumer, A; Voss, K; Zhang, WH; Ramirez-Solis, R; Bis, JC; Ellinghaus, D; Gogele, M; Hottenga, JJ; Langenberg, C; Kovacs, P; O'Reilly, PF; Shin, SY; Esko, T; Hartiala, J; Kanoni, S; Murgia, F; Parsa, A; Stephens, J; van der Harst, P; van der Schoot, CE; Allayee, H; Attwood, A; Balkau, B; Bastardot, F; Basu, S; Baumeister, SE; Biino, G; Bomba, L; Bonnefond, A; Cambien, F; Chambers, JC; Cucca, F; D'Adamo, P; Davies, G; de Boer, RA; de Geus, EJC; Doring, A; Elliott, P; Erdmann, J; Evans, DM; Falchi, M; Feng, W; Folsom, AR; Frazer, IH; Gibson, QD; Glazer, NL; Hammond, C; Hartikainen, AL; Heckbert, SR; Hengstenberg, C; Hersch, M; Illig, T; Loos, RJF; Jolley, J; Khaw, KT; Kuhnel, B; Kyrtsonis, MC; Lagou, V; Lloyd-Jones, H; Lumley, T; Mangino, M; Maschio, A; Leach, IM; McKnight, B; Memari, Y; Mitchell, BD; Montgomery, GW; Nakamura, Y; Nauck, M; Navis, G; Nothlings, U; Nolte, IM; Porteous, DJ; Pouta, A; Pramstaller, PP; Pullat, J; Ring, SM; Rotter, JI; Ruggiero, D; Ruokonen, A; Sala, C; Samani, NJ; Sambrook, J; Schlessinger, D; Schreiber, S; Schunkert, H; Scott, J; Smith, NL; Snieder, H; Starr, JM; Stumvoll, M; Takahashi, A; Tang, WHW; Taylor, K; Tenesa, A; Thein, SL; Tonjes, A; Uda, M; Ulivi, S; van Veldhuisen, DJ; Visscher, PM; Volker, U; Wichmann, HE; Wiggins, KL; Willemsen, G; Yang, TP; Zhao, JH; Zitting, P; Bradley, JR; Dedoussis, GV; Gasparini, P; Hazen, SL; Metspalu, A; Pirastu, M; Shuldiner, AR; van Pelt, LJ; Zwaginga, JJ; Boomsma, DI; Deary, IJ; Franke, A; Froguel, P; Ganesh, SK; Jarvelin, MR; Martin, NG; Meisinger, C; Psaty, BM; Spector, TD; Wareham, NJ; Akkerman, JWN; Ciullo, M; Deloukas, P; Greinacher, A; Jupe, S; Kamatani, N; Khadake, J; Kooner, JS; Penninger, J; Prokopenko, I; Stemple, D; Toniolo, D; Wernisch, L; Sanna, S; Hicks, AA; Rendon, A; Ferreira, MA; Ouwehand, WH; Soranzo, N				Gieger, Christian; Radhakrishnan, Aparna; Cvejic, Ana; Tang, Weihong; Porcu, Eleonora; Pistis, Giorgio; Serbanovic-Canic, Jovana; Elling, Ulrich; Goodall, Alison H.; Labrune, Yann; Lopez, Lorna M.; Maegi, Reedik; Meacham, Stuart; Okada, Yukinori; Pirastu, Nicola; Sorice, Rossella; Teumer, Alexander; Voss, Katrin; Zhang, Weihua; Ramirez-Solis, Ramiro; Bis, Joshua C.; Ellinghaus, David; Goegele, Martin; Hottenga, Jouke-Jan; Langenberg, Claudia; Kovacs, Peter; O'Reilly, Paul F.; Shin, So-Youn; Esko, Toenu; Hartiala, Jaana; Kanoni, Stavroula; Murgia, Federico; Parsa, Afshin; Stephens, Jonathan; van der Harst, Pim; van der Schoot, C. Ellen; Allayee, Hooman; Attwood, Antony; Balkau, Beverley; Bastardot, Francois; Basu, Saonli; Baumeister, Sebastian E.; Biino, Ginevra; Bomba, Lorenzo; Bonnefond, Amelie; Cambien, Francois; Chambers, John C.; Cucca, Francesco; D'Adamo, Pio; Davies, Gail; de Boer, Rudolf A.; de Geus, Eco J. C.; Doering, Angela; Elliott, Paul; Erdmann, Jeanette; Evans, David M.; Falchi, Mario; Feng, Wei; Folsom, Aaron R.; Frazer, Ian H.; Gibson, Quince D.; Glazer, Nicole L.; Hammond, Chris; Hartikainen, Anna-Liisa; Heckbert, Susan R.; Hengstenberg, Christian; Hersch, Micha; Illig, Thomas; Loos, Ruth J. F.; Jolley, Jennifer; Khaw, Kay Tee; Kuehnel, Brigitte; Kyrtsonis, Marie-Christine; Lagou, Vasiliki; Lloyd-Jones, Heather; Lumley, Thomas; Mangino, Massimo; Maschio, Andrea; Leach, Irene Mateo; McKnight, Barbara; Memari, Yasin; Mitchell, Braxton D.; Montgomery, Grant W.; Nakamura, Yusuke; Nauck, Matthias; Navis, Gerjan; Noethlings, Ute; Nolte, Ilja M.; Porteous, David J.; Pouta, Anneli; Pramstaller, Peter P.; Pullat, Janne; Ring, Susan M.; Rotter, Jerome I.; Ruggiero, Daniela; Ruokonen, Aimo; Sala, Cinzia; Samani, Nilesh J.; Sambrook, Jennifer; Schlessinger, David; Schreiber, Stefan; Schunkert, Heribert; Scott, James; Smith, Nicholas L.; Snieder, Harold; Starr, John M.; Stumvoll, Michael; Takahashi, Atsushi; Tang, W. H. Wilson; Taylor, Kent; Tenesa, Albert; Thein, Swee Lay; Toenjes, Anke; Uda, Manuela; Ulivi, Sheila; van Veldhuisen, Dirk J.; Visscher, Peter M.; Voelker, Uwe; Wichmann, H-Erich; Wiggins, Kerri L.; Willemsen, Gonneke; Yang, Tsun-Po; Zhao, Jing Hua; Zitting, Paavo; Bradley, John R.; Dedoussis, George V.; Gasparini, Paolo; Hazen, Stanley L.; Metspalu, Andres; Pirastu, Mario; Shuldiner, Alan R.; van Pelt, L. Joost; Zwaginga, Jaap-Jan; Boomsma, Dorret I.; Deary, Ian J.; Franke, Andre; Froguel, Philippe; Ganesh, Santhi K.; Jarvelin, Marjo-Riitta; Martin, Nicholas G.; Meisinger, Christa; Psaty, Bruce M.; Spector, Timothy D.; Wareham, Nicholas J.; Akkerman, Jan-Willem N.; Ciullo, Marina; Deloukas, Panos; Greinacher, Andreas; Jupe, Steve; Kamatani, Naoyuki; Khadake, Jyoti; Kooner, Jaspal S.; Penninger, Josef; Prokopenko, Inga; Stemple, Derek; Toniolo, Daniela; Wernisch, Lorenz; Sanna, Serena; Hicks, Andrew A.; Rendon, Augusto; Ferreira, Manuel A.; Ouwehand, Willem H.; Soranzo, Nicole			New gene functions in megakaryopoiesis and platelet formation	NATURE			English	Article							GENOME-WIDE ASSOCIATION; LOCI; BLOOD	Platelets are the second most abundant cell type in blood and are essential for maintaining haemostasis. Their count and volume are tightly controlled within narrow physiological ranges, but there is only limited understanding of the molecular processes controlling both traits. Here we carried out a high-powered meta-analysis of genome-wide association studies (GWAS) in up to 66,867 individuals of European ancestry, followed by extensive biological and functional assessment. We identified 68 genomic loci reliably associated with platelet count and volume mapping to established and putative novel regulators of megakaryopoiesis and platelet formation. These genes show megakaryocyte-specific gene expression patterns and extensive network connectivity. Using gene silencing in Danio rerio and Drosophila melanogaster, we identified 11 of the genes as novel regulators of blood cell formation. Taken together, our findings advance understanding of novel gene functions controlling fate-determining events during megakaryopoiesis and platelet formation, providing a new example of successful translation of GWAS to function.	[Gieger, Christian; Kuehnel, Brigitte] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Radhakrishnan, Aparna; Cvejic, Ana; Serbanovic-Canic, Jovana; Meacham, Stuart; Voss, Katrin; Stephens, Jonathan; Attwood, Antony; Jolley, Jennifer; Lloyd-Jones, Heather; Sambrook, Jennifer; Rendon, Augusto; Ouwehand, Willem H.] Univ Cambridge & NHS Blood & Transplant, Dept Haematol, Cambridge CB2 0PT, England; [Radhakrishnan, Aparna; Cvejic, Ana; Serbanovic-Canic, Jovana; Meacham, Stuart; Ramirez-Solis, Ramiro; Shin, So-Youn; Kanoni, Stavroula; Attwood, Antony; Memari, Yasin; Yang, Tsun-Po; Deloukas, Panos; Stemple, Derek; Ouwehand, Willem H.; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Radhakrishnan, Aparna; Cvejic, Ana; Serbanovic-Canic, Jovana; Meacham, Stuart; Ramirez-Solis, Ramiro; Shin, So-Youn; Kanoni, Stavroula; Attwood, Antony; Memari, Yasin; Yang, Tsun-Po; Deloukas, Panos; Stemple, Derek; Ouwehand, Willem H.; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tang, Weihong; Folsom, Aaron R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Porcu, Eleonora; Cucca, Francesco; Uda, Manuela; Sanna, Serena] Cittadella Univ Monserrato, CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, I-20132 Milan, Italy; [Elling, Ulrich; Penninger, Josef] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Goodall, Alison H.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Labrune, Yann; Bonnefond, Amelie; Froguel, Philippe] Inst Biol Lille, CNRS, UMR 8199, F-59019 Lille, France; [Lopez, Lorna M.; Porteous, David J.; Starr, John M.; Visscher, Peter M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Maegi, Reedik] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Okada, Yukinori; Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN Ctr Genom Med, Inst Phys & Chem Res, Lab Stat Anal, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138654, Japan; [Pirastu, Nicola; D'Adamo, Pio; Ulivi, Sheila; Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Sorice, Rossella; Ruggiero, Daniela; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-8031 Naples, Italy; [Teumer, Alexander; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Zhang, Weihua; Chambers, John C.; Elliott, Paul] Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Bis, Joshua C.; Wiggins, Kerri L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Goegele, Martin; Pramstaller, Peter P.; Hicks, Andrew A.] European Acad Bozen Bolzano, Ctr Biomed, I-39100 Bolzano, Italy; [Hottenga, Jouke-Jan; de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Langenberg, Claudia; Loos, Ruth J. F.; Zhao, Jing Hua; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany; [O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Shin, So-Youn; Hammond, Chris; Mangino, Massimo; Memari, Yasin; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Maegi, Reedik; Esko, Toenu; Pullat, Janne; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50410 Tartu, Estonia; [Esko, Toenu; Metspalu, Andres] Estonian Bioctr, EE-51010 Tartu, Estonia; [Esko, Toenu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50410 Tartu, Estonia; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA; [Kanoni, Stavroula; Dedoussis, George V.] Harokopio Univ, Dept Nutr Dietet, Athens 17671, Greece; [Murgia, Federico; Biino, Ginevra; Pirastu, Mario] CNR, Inst Populat Genet, I-07100 Sassari, Italy; [Parsa, Afshin; Gibson, Quince D.; Maschio, Andrea; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [van der Harst, Pim; de Boer, Rudolf A.; Leach, Irene Mateo; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands; [van der Schoot, C. Ellen] Sanquin Res, Dept Expt Immunohaematol, NL-1066 CX Amsterdam, Netherlands; [van der Schoot, C. Ellen] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Balkau, Beverley] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Bastardot, Francois] CHU Vaudois, Serv Med Interne, CH-1011 Lausanne, Switzerland; [Basu, Saonli; Feng, Wei] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Baumeister, Sebastian E.] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Biino, Ginevra; Pirastu, Mario] Shardna Life Sci, Loc Piscinamanna, I-09010 Pula, CA, Italy; [Biino, Ginevra; Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Bomba, Lorenzo] Univ Cattolica Sacro Cuore Sede Piacenza, Ist Zootecnia, I-29122 Piacenza, Italy; [Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, F-75013 Paris, France; [Cambien, Francois] Sch Med, F-75013 Paris, France; [Doering, Angela; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Doering, Angela; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Erdmann, Jeanette; Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Evans, David M.; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Falchi, Mario; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England; [Frazer, Ian H.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Glazer, Nicole L.] Boston Univ, Dept Med, Boston, MA 02118 USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, SF-90220 Oulu, Finland; [Heckbert, Susan R.; Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Hengstenberg, Christian] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Hersch, Micha] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Hersch, Micha] Swiss Inst Bioinformat, Lausanne, Switzerland; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Khaw, Kay Tee] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Khaw, Kay Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge CB2 2QQ, England; [Kyrtsonis, Marie-Christine] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Propedeut Internal Med 1, Athens 11727, Greece; [Kyrtsonis, Marie-Christine] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Hematol, Athens 11727, Greece; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lumley, Thomas; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Montgomery, Grant W.; Visscher, Peter M.; Martin, Nicholas G.; Ferreira, Manuel A.] Queensland Inst Med Res, Bancroft Ctr, Herston, Qld 4006, Australia; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 GZ Groningen, Netherlands; [Noethlings, Ute] Univ Kiel, Inst Expt Med, Epidemiol Sect, D-24105 Kiel, Germany; [Noethlings, Ute] Univ Clin Schleswig Holstein, D-24105 Kiel, Germany; [Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, NL-9713 GZ Groningen, Netherlands; [Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Pouta, Anneli] Natl Inst Hlth & Welf, Oulu 90220, Finland; [Rotter, Jerome I.; Taylor, Kent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu 90014, Finland; [Sambrook, Jennifer; Bradley, John R.; Ouwehand, Willem H.] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, Fac Med, London W12 0HS, England; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA 98108 USA; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh EH4 2DN, Midlothian, Scotland; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol & Cardiovasc Med, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Tang, W. H. Wilson] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44195 USA; [Tenesa, Albert] MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Thein, Swee Lay] Kings Coll London, Dept Mol Haematol, London SE5 9NU, England; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H-Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi 96101, Finland; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21208 USA; [van Pelt, L. Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 GZ Groningen, Netherlands; [Zwaginga, Jaap-Jan] Sanquin Res Leiden, Jon J van Rood Ctr Clin Transfus Res, NL-2333 Leiden, Netherlands; [Zwaginga, Jaap-Jan] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 Leiden, Netherlands; [Ganesh, Santhi K.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, SF-90220 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Natl Inst Hlth & Welf, SF-90220 Oulu, Finland; [Psaty, Bruce M.] Univ Washington, Dept Med Epidemiol & Hlth Serv, Seattle, WA 98101 USA; [Akkerman, Jan-Willem N.] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Greinacher, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany; [Jupe, Steve; Khadake, Jyoti] EMBL European Bioinformat Inst, Prote Serv, Cambridge CB10 1SD, England; [Wernisch, Lorenz; Rendon, Augusto] Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 0SR, England; [Erdmann, Jeanette; Schunkert, Heribert] Nord Ctr Cardiovasc Res, Lubeck, Germany; [Pirastu, Nicola; D'Adamo, Pio; Gasparini, Paolo] Univ Trieste, I-34127 Trieste, Italy	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Edinburgh; University of Edinburgh; University of Oxford; Wellcome Centre for Human Genetics; RIKEN; University of Tokyo; IRCCS Burlo Garofolo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Kiel; European Academy of Bozen-Bolzano; Vrije Universiteit Amsterdam; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leipzig University; Imperial College London; University of London; King's College London; University of Tartu; Estonian Biocentre; University of Tartu; University of Southern California; University of Southern California; Harokopio University Athens; Consiglio Nazionale delle Ricerche (CNR); University System of Maryland; University of Maryland Baltimore; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Minnesota System; University of Minnesota Twin Cities; Ernst Moritz Arndt Universitat Greifswald; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Catholic University of the Sacred Heart; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Bristol; Imperial College London; University of Queensland; Boston University; University of Oulu; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Regensburg; University of Lausanne; Swiss Institute of Bioinformatics; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; University of Oxford; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; University of Tokyo; Ernst Moritz Arndt Universitat Greifswald; University of Groningen; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Groningen; University of Edinburgh; Finland National Institute for Health & Welfare; Cedars Sinai Medical Center; University of Oulu; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; University of Edinburgh; Leipzig University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; King's College London; University of Munich; University of Munich; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University Medical Center; Ernst Moritz Arndt Universitat Greifswald; European Molecular Biology Laboratory (EMBL); MRC Biostatistics Unit; University of Cambridge; University of Trieste	Gieger, C (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	christian.gieger@helmholtz-muenchen.de; who1000@cam.ac.uk; ns6@sanger.ac.uk	Pirastu, Nicola/G-4358-2011; Meisinger, Christine/B-5358-2014; Ulivi, Sheila/H-3700-2013; Nöthlings, Ute/B-2713-2010; Penninger, Josef M/I-6860-2013; Mägi, Reedik/AAJ-9679-2021; Deloukas, Panos/B-2922-2013; Stumvoll, Michael/ABE-1121-2021; Lagou, Vasiliki/N-8451-2013; Porteous, David J/C-7289-2013; FROGUEL, Philippe/O-6799-2017; Boomsma, Dorret I/AAX-4470-2020; de Boer, Rudolf/ABE-9879-2020; Baumeister, Sebastian-Edgar/P-7894-2019; Ciullo, Marina/AAE-3041-2020; Hicks, Andrew Anthony/E-9518-2017; Kanoni, Stavroula/AAN-7161-2021; Khaw, Kay-Tee/AAZ-3209-2021; ruggiero, daniela/K-5638-2016; Lopez, Lorna/AAR-4912-2020; Prokopenko, Inga/AAU-9895-2020; Cambien, Francois/AAP-9751-2020; Uda, Manuela/AAC-2645-2019; sanna, serena/H-3009-2019; Ellinghaus, David/ABC-3610-2020; Hartiala, Jaana A/GLR-1825-2022; Loos, Ruth/GON-5877-2022; Hengstenberg, Christian/U-5485-2019; Pirastu, Nicola/AHB-6226-2022; Martin, Nicholas/R-9235-2019; de Geus, Eco J.C./M-9318-2015; Dedoussis, George/AAN-7252-2021; Porteous, David/AAA-3446-2021; Loos, Ruth J F/Q-2862-2016; Teumer, Alexander/S-7438-2019; Wichmann, Heinz Erich/AAA-5695-2022; Mangino, Massimo/F-5134-2011; Sala, Cinzia Felicita/AAN-1900-2020; Bonnefond, Amélie/O-2784-2017; Franke, Andre/B-2151-2010; Deary, Ian J/C-6297-2009; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013; Toniolo, Daniela/AAE-2969-2019; Montgomery, Grant W/B-7148-2008; Evans, David M/H-6325-2013; Ferreira, Manuel A R/D-3609-2013; Biino, Ginevra/B-5334-2013; Falchi, Mario/F-5956-2013; d'Adamo, Adamo Pio/G-4064-2011; zhang, weihua/GXV-1334-2022; van Veldhuisen, Dirk Jan/E-8967-2014; Pramstaller, Peter P/C-2357-2008; Prokopenko, Inga/H-3241-2014; Mitchell, Braxton/CAF-0876-2022; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; bomba, lorenzo/AAE-3413-2020; Rotter, Jerome/AAY-6598-2021; Bastardot, Francois/J-4013-2017; Visscher, Peter/ABB-6151-2020; Ellinghaus, David/G-4467-2012; Bastardot, François/P-7809-2019; Maschio, Andrea/AAX-8185-2020; Gasparini, Paolo/B-6173-2014; Lopez, Lorna M/F-7265-2010; Langenberg, Claudia/ABG-9067-2021; Frazer, Ian/A-1137-2007	Ulivi, Sheila/0000-0003-3606-835X; Penninger, Josef M/0000-0002-8194-3777; Deloukas, Panos/0000-0001-9251-070X; Stumvoll, Michael/0000-0001-6225-8240; Porteous, David J/0000-0003-1249-6106; FROGUEL, Philippe/0000-0003-2972-0784; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Ciullo, Marina/0000-0002-9621-9984; Hicks, Andrew Anthony/0000-0001-6320-0411; Kanoni, Stavroula/0000-0002-1691-9615; ruggiero, daniela/0000-0003-3898-7827; Lopez, Lorna/0000-0002-0241-9783; Uda, Manuela/0000-0002-4890-6456; sanna, serena/0000-0002-3768-1749; Ellinghaus, David/0000-0002-4332-6110; Hartiala, Jaana A/0000-0003-4883-9318; Martin, Nicholas/0000-0003-4069-8020; de Geus, Eco J.C./0000-0001-6022-2666; Dedoussis, George/0000-0002-7798-6221; Porteous, David/0000-0003-1249-6106; Loos, Ruth J F/0000-0002-8532-5087; Teumer, Alexander/0000-0002-8309-094X; Mangino, Massimo/0000-0002-2167-7470; Bonnefond, Amélie/0000-0001-9976-3005; Franke, Andre/0000-0003-1530-5811; Deary, Ian J/0000-0002-1733-263X; Toniolo, Daniela/0000-0001-9545-6032; Montgomery, Grant W/0000-0002-4140-8139; Evans, David M/0000-0003-0663-4621; Ferreira, Manuel A R/0000-0001-9059-1825; Biino, Ginevra/0000-0002-9936-946X; d'Adamo, Adamo Pio/0000-0001-9367-4909; Prokopenko, Inga/0000-0003-1624-7457; Erdmann, Jeanette/0000-0002-4486-6231; bomba, lorenzo/0000-0002-6290-8984; Bastardot, Francois/0000-0003-4060-0353; Visscher, Peter/0000-0002-2143-8760; Bastardot, François/0000-0003-4060-0353; Langenberg, Claudia/0000-0002-5017-7344; Hammond, Christopher/0000-0002-3227-2620; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Shuldiner, Alan/0000-0001-9921-4305; Soranzo, Nicole/0000-0003-1095-3852; Volker, Uwe/0000-0002-5689-3448; Yang, Tsun-Po/0000-0002-9077-4434; Radhakrishnan, Aparna/0000-0002-8153-9037; Meacham, Stuart/0000-0002-3667-6059; Gasparini, Paolo/0000-0002-0859-0856; Gieger, Christian/0000-0001-6986-9554; Ballantyne, Christie/0000-0002-6432-1730; Glazer, Nicole/0000-0002-6397-609X; Willemsen, Gonneke/0000-0003-3755-0236; Serbanovic-Canic, Jovana/0000-0002-8835-1491; Wiggins, Kerri L/0000-0003-2749-1279; maschio, andrea/0000-0002-4238-9144; Pirastu, Nicola/0000-0002-5363-3886; Frazer, Ian/0000-0002-8002-4680; Pramstaller, Peter P/0000-0002-9831-8302; Basu, Saonli/0000-0003-1200-4546; Gogele, Martin/0000-0003-4785-4348; Tang, W. H. Wilson/0000-0002-8335-735X; Bradley, John/0000-0002-7774-8805; Magi, Reedik/0000-0002-2964-6011; Mitchell, Braxton/0000-0003-4920-4744; van Pelt, Joost/0000-0001-5538-1806; Kovacs, Peter/0000-0002-0290-5423; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Cvejic, Ana/0000-0003-3204-9311; Lagou, Vasiliki/0000-0003-3165-8940; Ouwehand, Willem/0000-0002-7744-1790; Goodall, Alison/0000-0002-7883-9645; Elliott, Paul/0000-0002-7511-5684; Murgia, Federico/0000-0002-3608-845X; Falchi, Mario/0000-0002-5646-1004; Tenesa, Albert/0000-0003-4884-4475; O'Reilly, Paul/0000-0001-7515-0845; CUCCA, Francesco/0000-0002-7414-1995; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Jupe, Steven/0000-0001-5807-0069; Meisinger, Christa/0000-0002-9026-6544; Rendon, Augusto/0000-0001-8994-0039; Stephens, Jonathan/0000-0003-2020-9330; s, hema/0000-0002-3440-9475; Memari, Yasin/0000-0002-1747-542X; Esko, Tonu/0000-0003-1982-6569	US National Institutes of Health [P41 HG003751]; EU [LSHG-CT-2005-518254 'ENFIN', 215820]; EBI Industry Programme; Wellcome Trust [WT 082597/Z/07/Z, WT 077037/Z/05/Z, WT 077047/Z/05/Z, 098051]; National Institute for Health Research, UK; British Heart Foundation [RG/09/012/28096]; ERC; EC under SLING [226073, FP7-HEALTH-2007-223411]; European Community; ENGAGE Consortium [HEALTH-F4-2007-201413]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC055015, N01HC055016, N01HC055019, N01HC055021, N01HC055018, N01HC055020, N01HC055022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250, UL1RR025005, M01RR016500, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073410, R01HL103866, R01HL085251, R01HL087641, P01HL098055, R01HL087679, R01HL068986, P01HL076491, R01HL105756, R01HL086694, U01HL084756, R01HL088119, U01HL072515, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG003751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, R01AG018728] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704B, G0700931, MC_U106179471, G0601966, G0701863, G1000143, G0000111, G0801056, G0700704, G0401527, G0801056B, MC_U106188470, MC_U105260799] Funding Source: researchfish; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0000111, G0701863, G0700931, MC_U105260799, G0700704, G0601966, G0801056, MC_U106188470] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); EBI Industry Programme; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research, UK(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); ERC(European Research Council (ERC)European Commission); EC under SLING; European Community(European Commission); ENGAGE Consortium; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Reactome is supported by grants from the US National Institutes of Health (P41 HG003751), EU grant LSHG-CT-2005-518254 'ENFIN', and the EBI Industry Programme. A. C. and D. L. S. are supported by the Wellcome Trust grants WT 082597/Z/07/Z and WT 077037/Z/05/Z and WT 077047/Z/05/Z, respectively. J.S.C. and K. V. are supported by the European Union NetSim training fellowship scheme (number 215820). A. Radhakrishnan, A. A., H.L.J., J.J., J.S. and W.H.O. are funded by the National Institute for Health Research, UK. Augusto Rendon is funded by programme grant RG/09/012/28096 from the British Heart Foundation. J.M.P. is supported by an Advanced ERC grant. IntAct is funded by the EC under SLING, grant agreement no. 226073 (Integrating Activity) within Research Infrastructures of the FP7, under PSIMEX, contract no. FP7-HEALTH-2007-223411. C. G. received support by the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. N.S. is supported by the Wellcome Trust (Grant Number 098051). Acknowledgements by individual participating studies are provided in Supplementary Information.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-00011; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garner C, 2006, EUR J HUM GENET, V14, P101, DOI 10.1038/sj.ejhg.5201499; Goldfarb AN, 2007, ONCOGENE, V26, P6795, DOI 10.1038/sj.onc.1210762; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Klovaite J, 2011, J THROMB HAEMOST, V9, P49, DOI 10.1111/j.1538-7836.2010.04110.x; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Serbanovic-Canic J, 2011, BLOOD, V118, P4967, DOI 10.1182/blood-2011-02-337295; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; WENDLING F, 1994, NATURE, V369, P571, DOI 10.1038/369571a0	25	299	301	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					201	208		10.1038/nature10659	http://dx.doi.org/10.1038/nature10659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22139419	Green Published, Green Accepted			2022-12-28	WOS:000297744200043
J	Schlutter, J				Schluetter, Jana			Vaccine for all seasons	NATURE			English	Editorial Material																			0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S6	S8		10.1038/480S6a	http://dx.doi.org/10.1038/480S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158298	Bronze			2022-12-28	WOS:000297744200006
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Why do you want to be a doctor?	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7976	10.1136/bmj.d7976	http://dx.doi.org/10.1136/bmj.d7976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SP	22162386				2022-12-28	WOS:000298039800010
J	Pagani, M; Huber, M; Liu, ZH; Bohaty, SM; Henderiks, J; Sijp, W; Krishnan, S; DeConto, RM				Pagani, Mark; Huber, Matthew; Liu, Zhonghui; Bohaty, Steven M.; Henderiks, Jorijntje; Sijp, Willem; Krishnan, Srinath; DeConto, Robert M.			The Role of Carbon Dioxide During the Onset of Antarctic Glaciation	SCIENCE			English	Article							ISOTOPE FRACTIONATION; EOCENE; PACIFIC; CO2; PHYTOPLANKTON; SEDIMENTARY; EVOLUTION; OCEAN	Earth's modern climate, characterized by polar ice sheets and large equator-to-pole temperature gradients, is rooted in environmental changes that promoted Antarctic glaciation similar to 33.7 million years ago. Onset of Antarctic glaciation reflects a critical tipping point for Earth's climate and provides a framework for investigating the role of atmospheric carbon dioxide (CO2) during major climatic change. Previously published records of alkenone-based CO2 from high-and low-latitude ocean localities suggested that CO2 increased during glaciation, in contradiction to theory. Here, we further investigate alkenone records and demonstrate that Antarctic and subantarctic data overestimate atmospheric CO2 levels, biasing long-term trends. Our results show that CO2 declined before and during Antarctic glaciation and support a substantial CO2 decrease as the primary agent forcing Antarctic glaciation, consistent with model-derived CO2 thresholds.	[Pagani, Mark; Krishnan, Srinath] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Huber, Matthew] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47906 USA; [Huber, Matthew] Purdue Univ, PCCRC, W Lafayette, IN 47906 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Bohaty, Steven M.] Univ Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Henderiks, Jorijntje] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Sijp, Willem] Univ New S Wales, Fac Sci, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [DeConto, Robert M.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA	Yale University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hong Kong; NERC National Oceanography Centre; University of Southampton; Uppsala University; University of New South Wales Sydney; University of Massachusetts System; University of Massachusetts Amherst	Pagani, M (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	mark.pagani@yale.edu	Huber, Matthew/A-7677-2008; Sijp, Willem/E-5988-2012; Henderiks, Jorijntje/ABB-1080-2020; Liu, Zhonghui/D-3163-2009; Pagani, Mark/B-3233-2008	Huber, Matthew/0000-0002-2771-9977; Henderiks, Jorijntje/0000-0001-9486-6275; Liu, Zhonghui/0000-0002-2168-8305; Sijp, Willem/0000-0002-5971-3860	Yale University Department of Geology and Geophysics; NSF [OCE-0902882, OCE-0902993, EAR-0628358, ATM-0513402, ATM-0927946, ANT-034248]; Natural Environment Research Council [NE/G003270/1]; Royal Swedish Academy of Sciences [KAW 2009.0287]; NERC [NE/G003270/1] Funding Source: UKRI	Yale University Department of Geology and Geophysics; NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Swedish Academy of Sciences; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a postdoctoral fellowship provided by Yale University Department of Geology and Geophysics, with funding provided by the NSF under awards OCE-0902882, OCE-0902993, EAR-0628358, ATM-0513402, ATM-0927946, and ANT-034248. This is PCCRC publication number 1115. Natural Environment Research Council grant NE/G003270/1 provided funds for the stable isotope analysis of carbonates. J.H. was funded by the Royal Swedish Academy of Sciences (KAW 2009.0287).	Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Bijl PK, 2010, SCIENCE, V330, P819, DOI 10.1126/science.1193654; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; CONTE MH, 1994, HAPTOPHYTE ALGAE, P351; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Ehrmann W.U., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V119, P185, DOI 10.2973/odp.proc.sr.119.121.1991; Eldrett JS, 2009, NATURE, V459, P969, DOI 10.1038/nature08069; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Goericke R., 1994, STABLE ISOTOPES ECOL, P187; HAMBREY MJ, 1991, P OCEAN DRILLING PRO, V0119; HAMBREY MJ, 1993, ANTAR RES S, V60, P91; Henderiks J, 2008, EARTH PLANET SC LETT, V269, P575, DOI 10.1016/j.epsl.2008.03.016; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000756; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; RAVEN JA, 1991, LIMNOL OCEANOGR, V36, P1701, DOI 10.4319/lo.1991.36.8.1701; Riebesell U, 2000, GEOCHIM COSMOCHIM AC, V64, P4179, DOI 10.1016/S0016-7037(00)00474-9; Robert C, 1997, GEOLOGY, V25, P587, DOI 10.1130/0091-7613(1997)025<0587:ACWCDE>2.3.CO;2; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Sijp WP, 2009, J CLIMATE, V22, P6639, DOI 10.1175/2009JCLI3003.1; Toggweiler JR, 2000, J QUATERNARY SCI, V15, P319, DOI 10.1002/1099-1417(200005)15:4<319::AID-JQS545>3.0.CO;2-C; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	193	197	7	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1261	1264		10.1126/science.1203909	http://dx.doi.org/10.1126/science.1203909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144622				2022-12-28	WOS:000297553600046
J	Campana, S; Lodato, G; D'Avanzo, P; Panagia, N; Rossi, EM; Della Valle, M; Tagliaferri, G; Antonelli, LA; Covino, S; Ghirlanda, G; Ghisellini, G; Melandri, A; Pian, E; Salvaterra, R; Cusumano, G; D'Elia, V; Fugazza, D; Palazzi, E; Sbarufatti, B; Vergani, SD				Campana, S.; Lodato, G.; D'Avanzo, P.; Panagia, N.; Rossi, E. M.; Della Valle, M.; Tagliaferri, G.; Antonelli, L. A.; Covino, S.; Ghirlanda, G.; Ghisellini, G.; Melandri, A.; Pian, E.; Salvaterra, R.; Cusumano, G.; D'Elia, V.; Fugazza, D.; Palazzi, E.; Sbarufatti, B.; Vergani, S. D.			The unusual gamma-ray burst GRB 101225A explained as a minor body falling onto a neutron star	NATURE			English	Article							MASSIVE BLACK-HOLE; TIDALLY DISRUPTED STAR; WHITE-DWARF; COMETS; ACCRETION; OUTBURST; DISK	The tidal disruption of a solar-mass star around a supermassive black hole has been extensively studied analytically(1,2) and numerically(3). In these events, the star develops into an elongated banana-shaped structure. After completing an eccentric orbit, the bound debris falls into the black hole, forming an accretion disk and emitting radiation(4-6). The same process may occur on planetary scales if a minor body passes too close to its star. In the Solar System, comets fall directly into our Sun(7) or onto planets(8). If the star is a compact object, the minor body can become tidally disrupted. Indeed, one of the first mechanisms invoked to produce strong gamma-ray emission involved accretion of comets onto neutron stars in our Galaxy(9). Here we report that the peculiarities of the 'Christmas' gamma-ray burst (GRB 101225A(10)) can be explained by a tidal disruption event of a minor body around an isolated Galactic neutron star. This would indicate either that minor bodies can be captured by compact stellar remnants more frequently than occurs in the Solar System or that minor-body formation is relatively easy around millisecond radio pulsars. A peculiar supernova associated with a gamma-ray burst provides an alternative explanation(11).	[Campana, S.; D'Avanzo, P.; Tagliaferri, G.; Covino, S.; Ghirlanda, G.; Ghisellini, G.; Melandri, A.; Fugazza, D.; Sbarufatti, B.; Vergani, S. D.] INAF Osservatorio Astron Brera, I-23807 Merate, LC, Italy; [Lodato, G.] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Panagia, N.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Panagia, N.] INAF Osservatorio Astrofis Catania, I-95123 Catania, Italy; [Rossi, E. M.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Della Valle, M.] INAF Osservatorio Astron Capodimonte, I-80131 Naples, Italy; [Antonelli, L. A.; D'Elia, V.] INAF Osservatorio Astron Roma, I-00044 Rome, Italy; [Pian, E.] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Pian, E.] INAF Osservatorio Astron Trieste, I-34143 Trieste, Italy; [Salvaterra, R.] Univ Insubria, Dipartimento Fis & Matemat, I-22100 Como, Italy; [Cusumano, G.] INAF Ist Astrofis Spaziale & Fis Cosm, I-90146 Palermo, Italy; [D'Elia, V.] ASI Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Palazzi, E.] INAF Ist Astrofis Spaziale & Fis Cosm, Sez Bologna, I-40129 Bologna, Italy	Istituto Nazionale Astrofisica (INAF); University of Milan; Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); Leiden University; Leiden University - Excl LUMC; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Scuola Normale Superiore di Pisa; Istituto Nazionale Astrofisica (INAF); University of Insubria; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF)	Campana, S (corresponding author), INAF Osservatorio Astron Brera, Via E Bianchi 46, I-23807 Merate, LC, Italy.	sergio.campana@brera.inaf.it	Rossi, Elena Maria Maria/AAX-3567-2021; Campana, Sergio/AAL-6012-2020; Tagliaferri, Gianpiero/ABD-7556-2021; Palazzi, Eliana/N-4746-2015; Covino, Stefano/AAQ-5188-2021; Della Valle, Massimo/AAE-8884-2021	Rossi, Elena Maria Maria/0000-0002-0587-6680; Campana, Sergio/0000-0001-6278-1576; Tagliaferri, Gianpiero/0000-0003-0121-0723; Covino, Stefano/0000-0001-9078-5507; Della Valle, Massimo/0000-0003-3142-5020; Melandri, Andrea/0000-0002-2810-2143; Ghisellini, Gabriele/0000-0002-0037-1974; D'Avanzo, Paolo/0000-0001-7164-1508; Pian, Elena/0000-0001-8646-4858; Antonelli, Lucio Angelo/0000-0002-5037-9034; Fugazza, Dino Pierluigi/0000-0001-9942-277X; Ghirlanda, Giancarlo/0000-0001-5876-9259; Vergani, Daniela/0000-0003-0898-2216; Palazzi, Eliana/0000-0002-8691-7666; D'Elia, Valerio/0000-0002-7320-5862; Sbarufatti, Boris/0000-0001-6620-8347; LODATO, GIUSEPPE/0000-0002-2357-7692; Cusumano, Giancarlo/0000-0002-8151-1990; Salvaterra, Ruben/0000-0002-9393-8078	ASI; INAF	ASI(Agenzia Spaziale Italiana (ASI)); INAF(Istituto Nazionale Astrofisica (INAF))	The authors acknowledge support from ASI and INAF. S. Campana wants to thank A. Possenti and N. Tanvir for conversations, and acknowledges N. Schartel for granting a DDT XMM-Newton observation.	Bade N, 1996, ASTRON ASTROPHYS, V309, pL35; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; CANNIZZO JK, 1990, ASTROPHYS J, V351, P38, DOI 10.1086/168442; Chornock R., 2010, 11507 GCN, V11507; EVANS CR, 1989, ASTROPHYS J, V346, pL13, DOI 10.1086/185567; Gansicke BT, 2006, SCIENCE, V314, P1908, DOI 10.1126/science.1135033; Gehrels N, 2009, ANNU REV ASTRON ASTR, V47, P567, DOI 10.1146/annurev.astro.46.060407.145147; Guillochon J, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/74; HARRINGTON J, 1994, NATURE, V368, P525, DOI 10.1038/368525a0; HARWIT M, 1973, ASTROPHYS J, V186, pL37, DOI 10.1086/181352; Jura M, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/5/155; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Lasota JP, 2008, ASTRON ASTROPHYS, V486, P523, DOI 10.1051/0004-6361:200809658; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; Lodato G, 2011, MON NOT R ASTRON SOC, V410, P359, DOI 10.1111/j.1365-2966.2010.17448.x; Phinney E. S., 1989, IAU S, V136, P543; Racusin J. L., 2011, 3141 GCN, V314.1; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; RENZINI A, 1995, NATURE, V378, P39, DOI 10.1038/378039a0; SHEELEY NR, 1982, NATURE, V300, P239, DOI 10.1038/300239a0; SHULL JM, 1995, ASTRON J, V109, P690, DOI 10.1086/117311; Sigurdsson S, 2003, SCIENCE, V301, P193, DOI 10.1126/science.1086326; Tanvir N. R., 2011, 11564 GCN, V11564; Ulmer A, 1999, ASTROPHYS J, V514, P180, DOI 10.1086/306909; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	27	49	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					69	71		10.1038/nature10592	http://dx.doi.org/10.1038/nature10592			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129725	Green Submitted			2022-12-28	WOS:000298031900034
J	Danuser, G				Danuser, Gaudenz			Computer Vision in Cell Biology	CELL			English	Article							TIME-LAPSE SEQUENCES; PARTICLE TRACKING; IMAGE-ANALYSIS; MICROSCOPY; ENDOCYTOSIS; MIGRATION; RESPONSES; PATTERNS; SPINDLE	Computer vision refers to the theory and implementation of artificial systems that extract information from images to understand their content. Although computers are widely used by cell biologists for visualization and measurement, interpretation of image content, i.e., the selection of events worth observing and the definition of what they mean in terms of cellular mechanisms, is mostly left to human intuition. This Essay attempts to outline roles computer vision may play and should play in image-based studies of cellular life.	Harvard Univ, Sch Med, Boston, MA 02140 USA	Harvard University; Harvard Medical School	Danuser, G (corresponding author), Harvard Univ, Sch Med, 240 Longwood Ave, Boston, MA 02140 USA.	gaudenz_danuser@hms.harvard.edu		Danuser, Gaudenz/0000-0001-8583-2014	 [U01 GM067230];  [R01 GM071868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071868, U01GM067230] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank my colleagues and my lab for the many insights they provided me on my transition from a computer vision scientist to a cell biologist using computer vision. Special thanks go to Khuloud Jaqaman for her help with preparing Figure 2 and her critical reading of the Essay. Cited data and methods from my lab were acquired using funding from U01 GM067230 and R01 GM071868.	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CASTLEMAN KR, 1976, MUTAT RES, V41, P153, DOI 10.1016/0027-5107(76)90085-3; Chen Y, 2009, J IMMUNOL METHODS, V340, P65, DOI 10.1016/j.jim.2008.09.024; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; FARNOUSH A, 1977, MICROSC ACTA, V80, P43; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; GILBERT CW, 1966, NATURE, V212, P1437, DOI 10.1038/2121437a0; HOWE GB, 1980, BLOOD, V56, P696; Inoue S., 1997, VIDEO MICROSCOPY; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; LEWANDOWSKA K, 1979, COMPUT BIOL MED, V9, P331, DOI 10.1016/0010-4825(79)90039-8; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Shariff A, 2010, CYTOM PART A, V77A, P457, DOI 10.1002/cyto.a.20854; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643	31	98	99	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					973	978		10.1016/j.cell.2011.11.001	http://dx.doi.org/10.1016/j.cell.2011.11.001			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118455	Bronze			2022-12-28	WOS:000297376600010
J	Zhan, S; Merlin, C; Boore, JL; Reppert, SM				Zhan, Shuai; Merlin, Christine; Boore, Jeffrey L.; Reppert, Steven M.			The Monarch Butterfly Genome Yields Insights into Long-Distance Migration	CELL			English	Article							JUVENILE-HORMONE REGULATION; PIGMENT-DISPERSING FACTOR; OUABAIN BINDING-SITE; DANAUS-PLEXIPPUS; SUN COMPASS; DROSOPHILA-MELANOGASTER; CARDIAC-GLYCOSIDES; RNA-INTERFERENCE; CIRCADIAN CLOCKS; CENTRAL COMPLEX	We present the draft 273 Mb genome of the migratory monarch butterfly (Danaus plexippus) and a set of 16,866 protein-coding genes. Orthology properties suggest that the Lepidoptera are the fastest evolving insect order yet examined. Compared to the silkmoth Bombyx mori, the monarch genome shares prominent similarity in orthology content, microsynteny, and protein family sizes. The monarch genome reveals a vertebrate-like opsin whose existence in insects is widespread; a full repertoire of molecular components for the monarch circadian clockwork; all members of the juvenile hormone biosynthetic pathway whose regulation shows unexpected sexual dimorphism; additional molecular signatures of oriented flight behavior; microRNAs that are differentially expressed between summer and migratory butterflies; monarch-specific expansions of chemo-receptors potentially important for long-distance migration; and a variant of the sodium/potassium pump that underlies a valuable chemical defense mechanism. The monarch genome enhances our ability to better understand the genetic and molecular basis of long-distance migration.	[Zhan, Shuai; Merlin, Christine; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	zhang, tingting/K-6664-2018		NIH [GM086794-02S1]; Higgins Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higgins Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stanley Heinze and Surainder Asokaraj for providing the three-dimensional reconstruction images of the monarch antennal lobe shown in Figure 6A; Alan Ritacco for use of the computing server; and Susan Fuerstenberg, Amy Casselman, and Lauren Foley for assistance. S. M. R. initiated and oversaw the project. J. L. B. designed the sequencing strategy, provided sequence quality control, and generated the v0 assemblies. S. Z. performed the v1 and v2 assemblies, generated the gene sets, and provided quality control and the data for all figures, except Figure 6A. C. M. performed the genomic DNA preparations, collected and prepared RNA for the transcriptome library, helped with the annotation of the chemosensory receptors, and properly formatted all the figures. S. Z., C. M., J. L. B., and S. M. R. performed data analyses. S. Z., C. M., and S. M. R. wrote the paper. This work was supported by NIH grant GM086794-02S1 and the Higgins Foundation.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Baumann O, 2010, CELL TISSUE RES, V340, P215, DOI 10.1007/s00441-010-0948-x; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; BROWER JV, 1958, EVOLUTION, V12, P32, DOI 10.1111/j.1558-5646.1958.tb02926.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Brown KS, 2004, HEREDITAS, V141, P216; COHEN JA, 1985, J CHEM ECOL, V11, P85, DOI 10.1007/BF00987608; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Grimaldi David, 2005, pi; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Herbert Z, 2010, J MORPHOL, V271, P1509, DOI 10.1002/jmor.10895; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; HERMAN WS, 1975, GEN COMP ENDOCR, V26, P534, DOI 10.1016/0016-6480(75)90176-8; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Ooka S, 2010, DEV GROWTH DIFFER, V52, P195, DOI 10.1111/j.1440-169X.2009.01154.x; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; PLISKE TE, 1975, ANN ENTOMOL SOC AM, V68, P143, DOI 10.1093/aesa/68.1.143; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; RITLAND DB, 1991, NATURE, V350, P497, DOI 10.1038/350497a0; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner Kevin W., 2010, P153; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; XIANG ZH, 1995, GENETICS BREEDING SI; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	79	383	414	6	253	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1171	1185		10.1016/j.cell.2011.09.052	http://dx.doi.org/10.1016/j.cell.2011.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118469	Bronze, Green Accepted			2022-12-28	WOS:000297376600026
J	Williams, RA; LeBlanc, LJ; Jimenez-Garcia, K; Beeler, MC; Perry, AR; Phillips, WD; Spielman, IB				Williams, R. A.; LeBlanc, L. J.; Jimenez-Garcia, K.; Beeler, M. C.; Perry, A. R.; Phillips, W. D.; Spielman, I. B.			Synthetic Partial Waves in Ultracold Atomic Collisions	SCIENCE			English	Article							NEUTRAL ATOMS	Interactions between particles can be strongly altered by their environment. We demonstrate a technique for modifying interactions between ultracold atoms by dressing the bare atomic states with light, creating an effective interaction of vastly increased range that scatters states of finite relative angular momentum at collision energies where only s-wave scattering would normally be expected. We collided two optically dressed neutral atomic Bose-Einstein condensates with equal, and opposite, momenta and observed that the usual s-wave distribution of scattered atoms was altered by the appearance of d- and g-wave contributions. This technique is expected to enable quantum simulation of exotic systems, including those predicted to support Majorana fermions.	[Williams, R. A.; LeBlanc, L. J.; Jimenez-Garcia, K.; Beeler, M. C.; Perry, A. R.; Phillips, W. D.; Spielman, I. B.] NIST, JQI, Gaithersburg, MD 20899 USA; [Williams, R. A.; LeBlanc, L. J.; Jimenez-Garcia, K.; Beeler, M. C.; Perry, A. R.; Phillips, W. D.; Spielman, I. B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Jimenez-Garcia, K.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07360, DF, Mexico	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Spielman, IB (corresponding author), NIST, JQI, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov	Williams, Ross/C-3429-2012; LeBlanc, Lindsay/ABA-8511-2020	LeBlanc, Lindsay/0000-0002-9156-6100; Williams, Ross/0000-0001-9347-0922	Office of Naval Research; Army Research Office; Defense Advanced Research Projects Agency; Atomtronics Multidisciplinary University Research Initiative; NSF through the Physics Frontier Center at JQI	Office of Naval Research(Office of Naval Research); Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Atomtronics Multidisciplinary University Research Initiative; NSF through the Physics Frontier Center at JQI	We thank C. Sa de Melo, J. V. Porto, and V. Galitski for useful conversations. This work was partially supported by the Office of Naval Research; by Army Research Office with funds from the Defense Advanced Research Projects Agency Optical Lattice Emulator program and the Atomtronics Multidisciplinary University Research Initiative; and by the NSF through the Physics Frontier Center at JQI. L.J.L. acknowledges National Sciences and Engineering Research Council of Canada, K.J.-G. acknowledges CONACYT (Consejo Nacional de Ciencia y Technologia), and M. C. B. acknowledges NIST-American Recovery and Reinvestment Act.	Alicea J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125318; [Anonymous], 2003, QUANTUM THEORY MANY; Buggle C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173202; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Jiang LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220402; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lin YJ, 2011, NAT PHYS, V7, P531, DOI [10.1038/nphys1954, 10.1038/NPHYS1954]; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.053201; Romanovsky I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.230405; Sakurai JJ., 1993, MODERN QUANTUM MECH; Scarola VW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033003; Spielman IB, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063613; Stamper-Kurn DM, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/350; Thomas NR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173201; Tikhonenkov I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.090406; Widera A, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/152; Zhang CW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.160401	19	115	117	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					314	317		10.1126/science.1212652	http://dx.doi.org/10.1126/science.1212652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22157082	Green Submitted			2022-12-28	WOS:000299273400041
J	Png, KJ; Halberg, N; Yoshida, M; Tavazoie, SF				Png, Kim J.; Halberg, Nils; Yoshida, Mitsukuni; Tavazoie, Sohail F.			A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells	NATURE			English	Article							GROWTH	Metastatic progression of cancer is a complex and clinically daunting process(1-4). We previously identified a set of human microRNAs ( miRNAs) that robustly suppress breast cancer metastasis to lung and bone(5,6) and which display expression levels that predict human metastasis. Although these findings revealed miRNAs as suppressors of cell-autonomous metastatic phenotypes, the roles of noncoding RNAs in non-cell-autonomous cancer progression processes remain unknown. Here we reveal that endogenous miR-126, an miRNA silenced in a variety of common human cancers(7,8), non-cell-autonomously regulates endothelial cell recruitment to metastatic breast cancer cells, in vitro and in vivo. It suppresses metastatic endothelial recruitment, metastatic angiogenesis and metastatic colonization through coordinate targeting of IGFBP2, PITPNC1 and MERTK-novel pro-angiogenic genes and biomarkers of human metastasis. Insulin-like growth factor binding protein 2 ( IGFBP2) secreted by metastatic cells recruits endothelia by modulating IGF1-mediated activation of the IGF type-I receptor on endothelial cells; whereas c-Mer tyrosine kinase (MERTK) receptor cleaved from metastatic cells promotes endothelial recruitment by competitively antagonizing the binding of its ligand GAS6 to endothelial MERTK receptors. Co-injection of endothelial cells with breast cancer cells non-cell-autonomously rescues their miR-126-induced metastatic defect, revealing a novel and important role for endothelial interactions in metastatic initiation. Through loss-of-function and epistasis experiments, we delineate an miRNA regulatory network's individual components as novel and cell-extrinsic regulators of endothelial recruitment, angiogenesis and metastatic colonization. We also identify the IGFBP2/IGF1/IGF1R and GAS6/MERTK signalling pathways as regulators of cancer-mediated endothelial recruitment. Our work further reveals endothelial recruitment and endothelial interactions in the tumour microenvironment to be critical features of metastatic breast cancer.	[Png, Kim J.; Halberg, Nils; Yoshida, Mitsukuni; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Halberg, Nils/AAF-8153-2019	Halberg, Nils/0000-0002-2943-3147; Yoshida, Mitsukuni/0000-0002-2752-1231				Arnold SA, 2010, DIS MODEL MECH, V3, P57, DOI 10.1242/dmm.003228; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	18	401	424	1	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2012	481	7380					190	+		10.1038/nature10661	http://dx.doi.org/10.1038/nature10661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22170610				2022-12-28	WOS:000298981200037
J	Williams, JH; DeBenedictis, A; Ghanadan, R; Mahone, A; Moore, J; Morrow, WR; Price, S; Torn, MS				Williams, James H.; DeBenedictis, Andrew; Ghanadan, Rebecca; Mahone, Amber; Moore, Jack; Morrow, William R., III; Price, Snuller; Torn, Margaret S.			The Technology Path to Deep Greenhouse Gas Emissions Cuts by 2050: The Pivotal Role of Electricity	SCIENCE			English	Article							STABILIZATION WEDGES; CLIMATE; BIOFUELS	Several states and countries have adopted targets for deep reductions in greenhouse gas emissions by 2050, but there has been little physically realistic modeling of the energy and economic transformations required. We analyzed the infrastructure and technology path required to meet California's goal of an 80% reduction below 1990 levels, using detailed modeling of infrastructure stocks, resource constraints, and electricity system operability. We found that technically feasible levels of energy efficiency and decarbonized energy supply alone are not sufficient; widespread electrification of transportation and other sectors is required. Decarbonized electricity would become the dominant form of energy supply, posing challenges and opportunities for economic growth and climate policy. This transformation demands technologies that are not yet commercialized, as well as coordination of investment, technology development, and infrastructure deployment.	[Ghanadan, Rebecca; Torn, Margaret S.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Williams, James H.; DeBenedictis, Andrew; Ghanadan, Rebecca; Mahone, Amber; Moore, Jack; Price, Snuller] Energy & Environm Econ, San Francisco, CA 94104 USA; [Williams, James H.] Monterey Inst Int Studies, Monterey, CA 93940 USA; [Morrow, William R., III] Lawrence Berkeley Natl Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Torn, MS (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	mstorn@lbl.gov	Torn, Margaret/CAF-8960-2022; Torn, Margaret S/D-2305-2015	Torn, Margaret/0000-0002-8174-0099; Torn, Margaret S/0000-0002-8174-0099; Morrow, William/0000-0001-6640-5711	Hydrogen Energy International; Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, U.S. Department of Energy [DE-AC02-05CH11231]	Hydrogen Energy International; Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, U.S. Department of Energy	We thank the anonymous reviewers. We are grateful for the contributions and helpful comments of R. Orans, B. Horii, L. Alagappan, A. Whitmore, J. Shipley, D. Fridley, J. Koomey, A. Sanstad, R. Socolow, J. Zysman, W. Denn, and C. Greacen. The early modeling work was carried out with partial support from Hydrogen Energy International. The contributions of M. S. T. were supported by the Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, U.S. Department of Energy, under contract DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory.	[Anonymous], CONTRIBUTION WORKING; Bonbright J. C., 1961, PRINCIPLES PUBLIC UT; Bushnell J., 2009, 183 U CAL CTR STUD E; California Air Resources Board, 2008, AB32 SCOP PLAN; California Energy Commission, 2008, CEC1002008007F CAL P; California Public Utilities Commission, 2010, ZER NET EN ACT PLAN; Center for Clean Air Policy, 2005, RED CO2 EM CAL CEM S; Chen YH, 2009, ENERG ECON, V31, P667, DOI 10.1016/j.eneco.2009.02.003; Coffey B, 2009, BUILD RES INF, V37, P610, DOI 10.1080/09613210903189467; Committee on America's Energy Future Division on Engineering and Physical Sciences and National Research Council, 2009, AM EN FUT TECHN TRAN; DeCanio SJ, 2003, ECONOMIC MODELS OF CLIMATE CHANGE: A CRITIQUE, P1, DOI 10.1057/9780230509467; Electric Power Research Institute, 2009, 1016987 EL POW RES I; Electric Power Research Institute, 2009, 1020389 EL POW RES I; Energy and Environmental Economics Inc, 2010, GREENH GAS MOD CAL E; European Climate Foundation, 2010, ROADM 2050 PRACT GUI; Goldman C. A., 2002, J IND COMPETITION TR, V2, P113, DOI DOI 10.1023/A:1020883005951; Hanemann M, 2009, ENERG J, V30, P79; ICF Consulting, 2005, CEC5002005121 ICF CO; Intergovernmental Panel on Climate Change, 2011, SPEC REP REN EN SOUR; International Energy Agency, 2011, EN TECHN PERSP 2008; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jenkins B.M., 2006, CEC5002006095D; Johnson J, 2009, ENVIRON SCI TECHNOL, V43, P2234, DOI 10.1021/es801700a; Koonin S. E., 2010, ISSUES SCI TECHNOL O; Lawrence Berkeley National Laboratory, 2005, CEC5002005097 LAWR B; Mahone A, 2009, ENERG POLICY, V37, P774, DOI 10.1016/j.enpol.2008.11.033; Martinot E, 2007, ANNU REV ENV RESOUR, V32, P205, DOI 10.1146/annurev.energy.32.080106.133554; Mathiesen BV, 2011, APPL ENERG, V88, P488, DOI 10.1016/j.apenergy.2010.03.001; McKinsey & CO, 2009, UNL EN EFF US EC; National Research Council, 2010, LIM MAGN FUT CLIM CH; Olabisi LS, 2009, ENVIRON SCI TECHNOL, V43, P1696, DOI 10.1021/es801171a; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Paltsev S, 2009, ENERG ECON, V31, pS235, DOI 10.1016/j.eneco.2009.06.005; Rai V, 2010, ENERG POLICY, V38, P4089, DOI 10.1016/j.enpol.2010.03.035; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Skea J., 2010, ENERGY 2050 MAKING T; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Taylor M.R., 2005, LAW POLICY, V27, P348, DOI [DOI 10.1111/J.1467-9930.2005.00203.X, 10.1111/j.1467-9930.2005.00203.x]; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tuladhar SD, 2009, ENERG ECON, V31, pS223, DOI 10.1016/j.eneco.2009.07.007; University of California, 2008, CEC5002008039 U CAL; Williams RB, 2007, P 15 EUR BIOM C EXH; World Bank, WORLD DEV IND; World Resources Institute, 2010, CLIM AN IND TOOLS VE; Yang C, 2009, TRANSPORT RES D-TR E, V14, P147, DOI 10.1016/j.trd.2008.11.010; zysman J., 2010, GOVT MARKETS GREEN G	46	500	502	10	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2012	335	6064					53	59		10.1126/science.1208365	http://dx.doi.org/10.1126/science.1208365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22116030	Green Submitted			2022-12-28	WOS:000298846200047
J	Zofall, M; Yamanaka, S; Reyes-Turcu, FE; Zhang, K; Rubin, C; Grewal, SIS				Zofall, Martin; Yamanaka, Soichiro; Reyes-Turcu, Francisca E.; Zhang, Ke; Rubin, Chanan; Grewal, Shiv I. S.			RNA Elimination Machinery Targeting Meiotic mRNAs Promotes Facultative Heterochromatin Formation	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SELECTIVE ELIMINATION; QUALITY-CONTROL; S. POMBE; CHROMATIN; MEIOSIS; PROTEIN; TRANSCRIPTION; TERMINATION	Facultative heterochromatin that changes during cellular differentiation coordinates regulated gene expression, but its assembly is poorly understood. Here, we describe facultative heterochromatin islands in fission yeast and show that their formation at meiotic genes requires factors that eliminate meiotic messenger RNAs (mRNAs) during vegetative growth. Blocking production of meiotic mRNA or loss of RNA elimination factors, including Mmi1 and Red1 proteins, abolishes heterochromatin islands. RNA elimination machinery is enriched at meiotic loci and interacts with Clr4/SUV39h, a methyltransferase involved in heterochromatin assembly. Heterochromatin islands disassemble in response to nutritional signals that induce sexual differentiation. This process involves the antisilencing factor Epe1, the loss of which causes dramatic increase in heterochromatic loci. Our analyses uncover unexpected regulatory roles for mRNA-processing factors that assemble dynamic heterochromatin to modulate gene expression.	[Zofall, Martin; Yamanaka, Soichiro; Reyes-Turcu, Francisca E.; Zhang, Ke; Rubin, Chanan; Grewal, Shiv I. S.] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov			NIH; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Sugiyama for constructions of red1 Delta and tagged alleles during his time in the Grewal lab and M. Yamamoto and T. Sugiyama for their gift of strains. Microarray data are avaiable at the National Center for Biotechnology Information Gene Expression Omnibus repository under accession no. GSE33404. This work is supported by the Intramural Research Program of the NIH and National Cancer Institute.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Isaac S, 2007, GENETICS, V175, P1549, DOI 10.1534/genetics.106.068684; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	24	132	132	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 6	2012	335	6064					96	100		10.1126/science.1211651	http://dx.doi.org/10.1126/science.1211651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872YA	22144463	Green Accepted			2022-12-28	WOS:000298846200059
J	Cebrian, I; Visentin, G; Blanchard, N; Jouve, M; Bobard, A; Moita, C; Enninga, J; Moita, LF; Amigorena, S; Savina, A				Cebrian, Ignacio; Visentin, Geraldine; Blanchard, Nicolas; Jouve, Mabel; Bobard, Alexandre; Moita, Catarina; Enninga, Jost; Moita, Luis F.; Amigorena, Sebastian; Savina, Ariel			Sec22b Regulates Phagosomal Maturation and Antigen Crosspresentation by Dendritic Cells	CELL			English	Article							CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; TOXOPLASMA-GONDII; LEGIONELLA-PNEUMOPHILA; CROSS-PRESENTATION; INTERMEDIATE COMPARTMENT; PARASITOPHOROUS VACUOLE; MEDIATED PHAGOCYTOSIS; SNARE COMPLEX; MEMBRANE	Antigen (Ag) crosspresentation by dendritic cells (DCs) involves the presentation of internalized Ags on MHC class I molecules to initiate CD8+ T cell-mediated immunity in response to certain pathogens and tumor cells. Here, we identify the SNARE Sec22b as a specific regulator of Ag crosspresentation. Sec22b localizes to the ER-Golgi intermediate compartment (ERGIC) and pairs to the plasma membrane SNARE syntaxin 4, which is present in phagosomes (Phgs). Depletion of Sec22b inhibits the recruitment of ER-resident proteins to Phgs and to the vacuole containing the Toxoplasma gondii parasite. In Sec22b-deficient DCs, crosspresentation is compromised after Ag phagocytosis or endocytosis and after invasion by T. gondii. Sec22b silencing inhibited Ag export to the cytosol and increased phagosomal degradation by accelerating lysosomal recruitment. Our findings provide insight into an intracellular traffic pathway required for crosspresentation and show that Sec22b-dependent recruitment of ER proteins to Phgs critically influences phagosomal functions in DCs.	[Cebrian, Ignacio; Visentin, Geraldine; Amigorena, Sebastian; Savina, Ariel] Inst Curie, INSERM, U932, F-75248 Paris 05, France; [Blanchard, Nicolas] Univ Toulouse 3, CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM,CNRS,UMR 1043,UMR5282, F-31024 Toulouse 3, France; [Bobard, Alexandre; Enninga, Jost] Inst Pasteur, F-75724 Paris, France; [Moita, Catarina; Moita, Luis F.] Univ Lisbon, Cell Biol Immune Syst Unit, Inst Med Mol, Fac Med, P-1649028 Lisbon, Portugal; [Jouve, Mabel] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, F-75205 Paris 13, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr; ariel.savina@curie.fr	Moita, Luis F./L-1296-2013; Blanchard, Nicolas/I-5255-2014; Blanchard, Nicolas/AAD-6601-2020; Cebrian, Ignacio/L-2764-2016; Moita, Luis/HCI-2793-2022	Moita, Luis F./0000-0003-0707-315X; Blanchard, Nicolas/0000-0002-4924-2161; Blanchard, Nicolas/0000-0002-4924-2161; Cebrian, Ignacio/0000-0001-6505-0875; Moita, Luis/0000-0003-0707-315X; Amigorena, Sebastian/0000-0001-8583-8416; Jouve San Roman, Mabel Juana/0000-0002-3115-4681; Ferreira Moita, Catarina/0000-0002-9910-2343	Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM); ARC (Association de la Recherche contre le Cancer) [SFI20101201629]; Ligue National de Lutte contre le Cancer; European Research Council [233062]; Agence National de Recherche (ANR MIME APAT); Bettencourt-Schueller Foundation (FBS); Curie Institute; Human Frontier Science Program Organization; Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008, PIC/IC/82991/2007]	Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM); ARC (Association de la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue National de Lutte contre le Cancer; European Research Council(European Research Council (ERC)European Commission); Agence National de Recherche (ANR MIME APAT)(French National Research Agency (ANR)); Bettencourt-Schueller Foundation (FBS); Curie Institute; Human Frontier Science Program Organization(Human Frontier Science Program); Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We are grateful to Boris Striepen (U. of Georgia, Athens, GA, USA) and Marc-Jan Gubbels (Boston College, Chestnut Hill, MA, USA) for the gift of YFP- and OVA/YFP-expressing RH parasites and Marie-France Cesbron-Delauw for the anti-GRA2 antibody. We thank Thierry Galli (Institut Jacques Monod) for the gift of Ykt6 and SNAP-23 antibodies and for helpful discussions and comment on the manuscript. Maria Rescigno (European Institute of Oncology, Milan) for the gift of OVA-expressing E. coli strains. We thank Philippe Benaroch for helpful discussion about the protocol of export to the cytosol with beta-lactamase; A.-M. Lennon and F. Kotsias for comments on the manuscript; and Michel Desjardins for helpful discussions. We thank Patricia Le Baccon for assistance with Delta Vision system and Christine Sedlik for technical assistance with T. gondii experiments. We thank the PICT-IBiSA@BDD (UMR3215/U934) Imaging facility of Institut Curie. This work was financed by Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM), ARC (Association de la Recherche contre le Cancer, No SFI20101201629), Ligue National de Lutte contre le Cancer (Ligue labelisee 2007-2010 and 2011-2013), European Research Council (PhagoDC no 233062), Agence National de Recherche (ANR MIME APAT), and the Bettencourt-Schueller Foundation (FBS). I.C. was supported by the Curie Institute PhD Scholarship program and the ARC. N.B. was supported by the Human Frontier Science Program Organization, INSERM, and FBS. L.F.M. receives support from Fundacao Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-IMU/110303/2009, PTDC/SAU-MII/100780/2008, and PIC/IC/82991/2007).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Ghanem E, 2010, J CELL SCI, V123, P4271, DOI 10.1242/jcs.060632; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; Hatsuzawa K, 2009, MOL BIOL CELL, V20, P4435, DOI 10.1091/mbc.E09-03-0241; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kagan JC, 2005, METHOD ENZYMOL, V403, P71, DOI 10.1016/S0076-6879(05)03007-7; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Melo EJT, 1997, CELL STRUCT FUNCT, V22, P317, DOI 10.1247/csf.22.317; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	44	210	215	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1355	1368		10.1016/j.cell.2011.11.021	http://dx.doi.org/10.1016/j.cell.2011.11.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153078	Bronze			2022-12-28	WOS:000298148100023
J	Brody, H				Brody, Herb			INFLUENZA	NATURE			English	Editorial Material																			0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					S1	S1		10.1038/480S1a	http://dx.doi.org/10.1038/480S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158293	Bronze			2022-12-28	WOS:000297744200003
J	Kassen, R				Kassen, Rees			If you want to win the game, you must join in	NATURE			English	Editorial Material									[Kassen, Rees] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Kassen, Rees] Partnership Grp Sci & Engn, Ottawa, ON, Canada; [Kassen, Rees] World Econ Forum, Geneva, Switzerland	University of Ottawa	Kassen, R (corresponding author), Univ Ottawa, Ottawa, ON K1N 6N5, Canada.	rees.kassen@uottawa.ca							0	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					153	153		10.1038/480153a	http://dx.doi.org/10.1038/480153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	857TR	22158205	Bronze			2022-12-28	WOS:000297744200013
J	Nguyen, PL; Je, YJ; Schutz, FAB; Hoffman, KE; Hu, JC; Parekh, A; Beckman, JA; Choueiri, TK				Nguyen, Paul L.; Je, Youjin; Schutz, Fabio A. B.; Hoffman, Karen E.; Hu, Jim C.; Parekh, Arti; Beckman, Joshua A.; Choueiri, Toni K.			Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer A Meta-analysis of Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NEOADJUVANT HORMONAL-THERAPY; CONGESTIVE-HEART-FAILURE; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; FOLLOW-UP; EUROPEAN ORGANIZATION; LOCAL TREATMENT; MEN; SUPPRESSION; MORTALITY	Context Whether androgen deprivation therapy (ADT) causes excess cardiovascular deaths in men with prostate cancer is highly controversial and was the subject of a joint statement by multiple medical societies and a US Food and Drug Administration safety warning. Objective To perform a systematic review and meta-analysis of randomized trials to determine whether ADT is associated with cardiovascular mortality, prostate cancer-specific mortality (PCSM), and all-cause mortality in men with unfavorable-risk, non-metastatic prostate cancer. Data Sources A search of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials databases for relevant randomized controlled trials in English between January 1, 1966, and April 11, 2011. Study Selection Inclusion required nonmetastatic disease, intervention group with gonadotropin-releasing hormone agonist-based ADT, control group with no immediate ADT, complete information on cardiovascular deaths, and median follow-up of more than 1 year. Data Extraction Extraction was by 2 independent reviewers. Summary incidence, relative risk (RR), and CIs were calculated using random-effects or fixed-effects models. Results Among 4141 patients from 8 randomized trials, cardiovascular death in patients receiving ADT vs control was not significantly different (255/2200 vs 252/1941 events; incidence, 11.0%; 95% CI, 8.3%-14.5%; vs 11.2%; 95% CI, 8.3%-15.0%; RR, 0.93; 95% CI, 0.79-1.10; P=.41). ADT was not associated with excess cardiovascular death in trials of at least 3 years (long duration) of ADT (11.5%; 95% CI, 8.1%-16.0%; vs 11.5%; 95% CI, 7.5%-17.3%; RR, 0.91; 95% CI, 0.75-1.10; P=.34) or in trials of 6 months or less (short duration) of ADT (10.5%; 95% CI, 6.3%-17.0%; vs 10.3%; 95% CI, 8.2%-13.0%; RR, 1.00; 95% CI, 0.73-1.37; P=.99). Among 4805 patients from 11 trials with overall death data, ADT was associated with lower PCSM (443/2527 vs 552/2278 events; 13.5%; 95% CI, 8.8%-20.3%; vs 22.1%; 95% CI, 15.1%-31.1%; RR, 0.69; 95% CI, 0.56-0.84; P<.001) and lower all-cause mortality (1140/2527 vs 1213/2278 events; 37.7%; 95% CI, 27.3%-49.4%; vs 44.4%; 95% CI, 32.5%-57.0%; RR, 0.86; 95% CI, 0.80-0.93; P<.001). Conclusion In a pooled analysis of randomized trials in unfavorable-risk prostate cancer, ADT use was not associated with an increased risk of cardiovascular death but was associated with a lower risk of PCSM and all-cause mortality. JAMA. 2011;306(21):2359-2366	[Nguyen, Paul L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Radiat Oncol, Boston, MA 02115 USA; [Schutz, Fabio A. B.; Choueiri, Toni K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Lank Ctr Genitourinary Onco, Boston, MA 02115 USA; [Je, Youjin] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hoffman, Karen E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Hu, Jim C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Hu, Jim C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Urol, Boston, MA 02115 USA; [Beckman, Joshua A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Parekh, Arti] Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Nguyen, PL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.	pnguyen@LROC.harvard.edu	Je, Youjin/N-2822-2018; Choueiri, Toni/K-5238-2019; Beckman, Joshua/A-7537-2016	Je, Youjin/0000-0002-2099-4204; Choueiri, Toni/0000-0002-9201-3217; Nguyen, Paul/0000-0003-4268-3973; Beckman, Joshua/0000-0001-8332-8439	JCRT Foundation; Doris Duke Clinical Research Fellowship; anonymous Family Foundation	JCRT Foundation; Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); anonymous Family Foundation	This work was supported by a JCRT Foundation grant; a Doris Duke Clinical Research Fellowship; David and Cynthia Chapin; Richard, Nancy, and Karis Cho; and a grant from an anonymous Family Foundation.	Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Aus G, 2002, BJU INT, V90, P561, DOI 10.1046/j.1464-410X.2002.02982.x; Black PC, 2007, BJU INT, V100, P63, DOI 10.1111/j.1464-410X.2007.06846.x; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; Dalkin BL, 1996, J UROLOGY, V155, P1357, DOI 10.1016/S0022-5347(01)66266-9; Denham JW, 2011, LANCET ONCOL, V12, P451, DOI 10.1016/S1470-2045(11)70063-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Efstathiou JA, 2009, J CLIN ONCOL, V27, P92, DOI 10.1200/JCO.2007.12.3752; Green HJ, 2004, BJU INT, V93, P975, DOI 10.1111/j.1464-410X.2004.04763.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Labrie F, 1997, UROLOGY, V49, P56, DOI 10.1016/S0090-4295(97)00170-2; Laverdiere J, 2004, J UROLOGY, V171, P1137, DOI 10.1097/01.ju.0000112979.97941.7f; Levine GN, 2010, CIRCULATION, V121, P833, DOI 10.1161/CIRCULATIONAHA.109.192695; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nanda A, 2009, JAMA-J AM MED ASSOC, V302, P866, DOI 10.1001/jama.2009.1137; Nguyen PL, 2012, INT J RADIAT ONCOL, V82, P1411, DOI 10.1016/j.ijrobp.2011.04.067; Nguyen PL, 2011, CANCER-AM CANCER SOC, V117, P406, DOI 10.1002/cncr.25597; Prezioso D, 2004, UROL INT, V72, P189, DOI 10.1159/000077113; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Schroder FH, 2009, EUR UROL, V55, P14, DOI 10.1016/j.eururo.2008.09.008; Schulman CC, 2000, EUR UROL, V38, P706, DOI 10.1159/000020366; Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507; Soloway MS, 2002, J UROLOGY, V167, P112, DOI 10.1016/S0022-5347(05)65393-1; Studer UE, 2006, J CLIN ONCOL, V24, P1868, DOI 10.1200/JCO.2005.04.7423; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; US Food and Drug Administration, FDA DRUG SAF COMM UP; Yee DS, 2010, BJU INT, V105, P185, DOI 10.1111/j.1464-410X.2009.08698.x	33	319	325	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2359	2366		10.1001/jama.2011.1745	http://dx.doi.org/10.1001/jama.2011.1745			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22147380				2022-12-28	WOS:000297680300021
J	Spence, D				Spence, Des			FROM THE FRONTLINE NICE needs reform	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2011	343								d7945	10.1136/bmj.d7945	http://dx.doi.org/10.1136/bmj.d7945			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861SP	22162385				2022-12-28	WOS:000298039800009
J	Labonte, R; Ruckert, A				Labonte, Ronald; Ruckert, Arne			The Commission on Macroeconomics and Health: was it the right recipe?	LANCET			English	Editorial Material									[Labonte, Ronald] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Labonte, Ronald; Ruckert, Arne] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Labonte, R (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					[Anonymous], 2001, MACR HLTH INV HLTH E; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Katz A, 2004, INT J HEALTH SERV, V34, P751, DOI 10.2190/6BVE-W9G4-GWBN-LNVK; Labonte R, 2008, AUST J PRIM HEALTH, V14, P58, DOI 10.1071/PY08037; LIPSON DJ, 2001, CMH WORKING PAPER SE; Morrow RH, 2002, BRIT MED J, V325, P53, DOI 10.1136/bmj.325.7355.53; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Organization WH, 2016, GLOBAL STATUS REPORT; Sustainable Development Commission, 2009, PROSP GROWTH TRANS S; Waitzkin H, 2003, LANCET, V361, P523, DOI 10.1016/S0140-6736(03)12491-9; WHO, 2008, PHARMAFORUM 0121	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2011	378	9807					1902	1903		10.1016/S0140-6736(11)61785-6	http://dx.doi.org/10.1016/S0140-6736(11)61785-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863AW	22137832				2022-12-28	WOS:000298136200014
J	Schreiber, SJ				Schreiber, Sebastian J.			Mathematical Dances with Wolves	SCIENCE			English	Editorial Material							EVOLUTIONARY; POPULATION		Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Schreiber, SJ (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	sschreiber@ucdavis.edu		Schreiber, Sebastian/0000-0002-5481-4822				Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Bangs EE, 1998, WILDLIFE SOC B, V26, P785; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Caswell, 2000, MATRIX POPULATION MO; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Schreiber SJ, 2011, ECOLOGY, V92, P1582; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; US Fish and Wildlife Service, 2010, ROCK MOUNT WOLF REC	14	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1214	1215		10.1126/science.1214845	http://dx.doi.org/10.1126/science.1214845			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144606				2022-12-28	WOS:000297553600027
J	O'Donnell, CJ; Nabel, EG				O'Donnell, Christopher J.; Nabel, Elizabeth G.			GENOMIC MEDICINE Genomics of Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-ARTERY-DISEASE; SCALE ASSOCIATION ANALYSIS; ABDOMINAL AORTIC-ANEURYSM; WIDE ASSOCIATION; HEART-FAILURE; MYOCARDIAL-INFARCTION; INTRACRANIAL ANEURYSM; SUSCEPTIBILITY LOCI; ATRIAL-FIBRILLATION; CHARGE CONSORTIUM		[Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [O'Donnell, Christopher J.] NHLBI, NIH, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] NIH, Framingham Heart Study, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [O'Donnell, Christopher J.; Nabel, Elizabeth G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nabel, EG (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	enabel@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CD, 2010, STROKE, V41, P1123, DOI 10.1161/STROKEAHA.110.580589; [Anonymous], 2010, NHLBI FACT BOOK FISC; Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Arking DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009879; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), 2011, BRIT MED J, V342, pd548; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Elmore JR, 2009, J VASC SURG, V49, P1525, DOI 10.1016/j.jvs.2009.01.041; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harismendy O, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r118; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kathiresan S, 2007, AM J CARDIOL, V99, P310, DOI 10.1016/j.amjcard.2006.08.028; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koriyama H, 2010, J ATHEROSCLER THROMB, V17, P1054, DOI 10.5551/jat.4291; Kucharska-Newton AM, 2009, ARTERIOSCL THROM VAS, V29, P2182, DOI 10.1161/ATVBAHA.109.192740; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Malarstig A, 2009, BLOOD, V114, P1417, DOI 10.1182/blood-2009-04-215269; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; O'Donnell CJ, 2008, CIRC-CARDIOVASC GENE, V1, P51, DOI 10.1161/CIRCGENETICS.108.813337; Palomaki GE, 2010, GENET MED, V12, P772, DOI 10.1097/GIM.0b013e3181f8728d; Parikh NI, 2007, CIRCULATION, V116, P1473, DOI 10.1161/CIRCULATIONAHA.107.705202; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pepe MS, 2010, CANCER EPIDEM BIOMAR, V19, P655, DOI 10.1158/1055-9965.EPI-09-0510; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Szustakowski J, 2001, NATURE, V411, P720; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Yamada Y, 2009, ATHEROSCLEROSIS, V207, P144, DOI 10.1016/j.atherosclerosis.2009.03.038; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855	80	171	185	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2098	2109		10.1056/NEJMra1105239	http://dx.doi.org/10.1056/NEJMra1105239			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129254	Bronze			2022-12-28	WOS:000297499000010
J	Kendall, T; Taylor, C; Bhatti, H; Chan, M; Kapur, N				Kendall, Tim; Taylor, Clare; Bhatti, Henna; Chan, Melissa; Kapur, Navneet		Guideline Dev Grp	Longer term management of self harm: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							SERVICES; SUICIDE		[Kendall, Tim; Taylor, Clare; Bhatti, Henna; Chan, Melissa] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Univ Coll London Clin Educ & Hlth Psychol, London WC1E 7HB, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Kapur, Navneet] Univ Manchester, Ctr Mental Hlth & Risk, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England; [Kapur, Navneet] Manchester Mental Hlth & Social Care Trust, Manchester M21 9UN, Lancs, England	University of London; University College London; University of London; University College London; University of Manchester; Open University - UK	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim2.kendall@virgin.net		Kapur, Nav/0000-0002-3100-3234; Meader, Nicholas/0000-0001-9332-6605				[Anonymous], 2009, SCHIZ COR INT TREATM; Arnold L., 1995, WOMEN SELF INJURY SU; Bennewith O, 2004, BMJ-BRIT MED J, V328, P1108, DOI 10.1136/bmj.328.7448.1108; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton KKE, COCHRANE DA IN PRESS; Kapur N, 1999, POSTGRAD MED J, V75, P599, DOI 10.1136/pgmj.75.888.599; *NAT I HLTH CLIN E, 2007, DRUG MIS OP DET; National Institute for Health and Care Excellence, 2009, BORDERLINE PERSONALI; National Institute for Health and Care Excellence (NICE), 2011, ALCOHOL USE DISORDER; National Institute for Health and Clinical Excellence, 2011, SELF HARM LONG TERM; National Institute for Health and Clinical Excellence, 2006, BIP DIS MAN BIP DIS; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT; National Institute for Health and Clinical Excellence, 2004, SELF HARM SHORT TERM; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Office for National Statistics, 2011, SUIC RAT UK 2000 200; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Taylor TL, 2009, BRIT J PSYCHIAT, V194, P104, DOI 10.1192/bjp.bp.107.046425; The Manchester Self-Harm Project, 2022, MANCH SELF HARM PROJ	22	23	23	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2011	343								d7073	10.1136/bmj.d7073	http://dx.doi.org/10.1136/bmj.d7073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	875FH	22113565				2022-12-28	WOS:000299015300007
J	Burke, A; Robinson, LF				Burke, Andrea; Robinson, Laura F.			The Southern Ocean's Role in Carbon Exchange During the Last Deglaciation	SCIENCE			English	Article							ATMOSPHERIC CO2 CONCENTRATIONS; GEOMAGNETIC-FIELD INTENSITY; ATLANTIC DEEP-WATER; SEA-ICE; GLACIAL PERIOD; RADIOCARBON AGES; PACIFIC-OCEAN; ANTARCTICA; CLIMATE; RISE	Changes in the upwelling and degassing of carbon from the Southern Ocean form one of the leading hypotheses for the cause of glacial-interglacial changes in atmospheric carbon dioxide. We present a 25,000-year-long Southern Ocean radiocarbon record reconstructed from deep-sea corals, which shows radiocarbon-depleted waters during the glacial period and through the early deglaciation. This depletion and associated deep stratification disappeared by similar to 14.6 ka (thousand years ago), consistent with the transfer of carbon from the deep ocean to the surface ocean and atmosphere via a Southern Ocean ventilation event. Given this evidence for carbon exchange in the Southern Ocean, we show that existing deep-ocean radiocarbon records from the glacial period are sufficiently depleted to explain the similar to 190 per mil drop in atmospheric radiocarbon between similar to 17 and 14.5 ka.	[Burke, Andrea] MIT, Woods Hole Oceanog Inst Joint Program Oceanog, Woods Hole, MA 02543 USA; [Burke, Andrea; Robinson, Laura F.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Robinson, Laura F.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; University of Bristol	Burke, A (corresponding author), MIT, Woods Hole Oceanog Inst Joint Program Oceanog, Mailstop 24, Woods Hole, MA 02543 USA.	aburke@whoi.edu		Robinson, Laura/0000-0001-6811-0140; Burke, Andrea/0000-0002-3754-1498	NSF [0636787, 0944474, 0902957, 0338087, 0819714]	NSF(National Science Foundation (NSF))	This research was funded by NSF grants 0636787, 0944474, 0902957, 0338087, and 0819714. The data reported in this study are tabulated in the supporting online material. We acknowledge R. Waller and the science parties of cruises LMG06-05 and NBP08-05 for supplying samples used in this study. We also thank the crews of the R/V Nathaniel B. Palmer and R/V Laurence M. Gould, NOSAMS staff, the WHOI plasma facility, J. Blusztajn, M. Auro, and two anonymous reviewers for help with this project.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2010, NAT GEOSCI, V3, P567, DOI [10.1038/ngeo921, 10.1038/NGEO921]; Broecker W, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001359; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2009, RADIOCARBON, V51, P109, DOI 10.1017/S0033822200033737; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Burke A, 2010, DEEP-SEA RES PT I, V57, P1510, DOI 10.1016/j.dsr.2010.07.010; Butzin M, 2005, EARTH PLANET SC LETT, V235, P45, DOI 10.1016/j.epsl.2005.03.003; De Pol-Holz R, 2010, NAT GEOSCI, V3, P192, DOI 10.1038/NGEO745; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Frank M, 1997, EARTH PLANET SC LETT, V149, P121, DOI 10.1016/S0012-821X(97)00070-8; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Goldstein SJ, 2001, EARTH PLANET SC LETT, V193, P167, DOI 10.1016/S0012-821X(01)00494-0; Hain MP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046158; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Laj C, 2002, EARTH PLANET SC LETT, V200, P177, DOI 10.1016/S0012-821X(02)00618-0; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lund DC, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001938; Magana Alexandra L., 2010, Paleoceanography, V25, pUnpaginated, DOI 10.1029/2010PA002011; Mangini A, 2010, EARTH PLANET SC LETT, V293, P269, DOI 10.1016/j.epsl.2010.02.041; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PENG TH, 1984, NUCL INSTRUM METH B, V5, P346, DOI 10.1016/0168-583X(84)90540-8; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Robinson LF, 2009, GEOLOGY, V37, P195, DOI 10.1130/G25363A.1; Schmittner A, 2003, EARTH PLANET SC LETT, V213, P53, DOI 10.1016/S0012-821X(03)00291-7; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Waller RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016153	41	198	202	2	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					557	561		10.1126/science.1208163	http://dx.doi.org/10.1126/science.1208163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22174131				2022-12-28	WOS:000299769200036
J	Roberts, ISD; Benamore, RE; Benbow, EW; Lee, SH; Harris, JN; Jackson, A; Mallett, S; Patankar, T; Peebles, C; Roobottom, C; Traill, ZC				Roberts, Ian S. D.; Benamore, Rachel E.; Benbow, Emyr W.; Lee, Stephen H.; Harris, Jonathan N.; Jackson, Alan; Mallett, Susan; Patankar, Tufail; Peebles, Charles; Roobottom, Carl; Traill, Zoe C.			Post-mortem imaging as an alternative to autopsy in the diagnosis of adult deaths: a validation study	LANCET			English	Article							MINIMALLY INVASIVE AUTOPSY; CT; ANGIOGRAPHY; ATTITUDES; BIOPSY	Background Public objection to autopsy has led to a search for minimally invasive alternatives. Imaging has potential, but its accuracy is unknown. We aimed to identify the accuracy of post-mortem CT and MRI compared with full autopsy in a large series of adult deaths. Methods This study was undertaken at two UK centres in Manchester and Oxford between April, 2006, and November, 2008. We used whole-body CT and MRI followed by full autopsy to investigate a series of adult deaths that were reported to the coroner. CT and MRI scans were reported independently, each by two radiologists who were masked to the autopsy findings. All four radiologists then produced a consensus report based on both techniques, recorded their confidence in cause of death, and identified whether autopsy was needed. Findings We assessed 182 unselected cases. The major discrepancy rate between cause of death identified by radiology and autopsy was 32% (95% CI 26-40) for CT, 43% (36-50) for MRI, and 30% (24-37) for the consensus radiology report; 10% (3-17) lower for CT than for MRI. Radiologists indicated that autopsy was not needed in 62 (34%; 95% CI 28-41) of 182 cases for CT reports, 76 (42%; 35-49) of 182 cases for MRI reports, and 88 (48%; 41-56) of 182 cases for consensus reports. Of these cases, the major discrepancy rate compared with autopsy was 16% (95% CI 9-27), 21% (13-32), and 16% (10-25), respectively, which is significantly lower (p<0.0001) than for cases with no definite cause of death. The most common imaging errors in identification of cause of death were ischaemic heart disease (n=27), pulmonary embolism (11), pneumonia (13), and intra-abdominal lesions (16). Interpretation We found that, compared with traditional autopsy, CT was a more accurate imaging technique than MRI for providing a cause of death. The error rate when radiologists provided a confident cause of death was similar to that for clinical death certificates, and could therefore be acceptable for medicolegal purposes. However, common causes of sudden death are frequently missed on CT and MRI, and, unless these weaknesses are addressed, systematic errors in mortality statistics would result if imaging were to replace conventional autopsy.	[Roberts, Ian S. D.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England; [Benamore, Rachel E.; Traill, Zoe C.] Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England; [Benbow, Emyr W.] Manchester Royal Infirm, Dept Histopathol, Manchester M13 9WL, Lancs, England; [Lee, Stephen H.] Manchester Royal Infirm, Dept Radiol, Manchester M13 9WL, Lancs, England; [Harris, Jonathan N.] Hope Hosp, Dept Radiol, Salford M6 8HD, Lancs, England; [Jackson, Alan] Univ Manchester, Dept Neuroradiol, Manchester, Lancs, England; [Mallett, Susan] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Patankar, Tufail] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Peebles, Charles] Southampton Gen Hosp, Dept Radiol, Southampton SO9 4XY, Hants, England; [Roobottom, Carl] Univ Plymouth, Peninsula Med Sch, Plymouth PL4 8AA, Devon, England	University of Oxford; University of Oxford; University of Manchester; University of Manchester; University of Manchester; University of Oxford; Leeds General Infirmary; University of Leeds; University of Southampton; University of Plymouth	Roberts, ISD (corresponding author), John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England.	ian.roberts@ouh.nhs.uk	Mallett, Sue/GPS-9933-2022	Mallett, Sue/0000-0002-0596-8200; JACKSON, ALAN/0000-0002-1623-0383	Department of Health, UK	Department of Health, UK	Policy Research Programme, Department of Health, UK.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; [Anonymous], 2006, CORONERS AUTOPSY DO; Bisset RAL, 2002, BRIT MED J, V324, P1423, DOI 10.1136/bmj.324.7351.1423; Bolliger SA, 2010, AM J ROENTGENOL, V195, P1051, DOI 10.2214/AJR.10.4600; FOROUDI F, 1995, PATHOLOGY, V27, P79, DOI 10.1080/00313029500169532; GELLER SA, 1984, ARCH PATHOL LAB MED, V108, P494; Huston BM, 1996, MODERN PATHOL, V9, P1101; Luce T., 2003, DEATH CERTIFICATION; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; Office for National Statistics' Death Certifi cation Advisory Group, 2005, GUID DOCT CERT CAUS; Patriquin L, 2001, J MAGN RESON IMAGING, V13, P277, DOI 10.1002/1522-2586(200102)13:2<277::AID-JMRI1040>3.0.CO;2-W; Roberts ISD, 2011, CLIN RADIOL, V66, P645, DOI 10.1016/j.crad.2011.01.007; Roberts ISD, 2000, J CLIN PATHOL, V53, P367, DOI 10.1136/jcp.53.5.367; Roberts ISD, 2003, HISTOPATHOLOGY, V42, P424, DOI 10.1046/j.1365-2559.2003.01614.x; ROS PR, 1990, MAGN RESON IMAGING, V8, P303, DOI 10.1016/0730-725X(90)90103-9; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Saunders SL, 2011, INT J LEGAL MED, V125, P609, DOI 10.1007/s00414-011-0559-4; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tsitsikas DA, 2011, J CLIN PATHOL, V64, P412, DOI 10.1136/jcp.2010.086645; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	22	327	338	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					136	142		10.1016/S0140-6736(11)61483-9	http://dx.doi.org/10.1016/S0140-6736(11)61483-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22112684	Green Published			2022-12-28	WOS:000299317700035
J	Henderson, DK				Henderson, David K.			Management of Needlestick Injuries A House Officer Who Has a Needlestick	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE WORKERS; HIV POSTEXPOSURE PROPHYLAXIS; T-LYMPHOCYTE RESPONSES; ACUTE HEPATITIS-C; DRUG USE EXPOSURE; OCCUPATIONAL-EXPOSURE; PERCUTANEOUS INJURY; GLOVE PERFORATIONS; UNIVERSAL PRECAUTIONS	Since its identification in 1985, human immunodeficiency virus (HIV) has challenged several aspects of health care delivery. Because HIV is a blood-borne infectious disease, from the early days of the epidemic, concern was raised about risks of occupational exposures and infections among health care workers. Despite the development of highly active antiretroviral therapy, which has effectively modulated HIV into a chronic disease in many settings, risks of occupational infection with 3 blood-borne pathogens remain in the health care workplace. Using the case of a house officer who has a needlestick during a resuscitation attempt, prevention of needlesticks including universal precautions and postexposure management of occupational HIV, hepatitis B, and hepatitis C exposures is discussed. JAMA. 0;0(1):75-84	NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Henderson, DK (corresponding author), NIH, Ctr Clin, 10 Ctr Dr,MSC 1504, Bethesda, MD 20892 USA.	dkh@nih.gov						Aarnio P, 2001, VASA-J VASCULAR DIS, V30, P122, DOI 10.1024/0301-1526.30.2.122; Akduman D, 1999, INFECT CONT HOSP EP, V20, P110, DOI 10.1086/501601; Alvarado-Ramy F, 2003, INFECT CONT HOSP EP, V24, P97, DOI 10.1086/502179; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1; ARMSTRONG K, 1995, SOC WORK HEALTH CARE, V21, P61, DOI 10.1300/J010v21n03_06; Avery CME, 1999, BRIT J ORAL MAX SURG, V37, P316, DOI 10.1054/bjom.1998.0018; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; BEEKMANN SE, 1994, CLIN INFECT DIS, V18, P562, DOI 10.1093/clinids/18.4.562; Beekmann SE, 1992, INFECT DIS CLIN PRAC, V1, P424; Beltrami EM, 2000, INFECT CONT HOSP EP, V21, P765, DOI 10.1086/501730; BENNETT NT, 1994, J AM COLL SURGEONS, V178, P107; Blauvelt A, 2000, AIDS, V14, P647, DOI 10.1097/00002030-200004140-00003; Bottiger D, 1997, AIDS, V11, P157, DOI 10.1097/00002030-199702000-00004; Bulterys M, 1999, GLOB STRAT PREV HIV; Burke S, 1997, OCCUP MED-OXFORD, V47, P357, DOI 10.1093/occmed/47.6.357; Cao YZ, 1997, NAT MED, V3, P549, DOI 10.1038/nm0597-549; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V36, p1S; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Centers for Disease Control and Prevention, 1988, MMWR MORB MORTAL WKL, V37, P387; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V49, P1153; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P21; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P929; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P377; CHAPMAN S, 1993, AM J OBSTET GYNECOL, V168, P1354, DOI 10.1016/S0002-9378(11)90764-9; CHEYNIER R, 1992, EUR J IMMUNOL, V22, P2211, DOI 10.1002/eji.1830220905; CLERICI M, 1994, JAMA-J AM MED ASSOC, V271, P42, DOI 10.1001/jama.271.1.42; CLERICI M, 1992, J INFECT DIS, V165, P1012, DOI 10.1093/infdis/165.6.1012; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DAVIS JM, 1992, ARCH SURG-CHICAGO, V127, P218; Dilley JW, 1990, FOCUS, V5, P3; Do AN, 2003, INFECT CONT HOSP EP, V24, P86, DOI 10.1086/502178; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; Fahey BJ, 1995, 35 INT C ANT AG CHEM; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; GERBERDING JL, 1987, J INFECT DIS, V156, P861, DOI 10.1093/infdis/156.6.861; GERBERDING JL, 1990, NEW ENGL J MED, V322, P1788, DOI 10.1056/NEJM199006213222506; GERBERDING JL, 1995, SURG CLIN N AM, V75, P1133; Gerberding Julie L., 1997, American Journal of Medicine, V102, P85, DOI 10.1016/S0002-9343(97)00157-5; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Gulick RM, 2003, CLIN MICROBIOL INFEC, V9, P186, DOI 10.1046/j.1469-0691.2003.00570.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HAIDUVEN DJ, 1995, INFECT CONT HOSP EP, V16, P582; HAIDUVEN DJ, 1992, INFECT CONT HOSP EP, V13, P265, DOI 10.2307/30145501; HAMORY BH, 1983, AM J INFECT CONTROL, V11, P174, DOI 10.1016/0196-6553(83)90077-9; Henderson DK, 1999, JAMA-J AM MED ASSOC, V281, P931, DOI 10.1001/jama.281.10.931; Henderson DK, 2003, CLIN MICROBIOL REV, V16, P546, DOI 10.1128/CMR.16.3.546-568.2003; Henderson DK, 2001, EMERG INFECT DIS, V7, P254, DOI 10.3201/eid0702.010221; HENDERSON DK, 1989, J INFECT DIS, V160, P321, DOI 10.1093/infdis/160.2.321; Henderson DK, 2009, PRINCIPLES PRACTICE, V7th, P3753; Heptonstall J, 1997, NEW ENGL J MED, V336, P178, DOI 10.1056/NEJM199701163360304; Ippolito G, 1999, CLIN INFECT DIS, V28, P365, DOI 10.1086/515101; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Johnson S, 2002, ANN INTERN MED, V137, P146, DOI 10.7326/0003-4819-137-2-200207160-00025; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; KELKER HC, 1992, AIDS RES HUM RETROV, V8, P1355, DOI 10.1089/aid.1992.8.1355; Kovavisarach E, 2002, AUST NZ J OBSTET GYN, V42, P519, DOI 10.1111/j.0004-8666.2002.00519.x; KRISTENSEN MS, 1992, INFECT CONT HOSP EP, V13, P719; Laine T, 2001, AM J SURG, V181, P564, DOI 10.1016/S0002-9610(01)00626-2; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Larghi A, 2002, HEPATOLOGY, V36, P993, DOI 10.1053/jhep.2002.36129; Leslie LF, 1996, J BIOMED MATER RES, V33, P41, DOI 10.1002/(SICI)1097-4636(199621)33:1<41::AID-JBM7>3.3.CO;2-1; Loudon MA, 1998, J ROY COLL SURG EDIN, V43, P6; Luque A, 2007, INFECT CONT HOSP EP, V28, P695, DOI 10.1086/518349; MANGIONE CM, 1991, AM J MED, V90, P85, DOI 10.1016/0002-9343(91)90510-5; MAST ST, 1993, J INFECT DIS, V168, P1589, DOI 10.1093/infdis/168.6.1589; Mayer KH, 2008, JAIDS-J ACQ IMM DEF, V47, P494, DOI 10.1097/QAI.0b013e318162afcb; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mechai F, 2008, J MED VIROL, V80, P9, DOI 10.1002/jmv.21000; Mendelson MH, 2003, INFECT CONT HOSP EP, V24, P105, DOI 10.1086/502174; Missale G, 2004, EUR J IMMUNOL, V34, P3208, DOI 10.1002/eji.200424889; Naver LPS, 2000, EUR J SURG, V166, P293; Panlilio AL, 2004, INFECT CONT HOSP EP, V25, P556, DOI 10.1086/502439; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; Pinto Ligia A., 1997, American Journal of Medicine, V102, P21, DOI 10.1016/S0002-9343(97)00056-9; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Porta C, 1999, AAOHN J, V47, P237; Quinn MM, 2009, AM J PUBLIC HLTH S3, V99, pS710, DOI DOI 10.2105/AJPH.2008.150169; Radecki S, 2000, ARCH INTERN MED, V160, P3107, DOI 10.1001/archinte.160.20.3107; Roland ME, 2001, J INFECT DIS, V184, P1608, DOI 10.1086/324580; Rowland-Jones S, 1998, DEV BIOL STAND, V92, P209; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; SAAG MS, 1991, J INFECT DIS, V164, P72, DOI 10.1093/infdis/164.1.72; Schmid K, 2007, J HOSP INFECT, V65, P124, DOI 10.1016/j.jhin.2006.10.002; SEEFF LB, 1978, ANN INTERN MED, V88, P285, DOI 10.7326/0003-4819-88-3-285; Sha BE, 2000, JAMA-J AM MED ASSOC, V284, P2723; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Tadesse M, 2010, TROP DOCT, V40, P111, DOI 10.1258/td.2009.090191; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1; Tsai CC, 2000, J MED PRIMATOL, V29, P248, DOI 10.1034/j.1600-0684.2000.290318.x; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Van Rompay KKA, 1999, J VIROL, V73, P2947, DOI 10.1128/JVI.73.4.2947-2955.1999; Venier AG, 2007, INFECT CONT HOSP EP, V28, P1196, DOI 10.1086/520742; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; Wang SA, 2000, INFECT CONT HOSP EP, V21, P780, DOI 10.1086/501736; WERNER BG, 1982, ANN INTERN MED, V97, P367, DOI 10.7326/0003-4819-97-3-367; Woods JA, 1996, J BIOMED MATER RES, V33, P47, DOI 10.1002/(SICI)1097-4636(199621)33:1<47::AID-JBM8>3.0.CO;2-M; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3	100	32	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2012	307	1					75	84		10.1001/jama.2011.1828	http://dx.doi.org/10.1001/jama.2011.1828			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872ET	22146902				2022-12-28	WOS:000298792300024
J	DeHaan, RL				DeHaan, Robert L.			Teaching Creative Science Thinking	SCIENCE			English	Editorial Material							UNDERGRADUATE BIOLOGY; INNOVATIONS		Emory Univ, Div Educ Studies, Atlanta, GA 30322 USA	Emory University	DeHaan, RL (corresponding author), Emory Univ, Div Educ Studies, Atlanta, GA 30322 USA.	rdehaan@emory.edu						Abrami PC, 2008, REV EDUC RES, V78, P1102, DOI 10.3102/0034654308326084; Allen Deborah, 2006, CBE Life Sci Educ, V5, P197, DOI 10.1187/cbe.06-06-0168; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; [Anonymous], 2011, HDB DESIGNING PROBLE; Ansburg PI, 2003, PERS INDIV DIFFER, V34, P1141, DOI 10.1016/S0191-8869(02)00104-6; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Cortright RN, 2005, ADV PHYSIOL EDUC, V29, P107, DOI 10.1152/advan.00060.2004; Cracolice MS, 2008, J CHEM EDUC, V85, P873, DOI 10.1021/ed085p873; DeHaan R. L., 2005, J SCI EDUC TECHNOL, V14, P253, DOI DOI 10.1007/S10956-005-4425-3; DeHaan RL, 2009, CBE-LIFE SCI EDUC, V8, P172, DOI 10.1187/cbe.08-12-0081; Dunbar K, 1999, MODEL-BASED REASONING IN SCIENTIFIC DISCOVERY, P85; DUNBAR K, 1995, NATURE INSIGHT, P365; Fauconnier G, 1998, COGNITIVE SCI, V22, P133, DOI 10.1016/S0364-0213(99)80038-X; Felder, 2009, ASQ HIGHER ED BRIEF, V2, P4, DOI DOI 10.14201/EKS2016171718; Feldman M. P., 2008, ED INNOVATION IMPLIC, P49; Handelsman J, 2007, SCI TEACHING; Hu WP, 2002, INT J SCI EDUC, V24, P389, DOI 10.1080/09500690110098912; Jacob F, 2011, SCIENCE, V332, P767, DOI 10.1126/science.1207943; Johnson D.W., 1991, ACTIVE LEARNING COOP; Karpicke JD, 2011, SCIENCE, V331, P772, DOI 10.1126/science.1199327; Kim KH, 2006, CREATIVITY RES J, V18, P3, DOI 10.1207/s15326934crj1801_2; Kim MH, 2007, DESIGN STUD, V28, P585, DOI 10.1016/j.destud.2007.04.006; Koestler A., 1964, ACT CREATION; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Lyman F., 1981, MAINSTREAMING DIGEST; McWilliam E, 2008, J SCI EDUC TECHNOL, V17, P226, DOI 10.1007/s10956-008-9092-8; Momsen JL, 2010, CBE-LIFE SCI EDUC, V9, P435, DOI 10.1187/cbe.10-01-0001; National Science Board, 2010, PREP NEXT GEN STEM I; Pereira F. C., CONCEPTUAL BLENDING; Ruiz-Primo MA, 2011, SCIENCE, V331, P1269, DOI 10.1126/science.1198976; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Scott G, 2004, CREATIVITY RES J, V16, P361, DOI 10.1207/s15326934crj1604_1; Simonton D.K., 2004, CREATIVITY SCI CHANC; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; Thagard P, 2011, COGNITIVE SCI, V35, P1, DOI 10.1111/j.1551-6709.2010.01142.x; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306	37	50	51	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1499	1500		10.1126/science.1207918	http://dx.doi.org/10.1126/science.1207918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174233				2022-12-28	WOS:000298091400032
J	Sims, IR				Sims, Ian R.			Arranging Reactive Meetings of Cold Radicals	SCIENCE			English	Editorial Material							TEMPERATURE KINETICS; CHEMISTRY; NITROGEN		Univ Rennes 1, Inst Phys Rennes, CNRS, UMR UR1 6251, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes	Sims, IR (corresponding author), Univ Rennes 1, Inst Phys Rennes, CNRS, UMR UR1 6251, 263 Ave Gen Leclerc, F-35042 Rennes, France.	ian.sims@univ-rennes1.fr	Sims, Ian R/F-8989-2014	Sims, Ian R/0000-0001-7870-1585				Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Bergeat A, 2009, PHYS CHEM CHEM PHYS, V11, P8149, DOI 10.1039/b905702a; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; Canosa A., 2008, LOW TEMPERATURES COL, P55; Carty D, 2006, J PHYS CHEM A, V110, P3101, DOI 10.1021/jp054429u; Daranlot J, 2011, SCIENCE, V334, P1538, DOI 10.1126/science.1213789; DUPEYRAT G, 1985, PHYS FLUIDS, V28, P1273, DOI 10.1063/1.865010; Herbst E, 2005, J PHYS CHEM A, V109, P4017, DOI 10.1021/jp050461c; Hily-Blant P, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913200; Maret S, 2006, NATURE, V442, P425, DOI 10.1038/nature04919; Pilling MJ, 1996, ANNU REV PHYS CHEM, V47, P81, DOI 10.1146/annurev.physchem.47.1.81; SIMS IR, 1994, J CHEM PHYS, V100, P4229, DOI 10.1063/1.467227; SMITH IWM, 1991, J CHEM SOC FARADAY T, V87, P2271, DOI 10.1039/ft9918702271; SMITH IWM, 1994, J CHEM SOC FARADAY T, V90, P3221, DOI 10.1039/ft9949003221; Soorkia S, 2010, J PHYS CHEM A, V114, P3340, DOI 10.1021/jp911132r	15	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1506	1507		10.1126/science.1215318	http://dx.doi.org/10.1126/science.1215318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174238				2022-12-28	WOS:000298091400037
J	Massel, F; Heikkila, TT; Pirkkalainen, JM; Cho, SU; Saloniemi, H; Hakonen, PJ; Sillanpaa, MA				Massel, F.; Heikkila, T. T.; Pirkkalainen, J. -M.; Cho, S. U.; Saloniemi, H.; Hakonen, P. J.; Sillanpaa, M. A.			Microwave amplification with nanomechanical resonators	NATURE			English	Article							PARAMETRIC AMPLIFICATION; QUANTUM-NOISE; GROUND-STATE; INSTABILITY; MOTION; LIMITS	The sensitive measurement of electrical signals is at the heart of modern technology. According to the principles of quantum mechanics, any detector or amplifier necessarily adds a certain amount of noise to the signal, equal to at least the noise added by quantum fluctuations(1,2). This quantum limit of added noise has nearly been reached in superconducting devices that take advantage of nonlinearities in Josephson junctions(3,4). Here we introduce the concept of the amplification of microwave signals using mechanical oscillation, which seems likely to enable quantum-limited operation. We drive a nanomechanical resonator with a radiation pressure force(5-7), and provide an experimental demonstration and an analytical description of how a signal input to a microwave cavity induces coherent stimulated emission and, consequently, signal amplification. This generic scheme, which is based on two linear oscillators, has the advantage of being conceptually and practically simpler than the Josephson junction devices. In our device, we achieve signal amplification of 25 decibels with the addition of 20 quanta of noise, which is consistent with the expected amount of added noise. The generality of the model allows for realization in other physical systems as well, and we anticipate that near-quantum-limited mechanical microwave amplification will soon be feasible in various applications involving integrated electrical circuits.	[Massel, F.; Heikkila, T. T.; Pirkkalainen, J. -M.; Cho, S. U.; Hakonen, P. J.; Sillanpaa, M. A.] Aalto Univ, Low Temp Lab, FI-00076 Aalto, Finland; [Saloniemi, H.] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland	Aalto University; VTT Technical Research Center Finland	Massel, F (corresponding author), Aalto Univ, Low Temp Lab, POB 15100, FI-00076 Aalto, Finland.	francesco.massel@aalto.fi	Sillanpaa, Mika/A-3554-2013; Heikkila, Tero/B-2973-2009; Massel, Francesco P/F-3372-2012; Hakonen, Pertti J/E-7688-2012; Heikkila, Tero/B-2973-2009	Heikkila, Tero/0000-0002-7732-691X; Massel, Francesco P/0000-0002-6132-109X; Hakonen, Pertti J/0000-0002-8247-4108; Heikkila, Tero/0000-0001-7408-9384; Pirkkalainen, Juha-Matti/0000-0002-8631-7767	Academy of Finland; European Research Council [240362-Heattronics, 240387-NEMSQED];  [EU-FP7-NMP-246026]	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); 	We would like to thank S. Paraoanu and H. Seppa for discussions. This work was supported by the Academy of Finland and by the European Research Council (grant numbers 240362-Heattronics and 240387-NEMSQED) and EU-FP7-NMP-246026.	Andre MO, 1999, APPL PHYS LETT, V75, P698, DOI 10.1063/1.124486; Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Braginsky VB, 2001, PHYS LETT A, V287, P331, DOI 10.1016/S0375-9601(01)00510-2; Carr DW, 2000, APPL PHYS LETT, V77, P1545, DOI 10.1063/1.1308270; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Genes C, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033804; HAUS HA, 2000, ADV TEXTS PHYS, P1; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Leggett AJ, 2002, J PHYS-CONDENS MAT, V14, pR415, DOI 10.1088/0953-8984/14/15/201; MANCINI S, 1994, PHYS REV A, V49, P4055, DOI 10.1103/PhysRevA.49.4055; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Raskin JP, 2000, J MICROELECTROMECH S, V9, P528, DOI 10.1109/84.896775; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; RUGAR D, 1991, PHYS REV LETT, V67, P699, DOI 10.1103/PhysRevLett.67.699; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Sillanpaa MA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3173826; Sulkko J, 2010, NANO LETT, V10, P4884, DOI 10.1021/nl102771p; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901; Woolley MJ, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062303; YURKE B, 1988, PHYS REV LETT, V60, P764, DOI 10.1103/PhysRevLett.60.764	30	213	214	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					351	354		10.1038/nature10628	http://dx.doi.org/10.1038/nature10628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170682	Green Submitted			2022-12-28	WOS:000298033000047
J	Parker, T				Parker, Thomas			Cutting science's electricity bill	NATURE			English	Editorial Material												thomas.parker@esss.se		Parker, Thomas/0000-0001-8043-0243					0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					315	316		10.1038/480315a	http://dx.doi.org/10.1038/480315a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22170663	Bronze			2022-12-28	WOS:000298033000028
J	Peltz, E; Kohrmann, M				Peltz, Elena; Koehrmann, Martin			Internal-Carotid-Artery Dissection and Cranial-Nerve Palsies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Peltz, Elena; Koehrmann, Martin] Univ Erlangen Nurnberg, Erlangen, Germany	University of Erlangen Nuremberg	Peltz, E (corresponding author), Univ Erlangen Nurnberg, Erlangen, Germany.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					E43	E43		10.1056/NEJMicm1009319	http://dx.doi.org/10.1056/NEJMicm1009319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150058				2022-12-28	WOS:000297731400008
J	Hyman, AH; Simons, K				Hyman, Anthony H.; Simons, Kai			Beyond HeLa cells	NATURE			English	Editorial Material									[Hyman, Anthony H.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Hyman, AH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Tony/F-1923-2011	Simons, Kai/0000-0002-9231-9996					0	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					34	34		10.1038/480034a	http://dx.doi.org/10.1038/480034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129708				2022-12-28	WOS:000298031900016
J	Dienstag, JL				Dienstag, Jules L.			The Medical College Admission Test - Toward a New Balance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LICENSING EXAMINATIONS; PREDICTIVE-VALIDITY; SCHOOL; PERFORMANCE; MCAT		Harvard Univ, Sch Med, Off Dean Med Educ, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Dienstag, JL (corresponding author), Harvard Univ, Sch Med, Off Dean Med Educ, Boston, MA 02114 USA.			Dienstag, Jules/0000-0001-7024-0980				Andriole DA, 2010, JAMA-J AM MED ASSOC, V304, P1212, DOI 10.1001/jama.2010.1321; Callahan CA, 2010, ACAD MED, V85, P980, DOI 10.1097/ACM.0b013e3181cece3d; Donnon T, 2007, ACAD MED, V82, P100, DOI 10.1097/01.ACM.0000249878.25186.b7; Hojat M, 2000, ACAD MED, V75, pS25, DOI 10.1097/00001888-200010001-00008; McGaghie WC, 2002, JAMA-J AM MED ASSOC, V288, P1085, DOI 10.1001/jama.288.9.1085	5	10	10	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1955	1957		10.1056/NEJMp1110171	http://dx.doi.org/10.1056/NEJMp1110171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22111717				2022-12-28	WOS:000297282600005
J	Kinnard, C; Zdanowicz, CM; Fisher, DA; Isaksson, E; de Vernal, A; Thompson, LG				Kinnard, Christophe; Zdanowicz, Christian M.; Fisher, David A.; Isaksson, Elisabeth; de Vernal, Anne; Thompson, Lonnie G.			Reconstructed changes in Arctic sea ice over the past 1,450 years	NATURE			English	Article							LAST MILLENNIUM; CLIMATE; VARIABILITY; REGRESSION; EXTENT; BAY	Arctic sea ice extent is now more than two million square kilometres less than it was in the late twentieth century, with important consequences for the climate, the ocean and traditional lifestyles in the Arctic(1,2). Although observations show a more or less continuous decline for the past four or five decades(3,4), there are few long-term records with which to assess natural sea ice variability. Until now, the question of whether or not current trends are potentially anomalous(5) has therefore remained unanswerable. Here we use a network of high-resolution terrestrial proxies from the circum-Arctic region to reconstruct past extents of summer sea ice, and show that-although extensive uncertainties remain, especially before the sixteenth century-both the duration and magnitude of the current decline in sea ice seem to be unprecedented for the past 1,450 years. Enhanced advection of warm Atlantic water to the Arctic(6) seems to be the main factor driving the decline of sea ice extent on multidecadal timescales, and may result from nonlinear feedbacks between sea ice and the Atlantic meridional overturning circulation. These results reinforce the assertion that sea ice is an active component of Arctic climate variability and that the recent decrease in summer Arctic sea ice is consistent with anthropogenically forced warming.	[Kinnard, Christophe] Ctr Estudios Avanzados Zonas Aridas, La Serena 1720170, Chile; [Zdanowicz, Christian M.; Fisher, David A.] Geol Survey Canada, NRCAN, Ottawa, ON K1A 0E8, Canada; [Isaksson, Elisabeth] FRAM High N Res Ctr Climate & Environm, Norwegian Polar Res Inst, NO-9296 Tromso, Norway; [de Vernal, Anne] Univ Quebec, GEOTOP, Montreal, PQ H3C 3P8, Canada; [Thompson, Lonnie G.] Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Norwegian Polar Institute; University of Quebec; University of Quebec Montreal; University System of Ohio; Ohio State University	Kinnard, C (corresponding author), Ctr Estudios Avanzados Zonas Aridas, Benavente 980,Casilla 554, La Serena 1720170, Chile.	christophe.kinnard@ceaza.cl	de Vernal, Anne/D-5602-2013; Kinnard, Christophe/AAI-2468-2020	de Vernal, Anne/0000-0001-5656-724X; Kinnard, Christophe/0000-0002-4553-5258; Zdanowicz, Christian/0000-0002-1045-5063	Canadian Foundation for Climate and Atmospheric Sciences (Polar Climate Stability Network); Natural Sciences and Engineering Research Council of Canada	Canadian Foundation for Climate and Atmospheric Sciences (Polar Climate Stability Network); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported jointly by the Canadian Foundation for Climate and Atmospheric Sciences (Polar Climate Stability Network) and the Natural Sciences and Engineering Research Council of Canada.	Beckers JM, 2003, J ATMOS OCEAN TECH, V20, P1839, DOI 10.1175/1520-0426(2003)020<1839:ECADFF>2.0.CO;2; Bonnet S, 2010, MAR MICROPALEONTOL, V74, P59, DOI 10.1016/j.marmicro.2009.12.001; Christiansen B, 2009, J CLIMATE, V22, P951, DOI 10.1175/2008JCLI2301.1; Comiso JC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004257; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Crespin E, 2009, CLIM PAST, V5, P389, DOI 10.5194/cp-5-389-2009; de Vernal A., 2008, GEOPHYS MONOGR SER, V80, P27; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Fauria MM, 2010, CLIM DYNAM, V34, P781, DOI 10.1007/s00382-009-0610-z; Fisher D., 2006, EOS, V87, P273, DOI [10.1029/2006EO280001, DOI 10.1029/2006EO280001]; Grumet NS, 2001, CLIMATIC CHANGE, V49, P129, DOI 10.1023/A:1010794528219; Holland MM, 2001, J CLIMATE, V14, P656, DOI 10.1175/1520-0442(2001)014<0656:TROIOI>2.0.CO;2; JACOBY GC, 1982, NATURE, V298, P637, DOI 10.1038/298637a0; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Lee TCK, 2008, CLIM DYNAM, V31, P263, DOI 10.1007/s00382-007-0351-9; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Mann ME, 2007, ANNU REV EARTH PL SC, V35, P111, DOI 10.1146/annurev.earth.35.031306.140042; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Masse G, 2008, EARTH PLANET SC LETT, V269, P565, DOI 10.1016/j.epsl.2008.03.017; MICHAELSEN J, 1987, J CLIM APPL METEOROL, V26, P1589, DOI 10.1175/1520-0450(1987)026<1589:CVISCF>2.0.CO;2; Min SK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035725; Naes T., 2004, MULTIVARIATE CALIBRA; Perovich DK, 2009, ANNU REV MAR SCI, V1, P417, DOI 10.1146/annurev.marine.010908.163805; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Polyakov IV, 2003, J CLIMATE, V16, P2078, DOI 10.1175/1520-0442(2003)016<2078:LIVIAM>2.0.CO;2; Richefol T, 2008, MAR MICROPALEONTOL, V68, P6, DOI 10.1016/j.marmicro.2008.03.003; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Spielhagen RF, 2011, SCIENCE, V331, P450, DOI 10.1126/science.1197397; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Vare LL, 2010, HOLOCENE, V20, P637, DOI 10.1177/0959683609355179; Wahl ER, 2007, CLIMATIC CHANGE, V85, P33, DOI 10.1007/s10584-006-9105-7; Walsh JE, 2001, ANN GLACIOL, V33, P444, DOI 10.3189/172756401781818671; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	38	222	234	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					509	U231		10.1038/nature10581	http://dx.doi.org/10.1038/nature10581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113692				2022-12-28	WOS:000297285600046
J	Pealing, L; Iliffe, S				Pealing, Louise; Iliffe, Steve			A woman with forgetfulness and falls	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEWY BODIES DLB; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MYOCARDIAL SCINTIGRAPHY; INTERNATIONAL WORKSHOP; ELDERLY-PATIENTS; SENILE DEMENTIA; PRIMARY-CARE; BODY TYPE; DIAGNOSIS		[Pealing, Louise; Iliffe, Steve] Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Iliffe, S (corresponding author), Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England.	s.iliffe@ucl.ac.uk	Iliffe, Steve/L-8379-2019	Iliffe, Stephen/0000-0003-2806-3997	National Institute for Health Research [RP-PG-0606-1005] Funding Source: researchfish; Department of Health [RP-PG-0606-1005] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P164, DOI 10.1177/0891988704267463; Alzheimer's Society, 2007, FULL DEM UK REP; Alzheimer's Society, 2010, WHAT IS DEM LEW BOD; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2006, DEM SUPP PEOPL DEM T; Black SA, 1999, J CLIN EPIDEMIOL, V52, P1095, DOI 10.1016/S0895-4356(99)00100-6; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Brooks Augustin, 2010, BMJ, V340, pc1998, DOI 10.1136/bmj.c1998; Burn DJ, 2002, MOVEMENT DISORD, V17, P445, DOI 10.1002/mds.10114; Cole MG, 2007, J NEUROPSYCH CLIN N, V19, P151, DOI 10.1176/appi.neuropsych.19.2.151; Cole MG, 2004, AM J GERIAT PSYCHIAT, V12, P7, DOI 10.1176/appi.ajgp.12.1.7; Dennis M, 1997, POSTGRAD MED J, V73, P755, DOI 10.1136/pgmj.73.865.755; Department of Health, 2009, LIVING WELL DEMENTIA; Department of Health, 2010, NOTHING VENTURED NOT; Fischer C, 2007, DEMENT GERIATR COGN, V23, P307, DOI 10.1159/000100901; George J, 1997, AGE AGEING, V26, P423, DOI 10.1093/ageing/26.6.423; Geser F, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20535; Higuchi M, 2000, EXP NEUROL, V162, P247, DOI 10.1006/exnr.2000.7342; Iliffe S, 2009, INT J GERIATR PSYCH, V24, P895, DOI 10.1002/gps.2204; Imamura T, 1999, NEUROREPORT, V10, P1903, DOI 10.1097/00001756-199906230-00020; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Ishii K, 1998, NEUROLOGY, V51, P125, DOI 10.1212/WNL.51.1.125; Kemp PM, 2007, NUCL MED COMMUN, V28, P511, DOI 10.1097/MNM.0b013e3281e20a12; MCKEITH I, 1992, BRIT MED J, V305, P673, DOI 10.1136/bmj.305.6855.673; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith I, 1992, BRIT MED J, V305, P6783; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2004, PARKINSONISM RELAT D, V10, pS15, DOI 10.1016/j.parkreldis.2003.12.005; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MIND, 2008, UND DEM; Minoshima S, 2001, ANN NEUROL, V50, P358, DOI 10.1002/ana.1133; Norman DC, 2000, CLIN INFECT DIS, V31, P148, DOI 10.1086/313896; Oide T, 2003, INTERNAL MED, V42, P686, DOI 10.2169/internalmedicine.42.686; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; Poewe W, 2005, MOVEMENT DISORD, V20, pS77, DOI 10.1002/mds.20544; Saxena S, 2009, POSTGRAD MED J, V85, P405, DOI 10.1136/pgmj.2008.072025; Swanberg MM, 2002, DRUG SAFETY, V25, P511, DOI 10.2165/00002018-200225070-00005; Walker Z, 2007, J NEUROL NEUROSUR PS, V78, P1176, DOI 10.1136/jnnp.2006.110122; Watanabe H, 2001, J NEUROL NEUROSUR PS, V70, P781, DOI 10.1136/jnnp.70.6.781; Yoshita M, 2001, J NEUROL NEUROSUR PS, V71, P583, DOI 10.1136/jnnp.71.5.583	43	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 24	2011	343								d7412	10.1136/bmj.d7412	http://dx.doi.org/10.1136/bmj.d7412			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861QW	22115903	Green Submitted			2022-12-28	WOS:000298035300004
J	Gholitabar, M; Ullman, R; James, D; Griffiths, M				Gholitabar, Maryam; Ullman, Roz; James, David; Griffiths, Malcolm		Guideline Dev Grp	GUIDELINES Caesarean section: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gholitabar, Maryam; Ullman, Roz; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Griffiths, Malcolm] Luton & Dunstable Hosp NHS Fdn Trust, Luton LU4 0DZ, Beds, England		Ullman, R (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	rullman@ncc-wch.org.uk	Griffiths, Malcolm/C-5918-2009	Griffiths, Malcolm/0000-0001-6910-2249				[Anonymous], 2008, ANT CAR ROUT CAR HLT; [Anonymous], 2008, MMWR-MORBID MORTAL W, V57, P1019; Eriksson JG, 2005, BMJ-BRIT MED J, V330, P1096, DOI 10.1136/bmj.330.7500.1096; National Institute for Health and Clinical Excellence, 2007, INTR CAR CLIN GUID 5, V55; National Institute for Health and Clinical Excellence, 2005, INTR BLOOD CELL SALV; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2006, POSTN CAR ROUT POSTN; National Institute for Health and Clinical Excellence, 2008, IND LAB CLIN GUID 70, V70; National Institute for Health & Clinical Excellence, 2011, CLIN GUID 132; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; The National Institute for Health and Clinical Excellence, 2010, MAN HYP DIS PREGN CL; Thomas J., 2001, NATL SENTINEL CAESAR; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR; HOSP EPISODE STAT MA	14	34	36	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2011	343								d7108	10.1136/bmj.d7108	http://dx.doi.org/10.1136/bmj.d7108			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857NE	22113566				2022-12-28	WOS:000297724400001
J	Kessler, JD; Kahle, KT; Sun, TT; Meerbrey, KL; Schlabach, MR; Schmitt, EM; Skinner, SO; Xu, QK; Li, MZ; Hartman, ZC; Rao, M; Yu, P; Dominguez-Vidana, R; Liang, AC; Solimini, NL; Bernardi, RJ; Yu, B; Hsu, T; Golding, I; Luo, J; Osborne, CK; Creighton, CJ; Hilsenbeck, SG; Schiff, R; Shaw, CA; Elledge, SJ; Westbrook, TF				Kessler, Jessica D.; Kahle, Kristopher T.; Sun, Tingting; Meerbrey, Kristen L.; Schlabach, Michael R.; Schmitt, Earlene M.; Skinner, Samuel O.; Xu, Qikai; Li, Mamie Z.; Hartman, Zachary C.; Rao, Mitchell; Yu, Peng; Dominguez-Vidana, Rocio; Liang, Anthony C.; Solimini, Nicole L.; Bernardi, Ronald J.; Yu, Bing; Hsu, Tiffany; Golding, Ido; Luo, Ji; Osborne, C. Kent; Creighton, Chad J.; Hilsenbeck, Susan G.; Schiff, Rachel; Shaw, Chad A.; Elledge, Stephen J.; Westbrook, Thomas F.			A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis	SCIENCE			English	Article							NEGATIVE BREAST-CANCER; C-MYC; EXPRESSION SIGNATURE; THERAPY; P53; METASTASIS; TRANSACTIVATION; ACTIVATION; INHIBITION; ADDICTION	Myc is an oncogenic transcription factor frequently dysregulated in human cancer. To identify pathways supporting the Myc oncogenic program, we used a genome-wide RNA interference screen to search for Myc-synthetic lethal genes and uncovered a role for the SUMO-activating enzyme (SAE1/2). Loss of SAE1/2 enzymatic activity drives synthetic lethality with Myc. Inactivation of SAE2 leads to mitotic catastrophe and cell death upon Myc hyperactivation. Mechanistically, SAE2 inhibition switches a transcriptional subprogram of Myc from activated to repressed. A subset of these SUMOylation-dependent Myc switchers (SMS genes) is required for mitotic spindle function and to support the Myc oncogenic program. SAE2 is required for growth of Myc-dependent tumors in mice, and gene expression analyses of Myc-high human breast cancers suggest that low SAE1 and SAE2 abundance in the tumors correlates with longer metastasis-free survival of the patients. Thus, inhibition of SUMOylation may merit investigation as a possible therapy for Myc-driven human cancers.	[Kahle, Kristopher T.; Schlabach, Michael R.; Xu, Qikai; Li, Mamie Z.; Liang, Anthony C.; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Div Genet,Dept Genet, Boston, MA 02115 USA; [Kessler, Jessica D.; Sun, Tingting; Meerbrey, Kristen L.; Schmitt, Earlene M.; Skinner, Samuel O.; Dominguez-Vidana, Rocio; Hsu, Tiffany; Golding, Ido; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kessler, Jessica D.; Meerbrey, Kristen L.; Schmitt, Earlene M.; Rao, Mitchell; Yu, Peng; Dominguez-Vidana, Rocio; Hsu, Tiffany; Shaw, Chad A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Skinner, Samuel O.; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Hartman, Zachary C.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Bernardi, Ronald J.; Westbrook, Thomas F.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yu, Bing; Luo, Ji] NCI, Med Oncol Branch, Ctr Drive, Bethesda, MD 20892 USA; [Osborne, C. Kent; Creighton, Chad J.; Hilsenbeck, Susan G.; Schiff, Rachel; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Hilsenbeck, Susan G.; Schiff, Rachel] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu; thomasw@bcm.edu	Vidana, Rocio Dominguez/A-1153-2009	Vidana, Rocio Dominguez/0000-0003-3855-5178; Shaw, Chad/0000-0001-7267-5398; Hartman, Jessica/0000-0003-1578-3389	NIH [T32HD05520/T32CA090221-09, R01GM082837, CA149196]; U.S. Department of Defense [W81XWH-10-1-0354]; Human Frontier Science Program [RGY70/2008]; Welch Foundation [Q-1759]; NSF [082265]; Susan G. Komen for the Cure [KG090355]; CPRIT [RP120583]; Specialized Program of Research Excellence developmental grant [P50 CA058183]; SU2C-American Association for Cancer Research; U.S. Army [W81XWH0410197]; NATIONAL CANCER INSTITUTE [T32CA090221, ZIABC011303, U54CA149196, ZIABC011438, P50CA058183, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Human Frontier Science Program(Human Frontier Science Program); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); CPRIT; Specialized Program of Research Excellence developmental grant; SU2C-American Association for Cancer Research; U.S. Army(United States Department of DefenseUnited States Army); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bland for critical comments on the manuscript and T. Mitchell, W. Choi, S. Songyang, and the BCM C-BASS and CCSC Cores for reagents and technical assistance. J.D.K and K. L. M. are supported by NIH training grants T32HD05520/T32CA090221-09 and U.S. Department of Defense predoctoral fellowship W81XWH-10-1-0354, respectively. The Golding lab is supported by NIH grant R01GM082837, Human Frontier Science Program grant RGY70/2008, Welch Foundation grant Q-1759, and NSF grant 082265 (PFC: Center for the Physics of Living Cells). This work was supported by a Susan G. Komen for the Cure grant (KG090355), CPRIT grant (RP120583), and NIH grant (CA149196) to T. F. W., Specialized Program of Research Excellence developmental grant (P50 CA058183) to T. F. W., SU2C-American Association for Cancer Research Breast Cancer program grant to R. S. and C.K.O., and U.S. Army Innovator Award (W81XWH0410197) to S.J.E. S.J.E. is an Investigator with the Howard Hughes Medical Institute. T. F. W. is a scholar of The V Foundation and The Mary Kay Ash Foundation for Cancer Research. Gene Expression data are deposited in GEO (accession no. GSE34055).	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	307	320	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2012	335	6066					348	353		10.1126/science.1212728	http://dx.doi.org/10.1126/science.1212728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878RE	22157079	Bronze, Green Accepted			2022-12-28	WOS:000299273400051
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Idrabiotaparinux treatment for venous thromboembolism	LANCET			English	Editorial Material							ANTICOAGULANT-THERAPY; ATRIAL-FIBRILLATION; IDRAPARINUX; THROMBOSIS; WARFARIN; DISEASE		[Eikelboom, John W.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Eikelboom, John W.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada.	weitzj@taari.ca	Eikelboom, John/AAG-6117-2019; Weitz, Jeffrey/AAD-1929-2019	Eikelboom, John/0000-0003-4126-1285; Weitz, Jeffrey/0000-0002-1092-7550				Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, LANCET, V379, P123, DOI 10.1016/S0140-6736(11)61505-5; Buller HR, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2010.04100.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Harenberg J, 2009, THROMB HAEMOSTASIS, V102, P811, DOI 10.1160/TH09-08-0555; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Prins MH, 2007, J THROMB HAEMOST S2, V5; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598	12	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					96	98		10.1016/S0140-6736(11)61580-8	http://dx.doi.org/10.1016/S0140-6736(11)61580-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22127297				2022-12-28	WOS:000299317700011
J	Shima, S; Krueger, M; Weinert, T; Demmer, U; Kahnt, J; Thauer, RK; Ermler, U				Shima, Seigo; Krueger, Martin; Weinert, Tobias; Demmer, Ulrike; Kahnt, Joerg; Thauer, Rudolf K.; Ermler, Ulrich			Structure of a methyl-coenzyme M reductase from Black Sea mats that oxidize methane anaerobically	NATURE			English	Article							METHANOTROPHIC ARCHAEA; OXIDATION; METHANOGENESIS; DIVERSITY; MECHANISM; ANME-1; MODEL	The anaerobic oxidation of methane (AOM) with sulphate, an area currently generating great interest in microbiology, is accomplished by consortia of methanotrophic archaea (ANME) and sulphate-reducing bacteria(1,2). The enzyme activating methane in methanotrophic archaea has tentatively been identified as a homologue of methyl-coenzyme M reductase (MCR) that catalyses the methane-forming step in methanogenic archaea(3,4). Here we report an X-ray structure of the 280 kDa heterohexameric ANME-1 MCR complex. It was crystallized uniquely from a protein ensemble purified from consortia of microorganisms collected with a submersible from a Black Sea mat catalysing AOM with sulphate(4). Crystals grown from the heterogeneous sample diffract to 2.1 angstrom resolution and consist of a single ANME-1MCR population, demonstrating the strong selective power of crystallization. The structure revealed ANME-1 MCR in complex with coenzyme M and coenzyme B, indicating the same substrates for MCR from methanotrophic and methanogenic archaea. Differences between the highly similar structures of ANME-1MCR and methanogenic MCR include a F-430 modification, a cysteine-rich patch and an altered post-translational amino acid modification pattern, which may tune the enzymes for their functions in different biological contexts.	[Shima, Seigo; Kahnt, Joerg; Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Shima, Seigo] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Krueger, Martin] Fed Inst Geosci & Resources, D-30655 Hannover, Germany; [Weinert, Tobias; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society; Japan Science & Technology Agency (JST); Max Planck Society	Shima, S (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de; ulrich.ermler@biophys.mpg.de	Weinert, Tobias/I-4813-2013; Weinert, Tobias/J-6353-2017	Weinert, Tobias/0000-0002-0339-3722; Weinert, Tobias/0000-0002-0339-3722	Max Planck Society; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [SPP 1319, ER 222/5-1, KR 3311/6-2]; MUMM; BEBOP; University of Hamburg; PRESTO, Japan Science and Technology Agency (JST)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MUMM; BEBOP; University of Hamburg; PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by the Max Planck Society, the Fonds der Chemischen Industrie, the Deutsche Forschungsgemeinschaft (SPP 1319, ER 222/5-1, KR 3311/6-2) and the projects MUMM, and BEBOP (Biogeochemistry and Microbiology of Bioherms Prospering in the Black Sea funded by the University of Hamburg). S. S. was financed by the PRESTO program, Japan Science and Technology Agency (JST). We are indebted to W. Michaelis and R. Seifert for access to samples. We thank the crews of RV Poseidon with JAGO for help during field work, M. Brefort and L. Kanel for the electron spin resonance measurement and Edman sequencing, respectively. We are grateful to H. Michel for continuous support, the staff of the PXII beamline at the Swiss-Light-Source, Villigen for assistance during data collection, and K. Davies for critical reading of the manuscript.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Heller C, 2008, GEOMICROBIOL J, V25, P149, DOI 10.1080/01490450802006884; Jensen LMR, 2010, SCIENCE, V327, P1392, DOI 10.1126/science.1182492; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahnt J, 2007, FEBS J, V274, P4913, DOI 10.1111/j.1742-4658.2007.06016.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Mayr S, 2008, J AM CHEM SOC, V130, P10758, DOI 10.1021/ja802929z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Satzger H, 2005, J PHYS CHEM B, V109, P4770, DOI 10.1021/jp045151t; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003	30	105	111	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2012	481	7379					98	101		10.1038/nature10663	http://dx.doi.org/10.1038/nature10663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	872VD	22121022				2022-12-28	WOS:000298836900037
J	Wang, LL; Lawrence, MS; Wan, YZ; Stojanov, P; Sougnez, C; Stevenson, K; Werner, L; Sivachenko, A; DeLuca, DS; Zhang, L; Zhang, WD; Vartanov, AR; Fernandes, SM; Goldstein, NR; Folco, EG; Cibulskis, K; Tesar, B; Sievers, QL; Shefler, E; Gabriel, S; Hacohen, N; Reed, R; Meyerson, M; Golub, TR; Lander, ES; Neuberg, D; Brown, JR; Getz, G; Wu, CJ				Wang, Lili; Lawrence, Michael S.; Wan, Youzhong; Stojanov, Petar; Sougnez, Carrie; Stevenson, Kristen; Werner, Lillian; Sivachenko, Andrey; DeLuca, David S.; Zhang, Li; Zhang, Wandi; Vartanov, Alexander R.; Fernandes, Stacey M.; Goldstein, Natalie R.; Folco, Eric G.; Cibulskis, Kristian; Tesar, Bethany; Sievers, Quinlan L.; Shefler, Erica; Gabriel, Stacey; Hacohen, Nir; Reed, Robin; Meyerson, Matthew; Golub, Todd R.; Lander, Eric S.; Neuberg, Donna; Brown, Jennifer R.; Getz, Gad; Wu, Catherine J.			SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRE-MESSENGER-RNA; MUTATION STATUS; IN-VITRO; GENOME; ACTIVATION; SURVIVAL; PATHWAYS; CELLS; SPLICEOSTATIN; REVEALS	BACKGROUND The somatic genetic basis of chronic lymphocytic leukemia, a common and clinically heterogeneous leukemia occurring in adults, remains poorly understood. METHODS We obtained DNA samples from leukemia cells in 91 patients with chronic lymphocytic leukemia and performed massively parallel sequencing of 88 whole exomes and whole genomes, together with sequencing of matched germline DNA, to characterize the spectrum of somatic mutations in this disease. RESULTS Nine genes that are mutated at significant frequencies were identified, including four with established roles in chronic lymphocytic leukemia (TP53 in 15% of patients, ATM in 9%, MYD88 in 10%, and NOTCH1 in 4%) and five with unestablished roles (SF3B1, ZMYM3, MAPK1, FBXW7, and DDX3X). SF3B1, which functions at the catalytic core of the spliceosome, was the second most frequently mutated gene (with mutations occurring in 15% of patients). SF3B1 mutations occurred primarily in tumors with deletions in chromosome 11q, which are associated with a poor prognosis in patients with chronic lymphocytic leukemia. We further discovered that tumor samples with mutations in SF3B1 had alterations in pre-messenger RNA (mRNA) splicing. CONCLUSIONS Our study defines the landscape of somatic mutations in chronic lymphocytic leukemia and highlights pre-mRNA splicing as a critical cellular process contributing to chronic lymphocytic leukemia.	[Wang, Lili; Wan, Youzhong; Zhang, Li; Zhang, Wandi; Sievers, Quinlan L.; Wu, Catherine J.] Harvard Inst Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Wang, Lili; Wan, Youzhong; Zhang, Li; Zhang, Wandi; Vartanov, Alexander R.; Fernandes, Stacey M.; Goldstein, Natalie R.; Tesar, Bethany; Sievers, Quinlan L.; Meyerson, Matthew; Brown, Jennifer R.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Werner, Lillian; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Folco, Eric G.; Reed, Robin; Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Folco, Eric G.; Reed, Robin; Golub, Todd R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Brown, Jennifer R.; Wu, Catherine J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Boston, MA 02114 USA; [Brown, Jennifer R.; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Wu, CJ (corresponding author), Harvard Inst Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Rm 416B,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwu@partners.org	Folco, Eric/M-2665-2013; wang, lili/HDL-7210-2022; Stojanov, Petar/GQI-4462-2022; Meyerson, Matthew L/E-7123-2012; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019	Stojanov, Petar/0000-0001-7815-776X; Meyerson, Matthew/0000-0002-9133-8108; Vartanov, Alexander/0000-0001-5744-4882; Cibulskis, Kristian/0000-0003-1343-1582	Broad Institute through the National Human Genome Research Institute at the National Institutes of Health [U54HG003067]; National Institutes of Health [GM43375, K23 CA115682]; National Cancer Institute [5R21CA115043-2]; Melton and Rosenbach Funds; Blavatnik Family Foundation; Howard Hughes Medical Institute; Damon Runyon Cancer Research Foundation [CI-38-07]; NATIONAL CANCER INSTITUTE [R21CA115043, K23CA115682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM043375, R01GM043375] Funding Source: NIH RePORTER	Broad Institute through the National Human Genome Research Institute at the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melton and Rosenbach Funds; Blavatnik Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Broad Institute through a grant from the National Human Genome Research Institute at the National Institutes of Health (U54HG003067) and by grants from the National Institutes of Health (GM43375, to Drs. Folco and Reed, and K23 CA115682, to Dr. Brown), the National Cancer Institute (5R21CA115043-2), the Melton and Rosenbach Funds (to Dr. Brown), the Blavatnik Family Foundation (to Dr. Wu), the Early Career Physician-Scientist Award of the Howard Hughes Medical Institute (to Dr. Wu), and the Damon Runyon Cancer Research Foundation (CI-38-07, to Dr. Wu). Dr. Brown is a Scholar of the American Society of Hematology and a Scholar in Clinical Research of the Leukemia and Lymphoma Society.	Austen B, 2005, BLOOD, V106, P3175, DOI 10.1182/blood-2004-11-4516; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosner A, 2007, CURR MED CHEM, V14, P2517, DOI 10.2174/092986707782023677; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	35	803	825	3	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2011	365	26					2497	2506		10.1056/NEJMoa1109016	http://dx.doi.org/10.1056/NEJMoa1109016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868SD	22150006	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000298544600010
J	Wazni, O; Wilkoff, B; Saliba, W				Wazni, Oussama; Wilkoff, Bruce; Saliba, Walid			Catheter Ablation for Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY-VEIN ABLATION; RADIOFREQUENCY ABLATION; RHYTHM CONTROL; TASK-FORCE; BIOPHYSICS; GUIDELINES; MANAGEMENT; MECHANISM; SOCIETY	A 59-year-old man with hypertension and diabetes presents with palpitations, fatigue, and shortness of breath and is found to be in atrial fibrillation. He has had recurring episodes of atrial fibrillation over the previous 5 years, typically with similar symptoms, and has received warfarin for stroke prevention. He has required direct-current cardioversion to restore sinus rhythm on two occasions despite treatment with flecainide and subsequently with dofetilide. The use of amiodarone resulted in hyperthyroidism. After undergoing cardioversion, he is referred to a cardiac electrophysiologist, who recommends catheter ablation.	[Saliba, Walid] Cleveland Clin, Ctr Atrial Fibrillat, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Saliba, W (corresponding author), Cleveland Clin, Ctr Atrial Fibrillat, 9500 Euclid Ave,Desk J2-2, Cleveland, OH 44195 USA.	salibaw@ccf.org		Wilkoff, Bruce/0000-0001-8905-9233				Bunch TJ, 2009, J CARDIOVASC ELECTR, V20, P1326, DOI 10.1111/j.1540-8167.2009.01582.x; Calkins H, 2007, EUROPACE, V9, P335, DOI 10.1093/europace/eum120; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Calkins H, 2009, EUROPACE, V11, P132, DOI 10.1093/europace/eun341; Camm AJ, 2011, EUROPACE, V13, P1058, DOI 10.1093/europace/eur134; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Cheema A, 2006, J INTERV CARD ELECTR, V15, P145, DOI 10.1007/s10840-006-9005-9; CHEUNG DW, 1981, J PHYSIOL-LONDON, V314, P445, DOI 10.1113/jphysiol.1981.sp013718; Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Haines D, 2004, J CARDIOVASC ELECTR, V15, pS2, DOI 10.1046/j.1540-8167.2004.15102.x; HAINES DE, 1993, PACE, V16, P586, DOI 10.1111/j.1540-8159.1993.tb01630.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hou YL, 2007, HEART RHYTHM, V4, P56, DOI 10.1016/j.hrthm.2006.09.020; Hussein AA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P271, DOI 10.1161/CIRCEP.111.962100; Jais P, 2009, CIRCULATION, V120, pE83, DOI 10.1161/CIRCULATIONAHA.109.192636; KASEDA S, 1988, J AM COLL CARDIOL, V11, P1327, DOI 10.1016/0735-1097(88)90300-2; Krittayaphong Rungroj, 2003, J Med Assoc Thai, V86 Suppl 1, pS8; Lin JX, 2007, J CARDIOVASC ELECTR, V18, P1197, DOI 10.1111/j.1540-8167.2007.00976.x; Marrouche NF, 2003, CIRCULATION, V107, P2710, DOI 10.1161/01.CIR.0000070541.83326.15; MASANI F, 1986, J ANAT, V145, P133; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Moe G K, 1968, J Electrocardiol, V1, P145; MOE GK, 1975, REV PHYSIOL BIOCH P, V72, P55, DOI 10.1007/BFb0031546; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Packer D, 2010, AM COLL CARD 59 ANN; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Themistoclakis S, 2008, HEART RHYTHM, V5, P679, DOI 10.1016/j.hrthm.2008.01.031; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Verma A, 2011, CAN J CARDIOL, V27, P60, DOI 10.1016/j.cjca.2010.11.011; Wann LS, 2011, J AM COLL CARDIOL, V57, P223, DOI 10.1016/j.jacc.2010.10.001; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	41	62	65	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2296	2304		10.1056/NEJMct1109977	http://dx.doi.org/10.1056/NEJMct1109977			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168644				2022-12-28	WOS:000298031800010
J	Dzingina, M; Stegenga, H; Heath, M; Jones, D; Rogers, G; Kleijnen, J; Wolff, R; Armstrong, N; Howdle, PD				Dzingina, M.; Stegenga, H.; Heath, M.; Jones, D.; Rogers, G.; Kleijnen, J.; Wolff, R.; Armstrong, N.; Howdle, P. D.		Guideline Dev Grp	GUIDELINES Assessment and referral after emergency treatment of a suspected anaphylactic episode: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Howdle, P. D.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Dzingina, M.; Heath, M.; Jones, D.; Rogers, G.] Natl Inst Hlth & Clin Excellence, Manchester M1 4BT, Lancs, England; [Stegenga, H.] Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England; [Kleijnen, J.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands; [Wolff, R.; Armstrong, N.] Kleijnen Systemat Reviews, York YO19 6FD, N Yorkshire, England	University of Leeds; National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; Maastricht University; Kleijnen Systematic Reviews	Howdle, PD (corresponding author), Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.	p.d.howdle@leeds.ac.uk	Dzingina, Mendwas/C-4957-2014; Wolff, Robert F/E-2322-2016	Wolff, Robert F/0000-0003-3270-7791; Rogers, Gabriel/0000-0001-9339-7374				Capps JA, 2010, RESUSCITATION, V81, P653, DOI 10.1016/j.resuscitation.2010.01.021; National Institute for Health and Clinical Excellence, 2011, AN ASS CONF AN EP DE; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Stewart AG, 1996, QJM-MON J ASSOC PHYS, V89, P859, DOI 10.1093/qjmed/89.11.859; United Kingdom (UK) Resuscitation Council, 2008, EM TREATM AN REACT G	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2011	343								d7595	10.1136/bmj.d7595	http://dx.doi.org/10.1136/bmj.d7595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865NO	22171344				2022-12-28	WOS:000298317800006
J	Coppock, DL; Desta, S; Tezera, S; Gebru, G				Coppock, D. Layne; Desta, Solomon; Tezera, Seyoum; Gebru, Getachew			Capacity Building Helps Pastoral Women Transform Impoverished Communities in Ethiopia	SCIENCE			English	Article								Poverty, drought, and hunger devastate people on Africa's rangelands. We used an action-oriented approach from 2000 to 2004 to build capacity among thousands of pastoralists to diversify livelihoods, improve living standards, and enhance livestock marketing. The process included collective action, microfinance, and participatory education. Poor women previously burdened by domestic chores became leaders and rapidly changed their communities. Drought occurred from 2005 to 2008. We assessed intervention effects on household drought resilience with a quasiexperimental format that incorporated survey-based comparisons of treatment groups with ex post controls. Interventions led to major improvements in trends for quality of life, wealth accumulation, hunger reduction, and risk management. Human capacity building can be a driver for change, generating hope and aspirations that set the stage for the use of new information and technology.	[Coppock, D. Layne] Utah State Univ, Dept Environm & Soc EnvS, Logan, UT 84322 USA; [Desta, Solomon; Tezera, Seyoum; Gebru, Getachew] Managing Risk Improved Livelihoods MARIL PLC, Addis Ababa, Ethiopia	Utah System of Higher Education; Utah State University	Coppock, DL (corresponding author), Utah State Univ, Dept Environm & Soc EnvS, Logan, UT 84322 USA.	layne.coppock@usu.edu			Office of Agriculture, Bureau of Economic Growth, Agriculture and Trade, United States Agency for International Development (USAID) [PCE-G-00-98-00036-00]; USAID Mission	Office of Agriculture, Bureau of Economic Growth, Agriculture and Trade, United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID Mission(CGIAR)	Authors were members of the Pastoral Risk Management (PARIMA) project of the Global Livestock Collaborative Research Support Program (GL-CRSP). S. D. and G. G. were research associates in EnvS, and S. T. was a PARIMA employee based at the International Livestock Research Institute (ILRI) in Addis Ababa. Participation of project stakeholders is greatly appreciated. M. Demment, S. Johnson, and J. Turk are thanked for their support. S. Durham assisted with data analysis. B. Norton provided valuable editing feedback on manuscript drafts. ILRI hosted the project. This publication was made possible through support provided to the GL-CRSP by the Office of Agriculture, Bureau of Economic Growth, Agriculture and Trade, United States Agency for International Development (USAID) under the terms of grant PCE-G-00-98-00036-00 to the University of California, Davis, and by contributions from participating institutions. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID. The USAID Mission to Ethiopia is acknowledged for funding the capacity-building activities. Logit and chi square data access is at https://cnr.usu.edu/envs/htm/faculty-staff/coppockdata-sets-for-public-access.	Alexandratos N., 1995, WORLD AGR 2010 FAO S; ARMENDARIZ B, 2010, EC MICROFINANCE, P211; BASSETT T, 2010, ATLAS WORLD HUNGER, P43; BLUMBERG RL, 1995, ENGENDERING WEALTH W, P1; BOGALE S, 2010, LINKING POOR RURAL H; Burns John, 2010, LINKING POOR RURAL H; Coppock D.L., 1994, BORANA PLATEAU SO ET; COPPOCK D. L., 2012, ACHIEVING DEV IMPACT; Coppock DL, 2009, INNOVATION AFRICA EN, P104; Desta S, 2004, HUM ECOL, V32, P465, DOI 10.1023/B:HUEC.0000043516.56037.6b; Desta S, 2002, J RANGE MANAGE, V55, P439, DOI 10.2307/4003221; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Holechek JL, 2011, RANGE MANAGEMENT PRI, P337; JAHNKE H, 1982, LIVESTOCK PRODUCTION, P102; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; Karlan D, 2011, REV ECON STAT, V93, P510, DOI 10.1162/REST_a_00074; Little PD, 2001, DEV CHANGE, V32, P401, DOI 10.1111/1467-7660.00211; MAYOUX L., 2009, GENDER AGR SOURCEBOO, P85; Pandolfelli L., 2008, Journal of International Development, V20, P1, DOI 10.1002/jid.1424; ROGERS E, 2003, DIFFUSION INNOVATION, P18; SANDFORD S, 1983, MANAGEMENT PASTORAL, P1; Whitmer A, 2010, FRONT ECOL ENVIRON, V8, P314, DOI 10.1890/090241; Yunus M, 1999, SCI AM, V281, P114, DOI 10.1038/scientificamerican1199-114	23	34	34	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1394	1398		10.1126/science.1211232	http://dx.doi.org/10.1126/science.1211232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858HW	22158816				2022-12-28	WOS:000297787700051
J	van der Leij, MJ				van der Leij, Marco J.			Experimenting with Buddies	SCIENCE			English	Editorial Material							CONTAGION		[van der Leij, Marco J.] Univ Amsterdam, Ctr Nonlinear Dynam Econ & Finance, NL-1018 XE Amsterdam, Netherlands; [van der Leij, Marco J.] Tinbergen Inst, NL-3062 PA Rotterdam, Netherlands; [van der Leij, Marco J.] Nederlandsche Bank, Dept Res, NL-1000 AB Amsterdam, Netherlands	University of Amsterdam; Tinbergen Institute; European Central Bank; De Nederlandsche Bank NV	van der Leij, MJ (corresponding author), Univ Amsterdam, Ctr Nonlinear Dynam Econ & Finance, Valckenierstr 65-67, NL-1018 XE Amsterdam, Netherlands.	m.j.vanderleij@uva.nl		van der Leij, Marco/0000-0003-3591-9343				Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis N.A., 2009, CONNECTED; DiMaggio P, 2011, AM J SOCIOL, V116, P1887, DOI 10.1086/659653; Lyons Russel, 2011, STAT POLITICS POLICY, V2, P1, DOI DOI 10.2202/2151-7509.1024; Manski CF, 2000, J ECON PERSPECT, V14, P115, DOI 10.1257/jep.14.3.115; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836	12	10	10	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1220	1221		10.1126/science.1214836	http://dx.doi.org/10.1126/science.1214836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HD	22144610				2022-12-28	WOS:000297553600031
J	Abrams, P				Abrams, Paul			Should we treat lower urinary tract symptoms without a definitive diagnosis? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERACTIVE BLADDER; MEN; INCONTINENCE; DYSFUNCTION; MANAGEMENT		Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England	Southmead Hospital	Abrams, P (corresponding author), Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England.	paul_abrams@bui.ac.uk	Hug, Balthasar L./G-1568-2010					Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2009, J UROLOGY, V181, P1779, DOI 10.1016/j.juro.2008.11.127; ABRAMS P, 1994, BRIT MED J, V308, P929, DOI 10.1136/bmj.308.6934.929; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bates TS, 2003, BJU INT, V92, P581, DOI 10.1046/j.1464-410X.2003.04444.x; Bryant Charmaine M, 2002, Br J Nurs, V11, P560; Hashim H, 2008, BJU INT, V102, P62, DOI 10.1111/j.1464-410X.2008.07463.x; Hashim H, 2006, DRUGS, V66, P591, DOI 10.2165/00003495-200666050-00002; Irwin DE, 2011, BJU INT         0113; Irwin DE, 2008, J SEX MED, V5, P2904, DOI 10.1111/j.1743-6109.2008.01000.x; National Institute for Health and Clinical Excellence, 2010, LOW UR TRACT SYMPT N; National Institute for Health and Clinical Excellence, 2006, UR INC NICE GUID CG4; Thomas AW, 2005, BJU INT, V96, P1301, DOI 10.1111/j.1464-410X.2005.05815.x	13	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2011	343								d6038	10.1136/bmj.d6038	http://dx.doi.org/10.1136/bmj.d6038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EO	22134965				2022-12-28	WOS:000298938400005
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Barnardo's misleading survey: publicity at what cost?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7802	10.1136/bmj.d7802	http://dx.doi.org/10.1136/bmj.d7802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131214				2022-12-28	WOS:000298037300006
J	Patel, K				Patel, Kinesh			STARTING OUT Let someone else sign off sick notes	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk						2011, BRIT MED J, V343, pD3482, DOI DOI 10.1136/BMJ.D7594	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2011	343								d7750	10.1136/bmj.d7750	http://dx.doi.org/10.1136/bmj.d7750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	861RQ	22131207				2022-12-28	WOS:000298037300010
J	Holmes, D				Holmes, David			Profile Vincent Rajkumar: from Madras to Minnesota for myeloma	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 26	2011	378	9806					1842	1842		10.1016/S0140-6736(11)61801-1	http://dx.doi.org/10.1016/S0140-6736(11)61801-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	22118436				2022-12-28	WOS:000297695800019
J	Akhmanova, A; Dogterom, M				Akhmanova, Anna; Dogterom, Marileen			Kinesins Lead Aging Microtubules to Catastrophe	CELL			English	Editorial Material							DYNAMIC INSTABILITY; FORCE	The ability of growing microtubules to undergo catastrophes-abrupt switches from growth to shortening-is one of the key aspects of microtubule dynamics important for shaping cellular microtubule arrays. Gardner et al. show that catastrophes occur at a microtubule age-dependent rate and that depolymerizing kinesins can affect this process in fundamentally different ways.	[Akhmanova, Anna] Univ Utrecht, Div Cell Biol, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Dogterom, Marileen] FOM Inst Atom & Mol Phys AMOLF, NL-1098 XG Amsterdam, Netherlands	Utrecht University; AMOLF	Akhmanova, A (corresponding author), Univ Utrecht, Div Cell Biol, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.akhmanova@uu.nl; dogterom@amolf.nl	Akhmanova, Anna S/B-8896-2011	Akhmanova, Anna S/0000-0002-9048-8614				Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; ODDE DJ, 1995, BIOPHYS J, V69, P796, DOI 10.1016/S0006-3495(95)79953-2; Stepanova T, 2010, CURR BIOL, V20, P1023, DOI 10.1016/j.cub.2010.04.024; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	10	7	7	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					966	968		10.1016/j.cell.2011.11.011	http://dx.doi.org/10.1016/j.cell.2011.11.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118452	Bronze, Green Submitted			2022-12-28	WOS:000297376600007
J	Carwile, JL; Ye, XY; Zhou, XL; Calafat, AM; Michels, KB				Carwile, Jenny L.; Ye, Xiaoyun; Zhou, Xiaoliu; Calafat, Antonia M.; Michels, Karin B.			Canned Soup Consumption and Urinary Bisphenol A: A Randomized Crossover Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Carwile, Jenny L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ye, Xiaoyun; Zhou, Xiaoliu; Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Michels, Karin B.] Harvard Univ, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School	Carwile, JL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu	Calafat, Antonia/N-1183-2019; Calafat, Antonia/B-8076-2012; Calafat, Antonia/GOP-1115-2022	Calafat, Antonia/0000-0002-9796-7482	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32 ES 007069, T32 ES007069] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 2009, CANN FOODS OUR TESTS; Centers for Disease Control and Prevention, 4 CDCP; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Noonan GO, 2011, J AGR FOOD CHEM, V59, P7178, DOI 10.1021/jf201076f; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d	6	110	111	6	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2218	2220		10.1001/jama.2011.1721	http://dx.doi.org/10.1001/jama.2011.1721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22110104	Green Accepted, Bronze			2022-12-28	WOS:000297255500019
J	Palmieri, C; Jones, A				Palmieri, Carlo; Jones, Alison			The 2011 EBCTCG polychemotherapy overview	LANCET			English	Editorial Material							BREAST; CHEMOTHERAPY		[Palmieri, Carlo] Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England; [Jones, Alison] Univ Coll Hosp, Dept Med Oncol, London, England	Imperial College London; University of London; University College London	Palmieri, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England.	c.palmieri@imperial.ac.uk						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Baselga J, 1998, CANCER RES, V58, P2825; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; BONADONNA G, 1976, NEW ENGL J MED, V294, P405, DOI 10.1056/NEJM197602192940801; Darby S, 2005, CELEBRATING STAT; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Perez EA, 2005, 41 AM SOC CLIN ONC A; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; VONHOFF DD, 1977, AM J MED, V62, P200, DOI 10.1016/0002-9343(77)90315-1	12	32	34	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					390	392		10.1016/S0140-6736(11)61823-0	http://dx.doi.org/10.1016/S0140-6736(11)61823-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AF	22152852				2022-12-28	WOS:000300187800011
J	Nugent, PE; Sullivan, M; Cenko, SB; Thomas, RC; Kasen, D; Howell, DA; Bersier, D; Bloom, JS; Kulkarni, SR; Kandrashoff, MT; Filippenko, AV; Silverman, JM; Marcy, GW; Howard, AW; Isaacson, HT; Maguire, K; Suzuki, N; Tarlton, JE; Pan, YC; Bildsten, L; Fulton, BJ; Parrent, JT; Sand, D; Podsiadlowski, P; Bianco, FB; Dilday, B; Graham, ML; Lyman, J; James, P; Kasliwal, MM; Law, NM; Quimby, RM; Hook, IM; Walker, ES; Mazzali, P; Pian, E; Ofek, EO; Gal-Yam, A; Poznanski, D				Nugent, Peter E.; Sullivan, Mark; Cenko, S. Bradley; Thomas, Rollin C.; Kasen, Daniel; Howell, D. Andrew; Bersier, David; Bloom, Joshua S.; Kulkarni, S. R.; Kandrashoff, Michael T.; Filippenko, Alexei V.; Silverman, Jeffrey M.; Marcy, Geoffrey W.; Howard, Andrew W.; Isaacson, Howard T.; Maguire, Kate; Suzuki, Nao; Tarlton, James E.; Pan, Yen-Chen; Bildsten, Lars; Fulton, Benjamin J.; Parrent, Jerod T.; Sand, David; Podsiadlowski, Philipp; Bianco, Federica B.; Dilday, Benjamin; Graham, Melissa L.; Lyman, Joe; James, Phil; Kasliwal, Mansi M.; Law, Nicholas M.; Quimby, Robert M.; Hook, Isobel M.; Walker, Emma S.; Mazzali, Paolo; Pian, Elena; Ofek, Eran O.; Gal-Yam, Avishay; Poznanski, Dovi			Supernova SN 2011fe from an exploding carbon-oxygen white dwarf star	NATURE			English	Article							IA SUPERNOVAE; SPECTRA; 1994D	Type Ia supernovae have been used empirically as 'standard candles' to demonstrate the acceleration of the expansion of the Universe(1-3) even though fundamental details, such as the nature of their progenitor systems and how the stars explode, remain a mystery(4-6). There is consensus that a white dwarf star explodes after accreting matter in a binary system, but the secondary body could be anything from a main-sequence star to a red giant, or even another white dwarf. This uncertainty stems from the fact that no recent type Ia supernova has been discovered close enough to Earth to detect the stars before explosion. Here we report early observations of supernova SN 2011fe in the galaxy M101 at a distance(7) from Earth of 6.4 megaparsecs. We find that the exploding star was probably a carbon-oxygen white dwarf, and from the lack of an early shock we conclude that the companion was probably a main-sequence star. Early spectroscopy shows high-velocity oxygen that slows rapidly, on a timescale of hours, and extensive mixing of newly synthesized intermediate-mass elements in the outermost layers of the supernova. A companion paper(8) uses pre-explosion images to rule out luminous red giants and most helium stars as companions to the progenitor.	[Nugent, Peter E.; Thomas, Rollin C.; Kasen, Daniel; Suzuki, Nao; Poznanski, Dovi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Nugent, Peter E.; Cenko, S. Bradley; Bloom, Joshua S.; Kandrashoff, Michael T.; Filippenko, Alexei V.; Silverman, Jeffrey M.; Marcy, Geoffrey W.; Howard, Andrew W.; Isaacson, Howard T.; Poznanski, Dovi] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Sullivan, Mark; Maguire, Kate; Tarlton, James E.; Pan, Yen-Chen; Podsiadlowski, Philipp; Hook, Isobel M.] Univ Oxford, Dept Phys Astrophys, Oxford OX1 3RH, England; [Kasen, Daniel] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Howell, D. Andrew; Fulton, Benjamin J.; Parrent, Jerod T.; Sand, David; Bianco, Federica B.; Dilday, Benjamin; Graham, Melissa L.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Howell, D. Andrew; Bildsten, Lars; Fulton, Benjamin J.; Sand, David; Bianco, Federica B.; Dilday, Benjamin; Graham, Melissa L.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Bersier, David; Lyman, Joe; James, Phil] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Kulkarni, S. R.; Kasliwal, Mansi M.; Ofek, Eran O.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Bildsten, Lars] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Parrent, Jerod T.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Law, Nicholas M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Quimby, Robert M.] Univ Tokyo, IPMU, Kashiwa, Chiba 2778583, Japan; [Hook, Isobel M.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, RM, Italy; [Walker, Emma S.] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Mazzali, Paolo; Pian, Elena] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Mazzali, Paolo; Pian, Elena] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Ofek, Eran O.; Gal-Yam, Avishay] Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Poznanski, Dovi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oxford; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; Liverpool John Moores University; California Institute of Technology; University of California System; University of California Santa Barbara; Dartmouth College; University of Toronto; University of Tokyo; Istituto Nazionale Astrofisica (INAF); Scuola Normale Superiore di Pisa; Istituto Nazionale Astrofisica (INAF); University of Padua; Max Planck Society; Weizmann Institute of Science; Tel Aviv University	Nugent, PE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	penugent@lbl.gov	Maguire, Kate/HHN-6122-2022; Hook, Isobel M/S-8590-2017; Howell, Andy/ABE-6446-2020; Nugent, Peter Edward/AGG-8472-2022; bianco, federica/AAI-5454-2020; Marcy, Geoff/AAC-6050-2019; Kasen, Daniel/I-3443-2015	Maguire, Kate/0000-0002-9770-3508; Hook, Isobel M/0000-0002-2960-978X; bianco, federica/0000-0003-1953-8727; Kasliwal, Tamay/0000-0001-5634-7167; Graham, Melissa Lynn/0000-0002-9154-3136; Kasen, Daniel/0000-0002-5981-1022; Fulton, Benjamin/0000-0003-3504-5316; Mazzali, Paolo/0000-0001-6876-8284; Pian, Elena/0000-0001-8646-4858; Poznanski, Dovi/0000-0003-1470-7173; Nugent, Peter/0000-0002-3389-0586; Bloom, Joshua/0000-0002-7777-216X; Sullivan, Mark/0000-0001-9053-4820; James, Philip/0000-0003-4131-5183	Office of Science of the US Department of Energy (DOE); US DOE; Royal Society; National Science Foundation (NSF); NSF; TABASGO Foundation; Gary and Cynthia Bengier; Richard and Rhoda Goldman Fund; UK Science and Technology Facilities Council; W. M. Keck Foundation; STFC [PP/E003427/1, PP/E001149/1, ST/H002391/1, ST/H000704/1, ST/G004331/1, ST/I003673/1, ST/H002456/1, ST/I505821/1, ST/G009465/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I003673/1, ST/I505821/1, ST/H002391/1, ST/G009465/1, PP/E001149/1, PP/E003427/1, ST/H000704/1, ST/G004331/1, ST/H002456/1] Funding Source: researchfish; Division Of Astronomical Sciences [1009991, 1109896, 1109174, 1009987] Funding Source: National Science Foundation; Office Of The Director [0941742] Funding Source: National Science Foundation	Office of Science of the US Department of Energy (DOE)(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Royal Society(Royal Society of London); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); TABASGO Foundation; Gary and Cynthia Bengier; Richard and Rhoda Goldman Fund; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); W. M. Keck Foundation(W.M. Keck Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The PTF project is a scientific collaboration between the California Institute of Technology, Columbia University, Las Cumbres Observatory, the Lawrence Berkeley National Laboratory, the National Energy Research Scientific Computing Center, the University of Oxford and the Weizmann Institute of Science. The National Energy Research Scientific Computing Center, supported by the Office of Science of the US Department of Energy (DOE), provided staff, computational resources and data storage for this project. P. E. N. acknowledges support from the US DOE Scientific Discovery through Advanced Computing programme. M. S. acknowledges support from the Royal Society. J.S.B. and L. B. were supported by the National Science Foundation (NSF). The work of A. V. F. is funded by the NSF, the TABASGO Foundation, Gary and Cynthia Bengier, and the Richard and Rhoda Goldman Fund. A. G. thanks the ISF and BSF. The Liverpool Telescope is operated by Liverpool John Moores University in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias with financial support from the UK Science and Technology Facilities Council. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA; the observatory was made possible by the generous financial support of the W. M. Keck Foundation. We thank the staffs of the many observatories at which data were obtained for their assistance.	Bloom J. S., 2011, AUTOMATING DISCOVERY; BRANCH D, 1983, ASTROPHYS J, V270, P123, DOI 10.1086/161103; DEVAUCOULEURS G, 1991, 3 REFERENCE CATALOGU; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Fryer CL, 2010, ASTROPHYS J, V725, P296, DOI 10.1088/0004-637X/725/1/296; Gal-Yam A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/159; Hatano K, 1999, ASTROPHYS J, V525, P881, DOI 10.1086/307947; Howell DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1344; Kasen D, 2009, NATURE, V460, P869, DOI 10.1038/nature08256; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; KIRSHNER RP, 1993, ASTROPHYS J, V415, P589, DOI 10.1086/173188; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395, DOI 10.1086/648598; LEIBUNDGUT B, 1991, ASTROPHYS J, V371, pL23, DOI 10.1086/185993; Li W., 2011, NATURE; NUGENT P, 1995, ASTROPHYS J, V455, pL147, DOI 10.1086/309846; Nugent P. E., 2011, ATEL, V3581, P1; Patat F, 1996, MON NOT R ASTRON SOC, V278, P111, DOI 10.1093/mnras/278.1.111; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Piro AL, 2010, ASTROPHYS J, V708, P598, DOI 10.1088/0004-637X/708/1/598; Rabinak I., 2011, EARLY EMISSION TYPE; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Shappee BJ, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/124; Shen K. J., 2011, LONG TERM EVOLUTION; Sullivan M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/102; Thomas RC, 2011, PUBL ASTRON SOC PAC, V123, P237, DOI 10.1086/658673; Yoon SC, 2007, MON NOT R ASTRON SOC, V380, P933, DOI 10.1111/j.1365-2966.2007.12161.x	27	357	357	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					344	347		10.1038/nature10644	http://dx.doi.org/10.1038/nature10644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22170680	Green Accepted, Green Submitted			2022-12-28	WOS:000298033000045
J	Jahnke, SA; Haddock, CK; Poston, WSC; Hyder, ML; Lando, H				Jahnke, Sara A.; Haddock, Christopher K.; Poston, W. S. Carlos; Hyder, Melissa L.; Lando, Harry			A National Survey of Cigarette Prices at Military Retail Outlets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jahnke, Sara A.; Haddock, Christopher K.; Poston, W. S. Carlos; Hyder, Melissa L.] Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, New York, NY 10010 USA; [Lando, Harry] Univ Minnesota, Div Epidemiol & Community Hlth, St Paul, MN 55108 USA	National Development & Research Institutes, Inc; University of Minnesota System; University of Minnesota Twin Cities	Jahnke, SA (corresponding author), Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, New York, NY 10010 USA.	jahnke@ndri.org		Lando, Harry/0000-0002-7519-4810	NCI NIH HHS [R01 CA109153-06A2, R01 CA109153, 2R01CA109153] Funding Source: Medline; NIDA NIH HHS [R01 DA036507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bray RM, 2009, 2008 DEP DEFENSE SUR; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P441; CQ Congressional Transcripts, 2011, CQ C TRANSCRIPTS HOU; Hership S, 2011, MILITARY UNDERPRICES; National Cancer Institute, 2008, ROL MED PROM RED TOB; Smith EA, 2007, TOB CONTROL, V16, P38, DOI 10.1136/tc.2006.017350	6	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2456	2457		10.1001/jama.2011.1774	http://dx.doi.org/10.1001/jama.2011.1774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166604	Green Accepted, Bronze			2022-12-28	WOS:000297983300018
J	Weir, G; Kos, S; Burrill, J; Salat, P; Ho, S; Liu, D				Weir, Graeme; Kos, Sebastian; Burrill, Josh; Salat, Peter; Ho, Stephen; Liu, David			CASE REPORT Diagnosis and management of the solitary pulmonary nodule	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; RADIOFREQUENCY ABLATION		[Weir, Graeme; Kos, Sebastian; Burrill, Josh; Salat, Peter; Ho, Stephen; Liu, David] Royal Infirm Edinburgh NHS Trust, Dept Radiol, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Weir, G (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Radiol, Edinburgh, Midlothian, Scotland.	graeme.weir@gmail.com						Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Beckles MA, 2003, CHEST, V123, p97S, DOI 10.1378/chest.123.1_suppl.97S; Choe YH, 2009, EUR J CANCER, V45, P1773, DOI 10.1016/j.ejca.2009.02.016; Detterbeck FC, 2001, DIAGNOSIS AND TREATMENT OF LUNG CANCER: AN EVIDENCE-BASED GUIDE FOR THE PRACTICING CLINICIAN, P45; Dupuy DE, 2006, CHEST, V129, P738, DOI 10.1378/chest.129.3.738; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; MACFARLANE J, 1985, BRIT MED J, V290, P97, DOI 10.1136/bmj.290.6462.97; Manser R, 2005, COCHRANE DB SYST REV, V1; National Institute for Health and Clinical Excellence, 2005, DIAGN TREATM LUNG CA; Prosch H, 2006, AM J ROENTGENOL, V187, P143, DOI 10.2214/AJR.05.1229; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Robinson LA, 2007, CHEST, V132, p243S, DOI 10.1378/chest.07-1379; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Scottish Intercollegiate Guidelines Network (SIGN), 2005, SIGN PUBL; Thirumaran M, 2009, THORAX, V64, P854, DOI 10.1136/thx.2008.108795; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; WESTCOTT JL, 1980, RADIOLOGY, V137, P31, DOI 10.1148/radiology.137.1.7422857; Zee YK, 2008, BRIT J CANCER, V99, pS43, DOI 10.1038/sj.bjc.6604584; Zhu JC, 2008, ANN SURG ONCOL, V15, P1765, DOI 10.1245/s10434-008-9848-7	22	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2011	343								d4866	10.1136/bmj.d4866	http://dx.doi.org/10.1136/bmj.d4866			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865NM	22167792				2022-12-28	WOS:000298317600027
J	Christmas, C				Christmas, Colleen			Hip Fracture	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BONE-MINERAL DENSITY; PERIOPERATIVE CARDIOVASCULAR EVALUATION; VITAMIN-D SUPPLEMENTATION; ESTROGEN PLUS PROGESTIN; ACC/AHA 2007 GUIDELINES; OLDER-WOMEN; RISK-FACTORS; VENOUS THROMBOEMBOLISM; NONCARDIAC SURGERY; METAANALYSIS											Abrahamsen B, 2011, ARCH INTERN MED, V171, P998, DOI 10.1001/archinternmed.2011.20; Adunsky A, 2002, ARCH GERONTOL GERIAT, V35, P253, DOI 10.1016/S0167-4943(02)00045-6; Berry SD, 2007, ARCH INTERN MED, V167, P1971, DOI 10.1001/archinte.167.18.1971; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; BOGOST GA, 1995, RADIOLOGY, V197, P263, DOI 10.1148/radiology.197.1.7568834; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chopra V, 2010, ANN INTERN MED, V152, P47, DOI 10.7326/0003-4819-152-1-201001050-00184; Clemson L, 2008, J AGING HEALTH, V20, P954, DOI 10.1177/0898264308324672; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; Ferrari S, 2011, J BONE MINER METAB, V29, P561, DOI 10.1007/s00774-010-0249-1; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gent M, 1996, CIRCULATION, V93, P80, DOI 10.1161/01.CIR.93.1.80; Gillespie W. J., 2010, COCHRANE DATABASE SY; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Handoll HH, 2007, COCHRANE DATABASE SY; Handoll HH, 2008, COCHRANE DATABASE SY; HANDOLL HHG, 2000, COCHRANE DATABASE SY; Herrick C, 2004, J AM GERIATR SOC, V52, P2062, DOI 10.1111/j.1532-5415.2004.52566.x; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Korpelainen R, 2010, ARCH INTERN MED, V170, P1548, DOI 10.1001/archinternmed.2010.311; Kuzyk PRT, 2009, J ORTHOP TRAUMA, V23, P447, DOI 10.1097/BOT.0b013e3181acc505; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lyons Anthony R., 1997, American Journal of Medicine, V103, p51S, DOI 10.1016/S0002-9343(97)90027-9; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Miller PD, 2010, OSTEOPOROSIS INT, V21, P1793, DOI 10.1007/s00198-010-1208-3; Morrison RS, 1998, ANN INTERN MED, V128, P1010, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00010; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; NOVACK V, 2004, JAMA-J AM MED ASSOC, V291, P1738; ODONNELL S, 2006, COCHRANE DATABASE SY, V3; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Pandey R, 1998, INJURY, V29, P61, DOI 10.1016/S0020-1383(97)00165-4; PARKER MJ, 1999, COCHRANE LIB, V4; Parker MJ, 2000, COCHRANE DATABASE SY; Penrod JD, 2004, J AM GERIATR SOC, V52, P1114, DOI 10.1111/j.1532-5415.2004.52309.x; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Sadowski C, 2002, J BONE JOINT SURG AM, V84A, P372, DOI 10.2106/00004623-200203000-00007; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Wenger NS, 2007, J AM GERIATR SOC, V55, pS247, DOI 10.1111/j.1532-5415.2007.01328.x; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010; 2011, 2010 AGS BGS CLIN PR	60	5	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11							ITC6	10.7326/0003-4819-155-11-201112060-01006	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-01006			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147729				2022-12-28	WOS:000297988400019
J	Fisher, RA; Lavery, SA; Carby, A; Abu-Hayyeh, S; Swingler, R; Sebire, NJ; Seckl, MJ				Fisher, Rosemary A.; Lavery, Stuart A.; Carby, Anna; Abu-Hayyeh, Shadi; Swingler, Rebecca; Sebire, Neil J.; Seckl, Michael J.			What a difference an egg makes	LANCET			English	Editorial Material							HYDATIDIFORM MOLES; MUTATIONS		[Fisher, Rosemary A.; Sebire, Neil J.; Seckl, Michael J.] Imperial Coll Healthcare NHS Trust, Trophoblast Tumour Screening & Treatment Ctr, Charing Cross Hosp, London W6 8RF, England; [Fisher, Rosemary A.; Abu-Hayyeh, Shadi] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Lavery, Stuart A.; Carby, Anna] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Swingler, Rebecca] Gloucestershire Royal Hosp, Dept Obstet & Gynaecol, Gloucester GL1 3NN, England	Imperial College London; Imperial College London; Imperial College London; Gloucestershire Royal Hospital	Seckl, MJ (corresponding author), Imperial Coll Healthcare NHS Trust, Trophoblast Tumour Screening & Treatment Ctr, Charing Cross Hosp, London W6 8RF, England.	m.seckl@imperial.ac.uk		Sebire, Neil/0000-0001-5348-9063; Fisher, Rosemary/0000-0002-2721-8726	Great Ormond Street Hospital Childrens Charity [V0907] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196	5	34	34	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 3	2011	378	9807					1974	1974		10.1016/S0140-6736(11)61751-0	http://dx.doi.org/10.1016/S0140-6736(11)61751-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863AW	22130487				2022-12-28	WOS:000298136200031
J	Peng, RD				Peng, Roger D.			Reproducible Research in Computational Science	SCIENCE			English	Editorial Material								Computational science has led to exciting new developments, but the nature of the work has exposed limitations in our ability to evaluate published findings. Reproducibility has the potential to serve as a minimum standard for judging scientific claims when full independent replication of a study is not possible.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Peng, RD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	rpeng@jhsph.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019560] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES019560] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; KING G, 1995, PS, V28, P444, DOI 10.2307/420301; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Madrid J. P., 2009, B AAS; McCullough BD, 2008, CAN J ECON, V41, P1406, DOI 10.1111/j.1540-5982.2008.00509.x; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Peng RD, 2006, AM J EPIDEMIOL, V163, P783, DOI 10.1093/aje/kwj093; Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014; Schwab M, 2000, COMPUT SCI ENG, V2, P61, DOI 10.1109/5992.881708; Yale Law Sch Roundtable Data Code, 2010, COMPUT SCI ENG, V12, P8	13	655	662	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1226	1227		10.1126/science.1213847	http://dx.doi.org/10.1126/science.1213847			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144613	Green Accepted			2022-12-28	WOS:000297553600034
J	Becken, M; Ritter, O; Bedrosian, PA; Weckmann, U				Becken, Michael; Ritter, Oliver; Bedrosian, Paul A.; Weckmann, Ute			Correlation between deep fluids, tremor and creep along the central San Andreas fault	NATURE			English	Article							MAGNETOTELLURIC DATA; ELECTRICAL-RESISTIVITY; INTERNAL STRUCTURE; NEW-ZEALAND; CALIFORNIA; BENEATH; PARKFIELD; CRUST; PERMEABILITY; SERPENTINITE	The seismicity pattern along the San Andreas fault near Parkfield and Cholame, California, varies distinctly over a length of only fifty kilometres. Within the brittle crust, the presence of frictionally weak minerals, fault-weakening high fluid pressures and chemical weakening are considered possible causes of an anomalously weak fault northwest of Parkfield(1-4). Non-volcanic tremor from lower-crustal and upper-mantle depths(5-7) is most pronounced about thirty kilometres southeast of Parkfield and is thought to be associated with high pore-fluid pressures at depth(8). Here we present geophysical evidence of fluids migrating into the creeping section of the San Andreas fault that seem to originate in the region of the uppermost mantle that also stimulates tremor, and evidence that along-strike variations in tremor activity and amplitude are related to strength variations in the lower crust and upper mantle. Interconnected fluids can explain a deep zone of anomalously low electrical resistivity that has been imaged by magnetotelluric data southwest of the Parkfield-Cholame segment. Near Cholame, where fluids seem to be trapped below a high-resistivity cap, tremor concentrates adjacent to the inferred fluids within a mechanically strong zone of high resistivity. By contrast, sub-vertical zones of low resistivity breach the entire crust near the drill hole of the San Andreas Fault Observatory at Depth, northwest of Parkfield, and imply pathways for deep fluids into the eastern fault block, coincident with a mechanically weak crust and the lower tremor amplitudes in the lower crust. Fluid influx to the fault system is consistent with hypotheses of fault-weakening high fluid pressures in the brittle crust.	[Becken, Michael; Weckmann, Ute] Univ Potsdam, Inst Geosci, D-14476 Potsdam, Germany; [Bedrosian, Paul A.] US Geol Survey, Denver, CO 80225 USA; [Becken, Michael; Ritter, Oliver; Weckmann, Ute] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany	University of Potsdam; United States Department of the Interior; United States Geological Survey; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Becken, M (corresponding author), Univ Munster, Inst Geophys, D-48149 Munster, Germany.	michael.becken@uni-muenster.de		Ritter, Oliver/0000-0002-2227-9503; Bedrosian, Paul/0000-0002-6786-1038	German Science Foundation (DFG); Helmholtz Centre Potsdam GFZ German Research Centre for Geosciences	German Science Foundation (DFG)(German Research Foundation (DFG)); Helmholtz Centre Potsdam GFZ German Research Centre for Geosciences	This research was supported by the German Science Foundation (DFG) and the Helmholtz Centre Potsdam GFZ German Research Centre for Geosciences. Instruments were provided by the Geophysical Instrument Pool Potsdam and the instrument facility for Electromagnetic Studies of the Continents. Seismicity data are taken from the catalogue provided by the Northern California Earthquake Data Center, Northern California Seismic Network, US Geological Survey, Menlo Park (http://www.ncedc.org). Fault zone locations are from the California Geological Survey, Geologic Data Map Series No. 6. H. Zhang and D. Shelly provided their tremor source location estimates. This work would not have been possible without field support and the cooperation of numerous landowners.	Becken M, 2008, GEOPHYS J INT, V173, P718, DOI 10.1111/j.1365-246X.2008.03754.x; Becken M, 2008, GEOPHYS J INT, V172, P67, DOI [10.1111/j.1365-246X.2007.03612.x, 10.1111/J.1365-246X.2007.03612.X]; Becken M, 2004, GEOPHYS J INT, V159, P69, DOI 10.1111/j.1365-246X.2004.02376.x; Bedrosian PA, 2004, TECTONOPHYSICS, V385, P137, DOI 10.1016/j.tecto.2004.02.010; Booker JR, 2004, NATURE, V429, P399, DOI 10.1038/naturt02565; Brasse H, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000391; Burgmann R, 2008, ANNU REV EARTH PL SC, V36, P531, DOI 10.1146/annurev.earth.36.031207.124326; DEGROOTHEDLIN C, 1990, GEOPHYSICS, V55, P1613, DOI 10.1190/1.1442813; Egbert GD, 1997, GEOPHYS J INT, V130, P475, DOI 10.1111/j.1365-246X.1997.tb05663.x; EGBERT GD, 1986, GEOPHYS J ROY ASTR S, V87, P173, DOI 10.1111/j.1365-246X.1986.tb04552.x; Fulton PM, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006087; GROOM RW, 1989, J GEOPHYS RES-SOLID, V94, P1913, DOI 10.1029/JB094iB02p01913; Gueguen Y., 1994, INTRO PHYS ROCKS, P182; Gurer A, 2007, TECTONOPHYSICS, V445, P49, DOI 10.1016/j.tecto.2007.06.009; HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579; Holdsworth RE, 2011, J STRUCT GEOL, V33, P132, DOI 10.1016/j.jsg.2010.11.010; Laakso TI, 1996, IEEE SIGNAL PROC MAG, V13, P30, DOI 10.1109/79.482137; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; Moore DE, 2007, NATURE, V448, P795, DOI 10.1038/nature06064; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Ozacar AA, 2009, GEOPHYS J INT, V178, P1098, DOI [10.1111/J.1365-246X.2009.04198.x, 10.1111/j.1365-246X.2009.04198.x]; QUIST AS, 1968, J PHYS CHEM-US, V72, P684, DOI 10.1021/j100848a050; Ritter O, 2005, GEOL SOC SPEC PUBL, V245, P165, DOI 10.1144/GSL.SP.2005.245.01.08; Ritter O, 1999, GEOPHYS J INT, V139, P161, DOI 10.1046/j.1365-246X.1999.00937.x; Ritter O, 1998, GEOPHYS J INT, V132, P535, DOI 10.1046/j.1365-246X.1998.00440.x; Rodi W, 2001, GEOPHYSICS, V66, P174, DOI 10.1190/1.1444893; Sass JH, 1997, J GEOPHYS RES-SOL EA, V102, P27575, DOI 10.1029/97JB02350-B; Schilling FR, 2001, PHYS CHEM EARTH PT A, V26, P239, DOI 10.1016/S1464-1895(01)00051-5; Shelly DR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043672; SMITH JT, 1995, GEOPHYS J INT, V122, P219, DOI 10.1111/j.1365-246X.1995.tb03549.x; Tenthorey E, 2003, GEOLOGY, V31, P921, DOI 10.1130/G19724.1; Thomas AM, 2009, NATURE, V462, P1048, DOI 10.1038/nature08654; TREHU AM, 1987, GEOLOGY, V15, P254, DOI 10.1130/0091-7613(1987)15<254:PEFSSM>2.0.CO;2; Unsworth M, 2000, GEOPHYS RES LETT, V27, P3021, DOI 10.1029/2000GL011476; Unsworth MJ, 2005, NATURE, V438, P78, DOI 10.1038/nature04154; Unsworth MJ, 1997, GEOLOGY, V25, P359, DOI 10.1130/0091-7613(1997)025<0359:ISOTSA>2.3.CO;2; Wannamaker P. E., 1999, 3 DIMENSIONAL ELECTR, P349; Wannamaker PE, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000186; Wannamaker PE, 2009, NATURE, V460, P733, DOI 10.1038/nature08204; Weckmann U, 2005, GEOPHYS J INT, V161, P635, DOI 10.1111/j.1365-246X.2005.02621.x; Weckmann U, 2003, PHYS EARTH PLANET IN, V138, P91, DOI 10.1016/S0031-9201(03)00079-7; Wiersberg T, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001388; Zhang HJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043577; Zoback M., 2010, EOS T AGU, V91, P197, DOI [10.1029/2010EO220001, DOI 10.1029/2010EO220001]	44	148	156	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					87	U248		10.1038/nature10609	http://dx.doi.org/10.1038/nature10609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129729				2022-12-28	WOS:000298031900039
J	Christian, W; Esquembre, F; Barbato, L				Christian, Wolfgang; Esquembre, Francisco; Barbato, Lyle			Open Source Physics	SCIENCE			English	Editorial Material									[Christian, Wolfgang] Davidson Coll, Davidson, NC 28035 USA; [Esquembre, Francisco] Univ Murcia, Dept Matemat, E-30071 Murcia, Spain; [Barbato, Lyle] Amer Assoc Phys Teachers, College Pk, MD 20740 USA	Davidson College; University of Murcia	Christian, W (corresponding author), Davidson Coll, POB 6926, Davidson, NC 28035 USA.	wochristian@davidson.edu	Paniagua, Enrique/H-3536-2015; Esquembre, Francisco/L-3765-2014	Paniagua, Enrique/0000-0001-5006-6428; Esquembre, Francisco/0000-0003-4550-0183	Direct For Education and Human Resources [0937836] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Cox Anne J., 2011, Physics Teacher, V49, P273, DOI 10.1119/1.3578417; Gould H., 2006, INTRO COMPUTER SIMUL; Jackson J., 2008, SCI ED, V17, P10; Karplus R., 1977, J RES SCI TEACH, V14, P169, DOI DOI 10.1002/TEA.3660140212; Rieber LP, 2004, LEARN INSTR, V14, P307, DOI 10.1016/j.learninstruc.2004.06.008; TRACKER	6	47	48	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1077	1078		10.1126/science.1196984	http://dx.doi.org/10.1126/science.1196984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852AF	22116876				2022-12-28	WOS:000297313900037
J	Juma, C				Juma, Calestous			Preventing hunger: Biotechnology is key	NATURE			English	Editorial Material									Harvard Univ, Kennedy Sch, Agr Innovat Africa Project, Cambridge, MA 02138 USA	Harvard University	Juma, C (corresponding author), Harvard Univ, Kennedy Sch, Agr Innovat Africa Project, Cambridge, MA 02138 USA.	calestous_juma@harvard.edu						Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710	1	22	23	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					471	472		10.1038/479471a	http://dx.doi.org/10.1038/479471a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113675	Bronze			2022-12-28	WOS:000297285600026
J	Mellars, P				Mellars, Paul			PALAEOANTHROPOLOGY The earliest modern humans in Europe	NATURE			English	Editorial Material							SPECIES MODEL; AGE		Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England	University of Cambridge	Mellars, P (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.	pam59@cam.ac.uk						Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; Azoury I., 1986, KSAR AKIL LEBANON; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Keith A., 1927, T P TORQUAY NATURAL, V5, P1; KOZLOWSKI JK, 2007, RETHINKING HUMAN REV, P317; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Nigst PR, 2006, NEANDERTHALS MODERN, P269; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Svoboda J., 2007, RETHINKING HUMAN REV, P329; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P3320, DOI 10.1016/j.jas.2010.08.001; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913	17	41	42	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					483	485		10.1038/479483a	http://dx.doi.org/10.1038/479483a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	851QI	22113689				2022-12-28	WOS:000297285600039
J	Miller, SE; Sahlender, DA; Graham, SC; Honing, S; Robinson, MS; Peden, AA; Owen, DJ				Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Hoening, Stefan; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.			The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM	CELL			English	Article							TRANS-GOLGI NETWORK; COATED VESICLES; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; EARLY ENDOSOMES; FUSION PROTEIN; TRAFFICKING; AP180	SNAREs provide a large part of the specificity and energy needed for membrane fusion and, to do so, must be localized to their correct membranes. Here, we show that the R-SNAREs VAMP8, VAMP3, and VAMP2, which cycle between the plasma membrane and endosomes, bind directly to the ubiquitously expressed, PtdIns4, 5P(2)-binding, endocytic clathrin adaptor CALM/PICALM. X-ray crystallography shows that the N-terminal halves of their SNARE motifs bind the CALM(ANTH) domain as helices in a manner that mimics SNARE complex formation. Mutation of residues in the CALM: SNARE interface inhibits binding in vitro and prevents R-SNARE endocytosis in vivo. Thus, CALM: R-SNARE interactions ensure that R-SNAREs, required for the fusion of endocytic clathrin-coated vesicles with endosomes and also for subsequent postendosomal trafficking, are sorted into endocytic vesicles. CALM's role in directing the endocytosis of small R-SNAREs may provide insight into the association of CALM/PICALMmutations with growth retardation, cognitive defects, and Alzheimer's disease.	[Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Miller, Sharon E.; Sahlender, Daniela A.; Graham, Stephen C.; Robinson, Margaret S.; Peden, Andrew A.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cologne; University of Cologne	Peden, AA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	aap20@cam.ac.uk; djo30@cam.ac.uk		Sahlender, Daniela Andrea/0000-0002-0510-9529; Graham, Stephen/0000-0003-4547-4034; Peden, Andrew/0000-0003-0144-7712	Wellcome Trust; MRC CDF [G120/952]; German Science Foundation [SFB 635]; MRC [G120/952] Funding Source: UKRI; Medical Research Council [G120/952] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC CDF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Science Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the beamline scientists at Diamond Light Source plc and Janet Deane for assistance with data collection; and Susan Lea and Steven Johnson (University of Oxford) for assistance with MALS experiments. We also thank Bazbek Davletov (MRCLMB) for gifts of VAMP2, SNAP23, and syntaxin3 DNA. D.J.O. and M. S. R. are funded by Wellcome Trust fellowships; A. A. P. by an MRC CDF (G120/952); and S. C. G. is an 1851 Research Fellow. S. H. is funded by a grant from the German Science Foundation (SFB 635). The protein chemistry, structure determinations and biophysical assays were carried out by S. E. M., S. C. G., S. H., and D.J.O.; the cell biology by D. A. S., M. S. R., and A.A.P.	Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Bao H, 2005, J NEUROPHYSIOL, V94, P1888, DOI 10.1152/jn.00080.2005; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mengel-From J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.07.016; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Morgan JR, 2000, J NEUROSCI, V20, P8667; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7	53	134	134	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					1118	1131		10.1016/j.cell.2011.10.038	http://dx.doi.org/10.1016/j.cell.2011.10.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118466	Green Published, hybrid			2022-12-28	WOS:000297376600022
J	Britt, K; Short, R				Britt, Kara; Short, Roger			The plight of nuns: hazards of nulliparity	LANCET			English	Editorial Material							BREAST-CANCER; REPRODUCTIVE FACTORS; RISK; AGE		[Britt, Kara] Monash Univ, Dept Anat & Dev Biol, Prostate & Breast Canc Res Program, Clayton, Vic 3800, Australia; [Short, Roger] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Britt, K (corresponding author), Monash Univ, Dept Anat & Dev Biol, Prostate & Breast Canc Res Program, Clayton, Vic 3800, Australia.	kara.britt@monash.edu	Britt, Kara/B-2437-2013	Britt, Kara/0000-0001-6069-7856				BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; FRANCESCHI S, 1989, EUR J CANCER CLIN ON, V25, P1933, DOI 10.1016/0277-5379(89)90375-1; FRAUMENI JF, 1969, J NATL CANCER I, V42, P455; HANNAFORD PC, 2010, BRIT MED J, V340, DOI DOI 10.1136/BMJ.C927; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; KVALE G, 1988, CANCER RES, V48, P6217; LOUDON NB, 1977, BRIT MED J, V2, P487, DOI 10.1136/bmj.2.6085.487; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; PAUL VI, 1968, HUMANAE VITAE REGULA; Purdie DM, 2003, INT J CANCER, V104, P228, DOI 10.1002/ijc.10927; Ramazzini B, 1940, DIS WORKERS TRANSLAT; Vessey M, 2010, CONTRACEPTION, V82, P221, DOI 10.1016/j.contraception.2010.04.006	13	26	26	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 23	2012	379	9834					2322	2323		10.1016/S0140-6736(11)61746-7	http://dx.doi.org/10.1016/S0140-6736(11)61746-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22153781				2022-12-28	WOS:000305509600008
J	Albain, K; Anderson, S; Arriagada, R; Barlow, W; Bergh, J; Bliss, J; Buyse, M; Cameron, D; Carrasco, E; Clarke, M; Correa, C; Coates, A; Collins, R; Costantino, J; Cutter, D; Cuzick, J; Darby, S; Davidson, N; Davies, C; Davies, K; Delmestri, A; Di Leo, A; Dowsett, M; Elphinstone, P; Evans, V; Ewertz, M; Gelber, R; Gettins, L; Geyer, C; Goldhirsch, A; Godwin, J; Gray, R; Gregory, C; Hayes, D; Hill, C; Ingle, J; Jakesz, R; James, S; Kaufmann, M; Kerr, A; MacKinnon, E; McGale, P; McHugh, T; Norton, L; Ohashi, Y; Paik, S; Pan, HC; Perez, E; Peto, R; Piccart, M; Pierce, L; Pritchard, K; Pruneri, G; Raina, V; Ravdin, P; Robertson, J; Rutgers, E; Shao, YF; Swain, S; Taylor, C; Valagussa, P; Viale, G; Whelan, T; Winer, E; Wang, Y; Wood, W				Albain, K.; Anderson, S.; Arriagada, R.; Barlow, W.; Bergh, J.; Bliss, J.; Buyse, M.; Cameron, D.; Carrasco, E.; Clarke, M.; Correa, C.; Coates, A.; Collins, R.; Costantino, J.; Cutter, D.; Cuzick, J.; Darby, S.; Davidson, N.; Davies, C.; Davies, K.; Delmestri, A.; Di Leo, A.; Dowsett, M.; Elphinstone, P.; Evans, V.; Ewertz, M.; Gelber, R.; Gettins, L.; Geyer, C.; Goldhirsch, A.; Godwin, J.; Gray, R.; Gregory, C.; Hayes, D.; Hill, C.; Ingle, J.; Jakesz, R.; James, S.; Kaufmann, M.; Kerr, A.; MacKinnon, E.; McGale, P.; McHugh, T.; Norton, L.; Ohashi, Y.; Paik, S.; Pan, H. C.; Perez, E.; Peto, R.; Piccart, M.; Pierce, L.; Pritchard, K.; Pruneri, G.; Raina, V.; Ravdin, P.; Robertson, J.; Rutgers, E.; Shao, Y. F.; Swain, S.; Taylor, C.; Valagussa, P.; Viale, G.; Whelan, T.; Winer, E.; Wang, Y.; Wood, W.		EBCTCG	Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials	LANCET			English	Article							PHASE-III TRIAL; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL PATIENTS; GENE-EXPRESSION; PREMENOPAUSAL WOMEN; TAMOXIFEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PACLITAXEL	Background Moderate differences in efficacy between adjuvant chemotherapy regimens for breast cancer are plausible, and could affect treatment choices. We sought any such differences. Methods We undertook individual-patient-data meta-analyses of the randomised trials comparing: any taxane-plus-anthracycline-based regimen versus the same, or more, non-taxane chemotherapy (n=44 000); one anthracycline-based regimen versus another (n=7000) or versus cyclo phosphamide, methotrexate, and fluorouracil (CMF; n=18 000); and polychemotherapy versus no chemotherapy (n=32 000). The scheduled dosages of these three drugs and of the anthracyclines doxorubicin (A) and epirubicin (E) were used to define standard CMF, standard 4AC, and CAF and CEF. Log-rank breast cancer mortality rate ratios (RRs) are reported. Findings In trials adding four separate cycles of a taxane to a fixed anthracycline-based control regimen, extending treatment duration, breast cancer mortality was reduced (RR 0.86, SE 0.04, two-sided significance [2p]=0.0005). In trials with four such extra cycles of a taxane counterbalanced in controls by extra cycles of other cytotoxic drugs, roughly doubling non-taxane dosage, there was no significant difference (RR 0.94, SE 0.06, 2p=0.33). Trials with CMF-treated controls showed that standard 4AC and standard CMF were equivalent (RR 0.98, SE 0.05, 2p=0.67), but that anthracycline-based regimens with substantially higher cumulative dosage than standard 4AC (eg, CAF or CEF) were superior to standard CMF (RR 0.78, SE 0.06, 2p=0.0004). Trials versus no chemotherapy also suggested greater mortality reductions with CAF (RR 0.64, SE 0.09, 2p<0.0001) than with standard 4AC (RR 0.78, SE 0.09, 2p=0.01) or standard CMF (RR 0.76, SE 0.05, 2p<0.0001). In all meta-analyses involving taxane-based or anthracycline-based regimens, proportional risk reductions were little affected by age, nodal status, tumour diameter or differentiation (moderate or poor; few were well differentiated), oestrogen receptor status, or tamoxifen use. Hence, largely independently of age (up to at least 70 years) or the tumour characteristics currently available to us for the patients selected to be in these trials, some taxane-plus-anthracycline-based or higher-cumulative-dosage anthracycline-based regimens (not requiring stem cells) reduced breast cancer mortality by, on average, about one-third. 10-year overall mortality differences paralleled breast cancer mortality differences, despite taxane, anthracycline, and other toxicities. Interpretation 10-year gains from a one-third breast cancer mortality reduction depend on absolute risks without chemotherapy (which, for oestrogen-receptor-positive disease, are the risks remaining with appropriate endocrine therapy). Low absolute risk implies low absolute benefit, but information was lacking about tumour gene expression markers or quantitative immunohistochemistry that might help to predict risk, chemosensitivity, or both.	[Albain, K.; Buyse, M.; Clarke, M.; Collins, R.; Darby, S.; Davies, C.; Ewertz, M.; Peto, R.; Piccart, M.; Pritchard, K.; Winer, E.; Wood, W.] EBCTCG, CTSU, Execut Grp, Oxford OX3 7LF, England	University of Oxford	Albain, K (corresponding author), EBCTCG, CTSU, Execut Grp, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	bc.overview@CTSU.ox.ac.uk	Evans, Diane/F-9258-2017; Cutter, David/AAU-6599-2021; Pruneri, Giancarlo/AAC-7767-2022; Rutgers, Emiel J T/C-5934-2015; Viale, Giuseppe/AAE-8921-2019; Pritchard, Kathleen I/I-2184-2014; Whelan, Timothy/D-3185-2017; Geyer, Charles/AGY-0119-2022; Di Leo, Angelo/AAM-1267-2020	Cutter, David/0000-0001-7307-7488; Pruneri, Giancarlo/0000-0002-7963-7172; Pritchard, Kathleen I/0000-0003-0758-9666; Whelan, Timothy/0000-0001-9844-2023; Geyer, Charles/0000-0002-2379-5702; Di Leo, Angelo/0000-0002-3665-9056; Bergh, Jonas/0000-0001-5526-1847; Valentini, Miriam/0000-0002-1421-6975; Valagussa, Pinuccia/0000-0003-3590-7916; Arriagada, Rodrigo/0000-0002-3134-1735; Wang, Xiang/0000-0002-1522-9532; Bliss, Judith/0000-0001-7957-7424; Anderson, Stewart/0000-0001-8948-0650; Ewertz, Marianne/0000-0002-5965-969X; Delmestri, Antonella/0000-0003-0388-3403; Adolfsson, Jan/0000-0003-2992-1869; Swain, Sandra/0000-0002-1320-3830	Cancer Research UK; British Heart Foundation; UK Medical Research Council; BHF Centre for Research Excellence [RE/08/04]; Medical Research Council [MC_U137686850] Funding Source: researchfish; MRC [MC_U137686850] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre for Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This report is dedicated to Paul Meier (1924-2011), parent of Kaplan-Meier survival curves and effective advocate of widespread randomisation in US clinical research.<SUP>38,39</SUP> The main acknowledgment is to the many participants in the trials and the many staff who treated them, undertook trials, and shared the data. EBCTCG is funded by core support to the Oxford University CTSU from Cancer Research UK, the British Heart Foundation, and the UK Medical Research Council; DC is supported by the BHF Centre for Research Excellence (RE/08/04).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Bedgonetti D, 2011, JNCI-J NATL CANCER I, V103, P1529; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bonneterre Jacques M, 2004, Oncology (Williston Park), V18, P56; BRINCKER H, 1987, J CLIN ONCOL, V5, P1771, DOI 10.1200/JCO.1987.5.11.1771; Cardoso F, 2007, MOL ONCOL, V1, P246, DOI 10.1016/j.molonc.2007.10.004; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2010, J CLIN ONCOL, V28, P1829, DOI 10.1200/JCO.2009.24.4798; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; ENGELSMAN E, 1991, EUR J CANCER, V27, P966, DOI 10.1016/0277-5379(91)90259-G; Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054; Gonzalez-Angulo AM, 2011, P AM SOC CLIN ONCO S, V29; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hutchins LF, 2005, J CLIN ONCOL, V23, P8313, DOI 10.1200/JCO.2005.08.071; International Breast Cancer Study Group (IBCSG), 2004, ANN ONCOL, V15, P1749; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; Marks HM, 2004, CLIN TRIALS, V1, P131; Martin M, 2008, JNCI-J NATL CANCER I, V100, P805, DOI 10.1093/jnci/djn151; Montagna E, 2010, BREAST CANCER RES TR, V124, P689, DOI 10.1007/s10549-010-1027-4; Pagani O, 2009, BREAST CANCER RES TR, V116, P491, DOI 10.1007/s10549-008-0225-9; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Peto R, 2011, BRIT J CANCER, V104, P1057, DOI 10.1038/bjc.2011.79; Pico C, 2004, ANN ONCOL, V15, P79, DOI 10.1093/annonc/mdh016; Praga C, 2005, J CLIN ONCOL, V23, P4179, DOI 10.1200/JCO.2005.05.029; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; Straver ME, 2010, BREAST CANCER RES TR, V119, P551, DOI 10.1007/s10549-009-0333-1; van Dalen EC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005008.pub3; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	39	1373	1391	4	117	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					432	444		10.1016/S0140-6736(11)61625-5	http://dx.doi.org/10.1016/S0140-6736(11)61625-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	22152853	Green Published, Green Submitted			2022-12-28	WOS:000300187800033
J	Fedorov, A; Steffen, L; Baur, M; da Silva, MP; Wallraff, A				Fedorov, A.; Steffen, L.; Baur, M.; da Silva, M. P.; Wallraff, A.			Implementation of a Toffoli gate with superconducting circuits	NATURE			English	Article							QUANTUM ERROR-CORRECTION; QUBITS	The Toffoli gate is a three-quantum-bit (three-qubit) operation that inverts the state of a target qubit conditioned on the state of two control qubits. It makes universal reversible classical computation(1) possible and, together with a Hadamard gate(2), forms a universal set of gates in quantum computation. It is also a key element in quantum error correction schemes(3-7). The Toffoli gate has been implemented in nuclear magnetic resonance(3), linear optics(8) and ion trap systems(9). Experiments with superconducting qubits have also shown significant progress recently: two-qubit algorithms(10) and two-qubit process tomography have been implemented(11), three-qubit entangled states have been prepared(12,13), first steps towards quantum teleportation have been taken(14) and work on quantum computing architectures has been done(15). Implementation of the Toffoli gate with only single-and two-qubit gates requires six controlled-NOT gates and ten single-qubit operations(16), and has not been realized in any system owing to current limits on coherence. Here we implement a Toffoli gate with three superconducting transmon qubits coupled to a microwave resonator. By exploiting the third energy level of the transmon qubits, we have significantly reduced the number of elementary gates needed for the implementation of the Toffoli gate, relative to that required in theoretical proposals using only two-level systems. Using full process tomography and Monte Carlo process certification, we completely characterize the Toffoli gate acting on three independent qubits, measuring a fidelity of 68.5 +/- 0.5 per cent. A similar approach(15) to realizing characteristic features of a Toffoli-class gate has been demonstrated with two qubits and a resonator and achieved a limited characterization considering only the phase fidelity. Our results reinforce the potential of macroscopic superconducting qubits for the implementation of complex quantum operations with the possibility of quantum error correction(17).	[Fedorov, A.; Steffen, L.; Baur, M.; Wallraff, A.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [da Silva, M. P.] Raytheon BBN Technol, Disrupt Informat Proc Technol Grp, Cambridge, MA 02138 USA; [da Silva, M. P.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; Raytheon Technologies; Raytheon BBN Technologies; University of Sherbrooke	Fedorov, A (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	fedoroar@phys.ethz.ch; andreas.wallraff@phys.ethz.ch	Fedorov, Arkady/F-4764-2012; da Silva, Marcus P./H-7266-2019; Silva, Marcus P/B-2908-2010; Wallraff, Andreas J/C-2130-2009; Steffen, Lars/F-7711-2012; Baur, Matthias/E-6479-2013; Fedorov, Arkady/AAW-6070-2021	Fedorov, Arkady/0000-0002-9815-0968; da Silva, Marcus P./0000-0002-6641-8712; Silva, Marcus P/0000-0002-6641-8712; Wallraff, Andreas J/0000-0002-3476-4485; Fedorov, Arkady/0000-0002-9815-0968	Swiss National Science Foundation; EU IP SOLID; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU IP SOLID; ETH Zurich(ETH Zurich)	We thank S. Filipp, A. Blais for useful discussions and K. Pakrouski for his contributions in early stages of the experimental work. This work was supported by the Swiss National Science Foundation, the EU IP SOLID and ETH Zurich.	Aoki T, 2009, NAT PHYS, V5, P541, DOI 10.1038/NPHYS1309; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Baur M, 2011, BENCHMARKING TELEPOR; Borrelli M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012314; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; da Silva MP, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.210404; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Flammia ST, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230501; Gambetta JM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012308; Haack G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024514; Jezek M, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012305; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Lanyon BP, 2009, NAT PHYS, V5, P134, DOI 10.1038/NPHYS1150; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; Monz T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.040501; Motzoi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110501; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Paik H, 2011, COHERENT ARE JOSEPHS; Pittman TB, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052332; Ralph TC, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022313; Reed M. D, 2011, REALIZATION 3 QUBIT; Shi YY, 2003, QUANTUM INF COMPUT, V3, P84; Sporl A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.012302; Stojanovic V. M., 2011, QUANTUM CONTROL APPR; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; Toffoli, 1980, LECT NOTES COMPUTER, V85; Yamamoto T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184515	33	240	244	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2012	481	7380					170	172		10.1038/nature10713	http://dx.doi.org/10.1038/nature10713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	874TO	22170609	Green Submitted			2022-12-28	WOS:000298981200032
J	Farzadfar, F; Murray, CJL; Gakidou, E; Bossert, T; Namdaritabar, H; Alikhani, S; Moradi, G; Delavari, A; Jamshidi, H; Ezzati, M				Farzadfar, Farshad; Murray, Christopher J. L.; Gakidou, Emmanuela; Bossert, Thomas; Namdaritabar, Hengameh; Alikhani, Siamak; Moradi, Ghobad; Delavari, Alireza; Jamshidi, Hamidreza; Ezzati, Majid			Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; RISK-FACTORS; SYSTEMATIC ANALYSIS; POPULATION HEALTH; HUMAN-RESOURCES; ALMA-ATA; MORTALITY; DISEASE; TRENDS; PREVENTION	Background Non-communicable diseases and their risk factors are leading causes of disease burden in Iran and other middle-income countries. Little evidence exists for whether the primary health-care system can effectively manage non-communicable diseases and risk factors at the population level. Our aim was to examine the effectiveness of the Iranian rural primary health-care system (the Behvarz system) in the management of diabetes and hypertension, and to assess whether the effects depend on the number of health-care workers in the community. Methods We used individual-level data from the 2005 Non-Communicable Disease Surveillance Survey (NCDSS) for fasting plasma glucose (FPG) and systolic blood pressure (SBP), body-mass index, medication use, and sociodemographic variables. Data for Behvarz-worker and physician densities were from the 2006 Population and Housing Census and the 2005 Outpatient Care Centre Mapping Survey. We assessed the effectiveness of treatment on FPG and SBP, and associations between FPG or SBP and Behvarz-worker density with two statistical approaches: a mixed-effects regression analysis of the full NCDSS sample adjusting for individual-level and community-level covariates and an analysis that estimated average treatment effect on data balanced with propensity score matching. Results NCDSS had data for 65 619 individuals aged 25 years or older (11 686 of whom in rural areas); of these, 64 694 (11 521 in rural areas) had data for SBP and 50 202 (9337 in rural areas) had data for FPG. Nationally, 39.2% (95% CI 37.7 to 40.7) of individuals with diabetes and 35.7% (34.9 to 36.5) of those with hypertension received treatment, with higher treatment coverage in women than in men and in urban areas than in rural areas. Treatment lowered mean FPG by an estimated 1.34 mmol/L (0.58 to 2.10) in rural areas and 0.21 mmol/L (-0.15 to 0.56) in urban areas. Individuals in urban areas with hypertension who received treatment had 3.8 mm Hg (3.1 to 4.5) lower SBP than they would have had if they had not received treatment; the treatment effect was 2.5 mm Hg (1.1 to 3.9) lower FPG in rural areas. Each additional Behvarz worker per 1000 adults was associated with a 0.09 mmol/L (0.01 to 0.18) lower district-level average FPG (p=0.02); for SBP this effect was 0.53 mm Hg (-0.44 to 1.50; p=0.28). Our findings were not sensitive to the choice of statistical method. Interpretation Primary care systems with trained community health-care workers and well established guidelines can be effective in non-communicable disease prevention and management. Iran's primary care system should expand the number and scope of its primary health-care worker programmes to also address blood pressure and to improve performance in areas with few primary care personnel.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Farzadfar, Farshad] Univ Tehran Med Sci, Diabet Res Ctr, Tehran, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Moradi, Ghobad] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran; [Delavari, Alireza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Delavari, Alireza] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Bossert, Thomas] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Murray, Christopher J. L.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Namdaritabar, Hengameh; Alikhani, Siamak] Minist Hlth & Med Educ, Tehran, Iran; [Jamshidi, Hamidreza] Shahid Beheshti Univ Med Sci, Tehran, Iran	Imperial College London; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Ministry of Health & Medical Education (MOHME); Shahid Beheshti University Medical Sciences	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Moradi, Ghobad/R-1267-2016	Moradi, Ghobad/0000-0003-2612-6528; Jamshidi, Hamidreza/0000-0001-6887-1409; Alikhani, Siamak/0000-0001-8354-254X; Farzadfar, Farshad/0000-0001-8288-4046	UK Medical Research Council; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Iranian Ministry of Health and Medical Education; Medical Research Council [G0801056B] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London; Imperial College Healthcare NHS Trust; Iranian Ministry of Health and Medical Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ME is supported by a Strategic Award from the UK Medical Research Council and by the National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College London and Imperial College Healthcare NHS Trust. The NCDSS is a national health examination survey designed, implemented, and funded by the Iranian Ministry of Health and Medical Education.	Aakvik A, 2006, J HEALTH ECON, V25, P1139, DOI 10.1016/j.jhealeco.2006.04.001; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Azizi F, 2003, East Mediterr Health J, V9, P1114; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200; Coleman R, 2002, B WORLD HEALTH ORGAN, V80, P378; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Delavari AR, 2003, NATL DIABETES PREVEN; DRAKE C, 1995, INT J EPIDEMIOL, V24, P183, DOI 10.1093/ije/24.1.183; Farzadfar F, 2001, POPUL HLTH METRICS, V9, P55; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Frankenberg E, 1995, Health Transit Rev, V5, P143; Gulliford MC, 2002, J PUBLIC HEALTH MED, V24, P252, DOI 10.1093/pubmed/24.4.252; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; HERTZ E, 1994, SOC SCI MED, V39, P105, DOI 10.1016/0277-9536(94)90170-8; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [DOI 10.18637/JSS.V042.I08, 10.18637/jss.v042.i08]; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Janghorbani M, 2008, J HYPERTENS, V26, P419, DOI 10.1097/HJH.0b013e3282f2d34d; Johansen K, 1999, DIABETES CARE, V22, P33, DOI 10.2337/diacare.22.1.33; KIM KK, 1992, SOC SCI MED, V34, P837, DOI 10.1016/0277-9536(92)90253-M; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN DB, 1973, BIOMETRICS, V29, P159, DOI 10.2307/2529684; Samavat T, 2003, NATL HLTH PROGRAM CO; WHO, 2008, WORLD HLTH REPORT 20	38	149	152	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					47	54		10.1016/S0140-6736(11)61349-4	http://dx.doi.org/10.1016/S0140-6736(11)61349-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	22169105				2022-12-28	WOS:000298913000037
J	Ernst, U; Pawelzik, K				Ernst, Udo; Pawelzik, Klaus			Sensible Balance	SCIENCE			English	Editorial Material							INHIBITION; EXCITATION; NEURONS		[Ernst, Udo; Pawelzik, Klaus] Univ Bremen, Inst Theoret Phys, D-28334 Bremen, Germany	University of Bremen	Ernst, U (corresponding author), Univ Bremen, Inst Theoret Phys, D-28334 Bremen, Germany.	udo@neuro.uni-bremen.de						Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Kreiter AK, 2006, NEURAL NETWORKS, V19, P1443, DOI 10.1016/j.neunet.2006.09.005; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; 2004, J NEUROPHYSIOL, V91, P704	12	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1507	1508		10.1126/science.1216483	http://dx.doi.org/10.1126/science.1216483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22174239				2022-12-28	WOS:000298091400038
J	Heidrich, K; Wirthmueller, L; Tasset, C; Pouzet, C; Deslandes, L; Parker, JE				Heidrich, Katharina; Wirthmueller, Lennart; Tasset, Celine; Pouzet, Cecile; Deslandes, Laurent; Parker, Jane E.			Arabidopsis EDS1 Connects Pathogen Effector Recognition to Cell Compartment-Specific Immune Responses	SCIENCE			English	Article							DISEASE-RESISTANCE GENES; NUCLEAR ACCUMULATION; INNATE IMMUNITY; PLANT IMMUNITY; PROTEIN; ACTIVATION; BACTERIAL; DEFENSE; DEATH; THALIANA	Pathogen effectors are intercepted by plant intracellular nucleotide binding-leucine-rich repeat (NB-LRR) receptors. However, processes linking receptor activation to downstream defenses remain obscure. Nucleo-cytoplasmic basal resistance regulator EDS1 (ENHANCED DISEASE SUSCEPTIBILITY1) is indispensible for immunity mediated by TIR (Toll-interleukin-1 receptor)-NB-LRR receptors. We show that Arabidopsis EDS1 molecularly connects TIR-NB-LRR disease resistance protein RPS4 recognition of bacterial effector AvrRps4 to defense pathways. RPS4-EDS1 and AvrRps4-EDS1 complexes are detected inside nuclei of living tobacco cells after transient coexpression and in Arabidopsis soluble leaf extracts after resistance activation. Forced AvrRps4 localization to the host cytoplasm or nucleus reveals cell compartment-specific RPS4-EDS1 defense branches. Although nuclear processes restrict bacterial growth, programmed cell death and transcriptional resistance reinforcement require nucleo-cytoplasmic coordination. Thus, EDS1 behaves as an effector target and activated TIR-NB-LRR signal transducer for defenses across cell compartments.	[Heidrich, Katharina; Wirthmueller, Lennart; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Tasset, Celine; Deslandes, Laurent] CNRS, UMR 2594, LIPM, F-31326 Castanet Tolosan, France; [Pouzet, Cecile] Federat Rech 3450, Plateforme Imagerie TRI, Pole Biotechnol Vegetale, F-31326 Castanet Tolosan, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Parker, JE (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	parker@mpipz.mpg.de	Deslandes, Laurent/N-5752-2017; Wirthmueller, Lennart/H-3310-2019	Wirthmueller, Lennart/0000-0003-0667-5343	Max-Planck Society; IMPRS; Deutsche Forschungsgemeinschaft [SFB 670]; Laboratoire d'Excellence (LABEX) TULIP [ANR-10-LABX-41]	Max-Planck Society(Max Planck Society); IMPRS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Laboratoire d'Excellence (LABEX) TULIP	We thank J. Bautor for excellent technical assistance; J. Jones and K. H. Sohn (Sainsbury Laboratory, Norwich, UK) for the pEDV6 vector and advice on bacterial delivery assays; A. Jauneau for advice and technical support in fluorescence resonance energy transfer (FRET)-FLIM assays (FR3450); and C. Briere for statistical analysis of FRET-FLIM data (UMR CNRS-UPS 5546). This work was funded by The Max-Planck Society, an IMPRS PhD fellowship (K. H.), Deutsche Forschungsgemeinschaft SFB 670 grant (J. E. P.) and is part of the Laboratoire d'Excellence (LABEX) TULIP (ANR-10-LABX-41) program (L.D.).	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Gassmann W, 2005, MOL PLANT MICROBE IN, V18, P1054, DOI 10.1094/MPMI-18-1054; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	32	235	258	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1401	1404		10.1126/science.1211641	http://dx.doi.org/10.1126/science.1211641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22158818				2022-12-28	WOS:000297787700053
J	Oh, E; Becker, AH; Sandikci, A; Huber, D; Chaba, R; Gloge, F; Nichols, RJ; Typas, A; Gross, CA; Kramer, G; Weissman, JS; Bukau, B				Oh, Eugene; Becker, Annemarie H.; Sandikci, Arzu; Huber, Damon; Chaba, Rachna; Gloge, Felix; Nichols, Robert J.; Typas, Athanasios; Gross, Carol A.; Kramer, Guenter; Weissman, Jonathan S.; Bukau, Bernd			Selective Ribosome Profiling Reveals the Cotranslational Chaperone Action of Trigger Factor In Vivo	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; TRANSLATING RIBOSOMES; MEMBRANE-PROTEINS; COMPLEX; POLYPEPTIDE; DNAK; TRANSLOCATION; RESOLUTION	As nascent polypeptides exit ribosomes, they are engaged by a series of processing, targeting, and folding factors. Here, we present a selective ribosome profiling strategy that enables global monitoring of when these factors engage polypeptides in the complex cellular environment. Studies of the Escherichia coli chaperone trigger factor (TF) reveal that, though TF can interact with many polypeptides, beta-barrel outer-membrane proteins are the most prominent substrates. Loss of TF leads to broad outer-membrane defects and premature, cotranslational protein translocation. Whereas in vitro studies suggested that TF is prebound to ribosomes waiting for polypeptides to emerge from the exit channel, we find that in vivo TF engages ribosomes only after similar to 100 amino acids are translated. Moreover, excess TF interferes with cotranslational removal of the N-terminal formyl methionine. Our studies support a triaging model in which proper protein biogenesis relies on the fine-tuned, sequential engagement of processing, targeting, and folding factors.	[Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Chaba, Rachna; Nichols, Robert J.; Typas, Athanasios; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Becker, Annemarie H.; Sandikci, Arzu; Huber, Damon; Gloge, Felix; Kramer, Guenter; Bukau, Bernd] Univ Heidelberg, Ctr Biol Mol, German Canc Res Ctr, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; bukau@zmbh.uni-heidelberg.de		Kramer, Gunter/0000-0001-7552-8393; Weissman, Jonathan/0000-0003-2445-670X; Bukau, Bernd/0000-0003-0521-7199; Typas, Athanasios/0000-0002-0797-9018; Huber, Damon/0000-0002-7367-3244; Oh, Eugene/0000-0003-1970-8423	Deutsche Forschungsgemeinschaft [SFB638, FOR967]; Peter und Traudl Engelhorn-Stiftung and EMBO; NIH [P01 AG10770]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Peter und Traudl Engelhorn-Stiftung and EMBO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Ingolia for help with ribosome profiling and data analysis; C. Chu for help with sequencing; S. Rouskin for developing a method for ligation; G. Brar and J. Dunn for developing an rRNA subtraction strategy; N. Reifenberger and B. Zachmann-Brand for help with cloning and crosslinking experiments; Thomas Silhavy for providing antibodies; Thomas Ruppert and the mass spectrometry facility at the ZMBH for experimental support; Yves Cully for graphical assistance; and members of the Bukau, Gross and Weissman labs for insightful discussions and critical readings of the manuscript. This work was supported by the SFB638 and FOR967 of the Deutsche Forschungsgemeinschaft (B.B. and G.K.); the Peter und Traudl Engelhorn-Stiftung and EMBO (A.H.B.); and the NIH (P01 AG10770) and the Howard Hughes Medical Institute (J.S.W.).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; BALL LA, 1973, J MOL BIOL, V79, P531, DOI 10.1016/0022-2836(73)90404-X; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JOSEFSSON LG, 1981, CELL, V25, P151, DOI 10.1016/0092-8674(81)90239-7; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIGGS PD, 1988, GENETICS, V118, P571; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	47	312	315	2	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 9	2011	147	6					1295	1308		10.1016/j.cell.2011.10.044	http://dx.doi.org/10.1016/j.cell.2011.10.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153074	Bronze, Green Accepted			2022-12-28	WOS:000298148100019
J	Pavlopoulos, E; Trifilieff, P; Chevaleyre, V; Fioriti, L; Zairis, S; Pagano, A; Malleret, G; Kandel, ER				Pavlopoulos, Elias; Trifilieff, Pierre; Chevaleyre, Vivien; Fioriti, Luana; Zairis, Sakellarios; Pagano, Andrew; Malleret, Gael; Kandel, Eric R.			Neuralized1 Activates CPEB3: A Function for Nonproteolytic Ubiquitin in Synaptic Plasticity and Memory Storage	CELL			English	Article							LONG-TERM DEPRESSION; LOCAL PROTEIN-SYNTHESIS; NEURONAL ISOFORM; APLYSIA CPEB; EXPRESSION; RECEPTORS; GLUR2; CA1; FACILITATION; DEGRADATION	The cytoplasmic polyadenylation element-binding protein 3 (CPEB3), a regulator of local protein synthesis, is the mouse homolog of ApCPEB, a functional prion protein in Aplysia. Here, we provide evidence that CPEB3 is activated by Neuralized1, an E3 ubiquitin ligase. In hippocampal cultures, CPEB3 activated by Neuralized1-mediated ubiquitination leads both to the growth of new dendritic spines and to an increase of the GluA1 and GluA2 subunits of AMPA receptors, two CPEB3 targets essential for synaptic plasticity. Conditional overexpression of Neuralized1 similarly increases GluA1 and GluA2 and the number of spines and functional synapses in the hippocampus and is reflected in enhanced hippocampal-dependent memory and synaptic plasticity. By contrast, inhibition of Neuralized1 reduces GluA1 and GluA2 levels and impairs hippocampal-dependent memory and synaptic plasticity. These results suggest a model whereby Neuralized1-dependent ubiquitination facilitates hippocampal plasticity and hippocampal-dependent memory storage by modulating the activity of CPEB3 and CPEB3-dependent protein synthesis and synapse formation.	[Pavlopoulos, Elias; Trifilieff, Pierre; Chevaleyre, Vivien; Fioriti, Luana; Zairis, Sakellarios; Pagano, Andrew; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Chevaleyre, Vivien; Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, Coll Phys & Surg, New York, NY 10032 USA; [Trifilieff, Pierre] New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, New York, NY 10032 USA; [Malleret, Gael] Univ Lyon 1, Fac Med RTH Laennec, CNRS, UMR5167, F-69007 Lyon, France	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kandel, ER (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Trifilieff, Pierre/ABB-4317-2020; Fioriti, Luana/AAN-7207-2021	Chevaleyre, Vivien/0000-0002-3679-4856; Trifilieff, Pierre/0000-0002-7893-9697; fioriti, luana/0000-0003-2429-8967	HHMI; Broitman Program for Cognitive Disorders; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Broitman Program for Cognitive Disorders; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Steven A. Siegelbaum for his comments and help with the mEPSC recordings. We are also grateful to Thomas Jessell for his reading of the manuscript and to Eleanor Simpson, Christoph Kellendonk, Kausik Si, Sathya Puthanveettil, Sebastien Thuault, and Evangelia Koutelou for their critical comments. We also thank Kevin Karl for his technical help and Joan Conaway and Nicholas Moschonas for the gift of the Neurl1<SUP>Rm</SUP> and Ub cDNAs. The work was supported by HHMI and the Broitman Program for Cognitive Disorders (to E.R.K). P.T. was supported by the Fondation pour la Recherche Medicale. E.R.K is a senior investigator of HHMI.	Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Koutelou E, 2008, J BIOL CHEM, V283, P3846, DOI 10.1074/jbc.M706974200; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shimada AS, 2003, SYNAPSE, V48, P198, DOI 10.1002/syn.10209; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100	44	130	135	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 9	2011	147	6					1369	1383		10.1016/j.cell.2011.09.056	http://dx.doi.org/10.1016/j.cell.2011.09.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863FL	22153079	Green Accepted, Bronze			2022-12-28	WOS:000298148100024
J	Burga, A; Casanueva, MO; Lehner, B				Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben			Predicting mutation outcome from early stochastic variation in genetic interaction partners	NATURE			English	Article							T-BOX GENES; EXPRESSION; VARIABILITY; REDUNDANCY; EVOLUTION; CAPACITOR; HSP90	Many mutations, including those that cause disease, only have a detrimental effect in a subset of individuals. The reasons for this are usually unknown, but may include additional genetic variation and environmental risk factors(1). However, phenotypic discordance remains even in the absence of genetic variation, for example between monozygotic twins(2), and incomplete penetrance of mutations is frequent in isogenic model organisms in homogeneous environments(3,4). Here we propose a model for incomplete penetrance based on genetic interaction networks(5,6). Using Caenorhabditis elegans as a model system, we identify two compensation mechanisms that vary among individuals and influence mutation outcome. First, feedback induction of an ancestral gene duplicate differs across individuals, with high expression masking the effects of a mutation. This supports the hypothesis that redundancy is maintained in genomes to buffer stochastic developmental failure(7). Second, during normal embryonic development we find that there is substantial variation in the induction of molecular chaperones such as Hsp90 (DAF-21). Chaperones act as promiscuous buffers of genetic variation(8,9), and embryos with stronger induction of Hsp90 are less likely to be affected by an inherited mutation. Simultaneously quantifying the variation in these two independent responses allows the phenotypic outcome of a mutation to be more accurately predicted in individuals. Our model and methodology provide a framework for dissecting the causes of incomplete penetrance. Further, the results establish that inter-individual variation in both specific and more general buffering systems combine to determine the outcome inherited mutations in each individual.	[Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Burga, Alejandro; Olivia Casanueva, M.; Lehner, Ben] Univ Pompeu Fabra UPF, Barcelona 08003, Spain; [Lehner, Ben] Ctr Genom Regulat CRG, Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020; Burga, Alejandro/AAJ-8745-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Burga, Alejandro/0000-0002-0211-4357	European Research Council; Institucio Catalana de Recerca i Estudis Avancats; Ministerio de Ciencia e Innovacion Plan Nacional [BFU2008-00365]; Agencia de Gestio d'juts Universitaris i de Recerca; ERASysBio+; European Molecular Biology Organization; EMBL-CRG Systems Biology Program; Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship; Beatriu de Pinos Fellowship; National Institutes of Health National Center for Research Resources; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); Institucio Catalana de Recerca i Estudis Avancats(ICREA); Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestio d'juts Universitaris i de Recerca; ERASysBio+; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBL-CRG Systems Biology Program; Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship; Beatriu de Pinos Fellowship; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ICREA(ICREA)	This work was funded by grants from the European Research Council, Institucio Catalana de Recerca i Estudis Avancats, Ministerio de Ciencia e Innovacion Plan Nacional BFU2008-00365, Agencia de Gestio d'juts Universitaris i de Recerca, ERASysBio+, the European Molecular Biology Organization Young Investigator Programme, the EMBL-CRG Systems Biology Program, by a Formacion de Personal Investigador-Ministerio de Ciencia e Innovacion fellowship to A. B. and by a Beatriu de Pinos Fellowship to M.O.C. We thank I. Hope, V. Ambros and S. Kim for providing strains. Additional strains were obtained from the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank T. Zimmermann and R. Garcia from the CRG Advanced Light Microscopy Unit for advice and assistance, J. Miwa and Y. Yamaguchi for 608F antibody, J. Semple for providing complementary DNA clones, A. Marchetti and R. Garcia-Verdugo for technical assistance, J. Tischler and C. Kiel for advice on single-molecule fluorescence in situ hybridization and western blotting, respectively, and L. Serrano, M. Isalan and J. Semple for comments on the manuscript.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andachi Y, 2004, GENES CELLS, V9, P331, DOI 10.1111/j.1356-9597.2004.00725.x; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bateson W, 1909, MENDELS PRINCIPLES H; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564; BRENNER S, 1974, GENETICS, V77, P71; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; HORVITZ HR, 1980, GENETICS, V96, P435; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kelly WG, 1997, GENETICS, V146, P227; Koh K, 2001, DEVELOPMENT, V128, P2867; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lehner B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001185; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Pocock R, 2004, DEVELOPMENT, V131, P2373, DOI 10.1242/dev.01110; Praitis V, 2001, GENETICS, V157, P1217; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Wolf DE, 2007, METHOD CELL BIOL, V81, P365, DOI 10.1016/S0091-679X(06)81017-4; YAMAGUCHI Y, 1983, DEV GROWTH DIFFER, V25, P121	41	128	132	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					250	U133		10.1038/nature10665	http://dx.doi.org/10.1038/nature10665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158248				2022-12-28	WOS:000297744200053
J	Raftery, J; Chorozoglou, M				Raftery, James; Chorozoglou, Maria			Possible net harms of breast cancer screening: updated modelling of Forrest report	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; MORTALITY; PROGRAM; OVERDIAGNOSIS; LIFE	Objective To assess the claim in a Cochrane review that mammographic breast cancer screening could be doing more harm than good by updating the analysis in the Forrest report, which led to screening in the United Kingdom. Design Development of a life table model, which replicated Forrest's results before updating and extending them with data from relevant systematic reviews, trials, and other models based on purposive literature searches. Participants Women aged 50 and over invited for breast cancer screening. Main outcome measures Quality adjusted life years (QALYs), combining life years gained from screening with losses of quality of life from false positive diagnoses and surgery. Results Inclusion of the effects of harms reduced the updated estimate of net cumulative QALYs gained after 20 years from 3301 to 1536 or by more than half. The best estimates from the Cochrane review generated negative QALYs for the first seven years of screening, 70 QALYs after 10 years, and 834 QALYs after 20 years. Sensitivity analysis showed these results were robust to a range of assumptions, particularly up to 10 years. It also indicated the importance of the level and duration of harms from surgery. Conclusions This analysis supports the claim that the introduction of breast cancer screening might have caused net harm for up to 10 years after the start of screening.	[Raftery, James; Chorozoglou, Maria] Univ Southampton, Fac Med, Wessex Inst, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Fac Med, Wessex Inst, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk		Chorozoglou, Maria/0000-0001-5070-4653				[Anonymous], 1985, OFF NAT STAT SER DH2; [Anonymous], 2006, ADV COMM BREAST CANC; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Baum M., 2010, BREAST BEATING PERSO; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Brodersen J, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-3; Buxton M, 1988, MEASURING HLTH PROSP; Cancer Statistics, 2009, CANC STAT, P9; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Forrest APM, 1987, BREAST CANC SCREEN R, V3rd, P102; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Jorgensen KJ, 2010, ANN INTERN MED, V152, P538, DOI 10.7326/0003-4819-152-8-201004200-00198; Jorgensen KJ, 2011, RADIOLOGY, V260, P621, DOI 10.1148/radiol.11110210; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Madan J, 2008, VALUE HEALTH, V13, P215; Nelson H, 2009, SCREENING BREAST CAN; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; OPCS Department of Health, 1987, HOSP INP ENQ SUMM TA; OPCS Department of Health, 1987, HOSP INP ENQ INP DAY; Peasgood T, 2010, 1015 SCHARR HEDS U S; Pisani P, 2004, BRIT J CANCER, V90, P652, DOI 10.1038/sj.bjc.6601614; Quinn M, 2008, CANC TRENDS ENGLAND, V66; Raffle A, 2007, SCREENING EVIDENCE P, P82; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P77482; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; Welch H, 2011, OVERDIAGNOSED MAKING; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2011, ARCH INTERN MED 1024; WHO IARC, 2002, BREAST CANC SCREEN; Williams LJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15120	34	33	33	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2011	343								d7627	10.1136/bmj.d7627	http://dx.doi.org/10.1136/bmj.d7627			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EX	22155336	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000298939300005
J	Smith, AK; Williams, BA; Lo, B				Smith, Alexander K.; Williams, Brie A.; Lo, Bernard			Discussing Overall Prognosis with the Very Elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smith, Alexander K.; Williams, Brie A.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Lo, Bernard] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Smith, Alexander K.; Williams, Brie A.] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Smith, AK (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.				NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 2008, ANN INTERN MED, V149, P627; Back AL, 2006, J CLIN ONCOL, V24, P4214, DOI 10.1200/JCO.2006.06.008; Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750	5	62	62	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2149	2151		10.1056/NEJMp1109990	http://dx.doi.org/10.1056/NEJMp1109990			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857PQ	22150033	Green Accepted			2022-12-28	WOS:000297731400014
J	Sterling, TR; Villarino, ME; Borisov, AS; Shang, N; Gordin, F; Bliven-Sizemore, E; Hackman, J; Hamilton, CD; Menzies, D; Kerrigan, A; Weis, SE; Weiner, M; Wing, D; Conde, MB; Bozeman, L; Horsburgh, CR; Chaisson, RE				Sterling, Timothy R.; Villarino, M. Elsa; Borisov, Andrey S.; Shang, Nong; Gordin, Fred; Bliven-Sizemore, Erin; Hackman, Judith; Hamilton, Carol Dukes; Menzies, Dick; Kerrigan, Amy; Weis, Stephen E.; Weiner, Marc; Wing, Diane; Conde, Marcus B.; Bozeman, Lorna; Horsburgh, C. Robert, Jr.; Chaisson, Richard E.		TB Trials Consortium PREVENT TB	Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTIVE THERAPY; UNITED-STATES; RIFAMPIN; PYRAZINAMIDE; PHARMACOKINETICS; IMMUNOCOMPETENT; RIFABUTIN; REGIMENS; TRIAL; TWICE	BACKGROUND Treatment of latent Mycobacterium tuberculosis infection is an essential component of tuberculosis control and elimination. The current standard regimen of isoniazid for 9 months is efficacious but is limited by toxicity and low rates of treatment completion. METHODS We conducted an open-label, randomized noninferiority trial comparing 3 months of directly observed once-weekly therapy with rifapentine (900 mg) plus isoniazid (900 mg) (combination-therapy group) with 9 months of self-administered daily isoniazid (300 mg) (isoniazid-only group) in subjects at high risk for tuberculosis. Subjects were enrolled from the United States, Canada, Brazil, and Spain and followed for 33 months. The primary end point was confirmed tuberculosis, and the noninferiority margin was 0.75%. RESULTS In the modified intention-to-treat analysis, tuberculosis developed in 7 of 3986 subjects in the combination-therapy group (cumulative rate, 0.19%) and in 15 of 3745 subjects in the isoniazid-only group (cumulative rate, 0.43%), for a difference of 0.24 percentage points. Rates of treatment completion were 82.1% in the combination-therapy group and 69.0% in the isoniazid-only group (P<0.001). Rates of permanent drug discontinuation owing to an adverse event were 4.9% in the combination-therapy group and 3.7% in the isoniazid-only group (P = 0.009). Rates of investigator-assessed drug-related hepatotoxicity were 0.4% and 2.7%, respectively (P<0.001). CONCLUSIONS The use of rifapentine plus isoniazid for 3 months was as effective as 9 months of isoniazid alone in preventing tuberculosis and had a higher treatment-completion rate. Long-term safety monitoring will be important. (Funded by the Centers for Disease Control and Prevention; PREVENT TB ClinicalTrials.gov number, NCT00023452.)	[Villarino, M. Elsa; Borisov, Andrey S.; Shang, Nong; Bliven-Sizemore, Erin; Bozeman, Lorna] Ctr Dis Control & Prevent, Atlanta, GA USA; [Gordin, Fred] George Washington Univ, Washington, DC USA; [Gordin, Fred] Washington DC Vet Affairs Med Ctr, Washington, DC USA; [Hackman, Judith; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Hamilton, Carol Dukes] Family Hlth Int, Durham, NC USA; [Hamilton, Carol Dukes] Duke Univ, Durham, NC USA; [Menzies, Dick] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada; [Weis, Stephen E.] Univ N Texas Hlth Sci Ctr Ft Worth, Ft Worth, TX USA; [Weiner, Marc] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Weiner, Marc] S Texas Vet Hlth Care Syst, San Antonio, TX USA; [Wing, Diane] S Texas Consortium, Harlingen, TX USA; [Conde, Marcus B.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sterling, Timothy R.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Centers for Disease Control & Prevention - USA; George Washington University; Johns Hopkins University; Duke University; McGill University; University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Universidade Federal do Rio de Janeiro; Boston University; Vanderbilt University	Sterling, TR (corresponding author), A2209 Med Ctr N, 1161 21st Ave S, Nashville, TN 37232 USA.	timothy.sterling@vanderbilt.edu	Trajman, Anete/C-7679-2016; Conte, Marcus B/A-2501-2013; Franzeck, Fabian C/B-5055-2011	Trajman, Anete/0000-0002-4000-4984; Conte, Marcus B/0000-0002-7249-4455; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Tortajada, Cecilia/0000-0001-7320-3632; Borisov, Andrey/0000-0001-9124-8877; Narita, Masahiro/0000-0001-5825-5450; Millet, Joan Pau/0000-0003-0200-2459; Ocana, Inma/0000-0003-3699-0790; Horsburgh, C./0000-0001-6838-7895; Sanchez-Martinez, Francesca/0000-0002-5550-9790	CDC; Bristol-Myers Squibb; Pfizer; Sanofi-Aventis; Otsuka America Pharmaceutical	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Otsuka America Pharmaceutical(Otsuka Pharmaceutical)	Supported by the CDC.; Dr. Sterling reports receiving research grant funding from Bristol-Myers Squibb and Pfizer for HIV observational studies; Dr. Hamilton, being employed by Family Health International; Dr. Weiner, receiving research grant funding from Sanofi-Aventis; and Dr. Horsburgh, receiving payments from Otsuka America Pharmaceutical for scientific reviews of study protocols. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2011, GUID INT TUB CAS FIN; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blake MJ, 2006, PEDIATR INFECT DIS J, V25, P405, DOI 10.1097/01.inf.0000214963.55217.9c; Burman WJ, 2001, CLIN PHARMACOKINET, V40, P327, DOI 10.2165/00003088-200140050-00002; Cancer Therapy Evaluation Program, 1999, COMM TOX CRIT VERS 2; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P289; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P733; Chaisson RE, 2001, AM J MED, V110, P610, DOI 10.1016/S0002-9343(01)00695-7; CHAPUIS L, 1994, AM J RESP CRIT CARE, V150, P1355, DOI 10.1164/ajrccm.150.5.7952564; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; *I MED, 2000, END NEGL EL TUB US; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; JI BH, 1993, AM REV RESPIR DIS, V148, P1541, DOI 10.1164/ajrccm/148.6_Pt_1.1541; Kritski AL, 1996, AM J RESP CRIT CARE, V153, P331, DOI 10.1164/ajrccm.153.1.8542139; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P2126, DOI 10.1128/AAC.43.9.2126; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2006, JAMA-J AM MED ASSOC, V296, P1842; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; SNIDER DE, 1988, AM REV RESPIR DIS, V137, P2, DOI 10.1164/ajrccm/137.1.2; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; Sutherland I, 1976, Adv Tuberc Res, V19, P1; Sutherland I., 1968, 2550 INDIVIDUALS AGE; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; WHO, 2010, GLOB TUB CONTR 2010	39	594	622	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2155	2166		10.1056/NEJMoa1104875	http://dx.doi.org/10.1056/NEJMoa1104875			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150035				2022-12-28	WOS:000297731400001
J	Mora, S; Buring, JE; Ridker, PM; Cui, YD				Mora, Samia; Buring, Julie E.; Ridker, Paul M.; Cui, Yadong			Association of High-Density Lipoprotein Cholesterol With Incident Cardiovascular Events in Women, by Low-Density Lipoprotein Cholesterol and Apolipoprotein B100 Levels A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; A-I; HDL CHOLESTEROL; RISK; PREDICTION; CANCER; HEALTH; RATIO	Background: Prior studies have found inverse associations between high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I levels and cardiovascular disease (CVD). Whether this observation is consistent across low-density lipoprotein cholesterol (LDL-C) levels or total atherogenic particle burden (apolipoprotein B100) is less well-studied, particularly in women. Objective: To determine the association between HDL-C or apolipoprotein A-I level and CVD across a range of LDL-C and apolipoprotein B100 values. Design: Prospective cohort study. Setting: The Women's Health Study, a cohort of U.S. female health professionals. Participants: 26 861 initially healthy women, aged 45 years or older at study entry (1992-1995), who were followed for a mean of approximately 11 years. Measurements: Baseline lipids were measured directly, and apolipoproteins were measured with immunoassays. Outcomes were incident total CVD (n = 929), coronary events (n = 602), and stroke (n = 319). Results: In multivariable analyses, HDL-C and apolipoprotein A-I levels were inversely associated with CVD and coronary events but not stroke. Adjusted coronary hazard ratios for decreasing quintiles of HDL-C were 1.00 (reference), 1.23 (95% CI, 0.85 to 1.78), 1.42 (CI, 0.98 to 2.06), 1.90 (CI, 1.33 to 2.71), and 2.19 (CI, 1.51 to 3.19) (P for linear trend < 0.001); corresponding hazard ratios for apolipoprotein A-I were 1.00 (reference), 0.98 (CI, 0.71 to 1.35), 1.02 (CI, 0.72 to 1.44), 1.37 (CI, 0.98 to 1.90), and 1.58 (CI, 1.14 to 2.20) (P for linear trend = 0.005). Consistent inverse associations were found for HDL-C with coronary events across a range of LDL-C values, including among women with low LDL-C levels. No associations were noted for HDL-C or apolipoprotein A-I among women with low apolipoprotein B100 values (<0.90 g/L). Limitation: Participants were at low risk for CVD, the number of events in the lowest apolipoprotein B100 stratum was small, only a single baseline measurement was obtained, and residual confounding may have occurred. Conclusion: Consistent inverse associations were found for HDL-C with incident coronary events among women with a range of LDL-C values. Among women with low total atherogenic particle burden (apolipoprotein B100 level <0.90 g/L), few events occurred and no associations were seen.	[Mora, Samia] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; Merck & Co Inc, N Wales, PA 19454 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company	Mora, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E,3rd Floor, Boston, MA 02215 USA.	smora@partners.org		Mora, Samia/0000-0001-6283-0980	Merck Co.; National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health [K08 HL094375, HL 43851, HL 080467, CA 47988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467, K08HL094375] Funding Source: NIH RePORTER	Merck Co.(Merck & Company); National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research for this article was supported by an investigator-initiated research grant to Dr. Mora from Merck & Co. The study was also supported by grants K08 HL094375 (Dr. Mora) and HL 43851, HL 080467, and CA 47988 from the National Heart, Lung, and Blood Institute and the National Cancer Institute, National Institutes of Health.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; BASS KM, 1993, ARCH INTERN MED, V153, P2209, DOI 10.1001/archinte.153.19.2209; Bittner V, 2005, J AM COLL CARDIOL, V46, P1628, DOI 10.1016/j.jacc.2005.05.089; CASTELLI WP, 1988, CAN J CARDIOL, V0004; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner Steven M, 2004, Diabetes Care, V27 Suppl 1, pS68; Hainline A, 1982, MANUAL LAB OPERATION, V628; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Thompson A, 2006, J INTERN MED, V259, P481, DOI 10.1111/j.1365-2796.2006.01644.x; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; WARNER JG, 1995, CIRCULATION, V92, P773, DOI 10.1161/01.CIR.92.4.773	26	37	38	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					742	U157		10.7326/0003-4819-155-11-201112060-00006	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147713	Green Accepted			2022-12-28	WOS:000297988400003
J	McGurk, L; Bonini, NM				McGurk, Leeanne; Bonini, Nancy M.			Yeast Informs Alzheimer's Disease	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; GENETICS; CLU		[McGurk, Leeanne; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Dept Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	McGurk, L (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	McGurk, Leeanne/L-6734-2019	McGurk, Leeanne/0000-0002-6493-6751	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS066312, R01 NS073660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073660, R01NS066312] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210	10	5	5	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1212	1213		10.1126/science.1216073	http://dx.doi.org/10.1126/science.1216073			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22144604				2022-12-28	WOS:000297553600025
J	Feld, M; Frohlich, B; Vogt, E; Koschorreck, M; Kohl, M				Feld, Michael; Froehlich, Bernd; Vogt, Enrico; Koschorreck, Marco; Koehl, Michael			Observation of a pairing pseudogap in a two-dimensional Fermi gas	NATURE			English	Article							NORMAL-STATE; T-C; BEHAVIOR	Pairing of fermions is ubiquitous in nature, underlying many phenomena. Examples include superconductivity, superfluidity of He-3, the anomalous rotation of neutron stars, and the crossover between Bose-Einstein condensation of dimers and the BCS (Bardeen, Cooper and Schrieffer) regime in strongly interacting Fermi gases. When confined to two dimensions, interacting many-body systems show even more subtle effects(1), many of which are not understood at a fundamental level. Most striking is the (as yet unexplained) phenomenon of high-temperature superconductivity in copper oxides, which is intimately related to the two-dimensional geometry of the crystal structure. In particular, it is not understood how the many-body pairing is established at high temperature, and whether it precedes superconductivity. Here we report the observation of a many-body pairing gap above the superfluid transition temperature in a harmonically trapped, two-dimensional atomic Fermi gas in the regime of strong coupling. Our measurements of the spectral function of the gas are performed using momentum-resolved photoemission spectroscopy(2,3), analogous to angle-resolved photoemission spectroscopy in the solid state(4). Our observations mark a significant step in the emulation of layered two-dimensional strongly correlated superconductors using ultracold atomic gases.	[Feld, Michael; Froehlich, Bernd; Vogt, Enrico; Koschorreck, Marco; Koehl, Michael] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Kohl, M (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	mk540@cam.ac.uk	Kohl, Michael/C-6114-2009; Koschorreck, Marco/D-1536-2009	Kohl, Michael/0000-0003-4055-713X; Koschorreck, Marco/0000-0003-0974-7007	EPSRC [EP/G029547/1]; Daimler-Benz Foundation; Studienstiftung; DAAD; Engineering and Physical Sciences Research Council [EP/G029547/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Daimler-Benz Foundation; Studienstiftung; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Georges, C. Kollath, D. Pertot, D. Petrov, M. Randeria, W. Zwerger and M. Zwierlein for discussions. The work was supported by EPSRC (EP/G029547/1), Daimler-Benz Foundation (B. F.), Studienstiftung and DAAD (M.F.).	Bertaina G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110403; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Botelho SS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040404; Chien CC, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.023622; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Dao TL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.240402; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; DRECHSLER M, 1992, ANN PHYS-LEIPZIG, V1, P15, DOI 10.1002/andp.19925040105; Dyke P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105304; Frohlich B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105301; Gaebler JP, 2010, NAT PHYS, V6, P569, DOI 10.1038/NPHYS1709; GORKOV LP, 1961, SOV PHYS JETP-USSR, V13, P1018; Gunter K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.230401; Haussmann R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063612; Hu H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.240407; Loktev VM, 2001, PHYS REP, V349, P1, DOI 10.1016/S0370-1573(00)00114-9; Martiyanov K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.030404; MIYAKE K, 1983, PROG THEOR PHYS, V69, P1794, DOI 10.1143/PTP.69.1794; Nascimbene S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215303; Petrov DS, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.031601; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Pieri P, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.011608; RANDERIA M, 1989, PHYS REV LETT, V62, P981, DOI 10.1103/PhysRevLett.62.981; RANDERIA M, 1992, PHYS REV LETT, V69, P2001, DOI 10.1103/PhysRevLett.69.2001; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Schneider W, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.021601; Shin Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090403; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Stewart JT, 2008, NATURE, V454, P744, DOI 10.1038/nature07172; TRIVEDI N, 1995, PHYS REV LETT, V75, P312, DOI 10.1103/PhysRevLett.75.312; Tsuchiya S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033613; Wulin D, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100504	32	186	189	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					75	U233		10.1038/nature10627	http://dx.doi.org/10.1038/nature10627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129727	Green Submitted			2022-12-28	WOS:000298031900036
J	Kapoor, R; Johnson, RA				Kapoor, Roger; Johnson, Richard A.			Polydactyly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kapoor, Roger; Johnson, Richard A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kapoor, R (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	rogerkapoor@gmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2122	2122		10.1056/NEJMicm1100857	http://dx.doi.org/10.1056/NEJMicm1100857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129256				2022-12-28	WOS:000297499000012
J	Pramyothin, P; Leung, AM; Pearce, EN; Malabanan, AO; Braverman, LE				Pramyothin, Pornpoj; Leung, Angela M.; Pearce, Elizabeth N.; Malabanan, Alan O.; Braverman, Lewis E.			A Hidden Solution	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IODINE-INDUCED HYPERTHYROIDISM; THYROID-FUNCTION; POLYVINYLPYRROLIDONE-IODINE; THYROTOXICOSIS; ABSORPTION		[Pramyothin, Pornpoj; Leung, Angela M.; Pearce, Elizabeth N.; Braverman, Lewis E.] Boston Med Ctr, Sect Endocrinol Diab & Nutr, Boston, MA 02118 USA; [Pramyothin, Pornpoj; Leung, Angela M.; Pearce, Elizabeth N.; Braverman, Lewis E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Malabanan, Alan O.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Pramyothin, Pornpoj] Mahidol Univ, Dept Med, Siriraj Hosp, Bangkok 10700, Thailand	Boston Medical Center; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Mahidol University	Braverman, LE (corresponding author), Boston Med Ctr, Sect Endocrinol Diab & Nutr, Boston, MA 02118 USA.	lewis.braverman@bmc.org		Leung, Angela M./0000-0001-8935-9332; Pearce, Elizabeth/0000-0003-3799-0354; Braverman, Lewis/0000-0003-1263-1099	Novartis; Procter & Gamble/Sanofi-Aventis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD068552] Funding Source: NIH RePORTER	Novartis(Novartis); Procter & Gamble/Sanofi-Aventis(Sanofi-Aventis); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Malabanan reports receiving speaker's bureau fees from Novartis and Procter & Gamble/Sanofi-Aventis. Dr. Pearce reports receiving compensation from DuPont for testimony for the defense regarding the development of hypothyroidism after exposure to radioactive iodine released by the Hanford Nuclear Reservation. No other potential conflict of interest relevant to this article was reported.	ADER AW, 1988, J CLIN ENDOCR METAB, V66, P632, DOI 10.1210/jcem-66-3-632; BENOTTI J, 1965, CLIN CHEM, V11, P932; Cohen-Lehman J, 2010, NAT REV ENDOCRINOL, V6, P34, DOI 10.1038/nrendo.2009.225; Eng PHK, 1999, ENDOCRINOLOGY, V140, P3404, DOI 10.1210/en.140.8.3404; Institute of Medicine, 2006, DIET REF INT; Liel Y, 1996, ARCH INTERN MED, V156, P807, DOI 10.1001/archinte.156.7.807; MARTIN FIR, 1993, AM J MED, V95, P78, DOI 10.1016/0002-9343(93)90235-H; Nolte W, 1996, EUR J ENDOCRINOL, V134, P337, DOI 10.1530/eje.0.1340337; PAUL T, 1988, METABOLISM, V37, P121, DOI 10.1016/S0026-0495(98)90004-X; RAJATANAVIN R, 1984, AM J MED, V77, P378, DOI 10.1016/0002-9343(84)90726-5; SAFRAN M, 1982, OBSTET GYNECOL, V60, P35; SHETTY KR, 1990, ARCH INTERN MED, V150, P2400, DOI 10.1001/archinte.150.11.2400; Stanbury JB, 1998, THYROID, V8, P83, DOI 10.1089/thy.1998.8.83; VAGENAKIS AG, 1972, NEW ENGL J MED, V287, P523, DOI 10.1056/NEJM197209142871101; WOLFF J, 1948, J BIOL CHEM, V174, P555	15	24	25	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2123	2127		10.1056/NEJMcps1008908	http://dx.doi.org/10.1056/NEJMcps1008908			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854MO	22129257	Green Accepted			2022-12-28	WOS:000297499000013
J	Harley, CDG				Harley, Christopher D. G.			Climate Change, Keystone Predation, and Biodiversity Loss	SCIENCE			English	Article							PATTERNS; LIMITS; SHIFTS; RANGE; ZONATION; IMPACTS; STRESS	Climate change can affect organisms both directly via physiological stress and indirectly via changing relationships among species. However, we do not fully understand how changing interspecific relationships contribute to community- and ecosystem-level responses to environmental forcing. I used experiments and spatial and temporal comparisons to demonstrate that warming substantially reduces predator-free space on rocky shores. The vertical extent of mussel beds decreased by 51% in 52 years, and reproductive populations of mussels disappeared at several sites. Prey species were able to occupy a hot, extralimital site if predation pressure was experimentally reduced, and local species richness more than doubled as a result. These results suggest that anthropogenic climate change can alter interspecific interactions and produce unexpected changes in species distributions, community structure, and diversity.	[Harley, Christopher D. G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Harley, Christopher D. G.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Harley, CDG (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	harley@zoology.ubc.ca	Harley, Christopher D. G./K-5593-2012	Harley, Christopher D. G./0000-0003-4099-943X	National Science and Engineering Research Council (Canada); Padilla Bay National Estuarine Research Reserve	National Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Padilla Bay National Estuarine Research Reserve	T. Widdowson was instrumental in locating the historical data collection sites and accurately repeating the original surveys; his help is gratefully acknowledged. I also thank P. Martone, B. Matthews, M. O'Connor, R. T. Paine, T. Widdowson, and two anonymous referees for thoughtful comments on the manuscript. The Huu-ay-aht First Nation, Beecher Bay First Nation, Makah Tribal Nation, Correctional Service Canada, the Pfaff family, Point No Point Resort, and Friday Harbor Laboratories provided access to field sites. Historical temperature data for Victoria, British Columbia, are reproduced and distributed with the permission of the government of Canada. Funding was provided by the National Science and Engineering Research Council (Canada) and the Padilla Bay National Estuarine Research Reserve. Data are archived in the supporting online material.	BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; COLE K, 1982, SCIENCE, V217, P1142, DOI 10.1126/science.217.4565.1142; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Leonard GH, 2000, ECOLOGY, V81, P1015; Ministry of the Environment (MOE), 2006, BRIT COL COAST MAR E; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pincebourde S, 2008, LIMNOL OCEANOGR, V53, P1562, DOI 10.4319/lo.2008.53.4.1562; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Robles C, 2002, ECOLOGY, V83, P1521, DOI 10.1890/0012-9658(2002)083[1521:HACDOA]2.0.CO;2; ROMME WH, 1991, CONSERV BIOL, V5, P373, DOI 10.1111/j.1523-1739.1991.tb00151.x; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; TOKESHI M, 1995, MAR ECOL PROG SER, V125, P137, DOI 10.3354/meps125137; Tomanek L, 1999, J EXP BIOL, V202, P2925; WETHEY DS, 1983, BIOL BULL-US, V165, P330, DOI 10.2307/1541373; Widdowson T. B., 1959, THESIS U BRIT COLUMB	30	363	370	11	512	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1124	1127		10.1126/science.1210199	http://dx.doi.org/10.1126/science.1210199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116885				2022-12-28	WOS:000297313900048
J	Madix, RJ; Friend, CM				Madix, Robert J.; Friend, Cynthia M.			INTERFACIAL CHEMISTRY Gold's enigmatic surface	NATURE			English	Editorial Material							METAL-SURFACES; CATALYSIS		[Madix, Robert J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Friend, Cynthia M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA	Harvard University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Madix, RJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	rmadix@seas.harvard.edu; cfriend@slac.stanford.edu						Angelici RJ, 2008, J ORGANOMET CHEM, V693, P847, DOI 10.1016/j.jorganchem.2007.11.023; BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Christensen CH, 2010, SCIENCE, V327, P278, DOI 10.1126/science.1184203; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Guo XC, 2004, SURF SCI, V564, P21, DOI 10.1016/j.susc.2004.06.208; JAFFEY DM, 1994, J AM CHEM SOC, V116, P3012, DOI 10.1021/ja00086a034; Paserba KR, 2001, PHYS REV LETT, V86, P4338, DOI 10.1103/PhysRevLett.86.4338; PAUL A, 1993, SURF SCI, V297, P327, DOI 10.1016/0039-6028(93)90221-5; Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591; Xu B., 2010, ANGEW CHEM, V122, P404; Zhong DY, 2011, SCIENCE, V334, P213, DOI 10.1126/science.1211836	11	4	4	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					482	483		10.1038/479482a	http://dx.doi.org/10.1038/479482a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22113688				2022-12-28	WOS:000297285600038
J	Fujiki, R; Hashiba, W; Sekine, H; Yokoyama, A; Chikanishi, T; Ito, S; Imai, Y; Kim, J; He, HH; Igarashi, K; Kanno, J; Ohtake, F; Kitagawa, H; Roeder, RG; Brown, M; Kato, S				Fujiki, Ryoji; Hashiba, Waka; Sekine, Hiroki; Yokoyama, Atsushi; Chikanishi, Toshihiro; Ito, Saya; Imai, Yuuki; Kim, Jaehoon; He, Housheng Hansen; Igarashi, Katsuhide; Kanno, Jun; Ohtake, Fumiaki; Kitagawa, Hirochika; Roeder, Robert G.; Brown, Myles; Kato, Shigeaki			GlcNAcylation of histone H2B facilitates its monoubiquitination	NATURE			English	Article							O-GLCNAC TRANSFERASE; BETA-N-ACETYLGLUCOSAMINE; CHROMATIN; ACETYLATION; LANGUAGE; GENES	Chromatin reorganization is governed by multiple post-translational modifications of chromosomal proteins and DNA(1,2). These histone modifications are reversible, dynamic events that can regulate DNA-driven cellular processes(3,4). However, the molecular mechanisms that coordinate histone modification patterns remain largely unknown. In metazoans, reversible protein modification by O-linked N-acetylglucosamine (GlcNAc) is catalysed by two enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA)(5,6). However, the significance of GlcNAcylation in chromatin reorganization remains elusive. Here we report that histone H2B is GlcNAcylated at residue S112 by OGT in vitro and in living cells. Histone GlcNAcylation fluctuated in response to extracellular glucose through the hexosamine biosynthesis pathway (HBP)(5,6). H2B S112 GlcNAcylation promotes K120 monoubiquitination, in which the GlcNAc moiety can serve as an anchor for a histone H2B ubiquitin ligase. H2B S112 GlcNAc was localized to euchromatic areas on fly polytene chromosomes. In a genome-wide analysis, H2B S112 GlcNAcylation sites were observed widely distributed over chromosomes including transcribed gene loci, with some sites co-localizing with H2B K120 monoubiquitination. These findings suggest that H2B S112 GlcNAcylation is a histone modification that facilitates H2BK120 monoubiquitination, presumably for transcriptional activation.	[Fujiki, Ryoji; Hashiba, Waka; Sekine, Hiroki; Yokoyama, Atsushi; Chikanishi, Toshihiro; Ito, Saya; Imai, Yuuki; Ohtake, Fumiaki; Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [He, Housheng Hansen; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [He, Housheng Hansen; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Igarashi, Katsuhide; Kanno, Jun] Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan; [Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp	Yokoyama, Atsushi/W-3519-2019; He, Housheng/G-9614-2011; He, Hansen/ABD-8439-2020; Kim, Jaehoon/G-2711-2011; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008; Imai, Yuuki/ABC-4687-2020	He, Hansen/0000-0003-2898-3363; Kim, Jaehoon/0000-0003-4035-0438; Brown, Myles/0000-0002-8213-1658; Yokoyama, Atsushi/0000-0003-2842-4334	Naito Foundation; Astellas foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science	Naito Foundation(Naito Memorial Foundation); Astellas foundation(Astellas Pharmaceuticals); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. Miyajima, S. Saito and N. Moriyama for experimental support, and M. Yamaki for manuscript preparation. We also thank Y. Maekawa, J. Seta and N. Iwasaki for support with MS. This work was supported in part by The Naito Foundation, the Astellas foundation (to R. F.), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (to R.F. and S.K.).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chikanishi T, 2010, BIOCHEM BIOPH RES CO, V394, P865, DOI 10.1016/j.bbrc.2010.02.167; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sawatsubashi S, 2010, GENE DEV, V24, P159, DOI 10.1101/gad.1857410; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	25	220	233	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					557	U188		10.1038/nature10656	http://dx.doi.org/10.1038/nature10656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121020	Green Accepted			2022-12-28	WOS:000298318000068
J	Elser, JJ				Elser, James J.			A World Awash with Nitrogen	SCIENCE			English	Editorial Material							PHOSPHORUS LIMITATION; DEPOSITION; CYCLE		Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155				Craine JM., 2009, RESOURCE STRATEGIES; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2010, ECOL LETT, V13, P1256, DOI 10.1111/j.1461-0248.2010.01519.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Hastings MG, 2009, SCIENCE, V324, P1288, DOI 10.1126/science.1170510; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j	13	41	41	12	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2011	334	6062					1504	1505		10.1126/science.1215567	http://dx.doi.org/10.1126/science.1215567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	862LE	22174237				2022-12-28	WOS:000298091400036
J	Ryan, ET; Cronin, CG; Branda, JA				Ryan, Edward T.; Cronin, Carmel G.; Branda, John A.			Case 38-2011: A 34-Year-Old Man with Diarrhea and Weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; FLACCID QUADRIPARESIS; PARALYSIS; MICROSPORIDIOSIS; HYPOKALEMIA; ENTERITIS; GIARDIA		[Ryan, Edward T.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Cronin, Carmel G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, Edward T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Cronin, Carmel G.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020		DiaSorin	DiaSorin	Dr. Branda reports receiving grant support from DiaSorin. No other potential conflict of interest relevant to this article was reported.	Ash LR, 2007, ATLAS HUMAN PARASITO, V5th; CERVELLO A, 1993, NEW ENGL J MED, V329, P210, DOI 10.1056/NEJM199307153290318; DASILVA OA, 1981, AM J TROP MED HYG, V30, P69, DOI 10.4269/ajtmh.1981.30.69; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; EHERER AJ, 1992, GASTROENTEROLOGY, V103, P545, DOI 10.1016/0016-5085(92)90845-P; FORTHAL DN, 1984, AM J TROP MED HYG, V33, P1060, DOI 10.4269/ajtmh.1984.33.1060; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; Huang DB, 2006, GASTROENTEROL CLIN N, V35, P291, DOI 10.1016/j.gtc.2006.03.006; Jurkat-Rott K, 2006, J NEUROL, V253, P1391, DOI 10.1007/s00415-006-0339-0; Lewthwaite P, 2005, CURR OPIN INFECT DIS, V18, P427, DOI 10.1097/01.qco.0000182104.40128.18; Lin SH, 2005, MAYO CLIN PROC, V80, P99, DOI 10.1016/S0025-6196(11)62965-0; Lin SH, 2003, QJM-INT J MED, V96, P161, DOI 10.1093/qjmed/hcg021; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; ORMAN RA, 1989, ARCH INTERN MED, V149, P1193, DOI 10.1001/archinte.149.5.1193; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; REID AC, 1980, SCOT MED J, V25, P129, DOI 10.1177/003693308002500209; Sorvillo FJ, 1995, AM J TROP MED HYG, V53, P656, DOI 10.4269/ajtmh.1995.53.656; Soule JB, 1997, ARCH PATHOL LAB MED, V121, P880; STEDWELL RE, 1992, AM J EMERG MED, V10, P143, DOI 10.1016/0735-6757(92)90048-3; Tangri V, 2009, J CLIN GASTROENTEROL, V43, P293, DOI 10.1097/MCG.0b013e31818f50ce; WILLIAMS DT, 2008, J EMERG MED     1106	21	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2011	365	24					2307	2317		10.1056/NEJMcpc1011322	http://dx.doi.org/10.1056/NEJMcpc1011322			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861PN	22168646				2022-12-28	WOS:000298031800013
J	Willyard, C				Willyard, Cassandra			IMAGING Seeing is believing	NATURE			English	Editorial Material							MULTIPLE-MYELOMA											Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; Shortt CP, 2009, AM J ROENTGENOL, V192, P980, DOI 10.2214/AJR.08.1633	2	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					S52	S53		10.1038/480S52a	http://dx.doi.org/10.1038/480S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	861PZ	22169805				2022-12-28	WOS:000298033000011
J	Berardi, S; Berzigotti, A; Cappelli, A; Mastroroberto, M; Serra, C; D'Errico, A; Russo, V; Garcia-Criado, A; Sama, C				Berardi, Sonia; Berzigotti, Annalisa; Cappelli, Alberta; Mastroroberto, Marianna; Serra, Carla; D'Errico, Antonia; Russo, Vincenzo; Garcia-Criado, Angeles; Sama, Claudia			Routine blood tests? Helping you live(r) longer!	LANCET			English	Editorial Material							BUDD-CHIARI-SYNDROME; INFERIOR VENA-CAVA; OBSTRUCTION		[Berzigotti, Annalisa] Hosp Clin Barcelona, Hepat Hemodynam Lab, Liver Unit, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; [Berzigotti, Annalisa] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Berardi, Sonia; Cappelli, Alberta; Mastroroberto, Marianna; Serra, Carla; Sama, Claudia] St Orsola Malpighi Univ Hosp, Dept Digest Dis & Internal Med, Bologna, Italy; [D'Errico, Antonia] St Orsola Malpighi Univ Hosp, Dept Hematol Oncol & Lab Med, Bologna, Italy; [Russo, Vincenzo] St Orsola Malpighi Univ Hosp, Cardiothorac Vasc Dept, Bologna, Italy; [Berzigotti, Annalisa; Garcia-Criado, Angeles] Hosp Clin Barcelona, Abdominal Imaging Sect, Ctr Diagnost Imatge, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Barcelona; Hospital Clinic de Barcelona	Berzigotti, A (corresponding author), Hosp Clin Barcelona, Hepat Hemodynam Lab, Liver Unit, Inst Invest Biomed August Pi & Sunyer, C Villarroel 170, E-08036 Barcelona, Spain.	aberzigo@clinic.ub.es	García-Criado, Ángeles/AGV-5699-2022; Berzigotti, Annalisa/AGJ-9475-2022; Berzigotti, Annalisa/AAB-8999-2019; Cappelli, Alberta/AAD-1736-2021; Russo, Vincenzo/AAC-4996-2021; Mastroroberto, Marianna/K-9840-2016	Berzigotti, Annalisa/0000-0003-4562-9016; Cappelli, Alberta/0000-0003-1142-3917; Russo, Vincenzo/0000-0001-5087-242X; D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Garcia-Criado, Angeles/0000-0003-3536-4288; Mastroroberto, Marianna/0000-0001-8531-4153				Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Chawla Y, 2008, SEMIN LIVER DIS, V28, P270, DOI 10.1055/s-0028-1085095; KILMAN JW, 1971, J THORAC CARDIOV SUR, V62, P226, DOI 10.1016/S0022-5223(19)42075-8; SUCHATO C, 1977, J CAN ASSOC RADIOL, V28, P148; Valla DC, 2009, J HEPATOL, V50, P195, DOI 10.1016/j.jhep.2008.10.007	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					2048	2048		10.1016/S0140-6736(11)61456-6	http://dx.doi.org/10.1016/S0140-6736(11)61456-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	22153201				2022-12-28	WOS:000298144200029
J	Wadley, L; Sievers, C; Bamford, M; Goldberg, P; Berna, F; Miller, C				Wadley, Lyn; Sievers, Christine; Bamford, Marion; Goldberg, Paul; Berna, Francesco; Miller, Christopher			Middle Stone Age Bedding Construction and Settlement Patterns at Sibudu, South Africa	SCIENCE			English	Article							HUMAN-BEHAVIOR; SHELL BEADS; CAVE; DERIVATIVES; PLANTS; LAYERS; TOOLS	The Middle Stone Age (MSA) is associated with early behavioral innovations, expansions of modern humans within and out of Africa, and occasional population bottlenecks. Several innovations in the MSA are seen in an archaeological sequence in the rock shelter Sibudu (South Africa). At similar to 77,000 years ago, people constructed plant bedding from sedges and other monocotyledons topped with aromatic leaves containing insecticidal and larvicidal chemicals. Beginning at similar to 73,000 years ago, bedding was burned, presumably for site maintenance. By similar to 58,000 years ago, bedding construction, burning, and other forms of site use and maintenance intensified, suggesting that settlement strategies changed. Behavioral differences between similar to 77,000 and 58,000 years ago may coincide with population fluctuations in Africa.	[Wadley, Lyn; Sievers, Christine] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa; [Wadley, Lyn] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa; [Bamford, Marion] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, South Africa; [Goldberg, Paul; Miller, Christopher] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Goldberg, Paul; Berna, Francesco] Boston Univ, Dept Archaeol, Boston, MA 02215 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Eberhard Karls University of Tubingen; Boston University	Wadley, L (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa.	lyn.wadley@wits.ac.za	Wadley, Lyn/AAC-6577-2022	Berna, Francesco/0000-0002-3839-4012	Palaeontological Scientific Trust; National Research Foundation (NRF); U.S. National Science Foundation [0917739, 0551927]	Palaeontological Scientific Trust; National Research Foundation (NRF); U.S. National Science Foundation(National Science Foundation (NSF))	We thank M. Witcomb and M. Waldron for SEM assistance; T. Hodgskiss for photographing Fig. 3A; C. Dean for advice on the field curation of the C. woodii leaves; and Spectrum Petrographics for creating micromorphological thin sections. The Palaeontological Scientific Trust and National Research Foundation (NRF) funded M. B. and C.S.'s botanical work; NRF grants to L. W. and Muthama Muasya financed the SEM work. The U.S. National Science Foundation (grants 0917739 and 0551927) funds the MicroStratigraphy Laboratory at Boston University (P. G. and F. B.). The heritage agency, Amafa, supplied the excavation permit. The Institute for Human Evolution houses the Sibudu archaeological collections under the accession code 2931 CA 15; the micromorphological samples are housed in the Institute for Archaeological Sciences, Universitat Tubingen, with the accession code SIB CEM. The data reported in this paper are tabulated in the SOM.	Allott L.F., 2006, S AFR HUMANIT, V18, P173; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Cabanes D, 2010, J ARCHAEOL SCI, V37, P2947, DOI 10.1016/j.jas.2010.07.010; CAMERON CM, 1990, J FIELD ARCHAEOL, V17, P27, DOI 10.1179/009346990791548565; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; DREWES SE, 1995, PHYTOCHEMISTRY, V40, P321, DOI 10.1016/0031-9422(95)92696-6; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Kabir KE, 2003, J APPL ENTOMOL, V127, P112, DOI 10.1046/j.1439-0418.2003.00716.x; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marshall Lorna., 1976, KUNG NYAE NYAE; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Nadel D, 2004, P NATL ACAD SCI USA, V101, P6821, DOI 10.1073/pnas.0308557101; Opperman H, 1996, QUATERN INT, V33, P45, DOI 10.1016/1040-6182(95)00096-8; Rali T, 2007, MOLECULES, V12, P149, DOI 10.3390/12020149; Schmeda-Hirschmann G, 2001, J PHARM PHARMACOL, V53, P563, DOI 10.1211/0022357011775686; Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2; Sievers C., 2006, SOUTH AFR HUMANIT, V18, P203; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Zschocke S, 2000, J ETHNOPHARMACOL, V71, P473, DOI 10.1016/S0378-8741(00)00183-5	29	177	181	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1388	1391		10.1126/science.1213317	http://dx.doi.org/10.1126/science.1213317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	858HW	22158814				2022-12-28	WOS:000297787700049
J	Kinane, TB; Shailam, R; Mark, EJ				Kinane, T. Bernard; Shailam, Randheer; Mark, Eugene J.			Case 37-2011: A 9-Month-Old Boy with Recurrent Tachypnea and Respiratory Distress	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROENDOCRINE CELL HYPERPLASIA; INTERSTITIAL LUNG-DISEASE; INFANCY; CHILDREN; PNEUMONITIS; SPECTRUM		[Kinane, T. Bernard] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kinane, T. Bernard] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kinane, TB (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							AGUAYO SM, 1994, AM J RESP CELL MOL, V10, P635, DOI 10.1165/ajrcmb.10.6.8003340; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Brody AS, 2006, PEDIATR RADIOL, V36, P1328, DOI 10.1007/s00247-006-0302-3; Brody AS, 2010, AM J ROENTGENOL, V194, P238, DOI 10.2214/AJR.09.2743; Canakis AM, 2002, AM J RESP CRIT CARE, V165, P1557, DOI 10.1164/rccm.2105139; CHURCH JA, 1981, AM REV RESPIR DIS, V124, P491; Davies SJ, 2007, THORAX, V62, P248, DOI 10.1136/thx.2006.063065; Deterding RR, 2005, PEDIATR PULM, V40, P157, DOI 10.1002/ppul.20243; Deterding RR, 2001, PEDIATR PULM, P72; Deutsch GH, 2007, AM J RESP CRIT CARE, V176, P1120, DOI 10.1164/rccm.200703-393OC; Dinwiddle R, 2002, PEDIATR PULM, V34, P23, DOI 10.1002/ppul.10125; Doan ML, 2009, THORAX, V64, P677, DOI 10.1136/thx.2008.107979; Fan LL, 2004, PEDIATR PULM, V38, P369, DOI 10.1002/ppul.20114; Ge Y, 2007, ANN DIAGN PATHOL, V11, P122, DOI 10.1016/j.anndiagpath.2005.12.008; JOSHI VV, 1985, HUM PATHOL, V16, P241, DOI 10.1016/S0046-8177(85)80009-5; KINANE BT, 1993, CHEST, V104, P1183, DOI 10.1378/chest.104.4.1183; Koo CW, 2010, AM J ROENTGENOL, V195, P661, DOI 10.2214/AJR.09.3811; Langston C, 2001, PEDIATR PULM, P74; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moonnumakal SP, 2008, CURR OPIN PEDIATR, V20, P272, DOI 10.1097/MOP.0b013e3282ff62e9; Nogee LM, 2006, CURR OPIN PEDIATR, V18, P287, DOI 10.1097/01.mop.0000193310.22462.1f; Popler J, 2010, PEDIATR PULM, V45, P749, DOI 10.1002/ppul.21219; SCHROEDER SA, 1992, CHEST, V101, P1065, DOI 10.1378/chest.101.4.1065; Young LR, 2008, CHEST, V134, P192, DOI 10.1378/chest.07-2652; Young LR, 2011, CHEST, V139, P1060, DOI 10.1378/chest.10-1304	25	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2221	2228		10.1056/NEJMcpc1103560	http://dx.doi.org/10.1056/NEJMcpc1103560			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857PQ	22150041				2022-12-28	WOS:000297731400009
J	Recher, C; Coiffier, B; Haioun, C; Molina, TJ; Ferme, C; Casasnovas, O; Thieblemont, C; Bosly, A; Laurent, G; Morschhauser, F; Ghesquieres, H; Jardin, F; Bologna, S; Fruchart, C; Corront, B; Gabarre, J; Bonnet, C; Janvier, M; Canioni, D; Jais, JP; Salles, G; Tilly, H				Recher, Christian; Coiffier, Bertrand; Haioun, Corinne; Molina, Thierry Jo; Ferme, Christophe; Casasnovas, Olivier; Thieblemont, Catherine; Bosly, Andre; Laurent, Guy; Morschhauser, Franck; Ghesquieres, Herve; Jardin, Fabrice; Bologna, Serge; Fruchart, Christophe; Corront, Bernadette; Gabarre, Jean; Bonnet, Christophe; Janvier, Maud; Canioni, Danielle; Jais, Jean-Philippe; Salles, Gilles; Tilly, Herve		Grp Etud Lymphomes Adulte	Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; AGGRESSIVE LYMPHOMAS; RESPONSE CRITERIA; ELDERLY-PATIENTS; POOR-PROGNOSIS; YOUNG-PATIENTS; DES-LYMPHOMES; TRANSPLANTATION; REGIMEN; MULTICENTER	Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab to chemotherapy regimens. We aimed to assess, in patients aged 18-59 years, the potential survival benefit provided by a dose-intensive immunochemotherapy regimen plus rituximab compared with standard treatment plus rituximab. Methods We did an open-label randomised trial comparing dose-intensive rituximab, doxorubicin, cyclo phosphamide, vindesine, bleomycin, and prednisone (R-ACVBP) with subsequent consolidation versus standard rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisone (R-CHOP). Random assignment was done with a computer-assisted randomisation-allocation sequence with a block size of four. Patients were aged 18-59 years with untreated diffuse large B-cell lymphoma and an age-adjusted international prognostic index equal to 1. Our primary endpoint was event-free survival. Our analyses of efficacy and safety were of the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00140595. Findings One patient withdrew consent before treatment and 54 did not complete treatment. After a median follow-up of 44 months, our 3-year estimate of event-free survival was 81% (95% CI 75-86) in the R-ACVBP group and 67% (59-73) in the R-CHOP group (hazard ratio [HR] 0.56, 95% CI 0.38-0.83; p=0.0035). 3-year estimates of progression-free survival (87% [95% CI, 81-91] vs 73% [66-79]; HR 0.48 [0.30-0.76]; p=0.0015) and overall survival (92% [87-95] vs 84% [77-89]; HR 0.44 [0.28-0.81]; p=0.0071) were also increased in the R-ACVBP group. 82 (42%) of 196 patients in the R-ACVBP group experienced a serious adverse event compared with 28 (15%) of 183 in the R-CHOP group. Grade 3-4 haematological toxic effects were more common in the R-ACVBP group, with a higher proportion of patients experiencing a febrile neutropenic episode (38% [75 of 196] vs 9% [16 of 183]). Interpretation Compared with standard R-CHOP, intensified immunochemotherapy with R-ACVBP significantly improves survival of patients aged 18-59 years with diffuse large B-cell lymphoma with low-intermediate risk according to the International Prognostic Index. Haematological toxic effects of the intensive regimen were raised but manageable.	[Jardin, Fabrice; Tilly, Herve] Univ Rouen, Ctr Henri Becquerel, UMR918, F-76038 Rouen, France; [Recher, Christian; Laurent, Guy] Ctr Hosp Univ Toulouse, Toulouse, France; [Coiffier, Bertrand; Salles, Gilles] Univ Lyon 1, Hosp Civils Lyon, F-69622 Villeurbanne, France; [Haioun, Corinne] Hop Henri Mondor, AP HP, F-94010 Creteil, France; [Molina, Thierry Jo] Univ Paris 05, Hotel Dieu, AP HP, Paris, France; [Ferme, Christophe] Inst Cancerol Gustave Roussy, Villejuif, France; [Casasnovas, Olivier] Ctr Hosp Univ Dijon, Dijon, France; [Thieblemont, Catherine] Hop St Louis IUH INSERM U728, Paris, France; [Bosly, Andre] Catholic Univ Louvain, Mt Godinne, Belgium; [Morschhauser, Franck] CHU Lille, F-59037 Lille, France; [Ghesquieres, Herve] Ctr Leon Berard, F-69373 Lyon, France; [Bologna, Serge] Ctr Hosp Univ Nancy, Vandoeuvre Les Nancy, France; [Fruchart, Christophe] Ctr Francois Baclesse, F-14021 Caen, France; [Corront, Bernadette] Ctr Hosp Annecy, Pringy, France; [Gabarre, Jean] Hop La Pitie Salpetriere, AP HP, Paris, France; [Bonnet, Christophe] Ctr Hosp Liege, Liege, Belgium; [Janvier, Maud] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Canioni, Danielle; Jais, Jean-Philippe] Univ Paris 05, Hop Necker, AP HP, Paris, France	UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; CHU de Toulouse; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain; Universite de Lille - ISITE; CHU Lille; UNICANCER; Centre Leon Berard; CHU de Nancy; UNICANCER; Centre Francois Baclesse; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Liege; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Tilly, H (corresponding author), Univ Rouen, Ctr Henri Becquerel, UMR918, Rue Amiens, F-76038 Rouen, France.	herve.tilly@rouen.fnclcc.fr	Molina, Thierry/ABA-5214-2020; Zachee, Pierre/B-5391-2018; Mounier, Nicolas/X-2964-2018; Thieblemont, Catherine/AAZ-8423-2020; Besson, Caroline/H-4648-2018; Salles, Gilles/Z-2336-2019; Hug, Balthasar L./G-1568-2010; , Van Eygen Koen/AAF-7668-2020	Molina, Thierry/0000-0002-3929-9754; Zachee, Pierre/0000-0002-2275-5143; Mounier, Nicolas/0000-0002-0707-426X; Thieblemont, Catherine/0000-0002-9941-2448; Besson, Caroline/0000-0003-4364-7173; Salles, Gilles/0000-0002-9541-8666; , Van Eygen Koen/0000-0001-8285-906X; Delmer, Alain/0000-0002-1430-2574; Casasnovas, Rene-Olivier/0000-0002-1156-8983; Haioun, Corinne/0000-0003-0095-5379	Groupe d'Etudes des Lymphomes de l'Adulte; Amgen; Celgene; Roche; Chugai	Groupe d'Etudes des Lymphomes de l'Adulte; Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Roche(Roche Holding); Chugai	Groupe d'Etudes des Lymphomes de l'Adulte and Amgen.; BCoi, CH, OC, AB, GL, FM, GS, and HT have served as consultants, on advisory boards, or both for Roche, Genentech, or both. CR, GS, and HT have served as consultants, on advisory boards, or both for Celgene. CR is an advisory board member of Genzyme and received grant support from Celgene. BCoi received grant support from Amgen and payment for lectures from Amgen, Celgene, Roche, and GlaxoSmithKline. CH is an advisory board member of Pfizer and Janssen-Cilag, received grant support from Amgen, Celgene, and Roche, and received payment for lectures from Roche. OC received grants support from Amgen, Chugai, and Roche. AB received grant support from Roche and received payment for lectures from Roche. FM received payment for lectures from Bayer, Novartis, and Roche. GS received payment for lectures from Celgene, Mundi Pharma, and Roche, and received travel support from Pfizer. HT is an advisory board member of Seattle Genetics, received grant support from Amgen and Celgene, received payment for lectures from Amgen, Celgene, Janssen-Cilag, and Pfizer, and travel support from Celgene. TJM, CFer, CT, HG, FJ, SB, CFru, BCor, JG, CB, MJ, DC, and J-PJ declare that they have no conflicts of interest.	Abramson JS, 2010, CANCER-AM CANCER SOC, V116, P4283, DOI 10.1002/cncr.25278; Andre M, 2004, BLOOD, V103, P1222, DOI 10.1182/blood-2003-04-1124; Casasnovas RO, 2011, BLOOD, V118, P37, DOI 10.1182/blood-2010-12-327767; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; COIFFIER B, 1989, J CLIN ONCOL, V7, P1018, DOI 10.1200/JCO.1989.7.8.1018; COIFFIER B, 1986, J CLIN ONCOL, V4, P147, DOI 10.1200/JCO.1986.4.2.147; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dumontet C, 2002, BRIT J HAEMATOL, V118, P210, DOI 10.1046/j.1365-2141.2002.03565.x; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Glass B, 2010, ANN ONCOL, V21, P2255, DOI 10.1093/annonc/mdq235; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Morel P, 2008, ANN ONCOL, V19, P560, DOI 10.1093/annonc/mdm520; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Reyes F, 2005, NEW ENGL J MED, V352, P1197, DOI 10.1056/NEJMoa042040; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tarella C, 2007, LEUKEMIA, V21, P1802, DOI 10.1038/sj.leu.2404781; Tilly H, 2003, BLOOD, V102, P4284, DOI 10.1182/blood-2003-02-0542; Vitolo U, 2009, HAEMATOL-HEMATOL J, V94, P1250, DOI 10.3324/haematol.2009.007005; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391	29	256	268	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 26	2011	378	9806					1858	1867		10.1016/S0140-6736(11)61040-4	http://dx.doi.org/10.1016/S0140-6736(11)61040-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	22118442	Green Submitted			2022-12-28	WOS:000297695800030
J	Soler, MS; Fouillet, A; Viso, AC; Josseran, L; Smith, GE; Elliot, AJ; McMenamin, J; Ziemann, A; Krafft, T				Soler, Marta Sala; Fouillet, Anne; Viso, Anne Catherine; Josseran, Loic; Smith, Gillian E.; Elliot, Alex J.; McMenamin, Jim; Ziemann, Alexandra; Krafft, Thomas		Triple S Project	Assessment of syndromic surveillance in Europe	LANCET			English	Editorial Material									[Soler, Marta Sala; Fouillet, Anne; Viso, Anne Catherine; Josseran, Loic] French Inst Publ Hlth Surveillance, F-94415 St Maurice, France; [Smith, Gillian E.; Elliot, Alex J.] Hlth Protect Agcy W Midlands, Real Time Syndr Surveillance Team, Birmingham, W Midlands, England; [McMenamin, Jim] NHS Natl Serv Scotland, Glasgow, Lanark, Scotland; [Krafft, Thomas] Maastricht Univ, Sch Publ Hlth & Primary Care, GEOMED Res Forsch Gesell mbH, Maastricht, Netherlands	Institute of Public Health Surveillance; NHS National Services Scotland; Maastricht University	Soler, MS (corresponding author), French Inst Publ Hlth Surveillance, F-94415 St Maurice, France.		josseran, loic/F-3190-2019	josseran, loic/0000-0002-9021-1818; Ziemann, Alexandra/0000-0002-5996-8484; Krafft, Thomas/0000-0002-6164-7815; Elliot, Alex/0000-0002-6414-3065				Buelher JW, 2004, FRAMEWORK EVALUATING; Eidson M, 2005, EMERG INFECT DIS, V11, P1370; Flamand C, 2008, Euro Surveill, V13; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Kraff t T, 2008, EUR J PUBLIC HLTH S, V18, P187; Mazick A, 2007, EUROSURVEILLANCE, V12; Smith G E, 2006, Euro Surveill, V11, P220; Smith S, 2010, EUROSURVEILLANCE, V15; Triple-S, TRIPL S TRIPL S	10	117	117	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2011	378	9806					1833	1834		10.1016/S0140-6736(11)60834-9	http://dx.doi.org/10.1016/S0140-6736(11)60834-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857DQ	22118433				2022-12-28	WOS:000297695800012
J	Mitrofanov, IG; Boynton, WV; Litvak, ML; Sanin, AB; Starr, RD				Mitrofanov, I. G.; Boynton, W. V.; Litvak, M. L.; Sanin, A. B.; Starr, R. D.			Response to Comment on "Hydrogen Mapping of the Lunar South Pole Using the LRO Neutron Detector Experiment LEND"	SCIENCE			English	Editorial Material							RECONNAISSANCE ORBITER		[Mitrofanov, I. G.; Litvak, M. L.; Sanin, A. B.] Russian Acad Sci, Inst Space Res, Moscow 117997, Russia; [Boynton, W. V.] Univ Arizona, Tucson, AZ 85721 USA; [Starr, R. D.] Catholic Univ, Washington, DC 20015 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Arizona; Catholic University of America	Mitrofanov, IG (corresponding author), Russian Acad Sci, Inst Space Res, Moscow 117997, Russia.	imitrofa@space.ru	Sanin, Anton/T-9393-2017; Litvak, Maxim/C-6453-2017	Mitrofanov, Igor/0000-0001-7204-2101				Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Lawrence DJ, 2011, SCIENCE, V334, DOI 10.1126/science.1203341; Mitrofanov IG, 2008, ASTROBIOLOGY, V8, P793, DOI 10.1089/ast.2007.0158; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; Mitrofanov IG, 2010, SPACE SCI REV, V150, P183, DOI 10.1007/s11214-009-9608-4	5	11	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059								10.1126/science.1203483	http://dx.doi.org/10.1126/science.1203483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116866				2022-12-28	WOS:000297313900028
J	Reed, JC				Reed, John C.			Priming Cancer Cells for Death	SCIENCE			English	Editorial Material							RESISTANCE; APOPTOSIS		Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@sanfordburnham.org						Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Dean EJ, 2011, NEOPLASIA, V13, P339, DOI 10.1593/neo.101524; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; MIYASHITA T, 1992, CANCER RES, V52, P5407; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	17	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1075	1076		10.1126/science.1215568	http://dx.doi.org/10.1126/science.1215568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116875				2022-12-28	WOS:000297313900036
J	Anakwe, RE; Middleton, SD				Anakwe, R. E.; Middleton, S. D.			Osteoarthritis at the base of the thumb	BMJ-BRITISH MEDICAL JOURNAL			English	Review							METACARPAL EXTENSION OSTEOTOMY; TRAPEZIOMETACARPAL JOINT; CARPOMETACARPAL JOINT; DEGENERATIVE ARTHRITIS; HYALURONIC-ACID; PREVALENCE; INJECTION; EFFICACY; ARTHROPLASTY; TRAPEZIUM		[Anakwe, R. E.; Middleton, S. D.] Royal Infirm, Dept Trauma & Orthopaed Surg, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh	Anakwe, RE (corresponding author), Royal Infirm, Dept Trauma & Orthopaed Surg, Edinburgh EH16 4SA, Midlothian, Scotland.	raymundus@doctors.org.uk		Middleton, Scott/0000-0002-2808-4459; Anakwe, Raymond/0000-0003-1458-0790				ARMSTRONG AL, 1994, J HAND SURG-BRIT EUR, V19B, P340, DOI 10.1016/0266-7681(94)90085-X; Athwal GS, 2004, J HAND SURG-AM, V29A, P1080, DOI 10.1016/j.jhsa.2004.06.012; Bahadir C, 2009, CLIN RHEUMATOL, V28, P529, DOI 10.1007/s10067-008-1079-6; Berggren M, 2001, SCAND J PLAST RECONS, V35, P415; Brown GD, 2003, J HAND SURG-AM, V28A, P739, DOI 10.1016/S0363-5023(03)00258-2; COOKE KS, 1995, SKELETAL RADIOL, V24, P523; Davis TRC, 2004, J HAND SURG-AM, V29A, P1069, DOI 10.1016/j.jhsa.2004.06.017; Day CS, 2004, J HAND SURG-AM, V29A, P247, DOI 10.1016/j.jhsa.2003.12.002; Edwards SG, 2010, J HAND SURG-AM, V35A, P566, DOI 10.1016/j.jhsa.2009.12.022; Gervis WH, 1945, OSTEOARTHRITIS, V38, P615; Carreira ACG, 2010, J REHABIL MED, V42, P469, DOI 10.2340/16501977-0542; Haara MM, 2004, J BONE JOINT SURG AM, V86A, P1452, DOI 10.2106/00004623-200407000-00013; LEACH RE, 1968, J BONE JOINT SURG AM, VA 50, P1171, DOI 10.2106/00004623-196850060-00008; Maarse W, 2009, J HAND SURG-ASIAN-PA, V14, P99, DOI 10.1142/S0218810409004311; Meenagh GK, 2004, ANN RHEUM DIS, V63, P1260, DOI 10.1136/ard.2003.015438; Moran SL, 2009, J HAND SURG-AM, V34A, P942, DOI 10.1016/j.jhsa.2009.03.009; Neumann DA, 2003, J ORTHOP SPORT PHYS, V33, P386, DOI 10.2519/jospt.2003.33.7.386; Nilsson A, 2005, J HAND SURG-AM, V30A, P380, DOI 10.1016/j.jhsa.2004.12.001; Parker WL, 2008, J HAND SURG-AM, V33A, P1737, DOI 10.1016/j.jhsa.2008.08.003; PELLEGRINI VD, 1991, J HAND SURG-AM, V16A, P967, DOI 10.1016/S0363-5023(10)80054-1; PELLEGRINI VD, 1993, J HAND SURG-AM, V18A, P238, DOI 10.1016/0363-5023(93)90354-6; Rannou F, 2009, ANN INTERN MED, V150, P661, DOI 10.7326/0003-4819-150-10-200905190-00003; Seshadri V, 2009, ARTHROSCOPY, V25, P337, DOI 10.1016/j.arthro.2009.01.003; Stahl S, 2005, JCR-J CLIN RHEUMATOL, V11, P299, DOI 10.1097/01.rhu.0000191194.39926.c9; Stamm TA, 2002, ARTHRIT RHEUM-ARTHR, V47, P44, DOI 10.1002/art1.10246; Swindells MG, 2010, ANN ROY COLL SURG, V92, P680, DOI 10.1308/003588410X12699663905078; Tomaino MM, 2006, HAND CLIN, V22, P137, DOI 10.1016/j.hcl.2006.02.008; Tomaino MM, 1999, J HAND SURG-AM, V24A, P1220, DOI 10.1053/jhsu.1999.1220; Tsai P, 2008, HAND CLIN, V24, P231, DOI 10.1016/j.hcl.2008.03.004; van Cappelle HGJ, 1999, J HAND SURG-AM, V24A, P476; Wajon A, 2009, COCHRANE DB SYST REV, V4, P4631; Wohlmeiner A, 2005, JCR-J CLIN RHEUMATOL, V11, P299; Wolf JM, 2008, HAND CLIN, V24, P301, DOI 10.1016/j.hcl.2008.03.002; Yao J, 2008, HAND CLIN, V24, P251, DOI 10.1016/j.hcl.2008.03.001	34	21	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2011	343								d7122	10.1136/bmj.d7122	http://dx.doi.org/10.1136/bmj.d7122			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861QW	22115902				2022-12-28	WOS:000298035300003
J	Habel, LA; Cooper, WO; Sox, CM; Chan, KA; Fireman, BH; Arbogast, PG; Cheetham, TC; Quinn, VP; Dublin, S; Boudreau, DM; Andrade, SE; Pawloski, PA; Raebel, MA; Smith, DH; Achacoso, N; Uratsu, C; Go, AS; Sidney, S; Nguyen-Huynh, MN; Ray, WA; Selby, JV				Habel, Laurel A.; Cooper, William O.; Sox, Colin M.; Chan, K. Arnold; Fireman, Bruce H.; Arbogast, Patrick G.; Cheetham, T. Craig; Quinn, Virginia P.; Dublin, Sascha; Boudreau, Denise M.; Andrade, Susan E.; Pawloski, Pamala A.; Raebel, Marsha A.; Smith, David H.; Achacoso, Ninah; Uratsu, Connie; Go, Alan S.; Sidney, Steve; Nguyen-Huynh, Mai N.; Ray, Wayne A.; Selby, Joe V.			ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; UNMEASURED CONFOUNDERS; STIMULANT MEDICATIONS; MYOCARDIAL-INFARCTION; CARDIAC SAFETY; METHYLPHENIDATE; CHILDREN; DEATH; METAANALYSIS	Context More than 1.5 million US adults use stimulants and other medications labeled for treatment of attention-deficit/hyperactivity disorder (ADHD). These agents can increase heart rate and blood pressure, raising concerns about their cardiovascular safety. Objective To examine whether current use of medications prescribed primarily to treat ADHD is associated with increased risk of serious cardiovascular events in young and middle-aged adults. Design, Setting, and Participants Retrospective, population-based cohort study using electronic health care records from 4 study sites (OptumInsight Epidemiology, Tennessee Medicaid, Kaiser Permanente California, and the HMO Research Network), starting in 1986 at 1 site and ending in 2005 at all sites, with additional covariate assessment using 2007 survey data. Participants were adults aged 25 through 64 years with dispensed prescriptions for methylphenidate, amphetamine, or atomoxetine at baseline. Each medication user (n= 150 359) was matched to 2 nonusers on study site, birth year, sex, and calendar year (443 198 total users and nonusers). Main Outcome Measures Serious cardiovascular events, including myocardial infarction (MI), sudden cardiac death (SCD), or stroke, with comparison between current or new users and remote users to account for potential healthy-user bias. Results During 806 182 person-years of follow-up (median, 1.3 years per person), 1357 cases of MI, 296 cases of SCD, and 575 cases of stroke occurred. There were 107 322 person-years of current use (median, 0.33 years), with a crude incidence per 1000 person-years of 1.34 (95% CI, 1.14-1.57) for MI, 0.30 (95% CI, 0.20-0.42) for SCD, and 0.56 (95% CI, 0.43-0.72) for stroke. The multivariable-adjusted rate ratio (RR) of serious cardiovascular events for current use vs nonuse of ADHD medications was 0.83 (95% CI, 0.72-0.96). Among new users of ADHD medications, the adjusted RR was 0.77 (95% CI, 0.63-0.94). The adjusted RR for current use vs remote use was 1.03 (95% CI, 0.86-1.24); for new use vs remote use, the adjusted RR was 1.02 (95% CI, 0.82-1.28); the upper limit of 1.28 corresponds to an additional 0.19 events per 1000 person-years at ages 25-44 years and 0.77 events per 1000 person-years at ages 45-64 years. Conclusions Among young and middle-aged adults, current or new use of ADHD medications, compared with nonuse or remote use, was not associated with an increased risk of serious cardiovascular events. Apparent protective associations likely represent healthy-user bias. JAMA. 2011;306(24):2673-2683 Published online December 12, 2011. doi:10.1001/jama.2011.1830	[Habel, Laurel A.; Fireman, Bruce H.; Achacoso, Ninah; Uratsu, Connie; Go, Alan S.; Sidney, Steve; Nguyen-Huynh, Mai N.; Selby, Joe V.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Cooper, William O.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Cooper, William O.; Ray, Wayne A.] Vanderbilt Univ, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN USA; [Arbogast, Patrick G.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Sox, Colin M.] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Sox, Colin M.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Chan, K. Arnold] OptumInsight Epidemiol, Waltham, MA USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Downey, CA 90242 USA; [Cheetham, T. Craig; Quinn, Virginia P.] Kaiser Permanente So Calif, Res & Evaluat Dept, Pasadena, CA USA; [Dublin, Sascha; Boudreau, Denise M.] Grp Hlth Res Inst, Seattle, WA USA; [Dublin, Sascha] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Boudreau, Denise M.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Andrade, Susan E.] Meyers Primary Care Inst, Worcester, MA USA; [Pawloski, Pamala A.] HealthPartners Res Fdn, Bloomington, MN USA; [Raebel, Marsha A.] Kaiser Permanente Colorado, Inst Hlth Res, Pueblo, CO USA; [Raebel, Marsha A.] Univ Colorado, Sch Pharm, Denver, CO 80202 USA; [Smith, David H.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA; [Sidney, Steve] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Sidney, Steve] Univ Calif San Francisco, Dept Biostat & Med, San Francisco, CA 94143 USA	Kaiser Permanente; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Boston University; Optum; Kaiser Permanente; Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Colorado System; University of Colorado Denver; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Habel, LA (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway,5th Floor, Oakland, CA 94612 USA.	laurel.habel@kp.org	Go, Alan S./AAE-7745-2019	Sox, Colin/0000-0002-0249-9656; Habel, Laurel/0000-0002-7230-587X; Pawloski, Pamala/0000-0002-1005-5764; Chan, Kinwei/0000-0001-8161-1986	Merck; Takeda; sanofi-aventis; medical product manufacturers; Merck/American Geriatrics Society; GlaxoSmithKline; Novartis Pharmaceuticals; Abbott Laboratories; National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Thrasher Research Fund; American Heart Association; Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290-2005-0042, HHSA290-2005-0033]; FDA [223-2005-10012, 223-2005-10100C, 223-2005-20006C, 223-2005-10012C]; National Institute on Aging [K23AG028954]; NATIONAL INSTITUTE ON AGING [K23AG028954] Funding Source: NIH RePORTER	Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); sanofi-aventis(Sanofi-Aventis); medical product manufacturers; Merck/American Geriatrics Society(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Novartis Pharmaceuticals(Novartis); Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Thrasher Research Fund; American Heart Association(American Heart Association); Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; FDA(United States Department of Health & Human Services); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Habel reported receiving grants from Merck for a study of herpes zoster in patients with cancer, from Takeda for a study of pioglitazone and cancer, and from sanofi-aventis for a study of insulin and cancer. Dr Chan reported receiving support for travel to meetings for the purpose of the study or other purposes from the US Food and Drug Administration (FDA) and that he is a part-time employee of OptumInsight, a for-profit company that receives funding from medical product manufacturers to provide consultation and conduct research on medical products; because OptumInsight is a part of UnitedHealthGroup, Dr Chan has received UnitedHealthGroup stock options. Dr Dublin reported receiving a Merck/American Geriatrics Society New Investigator Award (honorarium paid directly to Dr Dublin) for unrelated work. Dr Andrade reported that the Meyers Primary Care Institute has received funding from GlaxoSmithKline and Novartis Pharmaceuticals, manufacturers of medications used to treat ADHD. Dr Smith reported that the Center for Health Research received funding from Abbott Laboratories to conduct a natural history study of patients with chronic kidney disease and from GlaxoSmithKline to study the burden of diabetes. Dr Sidney reported receiving grants or grants pending from the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Thrasher Research Fund. Dr Nguyen-Huynh reported receiving grants or grants pending from the American Heart Association. No other authors reported disclosures.; This project was funded in part under contract numbers HHSA290-2005-0042 (Vanderbilt) and HHSA290-2005-0033 (Harvard Pilgrim Health Care Institute) from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. The project was also funded by the FDA under contracts 223-2005-10012 (Kaiser Permanente Northern California), 223-2005-10100C (Vanderbilt), 223-2005-20006C (Ingenix), and 223-2005-10012C (Harvard Pilgrim Health Care Institute). The project was also funded by the National Institute on Aging under contract K23AG028954 (Group Health Research Institute).	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 2011, NEW REPORT AM STATE; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Cohen AL, 2006, NEW ENGL J MED, V354, P2294, DOI 10.1056/NEJMc060860; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; FRIERSON RL, 1991, AM FAM PHYSICIAN, V43, P163; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gould MS, 2009, AM J PSYCHIAT, V166, P992, DOI 10.1176/appi.ajp.2009.09040472; Grijalva CG, 2008, PHARMACOEPIDEM DR S, V17, P890, DOI 10.1002/pds.1625; Hammerness PG, 2011, CURR PSYCHIAT REP, V13, P357, DOI 10.1007/s11920-011-0213-3; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Leddy JJ, 2004, OBES RES, V12, P224, DOI 10.1038/oby.2004.29; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McCarthy S, 2009, DRUG SAFETY, V32, P1089, DOI 10.2165/11317630-000000000-00000; Meier MA, 2002, ARCH INTERN MED, V162, P1585, DOI 10.1001/archinte.162.14.1585; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Montejano L, 2011, CURR MED RES OPIN, V27, P5, DOI 10.1185/03007995.2011.603302; Peterson K, 2008, PSYCHOPHARMACOLOGY, V197, P1, DOI 10.1007/s00213-007-0996-4; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stiefel G, 2010, DRUG SAFETY, V33, P821, DOI 10.2165/11536380-000000000-00000; Suissa S, 1997, EPIDEMIOLOGY, V8, P275, DOI 10.1097/00001648-199705000-00008; Tharwani Haresh M, 2007, Curr Psychiatry Rep, V9, P225, DOI 10.1007/s11920-007-0023-9; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; West SL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P709; Wilens TE, 2011, EXPERT REV NEUROTHER, V11, P1443, DOI [10.1586/ern.11.137, 10.1586/ERN.11.137]; Winterstein AG, 2007, PEDIATRICS, V120, pE1494, DOI 10.1542/peds.2007-0675; Winterstein AG, 2009, PEDIATRICS, V124, pE75, DOI 10.1542/peds.2008-3138	36	186	190	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2011	306	24					2673	2683		10.1001/jama.2011.1830	http://dx.doi.org/10.1001/jama.2011.1830			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867VX	22161946	Green Accepted, Bronze			2022-12-28	WOS:000298484000018
J	Houck-Loomis, B; Durney, MA; Salguero, C; Shankar, N; Nagle, JM; Goff, SP; D'Souza, VM				Houck-Loomis, Brian; Durney, Michael A.; Salguero, Carolina; Shankar, Neelaabh; Nagle, Julia M.; Goff, Stephen P.; D'Souza, Victoria M.			An equilibrium-dependent retroviral mRNA switch regulates translational recoding	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; GAG-TERMINATION CODON; READ-THROUGH; GENE-EXPRESSION; INTERNAL LOOPS; NMR STRUCTURE; PSEUDOKNOT; NUCLEOTIDES; SUPPRESSION; READTHROUGH	Most retroviruses require translational recoding of a viral messenger RNA stop codon to maintain a precise ratio of structural (Gag) and enzymatic (Pol) proteins during virus assembly(1,2). Pol is expressed exclusively as a Gag-Pol fusion either by ribosomal frameshifting or by read-through of the gag stop codon(3). Both of these mechanisms occur infrequently and only affect 5-10% of translating ribosomes, allowing the virus to maintain the critical Gag to Gag-Pol ratio(4-8). Although it is understood that the frequency of the recoding event is regulated by cis RNA motifs, no mechanistic explanation is currently available for how the critical protein ratio is maintained. Here we present the NMR structure of the murine leukaemia virus recoding signal and show that a protonation-dependent switch occurs to induce the active conformation. The equilibrium is such that at physiological pH the active, read-through permissive conformation is populated at approximately 6%: a level that correlates with in vivo protein quantities. The RNA functions by a highly sensitive, chemo-mechanical coupling tuned to ensure an optimal read-through frequency. Similar observations for a frameshifting signal indicate that this novel equilibrium-based mechanism may have a general role in translational recoding.	[Durney, Michael A.; Salguero, Carolina; Shankar, Neelaabh; Nagle, Julia M.; D'Souza, Victoria M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Houck-Loomis, Brian; Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Columbia University; Howard Hughes Medical Institute	D'Souza, VM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dsouza@mcb.harvard.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Shankar, Neelaabh/0000-0001-5983-3152; Salguero, Carolina/0000-0001-6119-1937; Loomis, Brian/0000-0002-1863-1199	NCI/NIH [R37 CA30488]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Atkins for the p2luc plasmid, the New York Structural Biology Center for NMR time and A. Hawkins, S. Leiman and J. Gullinger for their contributions. B.H.-L. and S. P. G. would also like to thank the late D. Wolf for his inspiration and many helpful discussions. S. P. G. acknowledges grant R37 CA30488 from the NCI/NIH and is an Investigator with the Howard Hughes Medical Institute.	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Alam SL, 1999, J MOL BIOL, V288, P837, DOI 10.1006/jmbi.1999.2713; Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; Badhwar J, 2007, BIOCHEMISTRY-US, V46, P14715, DOI 10.1021/bi701024w; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Clanton-Arrowood K, 2008, BIOCHEMISTRY-US, V47, P13418, DOI 10.1021/bi801594k; Cornish PV, 2005, P NATL ACAD SCI USA, V102, P12694, DOI 10.1073/pnas.0506166102; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Grentzmann G, 1998, RNA, V4, P479; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HONIGMAN A, 1991, VIROLOGY, V183, P313, DOI 10.1016/0042-6822(91)90144-Z; Kuhlman B, 1999, BIOCHEMISTRY-US, V38, P4896, DOI 10.1021/bi982931h; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; Michiels PJA, 2001, J MOL BIOL, V310, P1109, DOI 10.1006/jmbi.2001.4823; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Nixon PL, 2000, J MOL BIOL, V296, P659, DOI 10.1006/jmbi.1999.3464; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Schroeder S, 1996, BIOCHEMISTRY-US, V35, P16105, DOI 10.1021/bi961789m; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; YOSHINAKA Y, 1985, P NATL ACAD SCI USA, V82, P1618, DOI 10.1073/pnas.82.6.1618	28	94	94	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2011	480	7378					561	U193		10.1038/nature10657	http://dx.doi.org/10.1038/nature10657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22121021	Green Accepted, Green Submitted			2022-12-28	WOS:000298318000069
J	Bukowski, R; Carpenter, M; Conway, D; Coustan, D; Dudley, DJ; Goldenberg, RL; Hogue, CJR; Koch, MA; Parker, CB; Pinar, H; Reddy, UM; Saade, GR; Silver, RM; Stoll, BJ; Varner, MW; Willinger, M				Bukowski, Radek; Carpenter, Marshall; Conway, Deborah; Coustan, Donald; Dudley, Donald J.; Goldenberg, Robert L.; Hogue, Carol J. Rowland; Koch, Matthew A.; Parker, Corette B.; Pinar, Halit; Reddy, Uma M.; Saade, George R.; Silver, Robert M.; Stoll, Barbara J.; Varner, Michael W.; Willinger, Marian		Stillbirth Collaborative Res Netwo	Association Between Stillbirth and Risk Factors Known at Pregnancy Confirmation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ABO(H) BLOOD-GROUPS; UNITED-STATES; METAANALYSIS; PREVALENCE; DISPARITY; DELIVERY; OBESITY; TRENDS; BIRTHS	Context Stillbirths account for almost half of US deaths from 20 weeks' gestation to 1 year of life. Most large studies of risk factors for stillbirth use vital statistics with limited data. Objective To determine the relation between stillbirths and risk factors that could be ascertained at the start of pregnancy, particularly the contribution of these factors to racial disparities. Design, Setting, and Participants Multisite population-based case-control study conducted between March 2006 and September 2008. Fifty-nine US tertiary care and community hospitals, with access to at least 90% of deliveries within 5 catchment areas defined by state and county lines, enrolled residents with deliveries of 1 or more stillborn fetuses and a representative sample of deliveries of only live-born infants, over-sampled for those at less than 32 weeks' gestation and those of African descent. Main Outcome Measure Stillbirth. Results Analysis included 614 case and 1816 control deliveries. In multivariate analyses, the following factors were independently associated with stillbirth: non-Hispanic black race/ethnicity (23.1% stillbirths, 11.2% live births) (vs non-Hispanic whites; adjusted odds ratio [AOR], 2.12 [95% CI, 1.41-3.20]); previous stillbirth (6.7% stillbirths, 1.4% live births); nulliparity with (10.5% stillbirths, 5.2% live births) and without (34.0% stillbirths, 29.7% live births) previous losses at fewer than 20 weeks' gestation (vs multiparity without stillbirth or previous losses; AOR, 5.91 [95% CI, 3.18-11.00]; AOR, 3.13 [95% CI, 2.06-4.75]; and AOR, 1.98 [95% CI, 1.51-2.60], respectively); diabetes (5.6% stillbirths, 1.6% live births) (vs no diabetes; AOR, 2.50 [95% CI, 1.39-4.48]); maternal age 40 years or older (4.5% stillbirths, 2.1% live births) (vs age 20-34 years; AOR, 2.41 [95% CI, 1.24-4.70]); maternal AB blood type (4.9% stillbirths, 3.0% live births) (vs type O; AOR, 1.96 [95% CI, 1.16-3.30]); history of drug addiction (4.5% stillbirths, 2.1% live births) (vs never use; AOR, 2.08 [95% CI, 1.12-3.88]); smoking during the 3 months prior to pregnancy (<10 cigarettes/d, 10.0% stillbirths, 6.5% live births) (vs none; AOR, 1.55 [95% CI, 1.02-2.35]); obesity/overweight (15.5% stillbirths, 12.4% live births) (vs normal weight; AOR, 1.72 [95% CI, 1.22-2.43]); not living with a partner (25.4% stillbirths, 15.3% live births) (vs married; AOR, 1.62 [95% CI, 1.15-2.27]); and plurality (6.4% stillbirths, 1.9% live births) (vs singleton; AOR, 4.59 [95% CI, 2.63-8.00]). The generalized R-2 was 0.19, explaining little of the variance. Conclusion Multiple risk factors that would have been known at the time of pregnancy confirmation were associated with stillbirth but accounted for only a small amount of the variance in this outcome. JAMA. 2011;306(22):2469-2479	[Saade, George R.] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Carpenter, Marshall; Coustan, Donald] Brown Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Providence, RI 02912 USA; [Conway, Deborah; Dudley, Donald J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Antonio, TX 78229 USA; [Goldenberg, Robert L.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Hogue, Carol J. Rowland] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hogue, Carol J. Rowland] Emory Univ, Womens & Childrens Ctr, Atlanta, GA 30322 USA; [Koch, Matthew A.; Parker, Corette B.] RTI Int, Div Hlth Sci, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Pinar, Halit] Brown Univ, Sch Med, Dept Pathol & Lab Med, Div Perinatal & Pediat Pathol, Providence, RI 02912 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA; [Silver, Robert M.; Varner, Michael W.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA; [Silver, Robert M.; Varner, Michael W.] Intermt Healthcare, Maternal Fetal Med, Salt Lake City, UT USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Texas System; University of Texas Health San Antonio; Drexel University; Emory University; Rollins School Public Health; Emory University; Research Triangle Institute; Brown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Emory University; Children's Healthcare of Atlanta (CHOA)	Saade, GR (corresponding author), Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	gsaade@utmb.edu	Bukowski, Radek/B-6976-2013; Hogue, Carol J/H-5442-2012; /AAO-2076-2020; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [U10-HD045953, U10-HD045925, U10-HD045952, U10-HDO45955, U10-HD045944, U01-HD045954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045952, U01HD045954, U10HD045944, U10HD045953, U10HD045925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health: U10-HD045953 (Brown University, Rhode Island); U10-HD045925 (Emory University, Georgia); U10-HD045952 (University of Texas Medical Branch at Galveston); U10-HDO45955 (University of Texas Health Sciences Center at San Antonio); U10-HD045944 (University of Utah Health Sciences Center); and U01-HD045954 (RTI International, North Carolina).	Balayla J, 2011, WOMEN HEALTH ISS, V21, P361, DOI 10.1016/j.whi.2011.04.001; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Centers for Disease Control and Prevention, 2007, PREV SMOK EXP SEC SM; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P119; Clark P, 2008, THROMB HAEMOSTASIS, V100, P469, DOI 10.1160/TH08-05-0302; Cox DR., 1989, ANAL BINARY DATA; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gold KJ, 2010, J WOMENS HEALTH, V19, P767, DOI 10.1089/jwh.2009.1561; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heuser CC, 2010, OBSTET GYNECOL, V116, P1296, DOI 10.1097/AOG.0b013e3181fb8838; Hogue CJR, 2011, SEMIN PERINATOL, V35, P221, DOI 10.1053/j.semperi.2011.02.019; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Parker CB, 2011, PAEDIATR PERINAT EP, V25, P425, DOI 10.1111/j.1365-3016.2011.01218.x; Pinar H, 2012, AM J PERINAT, V29, P187, DOI 10.1055/s-0031-1284228; Pinar H, 2011, AM J PERINAT, V28, P781, DOI 10.1055/s-0031-1281509; Pinar H, 2011, AM J PERINAT, V28, P793, DOI 10.1055/s-0031-1284229; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Salihu H, 2004, OBSTET GYNECOL, V104, P734, DOI 10.1097/01.AOG.0000139944.15133.e3; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Syed M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S2; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Wu O, 2008, J THROMB HAEMOST, V6, P62	31	156	157	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2469	2479		10.1001/jama.2011.1798	http://dx.doi.org/10.1001/jama.2011.1798			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166606	Green Accepted			2022-12-28	WOS:000297983300020
J	Kittle, JT				Kittle, Jessie T.			The Artist of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University	Kittle, JT (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	jkittle@tulane.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2429	2430		10.1001/jama.2011.1749	http://dx.doi.org/10.1001/jama.2011.1749			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166597				2022-12-28	WOS:000297983300001
J	Wynia, MK; Classen, DC				Wynia, Matthew K.; Classen, David C.			Improving Ambulatory Patient Safety Learning From the Last Decade, Moving Ahead in the Next	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wynia, Matthew K.] Amer Med Assoc, Ctr Patient Safety, Chicago, IL 60654 USA; [Classen, David C.] Univ Utah, Salt Lake City, UT USA	American Medical Association; Utah System of Higher Education; University of Utah	Wynia, MK (corresponding author), Amer Med Assoc, Ctr Patient Safety, 515 N State St, Chicago, IL 60654 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019					Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; Department of Health and Human Services, PARTN PAT BETT CAR L; Gandhi TK, 2010, NEW ENGL J MED, V363, P1001, DOI 10.1056/NEJMp1003294; HAMMONS T, 2001, AGENDA RES AMBULATOR; Hayes H, 2011, J AM BOARD FAM MED, V24, P576, DOI 10.3122/jabfm.2011.05.110043; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lorincz CY, 2011, RES AMBULATORY PATIE; Singh H, 2010, JAMA-J AM MED ASSOC, V304, P463, DOI 10.1001/jama.2010.1035; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	10	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2011	306	22					2504	2505		10.1001/jama.2011.1820	http://dx.doi.org/10.1001/jama.2011.1820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860YB	22166611				2022-12-28	WOS:000297983300026
J	Goette, L; Meier, S				Goette, Lorenz; Meier, Stephan			Can Integration Tame Conflicts?	SCIENCE			English	Editorial Material							PAROCHIAL ALTRUISM; PUNISHMENT; HUMANS; WAR		[Goette, Lorenz] Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland; [Meier, Stephan] Columbia Univ, Grad Sch Business, New York, NY 10027 USA	University of Lausanne; Columbia University	Goette, L (corresponding author), Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland.	lorenz.goette@unil.ch; sm3087@columbia.edu		Goette, Lorenz/0000-0002-1050-0354				Alexander M, 2011, SCIENCE, V334, P1392, DOI 10.1126/science.1202599; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, MANAGE SCI, V58, P948, DOI 10.1287/mnsc.1110.1466; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Posner DN, 2004, AM POLIT SCI REV, V98, P529, DOI 10.1017/S0003055404041334; SHERIF M, 1961, INTERGROUP CONFL ICT	12	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1356	1357		10.1126/science.1215617	http://dx.doi.org/10.1126/science.1215617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858HW	22158810				2022-12-28	WOS:000297787700038
J	Huybers, P				Huybers, Peter			Combined obliquity and precession pacing of late Pleistocene deglaciations	NATURE			English	Article							GLACIAL TERMINATIONS; CLIMATE-CHANGE; INSOLATION; PALEOCLIMATE; TEMPERATURE; SOUTHERN; CYCLES; CO2	Milankovitch(1) proposed that Earth resides in an interglacial state when its spin axis both tilts to a high obliquity and precesses to align the Northern Hemisphere summer with Earth's nearest approach to the Sun. This general concept has been elaborated into hypotheses that precession(2), obliquity(3,4) or combinations of both(5-8) could pace deglaciations during the late Pleistocene(9,10). Earlier tests have shown that obliquity paces the late Pleistocene glacial cycles(4,11) but have been inconclusive with regard to precession, whose shorter period of about 20,000 years makes phasing more sensitive to timing errors(4,11,12). No quantitative test has provided firm evidence for a dual effect. Here I show that both obliquity and precession pace late Pleistocene glacial cycles. Deficiencies in time control that have long stymied efforts to establish orbital effects on deglaciation are overcome using a new statistical test that focuses on maxima in orbital forcing. The results are fully consistent with Milankovitch's proposal but also admit the possibility that long Southern Hemisphere summers contribute to deglaciation.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Huybers, P (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	phuybers@fas.harvard.edu		Huybers, Peter/0000-0002-3734-8145				Berger A, 1999, QUATERNARY SCI REV, V18, P1, DOI 10.1016/S0277-3791(98)00033-X; BERGER A, 1988, REV GEOPHYS, V26, P624, DOI 10.1029/RG026i004p00624; Broecker W. S, 1984, MILANKOVITCH CLIMA 2, V126, P687; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; GHIL M, 1994, PHYSICA D, V77, P130, DOI 10.1016/0167-2789(94)90131-7; GIBBONS J, 1985, NONPARAMETRIC METHOD, P1; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herschel JWF., 1832, 17 ON ASTRONOMICAL C, V3, P293, DOI [DOI 10.1144/TRANSGSLB.3.2.293, 10.1144/transgslb.3.2.293]; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Joussaume S, 1997, J GEOPHYS RES-ATMOS, V102, P1943, DOI 10.1029/96JD01989; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lisiecki LE, 2010, NAT GEOSCI, V3, P349, DOI 10.1038/NGEO828; Liu HS, 1998, THEOR APPL CLIMATOL, V61, P217, DOI 10.1007/s007040050066; Milankovitch M., 1941, KANON ERDBESTRAHLUNG, P1; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; RAYMO M, 2006, SCIENCE, V313; Roe GH, 1999, GEOPHYS RES LETT, V26, P2259, DOI 10.1029/1999GL900509; Saltzman B., 2002, DYNAMICAL PALEOCLIMA; Schulz KG, 2006, EARTH PLANET SC LETT, V249, P326, DOI 10.1016/j.epsl.2006.07.004; Siddall M, 2007, DEV QUATER SCI, V7, P75, DOI 10.1016/S1571-0866(07)80032-7; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1; Tziperman E, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001241; Wunsch C, 2003, CLIM DYNAM, V20, P353, DOI 10.1007/s00382-002-0279-z	30	85	91	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					229	232		10.1038/nature10626	http://dx.doi.org/10.1038/nature10626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22158246				2022-12-28	WOS:000297744200048
J	Nayak, S; Roberts, MS; Greenspan, SL				Nayak, Smita; Roberts, Mark S.; Greenspan, Susan L.			Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women	ANNALS OF INTERNAL MEDICINE			English	Article							FRACTURE INTERVENTION TRIAL; QUALITY-OF-LIFE; LOW BONE-DENSITY; VERTEBRAL FRACTURES; HIP FRACTURE; ALENDRONATE THERAPY; RANDOMIZED-TRIAL; ELDERLY-WOMEN; RISK; HEALTH	Background: The best strategies to screen postmenopausal women for osteoporosis are not clear. Objective: To identify the cost-effectiveness of various screening strategies. Design: Individual-level state-transition cost-effectiveness model. Data Sources: Published literature. Target Population: U.S. women aged 55 years or older. Time Horizon: Lifetime. Perspective: Payer. Intervention: Screening strategies composed of alternative tests (central dual-energy x-ray absorptiometry [DXA], calcaneal quantitative ultrasonography [QUS], and the Simple Calculated Osteoporosis Risk Estimation [SCORE] tool) initiation ages, treatment thresholds, and rescreening intervals. Oral bisphosphonate treatment was assumed, with a base-case adherence rate of 50% and a 5-year on/off treatment pattern. Outcome Measures: Incremental cost-effectiveness ratios (2010 U.S. dollars per quality-adjusted life-year [QALY] gained). Results of Base-Case Analysis: At all evaluated ages, screening was superior to not screening. In general, quality-adjusted life-days gained with screening tended to increase with age. At all initiation ages, the best strategy with an incremental cost-effectiveness ratio (ICER) of less than $50 000 per QALY was DXA screening with a T-score threshold of -2.5 or less for treatment and with follow-up screening every 5 years. Across screening initiation ages, the best strategy with an ICER less than $50 000 per QALY was initiation of screening at age 55 years by using DXA -2.5 with rescreening every 5 years. The best strategy with an ICER less than $100 000 per QALY was initiation of screening at age 55 years by using DXA with a T-score threshold of -2.0 or less for treatment and then rescreening every 10 years. No other strategy that involved treatment of women with osteopenia had an ICER less than $100 000 per QALY. Many other strategies, including strategies with SCORE or QUS prescreening, were also cost-effective, and in general the differences in effectiveness and costs between evaluated strategies was small. Results of Sensitivity Analysis: Probabilistic sensitivity analysis did not reveal a consistently superior strategy. Limitations: Data were primarily from white women. Screening initiation at ages younger than 55 years were not examined. Only osteoporotic fractures of the hip, vertebrae, and wrist were modeled. Conclusion: Many strategies for postmenopausal osteoporosis screening are effective and cost-effective, including strategies involving screening initiation at age 55 years. No strategy substantially outperforms another.	[Nayak, Smita] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nayak, S (corresponding author), Univ Pittsburgh, Sch Med, 200 Meyran Ave,Suite 200, Pittsburgh, PA 15213 USA.	nayaks@upmc.edu	Golmohamad, Ramez/E-4848-2014	Golmohamad, Ramez/0000-0002-9958-7037	National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research [KL2 RR024154]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR060809-01]; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK062895]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By grant KL2 RR024154 from the National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research (Dr. Nayak), grant 1R01AR060809-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr. Nayak), and grant K24 DK062895 from the National Institute of Diabetes and Digestive and Kidney Diseases (Dr. Greenspan).	[Anonymous], 2010, RED BOOK; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brazier JE, 2002, OSTEOPOROSIS INT, V13, P768, DOI 10.1007/s001980200107; BRAZIER JE, 2000, PROSPECTIVE STUDY HL; Brenneman Susan K, 2003, Dis Manag, V6, P159, DOI 10.1089/109350703322425509; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Centers for Medicare & Medicaid Services, NAT PHYS FEE SCHED; Corliss GR, 2004, 4 SOC ACT; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dolan P, 1999, OSTEOPOROSIS INT, V9, P196, DOI 10.1007/s001980050136; Fraser LA, 2011, THER CLIN RISK MANAG, V7, P157, DOI 10.2147/TCRM.S19385; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; GE Financial Nursing Home Cost of Care Survey, 2003, GE FIN NURS HOM COST; Geusens P, 2002, MAYO CLIN PROC, V77, P629, DOI 10.4065/77.7.629; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kraemer DF, 2006, OSTEOPOROSIS INT, V17, P68, DOI 10.1007/s00198-005-1922-4; LaCroix AZ, 2005, MED CARE, V43, P293, DOI 10.1097/00005650-200503000-00012; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Liu H, 2006, ARCH INTERN MED, V166, P1209, DOI 10.1001/archinte.166.11.1209; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Mobley LR, 2006, MED DECIS MAKING, V26, P194, DOI 10.1177/0272989X06286478; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; National Osteoporosis Foundation, 2005, OST FAST FACTS; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Office of Technology Assessment, 1994, OTABPH120 US C; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Schousboe John T, 2007, Curr Rheumatol Rep, V9, P50, DOI 10.1007/s11926-007-0022-1; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Tosteson ANA, 2008, AM J MANAG CARE, V14, P605; Walmart Pharmacy Medication Finder, WALM PHARM MED FIND; Watts Nelson B, 2010, Endocr Pract, V16, P1016; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; 1998, OSTEOPOROS INT, V8, pS7	58	79	81	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					751	U176		10.7326/0003-4819-155-11-201112060-00007	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00007			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	22147714	Green Accepted			2022-12-28	WOS:000297988400004
J	Lifschitz, V				Lifschitz, Vladimir			John McCarthy (1927-2011) OBITUARY	NATURE			English	Biographical-Item									Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lifschitz, V (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	vl@cs.utexas.edu						MCCARTHY J, PUBLICATION LIST	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					40	40		10.1038/480040a	http://dx.doi.org/10.1038/480040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129718	Bronze			2022-12-28	WOS:000298031900024
J	Quinn, PK; Bates, TS				Quinn, P. K.; Bates, T. S.			The case against climate regulation via oceanic phytoplankton sulphur emissions	NATURE			English	Review							CLOUD CONDENSATION NUCLEI; MARINE BOUNDARY-LAYER; SEA-SALT AEROSOL; PARTICLE FORMATION; DIMETHYL SULFIDE; ATMOSPHERIC SULFUR; ORGANIC-MATTER; AIR; NUCLEATION; ATLANTIC	More than twenty years ago, a biological regulation of climate was proposed whereby emissions of dimethyl sulphide from oceanic phytoplankton resulted in the formation of aerosol particles that acted as cloud condensation nuclei in the marine boundary layer. In this hypothesis-referred to as CLAW-the increase in cloud condensation nuclei led to an increase in cloud albedo with the resulting changes in temperature and radiation initiating a climate feedback altering dimethyl sulphide emissions from phytoplankton. Over the past two decades, observations in the marine boundary layer, laboratory studies and modelling efforts have been conducted seeking evidence for the CLAW hypothesis. The results indicate that a dimethyl sulphide biological control over cloud condensation nuclei probably does not exist and that sources of these nuclei to the marine boundary layer and the response of clouds to changes in aerosol are much more complex than was recognized twenty years ago. These results indicate that it is time to retire the CLAW hypothesis.	[Quinn, P. K.; Bates, T. S.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Quinn, PK (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	patricia.k.quinn@noaa.gov	Quinn, Patricia/R-1493-2016; Bates, Timothy S/L-6080-2016	Quinn, Patricia/0000-0003-0337-4895; 				ANDREAE MO, 1985, J GEOPHYS RES-ATMOS, V90, P2891, DOI 10.1029/JD090iD07p12891; ANDREAE MO, 1982, J GEOPHYS RES-OCEANS, V87, P8875, DOI 10.1029/JC087iC11p08875; ANDREAE MO, 1995, J GEOPHYS RES-ATMOS, V100, P11335, DOI 10.1029/94JD02828; AYERS GP, 1991, NATURE, V353, P834, DOI 10.1038/353834a0; Ayers GP, 1997, PHILOS T R SOC B, V352, P203, DOI 10.1098/rstb.1997.0015; BATES TS, 1992, J ATMOS CHEM, V14, P315, DOI 10.1007/BF00115242; Biersmith A, 1998, MAR CHEM, V63, P131, DOI 10.1016/S0304-4203(98)00057-7; Bigg EK, 2007, ENVIRON CHEM, V4, P155, DOI 10.1071/EN07001; Bigg EK, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009078; Bigg EK, 2004, MAR CHEM, V91, P131, DOI 10.1016/j.marchem.2004.06.005; Cainey J, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014439; Campuzano-Jost P, 2003, J ATMOS OCEAN TECH, V20, P1421, DOI 10.1175/1520-0426(2003)020<1421:NMOSAD>2.0.CO;2; Carslaw KS, 2010, ATMOS CHEM PHYS, V10, P1701, DOI 10.5194/acp-10-1701-2010; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Clarke AD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006565; Clarke AD, 1996, GEOPHYS RES LETT, V23, P733, DOI 10.1029/96GL00778; Clarke AD, 1998, J GEOPHYS RES-ATMOS, V103, P16397, DOI 10.1029/97JD02987; COVERT DS, 1992, J GEOPHYS RES-ATMOS, V97, P20581, DOI 10.1029/92JD02074; Davison B, 1996, J GEOPHYS RES-ATMOS, V101, P22855, DOI 10.1029/96JD01166; de Leeuw G, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000349; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DINGER JE, 1970, J ATMOS SCI, V27, P791, DOI 10.1175/1520-0469(1970)027<0791:OTSACO>2.0.CO;2; Ehn M., 2007, NUCLEATION ATMOSPHER, P1; Facchini MC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034210; Fuentes E, 2010, ATMOS CHEM PHYS, V10, P9295, DOI 10.5194/acp-10-9295-2010; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gunson JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024982; Hawkins LN, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/612132; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; HEGG DA, 1990, J GEOPHYS RES-ATMOS, V95, P13917, DOI 10.1029/JD095iD09p13917; HEGG DA, 1991, J GEOPHYS RES-ATMOS, V96, P13189, DOI 10.1029/91JD01309; HOBBS PV, 1971, Q J ROY METEOR SOC, V97, P263, DOI 10.1002/qj.49709741302; HOPPEL WA, 1994, J GEOPHYS RES-ATMOS, V99, P14443, DOI 10.1029/94JD00797; Hultin KAH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012522; Kazil J, 2006, ATMOS CHEM PHYS, V6, P4905, DOI 10.5194/acp-6-4905-2006; Keene WC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008464; Korhonen H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041320; Korhonen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009718; LATHAM J, 1990, NATURE, V347, P372, DOI 10.1038/347372a0; Leck C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023651; Leck C, 2008, TELLUS B, V60, P118, DOI 10.1111/j.1600-0889.2007.00315.x; McInnes L, 1997, TELLUS B, V49, P300, DOI 10.1034/j.1600-0889.49.issue3.6.x; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Murphy DM, 1998, NATURE, V392, P62, DOI 10.1038/32138; O'Dowd CD, 2004, NATURE, V431, P676, DOI 10.1038/nature02959; O'Dowd CD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL030331; ODOWD CD, 1993, J GEOPHYS RES-ATMOS, V98, P1123, DOI 10.1029/92JD02387; ODowd CD, 1997, J GEOPHYS RES-ATMOS, V102, P12839, DOI 10.1029/96JD02749; ODOWD CD, 1993, J GEOPHYS RES-ATMOS, V98, P1137, DOI 10.1029/92JD02302; PARUNGO FP, 1986, J ATMOS CHEM, V4, P199, DOI 10.1007/BF00052001; PERRY KD, 1994, J GEOPHYS RES-ATMOS, V99, P22803, DOI 10.1029/94JD01926; Peter JR, 2008, Q J ROY METEOR SOC, V134, P1059, DOI 10.1002/qj.198; Pierce JR, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006186; Pirjola L, 2000, J GEOPHYS RES-ATMOS, V105, P26531, DOI 10.1029/2000JD900310; POSFAI M, 1994, ATMOS ENVIRON, V28, P1747, DOI 10.1016/1352-2310(94)90137-6; RAES F, 1995, J GEOPHYS RES-ATMOS, V100, P2893, DOI 10.1029/94JD02832; Roelofs GJ, 2008, ATMOS CHEM PHYS, V8, P709, DOI 10.5194/acp-8-709-2008; Russell LM, 2010, P NATL ACAD SCI USA, V107, P6652, DOI 10.1073/pnas.0908905107; SAVOIE DL, 1982, GEOPHYS RES LETT, V9, P1207, DOI 10.1029/GL009i010p01207; SHAW GE, 1983, CLIMATIC CHANGE, V5, P297, DOI 10.1007/BF02423524; Small JD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038888; Spracklen DV, 2007, ATMOS CHEM PHYS, V7, P2073, DOI 10.5194/acp-7-2073-2007; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Toole DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019581; Twohy CH, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045002; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Tyree CA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007729; Vallina SM, 2007, P NATL ACAD SCI USA, V104, P16004, DOI 10.1073/pnas.0700843104; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; WARREN DR, 1985, J COLLOID INTERF SCI, V105, P136, DOI 10.1016/0021-9797(85)90356-X; WELLS ML, 1991, NATURE, V353, P342, DOI 10.1038/353342a0; Wood R, 2007, J ATMOS SCI, V64, P2657, DOI 10.1175/JAS3942.1; Woodhouse MT, 2010, ATMOS CHEM PHYS, V10, P7545, DOI 10.5194/acp-10-7545-2010; Woodhouse MT, 2008, ATMOS ENVIRON, V42, P5728, DOI 10.1016/j.atmosenv.2008.05.005; Yang XY, 2007, J CLIMATE, V20, P3395, DOI 10.1175/JCLI4195.1; Zuidema P, 2008, J ATMOS SCI, V65, P1979, DOI 10.1175/2007JAS2447.1	77	401	413	9	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					51	56		10.1038/nature10580	http://dx.doi.org/10.1038/nature10580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22129724	Green Published			2022-12-28	WOS:000298031900031
J	Fary, C; Rhys, GE; Taylor, A; Beard, D; Carr, A; Glyn-Jones, S				Fary, Camdon; Rhys, Geraint Emyr; Taylor, Adrian; Beard, David; Carr, Andrew; Glyn-Jones, Sion			PRACTICE POINTER Diagnosing and investigating adverse reactions in metal on metal hip implants	BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-UP; RESURFACING ARTHROPLASTY; INFLAMMATORY PSEUDOTUMOR; REPLACEMENT; FAILURE; WEAR; COMPONENT; BEARINGS		[Rhys, Geraint Emyr; Taylor, Adrian; Beard, David; Carr, Andrew; Glyn-Jones, Sion] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, NIHR Biomed Res Unit Musculoskeletal Dis, Oxford OX3 7LD, England; [Fary, Camdon] Royal Melbourne & Western Hosp, Melbourne, Vic, Australia	Nuffield Orthopaedic Centre; University of Oxford	Fary, C (corresponding author), Western Hosp, Footscray, Vic, Australia.	camfary@gmail.com		Fary, Camdon/0000-0002-9586-6602; Beard, David/0000-0001-7884-6389				Australian Orthopaedic Association National Joint Replacement Registry, 2010, ANN REP 2010; Back DL, 2005, CLIN ORTHOP RELAT R, P177, DOI 10.1097/01.blo.0000166901.85323.5d; Ball ST, 2007, J BONE JOINT SURG AM, V89A, P735, DOI 10.2106/JBJS.F.00708; Campbell P, 2004, J ARTHROPLASTY, V19, P1, DOI 10.1016/j.arth.2004.09.051; Campbell P, 2008, J ARTHROPLASTY, V23, P1080, DOI 10.1016/j.arth.2007.09.024; Carrothers AD, 2010, J BONE JOINT SURG BR, V92B, P1344, DOI 10.1302/0301-620X.92B10.23504; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Fang CSJ, 2008, SKELETAL RADIOL, V37, P715, DOI 10.1007/s00256-008-0492-x; Glyn-Jones S, 2009, J BONE JOINT SURG BR, V91B, P1566, DOI 10.1302/0301-620X.91B12.22287; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Graves SE, 2011, MED J AUSTRALIA, V194, P620, DOI 10.5694/j.1326-5377.2011.tb03141.x; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P315, DOI 10.1302/0301-620X.93B3.25545; Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Medicines and Healthcare Products Regulatory Agency, 2010, MED DEV AL ALL MET O; National Joint Registry for England and Wales, 2011, 8 NAT JOINT REG ENG; Sauve P, 2007, J BONE JOINT SURG BR, V89B, P586, DOI 10.1302/0301-620X.89B5.18457; Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030; Wynn-Jones H, 2011, ACTA ORTHOP, V82, P301, DOI 10.3109/17453674.2011.579518; 2011, BRIT MED J, V342, pD2905, DOI DOI 10.1136/BMJ.D2905	26	18	20	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2011	343								d7441	10.1136/bmj.d7441	http://dx.doi.org/10.1136/bmj.d7441			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	874EL	22127518				2022-12-28	WOS:000298938100008
J	Ackermann, M; Ajello, M; Allafort, A; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Belfiore, A; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bottacini, E; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; de Angelis, A; de Palma, F; Dermer, CD; Silva, EDE; Drell, PS; Dumora, D; Favuzzi, C; Fegan, SJ; Focke, WB; Fortin, P; Fukazawa, Y; Fusco, P; Gargano, F; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Guillemot, L; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashida, M; Hayashi, K; Hays, E; Johannesson, G; Johnson, AS; Kamae, T; Katagiri, H; Kataoka, J; Kerr, M; Knodlseder, J; Kuss, M; Lande, J; Latronico, L; Lee, SH; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Martin, P; Mazziotta, MN; McEnery, JE; Mehault, J; Michelson, PF; Mitthumsiri, W; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Naumann-Godo, M; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Okumura, A; Orlando, E; Ormes, JF; Ozaki, M; Paneque, D; Parent, D; Pesce-Rollins, M; Pierbattista, M; Piron, F; Pohl, M; Prokhorov, D; Raino, S; Rando, R; Razzano, M; Reposeur, T; Ritz, S; Parkinson, PMS; Sgro, C; Siskind, EJ; Smith, PD; Spinelli, P; Strong, AW; Takahashi, H; Tanaka, T; Thayer, JG; Thayer, JB; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Troja, E; Uchiyama, Y; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Waite, AP; Wang, P; Winer, BL; Wood, KS; Yang, Z; Zimmer, S; Bontemps, S				Ackermann, M.; Ajello, M.; Allafort, A.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Belfiore, A.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bottacini, E.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; de Angelis, A.; de Palma, F.; Dermer, C. D.; do Couto e Silva, E.; Drell, P. S.; Dumora, D.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Fortin, P.; Fukazawa, Y.; Fusco, P.; Gargano, F.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Guillemot, L.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hayashi, K.; Hays, E.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kerr, M.; Knoedlseder, J.; Kuss, M.; Lande, J.; Latronico, L.; Lee, S. -H.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Martin, P.; Mazziotta, M. N.; McEnery, J. E.; Mehault, J.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Naumann-Godo, M.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Okumura, A.; Orlando, E.; Ormes, J. F.; Ozaki, M.; Paneque, D.; Parent, D.; Pesce-Rollins, M.; Pierbattista, M.; Piron, F.; Pohl, M.; Prokhorov, D.; Raino, S.; Rando, R.; Razzano, M.; Reposeur, T.; Ritz, S.; Parkinson, P. M. Saz; Sgro, C.; Siskind, E. J.; Smith, P. D.; Spinelli, P.; Strong, A. W.; Takahashi, H.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Troja, E.; Uchiyama, Y.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Waite, A. P.; Wang, P.; Winer, B. L.; Wood, K. S.; Yang, Z.; Zimmer, S.; Bontemps, S.			A Cocoon of Freshly Accelerated Cosmic Rays Detected by Fermi in the Cygnus Superbubble	SCIENCE			English	Article							SUPERNOVA REMNANT G78.2+2.1; PARTICLE-ACCELERATION; OB ASSOCIATIONS; STAR-FORMATION; GAMMA-RAYS; ORIGIN; GALAXY; EMISSION; REGION; DISCOVERY	The origin of Galactic cosmic rays is a century-long puzzle. Indirect evidence points to their acceleration by supernova shockwaves, but we know little of their escape from the shock and their evolution through the turbulent medium surrounding massive stars. Gamma rays can probe their spreading through the ambient gas and radiation fields. The Fermi Large Area Telescope (LAT) has observed the star-forming region of Cygnus X. The 1- to 100-gigaelectronvolt images reveal a 50-parsec-wide cocoon of freshly accelerated cosmic rays that flood the cavities carved by the stellar winds and ionization fronts from young stellar clusters. It provides an example to study the youth of cosmic rays in a superbubble environment before they merge into the older Galactic population.	[Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Naumann-Godo, M.; Pierbattista, M.; Tibaldo, L.] Univ Paris Diderot, CEA Saclay, CNRS, CEA IRFU,Lab AIM,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Ackermann, M.; Ajello, M.; Allafort, A.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Chiang, J.; Claus, R.; do Couto e Silva, E.; Drell, P. S.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Kerr, M.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Okumura, A.; Orlando, E.; Paneque, D.; Prokhorov, D.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wang, P.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Allafort, A.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Chiang, J.; Claus, R.; do Couto e Silva, E.; Drell, P. S.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Kerr, M.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Okumura, A.; Orlando, E.; Paneque, D.; Prokhorov, D.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Baldini, L.; Bellazzini, R.; Kuss, M.; Latronico, L.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Belfiore, A.; Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] IEEE CSIC, Inst Ciencies Espai, Barcelona 08193, Spain; [Chekhtman, A.] Artep Inc, Ellicott City, MD 21042 USA; [Cheung, C. C.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Ciprini, S.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Cohen-Tanugi, J.; Mehault, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Univers & Particules Montpellier, Montpellier, France; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [Dermer, C. D.; Lovellette, M. N.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Dumora, D.; Lott, B.; Reposeur, T.] Univ Bordeaux 1, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Fukazawa, Y.; Hanabata, Y.; Hayashi, K.; Mizuno, T.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Giroletti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Guillemot, L.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Guiriec, S.] Univ Alabama, CSPAR, Huntsville, AL 35899 USA; [Harding, A. K.; Hays, E.; McEnery, J. E.; Thompson, D. J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Johannesson, G.; Troja, E.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Katagiri, H.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Kataoka, J.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Knoedlseder, J.] CNRS, Res Inst Astrophys & Planetol IRAP, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, Toulouse, France; [Lee, S. -H.] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Martin, P.; Orlando, E.; Strong, A. W.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [McEnery, J. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McEnery, J. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Morselli, A.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Vitale, V.] Boise State Univ, Dept Phys, Boise, ID 83725 USA; [Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Okumura, A.; Ozaki, M.] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Parent, D.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Pohl, M.] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Pohl, M.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Ritz, S.; Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Torres, D. F.] ICREA, Barcelona, Spain; [Tramacere, A.; Vianello, G.] CIFS, I-10133 Turin, Italy; [Tramacere, A.] INTEGRAL Sci Data Ctr, CH-1290 Versoix, Switzerland; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Yang, Z.; Zimmer, S.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Yang, Z.; Zimmer, S.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Bontemps, S.] Univ Bordeaux, CNRS, INSU, Lab Astrophys Bordeaux, Floirac, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Artep Inc; National Academies of Sciences, Engineering & Medicine; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Defense; United States Navy; Naval Research Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Hiroshima University; Istituto Nazionale Astrofisica (INAF); Max Planck Society; University of Alabama System; University of Alabama Huntsville; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Iceland; Ibaraki University; Waseda University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Kyoto University; Max Planck Society; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Istituto Nazionale di Fisica Nucleare (INFN); Idaho; Boise State University; Hiroshima University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Denver; Max Planck Society; George Mason University; University of Potsdam; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University System of Ohio; Ohio State University; ICREA; University of Geneva; University of Rome Tor Vergata; Stockholm University; Oskar Klein Centre; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Grenier, IA (corresponding author), Univ Paris Diderot, CEA Saclay, CNRS, CEA IRFU,Lab AIM,Serv Astrophys, F-91191 Gif Sur Yvette, France.	isabelle.grenier@cea.fr; luigi.tibaldo@pd.infn.it	Mazziotta, Mario N/O-8867-2015; tramacere, andrea/B-9424-2012; Takahashi, Hiromitsu H/T-2713-2017; Jóhannesson, Guðlaugur/O-8741-2015; Torres, Diego F/ABD-7940-2020; Caraveo, Patrizia/AAL-5708-2020; Troja, Eleonora/I-5282-2017; Torres, Diego F./AAF-7931-2019; cohen-tanugi, Johann/ABB-1481-2021; Moskalenko, Igor V/A-1301-2007; Bontemps, Sylvain/AAH-3510-2021; Parkinson, Pablo Miguel Saz/I-7980-2013; Sgrò, Carmelo/K-3395-2016; Thompson, David J/D-2939-2012; Ozaki, Masanobu/K-1165-2013; lubrano, pasquale/F-7269-2012; Tosti, Gino/E-9976-2013; Baldini, Luca/E-5396-2012; Gargano, Fabio/O-8934-2015; Fukazawa, Yasushi/G-2081-2017; Bastieri, Denis/AAC-5917-2020; Okumura, Akira/I-2468-2014; Rando, Riccardo/O-1302-2019; giglietto, nicola/I-8951-2012; Loparco, Francesco/O-8847-2015; McEnery, Julie E/D-6612-2012; Jóhannesson, Guðlaugur/ABC-7216-2020; Harding, Alice K/D-3160-2012; Kuss, Michael W/H-8959-2012; Gargano, Fabio/AAD-5121-2021; Torres, Diego F./O-9422-2016; Troja, Eleonora/AAB-3604-2020; Hays, Elizabeth/D-3257-2012; Morselli, Aldo/G-6769-2011; Rando, Riccardo/M-7179-2013; Hadasch, Daniela/N-7819-2016; Pohl, Martin/P-4920-2017; Giglietto, Nicola/Y-2425-2019; Orlando, Elena/R-5594-2016	Mazziotta, Mario N/0000-0001-9325-4672; tramacere, andrea/0000-0002-8186-3793; Takahashi, Hiromitsu H/0000-0001-6314-5897; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Caraveo, Patrizia/0000-0003-2478-8018; Troja, Eleonora/0000-0002-1869-7817; Torres, Diego F./0000-0002-1522-9065; cohen-tanugi, Johann/0000-0001-9022-4232; Moskalenko, Igor V/0000-0001-6141-458X; Thompson, David J/0000-0001-5217-9135; lubrano, pasquale/0000-0003-0221-4806; Gargano, Fabio/0000-0002-5055-6395; Fukazawa, Yasushi/0000-0002-0921-8837; Bastieri, Denis/0000-0002-6954-8862; Okumura, Akira/0000-0002-3055-7964; Rando, Riccardo/0000-0001-6992-818X; giglietto, nicola/0000-0002-9021-2888; Loparco, Francesco/0000-0002-1173-5673; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Gargano, Fabio/0000-0002-5055-6395; Torres, Diego F./0000-0002-1522-9065; Troja, Eleonora/0000-0002-1869-7817; Morselli, Aldo/0000-0002-7704-9553; Hadasch, Daniela/0000-0001-8663-6461; Pohl, Martin/0000-0001-7861-1707; Giglietto, Nicola/0000-0002-9021-2888; Orlando, Elena/0000-0001-6406-9910; Kerr, Matthew/0000-0002-0893-4073; Ackermann, Markus/0000-0001-8952-588X; Monzani, Maria Elena/0000-0002-8254-5308; belfiore, andrea/0000-0002-2526-1309; Tibaldo, Luigi/0000-0001-7523-570X; de Palma, Francesco/0000-0001-5898-2834; SPINELLI, Paolo/0000-0001-6688-8864; Grenier, Isabelle/0000-0003-3274-674X; Casandjian, Jean-Marc/0000-0003-1404-0524; Pesce-Rollins, Melissa/0000-0003-1790-8018; Cheung, Chi (Teddy)/0000-0002-4377-0174; De Angelis, Alessandro/0000-0002-3288-2517; Sgro', Carmelo/0000-0001-5676-6214; Berenji, Bijan/0000-0002-4551-772X; Cameron, Robert/0000-0003-0942-2747; Cecchi, Claudia/0000-0002-2192-8233; Ciprini, Stefano/0000-0002-0712-2479; Katagiri, Hideaki/0000-0003-2347-8819; Ajello, Marco/0000-0002-6584-1703; Murgia, Simona/0000-0003-0516-9422; Vianello, Giacomo/0000-0002-2553-0839; Zimmer, Stephan/0000-0002-5735-0082; Buehler, Rolf/0000-0003-4425-6641; Raino', Silvia/0000-0002-9181-0345; Giordano, Francesco/0000-0002-8651-2394; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Tosti, Gino/0000-0002-0839-4126; Giroletti, Marcello/0000-0002-8657-8852; Baldini, Luca/0000-0002-9785-7726; Fusco, Piergiorgio/0000-0002-9383-2425; Buson, Sara/0000-0002-3308-324X; Tanaka, Takaaki/0000-0002-4383-0368; Lee, Shiu-Hang/0000-0002-2899-4241	International Doctorate on Astroparticle Physics (IDAPP) program; ICREA Funding Source: Custom	International Doctorate on Astroparticle Physics (IDAPP) program; ICREA(ICREA)	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and the Department of Energy in the United States; Commissariat a l'Energie Atomique et aux Energies Alternatives, Institut de Recherche sur les Lois Fondamentales de l'Univers (CEA/IRFU) and Institut National de Physique Nucleaire et de Physique des Particules, Centre National de la Recherche Scientifique (IN2P3/CNRS) in France; Agenzia Spaziale Italiana (ASI) and Istituto Nazionale di Fisica Nucleare (INFN) in Italy; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (JAXA) in Japan; and the K. A. Wallenberg Foundation, Swedish Research Council, and National Space Board in Sweden. Additional support from Istituto Nazionale di Astrofisica (INAF) in Italy and Centre National d'Etudes Spaciales (CNES) in France for science analysis during the operations phase is also gratefully acknowledged. L. T. is partially supported by the International Doctorate on Astroparticle Physics (IDAPP) program. E. T is a NASA Postdoctoral Program Fellow.	Abdo AA, 2007, ASTROPHYS J, V664, pL91, DOI 10.1086/520717; Abramowski A, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015290; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Binns WR, 2008, NEW ASTRON REV, V52, P427, DOI 10.1016/j.newar.2008.05.008; Binns WR, 2005, ASTROPHYS J, V634, P351, DOI 10.1086/496959; BLAAUW A, 1964, ANNU REV ASTRON ASTR, V2, P213, DOI 10.1146/annurev.aa.02.090164.001241; Bykov AM, 2001, ASTRON LETT+, V27, P625, DOI 10.1134/1.1404456; CESARSKY CJ, 1983, SPACE SCI REV, V36, P173, DOI 10.1007/BF00167503; Fermi LAT Collaboration, 2011, ASTRON ASTROPHYS; Ferrand G, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913520; Grenier I. A., 2008, 30 INT COSM RAY C, V6, P133; Hanson MM, 2003, ASTROPHYS J, V597, P957, DOI 10.1086/378508; Higdon JC, 2003, ASTROPHYS J, V590, P822, DOI 10.1086/375192; Kolaczkowski Z, 2004, ACTA ASTRONOM, V54, P33; Ladouceur Y, 2008, ASTRON ASTROPHYS, V490, P197, DOI 10.1051/0004-6361:200810599; Le Duigou JM, 2002, ASTRON ASTROPHYS, V392, P869, DOI 10.1051/0004-6361:20020984; Lozinskaya TA, 2000, ASTRON LETT+, V26, P77, DOI 10.1134/1.20371; MONTMERLE T, 1979, ASTROPHYS J, V231, P95, DOI 10.1086/157166; Ohm S., 2010, 25 TEX S REL ASTR; Parizot E, 2004, ASTRON ASTROPHYS, V424, P747, DOI 10.1051/0004-6361:20041269; Roy A, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/114; SIMBAD Astronomical Database CDS Strasbourg, SIMBAD ASTR DAT; Sodroski TJ, 1997, ASTROPHYS J, V480, P173, DOI 10.1086/303961; VOLK HJ, 1983, SPACE SCI REV, V36, P3, DOI 10.1007/BF00171897; Wiedenbeck ME, 1999, ASTROPHYS J, V523, pL61, DOI 10.1086/312242; Wright NJ, 2010, ASTROPHYS J, V713, P871, DOI 10.1088/0004-637X/713/2/871	28	180	184	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1103	1107		10.1126/science.1210311	http://dx.doi.org/10.1126/science.1210311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22116880				2022-12-28	WOS:000297313900042
J	Kondo, M; Sawa, A				Kondo, Mari; Sawa, Akira			Anti-/Propsychotic Drug Signaling via Heteromeric GPCRs-A Balancing Act?	CELL			English	Editorial Material							SCHIZOPHRENIA	In this issue, Fribourg et al. provide insight into a molecular basis of psychosis. They reveal that a heteromeric complex formed by the G protein-coupled receptors (GPCRs) for glutamate and serotonin is a convergent site for the activity of anti-or propsychotic drugs, opening a possibility for new therapeutic strategies for schizophrenia.	[Kondo, Mari; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA	Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA.	asawa1@jhmi.edu	Kondo, Mari/N-2461-2015	Kondo, Mari/0000-0001-7960-2888				Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; MCDANNALD MA, 2011, BIOL PSYCHIAT, DOI DOI 10.1016/J.BIO-PSYCH.2011.06.014; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532	9	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 23	2011	147	5					964	965		10.1016/j.cell.2011.11.012	http://dx.doi.org/10.1016/j.cell.2011.11.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22118451	Bronze			2022-12-28	WOS:000297376600006
J	Seigneurin, A; Francois, O; Labarere, J; Oudeville, P; Monlong, J; Colonna, M				Seigneurin, Arnaud; Francois, Olivier; Labarere, Jose; Oudeville, Pierre; Monlong, Jean; Colonna, Marc			Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERVICES TASK-FORCE; CARCINOMA IN-SITU; BREAST-CANCER; SPONTANEOUS REGRESSION; NATURAL-HISTORY; LEAD TIME; OVERTREATMENT; MORTALITY; SENSITIVITY; SENESCENCE	Objective To quantify the magnitude of overdiagnosis from non-progressive disease detected by screening mammography, after adjustment for the potential for lead time bias, secular trend in the underlying risk of breast cancer, and opportunistic screening. Design Approximate bayesian computation analysis with a stochastic simulation model designed to replicate standardised incidence rates of breast cancer. The model components included the lifetime probability of breast cancer, the natural course of breast cancer, and participation in organised and opportunistic mammography screening. Setting Isere, a French administrative region with nearly 1.2 million inhabitants. Participants All women living in Isere and aged 50-69 during 1991-2006. Main outcome measures Overdiagnosis, defined as the proportion of non-progressive cancers among all cases of invasive cancer and carcinoma in situ detected 1991-2006. Results In 1991-2006, overdiagnosis from non-progressive disease accounted for 1.5% of all cases of invasive cancer (95% credibility interval 0.3% to 2.9%) and 28.0% of all cases of carcinoma in situ (2.2% to 59.8%) detected either clinically or by screening mammography in Isore. When analysis was restricted to the cancers detected by screening mammography only, the estimates of overdiagnosis were 3.3% (0.7% to 6.5%) and 31.9% (2.9% to 62.3%) for invasive cancer and carcinomas in situ, respectively. Conclusion Overdiagnosis from the detection of non-progressive disease by screening mammography was limited in 1991-2006 in Isore. Because carcinoma in situ accounted for less than 15% of all incident breast cancer cases, its contribution to overdiagnosis was relatively limited and imprecise.	[Seigneurin, Arnaud; Colonna, Marc] CHU Grenoble, Registre Canc Isere, F-38043 Grenoble 9, France; [Seigneurin, Arnaud; Francois, Olivier; Labarere, Jose; Oudeville, Pierre; Monlong, Jean] Univ Grenoble 1, CNRS, TIMC IMAG, UMR 5525, F-38041 Grenoble, France; [Labarere, Jose] CHU Grenoble, Unit Evaluat Med, F-38043 Grenoble 9, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Seigneurin, A (corresponding author), CHU Grenoble, Registre Canc Isere, BP 217,Pavillon E, F-38043 Grenoble 9, France.	aseigneurin@chu-grenoble.fr	Monlong, Jean/AAZ-8589-2020; Francois, Olivier/A-6051-2012; Francois, Olivier/AAQ-3137-2020; Labarère, José/N-1688-2014; Seigneurin, Arnaud/M-6099-2014	Monlong, Jean/0000-0002-9737-5516; Francois, Olivier/0000-0003-2402-2442; Francois, Olivier/0000-0003-2402-2442; Labarère, José/0000-0001-7621-6586; 	Institut National du Cancer, Paris, France; Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France	Institut National du Cancer, Paris, France(Institut National du Cancer (INCA) France); Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France	This study was funded by grants from the Institut National du Cancer, Paris, France, and the Comite de l'Isere de la Ligue Nationale Contre le Cancer, Grenoble, France. The study sponsor had no role in the study design, collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	Beaumont MA, 2002, GENETICS, V162, P2025; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bland JM, 1998, BRIT MED J, V317, P1151; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Cancer incidence and mortality worldwide, 2011, CANC INC MORT WORLDW; Chen HH, 1996, J ROY STAT SOC D-STA, V45, P307; Csillery K, 2011, METHODS ECO IN PRESS; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Dussan C, 2008, GYNECOL OBSTET INVES, V65, P206, DOI 10.1159/000112228; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Fagnani F, 1989, J EC MED, V7, P319; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Institut de Veille Sanitaire, 2011, INC OBS DEP COUV REG; Jatoi I, 1999, AM J SURG, V177, P518, DOI 10.1016/S0002-9610(99)00096-3; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2005, BREAST CANCER RES, V7, P266, DOI 10.1186/bcr1339; PACI E, 1991, INT J EPIDEMIOL, V20, P852, DOI 10.1093/ije/20.4.852; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; ROSS MB, 1982, J SURG ONCOL, V19, P22, DOI 10.1002/jso.2930190107; Seigneurin A, 2009, BREAST, V18, P284, DOI 10.1016/j.breast.2009.07.007; Seigneurin A, 2011, BREAST CANCER RES TR, V127, P221, DOI 10.1007/s10549-010-1118-2; Serrano M, 2007, NEW ENGL J MED, V356, P1996, DOI 10.1056/NEJMcibr071461; Silcocks PBS, 2007, J PUBLIC HEALTH-UK, V29, P455, DOI 10.1093/pubmed/fdm053; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Wait S, 1997, B CANCER, V84, P619; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yen MF, 2003, EUR J CANCER, V39, P1746, DOI 10.1016/S0959-8049(03)00260-0; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	47	38	40	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2011	343								d7017	10.1136/bmj.d7017	http://dx.doi.org/10.1136/bmj.d7017			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	875FH	22113564	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000299015300005
